<SEC-DOCUMENT>0000950170-23-000348.txt : 20230106
<SEC-HEADER>0000950170-23-000348.hdr.sgml : 20230106
<ACCEPTANCE-DATETIME>20230106165442
ACCESSION NUMBER:		0000950170-23-000348
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20230106
DATE AS OF CHANGE:		20230106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269111
		FILM NUMBER:		23515675

	BUSINESS ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>gern010623.htm
<DESCRIPTION>424B5
<TEXT>
<html>
 <head>
  <title>424B5</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filed Pursuant to Rule 424(b)(5)<br>Registration No. 333-269111</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECTUS SUPPLEMENT<br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(To Prospectus Dated January 4, 2023)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><img src="img175210594_0.jpg" alt="img175210594_0.jpg" style="width:183px;height:67px;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,876,297 Shares of Common Stock</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Funded Warrants to Purchase 25,000,000</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">__________________________________</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are offering 55,876,297 shares of our common stock, or for certain investors that so choose, in lieu of shares of common stock, pre-funded warrants to purchase 25,000,000 shares of our common stock, or the &#x201c;pre-funded warrants,&#x201d; (and the shares of common stock issuable from time to time upon exercise of each of the pre-funded warrants) pursuant to this prospectus supplement and the accompanying prospectus. The pre-funded warrants will be exercisable immediately and are exercisable for one share of our common stock. The purchase price of each pre-funded warrant is equal to the public offering price at which a share of common stock is sold to the public in this offering, minus $0.001, and the exercise price of each pre-funded warrant is $0.001 per share of common stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d; On January 5, 2023, the last reported sale price of our common stock on The Nasdaq Global Select Market was $2.48 per share. There is no established public trading market for the pre-funded warrants, and we do not expect a market to develop. In addition, we do not intend to apply for listing of the pre-funded warrants on any securities exchange or recognized trading system.</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing in our securities involves a high degree of risk. See &#x201c;Risk Factors&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus supplement.</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:43.611%;"></td>
    <td style="width:1.293%;"></td>
    <td style="width:1.229%;"></td>
    <td style="width:15.705%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:1.303%;"></td>
    <td style="width:1.239%;"></td>
    <td style="width:15.705%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:1.303%;"></td>
    <td style="width:1.239%;"></td>
    <td style="width:14.359%;"></td>
    <td style="width:1.004%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Pre-Funded</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public offering price</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.450</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.449</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">198,121,928</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Underwriting discounts and commissions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.147</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.147</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,888,816</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds, before expenses, to us</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.303</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.302</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,233,112</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have agreed to reimburse the underwriters for certain expenses. See &#x201c;Underwriting&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus supplement for a description of the compensation payable to the underwriters.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have granted the underwriters an option to purchase 12,131,444 additional shares of common stock from us at the public offering price, less underwriting discounts and commissions, within 30 days from the date of this prospectus supplement.</font></p>
  <p style="text-indent:2.8%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The underwriters expect to deliver the securities to investors on or about January 10, 2023.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Book-Running Managers</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:68.002%;"></td>
    <td style="width:31.998%;"></td>
   </tr>
   <tr style="height:18.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:18.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Goldman Sachs &amp; Co. LLC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:18.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stifel</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Co-Lead Managers</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.344%;"></td>
    <td style="width:33.323%;"></td>
   </tr>
   <tr style="height:13.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Wedbush PacGrow</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">           </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Baird</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Co-Managers</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.344%;"></td>
    <td style="width:33.323%;"></td>
   </tr>
   <tr style="height:13.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B. Riley Securities</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Needham &amp; Company</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="table_of_contents"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus supplement dated January 5, 2023.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECTUS SUPPLEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:83.002%;"></td>
    <td style="width:16.998%;"></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#about_this_prospectus_supplement"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">About This Prospectus Supplement</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#prospectus_supplement_summary"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Supplement Summary</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12.25pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#risk_factors"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#special_note_regarding_forward_looking"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#use_of_proceeds"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#dilution"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dilution</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#description_of_securities_we_are_offerin"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Securities We Are Offering</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#material_us_federal_income_tax"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material U.S. Federal Income Tax Consequences</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#underwriting"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Underwriting</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#legal_matters"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Matters</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#experts"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Experts</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</font></p></td>
   </tr>
   <tr style="height:13.7pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#where_you_can_find_more"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where You Can Find More Information</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#incorporation_by_reference"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incorporation of Certain Information by Reference</font></a></p></td>
    <td style="background-color:rgba(204,237,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECTUS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:81.271%;"></td>
    <td style="width:1.485%;"></td>
    <td style="width:17.244%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_about_this_prospectus"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">About This Prospectus</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#prospectus_summary"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Summary</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_risk_factors"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_special_note_regarding_fls"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_use_of_proceeds"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_capital_stock"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Capital Stock</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_debt_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Debt Securities</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_warrants"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Warrants</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_legal_ownership_of_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Ownership of Securities</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_selling_stockholders"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholders</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_plan_of_distribution"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan of Distribution</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_legal_matters"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Matters</font></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_experts"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Experts</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_where_you_can_find_more_information"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where You Can Find More Information</font></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_incorporation_of_info_by_reference"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incorporation of Certain Information by Reference</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="about_this_prospectus_supplement"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ABOUT THIS PROSPECTUS SUPPLEMENT</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of the securities we are offering and also adds to, and updates, information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus dated January 4, 2023, including the documents incorporated by reference therein, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. To the extent there is a conflict between the information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or in any document incorporated by reference that was filed with the Securities and Exchange Commission, or the SEC, before the date of this prospectus supplement, on the other hand, you should rely on the information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having a later date&#x2014;for example, a document incorporated by reference in the accompanying prospectus&#x2014;the statement in the document having the later date modifies or supersedes the earlier statement.</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither we nor the underwriters have authorized anyone to provide you with information different from that contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus and in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any information that others may give you. We and the underwriters are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and in any free writing prospectus prepared by or on behalf of us or to which we have referred you, is accurate only as of the dates of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and any free writing prospectus prepared by or on behalf of us or to which we have referred you, in their entirety before making an investment decision regarding the securities we are offering. You should also read and consider the information in the documents to which we have referred you in the sections of this prospectus supplement entitled &#x201c;Where You Can Find More Information&#x201d; and &#x201c;Incorporation of Certain Information by Reference.&#x201d;</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless the context indicates otherwise, as used in this prospectus supplement and the accompanying prospectus, the terms &#x201c;Geron,&#x201d; &#x201c;Geron Corporation,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to Geron Corporation, a Delaware corporation, and its subsidiary on a consolidated basis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus supplement, the accompanying prospectus and the information incorporated herein and therein by reference include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus supplement or the accompanying prospectus are the property of their respective owners.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="prospectus_supplement_summary"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECTUS SUPPLEMENT SUMMARY</font></p><p style="text-indent:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">This summary highlights certain information about us, this offering and selected information contained elsewhere in or incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in our securities. For a more complete understanding of our company and this offering, we encourage you to read and consider carefully the more detailed information included or incorporated by reference in this prospectus supplement and the accompanying prospectus, including the factors described under the heading &#x201c;Risk Factors&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> of this prospectus supplement.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Overview</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Our investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes, or lower risk MDS. In January 2023, we reported positive top-line results from our IMerge Phase 3 clinical trial. The trial met its primary endpoint of 8-week transfusion independence rate and a key secondary endpoint of 24-week transfusion independence rate, demonstrating highly statistically significant (i.e., P&lt;0.001 for both) and clinically meaningful benefits in imetelstat versus placebo. Furthermore, statistically significant and clinically meaningful efficacy results were observed in the trial across key subtypes, including patients who were ringed sideroblast positive, or RS positive, and ringed sideroblast negative, or RS negative; patients with high and very high baseline transfusion burden; and patients classified as Low or Intermediate-1 risk according to the International Prognostic Scoring System, or IPSS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on the positive top-line data from IMerge Phase 3 and the prior IMerge Phase 2, we plan to submit a New Drug Application, or NDA, to the U.S. Food and Drug Administration, or FDA, in the U.S. in mid-2023 and a marketing authorization application, or MAA, in Europe in the second half of 2023 for the use of imetelstat in adult patients with lower risk MDS. If the NDA is accepted for filing and imetelstat is approved for commercialization by the FDA within the timelines we expect, we anticipate commercial launch of imetelstat in lower risk MDS in the U.S. could occur in the first half of 2024. In Europe, we anticipate review of the planned MAA, if validated by the European Medicines Agency, or EMA, could take approximately 14 months and, if approved, we anticipate that the commercial launch of imetelstat in lower risk MDS in Europe could occur by the end of 2024.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that the positive top-line data from IMerge Phase 3 and IMerge Phase 2, as well as our prior Phase 2 clinical trial of imetelstat in patients with Intermediate-2 or High-Risk myelofibrosis who have relapsed after or are refractory to treatment with a janus associate kinase inhibitor, or JAK inhibitor, or relapsed/refractory MF, provide strong evidence that imetelstat targets telomerase to inhibit the uncontrolled proliferation of malignant stem and progenitor cells enabling recovery of bone marrow and normal blood cell production, which suggest potential disease-modifying activity. We believe this potential for disease modification could differentiate imetelstat from currently approved treatments in myeloid hematologic malignancies. Accordingly, in addition to lower risk MDS, we are developing imetelstat for the treatment of several myeloid hematologic malignancies with the following ongoing clinical trials:</font></p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF, a Phase 3 clinical trial in relapsed/refractory MF with overall survival, or OS, as the primary endpoint, that currently is enrolling patients. Based on our planning assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS in IMpactMF may occur in 2024, and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMproveMF, a Phase 1 combination clinical trial in frontline Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that currently is enrolling patients and the first patient was dosed in April 2021; and </font></div></div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpress, an investigator-led Phase 2 clinical trial in Intermediate-2 or High-Risk myelodysplastic syndromes, or higher risk MDS, and acute myeloid leukemia, or AML, with the initial clinical site planned to open in the first quarter of 2023.</font></div></div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat Regulatory Designations</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat has been granted Fast Track designations by the FDA for development in two indications:  (1) for the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, who do not have a deletion 5q chromosomal abnormality, also known as non-del(5q), and who are refractory or resistant to treatment with an erythropoiesis stimulating agent, or ESA (i.e., the treatment population in IMerge Phase 3); and (2) for the treatment of adult patients with Intermediate-2 or High-Risk MF whose disease has relapsed after or is refractory to  JAK inhibitor treatment (i.e., the treatment population in IMpactMF). The FDA granted orphan drug designation to imetelstat in June 2015 for the treatment of MF and for the treatment of MDS in December 2015, and the EMA granted orphan drug designation in December 2015 to imetelstat for the treatment of MF and in July 2020 for the treatment of MDS. In October 2021, we gained access to the Innovative Licensing and Access Pathway, or ILAP, in the United Kingdom, or U.K., through the receipt of an Innovation Passport for imetelstat to treat lower risk MDS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stage-Gated Milestone-Driven Global Commercial Plans for Imetelstat</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If imetelstat is approved in lower risk MDS for marketing by regulatory authorities, we plan to commercialize imetelstat ourselves in the U.S. and may seek commercialization partners for territories outside of the U.S. We have therefore developed a commercial pre-launch and potential launch plan that is driven by the achievement of certain regulatory milestones, such as FDA acceptance for filing of our planned NDA, as well as EMA validation of our planned EU MAA submission. We are conducting pre-commercial preparations for the U.S., such as: enhancing and/or establishing company processes and systems to support a potential commercial launch, refining our market research in lower risk MDS, engaging in marketing and commercial access/reimbursement preparatory efforts, as well as executing on long-lead time activities, such as selecting a third-party logistics provider, completing state licensing requirements and hiring personnel to support potential sales, marketing and commercial operations. In light of the positive top-line IMerge Phase 3 results, we continue to evaluate our strategy for the potential launch and commercialization of imetelstat in Europe. Based on our internal estimates of pricing and addressable patient populations in 2030 and if regulatory authorities approve imetelstat for marketing in lower risk MDS and relapsed/refractory MF, we believe the combined potential peak market opportunity in the U.S. and key European markets for imetelstat is approximately $3.0 billion, of which lower risk MDS represents approximately $1.2 billion and relapsed/refractory MF represents approximately $1.8 billion.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMerge: Ongoing Phase 2/3 Clinical Trial in Lower Risk MDS</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Trial Design</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMerge is a two-part Phase 2/3 clinical trial evaluating imetelstat (7.5 mg/kg dose administered as a two-hour intravenous infusion every four weeks) in transfusion dependent lower risk MDS patients who are relapsed after or refractory to prior treatment with an ESA. To be eligible for IMerge, patients are required to be transfusion dependent, defined as requiring at least four units of packed red blood cells, or RBCs, over an eight-week period during the 16 weeks prior to entry into the trial.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMerge Phase 3 is a double-blind, 2:1 randomized, placebo-controlled clinical trial that, based on discussions with U.S. and European regulatory authorities, was designed to support, if successful, the registration of imetelstat in lower risk MDS. The trial enrolled patients with lower risk transfusion dependent MDS who were relapsed, or refractory to, or ineligible for ESA, had not received prior treatment with either a hypomethylating agent, or HMA, or lenalidomide and were non-del(5q). IMerge Phase 3 is being conducted at 118 medical centers globally in 17 countries in North America, Europe, Middle East and Asia.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary efficacy endpoint of IMerge Phase 3 is the rate of red blood cell transfusion independence, or RBC-TI, lasting at least eight weeks, defined as the proportion of patients without any RBC transfusions during any consecutive eight weeks since entry to the trial, or 8-week TI. Key secondary endpoints for IMerge Phase 3 include the rate of RBC-TI lasting at least 24 weeks, or 24-week TI, and the rate of hematologic improvement erythroid, or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HI-E, which is a rise in hemoglobin of at least 1.5 g/dL above the pretreatment level for at least eight weeks or a reduction of at least four units of RBC transfusions over eight weeks compared with the prior RBC transfusion burden. Other secondary endpoints include the time to and duration of RBC-TI; the proportion of patients achieving Complete Response, or CR, or Partial Response, or PR, according to the 2006 International Working Group, or IWG, criteria for MDS; the proportion of patients requiring RBC transfusions and the transfusion burden; the proportion of patients requiring the use of myeloid growth factors and the dose; assessments of the change in the patients&#x2019; quality of life using several validated instruments; as well as an assessment of OS, and time to progression to AML.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Positive Top-Line Results from IMerge Phase 3</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, we reported positive top-line results from IMerge Phase 3. A total of 178 patients were enrolled in IMerge Phase 3, with patients randomized on a 2:1 basis to imetelstat (n=118) or placebo (n=60), and represents the intent-to-treat population in the trial. The population for the analysis of safety data is based on 177 patients (imetelstat, n=118, placebo, n=59) because one patient in the placebo arm was enrolled, but did not receive any treatment. The trial met its primary endpoint of 8-week TI rate and key secondary endpoint of 24-week TI rate, among others, demonstrating statistically significant and clinically meaningful results with imetelstat versus placebo with no new safety signals and safety results consistent with prior imetelstat clinical trials. Key patient participation information is as follows:</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:66.225%;"></td>
     <td style="width:16.898%;"></td>
     <td style="width:16.877%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median time on study, months (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.5 (1.4-36.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.5 (0.7-34.3)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median time on treatment, months (range)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8 (0.03-32.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5 (0.03-26.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median time on treatment for 8-week TI responders, months (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.2 (1.8-32.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.0 (4.1-25.8)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median treatment, cycles (range)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (1-34)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (1-30)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median treatment cycles for 8-week TI responders, months (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 (3-34)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 (3-29)</font></p></td>
    </tr>
   </table><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Key baseline demographics and disease characteristics of patients in IMerge Phase 3, summarized below, demonstrate the broad range of lower risk MDS subtypes, and patients with high disease burden, enrolled in the trial:</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:63.754%;"></td>
     <td style="width:18.781%;"></td>
     <td style="width:17.465%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Age, years, median (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71.5 (44-87)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73.0 (39-85)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHO 2001 category, n (%)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS+</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73 (61.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37 (61.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS-</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44 (37.3)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (38.3)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RBC transfusion burden, units/8 weeks, median (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (4-33)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (4-13)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;4 - 6 units / 8 weeks, n (%)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62 (52.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (55.0)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&gt;6 units / 8 weeks, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56 (47.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 (45.0)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IPSS risk category, n (%)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Low</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80 (67.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39 (65.0)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Intermediate-1</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38 (32.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (35.0)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior luspatercept use, n (%)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">*</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (5.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.7)</font></p></td>
    </tr>
    <tr style="height:1.55pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-treatment hemoglobin</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">**</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, median (range), g/dL</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9 (5.3-10.1)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8 (6.1-9.2)</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      There were an insufficient number of patients (imetelstat: 7/118; placebo: 4/60) who were previously treated with luspatercept enrolled in IMerge Phase 3 to draw conclusions about the effect of imetelstat treatment in such patients. Of these patients, no imetelstat-treated patients and one placebo patient achieved 8-week TI.</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**    Pretreatment hemoglobin is defined as the average of all hemoglobin values in the eight weeks prior to the first dose date, excluding values that were within 14 days after transfusion (thus considered to be influenced by transfusion).</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After a median follow-up time of 18 months for all patients in the trial, the following chart is the status of patients as of October 13, 2022, the clinical cut-off date for top-line results.</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:66.032%;"></td>
     <td style="width:17.925%;"></td>
     <td style="width:16.043%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment ongoing, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 (22.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (23.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment discontinued, n (%)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91 (77.1)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45 (76.3)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Lack of efficacy</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28 (23.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25 (42.4)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Adverse event</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19 (16.1)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Cytopenias</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11 (9.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Unrelated</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (6.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Disease relapse after initial response on study</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 (14.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Patient decision</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16 (13.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (16.9)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Progressive disease</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (5.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 (8.5)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;AML progression</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Investigator decision</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Death</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;position:relative;min-width:fit-content;">*</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;Lost to follow up</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      On imetelstat treatment arm, patient death: neutropenic sepsis not related to drug after ~two-year treatment duration</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br>        On placebo treatment arm, patient deaths: (1) COVID-19 and (1) heart valve issue</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efficacy results for the primary 8-week TI endpoint and 24-week TI secondary endpoint summarized below illustrate the depth and durability of transfusion independence demonstrated with high statistical significance for imetelstat versus placebo in IMerge Phase 3.</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:42.011%;"></td>
     <td style="width:22.128%;"></td>
     <td style="width:19.925%;"></td>
     <td style="width:15.936%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value *</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Primary endpoint: 8-week TI, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47 (39.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;95% confidence interval</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(30.9, 49.3)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7.1, 26.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Secondary endpoint: 24-week TI, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (28.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;95% confidence interval</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(20.1, 37.0)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(0.4, 11.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Highly statistically significant (p&lt;0.001; hazard ratio 0.23) durable transfusion independence was achieved with median TI duration approaching one year (95% CI (weeks): 26.9, 83.9) for imetelstat and approximately 13 weeks for placebo (95% CI (weeks): 8.0, 24.9), using Kaplan Meier estimates, as shown in the following graph. Approximately 83% of patients achieving 8-week TI had a single continuous TI period. For imetelstat patients achieving 24-week TI, the median TI duration was 80.0 weeks (95% CI (weeks): 51.6, not estimable (NE)). In addition, approximately 70% of imetelstat patients who achieved 8-week TI continued to achieve 24-week TI.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_1.jpg" alt="img175210594_1.jpg" style="width:562px;height:285px;">&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there was an increasing magnitude of benefit for imetelstat versus placebo with longer time intervals, as shown in the graph below.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_2.jpg" alt="img175210594_2.jpg" style="width:526px;height:310px;">&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Highly statistically significant (p&lt;0.001) increase in hemoglobin levels over time for imetelstat patients as shown in the graph below. For patients achieving 8-week TI, median increases in hemoglobin were 3.6 g/dL for imetelstat and 0.8 g/dL for placebo. The peak hemoglobin reached for these patients was 11.3 g/dL for imetelstat and 8.9 g/dL for placebo.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_3.jpg" alt="img175210594_3.jpg" style="width:433px;height:316px;">&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corresponding to the increases in hemoglobin, a statistically significant decrease in the number of RBC units transfused was achieved for imetelstat treated patients versus placebo, as shown in the graph below.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_4.jpg" alt="img175210594_4.jpg" style="width:515px;height:300px;">&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, as shown in the table below, statistically significant 8-week RBC-TI was observed with imetelstat versus placebo across lower risk MDS subtypes (p&lt;0.05) and similar 8-week RBC-TI was observed for imetelstat within each subtype category in comparison to the overall population.</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:23.085%;"></td>
     <td style="width:21.303%;"></td>
     <td style="width:18.375%;"></td>
     <td style="width:23.258%;"></td>
     <td style="width:13.979%;"></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat, n (%)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo, n (%)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Difference (95% CI)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overall</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47/118 (39.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9/60 (15.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.8 (9.9, 36.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHO category</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;RS+</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33/73 (45.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7/37 (18.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.3 (5.9, 42.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.016</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;RS-</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14/44 (31.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/23 (8.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1 (-1.3, 40.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.038</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfusion burden</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;4-6 units</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28/62 (45.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7/33 (21.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.9 (1.9, 41.4)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.027</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&gt;6 units</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19/56 (33.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/27 (7.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.5 (4.7, 41.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.023</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IPSS risk category</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;Low</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32/80 (40.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8/39 (20.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.5 (-0.1, 35.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.034</font></p></td>
    </tr>
    <tr style="height:14.25pt;">
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;Intermediate-1</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15/38 (39.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1/21 (4.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.7 (8.8, 52.4)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.004</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically for the RS+ and RS- subtypes, statistically significant improvement in both 8-week and 24-week TI was achieved with imetelstat versus placebo, as shown in the table below.</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25.989%;"></td>
     <td style="width:14.995%;"></td>
     <td style="width:13.005%;"></td>
     <td style="width:11.005%;"></td>
     <td style="width:12.856%;"></td>
     <td style="width:13.005%;"></td>
     <td style="width:9.144%;"></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RS+</font></p></td>
     <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RS-</font></p></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=73)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=37)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=44)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=23)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</font></p></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-week TI responders, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (45.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (18.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.016</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (31.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (8.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.038</font></p></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration of TI*, weeks</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;(95% CI)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46.9</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.9, 83.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.9</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(8.0, 24.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.035</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51.6</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(11.9, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(10.1, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.062</font></p></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24-week TI responders, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24 (32.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (5.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.003</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (20.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0 (0.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.019</font></p></td>
    </tr>
    <tr style="height:9.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;Median duration of TI*, weeks</font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;(95% CI)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80.0</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(41.6, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(24.9, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.808</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122.9</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.0, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(NE, NE)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Kaplan-Meier estimates of duration of RBC TI; 8-week/24-week TI Responder Analysis Set; P-value for TI rate is based on Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1); P-value for duration of TI is based on stratified log-rank test.</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE = not estimable</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The IMerge Phase 3 protocol specified use of the International Working Group, or IWG, 2006 criteria to measure HI-E and was not statistically significant (p=0.112) for imetelstat versus placebo. The current IWG 2018 HI-E criteria places greater emphasis on durability by measuring response for &#x2265;16 weeks, rather than &#x2265;8 weeks. Under these new 2018 IWG criteria, a highly statistically significant (p&lt;0.001) HI-E rate was achieved for imetelstat versus placebo. See the table below for HI-E response under both 2018 and 2006 IWG criteria.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:54.995%;"></td>
     <td style="width:15.604%;"></td>
     <td style="width:15.604%;"></td>
     <td style="width:13.797%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value *</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HI-E per IWG 2018, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50 (42.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(33.3, 51.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5.9, 24.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">      </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;16-week TI, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37 (31.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(23.1, 40.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1.9, 16.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">       </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Transfusion reduction by &#x2265;50%/16 weeks</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51 (43.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(34.1, 52.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7.1, 26.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HI-E per IWG 2006, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75 (63.6)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31 (51.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.112</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(54.2, 72.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(38.4, 64.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2265;1.5 g/dL increase in Hgb &#x2265;8 weeks, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40 (33.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.4, 43.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3.8, 20.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Transfusion reduction by &#x2265;4U/8 weeks, n (%)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71 (60.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30 (50.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.175</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(50.8, 69.1)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(36.8, 63.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical and molecular evidence supporting the potential for disease modification with imetelstat includes a one-year median TI duration for imetelstat 8-week TI responders, a median rise of 3.6 g/dL in hemoglobin levels in those same patients and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50% variant allele frequency decreases in SF3B1, TET2, DNMT3A and ASXL1 mutations, as shown in the graph below.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_5.jpg" alt="img175210594_5.jpg" style="width:597px;height:288px;">&#160;</p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The safety results in IMerge Phase 3 were consistent with prior clinical trials of imetelstat in hematologic malignancies, and no new safety signals were identified. The most frequent non-hematologic toxicities occurring in &#x2265;10% of patients on either imetelstat or placebo arms are listed in the table below. Grade 3 elevations in liver function tests, or LFTs, on imetelstat were short in duration (median &lt; 2 weeks) and more than 80% resolved to Grade 2 or lower within 4 weeks, with no cases of liver test elevations consistent with Hy&#x2019;s Law or Drug Induced Liver Injury.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:41.412%;"></td>
     <td style="width:15.059%;"></td>
     <td style="width:14.235%;"></td>
     <td style="width:15.059%;"></td>
     <td style="width:14.235%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AE, n (%)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Asthenia</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22 (18.6)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COVID-19*</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (17.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Peripheral edema</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (11.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headache</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15 (12.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diarrhea</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;14 (11.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alanine aminotransferase increased</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (11.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (2.5)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hyperbilirubinemia</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11 (9.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Constipation</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pyrexia</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> _________________</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*    Includes COVID-19, asymptomatic COVID-19, COVID-19 pneumonia</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:40.995%;"></td>
     <td style="width:16.0%;"></td>
     <td style="width:13.701%;"></td>
     <td style="width:15.444%;"></td>
     <td style="width:13.861%;"></td>
    </tr>
    <tr style="height:3.1pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LFT Lab Abnormality, n (%)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alanine Aminotransferase (ALT*)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46 (39.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (3.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22 (37.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alkaline Phosphatase (ALP)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53 (44.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aspartate Aminotransferase (AST)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57 (48.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (22.0)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bilirubin</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46 (39.0)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (39.0)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     n=117 for ALT imetelstat patients</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The most frequent hematologic toxicities are listed in the table below.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:41.005%;"></td>
     <td style="width:15.337%;"></td>
     <td style="width:15.658%;"></td>
     <td style="width:14.0%;"></td>
     <td style="width:14.0%;"></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AE, n (%)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thrombocytopenia</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89 (75.4)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73 (61.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 (8.5)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neutropenia</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87 (73.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80 (67.8)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anemia</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24 (20.3)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (19.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</font></p></td>
    </tr>
    <tr style="height:1.3pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leukopenia</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12 (10.2)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
   </table><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical consequences from cytopenias were similar between imetelstat and placebo groups as shown in the table below.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:49.975%;"></td>
     <td style="width:26.323%;"></td>
     <td style="width:23.702%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event, n (%)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 bleeding events*</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (2.5)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 infections+</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (11.0)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade febrile neutropenia**</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     No &#x2265;Grade 3 bleeding events in the setting of Grade 3/4 thrombocytopenia; on imetelstat: two patients with Grade 4 gastrointestinal bleeding, unrelated and resolved and one Grade 3 hematuria, unrelated and resolved <br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+     On imetelstat: three patients with Grade 3/4 infections in setting of Grade 3/4 neutropenia; all three were sepsis and resolved with only one considered related<br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**   Occurred at day 33, lasted 8 days; assessed by investigator as possibly related to imetelstat; patient subsequently achieved TI &gt;40 weeks and remains on treatment at data cut-off</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, as shown in the table below, the median duration of cytopenias was shorter for imetelstat versus placebo and the resolution to Grade 2 or lower was higher for imetelstat versus placebo.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
   <table style="border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:49.975%;"></td>
     <td style="width:26.323%;"></td>
     <td style="width:23.702%;"></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</font></p></td>
     <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thrombocytopenia events*</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration, weeks, (range)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4 (0.1-12.6)</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.0 (0.3-11.6)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Resolved within &lt;4 weeks, %</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86.3</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44.4</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neutropenia events*</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration, weeks, (range)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.9 (0-15.9)</font></p></td>
     <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2 (1.0-4.6)</font></p></td>
    </tr>
    <tr style="height:10.0pt;">
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Resolved within &lt;4 weeks, %</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.0</font></p></td>
     <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50.0</font></p></td>
    </tr>
   </table><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+     18% of imetelstat treated patients received a median of 1 platelet transfusions; 35% of imetelstat treated patients received growth factor support</font></p><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     Analysis performed for patients who experienced Grade 3/4 cytopenias. Resolution determined by return to Grade 2 or lower</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Planned Next Steps to Advance Imetelstat in Lower Risk MDS Toward Potential Commercialization</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to present additional data from IMerge Phase 3 at medical meetings later this year, including data relating to potential correlation of decreases in mutation burden and abnormal cytogenetic clones with clinical responses, patient reported outcomes, hTERT and telomerase activity biomarker data and continued follow-up of durability of transfusion independence. These data, which are not yet available to Geron, will not be available to you prior to investing in this offering.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the depth, breadth and durability of transfusion independence reported from IMerge Phase 3 to date, as well as from IMerge Phase 2, provide strong support for our planned regulatory submissions in the U.S. and in the EU for the use of imetelstat in patients with lower risk MDS. We therefore plan to submit an NDA in the U.S. in mid-2023 and an MAA in Europe in the second half of 2023 for the use of imetelstat in adult patients with lower risk MDS. With Fast Track designation for imetelstat from the FDA for the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, non-del(5q), and who are refractory or resistant to treatment with an ESA (i.e., the treatment population in IMerge Phase 3), the FDA granted our request for rolling submission of the NDA. If the NDA is accepted for filing and approved within the timelines we expect, we anticipate that the commercial launch of imetelstat in lower risk MDS could occur in the U.S. in the first half of 2024. In Europe, we anticipate review of the planned MAA, if validated by the EMA could take approximately 14 months and, if approved, we anticipate that the commercial launch of imetelstat in lower risk MDS in Europe could occur by the end of 2024.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF: Ongoing Phase 3 Clinical Trial in Relapsed/Refractory MF</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF, our Phase 3 clinical trial in relapsed/refractory MF, is an open label, 2:1 randomized, controlled clinical trial designed to evaluate imetelstat (9.4 mg/kg administered by intravenous infusion over two hours every three weeks) in approximately 320 patients. Patients relapsed after or refractory to a JAK inhibitor are defined as</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">having an inadequate spleen response or symptom response after treatment with a JAK inhibitor for at least six months, including an optimal dose of a JAK inhibitor for at least two months. The best available therapy, or BAT, control arm of IMpactMF excludes the use of JAK inhibitors. With respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to assess a lower dose and/or a more frequent dosing schedule that might improve the planned trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. We believe existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity. For these reasons, we therefore determined not to add a third dosing arm to the trial design, and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary efficacy endpoint for IMpactMF is OS. Key secondary endpoints include symptom response; spleen response; progression free survival; complete remission, partial remission or clinical improvement, as defined by the International Working Group for Myeloproliferative Neoplasms Research and Treatment criteria; duration of response; safety; pharmacokinetics; and patient reported outcomes. Currently, we have selected 165 of the planned 180 sites to participate in IMpactMF across North America, South America, Europe, Australia and Asia.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF is designed with &gt;85% power to detect a 40% reduction in the risk of death (hazard ratio=0.60; one-sided alpha=0.025). The final analysis for OS is planned to be conducted after more than 50% of the patients planned to be enrolled in the trial have died (referred to as an event). An interim analysis of OS, in which the alpha spend is expected to be approximately 0.01, is planned to be conducted after approximately 70% of the total projected number of events (deaths) for the final analysis have occurred.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current Status of IMpactMF</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF opened for patient screening and enrollment in December 2020. As of December 31, 2022, we had 140 of the 165 selected sites open for patient enrollment, and we are continuing to select additional sites. The first patient was dosed in April 2021. Given the uncertain and unpredictable impact of the COVID-19 pandemic on our clinical trial activities, including the constraints on clinical site personnel resources due to other competing trials in MF at the sites where IMpactMF is planned to be conducted, under current planning assumptions, we expect IMpactMF to be fully enrolled in 2024. Based on our planning assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS in IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. At the interim analysis, if the pre-specified statistical OS criterion is met, then we expect such data may potentially support the registration of imetelstat in relapsed/refractory MF. Subject to protocol-specified stopping rules for futility, if the pre-specified OS criterion is not met at the interim analysis, the trial will continue to the final analysis, which is expected to occur approximately one year later.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The timing and achievement of either or both of the planned analyses depend on numerous factors, including delays or interruptions related to the effects of the COVID-19 pandemic or geopolitical events. In addition, our ability to enroll, conduct and complete IMpactMF depends on whether we can obtain and maintain the relevant clearances from regulatory authorities and other institutions to enroll, conduct and complete the trial, and our ability to raise additional capital following this offering if and when needed in order to complete the trial.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Improvement in Overall Survival and Potential Disease-Modifying Activity Observed in IMbark Phase 2</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The IMbark Phase 2 clinical trial was designed to evaluate two dosing regimens of imetelstat (either 4.7 mg/kg or 9.4 mg/kg administered by intravenous infusion every three weeks) in patients with relapsed/refractory MF. The co-primary efficacy endpoints for IMbark were spleen response rate, defined as the proportion of patients who achieve a reduction of at least 35% in spleen volume as assessed by imaging, and symptom response rate, defined as the proportion of patients who achieve a reduction of at least 50% in Total Symptom Score, at 24 weeks. Key secondary endpoints were OS and safety.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We previously reported efficacy and safety results from the IMbark Phase 2 clinical trial, including median OS of 28.1 months for patients on the high dose arm of the study, which is almost twice the reported median OS of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 &#x2013; 16 months in medical literature. To evaluate this potential benefit, we conducted a post-hoc analysis of OS for patients treated with imetelstat 9.4 mg/kg in IMbark compared to OS calculated from real world data, or RWD, collected at the Moffitt Cancer Center for patients who had discontinued treatment with ruxolitinib, a JAK inhibitor, and who were subsequently treated with BAT. To make a comparison between the IMbark data and RWD, a cohort from the real-world dataset was identified that closely matched the IMbark patients, using guidelines for inclusion and exclusion criteria as defined in the IMbark clinical protocol, such as platelet count and spleen size. Calculations from two propensity score analysis approaches resulted in a median OS of 30.7 months for the imetelstat-treated patients from IMbark, which is more than double the median OS of 12.0 months using RWD for patients treated with BAT. These analyses also showed a 65% &#x2013; 67% lower risk of death for the imetelstat-treated patients vs. BAT-treated patients. We believe these analyses suggest potentially longer OS for imetelstat-treated relapsed/refractory MF patients in IMbark, compared to BAT in closely-matched patients from RWD. However, comparative analyses between RWD and our clinical trial data have several limitations. For instance, the analyses create a balance between treatment groups with respect to commonly available covariates, but do not take into account the unmeasured and unknown covariates that may affect the outcomes of the analyses. Potential biases are introduced by factors which include, for example, the selection of the patients included in the analyses, misclassification in the matching process, the small sample size, and estimates that may not represent the outcomes for the true treated patient population. For these and other reasons, such comparative analyses and any conclusions from such analyses should be considered carefully and with caution, and should not be relied upon as demonstrative or otherwise predictive or indicative of any current or potential future clinical trial results of imetelstat in relapsed/refractory MF, including IMpactMF.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In IMbark, patients also experienced other positive clinical outcomes, including symptom improvement, spleen reduction and bone marrow fibrosis improvement. In June 2020, we reported correlation analyses from IMbark that showed a trend of longer OS in patients who achieved symptom response, spleen volume reductions and improved bone marrow fibrosis, in a dose-dependent manner. Furthermore, the reductions in the variant allele frequency of key driver mutations in MF and the improvement in bone marrow fibrosis observed in IMbark have also been correlated to the improvement in OS. We believe the improvement in bone marrow fibrosis, potential survival benefit, molecular data and correlations from IMbark provide strong evidence of the potential for disease modification with imetelstat, which we believe differentiates imetelstat from currently approved treatments for MF.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The safety results observed in IMbark were consistent with prior clinical trials of imetelstat in hematologic malignancies, and no new safety signals were identified. In the 9.4 mg/kg arm, reversible and manageable Grade 3/4 thrombocytopenia and neutropenia were reported in 24/59 patients (41%) and 19/59 patients (32%), respectively, without significant clinical consequences. 1/59 patients (2%) had Grade 3 febrile neutropenia. 3/59 patients (5%) had Grade 3/4 bleeding. 6/59 patients (10%) had Grade 3/4 infections. Furthermore, more than 70% of the observed Grade 3/4 cytopenias resolved to Grade 2 or lower by laboratory assessment within four weeks.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exploratory Clinical Trials of Imetelstat in Additional Indications</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMproveMF: Phase 1 Combination Clinical Trial in Frontline Myelofibrosis (Frontline MF)</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMproveMF is a two-part Phase 1 clinical trial evaluating imetelstat in combination with ruxolitinib in patients with frontline MF. The trial is designed to use a Bayesian Optimal Interval design to test various doses of imetelstat in an escalating dose sequence with a defined number of patients per dosing arm. Escalation to the next higher dosing arm will only occur if the prior dose is tolerable to the patients. The primary objective of the first part of IMproveMF is to identify a recommended dosing regimen for further evaluation. Up to 20 patients are expected to be enrolled into the first part of IMproveMF, or IMproveMF Part 1. The first patient was dosed in IMproveMF in August 2022.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon identification of a tolerable dosing regimen for the combination treatment of imetelstat and ruxolitinib, the second part of IMproveMF, or IMproveMF Part 2, is planned to evaluate the efficacy and further evaluate the safety of that dosing regimen. Under IMproveMF Part 2, the primary endpoints are safety and symptom response rate, defined as the proportion of patients who achieve a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50% reduction in Total Symptom Score at 24 weeks. Secondary endpoints include change in fibrosis; spleen response rate, defined as the proportion of patients who achieve a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35% reduction in spleen volume from baseline as assessed by imaging; and the number of patients achieving complete remission, partial remission or clinical improvement, as defined by the International Working</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Group for Myeloproliferative Neoplasms Research and Treatment criteria. Up to 20 patients are expected to be enrolled into the IMproveMF Part 2.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMpress: Investigator-Led Phase 2 Clinical Trial in Higher Risk Myelodysplastic Syndromes (Higher Risk MDS) and Acute Myeloid Leukemia (AML)</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In collaboration with investigators in Germany, France and Australia, we are supporting IMpress, an investigator-led study of imetelstat in patients with higher risk MDS and relapsed/refractory AML, post-treatment with a hypomethylating agent, or HMA. IMpress is an open-label, single arm, Phase 2 clinical trial being conducted at three clinical sites. The first site is planned to open in the first quarter of 2023. The primary endpoint is overall response rate per criteria from the 2018 International Working Group for MDS and the European LeukemiaNet for AML. Secondary endpoints include safety, duration of response, progression-free survival and overall survival. In addition, pending the results of IMpress, we plan to support a Phase 1/2 investigator-led study in relapsed/refractory AML using a combination approach of imetelstat and venetoclax or azacitidine.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Programs</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Lymphoid Hematologic Malignancy Program</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Academic research data suggests that certain lymphoid hematologic malignancies have higher telomerase activity and shorter telomeres when compared to normal healthy cells. Thus, we believe a telomerase inhibition approach may find utility in this disease setting.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on this scientific hypothesis, we initiated a preclinical research project with MD Anderson Cancer Center to determine the potential application of imetelstat in lymphoid hematologic malignancies. Preliminary results from this research were published in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Blood</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in November 2022. Based on early results, we plan to collaborate further with MD Anderson Cancer Center to conduct preclinical research to assess the potential therapeutic effect of imetelstat in lymphoid malignancies.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Next Generation Telomerase Inhibitor Discovery Program</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have initiated a discovery program to identify a lead compound as a potential next generation oral telomerase inhibitor. If such a compound is identified, we plan to conduct preclinical experiments that may serve as a basis for potential future clinical testing. Discovery research is an uncertain and unpredictable process. As such, the timing and nature of any results from this discovery effort are difficult to forecast. If we select a lead compound from this discovery program, we expect to provide an update on our efforts at that time.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preliminary Financial Information</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based upon preliminary estimates and information available to us as of the date of this prospectus supplement, we expect to report that we had approximately $173 million in cash, cash equivalents, restricted cash and current and noncurrent marketable securities as of December 31, 2022. We have not yet completed our financial close process for the quarter and year ended December 31, 2022. This estimate of our cash, cash equivalents, restricted cash and current and noncurrent marketable securities as of December 31, 2022 is preliminary, unaudited and is subject to change upon completion of our financial statement closing procedures and the audit of our consolidated financial statements.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our independent registered public accounting firm, Ernst &amp; Young LLP, has not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, Ernst &amp; Young LLP does not express an opinion or any other form of assurance with respect thereto. It is possible that we or Ernst &amp; Young LLP may identify items that require us to make adjustments to the financial information set forth above. We expect to complete our audited consolidated financial statements for the year ended December 31, 2022 subsequent to the completion of this offering. Accordingly, undue reliance should not be placed on this preliminary estimate.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factor Summary</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Below is a summary of material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address all of the risks and uncertainties that we face. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider this summary to be a complete discussion of all potential risks or uncertainties that may substantially impact our business. Additional discussion of the risks and uncertainties summarized in this risk factor summary, as well as other risks and uncertainties that we face, are described under the heading &#x201c;Risk Factors&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus supplement, and this summary is qualified in its entirety by that discussion. Moreover, we operate in a competitive and rapidly changing environment. New factors emerge from time to time and it is not possible to predict the impact of all of these factors on our business, financial condition or results of operations. You should consider carefully the risks and uncertainties described under the heading &#x201c;Risk Factors&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus supplement as part of your evaluation of an investment in our securities.</font></p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are wholly dependent on the success of our sole product candidate, imetelstat.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to demonstrate sufficient safety and efficacy data from IMerge Phase 3 to the satisfaction of the FDA or similar international regulatory authorities, additional clinical testing may be required before we can seek regulatory approval for imetelstat in lower risk MDS and begin commercialization, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our business and commercial prospects.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any suspension of or delays in IMpactMF, including due to the effects of macroeconomic conditions such the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects. </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any termination of IMpactMF would have a material adverse effect on our business, business prospects and the future of imetelstat.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events that could further delay or prevent the commencement and/or completion of clinical trials for imetelstat, further delay or prevent its regulatory approval, or limit its commercial potential.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If IMpactMF fails to demonstrate safety and effectiveness to the satisfaction of the FDA or similar regulatory authorities in other countries or does not otherwise produce positive results, we would incur additional costs, experience delays in completing or ultimately fail in completing the development and commercialization of imetelstat in relapsed/refractory MF, which would have a material adverse effect on our business, business prospects and the future of imetelstat.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and results of earlier stage clinical trials and non-clinical studies may not be predictive of future results.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third parties to conduct our clinical trials and their failure to perform could have a material adverse effect on our business that might cause us to cease operations.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to obtain regulatory approval for imetelstat in the U.S. would have a material adverse effect on our business that would likely cause us to cease operations.  </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If imetelstat is approved for marketing and commercialization and we are unable to establish sales, marketing and distribution capabilities, or obtain coverage and adequate third-party payor reimbursement, we will be unable to successfully commercialize imetelstat.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not successful in commercializing imetelstat, we will not be able to achieve our projections for future revenue, if any. </font></div></div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third parties to manufacture and supply imetelstat, and may be unable to ensure that we have adequate quantities of imetelstat that meet specifications that may be approved or required by regulatory authorities, and timelines necessary for current and potential future clinical trials and potential commercial uses.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory inspections of third-party manufacturers may identify deficiencies in manufacturing processes or facilities which could impact the ability of third-party manufacturers to produce and deliver products, including imetelstat.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic has affected and continues to affect our ability to conduct clinical trial activities, causing delays in IMpactMF, IMproveMF, and our investigator-led clinical trial, IMpress, in AML and higher risk MDS. Additionally, the COVID-19 pandemic may delay and disrupt regulatory activities and our manufacturing and supply chain and have other adverse effects on our business and operations.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under our term loan facility, or Loan Agreement, with Hercules Capital Inc., or Hercules, and Silicon Valley Bank, or SVB, we will require substantial additional funding following this offering to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all. The global economic slowdown, as well as inflation, rising interest rates and the prospects for recession, could materially and adversely affect our ability to raise additional capital, which could negative affect our liquidity, our business and business prospects and the future of imetelstat. If we are unable to raise this capital when needed, we would be forced to delay, reduce or eliminate our research and development activities and other operations or commercialization efforts which would have a material adverse effect on our business that might cause us to cease operations. Raising additional capital may subject us to unfavorable terms, cause dilution to our existing stockholders, restrict our operations, or require us to relinquish certain rights to imetelstat. </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant losses and negative cash flows from operations since our inception and anticipate that we will continue to incur significant expenses and losses for the foreseeable future.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our level of indebtedness and debt service obligations could adversely affect our financial condition, and may make it more difficult for us to fund our operations.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for imetelstat for an adequate amount of time, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to imetelstat, and our ability to successfully commercialize imetelstat may be adversely affected.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If competitors develop products, product candidates or technologies that are superior to or more cost-effective than imetelstat, this would significantly impact the development and commercial viability of imetelstat; severely and adversely affect our financial results, business and business prospects and the future of imetelstat; and might cause us to cease operations.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and certain of our officers have been named as defendants in two pending securities class action lawsuits and seven shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to legal and contractual obligations related to privacy and information security. Our actual or perceived failure, or that of third parties upon which we rely, to comply with such obligations could harm our business. </font></div></div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p></div>
  <hr style="page-break-after:always;">
  <div style="border-top:0.5pt solid #000000;padding-top:6%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:7%;padding-bottom:6%;border-bottom:0.5pt solid #000000;padding-right:7%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, if our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences.</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and failures to comply with privacy and data protection obligations may adversely affect our business, operations and financial performance. </font></div></div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Information</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were incorporated in 1990 under the laws of Delaware. Our principal executive offices are located at 919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404, and our telephone number is (650) 473-7700. Our website address is </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">www.geron.com.</font><font style="white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information found on, or accessible through, our website is not a part of, and is not incorporated into, this prospectus supplement or the accompanying prospectus, and you should not consider it part of this prospectus supplement or the accompanying prospectus. Our website address is included in this document as an inactive textual reference only.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p></div>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="margin-left:4.8%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:4.935%;text-align:center;" id="the_offering"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Offering</font></p>
  <p style="margin-left:1.093%;text-indent:2.947%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:4.815%;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.004%;"></td>
    <td style="width:68.996%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock offered by us</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,876,297 shares.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Option to purchase additional shares</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have granted the underwriters an option, exercisable for 30 days from the date of this prospectus supplement, to purchase 12,131,444 additional shares from us.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants offered by us</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants to purchase 25,000,000 shares of our common stock. Each pre-funded warrant will have an initial exercise price per share of $0.001, subject to certain adjustments. The purchase price of each pre-funded warrant is equal to the price at which the share of common stock is being sold to the public in this offering, minus $0.001. The pre-funded warrants are exercisable immediately and may be exercised at any time until all of the pre-funded warrants are exercised in full. For more information, see the section titled &#x201c;Description of Securities We Are Offering&#x2014;Pre-Funded Warrants&#x201d; on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;of this prospectus supplement. This prospectus supplement also relates to the offering of the shares of common stock issuable upon exercise of the pre-funded warrants.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock to be outstanding immediately after this offering</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">437,090,623 shares (or 449,222,067 shares if the underwriters exercise their option to purchase additional shares in full, in each case, assuming none of the pre-funded warrants issued in this offering are exercised).</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of proceeds</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate that the net proceeds to us from the sale of the 55,876,297 shares of common stock and pre-funded warrants to purchase 25,000,000 shares of common stock that we are offering, excluding the proceeds, if any, from the exercise of the pre-funded warrants offered hereby, will be approximately $185.4 million, or $213.3 million if the underwriters exercise their option to purchase additional shares in full based on the public offering price of $2.45 per share (or pre-funded warrants at the public offering price less $0.001), and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently intend to use the net proceeds from this offering, together with our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, to fund preparatory activities for the potential U.S. commercial launch of imetelstat in lower risk MDS, and, if approved, to fund the potential U.S. commercial launch of imetelstat. We intend to use the remaining proceeds, if any, for working capital and general corporate purposes.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See &#x201c;Use of Proceeds&#x201d; page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;of this prospectus supplement for more information.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq listing for our common stock</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d; There is no established public trading market for the pre-funded warrants and we do not expect a market to develop. In addition, we do not intend to apply for listing of the pre-funded warrants on any securities exchange or recognized trading system.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk factors</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing in our securities involves a high degree of risk. Please read the information under the heading &#x201c;Risk Factors&#x201d; beginning on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;of this prospectus supplement before deciding whether to invest in our securities.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of our common stock to be outstanding immediately after this offering as shown above is based on 381,214,326 shares of common stock outstanding as of September 30, 2022. This number excludes the shares of common stock issuable upon exercise of the pre-funded warrants offered hereby, and also excludes, as of September 30, 2022, the following:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,705,500 shares of common stock issuable upon the exercise of stock options with a weighted-average exercise price of $1.86 per share;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,430,477 shares of common stock issuable upon the exercise of warrants with an exercise price of $0.001 per share;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88,689,749 shares of common stock issuable upon the exercise of outstanding warrants with a weighted-average exercise price of $1.36 per share; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">up to an aggregate of 21,952,207 shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan, or the 2018 Plan, 2014 Employee Stock Purchase Plan, 2018 Inducement Award Plan and Directors&#x2019; Market Value Stock Purchase Plan.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, stock options to purchase 2,347,280 shares at a weighted-average exercise price of $2.18 per share and stock awards of 2,970 shares have been granted between September 30, 2022 and the date of this prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of common stock to be outstanding immediately following this offering does not include up to approximately $79.1 million of our common stock that remained available for sale as of September 30, 2022 under the at market issuance sales agreement we entered into with B. Riley Securities, Inc., dated as of September 4, 2020, or the Sales Agreement. Since December 31, 2021, we have not sold any shares under the Sales Agreement. We have agreed with the underwriters of this offering not to sell any shares of our common stock pursuant to the Sales Agreement for 75 days following this offering.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless otherwise stated, all information in this prospectus supplement:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assumes no exercise of outstanding options or warrants to purchase our common stock, and no issuance of shares available, or that may become available, for future issuance under our equity compensation plans; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assumes no exercise of the pre-funded warrants offered in this offering; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assumes no exercise by the underwriters of their option to purchase 12,131,444 additional shares of our common stock from us in this offering.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="risk_factors"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISK FACTORS</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks and uncertainties described below, together with the other information in this prospectus supplement, the accompanying prospectus, the information and documents incorporated by reference and any free writing prospectus prepared by or on behalf of us or to which we have referred you. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO THE DEVELOPMENT OF IMETELSTAT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our future success depends solely on imetelstat, our only product candidate, and we cannot be certain that we will be able to continue to develop imetelstat or advance imetelstat to subsequent clinical trials, or that we will be able to receive regulatory approval for or to commercialize imetelstat, on a timely basis or at all.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat is our sole product candidate, upon whose success we are wholly dependent. We do not currently have any other products or product candidates. Our ability to develop imetelstat and launch it commercially is subject to significant risks and uncertainties, including, obtaining regulatory approval from the FDA and EMA for commercializing imetelstat in lower risk MDS, as well as, among other things, our ability to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submit an NDA, to the FDA in the U.S., and a MAA to the EMA in the EU, that is accepted and/or validated for filing by the respective regulatory agency; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain from the FDA and EMA their respective determinations that the regulatory submissions are sufficient to support regulatory approval to commercialize imetelstat in lower risk MDS, without the requirement for additional pre-approval clinical trials or further testing or development commitments, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain sufficient safety and efficacy data from IMpactMF to support any application for regulatory approval in relapsed/refractory MF, without clinically meaningful safety issues, side effects or dose-limiting toxicities related to imetelstat that may negatively impact its benefit-risk profile, whether or not in the same indications or therapeutic areas;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ascertain that the use of imetelstat does not result in significant systemic or organ toxicities, including hepatotoxicity, or other safety issues resulting in an unacceptable benefit-risk profile;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain substantial additional capital following this offering in order to enable us to conduct our operations and further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">develop clinical plans for, and successfully commence, conduct and complete potential future clinical trials of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">generate sufficient safety and efficacy data from ongoing and potential future clinical trials of imetelstat that provide a positive benefit-risk profile to support the continued and future development of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain and maintain required regulatory clearances and approvals to enable continued clinical development, as well as potential commercialization, of imetelstat; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into and maintain arrangements with third parties to provide services needed to further research and develop imetelstat, including maintaining the agreements with our CROs, or to manufacture imetelstat, in each case at commercially reasonable costs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recruit and retain sufficient qualified and experienced personnel to support the development and potential commercialization of imetelstat in the U.S., including to enroll, conduct and complete current and potential future clinical trials of imetelstat, and to provide internal capabilities for sales, marketing, distribution and other functions to support the potential commercialization of imetelstat in the U.S.; </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into and maintain arrangements with third parties to provide services needed to support the potential commercialization of imetelstat for territories outside of the U.S. in compliance with applicable laws;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">achieve acceptance of imetelstat, if approved, by patients and the relevant medical communities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compete effectively with other approved treatments in lower risk MDS;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain appropriate coverage and reimbursement levels for the cost of imetelstat from governmental authorities, private health insurers and other third-party payors; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain, maintain and enforce adequate intellectual property and regulatory exclusivity for imetelstat both in the U.S. and globally.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not able to successfully achieve the above-stated goals and overcome other challenges that we may encounter in the research, development, manufacturing and potential commercialization of imetelstat, we may be forced to abandon our development and/or commercialization of imetelstat, which would severely harm our business, prospects and our ability to raise additional capital, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our current and potential future clinical trials of imetelstat could be interrupted, delayed, terminated or abandoned for a variety of reasons, including due to the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Currently, the active clinical trials of imetelstat are IMpactMF and IMproveMF, and the investigator-led clinical trial, IMpress, and we are also retaining remaining patients in the treatment or follow-up phase of IMerge Phase 3. The conduct and completion of IMpactMF, IMproveMF and IMpress could be interrupted, delayed or abandoned for a variety of reasons, including due to the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession. In particular, the fluidity and dynamic nature of the COVID-19 pandemic precludes any firm estimates as to the ultimate effect COVID-19 will have on our current and potential future clinical trials, our operations and our business, all of which depend on the continued worldwide progress toward managing this health crisis. Although vaccine distribution, including booster shots, is being conducted in many countries, the emergence of COVID-19 variants and subvariants, and the resurgence of COVID-19 cases in many parts of the world cause further uncertainty and unpredictability on clinical trial activities, including clinical site initiations, patient screening and enrollment, as well as constraints on available sites and site personnel. For instance, the pace of enrollment for IMerge Phase 3 was slower than planned due to the COVID-19 pandemic, and we have experienced a similar effect on our other clinical trials, and we may face difficulties in retaining patients in the treatment or follow-up phases of our clinical trials. Site personnel resources for IMpactMF and IMproveMF remain constrained in the countries where we plan to conduct the trials, due to the negative impact of COVID-19, as well as a number of competing trials in MF and other oncology indications. Based on assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS for IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. Such macroeconomic conditions have and may continue to cause delays and suspensions in clinical trial activities at clinical sites. In additional, we may also experience clinical trial failures or delays related to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">overcoming patient recruitment and enrollment challenges and operational delays related to opening new clinical sites, and conducting and completing IMpactMF, IMproveMF and IMpress due to the effects of the COVID-19 pandemic, while also competing with clinical trials for other investigational drugs in the same patient population; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinical sites electing to terminate their participation in any of our clinical trials, which would likely have a detrimental effect on patient enrollment;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any inability to successfully retain patients in IMpactMF, including completing the planned interim analysis for IMpactMF;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulties in patient recruitment and enrollment in IMproveMF;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patient recruitment, enrollment, or retention, clinical site initiation, or retention problems associated with civil or political unrest or military conflicts around the world, including specifically the current military conflict between Ukraine and Russia;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a higher number of patients being required for clinical trials, or higher than expected patient drop out rates;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and/or maintaining regulatory clearances in the U.S. or other countries to conduct clinical trials, such as obtaining or maintaining regulatory clearances to commence, conduct or modify current or potential future clinical trials of imetelstat, in a timely manner, or at all, which could, for example, prevent us from, or result in substantial delays in, conducting or completing IMpactMF, IMproveMF and IMpress, or commencing potential future clinical trials of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintaining the investigational new drug applications, or INDs, and equivalent submissions in other countries for imetelstat without such INDs and/or equivalent submissions in other countries being placed on full or partial clinical hold, suspended or subject to other requirements by the FDA or other similar international regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contracting with a sufficient number of clinical trial sites to conduct current and potential future clinical trials, and ensuring that such contracts contain all necessary terms and conditions required by applicable laws, including providing for valid mechanisms to engage in cross-border data transfers, as well as identifying, recruiting and training suitable clinical investigators, especially given the constraints caused by the COVID-19 pandemic, and other competing clinical trials in MF and other oncology indications;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining or accessing necessary clinical data in accordance with appropriate clinical or quality practices and regulatory requirements, in a timely and accurate manner to ensure complete data sets;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">responding to safety findings, recommendations or conclusions by the internal data safety review committees, independent data monitoring committees and/or hepatic expert committees of current and potential future clinical trials of imetelstat based on emerging data occurring during such clinical trials, such as significant systemic or organ toxicities, including severe cytopenias, hepatotoxicity, fatal bleeding with or without any associated thrombocytopenia, or reduced platelet count, patient injury or death, or other safety issues, resulting in an unacceptable benefit-risk profile;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">use of trial endpoints that inherently require prolonged periods of clinical observation or analysis of the resulting data to determine trial outcomes;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing sufficient quantities that meet our specifications and timelines of imetelstat, or other clinical trial materials, in a manner that meets the quality standards of the FDA and other similar international regulatory authorities, and responding to any disruptions to drug supply, clinical trial materials or quality issues that may arise, including as a result of (a) limitations in available manufacturing capacity due to obligations to manufacture and distribute vaccines to address the COVID-19 pandemic; (b) temporary or permanent shut down of contract manufacturing facilities due to violations of good manufacturing practices, or GMP, regulations or other applicable requirements; (c) infections or cross-contaminations of product candidates in the manufacturing process; (d) or capacity limitations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensuring the ability to manufacture and supply imetelstat at acceptable costs for potential future clinical trials of imetelstat and potential commercial uses;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining sufficient quantities of any study-related treatments, materials (including best available therapy, or BAT, comparator products, placebo or combination therapies) or ancillary supplies, including in light of challenges and delays that may arise from the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining acceptance by regulatory authorities of any manufacturing changes for imetelstat, as well as successfully implementing any such manufacturing changes;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complying with current and future regulatory requirements, policies or guidelines, including domestic and international laws and regulations pertaining to fraud and abuse, transparency, and the privacy and security of health information;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reaching agreement on acceptable terms and on a timely basis, if at all, with collaborators, physician investigators, vendors and other third parties located in the U.S. or jurisdictions in other countries, including our CROs, laboratory service providers and clinical trial sites, on all aspects of clinical development and collaborating with them successfully, including with respect to challenges and delays that have arisen and may continue to arise from the effects of the COVID-19 pandemic;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party clinical investigators or our CROs losing the licenses or permits necessary to perform our clinical trials, not performing our clinical trials according to our anticipated schedule or consistent with the clinical trial protocol, good clinical practices, or GCP, or regulatory requirements, or not performing data collection or analyses in a timely or accurate manner;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party contractors becoming debarred, disqualified or suspended or otherwise penalized by the FDA or other similar international regulatory authorities for violations of applicable regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or all of the data produced by such contractors in support of any applications for regulatory approval;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining timely review and clearances by regulatory authorities for any clinical protocol amendments, modifications to our manufacturing process which may be sought for current and potential future clinical trials of imetelstat, including responding to questions or comments from these authorities in a timely and adequate manner, which could, for example, prevent us from conducting or completing IMpactMF, IMproveMF or IMpress, or commencing potential future clinical trials of imetelstat; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining institutional review board or ethics committee approvals for clinical trial protocols or protocol amendments, including any future refinements to the trial designs we may seek for IMpactMF, IMproveMF or IMpress, or as a result of changes in regulatory requirements and policies, which could, for example, prevent us from conducting or completing IMpactMF, IMproveMF or IMpress, and commencing potential future clinical trials of imetelstat.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We could also encounter delays if a clinical trial is suspended or terminated. Clinical trials may be suspended or terminated due to a number of factors, including:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inspection of the clinical trial operations or trial site by the FDA or similar international regulatory authorities resulting in the imposition of a clinical hold;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safety issues or adverse side effects;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to demonstrate a benefit from using a drug; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in governmental regulations or administrative actions. </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failures or delays with respect to any of the aforementioned events could adversely affect our ability to conduct or complete IMpactMF, IMproveMF or IMpress, or to commence, conduct and complete potential future clinical trials of imetelstat, which could increase development costs, or interrupt, further delay or halt our development or potential commercialization of imetelstat, any of which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Further difficulties retaining patients in IMerge Phase 3 and enrolling or retaining patients in IMpactMF, IMproveMF and the investigator-led clinical trial IMpress, whether as a result of the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, could further delay or otherwise adversely affect our clinical development and commercialization activities, which would cause our business and business prospects to be severely harmed.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The timely completion of a clinical trial in accordance with its protocol depends, among other things, on the ability to enroll a sufficient number of patients who remain in the trial until its conclusion. Further challenges in retaining patients in IMerge Phase 3 and screening, enrolling and retaining patients in IMpactMF, IMproveMF and IMpress, whether as a result of the effects of due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, may further delay our conduct of such trials, or cause them to be discontinued. For example, we have clinical trial sites in Ukraine, Russia and nearby European countries, and have experienced, and may continue to experience, delays and suspensions in clinical trial activities at clinical sites in Ukraine and Russia due to the current civil or political unrest conditions, including delays in clinical site initiations, patient screening and enrollment, as well as constraints on available sites and site personnel.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we reported positive top-line results from IMerge Phase 3 in January 2023, retaining remaining patients in the treatment or follow-up phase would allow us to continue to assess the longer-term durability of RBC-TI responses. Therefore, if we experience difficulties in retaining such patients, whether due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, our ability to assess the longer-term durability of RBC-TI responses would be adversely affected. The retention of patients in IMerge Phase 3 and the enrollment and retention of patients in IMpactMF, IMproveMF and IMpress, depend on many factors, such as:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify and screen patients who meet the patient eligibility criteria specified in the protocol;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of the patient population required for analysis of the trial&#x2019;s primary endpoint;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the proximity of patients to trial sites, and patients&#x2019; willingness and ability to travel to trial sites for treatment or monitoring during the COVID-19 pandemic or civil or political unrest, such as the military conflict between Ukraine and Russia;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the design of the trial;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recruit and retain clinical trial investigators with the appropriate competencies and experience;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinicians&#x2019; and patients&#x2019; perceptions of the potential advantages of imetelstat, both in relation to other available therapies, including new drugs that have been approved or may be approved for the indications being investigated, and as a result of data reported from previous or current clinical trials of imetelstat, and their willingness to participate in clinical trials of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monitoring patients adequately during and after treatment;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to obtain and maintain patient consents; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk that disease progression will result in death or clinical deterioration before the patient can enroll in a clinical trial of imetelstat, or before sufficient data has been collected from such patient, such that any data collected from the patient does not contribute in a meaningful way to the interpretation of the results of the clinical trial in which the patient is enrolled; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk that patients enrolled in any imetelstat clinical trial will drop out of the trial before completion, due to lack of efficacy, adverse side effects, investigator decision, progressive disease, site restrictions due to the effects of macroeconomic conditions like the COVID-19 pandemic, or civil or political unrest </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or military conflicts around the world, such as the military conflict between Ukraine and Russia, alternate treatments being approved for the indication, or personal issues.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, IMpactMF has competed and will continue to compete with, and earlier stage clinical trials of imetelstat, such as IMproveMF and IMpress, will compete with, other clinical trials for product candidates that are in the same therapeutic areas with imetelstat, and such trials may also be conducted at the same clinical sites. This competition is reducing the number of clinical sites and hospital staff available to participate in IMpactMF, IMproveMF and IMpress, as well as the number and type of patients available to enroll or remain in current and potential future imetelstat clinical trials. Moreover, because imetelstat represents a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, rather than enroll patients into imetelstat clinical trials, or may decide not to enroll, or may not recommend enrollment, in IMpactMF, IMproveMF or IMpress, based on efficacy and safety results reported to date and that may be reported in the future.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, if imetelstat is approved for commercialization, we will need to complete substantial preparations to be ready for any potential future commercialization of imetelstat. The development of an in-house marketing and sales force or entering into an arrangement with a third party for the commercialization of imetelstat outside of the U.S. will require significant capital expenditures, management resources and time, and may have an adverse effect on the timely completion of IMpactMF, IMproveMF and IMpress.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delays caused by the effects of macroeconomic effects, like the COVID-19 pandemic or civil or political unrest or military conflicts around the world, such as the current military conflict between Ukraine and Russia, or other factors in patient enrollment, or the inability to retain or treat patients, have resulted in and may in the future result in further increased costs due to extended timelines and other factors, and may lead to incomplete data sets, or adversely affect the timing or outcome of current and potential future clinical trials of imetelstat which could delay or prevent the commencement, conduct or completion of these trials and adversely affect the clinical development, as well as the timing or outcome of the potential commercialization of imetelstat. Such occurrences would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events that could further delay or prevent the commencement and/or completion of clinical trials for imetelstat, further delay or prevent its regulatory approval, or limit its commercial potential.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events affecting its safety or efficacy that could interrupt, further delay or halt current or potential future clinical trials of imetelstat, such as IMerge Phase 3, IMpactMF, IMproveMF and IMpress. In this regard, adverse events and dose-limiting toxicities observed in previous and ongoing clinical trials of imetelstat include:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hematologic toxicities, such as profound and/or prolonged thrombocytopenia or neutropenia, including one case of febrile neutropenia after prolonged myelosuppression with intracranial hemorrhage resulting in patient death, which the investigator assessed as possibly related to imetelstat, as well as reversible Grade 4 febrile neutropenia;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">bleeding events, with or without thrombocytopenia, including reversible Grade 3/4 bleeding events;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hepatotoxicity and liver function test abnormalities, as well as hepatic failure;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">gastrointestinal events;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infections;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">muscular and joint pain;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fatigue;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">headache; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infusion-related reactions.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If patients in any clinical trials of imetelstat, including IMerge Phase 3, IMpactMF, IMproveMF, IMpress or any potential future clinical trials of imetelstat, experience similar or more severe adverse events, or new or unusual adverse events, or if the FDA or other similar international regulatory authorities determine that efficacy and safety data in current or potential future clinical trials of imetelstat do not support an adequate benefit-risk profile to justify continued treatment of patients, then the FDA or other similar international regulatory authorities may again place one or more of the INDs for imetelstat on clinical hold, as occurred in March 2014. If this were to occur, there would be a significant delay in, or possible termination of, such clinical trial or all the imetelstat clinical trials and any potential commercialization efforts, which might cause us to cease operations. For example, we recently became aware of a case in our IMpactMF clinical trial of a patient with myelofibrosis associated with underlying progressive bone marrow failure, who died from febrile neutropenia, pulmonary hemorrhage and bilateral pneumonia, which, at the time of reporting, the investigator related to imetelstat. If such toxicities or other safety issues in any clinical trial of imetelstat are determined by us, the FDA or similar international regulatory authorities to result in an unacceptable benefit-risk profile, then:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional information supporting the benefit-risk profile of imetelstat may be requested by the FDA or similar international regulatory authorities and if any such information supplied by us, or by our former collaboration partner, is not deemed acceptable, current clinical trials of imetelstat could be suspended, terminated, or placed on clinical hold by the FDA or similar international regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to retain enrolled patients in current clinical trials may be negatively affected, resulting in incomplete data sets and the inability to adequately assess the benefit-risk profile of imetelstat in a specific patient population; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional, unexpected clinical trials or non-clinical studies may be required to be conducted.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, clinical trials by their nature examine the effect of a potential therapy in a sample of the potential future patient population. As such, clinical trials conducted with imetelstat, to date and in the future, may not uncover all possible adverse events that patients treated with imetelstat may experience. Because remaining patients in IMerge Phase 3, IMpactMF and IMproveMF continue to receive imetelstat treatment, additional or more severe toxicities or safety issues, including additional non-serious or serious adverse events and dose-limiting toxicities, may be observed as patient treatment continues and more data become available. In addition, because additional data are being generated from these trials, the benefit-risk profile of imetelstat will continue to be assessed, including the risk of hepatotoxicity, severe cytopenias, fatal bleeding with or without any associated thrombocytopenia, patient injury or death, and any other severe adverse effects that may be associated with life-threatening clinical outcomes.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The occurrence of any of the aforementioned events could interrupt, further delay, or halt, any development, and as a result, impact or preclude the potential commercialization of imetelstat, as well as increase costs to develop imetelstat, which would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat, any of which might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The design of a clinical trial can determine whether its results will support regulatory approval of a product, and flaws in the trial design may not become apparent until the clinical trial is well advanced or during the approval process after the trial is completed.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A trial design that is considered appropriate for regulatory approval includes a sufficiently large sample size with appropriate statistical power, as well as proper control of bias, to allow a meaningful interpretation of the results. The preliminary results of imetelstat clinical trials with smaller sample sizes can be disproportionately influenced by the impact the treatment had on a few individuals, which limits the ability to generalize the results across a broader community, making the trial results of clinical trials with smaller sample sizes less reliable than trials with a larger number of patients. As a result, there may be less certainty that imetelstat will achieve a statistically significant effect in any future clinical trials.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, we shortened the follow-up period after the last patient has been enrolled from 15 months to 12 months to enable an earlier clinical cut-off date for the primary analysis in IMerge Phase 3. Although we reported positive top-line results from IMerge Phase 3 in January 2023, our decision to shorten the follow-up period after the last patient has been enrolled may result in further clinical responses that could occur after the 12-month clinical</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cut-off date being excluded from the primary analysis. The exclusion of this future data from the primary analysis could reduce the overall efficacy results of the trial, including durability of transfusion independence, which could limit or prevent marketing approval of imetelstat in lower risk MDS by the FDA or similar international regulatory authorities, cause them not to approve imetelstat at all or require additional clinical trials or further testing prior to granting any regulatory approval to market imetelstat in lower risk MDS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, with respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to the trial to assess a lower dose and/or a more frequent dosing schedule that might improve the trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. Existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity, and for these reasons we therefore determined not to add a third dosing arm to the trial design, and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks. Our belief may ultimately be incorrect. Therefore, our failure to add a third dosing arm could result in a failure to maintain regulatory clearance from the FDA and similar international regulatory authorities, could result in the trial&#x2019;s failure, or could otherwise delay, limit or prevent marketing approval of imetelstat in relapsed/refractory MF by the FDA or similar international regulatory authorities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Results and data we disclosed from prior non-clinical studies and clinical trials may not predict success in later clinical trials, and we cannot assure you that any ongoing or future clinical trials of imetelstat will lead to similar results and data that could potentially enable us to obtain any regulatory approvals.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Success in non-clinical testing and early clinical trials, including Phase 2 clinical trials, such as IMbark, does not ensure that later clinical trials will be successful, nor does it predict final clinical trial results. In addition, even though we reported positive top-line results from IMerge Phase 3 in January 2023, this does not ensure that any other clinical trials of imetelstat, including IMpactMF, IMproveMF and IMpress, will be successful. We cannot be certain that any of the prior, current or potential future clinical trials of imetelstat will generate sufficient, consistent or adequate efficacy and safety data demonstrating a positive benefit-risk profile, which would be necessary to obtain regulatory approval to market imetelstat in any indication. Imetelstat in later stages of clinical trials may fail to show the desired benefit-risk profile despite having progressed through non-clinical studies and initial clinical trials. Many companies in the biopharmaceutical industry have frequently suffered significant setbacks in later clinical trials, even after achieving promising results in earlier non-clinical studies or clinical trials.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In IMbark, we reported a median overall survival of 19.9 months and 28.1 months for the 4.7 mg/kg and 9.4 mg/kg dosing arms, respectively, in relapsed/refractory MF patients. In general, Phase 3 clinical trials with larger numbers of patients or longer durations of therapy may fail to replicate efficacy and safety results observed in earlier clinical trials, such as IMbark, and if this were to occur with IMpactMF, this would adversely affect future development prospects of imetelstat, and as a result, impact the potential commercialization of imetelstat, which would substantially impair our ability to raise additional capital.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, non-clinical and clinical data are often susceptible to varying interpretations and analyses. In some instances, there can be significant variability between different clinical trials of imetelstat due to numerous factors, including changes in trial procedures set forth in trial protocols, differences in the size and type of patient populations, and changes in and adherence to the dosing regimens. For example, complete and partial remissions were observed in an investigator-sponsored pilot study of imetelstat conducted at Mayo Clinic in MF patients, or the Pilot Study. However, similar activity was not observed in the MF patients enrolled in IMbark, as shown by the one partial remission observed in the IMbark primary analysis. We believe that differences in the IMbark study design when compared to the Pilot Study design, such as more restrictive patient enrollment criteria requiring either documented objective lack of response to a JAK inhibitor or evidence of progressive disease while on treatment with a JAK inhibitor, may have contributed to the data observed in IMbark differing significantly from data reported from the Pilot Study, but we cannot assure you that any future clinical trials of imetelstat in relapsed/refractory MF will yield results comparable to IMbark or the Pilot Study. In addition, the potential improvement in survival observed in the 9.4 mg/kg dosing arm in IMbark will need to be further assessed in IMpactMF, and similar results, including potential improvement in survival, if any, with respect to any patient population or patient population subgroup, may not be observed in IMpactMF. Likewise, although the statistical analyses comparing IMbark data to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">closely matched real world data, or RWD, published in the September 2021 issue of the Annals of Hematology, suggest potentially favorable OS for in relapsed/refractory MF patients treated with imetelstat, compared to BAT using closely matched patients&#x2019; RWD, such comparative analyses between RWD and our clinical trial data have several limitations. For instance, the analyses create a balance between treatment groups with respect to commonly available covariates, but do not take into account the unmeasured and unknown covariates that may affect the outcomes of the analyses. Potential biases are introduced by factors which include, for example, the selection of the patients included in the analyses, misclassification in the matching process, the small sample size, and estimates that may not represent the outcomes for the true treated patient population. For these and other reasons, such comparative analyses and any conclusions from such analyses should be considered carefully and with caution, and should not be relied upon as demonstrative or otherwise predictive or indicative of any current or potential future clinical trial results of imetelstat in relapsed/refractory MF, including IMpactMF.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to achieve results supporting a positive benefit-risk profile in current or potential future imetelstat clinical trials would interrupt, further delay, or halt, any development, and as a result, potential commercialization of imetelstat, which would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, &#x201c;snapshot,&#x201d; &#x201c;top-line,&#x201d; and preliminary data or statistical analyses from clinical trials that we announce or publish from time-to-time may change as more patient data become available, may be more positive than the final data, and are subject to audit and verification procedures that could result in material changes in the final data. Thus, such preliminary data should be considered carefully and with caution and not relied upon as indicative of future clinical results.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time-to-time, preliminary or interim safety and efficacy data from previous and current imetelstat clinical trials have been reported or announced by us, clinical investigators or our former collaboration partner. Preliminary data is based on a preliminary analysis of then available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As such, preliminary or interim results may not be reproduced in any current or potential future clinical trials of imetelstat, and thus should be considered carefully and with caution, and not relied upon as indicative of future clinical results. Additional or updated safety and efficacy data from current or potential future clinical trials of imetelstat may result in a benefit-risk profile that does not justify the continued development of imetelstat in a particular patient population, or at all. Any data reported from IMpactMF may materially differ from and be less positive than data previously reported from IMbark. Thus, reported data should be considered carefully and with caution, and not relied upon as indicative of future clinical results. Such additional data could result in a lower benefit-risk profile than initially expected, which could hinder the potential success of IMpactMF, IMproveMF or IMpress, or cause us to abandon further development of imetelstat entirely.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, we announced positive top-line results from IMerge Phase 3. Such top-line results may differ from future results of the same study, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, top-line data, including from IMerge Phase 3, should be viewed with caution until the final data are available. Material adverse differences in final data, compared to preliminary or interim data, could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, including the potential commercialization of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The research and development of imetelstat is subject to numerous risks and uncertainties.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The science and technology of telomere biology, telomerase and our proprietary oligonucleotide chemistry are relatively new. There is no precedent for the successful commercialization of a therapeutic product candidate based on these technologies. Significant research and development activities will be necessary to further develop imetelstat, our sole product candidate, and may take years to accomplish, if at all.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the significant scientific, regulatory and commercial challenges that must be overcome to successfully research, develop and commercialize imetelstat, the development of imetelstat in myeloid hematologic malignancies, including MDS and MF, may be further delayed or abandoned, even after significant resources have been expended on it. Examples of such situations include:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in September 2012, the discontinuation of our Phase 2 clinical trial of imetelstat in metastatic breast cancer;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in April 2013, the discontinuation of our development of imetelstat in solid tumors with short telomeres;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in March 2014, the full clinical hold placed by the FDA on imetelstat clinical trials; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the third quarter of 2016, closure of the 4.7 mg/kg dosing arm in IMbark to new patient enrollment and suspension of enrollment in the 9.4 mg/kg dosing arm in IMbark because an insufficient number of patients in the 9.4 mg/kg dosing arm met the protocol defined interim efficacy criteria at 12 weeks;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the third quarter of 2017, expansion of IMerge Phase 2 to enroll additional lower risk MDS patients in a target patient population; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in September 2018, our former collaboration partner&#x2019;s decision to terminate its imetelstat collaboration agreement with us.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further delay, suspension or abandonment of our development of imetelstat in myeloid hematologic malignancies, including with respect to our IMpactMF, IMproveMF and IMpress clinical trials, could have a material adverse effect on the future of imetelstat and our business prospects, including the potential commercialization of imetelstat in indications other than lower risk MDS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on third parties to conduct our current and potential future clinical trials of imetelstat. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may be unable to continue the development of, obtain regulatory approval for, or commercialize imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not have the ability to independently conduct clinical trials. Therefore, we rely on medical institutions, clinical investigators, contract laboratories and other third parties, such as CROs, service providers, vendors, suppliers and consultants, to conduct clinical trials of imetelstat. The third parties we contract with for execution of our current and potential future clinical trials of imetelstat play a critical role in the conduct of these trials and the subsequent collection and analysis of data. However, these third parties are not our employees, and except for contractual duties and obligations, we have limited ability to control their performance, or the amount or timing of resources that they devote to imetelstat. For example, we have retained CROs to support our imetelstat clinical development activities, and any failure by our CROs to perform their contractual obligations, whether due to the effects of the COVID-19 pandemic or otherwise, or disputes with our CROs about the quality of their performance or other matters, could further delay or halt our imetelstat clinical development activities including current or future imetelstat clinical trials. These third parties may also have relationships with other commercial entities, some of which may compete with us. Under certain circumstances, these third parties may terminate their agreements with us without cause and upon immediate written notice.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we rely on third parties to conduct our imetelstat clinical trials, including IMerge Phase 3, IMpactMF and IMproveMF, we remain responsible for ensuring that each clinical trial is conducted in accordance with its investigational plan and protocol, and applicable laws. Moreover, the FDA and similar international regulatory authorities require us to comply with GCP regulations and standards for conducting, monitoring, recording and reporting the results of clinical trials to ensure that the data and results are scientifically credible and accurate, and that the rights, integrity and confidentiality of patients participating in clinical trials are protected, including being adequately informed of the potential risks. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of our CROs fail to comply with applicable GCP requirements, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, or similar international regulatory authorities, may require us to perform additional clinical trials before approving any application for approval. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP or other applicable regulations. In addition, our clinical trials must be conducted with imetelstat produced under applicable GMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which would further delay the process for any regulatory approval. Our ability to comply with these regulations and standards may be contingent upon activities conducted by third parties, and if they fail to perform in accordance with contractual obligations and legal requirements, our development of imetelstat may be interrupted, further delayed or halted. Any failures by us or third parties noted above would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat, including the potential commercialization of imetelstat, any of which might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also are required to register imetelstat clinical trials that we sponsor and post the results of certain completed clinical trials on certain government-sponsored databases, such as ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, the execution of clinical trials and the subsequent compilation and analysis of the data produced, including the interim and final analyses for IMpactMF, requires coordination among various parties. In order for these functions to be carried out effectively and efficiently, it is imperative that these parties communicate and coordinate with one another. If the quality or accuracy of the clinical data obtained, compiled or analyzed by third parties is compromised due to their failure to adhere to our clinical trial protocols, GCP or GMP requirements, or for any other reason, we may need to enter into new arrangements with alternative third parties, which would cause delay, and could be difficult, costly or impossible. If third parties conducting our clinical trials do not perform their contractual duties or obligations, experience work stoppages, do not meet expected deadlines, terminate their agreements with us or need to be replaced, our clinical trials may be extended, delayed or terminated, or may be unsuccessful or need to be repeated, which could have a material adverse effect on our business, including the potential commercialization of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with alternative third parties or do so on commercially reasonable terms. Switching or adding CROs, investigators and other third parties involves additional costs and delays because of the time it takes to finalize a contract with a new CRO and for their commencement of work. As a result, delays can occur, which could materially impact our ability to meet our desired clinical development timelines. The COVID-19 pandemic and public health safety measures taken in response have also had a significant impact on our CROs and other third parties. Although we carefully manage our relationships with our CROs, investigators and other third parties, we and any of these third parties may nonetheless encounter challenges or delays in the future, which could have a material and adverse impact on our business, business prospects and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, certain principal investigators for our clinical trials serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected conduct of the trial. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of any applications for approval by the FDA and may ultimately lead to the denial of approval of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will not control the conduct of current or any potential future investigator-led clinical trials, and data from such trials could show marginal efficacy and/or clinically relevant safety concerns related to imetelstat resulting in an unfavorable benefit-to-risk assessment that could impact our ongoing clinical trials or development program for imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will not control the design or administration of the investigator-led clinical trial, IMpress, or any potential future investigator-led trials, nor the submission, approval or maintenance of any IND or foreign equivalent required to conduct these clinical trials. In addition, we will not have control over the timing and reporting of the data from any such investigator-led clinical trials. A delay in the timely completion of or reporting of data from any potential future investigator-led clinical trial could have a material adverse effect on our ability to further develop imetelstat or to advance imetelstat to subsequent clinical trials.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investigator-led clinical trials may be conducted under less rigorous clinical standards than those used in company-sponsored clinical trials. Accordingly, regulatory authorities may closely scrutinize the data collected from these investigator-led clinical trials. In addition, any potential future investigator-led clinical trials could show</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">marginal efficacy and/or clinically relevant safety concerns that could delay the further clinical development or marketing approval of imetelstat for any indication. To the extent that the results of any potential future investigator-led clinical trials raise safety or other concerns regarding imetelstat, regulatory authorities may question the results of such investigator-led clinical trials, or question the results of IMerge Phase 3, IMpactMF, and IMproveMF. Safety concerns arising from any potential future investigator-led clinical trials could result in partial or full clinical holds being placed on the imetelstat INDs by the FDA or other similar international regulatory authorities, as occurred in March 2014, which would further delay or prevent us from advancing imetelstat into further clinical development and cause us to discontinue our development of imetelstat, which would severely harm our business and prospects, including the potential commercialization of imetelstat, and could potentially cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Regulatory APPROVAL and Commercialization of Imetelstat</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our inability to obtain and maintain regulatory clearances and approvals to continue the clinical development of, and to potentially commercialize, imetelstat, would severely and adversely affect imetelstat&#x2019;s future value, and our business and business prospects, and might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal, state and local governments in the U.S. and governments in other countries have significant regulations in place that govern drug research and development and may prevent us from successfully conducting development efforts or potentially commercializing imetelstat. Delays in obtaining or failure to maintain regulatory clearances and approvals, or limitations in the scope of such clearances or approvals, could:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impede or halt our activities and plans for clinical development and commercialization;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significantly harm the commercial potential of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impose additional development costs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diminish any competitive advantages that may have been available to us; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further delay or preclude any revenue we may receive from the future commercialization of imetelstat, if any.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, with respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to the trial to assess a lower dose and/or a more frequent dosing schedule that might improve the trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. Existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity, and for these reasons we therefore determined not to add a third dosing arm to the trial design and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks. Our belief may ultimately be incorrect. Therefore, our failure to add a third dosing arm could result in a failure to maintain regulatory clearance from the FDA and similar international regulatory authorities, could result in the trial&#x2019;s failure, or could otherwise delay, limit or prevent marketing approval of imetelstat for relapsed/refractory MF by the FDA or similar international regulatory authorities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in IMerge Phase 3 we shortened the follow-up period after the last patient has been enrolled from 15 months to 12 months to enable an earlier clinical cut-off date for the primary analysis. Although we reported positive top-line results from IMerge Phase 3 in January 2023, our decision to shorten the follow-up period after the last patient has been enrolled may result in further clinical responses that could occur after the 12-month clinical cut-off date being excluded from the primary analysis. The exclusion of this future data from the primary analysis could reduce the overall efficacy results, including durability of transfusion independence, which could otherwise delay, limit or prevent marketing approval of imetelstat in lower risk MDS by the FDA or similar international regulatory authorities or require additional clinical trials and further testing prior to granting any regulatory approval to market imetelstat in lower risk MDS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even though we reported positive top-line results from IMerge Phase 3 in January 2023, those results are not necessarily be predictive of imetelstat activity in other indications and for other pivotal trials that may be needed to support any application to the FDA or similar international regulatory authorities for such other indications, such as from IMpactMF. We may therefore fail to further develop or commercialize imetelstat, which would severely and adversely affect our business and business prospects, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to prepare and timely submit the planned NDA for imetelstat in lower risk MDS, and to successfully obtain regulatory approval for and commercialize imetelstat, or experience significant delays in doing so, our business will be materially harmed.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of obtaining marketing approvals, both in the U.S. and in other countries, is lengthy, expensive and uncertain. It may take many years to obtain approval, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Of the large number of drugs in development, only a small percentage complete the regulatory approval process and are successfully commercialized. In addition, the lengthy review process as well as the unpredictability of future clinical trial results may result in a delay in obtaining, or our failure to obtain, regulatory approval for imetelstat in lower risk MDS, relapsed/refractory MF, or any other indication, which would significantly harm our business, business prospects, including the potential commercialization of imetelstat, and the future value of imetelstat and might cause us to cease operations.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securing marketing approval requires the submission of extensive non-clinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#x2019;s safety and efficacy, as well as information about the product manufacturing process and any inspections of manufacturing facilities conducted by regulatory authorities through the filing of an NDA in the U.S. and an MAA in Europe. As a company, we have not previously submitted an NDA to the FDA or similar applications to comparable international regulatory authorities for imetelstat. The preparation of an NDA requires a great deal of effort and expertise, and if we do not secure the necessary resources and retain personnel having the requisite expertise to prepare and submit an NDA, the filing of any NDA would be delayed. Further, if we submit an NDA, there can be no assurance that it will be accepted by the FDA. If the FDA determines after an initial review of the NDA that the data included in the application is insufficient and not ready for formal consideration, we could receive a &#x201c;refuse to file&#x201d; notice. The FDA also has substantial discretion in the approval process.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we reported positive top-line results from IMerge Phase 3 in lower risk MDS, and while we believe that these results and our assessment of the positive benefit-risk profile of imetelstat, combined with data from our Phase 2 clinical trials, are supportive of planned regulatory submissions in the U.S. and in the EU for imetelstat in lower risk MDS, regulatory authorities in those jurisdictions may disagree with our interpretation of the data and may require additional clinical testing before we can seek regulatory approval and begin commercialization of imetelstat, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects. There is no guarantee that we will obtain regulatory approval or be able to commence commercialization on the timeline we are planning or at all.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat must receive all relevant regulatory approvals before it may be marketed in the U.S. or other countries. Regulatory authorities have substantial discretion in the approval process and can delay, limit or deny approval of imetelstat or require us to conduct additional non-clinical or clinical testing or abandon a program for many reasons, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement with the design or implementation of our clinical trials, including our statistical analysis of trial results;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to demonstrate to the FDA or similar international regulatory authorities that imetelstat&#x2019;s efficacy results, including duration of response, is acceptable;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unfavorable benefit-to-risk assessment, in the case of marginal efficacy and/or clinically relevant safety concerns, for any proposed indication;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">serious and unexpected drug-related side effects experienced by participants in our clinical trials or by individuals using drugs similar to imetelstat;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement with our interpretation of data from non-clinical studies or clinical trials;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to collect data from clinical trials of imetelstat meeting the level of integrity or statistical or clinical significance required by the FDA or similar international regulatory authorities, or a determination such data is not sufficient to support the submission of an NDA, MAA, or other submission, or to obtain regulatory approval in the U.S., the EU or elsewhere;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deficiencies in our clinical trial operations or the clinical trial operations of trial sites;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">identification of critical issues as a result of a pre-approval health authority inspection that could negatively impact the integrity of data in an NDA or MAA and lead to a rejection by the FDA and similar international health authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">errors or deficiencies in the conduct of the imetelstat program prior to its transition to us by our former collaborator, and/or in the transition of the imetelstat program to us by our former collaborator;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unwillingness or inability by our former collaborator to provide information requested by the FDA or similar international regulatory authorities regarding the time period when our former collaborator was responsible for the imetelstat program;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA or similar international regulatory authorities that the appropriate indication for commercial use of imetelstat is narrower or more restrictive than anticipated;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to satisfy the requirement to develop a risk evaluation and mitigation strategy, or REMS, for the U.S. and a risk management plan for the EU including post-marketing studies, as a potential condition to approval;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement regarding the formulation, labeling and/or the specifications for imetelstat; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA or similar international regulatory authorities that the manufacturing processes, test procedures and specifications applicable to the manufacture of imetelstat, or the facilities of the third-party manufacturers with which we contract for clinical and commercial supplies of imetelstat are inadequate, or failure by such third-party manufacturers to maintain compliance with the regulatory and other requirements established by the FDA or similar international regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the failure of the quality or stability of imetelstat to meet acceptable regulatory standards;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or similar international regulatory authorities may lack resources or be delayed in conducting pre-approval inspections due to reasons related to COVID-19 or otherwise;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or any third-party service providers may be unable to demonstrate compliance with current good manufacturing practices, or cGMPs, and/or good clinical practices, GCPs, to the satisfaction of the FDA or similar international regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in regulatory policies or approval processes, or potential reduction of unmet medical need with the entry of competitive therapies to the market, could render our clinical efficacy or safety data insufficient for approval; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">political factors surrounding the approval process, such as government shutdowns, political instability or global pandemics, such as COVID-19.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in recent years, there has been increased public and political scrutiny on the FDA and similar international regulatory authorities with respect to the approval process for new drugs, and as a result regulatory authorities may apply more stringent regulatory standards, especially regarding drug safety, when reviewing regulatory submissions for new drugs.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we believe we have complied with all of the regulatory requirements to receive marketing approval for imetelstat, we may not obtain marketing approval for reasons that we do not currently predict. If we fail to obtain regulatory approval for imetelstat, we will have no commercialized products and correspondingly no revenue.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render imetelstat not commercially viable, which would harm imetelstat&#x2019;s future value and our business and business prospects. In addition, obtaining regulatory approval is a lengthy, expensive and uncertain process. For example, following the result of a referendum in 2016, the U.K. left the EU on January 31, 2020, commonly referred to as Brexit, and its withdrawal from the EU was completed on December 31, 2020. The withdrawal of the U.K. from the EU has resulted in uncertainty in relation to the regulatory process in the U.K., and for Europe could potentially result in a delay in the review of regulatory submissions which could also lead to less efficient, more expensive, and potentially lengthier regulatory review processes for companies like us, who may seek to obtain regulatory approval for drug products in the EU or the U.K. Such regulatory changes in the U.K. or elsewhere could adversely affect and/or delay our ability to obtain approval of, and market and sell, imetelstat in the U.S. or other countries.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory authorities may also not approve the labeling claims that are necessary or desirable for the successful commercialization of a drug, such as imetelstat. For example, future regulatory clearances, if any, that we might obtain for imetelstat may be limited to fewer or narrower indications than we might request, or may be granted subject to the performance of post-marketing studies, which may impose further requirements or restrictions on the distribution or use of imetelstat, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria, and requiring treated patients to enroll in a registry. These limitations and restrictions may limit the size of the market for imetelstat and affect reimbursement by third-party payors. Future regulatory clearances, if any, may be limited to a smaller patient population, or may require a different drug formulation or a different manufacturing process, than we might in the future decide to seek.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, failure by our former collaborator to comply with applicable regulatory guidelines prior to our assumption of sponsorship of the imetelstat program could result in administrative or judicially imposed sanctions on us, including warning letters, civil and criminal penalties, injunctions, product seizures or detention, product recalls, total or partial suspension of manufacturing activities, and the potential refusal to approve any NDAs.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any delay in obtaining or failure to obtain required approvals of imetelstat, or limitations on any regulatory approval that we might receive in the future, if any, could reduce the potential commercial use of imetelstat, and potential market demand for imetelstat and therefore result in decreased revenue for us from any commercialization of imetelstat, any of which would severely and adversely affect our financial results and ability to raise additional capital, the price of our common stock, our business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If imetelstat is approved for commercialization and we are unable to establish sales, marketing and distribution capabilities or enter into agreements with third parties to commercialize imetelstat, we will be unable to successfully commercialize imetelstat if and when it is approved.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will need to complete substantial preparations to be ready for any potential future commercialization of imetelstat, and currently we have no sales, marketing or distribution capabilities and no experience in marketing products. To advance imetelstat to potential marketing approval, we will be required to complete our commercialization preparatory activities, and continue to incur related expenses, before we obtain any marketing approval. These activities will include, among other things, the development of an in-house marketing and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other companies to recruit, hire, train and retain qualified marketing and sales personnel. If we are unable to adequately prepare for the potential future commercialization of imetelstat, we may not be able to generate product revenue if marketing authorization is obtained.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are risks involved with both establishing our own sales, marketing and distribution capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of imetelstat for which we recruit a sales and marketing force and establish distribution capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses, which would be costly. Even if imetelstat is approved in lower risk MDS and we are able to establish our own sales and marketing capabilities, imetelstat will be a newly-marketed drug. As a result, we will be required to expend</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant time and resources to train sales personnel in commercializing imetelstat. If we are unable to effectively train sales personnel and equip them with compliant and effective materials, our efforts to successfully commercialize imetelstat could be adversely affected, which would negatively impact our business, business prospects and the future value of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Factors that may inhibit our efforts to commercialize imetelstat on our own include:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to recruit, train and retain adequate numbers of effective sales, marketing, distribution, coverage or reimbursement, customer service, medical affairs and other support personnel;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to equip sales personnel with compliant and effective materials, including medical and sales literature to help them educate physicians regarding the indications we are targeting and imetelstat, if approved;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the lack of complementary medicines to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to price imetelstat at a sufficient price point to ensure an adequate and attractive level of profitability; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen costs and expenses associated with creating an independent sales and marketing organization;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to maintain existing supply arrangements, or to establish new supply arrangements with third-party suppliers and contract manufacturers to ensure sufficient commercial supplies; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to obtain and maintain patent protection, trade secret protection and regulatory exclusivity, both in the U.S. and in other countries;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lack of an acceptable safety profile following any regulatory approval; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to compete effectively with other therapies.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we enter into arrangements with third parties to perform commercialization services like sales, marketing and distribution, we will be reliant on the efforts of such third parties, and our sales revenue from sales of imetelstat or the profitability from such sales to us are likely to be lower than if we were to market and sell imetelstat ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize imetelstat or may be unable to do so on terms that are favorable to us. In entering into third-party commercialization arrangements, any revenue we receive will depend upon the efforts of the third parties, and we cannot assure you that such third parties will establish adequate commercialization capabilities or devote the necessary resources and attention to commercialize imetelstat effectively. We also face competition in our search for third parties to assist us with the commercialization efforts of imetelstat.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our inability to successfully establish commercialization capabilities for imetelstat, if we receive regulatory approval to do so, would severely and adversely affect our financial results, business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If acceptable prices or adequate reimbursement for imetelstat is not obtained, the use of imetelstat could be severely limited.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ability to successfully commercialize imetelstat, if approved, will depend significantly on obtaining acceptable prices and the availability of coverage and adequate reimbursement to the patient from third-party payors. Government payors, such as the Medicare and Medicaid programs, and other third-party payors, such as private health insurers and health maintenance organizations, determine which medications they will cover and the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reimbursement levels. Assuming we obtain coverage for imetelstat by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. If imetelstat is approved for commercial sale, patients are unlikely to use it unless coverage is provided, and reimbursement is adequate to cover all or a significant portion of its cost. Therefore, coverage and adequate reimbursement will be critical to new product acceptance.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government authorities and other third-party payors are developing increasingly sophisticated methods of controlling healthcare costs, such as by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices as a condition of coverage, are using restrictive formularies and preferred drug lists to leverage greater discounts in competitive classes, and are challenging the prices charged for medical products. Further, no uniform policy requirement for coverage and reimbursement for drug products exists among third-party payors in the U.S. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of imetelstat to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that coverage and reimbursement will be available for imetelstat, if approved for commercial sale, and, if reimbursement is available, what the level of reimbursement will be. There may also be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar international regulatory authorities. Coverage and reimbursement may impact the demand for, or the price of imetelstat, if marketing approval is obtained. If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully commercialize imetelstat, even if marketing approval is obtained, which would negatively impact our business and business prospects.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Although orphan drug designation has been granted to imetelstat for the treatment of MF and MDS in the U.S. and in the EU, these designations may not be maintained, which would eliminate the benefits associated with orphan drug designation, including the potential for market exclusivity, which would likely result in decreased sales revenue from commercialization of imetelstat, if any, and would likely harm our business and business prospects.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA granted orphan drug designation to imetelstat in June 2015 for the treatment of MF and for the treatment of MDS in December 2015, and the EMA granted orphan drug designation in December 2015 to imetelstat for the treatment of MF and in July 2020 for the treatment of MDS. The designation of imetelstat as an orphan drug does not guarantee that any regulatory authority will accelerate regulatory review of, or ultimately approve, imetelstat, nor does it limit the ability of any regulatory authority to grant orphan drug designation to product candidates of other companies that treat the same indications as imetelstat prior to imetelstat receiving any exclusive marketing approval.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may lose orphan drug exclusivity for certain reasons, including if the FDA or EMA determines that the request for orphan drug designation was materially defective or if we cannot ensure sufficient quantities of imetelstat to meet the needs of patients with MF or MDS. Failure to maintain orphan designation status in the EU at the time of submitting the MAA, or failure to complete the agreed pediatric plan, would lead to the loss of the additional two-year exclusivity period.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we maintain orphan drug exclusivity for imetelstat, the exclusivity may not effectively protect imetelstat from all competition because different drugs with different active moieties can be approved for the same condition. Even after an orphan drug product is approved, the FDA or EMA can subsequently approve a different drug with the same active moiety for the same condition, if the FDA or EMA concludes that the later drug is safer, more effective, or makes a major contribution to patient care. The occurrence of any of these events could result in decreased sales of imetelstat, should it ever receive marketing approval, and may harm our business and business prospects. In addition, orphan drug designation will neither shorten the development time nor regulatory review time for imetelstat, and it does not give imetelstat any advantage in the regulatory review or approval process.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">A Fast Track designation by the FDA, such as the Fast Track designations received for imetelstat for MDS and MF, does not guarantee marketing approval and may not lead to a faster development, regulatory review or approval process.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2017, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with transfusion-dependent low red blood cell counts, or anemia, due to non-del(5q) lower risk MDS and who are refractory or resistant to treatment with an ESA. In September 2019, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with relapsed/refractory MF.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fast Track designation provides opportunities for frequent interactions with FDA review staff, as well as eligibility for priority review, if relevant criteria are met, and rolling review of the sponsor&#x2019;s NDA. Fast Track designation is intended to facilitate and expedite development and review of an NDA to address unmet medical needs in the treatment of serious or life-threatening conditions. However, Fast Track designation does not accelerate conduct of clinical trials or mean that the regulatory requirements are less stringent, nor does it ensure that any imetelstat NDA will be approved or that any approval will be granted within any particular timeframe. In addition, the FDA may withdraw Fast Track designation for any indication if it believes that the designation is no longer supported by data emerging from the imetelstat clinical development program.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The Innovation Passport designation from the United Kingdom regulatory authorities does not guarantee marketing approval and may not lead to a faster development, regulatory review or approval process.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2021, we gained access to the ILAP through the receipt of an Innovation Passport for imetelstat to treat lower risk MDS. The ILAP is a new program sponsored by the Medicines and Healthcare products Regulatory Agency, or MHRA, in the U.K., post-Brexit. The objective of this new licensing and access pathway is to reduce the time to market and enable earlier patient access for innovative medicines. The Innovation Passport is the first prescribed entry point in the ILAP process. Key benefits of being within ILAP include a potential 150-day accelerated assessment and rolling review of an MAA, as well as opportunities for frequent interactions with the review staff at the MHRA and its partner agencies to discuss imetelstat&#x2019;s development, regulatory and reimbursement plans.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the goal of ILAP and the Innovation Passport is to reduce the time to market and enable earlier patient access, it does not accelerate conduct of clinical trials or mean that the regulatory requirements are less stringent, nor does it ensure that any imetelstat MAA will be approved or that any approval will be granted within any particular timeframe. Despite receiving Innovation Passport designation, we may decide to delay or forego the commercialization of imetelstat in the U.K.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure to achieve continued compliance with government regulations could delay or halt potential commercialization of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approved products and their manufacturers are subject to continual review, and discovery of previously unknown problems with a product or its manufacturer may result in restrictions on the product or manufacturer, including import restrictions, seizure and withdrawal of the product from the market. If approved for commercial sale, future sales of imetelstat will be subject to government regulation related to numerous matters, including the processes of:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advertising and promoting;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">selling and marketing;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">medical information;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">labeling; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">distribution.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If, and to the extent that, we are unable to comply with these regulations, our ability to earn potential revenue from the commercialization of imetelstat, if any, would be materially and adversely impacted.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if imetelstat causes serious or unexpected side effects or is associated with other safety risks after receiving marketing approval, a number of potential significant negative consequences could result, including, but not limited to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may withdraw their approval of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to recall imetelstat, seek to change the way it is administered, conduct additional clinical trials or change the labeling of the product;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may require revisions to the labeling of imetelstat,, including limitations on approved uses or the addition of further warnings, contraindications or other safety information, or may impose restrictions on distribution in the form of REMS in connection with approval, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may experience manufacturing delays and supply disruptions if regulatory inspectors identify regulatory noncompliance by third party manufacturers requiring remediation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">imetelstat may be rendered less competitive and sales may decrease;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our reputation may suffer generally both among clinicians and patients;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be exposed to potential lawsuits and associated legal expenses, including costs of resolving claims;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or similar international regulatory authorities may refuse to approve pending applications or supplements to approved applications filed by us, or may suspend or revoke license approvals; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to change or stop ongoing clinical trials of imetelstat, which would negatively impact the development of imetelstat for other potential indications.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance for imetelstat or could substantially increase the costs and expenses of commercializing imetelstat, which in turn could delay or prevent us from generating any revenues from the sale of the imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, the FDA strictly regulates the promotional claims that may be made about drug products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#x2019;s approved labeling. The FDA and other agencies actively enforce regulations prohibiting the promotion of any drug product for off-label uses. If we were found to have improperly promoted off-label use of imetelstat, we would be subject to significant civil, criminal and administrative penalties, which would inhibit our ability to commercialize imetelstat and generate revenue, require us to expend significant time and resources in response, and generate negative publicity. Enforcement actions include, among others:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse regulatory inspection findings;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters, or untitled letters;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">voluntary or mandatory product recalls or public notification or medical product safety alerts to healthcare professionals;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on, or prohibitions against, marketing imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on, or prohibitions against, importation or exportation of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">suspension of review or refusal to approve pending applications or supplements to approved applications;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusion from participation in government-funded healthcare programs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusion from eligibility for the award of government contracts for imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">suspension or withdrawal of product approvals;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizures;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">civil and criminal penalties and fines.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The imposition of any of these penalties or other commercial limitations would severely and adversely affect our financial results, business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If, in the future, we seek regulatory approval to market imetelstat internationally, we may experience a variety of risks that would materially adversely affect our business.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If, in the future, we seek regulatory approval of imetelstat outside of the U.S., and if the necessary approvals are obtained, we will be subject to additional risks related to operating in countries outside of the U.S., including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">foreign regulatory approvals, if any, may take longer and be more costly to obtain than approvals in the U.S., due to differing regulatory requirements in foreign countries, such as the lack of pathways for accelerated drug approval;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities outside of the U.S. may disagree with the design, implementation or results of our clinical trials or our interpretation of data from nonclinical studies or clinical trials;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approval policies or regulations of regulatory authorities outside of the U.S. may significantly change in a manner rendering our clinical data insufficient for potential approval;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the COVID-19 pandemic may negatively impact our ability to produce imetelstat and conduct clinical trials in countries outside of the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may experience unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general economic weakness, including inflation, rising interest rates, the prospect of a recession or civil or political instability in particular economies and markets outside of the U.S., including as a result of the conflict between Russia and Ukraine;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">risks of potential noncompliance with legal requirements applicable to privacy, data protection, information security and other matters;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">risks of potential noncompliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased taxes outside of the U.S., including withholding of payroll taxes;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulties staffing and managing operations outside of the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complexities associated with managing multiple payor reimbursement regimes and government payors in foreign countries;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable regulations outside of the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges enforcing our contractual and intellectual property rights, especially in those countries outside of the U.S. that do not respect and protect intellectual property rights to the same extent as the U.S.;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">business interruptions resulting from geopolitical actions, including war and terrorism including the conflict between Russia and Ukraine.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also subject to numerous regulatory requirements outside of the U.S. governing, among other things, the conduct of clinical trials, manufacturing and marketing authorization, pricing and third-party reimbursement. The regulatory approval process varies among countries and may include all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of local regulations in jurisdictions outside of the U.S. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities outside the U.S. and vice versa.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, the Clinical Trials Regulation, which came into effect in January 2022, introduced substantial changes in how clinical trials are authorized in the European Economic Area, or EEA, enabling sponsors to submit a single application to run a clinical trial in several European countries. The objectives of the new regulation include consistent rules for conducting trials throughout the European Union, consistent data standards and adverse events listing, and consistent information on the authorization status. Information on the conduct and results of each clinical trial carried out in the EU will be made publicly available. Commencing in January 2023, clinical trial sponsors will need to use the Clinical Trials Information System, or CTIS, to apply to start a new clinical trial in the EEA; and from January 2025, clinical trials in the EEA will need to comply with the Clinical Trials Regulation.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a new pan-European clinical trial data information database has been created that will be complementary to the database established for pharmacovigilance (Regulation (EC) No 726/2004 with respect to centrally authorized medicinal products). In addition, Commission Implementing Regulation (EU) No 520/2012 outlines the practical implications for marketing authorization holders, national competent authorities, and the EMA. Also, Commission Delegated Regulation (EU) No 357/2014 on post-authorization efficacy studies specifies the situations in which such studies may be required. Post-authorization efficacy studies may be required where concerns relating to some aspects of efficacy of the medicinal product are identified and can be resolved only after the medicinal product has been marketed, or where the understanding of the disease, the clinical methodology or the use of the medicinal product under real-life conditions indicate that previous efficacy evaluations might have to be revised significantly.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Brexit is also expected to disrupt the operation of pre- and post-authorization clinical trial infrastructure. The rules around GMP and pharmacovigilance in the U.K. currently remain similar to the EU requirements. However, the Falsified Medicines Directive will not apply in Great Britain though it is likely that the U.K. will implement a procedure to minimize the risk of falsified medicines.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Uncertainty in the regulatory framework and future legislation could lead to disruption in the execution of international multi-center clinical trials, the monitoring of adverse events through pharmacovigilance programs, the evaluation of the benefit-risk profiles of new medicinal products, and determination of marketing authorization across different jurisdictions. Changes to existing regulations may add considerably to the development lead time to marketing authorization and commercialization of products in the EU and increase our costs. We cannot predict the impact of such changes and future regulation on our business or the results of our operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to requests for access to imetelstat. Demand for compassionate use of imetelstat could strain our resources, delay our drug development activities, negatively impact our regulatory approval or commercial activities, and result in losses.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing imetelstat to treat life-threatening hematologic malignancies for which there are currently limited therapeutic options. Other companies in our field have been the target of campaigns requesting access to unapproved drugs. If we experience similar request for access campaigns, we may experience significant disruption to our business which could result in losses. We are a small company with limited resources, and any unanticipated</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">trials or access programs resulting from requests for access could deplete our drug supply, increase our capital expenditures, reduce the availability of potentially eligible clinical trial participants, and otherwise divert our resources from our primary goals.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, legislation referred to as &#x201c;Right to Try&#x201d; laws have been introduced at the local and national levels, which are intended to give patients access to unapproved therapies. New and emerging legislation regarding expanded access to unapproved drugs for life-threatening illnesses could negatively impact our business in the future. Either activism or legislation related to requests for access may require us to initiate an unanticipated expanded access program or to make imetelstat more widely available sooner than anticipated.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients who receive access to unapproved drugs through compassionate use or expanded access programs have life-threatening illnesses and generally have exhausted all other available therapies. The risk for serious adverse events, including those which may be unrelated to imetelstat, in this patient population is high and could have a negative impact on the safety profile of imetelstat, which could cause significant delays or an inability to successfully commercialize imetelstat and could materially harm our business. In addition, if, in order to perform the controlled clinical trials required for potential regulatory approval and successful commercialization of imetelstat, we do not provide compassionate use access or expanded access programs in response to requests for access from patients in the U.S. or elsewhere in the world, we may receive adverse publicity or experience other disruptions. Should we agree to provide compassionate use access or decide to initiate an expanded access program, we could experience adverse publicity or other disruptions related to potential participants in such programs. Similarly, we could experience adverse publicity or other disruptions if we were to restructure or pause any compassionate use and/or expanded access program after initiating such a program or after the provision of our product through compassionate access to an individual patient or patients.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Manufacturing Imetelstat</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure by us to establish and/or maintain a manufacturing supply chain to appropriately and adequately supply imetelstat for future clinical and commercial uses would result in a further delay in or cessation of clinical trials and a delay in our ability to obtain regulatory approvals of imetelstat, and affect our ability to commercialize imetelstat, and our business and business prospects could be severely harmed, and we could cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The manufacture of imetelstat must comply with applicable regulatory standards for current and potential future clinical trials and potential commercial uses. The process of manufacturing imetelstat is complex and remains subject to several risks, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to scale-up and attain sufficient production yields with appropriate quality control and quality assurance to meet the needs of our clinical trials and potential future market demand, and to establish commercial supply agreements;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reliance on third-party manufacturers and suppliers, whose efforts we do not control;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">supply chain issues, including the timely availability and shelf life requirements of raw materials and other supplies, any of which may be impacted by a number of factors, including the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shortage of qualified personnel; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory acceptance and compliance with regulatory requirements, which are less well-defined for oligonucleotide products than for small molecule drugs and vary in each country where imetelstat might be sold or used.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of these and other risks, we may be unable to establish and/or maintain a manufacturing infrastructure and supply chain capable of providing imetelstat for IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and potential future commercial uses, which would delay or result in a cessation of such current or potential future clinical trials of imetelstat. Occurrence of any such events would further delay or preclude any applications for regulatory approval and therefore further delay or preclude our ability to earn revenue from the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commercialization, if any, of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If third parties that manufacture imetelstat fail to perform as needed, then the clinical and commercial supply of imetelstat will be limited, and we may be unable to conduct or complete current or potential future clinical trials of imetelstat or to commercialize imetelstat in the future.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our imetelstat manufacturing supply chain relies, and will continue to rely, solely upon third-party manufacturers to perform certain process development or other technical and scientific work with respect to imetelstat, as well as to supply starting materials and manufacture drug substance and drug product. While we have established arrangements with third parties for the manufacture of imetelstat, our manufacturing supply chain is highly specialized, and as such we are reliant upon a small group of third-party manufacturers to supply starting materials, drug substance and drug product. Failure by such third-party manufacturers to perform in a timely manner and in compliance with all regulatory requirements, or at all, could further delay, perhaps substantially, or preclude our ability to pursue imetelstat development on our own, increase our costs and otherwise negatively affect our financial results, business and business prospects. In this regard, a recent FDA inspection of one of our third-party manufacturers identified certain deficiencies in the manufacturer&#x2019;s processes and facilities which, while not directly related to the production of imetelstat, could impact the manufacturer&#x2019;s ability to produce and deliver products, including imetelstat, if not remediated by the manufacturer, and could lead to delays or shortages in drug supply, or the inability to manufacture or ship drug supply necessary for non-clinical and clinical activities, and commercialization. In addition, we may not be able to obtain imetelstat from third-party manufacturers on acceptable terms, or at all. We expect to rely on third-party manufacturers to produce and deliver sufficient quantities of imetelstat and other materials to support clinical trials on a timely basis and to comply with applicable regulatory requirements. We do not have direct control over these third-party personnel or operations. Reliance on these third-party manufacturers is subject to numerous risks, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">being unable to contract with suitable third-party manufacturers, including for potential commercial supply of imetelstat, because the number of potential manufacturers is limited;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays and disruptions experienced by third-party manufacturers due to the effects of the COVID-19 pandemic, which have adversely impacted and could continue to adversely impact the ability of such parties to fulfill their contractual obligations to us;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">capacity limitations and scheduling constraints experienced by third-party manufacturers due to scheduling and other commitments, and queued manufacturing activities in contracted facilities; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential shortages of available manufacturing capacity or consumable manufacturing supplies at third-party manufacturers, due to obligations to manufacture and distribute vaccines to address the spread of COVID-19; and we anticipate that other delays, or potential shortages of consumable manufacturing supplies, may continue throughout 2023;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements by regulatory authorities to validate and qualify significant activities for any current or replacement manufacturer, which could involve new testing and compliance inspections;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to execute timely contracts with third-party manufacturers and suppliers on acceptable terms, or at all;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of third-party manufacturers to timely formulate and manufacture imetelstat or to produce or ship imetelstat in the quantities or of the quality required to meet clinical and commercial needs, whether due to the effects of the COVID-19 pandemic or any other reasons;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible mislabeling by third-party manufacturers of clinical supplies, potentially resulting in the wrong dose amounts being supplied or active drug or comparator not being properly identified;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decisions by third-party manufacturers to exit the contract manufacturing business during the time required to supply clinical trials or to successfully produce, store and distribute imetelstat to meet commercial needs;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance by third-party manufacturers with GMP standards mandated by the FDA and state agencies and other government regulations corresponding to similar international regulatory authorities, including any deficiencies identified during regulatory inspections, such as those identified in a recent FDA inspection of one of our third-party manufacturers;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">breach or termination of manufacturing or supply contracts;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inadequate storage or maintenance at contracted facilities resulting in theft or spoilage; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">natural disasters that affect contracted facilities.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of these risks could lead to delays or shortages in drug supply, or the inability to manufacture or ship drug supply necessary for non-clinical and clinical activities, and commercialization. For example, manufacturing delays could adversely impact the conduct or completion of imetelstat clinical trials, such as IMerge Phase 3, IMpactMF, IMproveMF and IMpress, or commencement of potential future clinical trials of imetelstat, or preclude or delay potential future commercial sales, which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, third-party manufacturers and/or any other manufacturers may need to make substantial investments to enable sufficient capacity increases and cost reductions, and to implement those regulatory and compliance standards necessary for successful Phase 3 clinical trials and commercial production of imetelstat. These third-party manufacturers may not be willing or able to achieve such capacity increases, cost reductions, or regulatory and compliance standards, and even if they do, such achievements may not be at commercially reasonable costs. Changing manufacturers may be prolonged and difficult due to inherent technical complexities and because the number of potential manufacturers is limited. It may be difficult or impossible for us to find a replacement manufacturer on acceptable terms, or at all.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">It may not be possible to manufacture imetelstat at costs or scales necessary to conduct clinical trials or potential future commercialization activities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oligonucleotides are relatively large molecules produced using complex chemistry, and the cost of manufacturing an oligonucleotide like imetelstat is greater than the cost of making typical small molecule drugs. Therefore, imetelstat for clinical use is more expensive to manufacture than most other treatments currently available today or that may be available in the future. Similarly, the cost of manufacturing imetelstat for commercial use will need to be significantly lower than current costs in order for imetelstat to become a commercially successful product. We may not be able to enter into suitable commercial supply agreements, or to achieve sufficient scale increases or cost reductions necessary for successful commercial production of imetelstat. Failure to achieve necessary cost reductions could result in decreased sales or reduced gross margins, if any, for us, which would materially and adversely affect our financial results, business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO COVID-19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The effects of the ongoing COVID-19 global pandemic have negatively impacted, and will likely continue to negatively impact, our business and healthcare resources around the world, including a significant number of current and planned clinical sites involved with IMpactMF, IMproveMF and IMpress.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat generally could be materially and adversely affected by the effects of the ongoing global COVID-19 pandemic. The ongoing COVID-19 pandemic and public health safety measures taken in response to COVID-19 have had a significant impact, both direct and indirect, on businesses, as significant reductions in business-related activities have occurred, clinical development and regulatory activities have been curtailed, delayed or suspended and supply chains have been disrupted. We have allowed voluntary access to our offices in California and New Jersey to employees who have been vaccinated. While almost all of our employees continue to work remotely without any significant disruption to our business, the effects of our policies regarding remote working may negatively impact productivity, disrupt our business and continue to delay our imetelstat development program and clinical trial timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. In addition, our increased reliance</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">on personnel working remotely could increase our cybersecurity risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations. These and similar, and perhaps more severe, disruptions in our operations could continue to negatively impact our business and business prospects, our financial condition and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the effects of the COVID-19 pandemic, we have had, and expect to continue to have, or we may potentially have in the future, disruptions and/or delays in our imetelstat development program, including with respect to our ability to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">open trial sites for screening and enrollment;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">screen, enroll and assess patients;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">retain enrolled patients in our clinical trials;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensure patient visits to clinical sites and laboratories;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conduct monitoring visits;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacture and/or supply study drug or other supplies;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">report trial results; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interact with regulators or other important agencies due to limitations in employee resources or otherwise. </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictions on travel, availability of site personnel, and diversion of hospital staff and resources to COVID-19 patients, have disrupted our clinical trial operations, as well as patient recruitment in many areas, resulting in a slowdown in patient enrollment and/or deviations from or disruptions in key clinical trial activities, such as opening, initiating and monitoring clinical trial sites. Although vaccine distribution, including booster shots, is being conducted in many countries, the emergence of COVID-19 variants and subvariants, and the resurgence of COVID-19 cases in parts of the world, causes further uncertainty and unpredictability in clinical trial activities, including clinical site initiations, patient screening and enrollment. Like many other biopharmaceutical companies, we have experienced and continue to experience delays in clinical site initiations and patient screening and enrollment in our clinical trials, IMerge Phase 3, IMpactMF and IMproveMF, due to the COVID-19 pandemic, which have impacted our trial operations. Even though we completed patient enrollment in IMerge Phase 3, the pace of enrollment was slower than planned.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For IMpactMF, in addition to the negative impact of COVID-19, site personnel resources remain constrained in the countries where we planned to conduct the trial due to the number of competing trials in MF and other oncology indications. As such, we have experienced and expect to continue to experience disruption in clinical trial activities and delays in enrollment, as well as constraints on available sites and site personnel. Based on assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS for IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The continuing effects of the COVID-19 pandemic could cause further disruptions to our clinical development timelines, including continued delays in enrollment and clinical trial site initiation in IMpactMF, IMproveMF and IMpress, and other disruptions that could severely impact our business and the imetelstat development program, including those resulting from:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">new, continued or heightened difficulties in opening clinical trial sites for patient screening and enrollment and recruiting clinical site investigators and clinical site staff;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continued or heightened delays or difficulties caused by missed patient visits to clinical sites and laboratories, and uncertainty how the FDA will view deviations from clinical protocols caused by the effects of the COVID-19 pandemic;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential refusal by the FDA to accept data, including from clinical trials in affected geographies or failure to comply with updated FDA guidance and expectations related to the conduct of clinical trials during the COVID-19 pandemic;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continued or heightened delays or disruptions in clinical trial activities, including executing clinical site contracts, due to reduced availability of personnel at CROs, clinical site legal groups and vendors, or for any other reasons;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial reduction of healthcare resources available for the conduct of clinical trials, including the temporary postponement of clinical trial activities at certain hospitals serving as our clinical trial sites and diversion of hospital staff away from the conduct of our clinical trials, such as those experienced by us to date;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interruption of, or delays in receiving, supplies of imetelstat from our third-party manufacturers due to among other things, staffing shortages, production slowdowns or stoppages, shipping delays, shortages in raw materials or laboratory supplies because of ongoing efforts to address the pandemic, limitations in available capacity at contract manufacturing vendors or drug distribution service providers due to obligations to manufacture and distribute vaccines to address the spread of COVID-19, disruptions in supply chain and production systems and import/export complications; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures (particularly any procedures that may be deemed non-essential), which may impact the integrity of subject data and clinical study endpoints;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of potential and recruited patients in clinical trials due to clinical site COVID-19 activities, desire of patients to avoid frequent visits to hospitals because of potential increased exposure to COVID-19, or loss of life of patients due to COVID-19;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased costs for clinical trial activities due to delays or disruptions in opening sites, screening and enrolling patients or treating and following patients,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether as a result of the effects of the COVID-19 pandemic or for any other reasons, which would require further additional capital that may not be available; and </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations on employee resources that would otherwise be focused on the conduct of our clinical trials, product development, manufacturing, potential commercialization activities and general company operations, including because of sickness of employees or their families, the desire of employees to avoid contact with large groups of people, an increased reliance on working from home, or mass transit disruptions.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other factors arising from the effects of the COVID-19 pandemic could further adversely impact our ability to enroll, conduct and complete IMpactMF, IMproveMF and IMpress and any potential future clinical trials of imetelstat, and could otherwise materially and adversely affect our business and business prospects, our financial condition and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we rely on third-party CROs and other third parties to assist us with clinical trial activities. The COVID-19 pandemic has also had a significant impact on our CROs and other vendors, and we cannot guarantee that they will continue to perform their contractual duties in a timely and satisfactory manner as a result of the COVID-19 pandemic. Also, absenteeism by governmental employees or the focus of regulatory authorities&#x2019; efforts and attention on the approval of other therapeutics or other activities related to COVID-19 could likewise impact the timeliness of regulatory authority responses and the processing of regulatory submissions for imetelstat. In any event, if the effects of the COVID-19 pandemic become more severe, we may experience more significant disruptions to our clinical development timelines, which would materially and adversely affect our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While at this time we believe that we have sufficient drug supply for potential commercialization activities necessary to potentially bring imetelstat to market in lower risk MDS in the U.S., as well as for clinical use in IMerge Phase 3, IMpactMF, IMproveMF and IMpress, we could experience disruptions to our supply chain, as well as delays or limitations in our ability to obtain sufficient materials for the manufacture of imetelstat for our current</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and potential future clinical trials. Such disruptions could adversely affect our ability to conduct ongoing and potential future clinical trials of imetelstat. For example, some of our suppliers of certain materials used in the production of imetelstat are located in countries that were or are heavily affected by the COVID-19 pandemic. In these countries, shipping delays, closures and other restrictions resulting from the COVID-19 pandemic in the region could disrupt our supply chain or limit our ability to obtain sufficient materials for the manufacture of imetelstat. In addition, we may experience limitations in available capacity at contract manufacturers or drug suppliers, or potential shortages of consumable manufacturing supplies, due to obligations to manufacture and distribute vaccines to address the spread of COVID-19. We anticipate other delays, or potential shortages of consumable manufacturing supplies due to the COVID-19 pandemic may continue throughout 2023.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The effects of the COVID-19 pandemic, as well as broader economic conditions, including inflation, rising interest rates and the prospects for recession, have increased market volatility and could result in a significant long-term disruption of global financial markets, reducing or eliminating our ability to raise additional capital. In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding following this offering to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing of availability of additional funds under the Loan Agreement, if at all. In addition, the global economic slowdown caused by, among other things, the COVID-19 pandemic and the military conflict between Ukraine and Russia, as well as inflation, rising interest rates and the prospects for recession, could materially and adversely affect our business and the value of our common stock. As a result of these factors, our ability to raise additional capital may be impaired which could negatively affect our liquidity, our business and business prospects, and the future of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The extent to which the COVID-19 pandemic impacts our business, our regulatory and clinical development activities, clinical supply chain and other business operations, as well as the value of and market for our common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time. Such developments include continued spread of COVID-19 variants and subvariants in the U.S. and other countries and the potential emergence of new variants or additional sub-variants that may prove especially contagious or virulent, the ultimate duration and severity of the pandemic, travel restrictions, quarantines, social distancing, shipping delays and business closure requirements in the U.S. and in other countries, and the effectiveness of vaccination programs and other actions taken globally to treat and manage this health crisis. Accordingly, we do not yet know the full extent of potential delays or impacts on our business, our regulatory and clinical development activities, clinical supply chain and other business operations or the global economy as a whole. However, these effects could materially and adversely affect our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat. In addition, to the extent the effects of the COVID-19 pandemic adversely affect our business and financial condition, they may also have the effect of heightening many of the other risks and uncertainties described elsewhere under the heading &#x201c;Risk Factors&#x201d;.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need For Additional Financing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our failure to obtain substantial additional capital following this offering would force us to further delay, reduce or eliminate development of imetelstat in current and any potential future clinical trials of imetelstat, and our potential future imetelstat commercialization efforts, any of which would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successful drug development and commercialization requires significant amounts of capital. Based on our current operating plan, our expectations regarding the timing of the submission, review and approval of our NDA in the U.S. for the use of imetelstat in adult patients with lower risk MDS, and our planned use of the net proceeds from this offering, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, together with the estimated net proceeds from this offering, will be sufficient to fund our projected operating requirements until the middle of 2024, which includes preparatory activities for potential U.S. commercial launch of imetelstat in lower risk MDS. Assuming future proceeds of up to $109.2 million from potential cash exercises of currently outstanding warrants and potential drawdowns of up to $75.0 million available</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">under the Loan Agreement (which is subject to our achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements to our existing capital resources, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche), we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, together with the estimated net proceeds from this offering, could be sufficient to fund our projected operating requirements until the end of 2025, which would include the anticipated completion of the final analysis for IMpactMF in 2025. In the absence of future proceeds from potential cash exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding following this offering to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all. For example, holders of our outstanding warrants may not exercise any portion of a warrant if, after giving effect to such exercise, the holder would own more than 9.99% of our outstanding common stock immediately after exercise, which percentage may be changed at the holder's election upon 61 days' notice to us subject to the terms of the warrants. In addition, in the event that a registration statement registering the issuance of the shares of common stock underlying our purchase warrants is not effective or available for the issuance of such shares to such holder at the time of exercise, a holder of our purchase warrants may only exercise such purchase warrants through a &#x201c;cashless exercise,&#x201d; in which case, the holder would receive upon such exercise, the net number of shares of common stock determined according to the formula set forth in the purchase warrant, and we would not receive any proceeds from the exercise of such purchase warrants. As a result, we may not receive our anticipated proceeds from certain of our outstanding warrants. In addition, drawdowns under the Loan Agreement are subject to our achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements to our existing capital resources, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche. Even if we receive the future proceeds in full from the potential cash exercise of outstanding warrants and potential drawdowns under the Loan Agreement, we may still require additional funding. If adequate funds are not available on a timely basis, if at all, we may be unable to pursue further development, including conducting and completing IMpactMF, IMproveMF and IMpress, or commencing, conducting or completing potential future clinical trials of imetelstat, or pursuing potential commercialization of imetelstat, which would severely harm our business and we might cease operations. In addition, our ability to commercialize imetelstat in the U.S., if regulatory approval is granted, depends on us being able to establish sales and marketing capabilities which we may be unable to do in a timely manner or at all.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because the outcome of any clinical activities and/or regulatory approval process is highly uncertain, we cannot reasonably estimate whether any development activities we may undertake will succeed, whether we will be able to commercialize imetelstat, and we may never recoup our investment in any imetelstat development, which would adversely affect our financial condition and our business and business prospects, and might cause us to cease operations. In addition, our plans and timing expectations will be further delayed or interrupted by macroeconomic conditions, such as if COVID-19 or pandemic conditions worsen, creating further limitations on our clinical trial or commercial preparatory activities, or could be disrupted by civil or political unrest or military conflicts around the world, such as the current military conflict between Ukraine and Russia. Further, our future capital requirements are difficult to forecast and will depend on many factors, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy of the assumptions underlying our estimates for our capital needs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, timing, magnitude and costs of clinical development, manufacturing and potential commercialization of imetelstat, including the number of indications being pursued, subject to clearances and approvals by the FDA and similar international regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, duration, results and costs of current clinical trials, including IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and any potential future clinical trials of imetelstat, as well as non-clinical studies and assessments of imetelstat;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays or disruptions in opening sites, screening and enrolling patients or treating and following patients,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in IMpactMF, IMproveMF, IMpress, or any potential future clinical trials of imetelstat, whether as a result of the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcomes of regulatory reviews or other regulatory actions related to imetelstat, such as obtaining and maintaining regulatory clearances and approvals to continue clinical development of imetelstat in current and potential future clinical trials, as well as to commence potential commercialization of imetelstat in the U.S. and in other countries;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications and maintaining, enforcing and defending intellectual property-related claims;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of manufacturing imetelstat, including our ability to achieve any meaningful reduction in manufacturing costs; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of multiple third-party vendors and service providers, including our CROs and third-party manufacturers, to pursue the development, manufacturing and potential commercialization of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish, enforce and maintain collaborative or other strategic arrangements for research, development, clinical testing and manufacturing of imetelstat and potential future commercialization and marketing;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational, financial and management processes and systems that will be required for future development and commercialization of imetelstat, and our ability to successfully recruit and retain additional key personnel to support the development and potential future commercialization of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully market and sell imetelstat, if imetelstat receives future regulatory approval or clearance, in the U.S. and other countries, and the associated costs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing necessary to build a sales force in the U.S. and potentially other countries to market and sell imetelstat, should it receive regulatory approval, to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of any collaborator; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the sales price for imetelstat, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate third-party reimbursement for imetelstat, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other drugs and technologies, or to which we out-license imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we are able to enter into strategic partnerships, collaborations and alliances or licensing arrangements with third parties including for the commercialization of imetelstat in certain global regions; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain collaborations on favorable terms, if at all;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of any collaborations that we may enter into with third parties;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses associated with settlement of the pending securities class action lawsuits, and the ongoing derivative lawsuits, as well as any other potential litigation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent and scope of our general and administrative expenses, including expenses associated with potential future litigation; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our level of indebtedness and associated debt service obligations; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of maintaining and operating facilities in California and New Jersey, telecommunications and administrative oversight, as well as higher expenses for travel; </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">broader economic conditions, including inflation, rising interest rates and the prospects for recession, that may reduce our ability to access debt capital or financing on preferable terms, which may adversely affect future capital requirements and forecasts; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of enabling our personnel to work remotely, including providing supplies, equipment and technology necessary for them to perform their responsibilities; and </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the amount of net proceeds we receive in this offering together with the proceeds, if any, of cash exercises of our currently outstanding warrants.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until we can generate a sufficient amount of revenue from imetelstat to finance our cash requirements, which we may never achieve, we expect to finance future cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, which may not be possible. Availability of such financing sources may be negatively impacted by any further delays in reporting results from IMpactMF or investors&#x2019; perception of top-line results from IMerge Phase 3, despite our interpretation of such data being positive, as well as factors such as the global economic slowdown caused by inflation, rising interest rates and the prospects for recession.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional financing through public or private debt or equity financings, including pursuant to the 2020 Sales Agreement with B. Riley Securities, Inc.; the remaining tranches of up to $75.0 million available under the Loan Agreement, which is subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche; capital lease transactions or other financing sources, may not be available on acceptable terms, or at all. We may be unable to raise equity capital, or may be forced to do so at a stock price or on other terms that could result in substantial dilution of ownership for our stockholders. The receptivity of the public and private debt and equity markets to proposed financings has been substantially affected by uncertainty in the general economic, market and political climate due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, and may in the future be affected by other factors which are unpredictable and over which we have no control. In this regard, the effects of the COVID-19 pandemic have increased market volatility and could result in a significant long-term disruption of global financial markets, which could reduce or eliminate our ability to raise additional funds through financings, and could negatively impact the terms upon which we may raise those funds. Similarly, these macroeconomic conditions have created extreme volatility and disruption in the capital markets and is expected to have further global economic consequences. If the equity and credit markets deteriorate, including as a result of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, it may make any necessary debt or equity financing more difficult to obtain in a timely manner or on favorable terms, more costly or more dilutive. If we are unable to raise additional capital or establish alternative collaborative arrangements with third-party collaborative partners for imetelstat, the development and potential commercialization of imetelstat may be further delayed, altered or abandoned, which might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may seek additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Due to uncertainty in the general economic, market and political climate, we may determine that it is necessary or appropriate to raise additional funds proactively to meet longer-term anticipated operating plans. To the extent that we raise additional capital following this offering through the sale of equity or convertible debt securities, including pursuant to the 2020 Sales Agreement, your ownership interest as a stockholder may be diluted, and the terms may include liquidation or other preferences that materially and adversely affect your rights as a stockholder. In addition, we have borrowed, and in the future may borrow, additional capital from institutional and commercial banking sources to fund imetelstat development and our future growth, including pursuant to our Loan Agreement or potentially pursuant to new arrangements with different lenders. We may borrow funds on terms under agreements, such as the Loan Agreement, that include restrictive covenants, including covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Moreover, if we raise additional funds through alliance, collaborative or licensing arrangements with third parties, we may have to relinquish valuable rights to imetelstat or our technologies or grant licenses on terms that are not favorable to us.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that our existing capital resources, together with the net proceeds from this offering, future interest income, future proceeds from potential cash exercises of currently outstanding warrants and potential future sales of our common stock, including under the 2020 Sales Agreement with B. Riley Securities, Inc. or potential future drawdowns, if available, of the remaining up to $75.0 million under the Loan Agreement (which is subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche), will be sufficient to fund our operating plans. In this regard, under the Loan Agreement, our ability to draw down any funds is subject to our achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization requirements and other conditions, including, with respect to the final $25.0 million tranche of the Loan Agreement, approval by an investment committee comprised of Hercules and SVB. Without such approval, we will not be eligible to draw down any funds under the final tranche, and we will need to obtain additional or alternative financing to advance our development of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently have no source of product revenue and may never become profitable.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although in the past we have received license and other payments under former license and collaboration agreements, we do not currently have any material revenue-generating license or collaboration agreements, have no products approved for commercialization and have never generated any revenue from product sales. In addition, we are incurring and have incurred operating losses every year since our operations began in 1990, except for one. As of September 30, 2022, our accumulated deficit was approximately $1.4 billion. Losses have resulted principally from costs incurred in connection with our research and development activities and from general and administrative costs associated with our operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Substantially all of our revenues to date have been payments under collaboration agreements and milestones, royalties and other revenues from our licensing arrangements. Our license agreements related to our hTERT technology have expired or been terminated due to expiration of the underlying hTERT patents, and will not generate any further revenues. We have no ongoing collaborations related to imetelstat and have no current plans to enter into any corporate collaboration, partnership or license agreements that result in revenues, although we may seek a collaborative partner or partners, at an appropriate time, to assist us in the potential development and commercialization of imetelstat, especially outside the U.S., and to provide funding for such activities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also expect to experience increased negative cash flow for the foreseeable future as we fund our operations and imetelstat clinical development activities and research programs continue, and we prepare for potential commercialization of imetelstat. This will result in decreases in our working capital, total assets and stockholders&#x2019; equity. Further, we may be unable to replenish our working capital by future financings. We will need to generate significant revenues to achieve consistent future profitability. We may never achieve consistent future profitability. Even if we do become profitable in the future, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to achieve consistent future profitability could negatively impact the market price of our common stock and our ability to sustain operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our net operating loss carryforwards attributable to tax years beginning before January 1, 2018 could expire unused and be unavailable to offset future income tax liabilities. Under the Tax Cuts and Jobs Act of 2017, or the Tax Act, as modified by the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, federal net operating losses incurred in taxable years beginning after December 31, 2017, can be carried forward indefinitely, but the deductibility of such federal net operating losses in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the Tax Act or the CARES Act.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and corresponding provisions of state law, if a corporation undergoes an &#x201c;ownership change,&#x201d; generally defined as a greater than 50&#x2011;percentage&#x2011;point cumulative change (by value) in its equity ownership over a three-year period, the corporation&#x2019;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes (such as research and development tax credits) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership, some of which are outside of our control, may have resulted in, or other future changes</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(including as a result of this offering) could result in, an ownership change. If a limitation were to apply, utilization of a portion of our domestic net operating loss and tax credit carryforwards could be limited in future periods. In addition, a portion of the carryforwards may expire before being available to reduce future income tax liabilities which could adversely impact our financial position. At the state level, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to our Indebtedness</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our level of indebtedness and debt service obligations could adversely affect our financial condition, and may make it more difficult for us to fund our operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of September 30, 2022, the total outstanding principal amount under the Loan Agreement was $50.0 million. The tranches for the remaining $75.0 million available to us under the Loan Agreement are as follows: (a) the first remaining tranche of $20.0 million is available within 30 days of the achievement of certain clinical and financial milestones until September 15, 2023, subject to the achievement of such milestones; (b) the second remaining tranche of $10.0 million is available from January 1, 2023 until December 15, 2023, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain other requirements; (c) the third remaining tranche of $20.0 million is available from September 15, 2023 until September 15, 2024, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain capitalization requirements; and (d) the final remaining tranche of $25.0 million is available through December 31, 2024, subject to approval by an investment committee comprised of Hercules and SVB. Without the achievement of the required clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, we will not be eligible to draw funds under the first three remaining tranches. If we do not receive investment committee approval, we will not be eligible to draw funds under the final remaining tranche under the Loan Agreement. If we are not able to draw additional funds under the Loan Agreement, we will need to obtain additional or alternative financing to advance our development of imetelstat. Such additional or alternative financing may not be available on attractive terms, if at all, and could be more costly for us to obtain. In addition, before we would consider drawing down any of the remaining tranches under the Loan Agreement, if available, we must first satisfy ourselves that we will have access to future alternate sources of capital, such as from the equity capital markets or debt capital markets, in order to repay any additional principal borrowed, which we may be unable to do, in which case, our liquidity and ability to fund our operations may be substantially impaired. As a result, our development and potential commercialization of imetelstat and other research and development programs could be significantly delayed, which would materially adversely affect our business, business prospects, financial condition and operating results.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All obligations under the Loan Agreement are secured by substantially all of our existing property and assets, excluding intellectual property, which is subject to a negative pledge. This indebtedness may create additional financing risk for us, particularly if our business or prevailing financial market conditions are not conducive to paying off or refinancing the outstanding debt obligations at maturity. If we are able to draw down any of the remaining tranches under the Loan Agreement, our indebtedness will increase, which would further increase our risk of being unable to pay off or refinance our outstanding debt obligations at maturity. Our indebtedness could also have important negative consequences, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we will need to repay the indebtedness by making payments of interest and principal, which will reduce the amount of cash available to finance our operations, our research and development efforts and other general corporate activities; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to comply with the obligations of our affirmative and restrictive covenants in the Loan Agreement could result in an event of default that, if not cured or waived, would accelerate our obligation to repay this indebtedness, and Hercules and SVB could seek to enforce its security interest in the assets securing such indebtedness.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent additional debt is added to our current debt levels, the risks described above could increase.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The terms of the Loan Agreement place restrictions on our operating and financial flexibility.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement imposes operating and other restrictions on us. Such restrictions will affect, and in many respects limit or prohibit, our ability and the ability of any future subsidiaries to, among other things:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dispose of certain assets;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">change our line of business;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">engage in mergers, acquisitions or consolidations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incur additional indebtedness;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">create liens on assets;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pay dividends and make contributions or repurchase our capital stock; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">engage in certain transactions with affiliates.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement, as recently amended in June 2022, also contains financial covenants. Beginning June 1, 2022 and prior to receiving potential regulatory approval for imetelstat, if any, we are required to maintain a minimum cash balance in an amount equal to the greater of: 50% of the outstanding principal amount under the Loan Agreement or $30.0 million. Under the Loan Agreement, if we enter into certain licensing transactions, this cash covenant requirement would increase to $35.0 million. After the potential regulatory approval for imetelstat, if any, the minimum cash requirement may be satisfied through one of the following three options, as elected by us: (a) maintaining a cash balance in an amount not less than 40% of the outstanding principal amount under the Loan Agreement; (b) maintaining a cash balance in an amount not less than 25% of the outstanding principal amount under the Loan Agreement, if our market cap is or exceeds $750.0 million; or (c) maintaining six month net product revenues of at least 70% of net product revenues forecasted by us, should any potential regulatory approval for imetelstat be obtained. The breach of any of these restrictive covenants or any other terms of the Loan Agreement would accelerate our obligation to repay our indebtedness under the Loan Agreement, which could have a material adverse effect on our business, business prospects and financial position.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not have cash available in an amount sufficient to enable us to make interest or principal payments on our indebtedness when due.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to make scheduled payments on or to refinance our indebtedness depends on our future performance and ability to raise additional sources of cash, which is subject to economic, financial, competitive and other factors beyond our control. If we are unable to generate sufficient cash to service our debt, we may be required to adopt one or more alternatives, such as selling assets, restructuring our debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. If we desire to refinance our indebtedness, our ability to do so will depend on the state of the capital and lending markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to satisfy our current and future debt obligations under the Loan Agreement could result in an event of default. In addition, the Loan Agreement includes customary affirmative and negative covenants and other events of default, the occurrence and continuance of which provide Hercules and SVB with the right to demand immediate repayment of all principal and unpaid interest under the Loan Agreement, and to exercise remedies against us and the collateral securing the Loan Agreement. These events of default include, among other things:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">insolvency, liquidation, bankruptcy or similar events; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to observe any covenant or secured obligation under the Loan Agreement, which failure, in most cases, is not cured within 15 days; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurrence of an event that could reasonably be expected to have a material adverse effect on our business, operations, properties, assets or financial condition; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material misrepresentations; </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurrence of any default under any other agreement involving indebtedness in excess of specified amounts, or the occurrence of a default under any agreement that could reasonably be expected to have a material adverse effect on us; and </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">certain money judgments being entered against us or any portion of our assets are attached or seized.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of default, Hercules and SVB could accelerate all of the amounts due under the Loan Agreement. Under such circumstances, we may not have enough available cash or be able to raise additional funds through equity or debt financings to repay such indebtedness at the time of such acceleration. In that case, we may be required to delay, limit, reduce or terminate imetelstat development or potential commercialization efforts or grant to others rights to develop and market imetelstat. Hercules and SVB could also exercise their rights to take possession and dispose of the collateral securing the Loan Agreement, which collateral includes substantially all of our property other than intellectual property. Our business, financial condition and results of operations could be materially adversely affected as a result of any of these events.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Protecting Our Intellectual Property</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for imetelstat for an adequate amount of time, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to imetelstat, and our ability to successfully commercialize imetelstat may be adversely affected.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Protection of our proprietary technology is critically important to our business. Our success and the success of our planned future development and commercialization of imetelstat will depend on our ability to protect our technologies and imetelstat through patents and other intellectual property rights. Our success will depend in part on our ability to obtain, maintain, enforce, and extend our patents and maintain trade secrets, both in the U.S. and in other countries.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the U.S. and in other countries. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated, or held unenforceable, which could limit our ability to stop others from using or commercializing imetelstat or our technology and/or limit the duration of the patent protection for imetelstat and our technology. In the event that we are unsuccessful in obtaining, maintaining, enforcing and extending our patents and other intellectual property rights or having our licensors maintain the intellectual property rights we have licensed, the value of imetelstat and/or our technologies will be adversely affected, and we may not be able to further develop or potentially commercialize imetelstat.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we have method-of-use patents that protect the use of imetelstat for the treatment of certain diseases, this type of patent does not prevent a generic competitor from making and marketing a product that is identical to imetelstat for an indication that is outside the scope of our approved use after our composition of matter patents or their patent term extensions have expired. Moreover, even if competitors do not actively promote their product for our approved indications, physicians may prescribe or use these generic products &#x201c;off-label,&#x201d; which would result in decreased sales for us.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss or impairment of our intellectual property rights related to imetelstat might further delay or halt ongoing or potential future clinical trials of imetelstat and any applications for regulatory approval, and therefore might further delay or preclude any future development or commercialization of imetelstat by us. Further, if imetelstat is approved for commercial sale, such loss of intellectual property rights could impair our ability to exclude others from commercializing products similar or identical to imetelstat and therefore result in decreased sales for us. Occurrence of any of these events would materially and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining our patent rights depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. Patent and Trademark Office, or the Patent Office, and various governmental patent agencies in other countries require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or patent applications will have to be paid to the Patent Office and various governmental patent agencies in other countries over the lifetime of our owned and licensed patents and/or patent applications and any patent rights we may own or license in the future. Maintaining such compliance may be impacted by the COVID-19 pandemic and the military conflict between Ukraine and Russia. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, nonpayment of fees and failure to properly legalize and submit formal documents. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. For example, we have issued and pending patents and patent applications in Ukraine and Russia, and if we are unable to submit responses to governmental patent agencies or make payments related to such patents and patent applications in a timely manner due to the military conflict in the region, these patents or patent applications may be irrevocably lost. In such an event, potential competitors might be able to enter the market with imetelstat or similar products, and this circumstance could harm our financial condition, business and business prospects and the future of imetelstat. In addition, if we are responsible for patent prosecution and maintenance of patent rights in-licensed to us or jointly owned with us, any of the foregoing could expose us to liability to the applicable patent owner or patent co-owner.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on imetelstat for an adequate amount of time.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20 years after its first effective nonprovisional filing date. Given the amount of time required for the development, testing and regulatory review of imetelstat, patents protecting imetelstat (e.g., patents claiming imetelstat and/or components thereof, methods of use, or methods of making) might expire before imetelstat is commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the Hatch-Waxman Act permits one patent per approved product to receive a patent term extension of up to five years beyond its normal expiration. The length of the patent term extension is typically calculated as one half of the clinical trial period plus the entire period of time during the review of the NDA by the FDA, minus any time of delay by us during these periods. There is also a limit on the patent term extension to a term that is no greater than fourteen years from drug approval. One of our owned or licensed U.S. patents may be eligible for patent term extension under the Hatch-Waxman Act.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar extensions are also available in certain countries and territories outside the U.S., such as in Japan, and in Europe as Supplementary Protection Certificates, or SPCs. If we select and are granted a patent term extension on a recently filed and issued patent, we may not receive the full benefit of a possible patent term extension, if at all. We might also not be granted a patent term extension at all, because of, for example, failure to apply within the applicable period, failure to apply prior to the expiration of relevant patents or otherwise failure to satisfy any of the numerous applicable requirements. Moreover, the applicable authorities, including the FDA and the Patent Office in the U.S., and any equivalent regulatory authorities in other countries, may not agree with our assessment of whether such extensions are available, may refuse to grant extensions to our patents, or may grant more limited extensions than we request. If we fail to apply for applicable patent term extensions or adjustments, we will have a more limited time during which we can enforce our granted patent rights. Should we seek a patent term extension, we may not be granted any such patent term extension and/or the applicable time period of such patent term extension could be less than five years. Moreover, in some countries, including the U.S., the scope of protection for claims under such patent term extensions, if any, does not extend to the full scope of the claims but is limited to the product composition as approved and, for a method of treatment patent, is limited to the approved indication. Thus, for example, if we do not receive a patent term extension for our U.S. composition of matter patent for imetelstat, as</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approved by the regulatory authorities, our U.S. composition of matter patent will expire in December 2025. If we do not have sufficient patent life to protect imetelstat, our financial results, business and business prospects, and the future of imetelstat would be materially and adversely affected, which might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If regulatory approval of imetelstat occurs after a patent has expired in a country that does not allow interim patent term extensions, as is the case in many countries and territories including Europe, we will be unable to obtain any patent term extension of that expired patent, and the duration of our patent rights may be limited. If we do not receive marketing approval and submit a request for an SPC before our patents expire in the European Economic Area, or EEA, where we have imetelstat composition of matter patents, our imetelstat composition of matter patents will expire in September 2024. In all other countries outside the U.S. and the EEA where we have imetelstat composition of matter patents, either: (a) extension of patent term is not available, and the patents will expire in September 2024, or (b) we may not have marketing authorization in those countries in sufficient time to file an extension of patent term before our composition of matter patents expire in September 2024. If we do not have sufficient patent life to protect imetelstat, our financial results, business and business prospects, and the future of imetelstat would be materially and adversely affected, which might cause us to cease operations.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Also, there are regulations for the listing of patents in the Approved Drug Products with Therapeutic Equivalence Evaluations, or the Orange Book. If we submit a patent for listing in the Orange Book, the FDA may decline to list the patent, or a manufacturer of generic drugs may challenge the listing. If imetelstat is approved and an appropriate patent covering imetelstat is not listed in the Orange Book or is subsequently removed from the Orange Book, a manufacturer of generic drugs would not be required to provide advance notice to us of any abbreviated NDA filed with the FDA to obtain permission to sell a generic version of imetelstat. Any of the foregoing could harm our competitive position, business, financial condition, results of operations and prospects.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in U.S. or international patent law or interpretations of such patent laws could diminish the value of our patents in general, thereby impairing our ability to protect our technologies and imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent positions of pharmaceutical and biopharmaceutical companies, including ours, are highly uncertain and involve complex legal and technical questions. In particular, legal principles for biotechnology and pharmaceutical patents in the U.S. and in other countries are evolving, and the extent to which we will be able to obtain patent coverage to protect our technologies and imetelstat, or enforce or defend issued patents, is uncertain.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. has enacted and implemented wide-ranging patent reform legislation, including the Leahy-Smith America Invents Act, or the AIA, signed into law on September 16, 2011. The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Depending on actions by Congress, the federal courts, and the Patent Office, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents or patents that we might obtain in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions or changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken our ability to obtain new patents or to enforce our existing patents or patents that we may obtain in the future. Occurrence of these events and/or significant impairment of our imetelstat patent rights would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, which might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the AIA, in March 2013, the U.S. transitioned to a first-inventor-to-file system under which, assuming the other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent. However, since the publication of discoveries in scientific or patent literature tends to lag behind actual discoveries by at least several months and sometimes several years, we are not able to be certain upon filing that the persons or entities that we name as inventors or applicants in our patent applications were the first to invent the inventions disclosed therein, or the first to file patent applications for these inventions. Thus, our ability to protect our patentable intellectual property depends, in part, on our ability to be the first to file patent applications with respect to our inventions, or inventions that were developed by our former collaboration partner and assigned to us, for the future development, commercialization and manufacture of imetelstat. As a result, if we are not the first-inventor-to-file, we may not be able to obtain patents for discoveries that we otherwise would consider patentable and that we consider to be significant to the future success of imetelstat. Delay in the filing of a patent application</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for any purpose, including further development or refinement of an invention, may result in the risk of loss of patent rights.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the result of a referendum in 2016, the U.K. left the EU on January 31, 2020, commonly referred to as Brexit. The impact of the withdrawal of the U.K. from the EU will not be known for some time, which could lead to a period of uncertainty relating to our ability to obtain and maintain SPCs of imetelstat based on our U.K. patents and our ability to establish and maintain European trademarks in the U.K. In 2012, the European Patent Package, or EU Patent Package, regulations were passed with the goal of providing for a single pan-European Unitary Patent, and a new European Unified Patent Court, or UPC, for litigation of European patents. It is possible that implementation of the EU Patent Package will occur in the first half of 2023. If the EU Patent Package is ratified and in effect, all European patents, including those issued prior to ratification, would by default automatically fall under the jurisdiction of the UPC and allow for the possibility of obtaining pan-European injunctions. Under the EU Patent Package as currently proposed, once the UPC is established, patent holders are permitted to &#x201c;opt out&#x201d; of the UPC on a patent-by-patent basis during an initial seven year period after the EU Patent Package is ratified. Owners of traditional European patent applications who receive notice of grant after the EU Patent Package is ratified could either accept a Unitary Patent or validate the patent nationally and file an opt-out demand. The EU Patent Package may increase the uncertainties and costs surrounding the enforcement or defense of our issued European patents and pending applications. The full impact on future European patent filing strategy and the enforcement or defense of our issued European patents in member states and/or the UPC is not known.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Challenges to our owned or licensed patent rights would result in costly and time-consuming legal proceedings that could prevent or limit development of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our patents or those patent rights we have licensed, including patent rights that we may seek with respect to inventions made by past or future collaborators, may be challenged through administrative or judicial proceedings, which could result in the loss of important patent rights. For example, where more than one party seeks U.S. patent protection for the same technology in patent applications that are subject to the law before the implementation of the AIA, the Patent Office may declare an interference proceeding in order to ascertain the party to which the patent should be issued. Patent interferences are typically complex, highly contested legal proceedings, subject to appeal. They are usually expensive and prolonged and can cause significant delay in the issuance of patents. Our pending patent applications or our issued patents, or those we have licensed and may license from others, may be drawn into interference proceedings or be challenged through post-grant review procedures or litigation, any of which could delay or prevent the issuance of patents, or result in the loss of issued patent rights. We may not be able to obtain from our past or future collaborators the information needed to support our patent rights which could result in the loss of important patent rights.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the AIA, interference proceedings between patent applications filed on or after March 16, 2013, have been replaced with other types of proceedings, including derivation proceedings. The AIA also includes post-grant review procedures subjecting U.S. patents to post-grant review procedures similar to European oppositions, such as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">inter partes </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">review, or IPR, covered business method post-grant reviews and other post-grant reviews. This applies to all of our U.S. patents and those we have licensed and may license from others, even those issued before March 16, 2013. Because of a lower evidentiary standard necessary to invalidate a patent claim in Patent Office proceedings compared to the evidentiary standard in U.S. federal court, a third-party could potentially provide evidence in a Patent Office proceeding sufficient for the Patent Office to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third-party could attempt to use the Patent Office procedures to invalidate patent claims that would not have been invalidated if first challenged by the third-party as a defendant in a district court action. U.S. patents owned or licensed by us may therefore be subject to post-grant review procedures, as well as other forms of review and re-examination. In addition, the IPR process under the AIA permits any person, whether they are accused of infringing the patent at issue or not, to challenge the validity of certain patents. As a result, entities associated with hedge funds have challenged valuable pharmaceutical patents through the IPR process. Significant impairment of our imetelstat patent rights would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, which might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain jurisdictions, such as Europe, New Zealand and Australia, permit oppositions to be filed against granted patents or patents proposed to be granted. Because we seek to enable potential global commercialization of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">imetelstat, securing both proprietary protection and freedom to operate outside of the U.S. is important to our business. Opposition proceedings require significant time and costs, and if we are unsuccessful or are unable to commit these types of resources to protect our imetelstat patent rights, we could lose our patent rights and we could be prevented or limited in the development and commercialization of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As more groups become engaged in scientific research and product development in the areas of telomerase biology and hematologic malignancies, the risk of our patents, or patents that we have in-licensed, being challenged through patent interferences, derivation proceedings, IPRs, post-grant proceedings, oppositions, re-examinations, litigation or other means will likely increase. For example, litigation may arise as a result of our decision to enforce our patent rights against third parties. Challenges to our patents through these procedures would be extremely expensive and time-consuming, even if the outcome was favorable to us. An adverse outcome in a patent dispute could severely harm our ability to further develop or commercialize imetelstat, or could otherwise have a material adverse effect on our business, and might cause us to cease operations, by:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">causing us to lose patent rights in the relevant jurisdiction(s);</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjecting us to litigation, or otherwise preventing us from commercializing imetelstat in the relevant jurisdiction(s);</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring us to obtain licenses to the disputed patents;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">forcing us to cease using the disputed technology; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring us to develop or obtain alternative technologies.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing, prosecuting, maintaining, defending and enforcing patents for imetelstat and our technologies in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. are less extensive than those in the U.S. The requirements for patentability may differ in certain countries, particularly in developing countries; thus, even in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover imetelstat and our technologies. There can be no assurance that we will obtain or maintain patent rights inside or outside the U.S. under any future license agreements. In addition, the laws of some countries outside the U.S. do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., even in jurisdictions where we pursue patent protection, or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with imetelstat and our technologies and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in jurisdictions outside the U.S. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. For example, many countries outside the U.S. have compulsory licensing laws under which a patent owner must grant licenses to third parties. Proceedings to enforce our patent rights, even if obtained, in jurisdictions outside the U.S. could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. While we intend to protect our intellectual property rights in major markets for imetelstat, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market imetelstat. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own and potentially develop in the future.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to infringement claims that are costly to defend, and such claims may limit our ability to use disputed technologies and prevent us from pursuing research, development, manufacturing or commercialization of imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The commercial success of imetelstat will depend upon our ability to research, develop, manufacture, market and sell imetelstat without infringing or otherwise violating the intellectual property and other proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries, and many pharmaceutical companies, including potential competitors, have substantial patent portfolios. Since we cannot be aware of all intellectual property rights potentially relating to imetelstat and its uses, we do not know with certainty that imetelstat, or the intended commercialization thereof, does not and will not infringe or otherwise violate any third-party&#x2019;s intellectual property. For example, we are aware that certain third parties have or may be prosecuting patents and patent estates that may relate to imetelstat, and while we believe these patents will expire before imetelstat is able to be commercialized and/or that these patents are invalid and/or would not be infringed by the manufacture, use or sale of imetelstat, it is possible that the owner(s) of these patents will assert claims against us in the future.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event our technologies infringe the rights of others or require the use of discoveries and technologies controlled by third parties, we may be prevented from pursuing research, development, manufacturing or commercialization of imetelstat, or may be required to obtain unblocking licenses from such third parties, develop alternative non-infringing technologies, which we may not be able to do at an acceptable cost or on acceptable terms, or at all, or cease the development of imetelstat. If we are unable to resolve an infringement claim successfully, we could be subject to an injunction that would prevent us from potentially commercializing imetelstat and could also require us to pay substantial damages. In addition, while our past collaboration agreements have terminated, we are still subject to indemnification obligations to certain collaborators, including with respect to claims of third-party patent infringement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to infringement claims, in the future we may also be subject to other claims relating to intellectual property, such as claims that we have misappropriated the trade secrets of third parties. Provided that we are successful in continuing the development of imetelstat, we expect to see more efforts by others to obtain patents that are positioned to cover imetelstat. Our success therefore depends significantly on our ability to operate without infringing patents and the proprietary rights of others.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may become aware of discoveries and technologies controlled by third parties that are advantageous or necessary to further develop or manufacture imetelstat. Under such circumstances, we may initiate negotiations for licenses to other technologies as the need or opportunity arises. We may not be able to obtain a license to a technology required to pursue the research, development, manufacture or commercialization of imetelstat on commercially favorable terms, or at all, or such licenses may be terminated on certain grounds, including as a result of our failure to comply with any material obligations under such licenses. If we do not obtain a necessary license or if such a license is terminated, we may need to redesign such technologies or obtain rights to alternative technologies, which may not be possible, and even if possible, could cause further delays in the development efforts for imetelstat and could increase the development and/or production costs of imetelstat. In cases where we are unable to license necessary technologies, we could be subject to litigation and prevented from pursuing research, development, manufacturing or commercialization of imetelstat, which would materially and adversely impact our business. Failure by us to obtain rights to alternative technologies or a license to any technology that may be required to pursue research, development, manufacturing or commercialization of imetelstat would further delay current and potential future clinical trials of imetelstat and any applications for regulatory approval, impair our ability to sell imetelstat, if approved, and therefore result in decreased sales of imetelstat for us. Occurrence of any of these events would materially and adversely affect our business, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are seeking registered trademarks for a commercial trade name for imetelstat in the U.S. and jurisdictions outside of the U.S. and failure to secure such registrations could adversely affect our business.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are seeking registration of trademarks for a potential commercial trade name for imetelstat in the U.S. and other jurisdictions outside of the U.S. During trademark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the U.S. Patent and Trademark Office and in comparable agencies in many jurisdictions outside of the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S., third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. Moreover, any name we propose to use for imetelstat in the U.S. and Europe must be approved by the FDA and the EMA respectively, regardless of whether we have registered it, or applied to register it, as a trademark. Both the FDA and the EMA typically conduct a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA or the EMA rejects all of our proposed proprietary product names, we may be required to expend additional time and resources in an effort to identify a suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA and the EMA.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may become involved in disputes with past or future collaborator(s) over intellectual property inventorship, ownership or use, and publications by us, or by investigators, scientific consultants, research collaborators or others. Such disputes could impair our ability to obtain patent protection or protect our proprietary information, which, in either case, could have a significant impact on our business.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventions discovered under research, material transfer or other collaboration agreements may become jointly owned by us and the other party to such agreements in some cases, and may be the exclusive property of either party in other cases. Under some circumstances, it may be difficult to determine who invents and owns a particular invention, or whether it is jointly owned, and disputes can arise regarding inventorship, ownership and use of those inventions. These disputes could be costly and time-consuming, and an unfavorable outcome could have a significant adverse effect on our business if we are not able to protect or license rights to these inventions. In addition, clinical trial investigators, scientific consultants and research collaborators generally have contractual rights to publish data and other proprietary information, subject to review by the trial sponsor. Publications by us, or by investigators, scientific consultants, previous employees, research collaborators or others, either with permission or in contravention of the terms of their agreements with us or with our past or future collaborators, may impair our ability to obtain patent protection or protect proprietary information which would have a material adverse effect on our business, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Much of the information and know-how that is critical to our business is not patentable, and we may not be able to prevent others from obtaining this information and establishing competitive enterprises.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on trade secrets to protect our proprietary technology, especially in circumstances in which we believe patent protection is not appropriate or available. We attempt to protect our proprietary technology in part by confidentiality agreements with our employees, consultants, collaborators and contractors. However, we cannot provide assurance that these agreements will not be breached, that we would have adequate remedies for any breach, or that our trade secrets will not otherwise become known or be independently discovered by competitors, any of which would harm our business significantly.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2016, the Defend Trade Secrets Act of 2016, or the DTSA, was enacted, providing a federal cause of action for misappropriation of trade secrets. Under the DTSA, an employer may not collect enhanced damages or attorney fees from an employee or contractor in a trade secret dispute brought under the DTSA, unless certain advanced provisions are observed. We cannot provide assurance that our existing agreements with employees and contractors contain notice provisions that would enable us to seek enhanced damages or attorneys&#x2019; fees in the event of any dispute for misappropriation of trade secrets brought under the DTSA.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Managing Our Growth and Other Business Operations</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be unable to successfully retain or recruit key personnel to support the development and potential future commercialization of imetelstat or to otherwise successfully manage our growth.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to successfully develop imetelstat in the future and to potentially commercialize imetelstat depends to a significant extent on the skills, experience and efforts of our executive officers and key members of our staff. In addition, we need to recruit, maintain, motivate and integrate additional personnel with expertise and experience in clinical science, biostatistics, clinical operations, pharmacovigilance, quality, manufacturing, regulatory affairs, medical affairs, legal affairs, market access, pricing, commercial operations, sales, and marketing, to enable us to further develop and potentially commercialize imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face intense competition for qualified individuals from numerous pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and other research institutions, and competition in our geographic regions is particularly intense. The substantial risks and uncertainties related to our development and potential commercialization of imetelstat and the risks and uncertainties regarding our future business viability could have an adverse impact on our ability to retain and recruit qualified personnel. We may also face higher than expected personnel costs in order to attract new personnel due to shortages in qualified applicants, or to maintain our current management and personnel due to the increased number of opportunities in the biotechnology sector. If we are unable to successfully retain, motivate and incentivize our existing personnel, or to attract, assimilate and retain other highly qualified personnel in the future on acceptable terms, our ability to further develop and potentially commercialize imetelstat will be impaired, and our business and the price of our common stock would be adversely impacted.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our personnel are currently performing their duties in multiple jurisdictions, and if we are unable or fail to comply with employment, tax, benefits and other laws in such jurisdictions, we may face penalties, fines or litigation. Further, if members of our management and other key personnel in critical functions across our organization are unable to perform their duties or have limited availability due to the effects of the COVID-19 pandemic, we may not be able to execute on our business strategy and/or our operations may be negatively impacted.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future financial performance and our ability to develop, manufacture and commercialize imetelstat will depend, in part, on our ability to effectively manage any future growth. Our management may have to divert financial and other resources, as well as devote a substantial amount of time, to managing growth activities, such as enhancing operational, financial and management processes and systems. If we do not effectively manage the expansion of our operations, we could experience weaknesses in our infrastructure and ability to comply with applicable legal and regulatory requirements and regulations, operational mistakes or shortcomings, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The expansion of our operations also could lead to significant costs and could delay the execution of our business plans or disrupt our current operations. Our ineffective performance in managing any such future growth would negatively impact our business prospects.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As our operations continue to expand, we expect that we will need to manage new and additional relationships with various service providers, vendors, suppliers and other third parties, as well as a workforce in multiple countries, jurisdictions and locations. For example, in September 2021, we established a subsidiary in the U.K. to accommodate our growing workforce in that location. Our business needs and the expansion of our workforce may require us to establish additional business offices or entities in additional jurisdictions outside of the U.S., including additional subsidiaries, or to retain third parties to manage employment-related matters in new countries, jurisdictions and locations. Because the legal and regulatory requirements related to the operation and maintenance of such entities, and the employment of personnel in such countries, jurisdictions and regions is multi-national and complex, we may be unable to effectively operate and maintain such entities, or be unable to attract and retain ex-U.S. personnel, which could lead to significant costs and could delay the execution of our business plans or disrupt our current and future operations. If we fail to achieve key development goals, our abilities to grow as a company, and to further develop and potentially commercialize imetelstat, could be prevented or hindered, and our business and business prospects would be severely harmed, which might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Notwithstanding our research and discovery efforts, we expect imetelstat to remain our sole product candidate for the foreseeable future. If we are unable to successfully develop and commercialize imetelstat, our business and business prospects would be severely harmed, which might cause us to cease operations.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other than imetelstat, we do not currently have any other product candidates. While we recently initiated a discovery program to identify a lead compound as a potential next generation oral telomerase inhibitor, our discovery efforts are at an early stage and may not be successful. In this regard, internal discovery efforts to identify new product candidates require substantial technical, financial and human resources, and the outcome of those efforts are uncertain and unpredictable. In addition, these discovery efforts may initially show promise in identifying a potential product candidate, yet fail to yield a product candidate for clinical development for a number of reasons, including where the research methodology used may not be successful in identifying a potential product candidate, or where a potential product candidate may, on further study, be shown to have inadequate efficacy, harmful side</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">effects, suboptimal pharmaceutical profile or other characteristics suggesting that it is unlikely to be an effective product. Furthermore, in addition to research and development risks, any potential lead compounds identified during discovery may not be patentable, and therefore unsuitable for further development. Likewise, our research efforts to evaluate imetelstat in lymphoid hematologic malignancies may not be successful. In any event, notwithstanding our research and discovery efforts, we remain and expect to continue remain wholly reliant upon the development of imetelstat, our sole product candidate, for the foreseeable future. If we are unable to successfully develop and commercialize imetelstat, our business and business prospects would be severely harmed, which might cause us to cease operations. Similarly, if we are unable to discover and develop new product candidates or to develop imetelstat in lymphoid hematologic malignancies through our research and discovery efforts, our business and business prospects would be harmed.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we seek to establish potential future collaborative arrangements for imetelstat, we may be unable to establish such collaborative arrangements on acceptable terms, or at all, and may have to delay, alter or abandon our imetelstat development and commercialization plans.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to develop imetelstat broadly for hematologic malignancies, and to potentially commercialize, market and sell imetelstat in the U.S. We may seek a collaborative partner or partners, at an appropriate time, to assist us in the potential development and commercialization of imetelstat, especially outside the U.S., and to provide funding for such activities. We face significant competition in seeking appropriate collaborative partners, and these potential collaborative arrangements are complex and time consuming to negotiate, document and implement. Our ability to seek and establish potential collaborative arrangements may be impacted by the effects of the COVID-19 pandemic on our clinical trial activities and the resulting delays in reporting any results from IMpactMF, as well as the period of the patent term for our intellectual property portfolio and market exclusivity for imetelstat. We may not be able to establish collaborative arrangements on acceptable terms, or at all. In this regard, collaborative arrangements with third parties may require us to relinquish material rights, including revenue from potential commercialization, or assume material ongoing development obligations that we would have to fund or otherwise support.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In any event, we are unable to predict when, if ever, we will enter into any collaborative arrangements because of the numerous risks and uncertainties associated with establishing collaborative arrangements. Moreover, given the significant risks and uncertainties regarding the future imetelstat development program, potential collaborative partners may be reluctant to enter into new collaborative arrangements with us, or may only be willing to do so on terms that are not favorable to us. As a result, we may not be successful in finding a collaborative partner or partners on favorable terms, if at all. If we are unable to negotiate collaborative arrangements, we may have to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delay or curtail the additional development of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further delay or abandon the potential commercialization of imetelstat outside of the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduce the scope of potential future sales or marketing activities; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increase our expenditures and undertake development or commercialization activities at our own expense, which will require substantial additional capital than our current resources.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to advance the imetelstat program, including through completion of IMpactMF, IMproveMF and IMpress, or to commence, conduct and complete potential future clinical trials of imetelstat, and in the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding following this offering. However, we cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all. In addition, if we elect to increase our expenditures to fund imetelstat development or commercialization activities outside the U.S., we will be required to substantially increase our personnel resources and we will need to obtain substantial further capital, which may not be available to us on acceptable terms, or at all. If we are unable to raise substantial additional capital if and when needed, we will not be able to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications to generate product revenues. Establishing the infrastructure necessary to further develop, commercialize, market and sell imetelstat worldwide will require substantial resources and may divert the attention of our management and key personnel and negatively impact our imetelstat development or commercialization efforts in the U.S.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently have no products approved for commercial sale, and we have not yet demonstrated an ability to obtain marketing approvals for any product candidates, which makes it difficult to assess our future viability.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never derived any revenue from the sales of any products. Our operations to date have been limited to organizing and staffing our company, acquiring, developing and securing our technology, undertaking non-clinical studies and clinical trials of imetelstat and past product candidates that we have subsequently discontinued, and engaging in research and development under collaboration agreements. We have not yet demonstrated an ability to obtain regulatory approvals for commercialization activities, formulate and manufacture commercial-scale products, or conduct sales and marketing activities necessary for successful product commercialization. Consequently, for these and other reasons discussed elsewhere in these risk factors, it is difficult to predict our future success and the viability of our business and the imetelstat program.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have business operations in the United Kingdom which exposes us to additional costs and risks.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business operations in the U.K. subject us to certain additional costs and risks associated with doing business outside the U.S., including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the increased complexity and costs inherent in managing international operations in geographically disparate locations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges of complying with diverse regulatory, financial and legal requirements, which are subject to change at any time;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potentially adverse tax consequences, including changes in applicable tax laws and regulations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potentially costly trade laws, tariffs, export quotas, custom duties or other trade restrictions, and any changes to them;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">liabilities for activities of, or related to, our international operations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges inherent in efficiently managing employees in diverse geographies, including the need to adapt systems, policies, benefits and compliance programs to differing labor and other regulations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">natural disasters, political and economic instability, including terrorism and civil and political unrest, outbreak of health epidemics, including the evolving COVID-19 pandemic, and the resulting global economic and social impacts;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with the United Kingdom Bribery Act 2010, or UK Bribery Act, and similar antibribery and anticorruption laws in other jurisdictions, and the Foreign Corrupt Practices Act, including its books and records provisions and its anti-bribery provisions, including by failing to maintain accurate information and control over sales and distributors&#x2019; activities.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our international operations in the U.K. expose us to fluctuations in currency exchange rates between the British pound and the U.S. dollar. Given the volatility of currency exchange rates, there is no assurance that we will be able to effectively manage currency transaction and/or conversion risks. To date, we have not entered into derivative instruments to offset the impact of foreign exchange fluctuations, which fluctuations could have an adverse effect on our financial condition and results of operations.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to obtain or maintain sufficient insurance on commercially reasonable terms or with adequate coverage against potential liabilities in order to protect ourselves against product liability claims or claims related to clinical trial conduct, or claims related to data protection.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business exposes us to potential product liability and other risks that are inherent in the testing, manufacturing and marketing of human therapeutic and diagnostic products. We may become subject to product liability claims or claims related to clinical trial conduct, including if the use of imetelstat is alleged to have injured patients, such as injuries alleged to arise from any hepatotoxicity or hemorrhagic event associated with the use of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">imetelstat. We currently have limited clinical trial liability insurance, and we may not be able to maintain this type of insurance for any of our current or potential future clinical trials of imetelstat. In addition, this type of insurance may become too expensive for us to afford because of the highly risky and uncertain nature of clinical trials generally and the high cost of insurance for our business activities. We may be unable to obtain or maintain clinical trial insurance in all of the jurisdictions where we conduct current or potential future clinical trials. In addition, business liability, product liability and cybersecurity insurance are becoming increasingly expensive, particularly for biotechnology and pharmaceutical companies, and the pool of insurers offering insurance coverage to biotechnology and pharmaceutical companies generally is becoming smaller, making it more difficult to obtain insurance for our business activities at a reasonable price, or at all. Being unable to obtain or maintain product liability, clinical trial liability, cybersecurity or other insurance for our business activities in the future on acceptable terms or with adequate coverage against potential liabilities would have a material adverse effect on our business, and could cause us to cease our development of imetelstat.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We and certain of our officers have been named as defendants in two pending securities class action lawsuits and seven shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities-related class action lawsuits and/or derivative lawsuits have often been brought against companies, including biotechnology and biopharmaceutical companies, that experience volatility in the market price of their securities. This risk is especially relevant for us because we often experience significant stock price volatility in connection with our product development activities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between January 23, 2020 and March 5, 2020, three securities class action lawsuits were filed against us and certain of our officers. One of the lawsuits was voluntarily dismissed on March 19, 2020. The other two lawsuits, filed in the U.S. District Court, or the Court, for the Northern District of California, or the Northern District, were consolidated by the Court on May 14, 2020, and on August 20, 2020, the lead plaintiffs filed a consolidated class action complaint. The consolidated class action complaint alleges violations of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with allegedly false and misleading statements made by us related to IMbark during the period from March 19, 2018, to September 26, 2018. The consolidated class action complaint alleges, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5 by failing to disclose facts related to the alleged failure of IMbark to meet the two primary endpoints of the trial, spleen response rate and Total Symptom Score, and that our stock price dropped when such information was disclosed. The plaintiffs in the consolidated class action complaint seek damages and interest, and an award of reasonable costs, including attorneys&#x2019; fees. On October 22, 2020, lead plaintiffs filed an amended consolidated class action complaint. We filed a motion to dismiss the amended consolidated class action complaint on November 23, 2020. On April 12, 2021, the Court granted in part and denied in part our motion to dismiss. Our answer to the amended consolidated class action complaint was filed on May 13, 2021. On September 30, 2021, lead plaintiffs filed their motion for class certification, and on April 2, 2022, the Court granted the lead plaintiffs&#x2019; motion for class certification. On September 2, 2022, the parties agreed to a settlement and entered into a Stipulation and Agreement of Settlement, or the Stipulation, which is subject to court approval. On October 13, 2022, the Court preliminarily approved the parties&#x2019; settlement, permitted notice to be distributed to the class members, and scheduled a final approval hearing for March 30, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or both of the parties to the settlement may exercise their right to terminate the settlement agreement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between April 23, 2020 and June 8, 2021, seven shareholder derivative actions were filed, naming as defendants certain of our current officers and certain current and former members of our board. Of these actions, or the Derivative Lawsuits, two were filed in the Northern District, two were filed in the Court of Chancery of the State of Delaware, two were filed in the U.S. District Court for the District of Delaware, and one was filed in the Superior Court of California for the County of San Mateo, respectively. The plaintiffs in the Derivative Lawsuits allege breach of fiduciary duty and/or violations of Section 14 of the Exchange Act, based on the same underlying facts as the consolidated class action lawsuit described above. The plaintiffs seek damages, corporate governance reforms,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">equitable relief, restitution, and an award of reasonable costs, including attorneys&#x2019; fees. The status of the seven Derivative Lawsuits is currently as follows:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 2, 2021, we filed a motion to dismiss the consolidated shareholder derivative actions filed in the Court of Chancery of the State of Delaware, or the Chancery Court Derivative Lawsuits. On September 1, 2021, the plaintiffs filed a consolidated amended complaint in the Chancery Court Derivative Lawsuits. On October 12, 2021, we filed our motion to dismiss the consolidated amended complaint. The Court of Chancery of the State of Delaware heard oral argument on the motion on February 15, 2022, and, on June 22, 2022, issued an order staying its decision on our motion to dismiss until after final resolution of the consolidated class action lawsuit described above. On December 21, 2022, the parties in the Chancery Court Derivative Lawsuits entered into a Stipulation of Settlement, or the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the Chancery Court Derivative Lawsuits;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the U.S. District Court for the District of Delaware have been stayed pending the ruling on our motion to dismiss the Chancery Court Derivative Lawsuits. On December 21, 2022, the parties in the consolidated District of Delaware derivative actions entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated District of Delaware derivative actions;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the Northern District were initially stayed through the ruling on our motion to dismiss in the consolidated class action lawsuit described above and then subsequently were stayed through the ruling on the lead plaintiffs&#x2019; motion for class certification in the consolidated class action lawsuit. Subsequent to the grant of class certification in the consolidated class action lawsuit, on May 3, 2022, the Northern District entered an order providing plaintiffs until June 7, 2022, to file an amended complaint. On June 7, 2022, plaintiffs filed an amended shareholder derivative complaint. On July 6, 2022, the Northern District entered an order staying the consolidated shareholder derivative actions filed in the Northern District until the earlier of either a public announcement of a settlement in the consolidated class action lawsuit or a final, non-appealable judgment in the consolidated class action lawsuit. The stay has subsequently been extended on a number of occasions and the case is currently stayed through December 31, 2022. On December 21, 2022, the parties in the consolidated derivative actions in the Northern District entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated derivative actions in the Northern District; and </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our motion to dismiss the shareholder derivative action pursuant to the forum selection clause in our amended and restated bylaws was filed in the Superior Court of California for the County of San Mateo on August 5, 2021. At the hearing on the motion to dismiss on November 2, 2021, the court granted our motion to dismiss and stayed the case until April 19, 2022. At the case management conference on April 19, 2022, the court continued the stay until June 14, 2022. At the case management conference on June 14, 2022, the court continued the stay until December 13, 2022. On December 13, 2022, the court dismissed the action without prejudice.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is possible that additional lawsuits will be filed, or allegations received from stockholders, with respect to these same or other matters and also naming us and/or our officers and directors as defendants. Such lawsuits and any other related lawsuits are subject to inherent uncertainties, and the actual defense and disposition costs will depend upon many unknown factors. The outcome of such lawsuits is necessarily uncertain. We could be forced to expend significant resources in the defense of the pending lawsuits and any additional lawsuits, and we may not prevail. In addition, we have and may continue to incur substantial legal fees and costs in connection with such lawsuits. As discussed in Note 5 on Contingencies and Uncertainties in Notes to Condensed Consolidated Financial Statements of our quarterly report on Form 10-Q for the quarter ended September 30, 2022, we recorded the total settlement amount for the Stipulation on our condensed consolidated balance sheet as of September 30, 2022. We currently are not able to estimate the possible additional costs to us, if any, from these matters, and we cannot be certain how long it may take to resolve the pending lawsuits or the possible amount of any damages or legal costs that we may be required to pay. Monitoring, initiating and defending against legal actions is time-consuming for our management, is likely to be expensive and may detract from our ability to fully focus our internal resources on our business activities. We could be forced to expend significant resources in the settlement or defense of the pending</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lawsuits and any potential future lawsuits, and we may not prevail in such lawsuits. Additionally, we may not be successful in having any such lawsuits dismissed or settled within the limits of our insurance coverage.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not established any reserve for any potential liability relating to the pending lawsuits or any potential future lawsuits, other than for the total settlement amount under the Stipulation. It is possible that we could, in the future, incur judgments or enter into settlements of claims for monetary damages. A decision adverse to our interests in the pending lawsuits, or in similar or related litigation, could result in the payment of substantial damages, or possibly fines, and could have a material adverse effect on our business, our stock price, cash flow, results of operations and financial condition.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to third-party litigation, and such litigation would be costly to defend or pursue and uncertain in its outcome.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business may bring us into conflict with our licensees, licensors, or others with whom we have contractual or other business relationships, or with our competitors or others whose interests differ from ours. We may experience employment-related disputes as we seek to expand our personnel resources. We may become involved in performance or other disputes with the CROs we have retained to support our imetelstat clinical development activities, or with other third parties such as service providers, vendors, manufacturers, suppliers or consultants, which could result in a further delay or cessation of current and potential future clinical trials and otherwise significantly further delay our ability to develop imetelstat. If we are unable to resolve those conflicts on terms that are satisfactory to all parties, we may become involved in litigation brought by or against us.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lawsuits are subject to inherent uncertainties, and defense and disposition costs depend upon many unknown factors. Despite the availability of insurance, we may incur substantial legal fees and costs in connection with litigation. Lawsuits could result in judgments against us that require us to pay damages, enjoin us from certain activities, or otherwise negatively affect our legal or contractual rights, which could have a significant adverse effect on our business. In addition, the inherent uncertainty of such litigation could lead to increased volatility in our stock price and a decrease in the value of our stockholders&#x2019; investment in our securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations.  Compliance with these legal standards could impair our ability to compete in domestic and international markets.  We can face criminal liability and other serious consequences for violations, which can harm our business.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#x2019;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, or FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities.  Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector.  We may engage third parties to sell our products outside the United States, to conduct clinical trials, and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals.  We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations.  We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities.  Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Competitive Factors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If competitors develop products, product candidates or technologies that are superior to or more cost-effective than imetelstat, this would significantly impact the development and commercial viability of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The pharmaceutical and biotechnology industries are characterized by intense and dynamic competition with rapidly advancing technologies and a strong emphasis on proprietary products. While we believe our proprietary oligonucleotide chemistry; experience with the biological mechanisms related to imetelstat, telomeres and telomerase; clinical data to date indicating potential disease-modifying activity with imetelstat treatment; and knowledge and expertise around the development of potential treatments for myeloid hematologic malignancies provide us with competitive advantages, we face competition from many different sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, governmental agencies, and public and private research institutions. Imetelstat will compete, if approved, with other products and therapies that currently exist, are being developed or will in the future be developed, some of which we may not currently be aware of.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of lower risk MDS, imetelstat would compete against a number of currently existing therapies, including ESAs and other hematopoietic growth factors that are indicated for anemia; immunomodulators, such as Revlimid (lenalidomide) by Celgene Corporation, a Bristol-Myers Squibb Corporation, or Celgene; hypomethylating agents, such as Vidaza (azacitidine) by Celgene and manufacturers of generic azacitidine; Dacogen (decitabine) by Otsuka America Pharmaceutical, Inc. and other manufacturers in the U.S. and Janssen in the EU; Inqovi (oral combination of decitabine and cedazuridine) by Astex Pharmaceuticals, Inc., or Astex; and Reblozyl (luspatercept), a TGF-beta inhibitor, by Acceleron Pharma, Inc., or Acceleron (acquired by Merck &amp; Co., Inc., or Merck, in November 2021), in collaboration with Celgene.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in lower risk MDS, some of which may obtain regulatory approval earlier than imetelstat include roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, by FibroGen, Inc; Onureg (oral azacytidine) by Bristol-Myers Squibb Corporation, or BMS; and Hengqu (hetrombopag), an oral nonpeptide thrombopoietin receptor agonist, by Jiangsu Hengrui Pharmaceuticals Co., Ltd.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there are multiple Phase 1 and Phase 2 clinical trials of other agents being developed for lower risk MDS, including but not limited to: LB&#x2010;100, a PP2A inhibitor, by Lixte Biotechnology Holdings, Inc.; bemcentinib, an AXL inhibitor, by BerGenBio ASA; H3B&#x2010;8800, a spliceosome inhibitor, by H3 Biomedicine, Inc.; KER-050, a TGF-beta inhibitor, by Keros Therapeutics, Inc., or Keros Therapeutics; TP-0184, an inhibitor of ALK2 or ACVR1 kinase, by Sumitomo Dainippon Pharma Oncology, Inc; ilginatinib (NS-018), a JAK2 inhibitor, by NS Pharma, Inc., a U.S. subsidiary of Nippon Shinyaku Co., Ltd., or NS Pharma; RVT-2001, a SF3B1 modulator, by Roivant Sciences, Ltd.; sabatolimab (MBG453), a TIM-3 inhibitor, by Novartis AG; a lower dose of ASTX727, an oral formulation of decitabine and cedazuridine, referred to as ASTX727 LD, by Astex; ASTX030, an oral formulation of azacitidine and cedazuridine, by Astex; R289, an oral inhibitor of interleukin receptor-associated kinases 1 and 4, or IRAK1/4, by Rigel Pharmaceuticals, Inc.; a combination treatment regimen of luspatercept and lenalidomide by BMS; and HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, by BMS and etavopivat, an oral, small molecule activator of erythrocyte pyruvate kinase (PKR) by Forma Therapeutics, Inc., a Novo Nordisk Company.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of MF, imetelstat would compete against currently approved JAK inhibitors: Jakafi (ruxolitinib) by Incyte Corporation, or Incyte, and Inrebic (fedratinib) by Celgene, as well as a kinase inhibitor, Vonjo (pacritinib), by CTI Biopharma Corp., which was approved in February 2022 for the treatment of adults with Intermediate or High-Risk primary or secondary myelofibrosis with a platelet count below 50 &times; 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/L. Other treatment modalities for MF include hydroxyurea for the management of splenomegaly, leukocytosis, thrombocytosis and constitutional symptoms; splenectomy and splenic irradiation for the management of splenomegaly and co-existing cytopenias; chemotherapy and pegylated interferon. Drugs for the treatment of MF-associated anemia include ESAs, androgens, danazol, corticosteroids, thalidomide and lenalidomide.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in MF, some of which may obtain regulatory approval earlier than imetelstat, include momelotinib, a JAK inhibitor, by GlaxoSmithKline plc; or momelotinib plus</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AZD5153, a BET inhibitor by GlaxoSmithKline plc; pelabresib (CPI-0610), a BET inhibitor, by MorphoSys AG; navitoclax, a BCLXL, BCL-2 and BCLW inhibitor, by AbbVie, Inc.; and parsaclisib, a PI3K delta inhibitor, by Incyte. Other approaches for MF currently under investigation that could compete with imetelstat in the future include luspatercept; zinpentraxin alfa (RG6354, formerly PRM-151), an anti-fibrosis antibody, by F. Hoffmann-La Roche, Ltd.; LCL-161, an inhibitor of apoptosis protein (IAP), by Novartis; KRT-232, an inhibitor of MDM2, by Kartos Therapeutics, Inc.; GB2064, a LOXL2 inhibitor, by Galecto Biotech; elraglusib (9-ING-41), a glycogen synthase kinase-3 beta inhibitor, by Actuate Therapeutics, Inc.; XPOVIO (selinexor), a nuclear export inhibitor, by Karyopharm Therapeutics, Inc.; TL-895, an oral tyrosine kinase inhibitor, by Telios Pharma, Inc.; IMG-7289, a LSD1 inhibitor, by Imago Biosciences, Inc.; APG-1252, a dual BCL-2/BCL-XL inhibitor, by Ascentage Pharma; ilginatinib (NS-018), a JAK2 inhibitor by NS Pharma; DISC-0974, a monoclonal antibody against hemojuvelin (HJV) by DISC Management Inc.; KER-050 in combination with ruxolitinib, by Keros Therapeutics; CK0804, an allogeneic T-regulatory cell agent, by Cellenkos, Inc. in collaboration with Incyte; and a mutated-CALR vaccine, a peptide-based vaccine, from the Icahn School of Medicine at Mount Sinai.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. We anticipate increased competition in the future as new companies explore treatments for myeloid hematologic malignancies, which may significantly impact the commercial viability of imetelstat. Academic institutions, government agencies and other public and private research organizations may also conduct research, seek patent protection and establish collaborative arrangements for research, clinical development and marketing of products similar to imetelstat. These companies and institutions compete with us in recruiting and retaining qualified development and management personnel as well as in acquiring technologies complementary to the imetelstat program.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors, either alone or with their strategic partners, could have substantially greater financial, technical and human resources than we do and significantly greater experience in obtaining FDA and other regulatory approvals of treatments and commercializing those treatments. We believe that the commercial success of imetelstat is subject to a number of factors, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product efficacy and safety;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">method of product administration;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost of manufacturing;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and scope of regulatory consents;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">status of coverage and level of reimbursement;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">level of generic competition;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">price; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent position, including potentially dominant patent positions of others.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the foregoing, competitors may develop more commercially desirable or affordable products than imetelstat, or achieve earlier patent protection or product commercialization than we may be able to achieve with imetelstat. Competitors have developed, or are in the process of developing, technologies that are, or in the future may be, competitive to imetelstat. Some of these products may have an entirely different approach or means of accomplishing therapeutic effects similar or superior to those that may be demonstrated by imetelstat. Competitors may develop products that are safer, more effective, or less costly than imetelstat, or more convenient to administer to patients and, therefore, present a serious competitive threat to imetelstat. In addition, competitors may price their products below what we may determine to be an acceptable price for imetelstat, may receive better third-party payor coverage and/or reimbursement, or may be more cost-effective than imetelstat. Such competitive products or activities by competitors may render imetelstat obsolete, which may cause us to cease any further development or future commercialization of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">To be commercially successful, imetelstat must be accepted by the healthcare community, which can be very slow to adopt or unreceptive to new technologies and products.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if approved for marketing, imetelstat may not achieve market acceptance, or the potential worldwide or U.S. revenue we believe may be possible, since hospitals, physicians, patients or the medical community in general may decide not to accept and utilize imetelstat. If approved for commercial sale, imetelstat will compete with a number of conventional and widely accepted drugs and therapies manufactured and marketed by major pharmaceutical companies. The degree of market acceptance of imetelstat will depend on a number of factors, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the clinical indications for which imetelstat is approved, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the country and/or regions within which imetelstat is approved, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the establishment and demonstration to the medical community of the clinical efficacy and safety of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to demonstrate that imetelstat is superior to alternatives on the market at the time;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to establish in the medical community the potential advantages of imetelstat over alternative treatment methods, including with respect to efficacy, safety, cost or route of administration;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of medical professionals to prescribe, and patients to use, imetelstat, or to continue to use imetelstat; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the publication of unfavorable safety or efficacy data concerning imetelstat by third parties or us;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on use of imetelstat in combination with other products;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the label and promotional claims allowed by the FDA or similar international regulatory authorities for imetelstat, if any, including usage for only certain indications and any limitations or warnings about the prevalence or severity of any side effects;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of market introduction of imetelstat as well as competitive products, including sequencing of available products;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effectiveness of sales, marketing and distribution support for imetelstat, particularly during the remote COVID-19 environment;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which imetelstat is approved for inclusion on formularies in hospitals and managed care organizations;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the pricing of imetelstat, both in absolute terms and relative to alternative treatments;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate reimbursement by government and third-party payors; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of patients to pay out-of-pocket in the absence of coverage by third-party payors, including governmental authorities.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The established use of conventional products competitive with imetelstat may limit or preclude the potential for imetelstat to receive market acceptance upon any commercialization. We may be unable to demonstrate any therapeutic or economic advantage for imetelstat compared to established or standard-of-care therapies, or newly developed therapies, for myeloid hematologic malignancies. Third-party payors may decide that any potential benefit that imetelstat may provide to clinical outcomes in myeloid hematologic malignancies is not adequate to justify the costs of treatment with imetelstat. If the healthcare community does not accept imetelstat for any of the foregoing reasons, or for any other reasons, our ability to further develop or potentially commercialize imetelstat may be negatively impacted or precluded altogether, which would seriously and adversely affect our business and business prospects.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If the market opportunities for imetelstat are smaller than we believe, our potential revenue may be adversely affected, and our business may suffer.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our initial focus for imetelstat development has been on the lead indications, lower risk MDS and relapsed/refractory MF. The addressable patient populations, if imetelstat is approved in those indications, are based on our estimates. These estimates, which have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations and market research, may prove to be incorrect. Further, new information from us or others may change the estimated incidence or prevalence of those indications.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any regulatory approval of imetelstat would be limited to the therapeutic indications examined in our clinical trials and as determined by the FDA and similar international regulatory authorities, which would not permit us to market imetelstat for any other indications not expressly approved by those regulatory authorities. Additionally, the potentially addressable patient population for imetelstat may not ultimately be amenable to treatment with imetelstat. Even if we receive regulatory approval for imetelstat, such approval could be conditioned upon label restrictions that materially limit the addressable patient population.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our market opportunity may also be limited by the pricing we are able to achieve for imetelstat, if approved, the quality and expiration of our intellectual property rights and licenses, and future competitor treatments that enter the market. If any of our estimates prove to be inaccurate, the market opportunities for imetelstat that we or any potential future collaborative partners develop could be significantly diminished which would have a material adverse impact on our business and business prospects.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The adoption of health policy changes and healthcare reform in the U.S. may adversely affect our business and financial results.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S. and some jurisdictions outside the U.S., there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could impact our business. For example, in response to the COVID-19 pandemic, the CARES Act was signed into law in March 2020. The CARES Act is aimed at providing emergency assistance and healthcare for individuals, families and businesses affected by the COVID-19 pandemic and generally supporting the U.S. economy. Generally, there has been increasing legislative and enforcement interest in the U.S. with respect to drug pricing, including specialty drug pricing practices, in light of the rising cost of prescription drugs and biologics. Specifically, there have been U.S. Congressional inquiries and federal and state legislative activity designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the price of drugs under Medicare, and reform government program reimbursement methodologies for drugs and biologics. In July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, the Department of Health and Human Services, or HHS, released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. Further, the Inflation Reduction Act of 2022, or the IRA, signed into law by President Biden on August 16, 2022, includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government. Some of the specific provisions under the IRA that could impact us include:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Requirement that the federal government negotiate prices for certain single-source drugs covered under Medicare Part B and D with the highest total spending, beginning in 2026; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Requirement that drug companies pay rebates to Medicare if prices rise faster than inflation for drugs used by Medicare beneficiaries, beginning in 2023.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report within 90 days on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. We expect that additional state and federal healthcare reform measures may be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could affect pricing for imetelstat if it is approved.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, the U.S. and some jurisdictions in other countries are considering or have enacted legislative and regulatory proposals to contain healthcare costs, as well as to improve quality and expand access. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA was signed into law, which included a number of provisions of importance to the biopharmaceutical industry. There have been judicial and Congressional challenges to certain aspects of the ACA, and it is possible that the ACA will be subject to judicial or Congressional challenges in the future. We expect that other healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and lower reimbursement, and additional downward pressure on the price that may be charged for imetelstat.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If future legislation were to impose direct governmental price controls and access restrictions, it could have a significant adverse impact on our business and financial results. Managed care organizations, as well as Medicaid and other government agencies, continue to seek price discounts. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biologic product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, to encourage importation from other countries and bulk purchasing. Due to the volatility in the current economic and market dynamics, we are unable to predict the impact of any unforeseen or unknown legislative, regulatory, payor or policy actions, which may include cost containment and healthcare reform measures. Such policy actions could have a material adverse impact on future worldwide sales of imetelstat, if approved.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost control initiatives also could decrease the price that we may receive for imetelstat in the future. If imetelstat is not considered cost-effective or adequate third-party reimbursement for the users of imetelstat cannot be obtained, then we may be unable to maintain price levels sufficient to realize an appropriate return on our investment in imetelstat. Any of these events would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with federal, state and international healthcare laws, including fraud and abuse, transparency, and health information privacy and security laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors and customers, may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, including federal and state fraud and abuse laws, including anti-kickback and false claims laws; data privacy and security laws, including the Health Insurance Portability and Accountability Act, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH; and transparency laws related to payments and/or other transfers of value made to physicians, other healthcare professionals and teaching hospitals. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell and distribute imetelstat, if marketing approval is obtained. For details regarding the restrictions under applicable federal and state healthcare laws and regulations that may affect our ability to operate see Item 1 &#x201c;Business&#x2014;Government Regulation&#x2014; Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2021.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. If our operations are found to be in violation of any of these or any other healthcare and privacy-related regulatory laws that may apply to us, we may be subject to significant penalties, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, reputational harm, diminished profits and future earnings, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, independent contractors, principal investigators, clinical trial sites, contract research organizations, consultants or vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, principal investigators, clinical trial sites, CROs, consultants or vendors may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate the FDA&#x2019;s or similar international regulatory authorities&#x2019; regulations, including those laws requiring the reporting of true, complete and accurate information; manufacturing standards; healthcare fraud and abuse laws and regulations; or laws that require the true, complete and accurate reporting of financial information or data. Specifically, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Activities subject to these laws also involve the improper use or misrepresentation of information obtained in the course of clinical trials or creating fraudulent data in our non-clinical studies or clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by our employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished potential profits and future earnings, and curtailment of our operations, any of which could adversely affect our business, financial condition, results of operations or prospects.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO INFORMATION TECHNOLOGY SYSTEMS,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DATA SECURITY AND DATA PRIVACY</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including, but not limited to, regulatory investigations and actions; litigation; fines and penalties; a disruption of our business operations such as our clinical trials; reputational harm; loss of revenue and profits; and other adverse consequences.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of our business, we (and third parties upon which we rely) may collect, receive, store, process, use, transfer, make accessible, protect, secure, dispose of, transmit, disclose, or otherwise process (commonly known as processing) proprietary, confidential, and sensitive data, including personal data (such as health-related data and participant study related data), intellectual property, and trade secrets (collectively, sensitive information). In addition, we rely on third-party service providers to establish and maintain appropriate information technology and data security protections over the information technology systems they provide us to operate our critical business systems, including cloud-based infrastructure and systems, employee email, and data storage and management systems. However, except for contractual duties and obligations, we have limited ability to control their safeguards and actions related to such matters, and these third parties may not have adequate information security measures in place. We may share or receive sensitive information with or from third parties. In particular, the COVID-19 pandemic has caused us to modify our business and information technology practices, including that most of our employees continue to work remotely. Additionally, the prevalent use of mobile devices that access our sensitive information increases the risk of breaches.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our information technology systems, including in our remote work environment as a result of the COVID-19 pandemic, and those of the third parties upon which we rely, are potentially vulnerable to evolving threats. These threats are prevalent, continue to increase, and come from a variety of sources such as &#x201c;hackers,&#x201d; threat or internal bad actors, personnel (such as through theft, error or misuse), sophisticated nation states and nation-state-supported actors. These threats include, but are not limited to, social-engineering attacks, malicious code or malware, unauthorized intrusions, denial-of-service attacks, personnel misconduct or errors, ransomware attacks, supply-chain</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">attacks, software bugs, computer viruses, server malfunctions, software, hardware or data center failures, loss of data or other information technology assets, natural disasters, terrorism, war, and telecommunication and electrical failures. In particular, ransomware attacks are becoming increasingly prevalent and severe and can lead to significant interruptions in operations, loss of data and income, reputational harm, and diversion of funds. If we were to experience such an attack, extortion payments might alleviate the negative impact of a ransomware attack, but we might be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Similarly, supply-chain attacks and attacks on clinical trial sites as well as regulatory and health authorities have increased in frequency and severity, and we cannot guarantee that third parties and infrastructure in our supply chain or our third-party partners&#x2019; supply chains, or of clinical trial sites and regulatory and health authorities, have not been compromised or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our information technology systems (including those related to imetelstat) or the third-party information technology systems that support us and the services provided to us. These threats may result in unauthorized, unlawful or accidental loss, corruption, access, modification, destruction, alteration, acquisition or disclosure of sensitive information, such as clinical trial data or information, intellectual property, proprietary business data and personal data. The costs to us to attempt to protect against such breaches could be significant, including potentially requiring us to modify our business (including non-clinical and clinical trial activities), and while we have implemented security measures designed to protect our information technology systems and to identify and remediate vulnerabilities, such measures may not be successful. We may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are sophisticated in nature, and may not be detected until after a security incident has occurred.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we or third parties upon which we rely experience or are perceived to have experienced a breach, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections), interruptions in our operations, including disruption of our imetelstat development program, interruptions or restrictions on processing sensitive data (which could result in delays in obtaining, or our inability to obtain, regulatory approvals and significantly increase our costs to recover or reproduce the data), reputational harm, litigation (including class action claims), indemnification obligations, negative publicity, monetary fund diversions, financial loss, and other harms. In addition, such a breach may require notification of the breach to relevant stakeholders. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our contracts with relevant stakeholders include obligations relating to the safeguard of sensitive information, and a breach could lead to claims against us by such stakeholders. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities, damages, or claims relating to our data privacy and security obligations. In addition, failure to maintain effective internal accounting controls related to data security breaches and cybersecurity in general could impact our ability to produce timely and accurate financial statements and could subject us to regulatory scrutiny.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to stringent and changing obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations and actions; litigation; fines and penalties; disruptions to our business operations; reputational harm; loss of revenue and profits; and other adverse business impacts.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, we process personal data and other sensitive data, including proprietary and confidential business data, trade secrets, intellectual property, data we collect about trial participants in connection with clinical trials, and sensitive third-party data. We are therefore subject to or affected by numerous data privacy and security obligations, such as various federal, state, local and foreign laws, regulations, guidances, industry standards, external and internal privacy and security policies, contracts, and other obligations governing the processing of personal data by us and on our behalf. These obligations may change, are subject to differing interpretations and may be inconsistent among jurisdictions or conflict. The global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. This evolution may create uncertainty in our business; affect us or our collaborators&#x2019;, service providers&#x2019; and contractors&#x2019; ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal data; necessitate the acceptance of more onerous obligations in our contracts; result in liability; or impose additional costs on us. The cost of compliance with these laws, regulations and guidances is high and is likely to increase in the future. These obligations may necessitate changes to our information technologies, systems, and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">practices and to those of any third parties that process personal data on our behalf. In addition, these obligations may require us to change our business model.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside the U.S., an increasing number of laws, regulations, and industry standards apply to data privacy and security. For example, the European Union&#x2019;s General Data Protection Regulation (GDPR) (EU) 2016/679, or the EU GDPR, imposes strict requirements on the processing of personal data. Under the EU GDPR, government regulators may impose temporary or definitive bans on data processing, as well as fines of up to &#x20ac;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain jurisdictions, including the EU and the U.K., have enacted data localization laws and cross-border personal data transfer laws, which would make it more difficult to transfer information across jurisdictions (such as transferring or receiving personal data that originates in the EU or in jurisdictions in other countries). Existing mechanisms that facilitate cross-border personal data transfers may change or be invalidated. The processing of sensitive personal data, such as physical health conditions, is a topic of active interest among regulators from other countries. As we expand into countries and jurisdictions outside the U.S., we may be subject to additional laws and regulations that may affect how we conduct business. For example, absent appropriate safeguards or other circumstances, the EU GDPR generally restricts the transfer of personal data to countries outside of the European Economic Area, or EEA, that the European Commission considers do not provide an adequate level of data privacy and security, such as the U.S.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To address this, the European Commission has released a set of &#x201c;Standard Contractual Clauses&#x201d; that are designed to be a valid mechanism by which entities can transfer personal data out of the EEA to jurisdictions that the European Commission has not found to provide an adequate level of protection. Currently, these Standard Contractual Clauses are a valid mechanism to transfer personal data outside of the EEA. The Standard Contractual Clauses, however, require parties that rely upon that legal mechanism to comply with additional obligations, such as conducting transfer impact assessments to determine whether additional security measures are necessary to protect the at-issue personal data. Moreover, due to potential legal challenges, there exists some uncertainty regarding whether the Standard Contractual Clauses will remain a valid mechanism for transfers of personal data out of the EEA. Addressing this uncertainty, on October 7, 2022, President Biden signed an executive order implementing the EU-U.S. Data Privacy Framework, to facilitate the cross-border transfer of personal information from the EU to the U.S. in compliance with the EU GDPR. The European Commission will conduct a determination as to whether the U.S. commitments meet GDPR's adequacy standard for the transfer of personal data, a process anticipated to take about six months. Once ratified by the European Commission, participation in the revised framework will require that companies self-certify their adherence with the U.S. Department of Commerce. In addition, the U.K. similarly restricts personal data transfers outside of those jurisdictions to countries such as the U.S. that do not provide an adequate level of personal data protection.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we cannot implement a valid compliance mechanism for cross-border data transfers, we may face increased exposure to regulatory actions, substantial fines, and injunctions against processing or transferring personal data from Europe or elsewhere. The GDPR has increased our responsibility and potential liability in relation to personal data that we process or control compared to prior EU law, including in clinical trials, which could divert management&#x2019;s attention and increase our cost of doing business; limit our ability to collaborate with parties that are subject to European and other data privacy and security laws; or require us to increase our personal data processing capabilities and infrastructure in Europe and/or elsewhere at significant expense.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Likewise, we expect that there will continue to be new proposed laws, regulations and industry standards relating to privacy and data protection in the U.S. For example, HIPAA, as amended by HITECH, imposes specific requirements relating to the privacy, security, and transmission of individually identifiable health data. Additionally, the California Consumer Privacy Act of 2018, or CCPA, imposes obligations on businesses to which it applies. These obligations include, but are not limited to, providing specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA allows for statutory fines for noncompliance (up to $7,500 per violation). While the CCPA contains limited exceptions for clinical trial data, the CCPA&#x2019;s implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. It is anticipated that the California Privacy Rights Act of 2020, or CPRA, will expand the CCPA. For example, the CPRA establishes a new California Privacy Protection Agency to implement and enforce the CPRA, which could increase the risk of an enforcement action. Other states have also enacted data privacy laws. For</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">example, Virginia passed the Consumer Data Protection Act, and Colorado passed the Colorado Privacy Act, both of which differ from the CPRA and become effective in 2023. If we become subject to new data privacy laws, at the state level, the risk of enforcement action against us could increase because we may become subject to additional obligations, and the number of individuals or entities that can initiate actions against us may increase (including individuals, via a private right of action, and state actors).</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail to do so or may be perceived to have failed to do so. Moreover, despite our efforts, we may not be successful in achieving compliance if our personnel or third parties upon whom we rely fail to comply with such obligations, which could negatively impact our business operations and compliance posture. For example, any failure by a third-party processor, including our clinical trial sites, to comply with applicable law, regulations, or contractual obligations could result in adverse effects, including inability to operate our business and proceedings against us by governmental entities or others. If we fail, or are perceived to have failed, to address or comply with data privacy and security obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar activities); litigation (including class-related claims); additional reporting requirements and/or oversight; bans on processing personal data; orders to destroy or not use personal data; and imprisonment of company officials. Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: interruptions or stoppages in our business operations (including, as relevant, our clinical trials if any); inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize imetelstat; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or revision or restructuring of our operations. Moreover, clinical trial participants or research subjects about whom we or our vendors obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Risk FACTORs</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operations, and those of our CROs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, public health pandemics or epidemics (including, for example, the ongoing COVID-19 pandemic), civil or political unrest or military conflicts around the world (such as the current military conflict between Ukraine and Russia), terrorism, insurrection or war, and other natural or man-made disasters or business interruptions. Furthermore, other events, such as the armed conflict between Russia and Ukraine, could lead to sanctions, embargoes, supply shortages, regional instability, geopolitical shifts, cyberattacks, other retaliatory actions, and adverse effects on macroeconomic conditions, currency exchange rates, and financial markets, which could adversely impact our operations and financial results, as well as those of third parties with whom we conduct business. There is a risk that one or more of our CROs, suppliers, and other contractors and consultants might not survive an economic downturn. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to develop and potentially commercialize imetelstat could be disrupted if our operations or those of our CROs and other contractors or consultants are affected by geopolitical events, man-made or natural disasters or other business interruptions. Our corporate headquarters are located in California near major earthquake faults and fire zones. The ultimate impact on us, our CROs, contractors and consultants, and our general infrastructure of being located near major earthquake faults and fire zones and being consolidated in certain geographical areas is unknown, but our operations and financial condition could suffer in the event of a major earthquake, fire or other natural disaster.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New income, sales, use, excise or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our domestic and foreign sales and earnings. Any new taxes could</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adversely affect our domestic and international business operations and our business and financial condition. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Act, as modified by the CARES Act, significantly revised the Code, and recently enacted federal tax legislation made additional changes. Future guidance from the U.S. Internal Revenue Service and other tax authorities with respect to such legislation may adversely affect us, and certain aspects of such legislation could be repealed or modified in the future, which could have an adverse effect on us. For example, the recently enacted Inflation Reduction Act of 2022, or the Inflation Reduction Act, includes provisions that will impact the U.S. federal income taxation of corporations, including imposing a minimum tax on the book income of certain large corporations and an excise tax on certain corporate stock repurchases that would be imposed on the corporation repurchasing such stock. It is uncertain if and to what extent various states will conform to the Tax Act, the CARES Act, the Inflation Reduction Act or any newly enacted federal tax legislation. Changes in corporate tax rates, the realization of net deferred tax assets relating to our U.S. operations, the taxation of earnings from other countries, and the deductibility of expenses under the Tax Act or future tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant one-time charges in the current or future taxable years, and could increase our future U.S. tax expense.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure to achieve and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on our business and stock price.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, requires that we establish and maintain an adequate internal control structure and procedures for financial reporting. Our Annual Reports on Form 10-K must contain an annual assessment by management of the effectiveness of our internal control over financial reporting and must include disclosure of any material weaknesses in internal control over financial reporting that we have identified. In the past, our independent registered public accounting firm provided an opinion annually on the effectiveness of our internal control over financial reporting. As a smaller reporting company, we are no longer subject to this requirement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The requirements of Section 404 are ongoing and also apply to future years. We expect that our internal control over financial reporting will continue to evolve as our business develops. Although we are committed to continue to improve our internal control processes and we will continue to diligently and vigorously review our internal control over financial reporting in order to ensure compliance with Section 404 requirements, any control system, regardless of how well designed, operated and evaluated, can provide only reasonable, not absolute, assurance that its objectives will be met. Therefore, we cannot assure you that material weaknesses or significant deficiencies will not exist or otherwise be discovered in the future, particularly in light of our increased reliance on personnel working remotely as a result of the COVID-19 pandemic. If material weaknesses or other significant deficiencies occur, such weaknesses or deficiencies could result in misstatements of our results of operations, restatements of our financial statements, a decline in our stock price, or other material adverse effects on our business, reputation, results of operations, financial condition or liquidity.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to THIS OFFERING, Our Common Stock and Financial Reporting</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Historically, our stock price has been extremely volatile and your investment may suffer a decline in value.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Historically, our stock price has been extremely volatile. Between January 1, 2013 and December 31, 2022, our stock has traded as high as $7.79 per share and as low as $0.75 per share. Between January 1, 2022 and December 31, 2022, the price has ranged between a high of $3.06 per share and a low of $0.99 per share. The significant market price fluctuations of our common stock have been due to and may in the future be influenced by a variety of factors, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding our ability to timely submit applications for regulatory approvals of imetelstat in lower risk MDS;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory approval or non-approval of imetelstat, specific label indications for or restrictions, warnings or limitations in its use, or delays in the regulatory review process;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding the research and development of imetelstat, or adverse efficacy or safety results of, further delays in the commencement, enrollment or conduct of, discontinuation of, or further modifications or refinements to any current clinical trials of imetelstat, including IMerge Phase 3 or IMpactMF, IMproveMF and IMpress, or for potential future clinical trials of imetelstat, for any reason, or our inability, for any reason, to successfully continue the development of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining substantial additional capital following this offering, on commercially reasonable terms, necessary to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and other future indications;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">timeliness of preliminary, interim or final clinical trial data expected to be reported with respect to current or potential future clinical trials of imetelstat, and investor perceptions thereof;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">not receiving timely regulatory clearances or approvals in any jurisdiction, whether within or outside of the U.S. to continue clinical development of imetelstat in relapsed/refractory MF, lower risk MDS or any additional myeloid hematologic malignancies in a timely manner or at all;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in laws or regulations applicable to imetelstat, including but not limited to clinical trial requirements for approval;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding the safety of imetelstat and partial or full clinical holds placed on the imetelstat INDs by the FDA or similar international regulatory authorities, or other regulatory developments related to imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the successful completion of any clinical trials, regulatory approval and commercialization of imetelstat for one or more label expansion indications;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of technological innovations, new commercial products, or clinical progress or lack thereof by us, potential future collaborative partners or our competitors;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse developments concerning our manufacturers, including our inability to obtain adequate product supply for imetelstat or inability to do so at acceptable prices;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to launch and commercialize imetelstat on the timelines anticipated, or at all;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and growth of our lead indications, lower risk MDS and relapsed/refractory MF;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements concerning imetelstat proprietary rights;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and timing of any future collaboration agreements for the development and potential commercialization of imetelstat that we may establish;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of significant acquisitions, strategic partnerships, collaborations, joint ventures or capital commitments by us or our competitors;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to acquire or in-license new product candidates to grow our pipeline; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the demand in the market for our common stock;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fluctuations in our operating results;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased or continuing operating losses;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general domestic and international market conditions or market conditions relating to the biopharmaceutical and pharmaceutical industries, especially given the volatility caused by macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">perceptions of the biotechnology and pharmaceutical industry by the public, legislature, regulators and the investment community;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">comments by securities analysts or other third parties, including blogs, articles and other media;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to the public;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">publication of research reports about us or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">large stockholders increasing or exiting their position in our common stock or an increase in the short interest in our common stock;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the market valuations of similar companies;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of or developments concerning pending and potential future litigation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">actions instituted by activist shareholders or others;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the issuance of common stock to partners, vendors or investors to raise additional capital; </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other events or factors that are beyond our control; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the occurrence of any other risks and uncertainties discussed under the heading &#x201c;Risk Factors.&#x201d;</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock prices and trading volumes for many biopharmaceutical companies fluctuate widely for a number of reasons, including factors which may be unrelated to their businesses or results of operations, such as media coverage, statements made on message boards and social media forums, legislative and regulatory measures and the activities of various interest groups or organizations. In addition to the risk factors described in this section, overall market volatility, as well as general domestic or international economic, market and political conditions, including those resulting from the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, could materially and adversely affect the market price of our common stock and the return on your investment in our securities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, as further discussed in the Risk Factor above entitled </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#x201c;We and certain of our officers have been named as defendants in two pending securities class action lawsuits and seven shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we and one of our officers have been named as defendants in two securities class action lawsuits. In addition, certain of our current officers and current and former board members have been named as defendants in the Derivative Lawsuits filed in the Northern District, the Court of Chancery of the State of Delaware, the District Court for the District of Delaware and the California Superior Court for the County of San Mateo, respectively. Such lawsuits have often been instituted against companies, including us, whose securities have experienced periods of volatility in market price. The pending lawsuits and any lawsuits brought against us in the future could result in substantial costs, which would hurt our financial condition and results of operations and divert management&#x2019;s attention and resources, which could result in delays of IMpactMF, IMproveMF and IMpress, and/or could preclude or delay potential future clinical trials, or could preclude or delay commercialization efforts.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The sale of a substantial number of shares may adversely affect the market price of our common stock.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of September 30, 2022, we had 675,000,000 shares of common stock authorized for issuance and 381,214,326 shares of common stock outstanding. Additionally, as of September 30, 2022, we had reserved 200,777,933 shares of our common stock for future issuance pursuant to our stock option and equity incentive plans and outstanding warrants.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future sales of our common stock or the perception that such sales could occur, or the issuance of common stock to fund our operations and imetelstat development, including pursuant to the 2020 Sales Agreement with B. Riley Securities, Inc. or upon the potential exercise of currently outstanding warrants, could cause immediate</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dilution and adversely affect the market price of our common stock. The sale or issuance of our securities, as well as the existence of outstanding stock options and shares of common stock reserved for issuance under our stock option and equity incentive plans and outstanding warrants, also may adversely affect the terms upon which we are able to obtain additional capital through the sale of equity securities, which could negatively affect the market price of our common stock and the return on stockholders&#x2019; investment.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our management team will have broad discretion to use the net proceeds from this offering and its investment of these proceeds may not yield a favorable return.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management team will have broad discretion in the application of the net proceeds from this offering and could spend or invest the proceeds in ways with which our stockholders disagree. Accordingly, investors will need to rely on our management team&#x2019;s judgment with respect to the use of these proceeds. We intend to use the proceeds from this offering in the manner described in the section titled &#x201c;Use of Proceeds.&#x201d; The failure by management to apply these funds effectively could negatively affect our ability to operate and grow our business. We cannot specify with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering.  Accordingly, we will have broad discretion in using these proceeds. Until the net proceeds are used, they may be placed in investments that do not produce significant income or that may lose value.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If you purchase securities in this offering, you will experience immediate dilution in your investment. You will experience further dilution if we issue additional equity securities in future fundraising transactions.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchasers of our securities in this offering will pay a price per share of common stock (or pre-funded warrant at the public offering price less $0.001) that exceeds the net tangible book value per share of our common stock. After giving effect to this offering at the public offering price of $2.45 per share of common stock (or pre-funded warrant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at the public offering price less $0.001) and, and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us (but excluding the shares of common stock to be issued and the proceeds received, if any, from exercises of the pre-funded warrants being offered in this offering), you will experience immediate dilution of $1.78 per share, representing the difference between our as adjusted net tangible book value per share as of September 30, 2022 after giving effect to this offering (but without giving effect to the exercise of the pre-funded warrants being offered in this offering) and the public offering price. Furthermore, if the underwriters exercise their option to purchase additional shares, you will experience further dilution. See the section entitled &#x201c;Dilution&#x201d; below for a more detailed illustration of the dilution you would incur if you purchase our securities in this offering.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we issue additional common stock, or securities convertible into or exchangeable or exercisable for common stock, including shares issuable upon the potential exercise of currently outstanding warrants, our stockholders, including investors who purchase our securities in this offering, will experience additional dilution, and any such issuances may cause the price of our common stock to decrease. We also cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than either the price per share of common stock (or pre-funded warrant) paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to investors in this offering.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">There is no public market for the pre-funded warrants being offered by us in this offering.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no established public trading market for the pre-funded warrants being sold in this offering, and we do not expect a market to develop. In addition, we do not intend to apply to list the pre-funded warrants on any securities exchange or recognized trading system. Without an active market, the liquidity of the pre-funded warrants will be limited.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Holders of the pre-funded warrants will have no rights as common stockholders until they acquire our common stock.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until you acquire shares of our common stock upon exercise of the pre-funded warrants, you will have no rights with respect to our common stock issuable upon exercise of the pre-funded warrants, including the right to receive dividend payments, vote or respond to tender offers. Upon exercise of your pre-funded warrants, you will be</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after the exercise date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will not receive any meaningful amount of additional funds upon the exercise of the pre-funded warrants.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each pre-funded warrant will be exercisable until it is fully exercised and by means of payment of the nominal cash purchase price upon exercise or by means of a &#x201c;cashless exercise&#x201d; according to a formula set forth in the pre-funded warrant. Accordingly, we will not receive any meaningful additional funds upon the exercise of the pre-funded warrants.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Significant holders or beneficial holders of shares of our common stock may not be permitted to exercise the pre-funded warrants that they hold.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A holder (together with its affiliates and other attribution parties) may not exercise any portion of a pre-funded warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 9.99% of our outstanding common stock immediately after exercise, which percentage may be changed at the holder's election to a higher or lower percentage not in excess of 19.99% (if exceeding such percentage would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) upon 61 days' notice to us subject to the terms of the pre-funded warrants. As a result, you may not be able to exercise your pre-funded warrants for shares of our common stock at a time when it would be financially beneficial for you to do so. In such a circumstance, you could seek to sell your pre-funded warrants to realize value, but you may be unable to do so in the absence of an established trading market and due to applicable transfer restrictions.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our undesignated preferred stock may inhibit potential acquisition bids; this may adversely affect the market price of our common stock and the voting rights of holders of our common stock.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our certificate of incorporation provides our board of directors with the authority to issue up to 3,000,000 shares of undesignated preferred stock and to determine or alter the rights, preferences, privileges and restrictions granted to or imported upon these shares without further vote or action by our stockholders. The issuance of shares of preferred stock may delay or prevent a change in control transaction without further action by our stockholders. As a result, the market price of our common stock may be adversely affected.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if in the future, we issue preferred stock that has preference over our common stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our common stock, the rights of holders of our common stock or the market price of our common stock could be adversely affected.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provisions in our charter, bylaws and Delaware law may inhibit potential acquisition bids for us, which may prevent holders of our common stock from benefiting from what they believe may be the positive aspects of acquisitions and takeovers.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of our charter documents and bylaws may make it substantially more difficult for a third-party to acquire control of us and may prevent changes in our management, including provisions that:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prevent stockholders from taking actions by written consent;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">divide the board of directors into separate classes with terms of office that are structured to prevent all of the directors from being elected in any one year; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">set forth procedures for nominating directors and submitting proposals for consideration at stockholders&#x2019; meetings.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of Delaware law may also inhibit potential acquisition bids for us or prevent us from engaging in business combinations. In addition, we have individual severance agreements with our executive officers and a company-wide severance plan, either of which could require a potential acquirer to pay a higher price. Either collectively or individually, these provisions may prevent holders of our common stock from benefiting from what they may believe are the positive aspects of acquisitions and takeovers, including the potential realization of a higher rate of return on their investment from these types of transactions.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our amended and restated bylaws provide that, unless we consent to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any derivative action or proceeding brought on our behalf;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or to our stockholders;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our certificate of incorporation, or our bylaws; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim governed by the internal affairs doctrine.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While the exclusive forum provisions in our bylaws do not apply to lawsuits brought to enforce a duty or liability created by the Exchange Act or the Securities Act of 1933, as amended, or any claim for which the federal courts have exclusive jurisdiction, these provisions may nonetheless limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our current or former directors, officers, or other employees, which may discourage such lawsuits against us and our current or former directors, officers, and other employees. Alternatively, if a court were to find the exclusive forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could have a material and adverse impact on our business and our financial condition.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We do not intend to pay cash dividends on our common stock in the foreseeable future.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not anticipate paying cash dividends on our common stock in the foreseeable future. Any payment of cash dividends will depend upon our financial condition, results of operations, capital requirements and other factors, and will be at the discretion of our board of directors. In addition, the terms of our Loan Agreement prevent us from paying dividends and any future debt agreements may continue to preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for our stockholders for the foreseeable future.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="special_note_regarding_forward_looking"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus supplement, the accompanying prospectus, the documents we have filed with the SEC that are incorporated by reference and any free writing prospectuses prepared by or on behalf of us or to which we have referred you contain &#x201c;forward-looking statements&#x201d; within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements about:</font></p>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the therapeutic potential of imetelstat and its expected uses and benefits;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to submit an NDA and an MAA for imetelstat in lower risk MDS, and the anticipated timing thereof;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the progress, timing, magnitude, scope and costs of clinical development, manufacturing and commercialization of imetelstat, including the number of indications which are or may in the future be pursued, subject to clearances and approvals by the FDA and other regulatory authorities;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the continued enrollment in, and the continued conduct and completion of, IMpactMF, IMproveMF and IMpress;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the achievement and timing of clinical trial events related to IMpactMF, IMproveMF and IMpress, including the completion of patient enrollment and anticipated timing of data availability;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other potential planned future clinical development plans for imetelstat;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to market and sell imetelstat, upon regulatory approval or clearance, in the United States and in Europe, whether alone or with new collaborative partners, and the anticipated timing thereof;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain potential new collaborative arrangements to assist us in the development and potential commercialization of imetelstat, especially outside the U.S.;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate third-party reimbursement for imetelstat, if any;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to consistently and reproducibly manufacture imetelstat;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to meaningfully reduce manufacturing costs of imetelstat;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impacts of the ongoing COVID-19 global pandemic, macroeconomic conditions, such as rising inflation rates, uncertain credit and global financial markets and supply chain disruptions, and geopolitical events, such as the conflict between Russia and Ukraine and related sanctions, on the foregoing;</font></div></div>
  <div style="margin-left:3.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6388874442213877%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain agreements with third-party service providers to support the development of imetelstat;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and timing of expenditures and whether there are unanticipated expenditures;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to manage the anticipated growth of our business, including our ability to recruit and retain key personnel to support the development and potential future commercialization of imetelstat;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates and expectations regarding the sufficiency of our cash resources, our cash resource conservation efforts and our use of the net proceeds from this offering;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates regarding the extent of our ability to progress our imetelstat program with our existing capital resources and the net proceeds from this offering, and our requirements for additional capital following this offering;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to protect our intellectual property and the duration of any such protection, and operate our business without infringing upon the intellectual property rights of others;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the implementation of our corporate strategy;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our future financial and operating performance;</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our anticipated use of our existing capital resources and the net proceeds from this offering; and</font></div></div>
  <div style="margin-left:3.87%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.546%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.6484968272131484%;">&#x25cf;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans, objectives, expectations and intentions and any other statements that are not historical fact.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;intend,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;would,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;projects,&#x201d; &#x201c;predicts,&#x201d; &#x201c;potential&#x201d; and similar expressions intended to identify forward-looking statements. These statements reflect our current views with respect to future events, are based on assumptions and are subject to risks and uncertainties. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. We discuss many of these risks, uncertainties and other factors in greater detail under the heading &#x201c;Risk Factors&#x201d; in this prospectus supplement. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should carefully read this prospectus supplement and the accompanying prospectus, the documents incorporated herein by reference as described under the heading &#x201c;Incorporation of Certain Information by Reference&#x201d; in this prospectus supplement, and any free writing prospectus prepared by or on behalf of us or to which we have referred you completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in the foregoing documents by these cautionary statements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="use_of_proceeds"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">USE OF PROCEEDS</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate that the net proceeds to us from the sale of the 55,876,297 shares of common stock and pre-funded warrants to purchase 25,000,000 shares of common stock that we are offering, excluding the proceeds, if any, from the exercise of the pre-funded warrants offered hereby, will be approximately $185.4 million, or $213.3 million if the underwriters exercise their option to purchase additional shares in full, based on the public offering price of $2.45 per share of common stock (or pre-funded warrants at the public offering price less $0.001), and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently intend to use the net proceeds from this offering, together with our existing cash, cash equivalents, restricted cash and marketable securities, to fund preparatory activities for the potential U.S. commercial launch of imetelstat in lower risk MDS, and, if approved, to fund the potential U.S. commercial launch of imetelstat. We intend to use the remaining proceeds, if any, for working capital and general corporate purposes.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This expected use of the net proceeds from this offering together with our existing cash, cash equivalents, restricted cash and marketable securities represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures, may change and will depend on a number of factors, such as the progress, timing, magnitude, scope and costs of clinical development and manufacturing of imetelstat, any further delays or interruptions related to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, and the amount of cash used in our operations. Accordingly, we will retain broad discretion over the allocation of the net proceeds from this offering.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operating plan, our expectations regarding the timing of the submission, review and approval of our NDA in the U.S. for the use of imetelstat in adult patients with lower risk MDS, and our planned use of the net proceeds from this offering, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, together with the estimated net proceeds from this offering, will be sufficient to fund our projected operating requirements until the middle of 2024, which includes preparatory activities for the potential U.S. commercial launch of imetelstat in lower risk MDS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assuming future proceeds of up to $109.2 million from potential cash exercises of currently outstanding warrants and potential drawdowns of up to $75.0 million available under the Loan Agreement (which is subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche), we believe that our existing cash, cash equivalents, restricted cash and marketable securities, together with the estimated net proceeds from this offering, could be sufficient to fund our projected operating requirements until the end of 2025, which would include anticipated completion of the final analysis for IMpactMF in 2025.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the absence of future proceeds from potential cash exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding following this offering to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all. For example, holders of our outstanding warrants may not exercise any portion of a warrant if, after giving effect to such exercise, the holder would own more than 9.99% of our outstanding common stock immediately after exercise, which percentage may be changed at the holder's election upon 61 days' notice to us subject to the terms of the warrants. Further, if no registration statement covering the shares of common stock to be issued upon the exercise of our outstanding purchase warrants is effective at the time of exercise, a holder of our purchase warrants may only exercise through a &#x201c;cashless exercise,&#x201d; in which case the holder would receive upon such exercise, the net number of shares of common stock determined according to the formula set forth in the purchase warrant, and we would not receive any proceeds from the exercise of such purchase warrants. As a result, we may not receive our anticipated proceeds from certain of our outstanding warrants. In addition, drawdowns under the Loan Agreement are subject to our achievement of certain clinical and regulatory milestones</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and satisfaction of certain capitalization and other requirements to our existing capital resources, as well as approval by an investment committee comprised of Hercules and SVB for the final $25.0 million tranche. For additional information, see &#x201c;Risk Factors&#x2014;Risks Related to Our Financial Position and Need for Additional Financing&#x2014;Our failure to obtain substantial additional capital following this offering would force us to further delay, reduce or eliminate development of imetelstat in current and any potential future clinical trials of imetelstat, and our potential future imetelstat commercialization efforts, any of which would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.&#x201d;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that we seek additional capital in the future through further equity offerings and/or debt borrowings, or through collaboration agreements, strategic alliances, licensing arrangements or marketing and distribution arrangements, we cannot guarantee that we will be able to raise additional capital on reasonable terms or at all.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pending application of the net proceeds as described above, we intend to temporarily invest the proceeds in short-term, interest-bearing instruments until we are ready to use them.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not sell any pre-funded warrants in this offering. If we sell any pre-funded warrants, we will receive only $0.001 per share upon exercise thereof.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="dilution"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DILUTION</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our net tangible book value as of September 30, 2022 was approximately $108.2 million, or $0.28 per share. We calculate net tangible book value per share by dividing the net tangible book value, which is tangible assets less total liabilities, by the number of outstanding shares of our common stock as of September 30, 2022.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dilution in net tangible book value per share represents the difference between the amount per share paid by purchasers of securities in this offering, and the as adjusted net tangible book value per share of our common stock immediately after completion of this offering.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After giving effect to the sale by us of (i) 55,876,297 shares of our common stock in this public offering at the public offering price of $2.45 per share and (ii) pre-funded warrants to purchase 25,000,000 shares of our common stock in this public offering at the public offering price minus $0.001 (excluding, in each case, the shares of common stock to be issued and the proceeds received, if any, from exercises of the pre-funded warrants), and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of September 30, 2022 would have been approximately $293.6 million, or $0.67 per share. This represents an immediate increase in the net tangible book value of $0.39 per share to existing stockholders and immediate dilution in net tangible book value of $1.78 per share to investors purchasing securities in this offering. The following table illustrates this dilution on a per share basis:</font></p>
  <table style="margin-left:0.25in;border-spacing:0;table-layout:fixed;width:94.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:75.563%;"></td>
    <td style="width:12.219%;"></td>
    <td style="width:12.219%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public offering price per share of common stock (or pre-funded warrant at the public offering price less $0.001)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.45</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:13.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-left:13.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Historical net tangible book value per share as of September 30, 2022</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.28</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:13.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-left:13.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase in net tangible book value per share attributable to this offering</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.39</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As adjusted net tangible book value per share as of September 30, 2022, after giving effect to this offering</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.67</font></p></td>
   </tr>
   <tr style="height:14.4pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:4.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dilution in net tangible book value per share to investors purchasing securities in this offering</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:4.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$1.78</font></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the underwriters exercise in full their option to purchase additional shares of common stock, the as adjusted net tangible book value after this offering would be $0.72 per share of our common stock, representing an increase of as adjusted net tangible book value of $0.44 per share to our existing stockholders and an immediate dilution of $1.73 per share to investors purchasing shares in this offering.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investors who purchase common stock upon the exercise of the pre-funded warrants offered hereby may experience dilution depending on our net tangible book value at the time of exercise.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The foregoing tables and calculations (other than historical net tangible book value) are based on 381,214,326 shares of common stock outstanding as of September 30, 2022. This number excludes the shares of common stock issuable upon exercise of the pre-funded warrants offered hereby, and also excludes, as of September 30, 2022, the following:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,705,500 shares of common stock issuable upon the exercise of outstanding stock options with a weighted-average exercise price of $1.86 per share;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,430,477 shares of common stock issuable upon the exercise of warrants with an exercise price of $0.001 per share;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88,689,749 shares of common stock issuable upon the exercise of outstanding warrants with a weighted-average exercise price of $1.36 per share; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">up to an aggregate of 21,952,207 shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan, or the 2018 Plan, 2014 Employee Stock Purchase Plan, 2018 Inducement Award Plan and Directors&#x2019; Market Value Stock Purchase Plan.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, stock options to purchase 2,347,280 shares at a weighted-average exercise price of $2.18 per share  and stock awards of 2,970 shares have been granted between September 30, 2022 and the date of this prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of common stock to be outstanding immediately following this offering does not include up to approximately $79.1 million of our common stock that remained available for sale as of September 30, 2022 under the at market issuance sales agreement we entered into with B. Riley Securities, Inc., dated as of September 4, 2020, or the Sales Agreement. Since December 31, 2021, we have not sold any shares under the Sales Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not yet determined whether the pre-funded warrants will be classified and accounted for as liabilities or as stockholders&#x2019; equity.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that options or the warrants outstanding as of September 30, 2022 have been or are exercised, or other shares are issued, investors purchasing our securities in this offering will experience further dilution. In addition, we may choose to raise additional capital, including pursuant to the Sales Agreement, due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="description_of_securities_we_are_offerin"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DESCRIPTION OF SECURITIES WE ARE OFFERING</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are offering 55,876,297 shares of our common stock, or for certain investors that so choose, in lieu of shares of common stock, pre-funded warrants to purchase shares of our common stock, or the pre-funded warrants. The common stock and the pre-funded warrants will be sold at the same time. The shares of common stock and the pre-funded warrants are immediately separable and will be issued separately. The shares of common stock issuable from time to time upon exercise of the pre-funded warrants, if any, are also being offered pursuant to this prospectus supplement and the accompanying prospectus.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of this prospectus supplement, our restated certificate of incorporation, as amended, authorizes us to issue 675,000,000 shares of common stock, par value $0.001 per share, and 3,000,000 shares of preferred stock, par value $0.001 per share. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. Subject to preferences that may be applicable to any outstanding shares of the preferred stock, the holders of common stock are entitled to receive ratably such dividends as may be declared by the board of directors out of legally available funds. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock legally available for distribution to stockholders. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which we may designate in the future. For more information, see &#x201c;Description of Capital Stock&#x201d; in Exhibit 4.1 to our Annual Report on Form 10-K for the year ended December 31, 2021, which Exhibit 4.1 is incorporated by reference into this prospectus supplement and the accompanying prospectus.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d; The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="prefundedwarrants_prosup"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Funded Warrants</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The material terms and provisions of the pre-funded warrants being issued in this offering are summarized below. The following description is subject to, and qualified in its entirety by, the form of pre-funded warrant which will be filed as an exhibit to a Current Report on Form 8-K to be filed by us with the SEC in connection with this</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">offering. You should review the form of pre-funded warrant for a complete description of the terms and conditions applicable to the pre-funded warrants. See &#x201c;Where You Can Find More Information&#x201d; on page S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">98</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> of this prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exercisability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The pre-funded warrants will be immediately exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and by payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise. The holder may also exercise the pre-funded warrant through a &#x201c;cashless exercise,&#x201d; in which case, the holder would receive upon such exercise, the net number of shares of common stock determined according to the formula set forth in the pre-funded warrant. The exercise price must be paid by the holder in cash in immediately available funds.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exercise Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. A holder (together with its affiliates and other attribution parties) may not exercise any portion of a pre-funded warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 9.99% of our outstanding common stock immediately after exercise, which percentage may be changed at the holder's election to a higher or lower percentage not in excess of 19.99% (if exceeding such percentage would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) upon 61 days' notice to us subject to the terms of the pre-funded warrants.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each pre-funded warrant offered hereby has an initial exercise price per share equal to $0.001. The pre-funded warrants are immediately exercisable and may be exercised at any time until the pre-funded warrants are exercised in full. The exercise price and number of shares of common stock issuable upon exercise is subject to adjustment in the event of stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common stock.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Transferability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to compliance with any applicable securities laws, the pre-funded warrants are separately tradeable immediately after issuance at the option of the holders and may be transferred at the option of the holders.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">No Listing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. There is no established public trading market for the pre-funded warrants and we do not expect a market to develop. In addition, we do not intend to apply for listing of the pre-funded warrants on any securities exchange or recognized trading system, including Nasdaq. Without an active market, the liquidity of the pre-funded warrants will be limited.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fundamental Transactions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In the event of a fundamental transaction, as described in the pre-funded warrants and generally including any reorganization, recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial owner of more than 50% of the voting power represented by our outstanding common stock, the holders of the pre-funded warrants will be entitled to receive upon exercise of the pre-funded warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the pre-funded warrants immediately prior to such fundamental transaction.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rights as a Stockholder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except for the right to participate in certain dividends and distributions and as otherwise provided in the pre-funded warrant or by virtue of a holder's ownership of shares of our common stock, the holders of the pre-funded warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their pre-funded warrants.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrant Agent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We are acting as warrant agent for the pre-funded warrants.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="material_us_federal_income_tax"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a general discussion of the material U.S. federal income tax considerations of the purchase, ownership and disposition of shares of our common stock issued pursuant to this offering, or the shares, and the purchase, ownership and disposition of pre-funded warrants to purchase shares of our common stock issued pursuant to this offering, or the pre-funded warrants. The shares and the pre-funded warrants are collectively referred to herein as our &#x201c;securities.&#x201d; All prospective holders of our securities should consult their tax advisors with respect to the U.S. federal, state, local and non-U.S. tax consequences of the purchase, ownership and disposition of our securities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This discussion is not a complete analysis of all potential U.S. federal income tax consequences relating to the purchase, ownership and disposition of our securities. This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, existing U.S. Treasury Regulations promulgated thereunder, published administrative pronouncements and rulings of the U.S. Internal Revenue Service, or the IRS, and judicial decisions, all as in effect as of the date of this prospectus supplement. These authorities are subject to change and to differing interpretation, possibly with retroactive effect. Any change or differing interpretation could alter the tax consequences to holders described in this discussion. There can be no assurance that a court or the IRS will not challenge one or more of the tax consequences described herein, and we have not obtained, nor do we intend to obtain, a ruling with respect to the U.S. federal income tax consequences to a holder of the purchase, ownership or disposition of our securities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We assume in this discussion that a holder holds our securities as a &#x201c;capital asset&#x201d; within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular holder in light of that holder&#x2019;s individual circumstances, nor does it address any alternative minimum, Medicare contribution, estate or gift tax consequences, or any aspects of U.S. state, local or non-U.S. taxes or any other U.S. federal tax laws. This discussion also does not address consequences relevant to holders subject to special tax rules, such as holders that own, or are deemed to own, more than 5% of our capital stock (except to the extent specifically set forth below), corporations that accumulate earnings to avoid U.S. federal income tax, tax-exempt organizations, governmental organizations, banks, financial institutions, investment funds, insurance companies, brokers, dealers or traders in securities, commodities or currencies, regulated investment companies or real estate investment trusts, persons that have a &#x201c;functional currency&#x201d; other than the U.S. dollar, tax-qualified retirement plans, holders who hold or receive our securities pursuant to the exercise of employee stock options or otherwise as compensation, holders holding our securities as part of a hedge, straddle or other risk reduction strategy, conversion transaction or other integrated investment, holders deemed to sell our securities under the constructive sale provisions of the Code, holders subject to special tax accounting rules under Section 451(b) of the Code, controlled foreign corporations, passive foreign investment companies and certain former U.S. citizens or long-term residents.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, this discussion does not address the tax treatment of partnerships (or entities or arrangements that are treated as partnerships or disregarded entities for U.S. federal income tax purposes) or persons that hold our securities through such partnerships. If a partnership, including any entity or arrangement treated as a partnership for U.S. federal income tax purposes, holds our securities, the U.S. federal income tax treatment of a partner in such partnership generally will depend upon the status of the partner, and the activities of the partnership and certain determinations made at the partner level. Such partners and partnerships should consult their tax advisors regarding the tax consequences of the purchase, ownership and disposition of our securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment of Pre-Funded Warrants</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although it is not entirely free from doubt, we believe a pre-funded warrant should be treated as a share for U.S. federal income tax purposes and a holder of pre-funded warrants should generally be taxed in the same manner as a holder of shares, as described below. Accordingly, no gain or loss should be recognized upon the exercise of a pre-funded warrant and, upon exercise, the holding period of a pre-funded warrant should carry over to the share received. Similarly, the tax basis of the pre-funded warrant should carry over to the shares received upon exercise, increased by the exercise price of $0.001 per share. However, our characterization is not binding on the IRS, and the IRS may treat the pre-funded warrants as warrants to acquire our shares. If so, the amount and character of your gain or loss with respect to an investment in our pre-funded warrants could change. Accordingly, each holder should</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">consult his, her or its own tax advisor regarding the risks associated with the acquisition of pre-funded warrants pursuant to this offering (including potential alternative characterizations). The balance of this discussion generally assumes that the characterization described above is respected for U.S. federal income tax purposes.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Considerations Applicable to U.S. Holders</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Definition of U.S. Holder</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In general, a &#x201c;U.S. holder&#x201d; means a beneficial owner of our securities (other than a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that is, for U.S. federal income tax purposes:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an individual who is a citizen or resident of the United States;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized in the United States or under the laws of the United States or of any state thereof or the District of Columbia;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a trust if (a) a U.S. court can exercise primary supervision over the trust's administration and one or more U.S. persons have the authority to control all of the trust's substantial decisions or (b) the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distributions on the Shares and Pre-Funded Warrants</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not anticipate declaring or paying any future distributions. However, if we do make distributions on our securities, such distributions will constitute dividends to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, and will be includible in your income as ordinary income when received. However, with respect to dividends received by individuals, such dividends are generally taxed at the lower applicable long-term capital gains rates, provided certain holding period and other requirements are satisfied. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a tax-free return of the U.S. holder&#x2019;s investment, up to such U.S. holder&#x2019;s adjusted tax basis in our securities. Any remaining excess will be treated as capital gain from the sale or exchange of such securities, subject to the tax treatment described below in &#x201c;&#x2014;Sale or Other Taxable Disposition of the Shares or Pre-Funded Warrants.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sale or Other Taxable Disposition of the Shares or Pre-Funded Warrants</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the sale, exchange or other taxable disposition of our securities, a U.S. holder generally will recognize capital gain or loss equal to the difference between the amount of cash and the fair market value of any property received upon the sale, exchange or other taxable disposition and such U.S. holder's adjusted tax basis in our securities. This capital gain or loss will be long-term capital gain or loss if the U.S. holder's holding period in such securities is more than one year at the time of the sale, exchange or other taxable disposition. Long-term capital gains recognized by certain non-corporate U.S. holders, including individuals, generally will be subject to reduced rates of U.S. federal income tax. The deductibility of capital losses is subject to certain limitations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Backup Withholding and Information Reporting</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A U.S. holder may be subject to information reporting and backup withholding when such holder receives payments on our securities (including constructive dividends) or receives proceeds from the sale or other taxable disposition of our securities. Certain U.S. holders are exempt from backup withholding, including C corporations and certain tax-exempt organizations. A U.S. holder will be subject to backup withholding if such holder is not otherwise exempt and such holder:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fails to furnish the holder&#x2019;s taxpayer identification number, which for an individual is ordinarily his or her social security number;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">furnishes an incorrect taxpayer identification number;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is notified by the IRS that the holder previously failed to properly report payments of interest or dividends; or</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fails to certify under penalties of perjury that the holder has furnished a correct taxpayer identification number and that the IRS has not notified the holder that the holder is subject to backup withholding.</font></div></div>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a U.S. holder&#x2019;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. U.S. holders should consult their tax advisors regarding their qualification for an exemption from backup withholding and the procedures for obtaining such an exemption.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Considerations Applicable to Non-U.S. Holders</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Definition of non-U.S. Holder</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this discussion, a &#x201c;non-U.S. holder&#x201d; is a beneficial owner of our securities that is neither a U.S. holder nor a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distributions on the Shares and Pre-Funded Warrants</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we make distributions on our securities such distributions will constitute dividends to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a tax-free return of the non-U.S. holder&#x2019;s investment, up to such non-U.S. holder&#x2019;s adjusted tax basis in our securities. Any remaining excess will be treated as capital gain from the sale or exchange of such securities, subject to the tax treatment described below in &#x201c;&#x2014;Gain on Sale, Exchange or Other Taxable Disposition of Our Shares or Pre-Funded Warrants.&#x201d;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividends paid to a non-U.S. holder will generally be subject to withholding of U.S. federal income tax at a 30% rate of the gross amount of the dividend or such lower rate as may be specified by an applicable income tax treaty between the United States and such non-U.S. holder's country of residence for purposes of such treaty.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividends that are treated as effectively connected with a trade or business conducted by a non-U.S. holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the non-U.S. holder within the United States, are generally exempt from the 30% withholding tax if the non-U.S. holder satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same U.S. federal income tax rates applicable to U.S. persons (as defined in the Code). Any U.S. effectively connected income received by a non-U.S. holder that is a corporation may also, under certain circumstances, be subject to an additional &#x201c;branch profits tax&#x201d; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such non-U.S. holder's country of residence for purposes of such treaty.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To claim a reduction or exemption from withholding, a non-U.S. holder generally will be required to provide (a) a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E (or successor form) and satisfy applicable certification and other requirements to claim the benefit of an applicable income tax treaty between the United States and such non-U.S. holder's country of residence, or (b) a properly executed IRS Form W-8ECI stating that dividends are not subject to withholding because they are effectively connected with such non-U.S. holder's conduct of a trade or business within the United States. Non-U.S. holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A non-U.S. holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distributions will also be subject to the discussion below under the headings &#x201c;&#x2014;Backup Withholding and Information Reporting&#x201d; and &#x201c;&#x2014;Foreign Accounts.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain on Sale, Exchange or Other Taxable Disposition of Our Shares or Pre-Funded Warrants</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the discussion below under the headings &#x201c;&#x2014;Backup Withholding and Information Reporting&#x201d; and &#x201c;&#x2014;Foreign Accounts,&#x201d; in general, a non-U.S. holder will not be subject to any U.S. federal income tax on any gain realized upon such non-U.S. holder's sale, exchange or other taxable disposition of our securities unless:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the gain is effectively connected with a U.S. trade or business of the non-U.S. holder and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed base maintained in the United States by such non-U.S. holder, in which case the non-U.S. holder generally will be taxed at the U.S. federal income tax rates applicable to U.S. persons (as defined in the Code) and, if the non-U.S. holder is a foreign corporation, the branch profits tax described above in &#x201c;&#x2014;Distributions on the Shares and Pre-Funded Warrants&#x201d; also may apply;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the non-U.S. holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the non-U.S. holder will be subject to a 30% U.S. federal income tax (or such lower rate as may be specified by an applicable income tax treaty) on the net gain derived from the disposition, which may be offset by U.S. source capital losses of the non-U.S. holder, if any (even though the individual is not considered a resident of the United States); or</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we are, or have been, at any time during the five-year period preceding such disposition (or the non-U.S. holder's holding period, if shorter) a &#x201c;U.S. real property holding corporation&#x201d; in which case such non-U.S. holder generally will be taxed on its net gain derived from the disposition as effectively connected income taxable at the U.S. federal income tax rates applicable to U.S. persons (as defined in the Code); however, the branch profits tax described above will not apply to a U.S. holder that is a foreign corporation. Generally, a corporation is a U.S. real property holding corporation if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. Even if we are or become a U.S. real property holding corporation, provided that our common stock is regularly traded, as defined by applicable U.S. Treasury Regulations, on an established securities market, our securities will be treated as a U.S. real property interest only with respect to a non-U.S. holder that holds more than 5% of our securities (as determined under U.S. federal income tax principles), directly or indirectly, actually or constructively, during the shorter of the 5-year period ending on the date of the disposition or the period that the non-U.S. holder held our securities. There can be no assurance that our common stock will continue to qualify as regularly traded on an established securities market. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Withholding and Information Reporting</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We must report annually to the IRS and to each non-U.S. holder the gross amount of the dividends on our securities paid to such non-U.S. holder and the tax withheld, if any, with respect to such dividends. Non-U.S. holders will have to comply with specific certification procedures to establish that the holder is not a U.S. person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to any dividends on our securities. A non-U.S. holder generally will not be subject to U.S. backup withholding with respect to payments of dividends on our securities if it certifies its non-U.S. status by providing a valid IRS Form W-8BEN or IRS Form W-8BEN-E (or successor form) or IRS Form W-8ECI, or otherwise establishes an exemption; provided we do not have actual knowledge or reason to know such non-U.S. holder is a U.S. person, as defined in the Code. Dividends paid to non-U.S. holders subject to the U.S. withholding tax, as described above in &#x201c;&#x2014;Distributions on the Shares and Pre-Funded Warrants&#x201d; generally will be exempt from U.S. backup withholding.</font></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information reporting and backup withholding generally will apply to the proceeds of a disposition of our securities by a non-U.S. holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a non-U.S. holder and satisfies certain other requirements, or otherwise establishes an</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a non-U.S. holder where the transaction is effected outside the United States through a non-U.S. office of a broker. However, for information reporting purposes, dispositions effected through a non-U.S. office of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. Non-U.S. holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Copies of information returns may be made available to the tax authorities of the country in which the non-U.S. holder resides or is established under the provisions of a specific treaty or agreement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a non-U.S. holder may be allowed as a credit against the non-U.S. holder's U.S. federal income tax liability, if any, and may entitle such holder to a refund, provided that the required information is timely furnished to the IRS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign Accounts</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Code generally imposes a U.S. federal withholding tax of 30% on dividends and, subject to the discussion below regarding proposed regulations issued by the U.S. Treasury Department, the gross proceeds of a disposition of our securities paid to a &#x201c;foreign financial institution&#x201d; (as defined in the Code), unless such institution enters into an agreement with the U.S. government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding accounts held by certain &#x201c;specific United States persons&#x201d; or &#x201c;United States owned foreign entities&#x201d; (each as defined in the Code), or otherwise qualifies for an exemption from these rules. A U.S. federal withholding tax of 30% also applies to dividends and, subject to the discussion below regarding proposed regulations issued by the U.S. Treasury Department, will apply to the gross proceeds of a disposition of our securities paid to a &#x201c;non-financial foreign entity&#x201d; (as defined in the Code), unless such entity provides the withholding agent with either a certification that it does not have any &#x201c;substantial United States owners&#x201d; (as defined in the Code), provides information regarding each substantial United States owners of the entity, or otherwise qualifies for an exemption from these rules. Under certain circumstances, a non-U.S. holder might be eligible for refunds or credits of such taxes. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The withholding provisions described above currently apply to dividends paid on our securities. The U.S. Treasury Department released proposed regulations which, if finalized in their present form, would eliminate the U.S. federal withholding tax of 30% applicable to the gross proceeds of a sale or other disposition of our securities. In its preamble to such proposed regulations, the U.S. Treasury Department stated that taxpayers may generally rely on the proposed regulations until final regulations are issued.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE AND LOCAL AND NON-U.S. TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR SECURITIES, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAWS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;" id="underwriting"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNDERWRITING</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and the underwriters named below will enter into an underwriting agreement with respect to the securities being offered. Subject to certain conditions, each underwriter will severally agree to purchase the number of shares of common stock and pre-funded warrants indicated in the following table. Goldman Sachs &amp; Co. LLC is the representative of the underwriters.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:86.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.888%;"></td>
    <td style="width:24.534%;"></td>
    <td style="width:27.578%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of Pre-Funded</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Underwriters</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of Shares</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Goldman Sachs &amp; Co. LLC</font></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,731,964</font></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,750,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stifel, Nicolaus &amp; Company, Incorporated</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,175,259</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,000,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Wedbush Securities Inc.</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,190,722</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,875,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Robert W. Baird &amp; Co. Incorporated</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,190,722</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,875,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B. Riley Securities, Inc.</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,793,815</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,250,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Needham &amp; Company, LLC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,793,815</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,250,000</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,876,297</font></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000,000</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The underwriters will commit to take and pay for all of the shares of common stock and pre-funded warrants being offered, if any are taken, other than the shares of common stock covered by the option described below unless and until this option is exercised.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have granted the underwriters an option to purchase additional shares of our common stock at the public offering price, less the underwriting discounts and commissions. The underwriters may exercise this option for a period of 30 days. If any shares are purchased pursuant to this option, the underwriters will severally purchase shares in approximately the same proportion as set forth in the table above.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The following table shows the public offering price per share of common stock and pre-funded warrant, underwriting discounts and commissions and proceeds to us, before expenses. Such amounts are shown assuming both no exercise and full exercise of the underwriters&#x2019; option to purchase additional shares.</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.996%;"></td>
    <td style="width:13.002%;"></td>
    <td style="width:16.998%;"></td>
    <td style="width:18.002%;"></td>
    <td style="width:18.002%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Pre-Funded Warrant</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total Without Option Exercise</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total with Full Option Exercise</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public offering price</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.450</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.449</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$198,121,928</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$227,843,965</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Underwriting discounts and commissions</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.147</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.147</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$11,888,816</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$13,672,138</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds before expenses, to us</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.303</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.302</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$186,233,112</font></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$214,171,828</font></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities sold by the underwriters to the public will initially be offered at the public offering price set forth on the cover of this prospectus. Any securities sold by the underwriters to securities dealers may be sold at a discount of up to $0.0882 per share of common stock or per pre-funded warrant from the public offering price. After the initial offering of the shares and pre-funded warrants, the representative may change the offering price and the other selling terms. The offering of the shares and pre-funded warrants by the underwriters is subject to receipt and acceptance and subject to the underwriters&#x2019; right to reject any order in whole or in part.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and our officers and directors have agreed with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through and including the date 75 days after the date of this prospectus, except with the prior written consent of the representative. These restrictions do not prohibit our officers and directors from establishing new trading plans pursuant to Rule 10b5-1 of the Exchange Act, provided that, other than with respect to the sale by certain of our officers of (i) an aggregate of up to 1,890,000 shares of our common stock following the exercise of options held by such officers that are scheduled to expire during the 75 days after the date of this prospectus and (ii) an aggregate of up to $160,000 of shares of our common stock held by certain of our officers to satisfy tax obligations of such officers following the exercise of options held by such officers in September 2022, no transfers of shares of our common stock may be effected pursuant to any such newly established trading plans during the 75 days after the date of this prospectus. To the extent such officers</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">do not establish any such newly established trading plans, the sales set out in clauses (i) and (ii) of the preceding sentence may still take place on or after the date that is 31 days following the date of this prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering, and a short position represents the amount of such sales that have not been covered by subsequent purchases. A &#x201c;covered short position&#x201d; is a short position that is not greater than the amount of additional shares for which the underwriters&#x2019; option described above may be exercised. The underwriters may cover any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to cover the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase additional shares pursuant to the option described above. &#x201c;Naked&#x201d; short sales are any short sales that create a short position greater than the amount of additional shares for which the option described above may be exercised. The underwriters must cover any such naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common stock made by the underwriters in the open market prior to the completion of the offering.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representative has repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases to cover a short position and stabilizing transactions, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of our common stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. The underwriters are not required to engage in these activities and may end any of these activities at any time. These transactions may be effected on The Nasdaq Global Select Market, in the over-the-counter market or otherwise.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate that the total expenses of the offering, excluding underwriting discounts and commissions, will be approximately $850,000 and are payable by us. We also have agreed to reimburse the underwriters for certain of their expenses in an amount up to $25,000.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and non-financial activities and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to the issuer and to persons and entities with relationships with the issuer, for which they received or will receive customary fees and expenses. For example, B. Riley Securities, Inc. is the sales agent under our Sales Agreement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> In the ordinary course of their various business activities, the underwriters and their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate to assets, securities and/or instruments of the issuer (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with the issuer. The underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may at any</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d; There is no established public trading market for the pre-funded warrants and we do not expect a market to develop. In addition, we do not intend to apply for listing of the pre-funded warrants on any securities exchange or recognized trading system.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">European Economic Area</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In relation to each Member State of the European Economic Area (each a Relevant Member State), no securities have been offered or will be offered pursuant to the offering to the public in that Relevant Member State prior to the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Regulation, except that the securities may be offered to the public in that Relevant Member State at any time:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the Prospectus Regulation) subject to obtaining the prior consent of the representative for any such offer; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided that no such offer of the securities shall require us or any representative to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the purposes of this provision, the expression an &#x2018;offer to the public&#x2019; in relation to the securities in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase any securities, and the expression &#34;Prospectus Regulation&#34; means Regulation (EU) 2017/1129.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each person in a Relevant Member State who receives any communication in respect of, or who acquires any securities under, the offering contemplated hereby will be deemed to have represented, warranted and agreed to and with each of the Underwriters and their affiliates and us that:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is a qualified investor within the meaning of the Prospectus Regulation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the case of any securities acquired by it as a financial intermediary, as that term is used in Article 5 of the Prospectus Regulation, (i) the securities acquired by it in the offering have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Relevant Member State other than qualified investors, as that term is defined in the Prospectus Regulation, or have been acquired in other circumstances falling within the points (a) to (d) of Article 1(4) of the Prospectus Regulation and the prior consent of the representative has been given to the offer or resale; or (ii) where the securities have been acquired by it on behalf of persons in any Relevant Member State other than qualified investors, the offer of those securities to it is not treated under the Prospectus Regulation as having been made to such persons. </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, the Underwriters and their affiliates, and others will rely upon the truth and accuracy of the foregoing representation, acknowledgement and agreement. Notwithstanding the above, a person who is not a qualified investor and who has notified the representative of such fact in writing may, with the prior consent of the representative, be permitted to acquire securities in the offering.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">United Kingdom</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus supplement and any other material in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this prospectus supplement</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">relates is available only to, and will be engaged in only with persons who are (i) persons having professional experience in matters relating to investments who fall within the definition of investment professionals in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or the FPO; or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the FPO; (iii) outside the United Kingdom, or the UK; or (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000, or the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated, (all such persons together being referred to as Relevant Persons). The securities are only available in the UK to, and any invitation, offer or agreement to purchase or otherwise acquire the securities will be engaged in only with, the Relevant Persons. This prospectus supplement and its contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed by recipients to any other person in the UK. Any person in the UK that is not a Relevant Person should not act or rely on this prospectus supplement or any of its contents.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No securities have been offered or will be offered pursuant to the offering to the public in the UK prior to the publication of a prospectus in relation to the securities which has been approved by the Financial Conduct Authority, except that the securities may be offered to the public in the UK at any time:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the representative for any such offer; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in any other circumstances falling within Section 86 of the FSMA. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provided that no such offer of the securities shall require us and/or the Underwriters or any of their affiliates to publish a prospectus pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. For the purposes of this provision, the expression an &#34;offer to the public&#34; in relation to the securities in the UK means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase or subscribe for any securities and the expression &#x201c;UK Prospectus Regulation&#x201d; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each person in the UK who acquires any securities in the offering or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with us, the Underwriters and their affiliates that it meets the criteria outlined in this section.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Canada</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption form, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this offering memorandum (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#x2019;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#x2019;s province or territory of these rights or consult with a legal advisor.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Hong Kong</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The securities may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) (&#x201c;Companies (Winding Up and Miscellaneous Provisions) Ordinance&#x201d;) or which do not constitute an invitation to the public within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (&#x201c;Securities and Futures Ordinance&#x201d;), or (ii) to &#34;professional investors&#34; as defined in the Securities and Futures Ordinance and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a &#34;prospectus&#34; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to the securities may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to securities which are or are intended to be disposed of only to persons outside Hong Kong or only to &#34;professional investors&#34; in Hong Kong as defined in the Securities and Futures Ordinance and any rules made thereunder.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Singapore</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the securities may not be circulated or distributed, nor may the securities be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined under Section 4A of the Securities and Futures Act, Chapter 289 of Singapore (the &#34;SFA&#34;)) under Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to conditions set forth in the SFA.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where the securities are subscribed or purchased under Section 275 of the SFA by a relevant person which is a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor, the securities (as defined in Section 239(1) of the SFA) of that corporation shall not be transferable for 6 months after that corporation has acquired the securities under Section 275 of the SFA except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (2) where such transfer arises from an offer in that corporation&#x2019;s securities pursuant to Section 275(1A) of the SFA, (3) where no consideration is or will be given for the transfer, (4) where the transfer is by operation of law, (5) as specified in Section 276(7) of the SFA, or (6) as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore (&#x201c;Regulation 32&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where the securities are subscribed or purchased under Section 275 of the SFA by a relevant person which is a trust (where the trustee is not an accredited investor (as defined in Section 4A of the SFA)) whose sole purpose is to hold investments and each beneficiary of the trust is an accredited investor, the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferable for 6 months after that trust has acquired the securities under Section 275 of the SFA except: (1) to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (2) where such transfer arises from an offer that is made on terms that such rights or interest are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction (whether such amount is to be paid for in cash or by exchange of securities or other assets), (3) where no consideration is or will be given for the transfer, (4) where the transfer is by operation of law, (5) as specified in Section 276(7) of the SFA, or (6) as specified in Regulation 32.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Japan</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The securities have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended), or the FIEA. The securities may not be offered or sold, directly or indirectly, in Japan or to or for the benefit of any resident of Japan (including any person resident in Japan or any corporation or other entity organized under the laws of Japan) or to others for reoffering or resale, directly or indirectly, in Japan or to or for the benefit of any resident of Japan, except pursuant to an exemption from the registration requirements of the FIEA and otherwise in compliance with any relevant laws and regulations of Japan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="legal_matters"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LEGAL MATTERS</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cooley LLP, San Francisco, California, has passed upon the validity of the common stock and pre-funded warrants offered by this prospectus supplement and the accompanying prospectus. The underwriters are being represented in connection with this offering by Latham &amp; Watkins LLP, Menlo Park, California.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="experts"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXPERTS</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The financial statements of Geron Corporation appearing in Geron Corporation&#x2019;s Annual Report (Form 10-K) for the year ended December 31, 2021 have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="where_you_can_find_more"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHERE YOU CAN FIND MORE INFORMATION</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus supplement is part of the registration statement on Form S-3 we filed with the SEC under the Securities Act and does not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus supplement and the accompanying prospectus to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus supplement and the accompanying prospectus for a copy of such contract, agreement or other document. Because we are subject to the information and reporting requirements of the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Such filings are also available free of charge through our website at </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">www.geron.com</font><font style="white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as soon as reasonably practicable after we file them with, or furnish them to, the SEC. Our website and the information contained on, or that can be accessed through, the website will not be deemed to be incorporated by reference in, and are not considered part of, this prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will furnish without charge to you, on written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents. You should direct any requests for documents to Stephen Rosenfield, Chief Legal Officer and Corporate Secretary, Geron Corporation, 919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404, telephone: (650) 473-7700.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="incorporation_by_reference"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The SEC allows us to &#x201c;incorporate by reference&#x201d; information from other documents that we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement and the accompanying prospectus. Information in this prospectus supplement supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus supplement, while information that we file later with the SEC will automatically update and supersede the information in this prospectus supplement. Our SEC filings are available to the public over the Internet at the SEC&#x2019;s website at </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">http://www.sec.gov.</font><font style="white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We incorporate by reference into this prospectus supplement and the registration statement of which this prospectus supplement is a part the information or documents listed below that we have filed with the SEC (Commission File No. 000-20859):</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000156459022009627/gern-10k_20211231.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 10, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;2021 Form 10-K&#x201d;);</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Quarterly Reports on Form 10-Q filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022008472/gern-20220331.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 9, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022016839/gern-20220630.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 11, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022022712/gern-20220930.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Current Reports on Form 8-K filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422000483/gern4025271-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 18, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000156459022012684/gern-8k_20220329.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 30, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001399/geron4061651-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 13, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001546/geron4073661-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 15, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001630/geron4078581-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022018084/gern-20220902.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 6, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022018252/gern-20220907.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 8, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022026975/gern-20221221.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 22, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017023000127/gern-20230104.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 4, 2023</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the information specifically incorporated by reference into the 2021 Form 10-K from our definitive proxy statement relating to our 2022 annual meeting of stockholders held on May 10, 2022, filed with the SEC on </font><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022011396/gern-def14a_20220510.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 22, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; and</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the description of our securities registered pursuant to Section 12 of the Exchange Act contained in </font><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022009627/gern-ex41_123.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 4.1</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the 2021 Form 10-K, including any amendment or report filed with the SEC for the purpose of updating such description.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this prospectus supplement or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also incorporate by reference any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement and prior to the termination of the offering of the common stock covered by this prospectus supplement and the accompanying prospectus. Information in such future filings updates and supplements the information provided in this prospectus supplement and the accompanying prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECTUS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_6.jpg" alt="img175210594_6.jpg" style="width:192px;height:70px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Stock</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt Securities</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we or selling securityholders may offer and sell any combination of the securities described in this prospectus, either individually or in combination with other securities. We or selling securityholders may also offer common stock or preferred stock upon conversion of debt securities, common stock upon conversion of preferred stock, or common stock, preferred stock or debt securities upon the exercise of warrants.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each time we sell securities pursuant to this prospectus, we will provide the specific terms of these offerings and securities in one or more supplements to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as the documents incorporated by reference, before buying any of the securities being offered.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the trading symbol &#x201c;GERN.&#x201d; On January 3, 2023, the last reported sale price of our common stock was $2.40 per share. The applicable prospectus supplement will contain information, where applicable, as to other listings, if any, on The Nasdaq Global Select Market or other securities exchange of the securities covered by the applicable prospectus supplement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:37.04%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:37.037%;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#x201c;Risk Factors&#x201d; contained in the applicable prospectus supplement and in any related free writing prospectuses we have authorized for use in connection with a specific offering, and under similar headings in the documents that are incorporated by reference into this prospectus.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus may not be used to consummate a sale of securities unless accompanied by a prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The securities may be sold by us or selling securityholders directly to investors, through agents designated from time to time or to or through underwriters or dealers, on a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section titled &#x201c;Plan of Distribution&#x201d; in this prospectus. If any agents or underwriters are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such agents or underwriters and any applicable fees, commissions, discounts and over-allotment or other options will be set forth in a prospectus supplement. The price to the public of such securities and the net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement. Unless the applicable prospectus supplement provides otherwise, we will not receive any proceeds from the sale of securities by selling securityholders.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></p>
  <p style="margin-left:37.04%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:37.037%;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The date of this prospectus is January 4, 2023.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:81.271%;"></td>
    <td style="width:1.485%;"></td>
    <td style="width:17.244%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_about_this_prospectus"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">About This Prospectus</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#prospectus_summary"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Summary</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_risk_factors"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_special_note_regarding_fls"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_use_of_proceeds"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_capital_stock"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Capital Stock</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_debt_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Debt Securities</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_description_of_warrants"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Warrants</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_legal_ownership_of_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Ownership of Securities</font></a></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_selling_stockholders"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Stockholders</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_plan_of_distribution"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan of Distribution</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_legal_matters"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Matters</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_experts"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Experts</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_where_you_can_find_more_information"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where You Can Find More Information</font></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><a href="#base_incorporation_of_info_by_reference"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incorporation of Certain Information by Reference</font></a></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:1.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">i</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_about_this_prospectus"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ABOU</font><font id="about_this_prospectus"></font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T THIS PROSPECTUS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a &#x201c;shelf&#x201d; registration process as a &#x201c;well-known seasoned issuer&#x201d; as defined in Rule 405 under the Securities Act of 1933, as amended, or the Securities Act. Under this shelf registration process, we or selling securityholders may offer and sell any combination of securities described in this prospectus, either individually or in combination with other securities described in this prospectus, in one or more offerings. There is no limit on the aggregate amount of the securities that we or selling securityholders may offer pursuant to the registration statement of which this prospectus is a part. This prospectus provides you with a general description of the securities we or selling securityholders may offer.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each time we or selling securityholders offer securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents that we have incorporated by reference into this prospectus. We urge you to read carefully this prospectus, any applicable prospectus supplement and any related free writing prospectuses we have authorized for use in connection with a specific offering, together with the information incorporated herein by reference as described under the heading &#x201c;Incorporation of Certain Information by Reference,&#x201d; before buying any of the securities being offered.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus may not be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You should rely only on the information contained in, or incorporated by reference into, this prospectus and any applicable prospectus supplement, along with the information contained in any related free writing prospectuses we have authorized for use in connection with a specific offering. We have not authorized anyone to provide you with different or additional information. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information appearing in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the front of the document and any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing prospectus, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the section titled &#x201c;Where You Can Find More Information.&#x201d;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus and the information incorporated herein by reference include trademarks, services marks and trade names owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus, any applicable prospectus supplement or any related free writing prospectuses are the property of their respective owners.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <hr style="page-break-after:always;">
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></div>
  <div style="border-top:0.5pt solid #000000;padding-top:0.6313131313131313%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.8169934640522876%;padding-bottom:0.6313131313131313%;border-bottom:0.5pt solid #000000;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="base_prospectus_summary"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PROSPECT</font><font id="prospectus_summary"></font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US SUMMARY</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">This summary highlights selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus, and does not contain all of the information that you need to consider in making your investment decision. You should carefully read the entire prospectus, the applicable prospectus supplement and any related free writing prospectus, including the risks of investing in our securities discussed under the heading &#x201c;Risk Factors&#x201d; contained in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus. You should also carefully read the information incorporated by reference into this prospectus, including our financial statements, and the exhibits to the registration statement of which this prospectus is a part.</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Overview</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Our investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes, or lower risk MDS. In January 2023, we reported positive top-line results from our IMerge Phase 3 clinical trial. The trial met its primary endpoint of 8-week transfusion independence rate and a key secondary endpoint of 24-week transfusion independence rate, demonstrating highly statistically significant (i.e., P&lt;0.001 for both) and clinically meaningful benefits in imetelstat versus placebo. Furthermore, statistically significant and clinically meaningful efficacy results were observed in the trial across key subtypes, including patients who were ringed sideroblast positive, or RS positive, and ringed sideroblast negative, or RS negative; patients with high and very high baseline transfusion burden; and patients classified as Low or Intermediate-1 risk according to the International Prognostic Scoring System, or IPSS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were incorporated in 1990 under the laws of Delaware. Our principal executive offices are located at 919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404 and our telephone number is (650) 473-7700. Our website address is www.geron.com. Information found on, or accessible through, our website is not a part of, and is not incorporated into, this prospectus, and you should not consider it part of this prospectus or part of any prospectus supplement. Our website address is included in this document as an inactive textual reference only.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless the context indicates otherwise, as used in this prospectus, the terms &#x201c;Geron,&#x201d; &#x201c;Geron Corporation,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to Geron Corporation, a Delaware corporation, and its subsidiary on a consolidated basis.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Securities</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may offer shares of our common stock and preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in combination with other securities from time to time under this prospectus, together with the applicable prospectus supplement and any related free writing prospectus, at prices and on terms to be determined by market conditions at the time of any offering. There is no limit on the aggregate amount of the securities that we or selling securityholders may offer pursuant to the registration statement of which this prospectus is a part. We may also offer common stock, preferred stock and/or debt securities upon the exercise of warrants. This prospectus provides you with a general description of the securities we or selling securityholders may offer. Each time we or selling securityholders offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable:</font></p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">designation or classification;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">aggregate principal amount or aggregate offering price;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maturity date, if applicable;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">original issue discount, if any;</font></div></div></div>
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></div>
  <div style="border-top:0.5pt solid #000000;padding-top:0.6313131313131313%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.8169934640522876%;padding-bottom:0.6313131313131313%;border-bottom:0.5pt solid #000000;padding-right:0.8169934640522876%;"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rates and times of payment of interest or dividends, if any;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">redemption, conversion, exercise, exchange or sinking fund terms, if any;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ranking;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictive covenants, if any;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">voting or other rights, if any;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conversion or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices or rates and in the securities or other property receivable upon conversion or exchange; and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material or important United States, or U.S., federal income tax considerations, if any. </font></div></div><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The applicable prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will offer a security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement of which this prospectus is a part.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THIS PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell the securities directly to investors or to or through agents, underwriters or dealers. We, and our agents or underwriters, reserve the right to acceptor reject all or part of any proposed purchase of securities. If we or selling securityholders do offer securities to or through agents or underwriters, we will include in the applicable prospectus supplement:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the names of those agents or underwriters;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">applicable fees, discounts and commissions to be paid to them;</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">details regarding over-allotment or other options under which underwriters may purchase additional securities from us or selling securityholders, if any; and</font></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the net proceeds to us.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell shares of our common stock from time to time. The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to receive ratably such dividends as may be declared by our board of directors out of legally available funds. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets legally available for distribution to stockholders remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to our common stock. When we issue shares of common stock under this prospectus, the shares will be fully paid and non-assessable. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which we may designate in the future. In this prospectus, we have summarized certain general features of the common stock under the heading &#x201c;Description of Capital Stock-Common Stock.&#x201d; We urge you, however, to read the applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to any common stock being offered.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preferred Stock. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell shares of our preferred stock from time to time, in one or more series. Under our restated certificate of incorporation, as amended, our board of directors has the authority to designate up to 3,000,000 shares of preferred stock, $0.001 par value per share, in one or more series and to fix the privileges, preferences and rights of each series of preferred stock, any or all of which may be greater than the</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></div>
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></div>
  <div style="border-top:0.5pt solid #000000;padding-top:0.6313131313131313%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.8169934640522876%;padding-bottom:0.6313131313131313%;border-bottom:0.5pt solid #000000;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rights of the common stock. If we sell any new series of preferred stock under this prospectus and any applicable prospectus supplement, our board of directors will determine the designations, voting powers, preferences and rights of the preferred stock being offered, as well as the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, preemptive rights, terms of redemption or repurchase, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of any series. Preferred stock may be convertible into our common stock or other securities of ours, or may be exchangeable for debt securities. Conversion may be mandatory or at the holder&#x2019;s option and would be at prescribed conversion rates. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of the certificate of designation that describes the terms of the series of preferred stock that we or selling securityholders are offering before the issuance of the related series of preferred stock. In this prospectus, we have summarized certain general features of the preferred stock under the heading &#x201c;Description of Capital Stock-Preferred Stock.&#x201d; We urge you, however, to read the applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to the series of preferred stock being offered, as well as the complete certificate of designation that contains the terms of the applicable series of preferred stock.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Debt Securities. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. The senior debt securities will rank equally with any other unsecured and unsubordinated debt. The subordinated debt securities will be subordinate and junior in right of payment, to the extent and in the manner described in the instrument governing the debt, to all of our senior indebtedness. Convertible debt securities will be convertible into or exchangeable for our common stock or our other securities. Conversion may be mandatory or at the holder&#x2019;s option and would be at prescribed conversion rates.</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The debt securities will be issued under an indenture that we will enter into with a national banking association or other eligible party, as trustee. In this prospectus, we have summarized certain general features of the debt securities under the heading &#x201c;Description of Debt Securities.&#x201d; We urge you, however, to read the applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to the series of debt securities being offered, as well as the complete indenture and any supplemental indentures that contain the terms of the debt securities. We have filed the form of indentures an exhibit to the registration statement of which this prospectus is a part ,and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the SEC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently or in combination with common stock, preferred stock and/or debt securities. In this prospectus, we have summarized certain general features of the warrants under the heading &#x201c;Description of Warrants.&#x201d; We urge you, however, to read the applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to the particular series of warrants being offered, as well as the form of warrant and/or the warrant agreement and warrant certificate, as applicable, that contain the terms of the warrants. We have filed the forms of the warrant agreements and forms of warrant certificates containing the terms of the warrants that we may offer as exhibits to the registration statement of which this prospectus is a part. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant and/or the warrant agreement and warrant certificate, as applicable, that contain the terms of the particular series of warrants we or selling securityholders are offering, and any supplemental agreements, before the issuance of such warrants.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants may be issued under a warrant agreement that we enter into with a warrant agent. We will indicate the name and address of the warrant agent, if any, in the applicable prospectus supplement relating to a particular series of warrants.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling Securityholders</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling securityholders are persons or entities that, directly or indirectly, have acquired or will from time to time acquire from us, our securities. Information about selling securityholders, if any, will be set forth in a prospectus supplement. See the section titled &#x201c;Selling Securityholders&#x201d; on page</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></div>
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></div>
  <div style="border-top:0.5pt solid #000000;padding-top:0.6313131313131313%;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.8169934640522876%;padding-bottom:0.6313131313131313%;border-bottom:0.5pt solid #000000;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as described in any applicable prospectus supplement or in any related free writing prospectuses we have authorized for use in connection with a specific offering, we intend to use the net proceeds from the sale of the securities under this prospectus for working capital and general corporate purposes, which may include funding research and development, general and administrative activities and capital expenditures, as well to potentially in-license or acquire other oncology products, programs or companies to diversify our business. See &#x201c;Use of Proceeds&#x201d; on page </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus. Unless the applicable prospectus supplement provides otherwise, we will not receive any of the proceeds from the sale of our securities by selling securityholders.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing in our securities involves a high degree of risk. Please read the information contained in and incorporated by reference under the heading &#x201c;Risk Factors&#x201d; beginning on page </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this prospectus, in the applicable prospectus supplement, and under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus and applicable prospectus supplement, before deciding whether to invest in our securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq Global Select Market Listing</font></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d;</font></p></div>
  <div style="padding-left:0.8169934640522876%;padding-right:0.8169934640522876%;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="base_risk_factors"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISK FACTORS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks and uncertainties described under the heading &#x201c;Risk Factors&#x201d; contained in the applicable prospectus supplement and any related free writing prospectus, and discussed under the section titled &#x201c;Risk Factors&#x201d; contained in our most recent Annual Report on Form 10-K and in our most recent Quarterly Report on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC, which are incorporated by reference into this prospectus in their entirety, together with other information in this prospectus, the documents incorporated by reference and any related free writing prospectus that we may authorize for use in connection with a specific offering. The risks described in these documents are not the only ones we face, but those that we consider to be material. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have material adverse effects on our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be unduly relied upon to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also read carefully the section below titled &#x201c;Special Note Regarding Forward-Looking Statements.&#x201d;</font></p>
  <p style="text-indent:2.773%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="base_special_note_regarding_fls"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus, any accompanying prospectus supplement, as well as the documents we have filed with the SEC that are incorporated by reference into this prospectus or any accompanying prospectus supplement, contain &#x201c;forward-looking statements&#x201d; within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements about:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the therapeutic potential of imetelstat and its expected uses and benefits;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to submit a New Drug Application in the U.S. and a marketing authorization application for imetelstat in lower risk MDS, and the anticipated timing thereof;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the progress, timing, magnitude, scope and costs of clinical development, manufacturing and commercialization of imetelstat, including the number of indications which are or may in the future be pursued, subject to clearances and approvals by the U.S. Food and Drug Administration and other regulatory authorities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the continued enrollment in and the continued conduct and completion of, IMpactMF, our Phase 3 clinical trial in relapsed/refractory myelofibrosis, or MF, IMproveMF, our Phase 1 combination clinical trial in frontline Intermediate-2 or High Risk MF, and IMpress, an investigator-led Phase 2 clinical trial in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the achievement and timing of clinical trial events related to IMpactMF, IMproveMF and IMpress including the completion of patient enrollment and anticipated timing of data availability;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other potential planned future clinical development plans for imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to market and sell imetelstat, upon regulatory approval or clearance, in the U.S. and in Europe, whether alone or with new collaborative partners, and the anticipated timing thereof;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain potential new collaborative arrangements to assist us in the development and potential commercialization of imetelstat, especially outside the U.S.;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate third-party reimbursement for imetelstat, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to consistently and reproducibly manufacture imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to meaningfully reduce manufacturing costs of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impacts of the ongoing COVID-19 global pandemic, macroeconomic conditions, such as rising inflation rates, uncertain credit and global financial markets and supply chain disruptions, and geopolitical events, such as the conflict between Russia and Ukraine and related sanctions, on the foregoing;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain agreements with third-party service providers to support the development of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and timing of expenditures and whether there are unanticipated expenditures;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to manage the anticipated growth of our business, including our ability to recruit and retain key personnel to support the development and potential future commercialization of imetelstat;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates and expectations regarding the sufficiency of our cash resources, our cash resource conservation efforts;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to protect our intellectual property and the duration of any such protection, and operate our business without infringing upon the intellectual property rights of others;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the implementation of our corporate strategy;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our future financial and operating performance;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our anticipated use of the net proceeds from offerings of our securities under this prospectus; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans, objectives, expectations and intentions and any other statements that are not historical fact.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;intend,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;would,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;projects,&#x201d; &#x201c;predicts,&#x201d; &#x201c;potential&#x201d; and similar expressions intended to identify forward-looking statements. These statements reflect our current views with respect to future events, are based on assumptions and are subject to risks and uncertainties. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. We discuss in greater detail, and incorporate by reference into this prospectus in their entirety, many of these risks and uncertainties under the heading &#x201c;Risk Factors&#x201d; contained in the applicable prospectus supplement, in any related free writing prospectus we may authorize for use in connection with a specific offering, and in our most recent annual report on Form 10-K and most recent quarterly report on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should read this prospectus, the applicable prospectus supplement, together with the documents we have filed with the SEC that are incorporated by reference and any related free writing prospectus that we may authorize for use in connection with a specific offering completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in the foregoing documents by these cautionary statements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="base_use_of_proceeds"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">USE OF PROCEEDS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as described in any applicable prospectus supplement or in any related free writing prospectus that we may authorize for use in connection with a specific offering, we currently intend to use the net proceeds from the sale of the securities under this prospectus for working capital and general corporate purposes, which may include funding research and development, selling, general and administrative activities and capital expenditures, as well as and manufacturing expenses. We will set forth in the applicable prospectus supplement our intended use for the net proceeds received from the sale of any securities. Pending the use of the net proceeds, we intend to temporarily invest the proceeds in short-term, interest-bearing instruments. Our management will have broad discretion over the use of such proceeds.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless the applicable prospectus supplement provides otherwise, we will not receive any of the proceeds from the sale of our securities by selling securityholders.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="base_description_of_capital_stock"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DESCRIPTION OF CAPITAL STOCK</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:5.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of this prospectus, our restated certificate of incorporation, as amended, or the Restated Certificate, authorizes us to issue 675,000,000 shares of common stock, par value $0.001 per share, and 3,000,000 shares of preferred stock, par value $0.001 per share.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following summary description of our capital stock is based on the provisions of our Restated Certificate, our amended and restated bylaws, as amended, or the Bylaws, and applicable provisions of the Delaware General Corporation Law. This information may not be complete in all respects and is qualified entirely by reference to the applicable provisions of our Restated Certificate, our Bylaws and the Delaware General Corporation Law. For information on how to obtain copies of our Restated Certificate and Bylaws, which are exhibits to the registration statement of which this prospectus is a part, see &#x201c;Where You Can Find More Information.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:5.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of our common stock are the only security of the company registered pursuant to Section 12 of the Exchange Act. The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. Subject to preferences that may be applicable to any outstanding shares of the preferred stock, the holders of common stock are entitled to receive ratably such dividends as may be declared by the board of directors out of legally available funds. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock legally available for distribution to stockholders. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional shares of authorized common stock may be issued, as authorized by our board of directors from time to time, without stockholder approval, except as may be required by applicable stock exchange requirements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Stock</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to our Restated Certificate, our board of directors has the authority, without further action by our stockholders, to issue up to 3,000,000 shares of preferred stock in one or more series and to fix the designations, powers, preferences, privileges and relative participating, optional or special rights and the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights of the common stock. The board of directors, without stockholder approval, can issue preferred stock with voting, conversion or other rights that could adversely affect the voting power and other rights of the holders of common stock. Preferred stock could thus be issued quickly with terms calculated to delay or prevent a change in control of our company or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of the common stock and may adversely affect the voting power of holders of common stock and reduce the likelihood that common stockholders will receive dividend payments and payments upon liquidation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our board of directors will fix the rights, preferences, privileges, qualifications, limitations or restrictions of the preferred stock of each series that we sell under this prospectus and applicable prospectus supplements in the certificate of designation relating to that series. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of any certificate of designation that describes the terms of the series of preferred stock we are offering before the issuance of the related series of preferred stock. This description will include:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the title and stated value;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of shares we are offering;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the liquidation preference per share;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the purchase price per share;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the dividend rate per share, if any, dividend period and payment dates and method of calculation for dividends;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether any dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our right, if any, to defer payment of dividends and the maximum length of any such deferral period;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the procedures for any auction and remarketing, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the provisions for a sinking fund, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any listing of the preferred stock on any securities exchange or market;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the preferred stock will be convertible into our common stock or other securities of ours, including warrants, and, if applicable, the conversion period, the conversion price, or how it will be calculated, and under what circumstances it may be adjusted;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the preferred stock will be exchangeable for debt securities, and, if applicable, the exchange period, the exchange price, or how it will be calculated, and under what circumstances it may be adjusted;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">voting rights, if any, of the preferred stock;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preemption rights, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on transfer, sale or other assignment, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a discussion of any material or special United States federal income tax considerations applicable to the preferred stock;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any limitations on issuances of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock being issued as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other specific terms, rights, preferences, privileges, qualifications or restrictions of the preferred stock.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When we issue shares of preferred stock under this prospectus, the shares will be fully paid and nonassessable and will not have, or be subject to, any preemptive or similar rights.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we specify otherwise in the applicable prospectus supplement, the preferred stock will rank, with respect to dividends and upon our liquidation, dissolution or winding up:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">senior to all classes or series of our common stock and to all of our equity securities ranking junior to the preferred stock;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">on a parity with all of our equity securities the terms of which specifically provide that the equity securities rank on a parity with the preferred stock; and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">junior to all of our equity securities the terms of which specifically provide that the equity securities rank senior to the preferred stock.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term &#x201c;equity securities&#x201d; does not include convertible debt securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The General Corporation Law of the State of Delaware, the state of our incorporation, provides that the holders of preferred stock will have the right to vote separately as a class on any proposal involving fundamental changes in the rights of holders of that preferred stock. This right is in addition to any voting rights that may be provided for in the applicable certificate of designation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anti-takeover Effects of Provisions of Charter Documents and Delaware Law</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Charter Documents. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Restated Certificate and Bylaws contain provisions that could discourage potential takeover attempts and make it more difficult for stockholders to change management, which could adversely affect the market price of our common stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Restated Certificate limits the personal liability for monetary damages for breach of fiduciary duty of our directors to Geron and our stockholders to the fullest extent permitted by the Delaware General Corporation Law. The inclusion of this provision in our Restated Certificate may reduce the likelihood of derivative litigation against directors and may discourage or deter stockholders or management from bringing a lawsuit against directors for breach of their fiduciary duty.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Restated Certificate provides that all stockholder action must be effected at a meeting of stockholders and not by a consent in writing. In addition, our Bylaws provide that special meetings of stockholders may only be called by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors, the chairman of the board of directors, the chief executive officer or president (in the absence of a chief executive officer),or at the request in writing of stockholders owning a majority of the amount of our entire capital stock issued and outstanding and entitled to vote. Further, our Bylaws establish procedures, including advance notice procedures, with regard to the nomination of candidates for election as directors and stockholder proposals. Finally our Bylaws provide that our stockholders may alter, amend or repeal our Bylaws or adopt new bylaws only by the affirmative vote of 66 2/3% of the outstanding voting stock, but our board of directors may also unilaterally alter, amend, repeal our Bylaws or adopt new bylaws.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Bylaws provide for the board of directors to be divided into three classes of directors, with each class as nearly equal in number as possible, serving staggered three-year terms. As a result, approximately one-third of</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the board of directors will be elected each year. The classified board provision could have the effect of discouraging a third party from making a tender offer or attempting to obtain control of us. In addition, the classified board provision could delay stockholders who do not agree with the policies of the board of directors from removing a majority of the board of directors for two years.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These provisions may have the effect of delaying, deferring or preventing a change in control and may also delay or prevent changes in management of Geron, which could have an adverse effect on the market price of our common stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Delaware Law. </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to Section 203 of the Delaware General Corporation Law. Section 203 generally prohibits a public Delaware corporation such as us from engaging in a &#x201c;business combination&#x201d; with an &#x201c;interested stockholder&#x201d; for a period of three years following the time that the stockholder became an interested stockholder, unless:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prior to the time the stockholder became an interested stockholder, the board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (but not the outstanding voting stock owned by the interested stockholder) (a) those shares owned by persons who are directors and also officers and (b) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at or subsequent to the time the stockholder became an interested stockholder, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2&#x2044;3% of the outstanding voting stock which is not owned by the interested stockholder.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 203 defines a business combination to include:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any merger or consolidation involving the corporation and the interested stockholder;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions) involving the interested stockholder of 10% of the aggregate market value, determined on a consolidated basis, of either all of the assets of the corporation or its outstanding stock;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to exceptions, any transaction involving the corporation that has the effect, directly or indirectly, of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the receipt by the interested stockholder of the benefit, directly or indirectly (except proportionately as a stockholder of such corporation), of any loans, advances, guarantees, pledges or other financial benefits, other than certain benefits set forth in Section 203, provided by or through the corporation.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In general, Section203 defines an &#x201c;interested stockholder&#x201d; as an entity or person who, together with the person&#x2019;s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although Section 203 permits us to elect not to be governed by its provisions, we have not made this election. As a result of the application of Section203, potential acquirers of Geron may be discouraged from attempting to effect an acquisition transaction with us, thereby possibly depriving holders of our securities of certain opportunities to sell or otherwise dispose of such securities at above-market prices pursuant to such transactions.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forum Selection Bylaw</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of Geron, (2) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee or stockholder of Geron to Geron or to our stockholders, (3) any action asserting a claim arising pursuant to any provision of the DGCL, the Restated Certificate or the Bylaws or (4) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery of the state of Delaware, in all cases subject to the court&#x2019;s having personal jurisdiction over the indispensable parties named as defendants. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of Geron is deemed to have notice of and consented to the forum selection provisions of the Bylaws. This provision does not apply to actions arising under the Securities Act of 1933, as amended, or the Exchange Act, or any claim for which the federal courts have exclusive jurisdiction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Agent and Registrar</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. The transfer agent for any series of preferred stock that we or selling securityholders may offer under this prospectus will be named and described in the applicable prospectus supplement for that series</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing on The Nasdaq Global Select Market</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#x201c;GERN.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="base_description_of_debt_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DESCRIPTION OF DEBT SECURITIES</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may issue debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context requires otherwise, whenever we refer to the indenture, we also are referring to any supplemental indentures that specify the terms of a particular series of debt securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will issue the debt securities under the indenture that we will enter into with the trustee named in the indenture. The indenture will be qualified under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. We have filed the form of indenture as an exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with the SEC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following summary of material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit that we may designate. Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the indenture, the terms of the indenture do not contain any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations, financial condition or transactions involving us.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may issue the debt securities issued under the indenture as &#x201c;discount securities,&#x201d; which means they may be sold at a discount below their stated principal amount. These debt securities, as well as other debt securities that are not issued at a discount, may be issued with &#x201c;original issue discount,&#x201d; or OID, for U.S. federal income tax purposes because of interest payment and other characteristics or terms of the debt securities. Material U.S. federal income tax considerations applicable to debt securities issued with OID will be described in more detail in any applicable prospectus supplement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms of the series of debt securities being offered, including:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the title of the series of debt securities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any limit upon the aggregate principal amount that may be issued;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the maturity date or dates;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the form of the debt securities of the series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the applicability of any guarantees;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether or not the debt securities will be secured or unsecured, and the terms of any secured debt;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the debt securities rank as senior debt, senior subordinated debt, subordinated debt or any combination thereof, and the terms of any subordination;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the price (expressed as a percentage of the aggregate principal amount thereof) at which such debt securities will be issued is a price other than the principal amount thereof, the portion of the principal </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion of the principal amount of such debt securities that is convertible into another security or the method by which any such portion shall be determined;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our right, if any, to defer payment of interest and the maximum length of any such deferral period;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if applicable, the date or dates after which, or the period or periods during which, and the price or prices at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the date or dates, if any, on which, and the price or prices at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&#x2019;s option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the denominations in which we will issue the series of debt securities, if other than denominations of</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$1,000 and any integral multiple thereof;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any and all terms, if applicable, relating to any auction or remarketing of the debt securities of that series and any security for our obligations with respect to such debt securities and any other terms which may be advisable in connection with the marketing of debt securities of that series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the debt securities of the series shall be issued in whole or in part in the form of a global security or securities; the terms and conditions, if any, upon which such global security or securities may be exchanged in whole or in part for other individual securities; and the depositary for such global security or securities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> if applicable, the provisions relating to conversion or exchange of any debt securities of the series and the terms and conditions upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at our option or the holders&#x2019; option) conversion or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if other than the full principal amount thereof, the portion of the principal amount of debt securities of the series which shall be payable upon declaration of acceleration of the maturity thereof;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions to or changes in the covenants applicable to the particular debt securities being issued, including, among others, the consolidation, merger or sale covenant;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions to or changes in the events of default with respect to the securities and any change in the right of the trustee or the holders to declare the principal, premium, if any, and interest, if any, with respect</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to such securities to be due and payable;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions to or changes in the provisions relating to satisfaction and discharge of the indenture;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions to or changes in the provisions relating to the modification of the indenture both with and without the consent of holders of debt securities issued under the indenture;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the currency of payment of debt securities if other than U.S. dollar sand the manner of determining the equivalent amount in U.S. dollars;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether interest will be payable in cash or additional debt securities at our or the holders&#x2019; option and the terms and conditions upon which the election may be made;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if any and principal amounts of the debt securities of the series to any holder that is not a &#x201c;United States person&#x201d; for federal tax purposes;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any restrictions on transfer, sale or assignment of the debt securities of the series; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, any other additions or changes in the provisions of the indenture, and any terms that may be required by us or advisable under applicable laws or regulations.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion or Exchange Rights</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will set forth in the applicable prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable for our common stock or our other securities. We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidation, Merger or Sale</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety or substantially as an entirety. However, any successor to or acquirer of such assets (other than a subsidiary of ours) must assume all of our obligations under the indenture or the debt securities, as appropriate.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Events of Default Under the Indenture</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indenture with respect to any series of debt securities that we may issue:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if we fail to pay any installment of interest on any series of debt securities, as and when the same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by us in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of interest for this purpose;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if we fail to pay the principal of, or premium, if any, on any series of debt securities as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous fund established with respect to such series; provided, however, that a valid extension of the maturity of such debt securities in accordance with the terms of any indenture supplemental thereto shall not constitute a default in the payment of principal or premium, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if we fail to observe or perform any other covenant or agreement contained in the debt securities or the indenture, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive written notice of such failure, requiring the same to be remedied and stating that such is a notice of default thereunder, from the trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if specified events of bankruptcy, insolvency or reorganization occur.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an event of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal of premium, if any, and accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs with respect to us, the principal</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amount of and accrued interest, if any, of each issue of debt securities then outstanding shall be due and payable without any notice or other action on the part of the trustee or any holder.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The holders of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the terms of the indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of that series, provided that:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the direction so given by the holder is not in conflict with any law or the applicable indenture ;and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A holder of the debt securities of any series will have the right to institute a proceeding under the indenture or to appoint a receiver or trustee, or to seek other remedies only if:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the holder has given written notice to the trustee of a continuing event of default with respect to that series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such holders have offered to the trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred by the trustee in compliance with the request; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 90 days after the notice, request and offer.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will periodically file statements with the trustee regarding our compliance with specified covenants in the indenture.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Modification of Indenture; Waiver</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and the trustee may change an indenture without the consent of any holders with respect to specific matters:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to cure any ambiguity, defect or inconsistency in the indenture or in the debt securities of any series; to comply with the provisions described above under the heading&#x201c; Description of Debt Securities- Consolidation, Merger or Sale;&#x201d;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to provide for uncertificated debt securities in addition to or in place of certificated debt securities;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to add to our covenants, restrictions, conditions or provisions such new covenants, restrictions, conditions or provisions for the benefit of the holders of all or any series of debt securities, to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred upon us in the indenture;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to add to, delete from or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication and delivery of debt securities, as set forth in the indenture;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to make any change that does not adversely affect the interests of any holder of debt securities of any series in any material respect;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided above under the heading &#x201c;Description of Debt Securities-General&#x201d; to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to evidence and provide for the acceptance of appointment under any indenture by a successor trustee;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, under the indenture, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extending the fixed maturity of any debt securities of any series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption of any series of any debt securities; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discharge</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The indenture provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified obligations, including obligations to:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide for payment;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">register the transfer or exchange of debt securities of the series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">replace stolen, lost or mutilated debt securities of the series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pay principal of and premium and interest on any debt securities of the series;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain paying agencies;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hold monies for payment in trust;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recover excess money held by the trustee;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compensate and indemnify the trustee; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">appoint any successor trustee.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to exercise our rights to be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal of, any premium, if any, and interest on, the debt securities of the series on the dates payments are due.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form, Exchange and Transfer</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will issue the debt securities of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement, in denominations of $1,000 and any integral multiple thereof. The indenture provides that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company, or DTC, or another depositary named by us and identified in the applicable prospectus supplement with respect to that series. To the extent the debt securities of a series are issued in global form and as book-entry, a description of terms relating to any book-entry securities will be set forth in the applicable prospectus supplement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the option of the holder, subject to the terms of the indenture and the limitations applicable to global securities described in the applicable prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the terms of the indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will name in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we elect to redeem the debt securities of any series, we will not be required to:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information Concerning the Trustee</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the trustee is under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payment and Paying Agents</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate the corporate trust office of the trustee as our sole paying agent for payments with respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All money we pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The indenture and the debt securities will be governed by and construed in accordance with the internal laws of the State of New York, except to the extent that the Trust Indenture Act is applicable.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_description_of_warrants"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DESCRIPTION OF WARRANTS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following description, together with the additional information we may include in any applicable prospectus supplement and in any related free writing prospectuses that we may authorize to be distributed to you, summarizes the material terms and provisions of the warrants that we may offer under this prospectus, which may consist of warrants to purchase common stock, preferred stock or debt securities and maybe issued in one or more series. Warrants may be offered independently or in combination with common stock, preferred stock or debt securities offered by any prospectus supplement. While the terms we have summarized below will apply generally to any warrants that we may offer under this prospectus, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. The following description of warrants will apply to the warrants offered by this prospectus unless we provide otherwise in the applicable prospectus supplement. The applicable prospectus supplement for a particular series of warrants may specify different or additional terms.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have filed forms of the warrant agreements and forms of warrant certificates containing the terms of the warrants that may be offered as exhibits to the registration statement of which this prospectus is a part. We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant and/or the warrant agreement and warrant certificate, as applicable, that contain the terms of the particular series of warrants we or selling securityholders are offering, and any supplemental agreements, before the issuance of such warrants. The following summaries of material terms and provisions of the warrants are subject to, and qualified in their entirety by reference to, all the provisions of the form of warrant and/or the warrant agreement and warrant certificate, as applicable, and any supplemental agreements applicable to a particular series of warrants that we or selling securityholders may offer under this prospectus. We urge you to read the applicable prospectus supplement related to the particular series of warrants that we or selling securityholders may offer under this prospectus, as well as any related free writing prospectuses, and the complete form of warrant and/or the warrant agreement and warrant certificate, as applicable, and any supplemental agreements, that contain the terms of the warrants.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will describe in the applicable prospectus supplement the terms of the series of warrants being offered, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the offering price and aggregate number of warrants offered;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the currency for which the warrants may be purchased;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms of any rights to redeem or call the warrants;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the dates on which the right to exercise the warrants will commence and expire;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the manner in which the warrant agreements and warrants may be modified;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a discussion of any material or special U.S. federal income tax considerations, if any, of holding or exercising the warrants;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms of the securities issuable upon exercise of the warrants; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of Warrants</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. The warrants may be exercised as set forth in the prospectus supplement relating to the warrants offered. Unless we otherwise specify in the applicable prospectus supplement, warrants may be exercised at any time up to the close of business on the expiration date set forth in the prospectus supplement relating to the warrants offered thereby. After the close of business on the expiration date, unexercised warrants will become void.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon receipt of payment and the warrant or warrant certificate, as applicable, properly completed and duly executed at the corporate trust office of the warrant agent, if any, or any other office, including ours, indicated in the prospectus supplement, we will, as soon as practicable, issue and deliver the securities purchasable upon such exercise. If less than all of the warrants (or the warrants represented by such warrant certificate) are exercised, a new warrant or a new warrant certificate, as applicable, will be issued for the remaining warrants.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we otherwise specify in the applicable prospectus supplement, the warrants and any warrant agreements will be governed by and construed in accordance with the internal laws of the State of New York.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforceability of Rights by Holders of Warrants</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each warrant agent, if any, will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_legal_ownership_of_securities"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LEGAL OWNERSHIP OF SECURITIES</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may issue securities in registered form or in the form of one or more global securities. We describe global securities in greater detail below. We refer to those persons who have securities registered in their own names on the books that we or any applicable trustee, depositary or warrant agent maintain for this purpose as the &#x201c;holders&#x201d; of those securities. These persons are the legal holders of the securities. We refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names, as &#x201c;indirect holders&#x201d; of those securities. As we discuss below, indirect holders are not legal holders, and investors in securities issued in book-entry form or in street name will be indirect holders.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Book-Entry Holders</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may issue securities in book-entry form only, as we will specify in the applicable prospectus supplement. This means securities may be represented by one or more global securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions that participate in the depositary&#x2019;s book-entry system. These participating institutions, which are referred to as participants, in turn, hold beneficial interests in the securities on behalf of themselves or their customers.</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Only the person in whose name a security is registered is recognized as the holder of that security. Securities issued in global form will be registered in the name of the depositary or its participants. Consequently, for securities issued in global form, we will recognize only the depositary as the holder of the securities, and we will make all payments on the securities to the depositary. The depositary passes along the payments it receives to its participants, which in turn pass the payments along to their customers who are the beneficial owners. The depositary and its participants do so under agreements they have made with one another or with their customers; they are not obligated to do so under the terms of the securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result, investors in a book-entry security will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary&#x2019;s book-entry system or holds an interest through a participant. As long as the securities are issued in global form, investors will be indirect holders, and not legal holders, of the securities.</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Street Name Holders</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may terminate a global security or issue securities that are not issued in global form. In these cases, investors may choose to hold their securities in their own names or in &#x201c;street name.&#x201d; Securities held by an investor in street name would be registered in the name of a bank, broker or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through an account he or she maintains at that institution.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For securities held in street name, we or any applicable trustee or depositary will recognize only the intermediary banks, brokers and other financial institutions in whose names the securities are registered as the holders of those securities, and we or any applicable trustee or depositary will make all payments on those securities to them. These institutions pass along the payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name will be indirect holders, not holders, of those securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Holders</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our obligations, as well as the obligations of any applicable trustee and of any third parties employed by us or a trustee, run only to the legal holders of the securities. We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means. This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing the securities only in global form.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, once we make a payment or give a notice to the legal holder, we have no further responsibility for the payment or notice even if that legal holder is required, under agreements with depositary participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly, we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our obligation to comply with a particular provision of the indenture or for other purposes. In such an event, we would seek approval only from the legal holders, and not the indirect holders, of the securities. Whether and how the legal holders contact the indirect holders is up to the legal holders.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Considerations for Indirect Holders</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If you hold securities through a bank, broker or other financial institution, either in book-entry form because the securities are represented by one or more global securities or in street name, you should check with your own institution to find out:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">how it handles securities payments and notices;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether it imposes fees or charges;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">how it would handle a request for the holders&#x2019; consent, if ever required;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether and how you can instruct it to send you securities registered in your own name so you can be a holder, if that is permitted in the future;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the securities are in book-entry form, how the depositary&#x2019;s rules and procedures will affect these matters.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Global Securities</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A global security is a security that represents one or any other number of individual securities held by a depositary. Generally, all securities represented by the same global securities will have the same terms.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each security issued in book-entry form will be represented by a global security that we issue to, deposit with and register in the name of a financial institution or its nominee that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise in the applicable prospectus supplement, DTC will be the depositary for all securities issued in book-entry form.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A global security may not be transferred to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special termination situations arise. We describe those situations below under the section captioned &#x201c;Special Situations When a Global Security Will Be Terminated&#x201d; in this prospectus. As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and legal holder of all securities represented by a global security, and investors will be permitted to own only beneficial interests in a global security. Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with the depositary or with another institution that does. Thus, an investor whose security is represented by a global security will not be a legal holder of the security, but only an indirect holder of a beneficial interest in the global security.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the prospectus supplement for a particular security indicates that the security will be issued in global form only, then the security will be represented by a global security at all times unless and until the global security is terminated. If termination occurs, we may issue the securities through another book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Considerations for Global Securities</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rights of an indirect holder relating to a global security will be governed by the account rules of the investor&#x2019;s financial institution and of the depositary, as well as general laws relating to securities transfers. We do not recognize an indirect holder as a holder of securities and instead deal only with the depositary that holds the global security.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are issued only in the form of a global security, an investor should be aware of the following:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> an investor cannot cause the securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we describe below;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an investor will be an indirect holder and must look to his or her own bank or broker for payment son the securities and protection of his or her legal rights relating to the securities, as we describe above;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an investor may not be able to sell interests in the securities to some insurance companies and to other institutions that are required by law to own their securities in non-book-entry form;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the depositary&#x2019;s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor&#x2019;s interest in a global security;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we and any applicable trustee have no responsibility for any aspect of the depositary&#x2019;s actions or for its records of ownership interests in a global security, nor do we or any applicable trustee supervise the depositary in any way;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the depositary may, and we understand that DTC will, require that those who purchase and sell interests in a global security within its book-entry system use immediately available funds, and your broker or bank may require you to do so as well; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">financial institutions that participate in the depositary&#x2019;s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters relating to the securities.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Situations When a Global Security Will Be Terminated</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In a few special situations described below, a global security will terminate and interests in it will be exchanged for physical certificates representing those interests. After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in securities transferred to their own names, so that they will be direct holders. We have described the rights of holders and street name investors above.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless we provide otherwise in the applicable prospectus supplement, the global security will terminate when the following special situations occur:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 90 days;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if we notify any applicable trustee that we wish to terminate that global security; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if an event of default has occurred with regard to securities represented by that global security and has not been cured or waived.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The applicable prospectus supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities covered by the applicable prospectus supplement. When a global security terminates, the depositary, and neither we nor any applicable trustee, is responsible for deciding the names of the institutions that will be the initial direct holders.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="base_selling_stockholders"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SELLING SECURITYHOLDERS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling securityholders are persons or entities that, directly or indirectly, have acquired or will from time to time acquire from us, our securities. If the registration statement of which this prospectus forms a part is used by selling securityholders for the resale of any securities registered thereunder pursuant to a registration rights agreement between us and such selling securityholders or otherwise, information about such selling securityholders, their beneficial ownership of our securities and their relationship with us will be set forth in a prospectus supplement, in a post-effective amendment or in filings we make with the SEC under the Exchange Act that are incorporated by reference.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_plan_of_distribution"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PLAN OF DISTRIBUTION</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell the securities from time to time pursuant to underwritten public offerings, &#x201c;at-the-market&#x201d; offerings, negotiated transactions, block trades or a combination of these methods. We or selling securityholders may sell the securities to or through one or more underwriters or dealers (acting as principal or agent),through agents, or directly to one or more purchasers. We or selling securityholders may distribute securities from time to time in one or more transactions:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at a fixed price or prices, which maybe changed;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at market prices prevailing at the time of sale;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at prices related to such prevailing market prices; or</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at negotiated prices.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the securities, including, to the extent applicable:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the name or names of the underwriters, dealers or agents, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the name or names of the selling securityholders, if any;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the purchase price of the securities or other consideration therefor, and the proceeds, if any, we will receive from the sale;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any over-allotment or other options under which underwriters may purchase additional securities from us or any selling securityholders;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any agency fees or underwriting discounts and other items constituting agents&#x2019; or underwriters&#x2019; compensation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any public offering price;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any discounts or concessions allowed or reallowed or paid to dealers; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any securities exchange or market on which the securities may be listed.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Only underwriters named in the prospectus supplement will be underwriters of the securities offered by the prospectus supplement. Dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them on resale of the securities may be deemed to be underwriting discounts. If such dealers or agents were deemed to be underwriters, they may be subject to statutory liabilities under the Securities Act.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If underwriters are used in the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more transactions at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We or selling securityholders may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the prospectus supplement, other than securities covered by any over-allotment or other option. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may change from time to time.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may use underwriters, dealers or agents with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter, dealer or agent, the nature of any such relationship.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or selling securityholders may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts basis for the period of its appointment.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus supplement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may provide agents, underwriters and dealers with indemnification against civil liabilities, including liabilities under the Securities Act, or contribution with respect to payments that the agents, underwriters or dealers may make with respect to these liabilities. Agents, underwriters and dealers, or their affiliates, may engage in transactions with, or perform services for, us in the ordinary course of business.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All securities we may offer, other than common stock, will be new issues of securities with no established trading market. Any underwriters may make a market in these securities, but will not be obligated to do so and may discontinue any market making at any time without notice. We cannot guarantee the liquidity of the trading markets for any securities.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any underwriters that are qualified market makers on The Nasdaq Global Select Market may engage in passive market making transactions in the common stock on The Nasdaq Global Select Market in accordance with Regulation M under the Exchange Act, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker&#x2019;s bid, however, the passive market maker&#x2019;s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In compliance with guidelines of the Financial Industry Regulatory Authority, or FINRA, the maximum consideration or discount to be received by any FINRA member or independent broker dealer may not exceed 8% of the aggregate amount of the securities offered pursuant to this prospectus and the applicable prospectus supplement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_legal_matters"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LEGAL MATTERS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered by this prospectus, and any supplement thereto, will be passed upon for us by Cooley LLP, San Francisco, California.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_experts"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXPERTS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The financial statements of Geron Corporation appearing in Geron Corporation&#x2019;s Annual Report (Form10-K) for the year ended December 31, 2021 have been audited by Ernst&amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_where_you_can_find_more_information"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This prospectus is part of the registration statement on Form S-3 we filed with the SEC under the Securities Act and does not contain all the information set forth or incorporated by reference in the registration statement. Whenever a reference is made in this prospectus to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus for a copy of such contract, agreement or other document. Because we are subject to the information and reporting requirements of the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#x2019;s website at http://www.sec.gov. The information found on, or otherwise accessible through our website is not incorporated by reference into, and does not form a part of, this prospectus or any accompanying prospectus supplement or any other document or report we file or furnish with the SEC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="base_incorporation_of_info_by_reference"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font><font style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The SEC allows us to &#x201c;incorporate by reference&#x201d; information from other documents that we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus, while information that we file later with the SEC will automatically update and supersede the information in this prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents listed below that we have filed with the SEC (Commission File No. 000-20859):</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 10, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;2021 Form 10-K&#x201d;);</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30, 2022 filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022008472/gern-20220331.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 9, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022016839/gern-20220630.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 11, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022022712/gern-20220930.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our Current Reports on Form 8-K (other than any items, exhibits or portions thereof furnished to, rather than filed with the SEC) filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422000483/gern4025271-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 18, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000156459022012684/gern-8k_20220329.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 30, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001399/geron4061651-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 13, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001546/geron4073661-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 15, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000120677422001630/geron4078581-8k.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022018084/gern-20220902.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 6, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022018252/gern-20220907.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 8, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886744/000095017022026975/gern-20221221.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 22, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the information specifically incorporated by reference into the 2021 Form 10-K from our definitive proxy statement relating to our 2022 annual meeting of stockholders, filed with the SEC on </font><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022011396/gern-def14a_20220510.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 22, 2022</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the description of our securities registered pursuant to Section 12 of the Exchange Act contained in </font><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022009627/gern-ex41_123.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 4.1</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the 2021 Form 10-K, including any amendment or report filed with the SEC for the purpose of updating such description.</font></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces such information.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also incorporate by reference any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until we file a post-effective amendment that indicates the termination of the offering of the securities made by this prospectus and will become a part of this prospectus from the date that such documents are filed with the SEC. Information in such future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will furnish without charge to you, on written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents. You should direct any requests for documents to Stephen Rosenfield, Chief Legal Officer and Corporate Secretary, Geron Corporation, 919 E. Hillsdale Blvd., Foster City, CA 94404, telephone: (650) 473-7700.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img175210594_6.jpg" alt="img175210594_6.jpg" style="width:192px;height:70px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,876,297 Shares of Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:4.935%;text-align:center;"><font style="white-space:pre-wrap;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:4.935%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Funded Warrants to Purchase 25,000,000 Shares of Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:4.935%;text-align:center;"><font style="white-space:pre-wrap;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="margin-left:37.04%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:37.037%;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Supplement</font></p>
  <p style="margin-left:37.04%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:37.037%;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Book-Running Managers</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:68.002%;"></td>
    <td style="width:31.998%;"></td>
   </tr>
   <tr style="height:18.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:18.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Goldman Sachs &amp; Co. LLC</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:18.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stifel</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Co-Lead Managers</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.344%;"></td>
    <td style="width:33.323%;"></td>
   </tr>
   <tr style="height:13.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Wedbush PacGrow</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Baird</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Co-Managers</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.344%;"></td>
    <td style="width:33.323%;"></td>
   </tr>
   <tr style="height:13.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B. Riley Securities</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">           </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:13.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Needham &amp; Company</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:13.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">            </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:4.935%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                    January 5, 2023</font></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:3pt solid rgba(166,166,166,1);text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>gern-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<html>
 <head>
  <title>EX-FILING FEES</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 107</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calculation of Filing Fee Tables</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">424(b)(5)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Form Type)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Geron Corporation</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact Name of Registrant as Specified in its Charter)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table 1: Newly Registered and Carry Forward Securities</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:11.353%;"></td>
    <td style="width:10.862%;"></td>
    <td style="width:11.121%;"></td>
    <td style="width:11.121%;"></td>
    <td style="width:11.677%;"></td>
    <td style="width:10.602%;"></td>
    <td style="width:11.362%;"></td>
    <td style="width:10.936%;"></td>
    <td style="width:10.964%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security</font></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Type</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security</font></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Class Title</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fee Calculation or Carry Forward Rule</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</font></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registered</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proposed Maximum Offering Price Per Share</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maximum Aggregate Offering Price</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fee Rate</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount of Registration Fee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;text-indent:4.05pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;"><p style="margin-left:4.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fees to be Paid</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, par value $0.001 per share</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 457(r)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,007,741</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(2)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.45</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$227,843,965</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$110.20 per $1,000,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$25,109</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;text-indent:4.05pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;"><p style="margin-left:4.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fees to be Paid</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants to purchase common stock</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 457(r)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.45</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$110.20 per $1,000,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total Offering Amounts</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$227,843,965</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$25,109</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total Fees Previously Paid</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total Fee Offsets</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Fee Due</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$25,109</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Payment of the registration fee at the time of filing of the registrant&#x2019;s Registration Statement on Form S-3 (File No. 333-269111) on January 4, 2023 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith.</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Includes 12,131,444 shares of common stock that the underwriters have an option to purchase and 25,000,000 shares of common stock that are issuable upon the exercise of the pre-funded warrants referenced below.</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Represents the sum of the pre-funded warrants sales price of $2.499 per pre-funded warrant and the exercise price of $0.001 per share issuable pursuant to the pre-funded warrants. Pursuant to Securities and Exchange Commission staff interpretation, the entire fee is allocated to the common stock underlying the pre-funded warrants.</font></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img175210594_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !N 2P# 2(  A$! Q$!_\0
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MJRY"M=XQ[#M7NU>&^-8)='\=277(#R"=<>F?_K5. ^*2ZV'B=DSW%0%4 #
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M_)4_^WL_RKVRN[';Q]#GP^S]0HHHKA.@*H:S</;:3<2Q_>"\5?JM?VHO+&:
M_P :D?C3C:ZN)['!>&90=7$<A^29#&V?<5@WD#Z3K;QX(,4F1] <BK>V6POP
M&&V2)Q^8K5\7VRWMI;:U .)%"R8['M7L4I<M6SVD?.9UAW4PZJQW@[_(Z76,
M7WAR.Y49.%?_ !KBSP:Z3PQ="]\)SV[-EH@R\^G:N<;[QK\^XDH>RQ2?E^1]
MSD&)^L813+>HVPU7P1J$#Y+VO[Z.H/A'(1%J$>#C<#GMTK2T\JFB:M)("8Q
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img175210594_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =&#ET# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKA/C)\9/#WP/\&S>(/$$S;,
M^7;6<.#-=2XR$0'\R3P!R:^'->_X*7>/+C5)7T;PWX?L=/S^[AO4GN)<9_B=
M9$!X]%'>O=R_),;F474H0]U=6[(\7'9Q@\ODH5Y>]V6K/T>HKYC_ &:?VVM'
M^-FJQ^&]=L(_#OBB12;=4E+6UX1DE8R>5?'.TYS@X/:OIRO/QF"KX"JZ.(CR
MR_K8[L+BZ.-IJK0E=!1117$=@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!YK_ ,-'?#O_ *&'_P DKG_X
MW39/VD/AXJ,PU\N0,A5LKC)]AF.O3*YKXF_\DW\6?]@F[_\ 1+U:Y6]B=3E_
M^&@_"_\ SSU#_ORO_P 51_PT'X7_ .>>H?\ ?E?_ (JO+/"GP9UOQAX=L=9L
M[JPBM;R/S(TGD<.!DCD!".WK6K_PSIXD_P"?W2O^_LO_ ,;K\+_UAXX_Z%\?
M_ 9?_+#]'_LOAW_H*?WK_P"1.^_X:#\+_P#//4/^_*__ !5'_#0?A?\ YYZA
M_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_^-T?\,Z>)/\ G]TK_O[+_P#&Z/\ 6'CC
M_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\ D3OO^&@_"_\ SSU#_ORO_P 51_PT'X7_
M .>>H?\ ?E?_ (JN!_X9T\2?\_NE?]_9?_C='_#.GB3_ )_=*_[^R_\ QNC_
M %AXX_Z%\?\ P&7_ ,L#^R^'?^@I_>O_ )$[[_AH/PO_ ,\]0_[\K_\ %4?\
M-!^%_P#GGJ'_ 'Y7_P"*K@?^&=/$G_/[I7_?V7_XW1_PSIXD_P"?W2O^_LO_
M ,;H_P!8>./^A?'_ ,!E_P#+ _LOAW_H*?WK_P"1.^_X:#\+_P#//4/^_*__
M !5'_#0?A?\ YYZA_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_^-T?\,Z>)/\ G]TK
M_O[+_P#&Z/\ 6'CC_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\ D3OO^&@_"_\ SSU#
M_ORO_P 51_PT'X7_ .>>H?\ ?E?_ (JN!_X9T\2?\_NE?]_9?_C='_#.GB3_
M )_=*_[^R_\ QNC_ %AXX_Z%\?\ P&7_ ,L#^R^'?^@I_>O_ )$[[_AH/PO_
M ,\]0_[\K_\ %4?\-!^%_P#GGJ'_ 'Y7_P"*K@?^&=/$G_/[I7_?V7_XW1_P
MSIXD_P"?W2O^_LO_ ,;H_P!8>./^A?'_ ,!E_P#+ _LOAW_H*?WK_P"1.^_X
M:#\+_P#//4/^_*__ !5'_#0?A?\ YYZA_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_
M^-T?\,Z>)/\ G]TK_O[+_P#&Z/\ 6'CC_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\
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M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#@/B-_R-/@S_K]_P#9XJ[^N ^(
MW_(T^#/^OW_V>*N_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KFOB;_R3?Q9_P!@F[_]$O72US7Q-_Y)OXL_[!-W_P"B7IQW0GL9
M7P-_Y)+X9_Z]?_9FKNJX7X&_\DE\,_\ 7K_[,U=U0]P6P4444AA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?$3?>/UK[=KXB;[Q^M?S]XL?\
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M^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\ GW'\?\S]-/\
MAL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^(K\RZ*/]2\%_S\G^'^0?ZW8S
M_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&Q/"/_0]VW_?IO_B*_,NBC_4O
M!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0]VW_ 'Z;_P"(H_X;$\(_]#W;
M?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_,_33_AL3PC_P!#W;?]^F_^
M(H_X;$\(_P#0]VW_ 'Z;_P"(K\RZ*/\ 4O!?\_)_A_D'^MV,_P"?<?Q_S/TT
M_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_ $/=M_WZ;_XBOS+HH_U+P7_/R?X?Y!_K
M=C/^?<?Q_P S]-/^&Q/"/_0]VW_?IO\ XBC_ (;$\(_]#W;?]^F_^(K\RZ*/
M]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_ -#W;?\ ?IO_ (BC_AL3PC_T
M/=M_WZ;_ .(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/_ $/=M_WZ
M;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2\%_S\G^'^0?ZW8S_ )]Q_'_,
M_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW_?IO_B*_,NBC_4O!?\_)_A_D
M'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B*/\ AL3PC_T/=M_WZ;_XBOS+
MHH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^F_\ B*/^&Q/"
M/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_\ 0]VW
M_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\ GW'\
M?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^(K\RZ*/]2\%_S\G^
M'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&Q/"/_0]VW_?IO_B*
M_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0]VW_ 'Z;_P"(H_X;
M$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_,_33_AL3PC_P!#
MW;?]^F_^(H_X;$\(_P#0]VW_ 'Z;_P"(K\RZ*/\ 4O!?\_)_A_D'^MV,_P"?
M<?Q_S/TT_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_ $/=M_WZ;_XBOS+HH_U+P7_/
MR?X?Y!_K=C/^?<?Q_P S]-/^&Q/"/_0]VW_?IO\ XBC_ (;$\(_]#W;?]^F_
M^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_ -#W;?\ ?IO_ (BC
M_AL3PC_T/=M_WZ;_ .(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/_
M $/=M_WZ;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2\%_S\G^'^0?ZW8S_
M )]Q_'_,_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW_?IO_B*_,NBC_4O!
M?\_)_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B*/\ AL3PC_T/=M_W
MZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^F_\
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M#W;?]^F_^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_ -#W;?\
M?IO_ (BC_AL3PC_T/=M_WZ;_ .(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\S]-
M/^&Q/"/_ $/=M_WZ;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2\%_S\G^'
M^0?ZW8S_ )]Q_'_,_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW_?IO_B*_
M,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B*/\ AL3P
MC_T/=M_WZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M
M_P!^F_\ B*/^&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S
M/TT_X;$\(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R
M?X?Y!_K=C/\ GW'\?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^
M(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&
MQ/"/_0]VW_?IO_B*_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0
M]VW_ 'Z;_P"(H_X;$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_
M'_,_33_AL3PC_P!#W;?]^F_^(KN+/XK7>H> 6\;6^L^;X56.28ZF$'E[$<HY
MQMSPRD=.U?DG7Z)>!O\ E&C<_P#8*U'_ -+IJ\/-N&<-@(494YR?/.,7>VSO
MY;Z'LY9Q#B,=*K&<(KE@Y:7W5O/S.B_X;$\(_P#0]VW_ 'Z;_P"(H_X;$\(_
M]#W;?]^F_P#B*_,NBO<_U+P7_/R?X?Y'C?ZW8S_GW'\?\S]-/^&Q/"/_ $/=
MM_WZ;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2\%_S\G^'^0?ZW8S_ )]Q
M_'_,_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW_?IO_B*_,NBC_4O!?\_)
M_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B*/\ AL3PC_T/=M_WZ;_X
MBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^F_\ B*/^
M&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_\
M0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\
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MTW_Q%?F711_J7@O^?D_P_P @_P!;L9_S[C^/^9^FG_#8GA'_ *'NV_[]-_\
M$4?\-B>$?^A[MO\ OTW_ ,17YET4?ZEX+_GY/\/\@_UNQG_/N/X_YGZ:?\-B
M>$?^A[MO^_3?_$4?\-B>$?\ H>[;_OTW_P 17YET4?ZEX+_GY/\ #_(/];L9
M_P ^X_C_ )GZ:?\ #8GA'_H>[;_OTW_Q%'_#8GA'_H>[;_OTW_Q%?F711_J7
M@O\ GY/\/\@_UNQG_/N/X_YGZ:?\-B>$?^A[MO\ OTW_ ,11_P -B>$?^A[M
MO^_3?_$5^9=%'^I>"_Y^3_#_ "#_ %NQG_/N/X_YGZ:?\-B>$?\ H>[;_OTW
M_P 11_PV)X1_Z'NV_P"_3?\ Q%?F711_J7@O^?D_P_R#_6[&?\^X_C_F?II_
MPV)X1_Z'NV_[]-_\11_PV)X1_P"A[MO^_3?_ !%?F711_J7@O^?D_P /\@_U
MNQG_ #[C^/\ F?II_P -B>$?^A[MO^_3?_$4?\-B>$?^A[MO^_3?_$5^9=%'
M^I>"_P"?D_P_R#_6[&?\^X_C_F?II_PV)X1_Z'NV_P"_3?\ Q%'_  V)X1_Z
M'NV_[]-_\17YET4?ZEX+_GY/\/\ (/\ 6[&?\^X_C_F?II_PV)X1_P"A[MO^
M_3?_ !%'_#8GA'_H>[;_ +]-_P#$5^9=%'^I>"_Y^3_#_(/];L9_S[C^/^9^
MFG_#8GA'_H>[;_OTW_Q%'_#8GA'_ *'NV_[]-_\ $5^9=%'^I>"_Y^3_  _R
M#_6[&?\ /N/X_P"9^KWP_P#C@GQ4O+NT\*>(5UJXM8Q+-'!& 44G )W*.]86
MN?M4^'_#>LWVDZGXS@M-1L9WMKBW>(EHY$8JRG"8R""*\._X)C_\C[XT_P"P
M9%_Z-KYQ_:(_Y+U\1/\ L8+[_P!'O7AT>&<-4S*M@G.7+!)IZ7U^1[-;B'$4
M\OI8M0CS2;76VGS/O+_AL3PC_P!#W;?]^F_^(H_X;$\(_P#0]VW_ 'Z;_P"(
MK\RZ*]S_ %+P7_/R?X?Y'C?ZW8S_ )]Q_'_,_33_ (;$\(_]#W;?]^F_^(H_
MX;$\(_\ 0]VW_?IO_B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_
M]#W;?]^F_P#B*/\ AL3PC_T/=M_WZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW
M'\?\S]-/^&Q/"/\ T/=M_P!^F_\ B*/^&Q/"/_0]VW_?IO\ XBOS+HH_U+P7
M_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^
MF_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\ GW'\?\S]-/\ AL3PC_T/=M_WZ;_X
MBC_AL3PC_P!#W;?]^F_^(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\ ,_33_AL3
MPC_T/=M_WZ;_ .(H_P"&Q/"/_0]VW_?IO_B*_,NBC_4O!?\ /R?X?Y!_K=C/
M^?<?Q_S/TT_X;$\(_P#0]VW_ 'Z;_P"(H_X;$\(_]#W;?]^F_P#B*_,NBC_4
MO!?\_)_A_D'^MV,_Y]Q_'_,_33_AL3PC_P!#W;?]^F_^(H_X;$\(_P#0]VW_
M 'Z;_P"(K\RZ*/\ 4O!?\_)_A_D'^MV,_P"?<?Q_S/TT_P"&Q/"/_0]VW_?I
MO_B*/^&Q/"/_ $/=M_WZ;_XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_P S]-/^
M&Q/"/_0]VW_?IO\ XBC_ (;$\(_]#W;?]^F_^(K\RZ*/]2\%_P _)_A_D'^M
MV,_Y]Q_'_,_33_AL3PC_ -#W;?\ ?IO_ (BC_AL3PC_T/=M_WZ;_ .(K\RZ*
M/]2\%_S\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/_ $/=M_WZ;_XBC_AL3PC_ -#W
M;?\ ?IO_ (BOS+HH_P!2\%_S\G^'^0?ZW8S_ )]Q_'_,_33_ (;$\(_]#W;?
M]^F_^(H_X;$\(_\ 0]VW_?IO_B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_ #/T
MT_X;$\(_]#W;?]^F_P#B*/\ AL3PC_T/=M_WZ;_XBOS+HH_U+P7_ #\G^'^0
M?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^F_\ B*/^&Q/"/_0]VW_?IO\ XBOS
M+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_\ 0]VW_?IO_B*]I^'7B:]U
M[4G,UXUS;M;>:F0,<LN#T]#7XQ5^P/P0^[:_]@U/_9*^0XAR2ADZI.C)OFOO
M;I;LEW/JLBSBMFDJBJQ2Y;;7ZW[OR/7:***^-/K0HHHH **** . ^(W_ "-/
M@S_K]_\ 9XJ[^N ^(W_(T^#/^OW_ -GBKOZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YKXF_P#)-_%G_8)N_P#T2]=+7-?$W_DF
M_BS_ +!-W_Z)>G'=">QE? W_ ))+X9_Z]?\ V9J[JN%^!O\ R27PS_UZ_P#L
MS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\1
M-]X_6OMVOB)OO'ZU_/WBQ_S _P#<3_VP_3N"?^8C_MW_ -N/4?V=?^1WO/\
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MC(Z]9^*_PB\,_&CPNV@^*+)KJT$@FAEB<I+!( 0'1AT."1SD'/(->3?LZ_\
M([WG_8/D_P#1D=?1E?:>&=2='(X5*;M)3E9H^>XPIPJYA*%173BM&?);?\$T
M_AD6)&N^+ /3[7;?_(])_P .T_AG_P!![Q9_X%VO_P CU]:T5^V?V]F?_/\
M9^;_ -B9=_SY1\E?\.T_AG_T'O%G_@7:_P#R/1_P[3^&?_0>\6?^!=K_ /(]
M?6M%']O9G_S_ &']B9=_SY1\E?\ #M/X9_\ 0>\6?^!=K_\ (]'_  [3^&?_
M $'O%G_@7:__ "/7UK11_;V9_P#/]A_8F7?\^4?)7_#M/X9_]![Q9_X%VO\
M\CU\C_M=_ W0O@#\1M,\/^'[O4+VSNM)COWDU*2-Y!(TTR$ HB#;B->V<D\U
M^MM?FM_P4L_Y+CH'_8N0_P#I3<U]3PWFN-Q>8*E7JN4;/1GS?$&6X/"X%U*-
M-1E=:D?_  35_P"2[:U_V+EQ_P"E-M7Z6U^:7_!-7_DNVM?]BY<?^E-M7Z6U
MY7%O_(S?^%'I<+_\BY>K"BBBOC#ZT**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *_/C]NC_D0='_["X_\ 14M?H/7Y
M\?MT?\B#H_\ V%Q_Z*EKZ#A__D:4/7]&>%GG_(MK>GZH^*****_H,_# HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^ Z_5#_@H!_R;9J__7[:?^C17Y?:'H.H^)M7M=*TFRGU'4KIQ'!:VR%Y)&]
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MU]CLA9<_0FO,?C%^RQ\0?@A:_;]?TR*YT?<J?VKILOG6ZL>@;(#)SQEE ).
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M1:O_ )7/K"BBBO(/="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?GQ^W1_R(.C_P#87'_HJ6OT
M'K\^/VZ/^1!T?_L+C_T5+7T'#_\ R-*'K^C/"SS_ )%M;T_5'Q11117]!GX8
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?2\5T:<L-A\6U^\E9-^5K[;;GSO#=:I'&5\(G^[7,TO.Z7KL?,'Q8_X*%?\
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M7_U]1?\ H8K.K1\._P#(P:7_ -?47_H8J)_"RX?$C[P_X*>_\BWX!_Z^[O\
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M*5.SY=MMK>2>_7[S',W2R7*_885-JI=<V^ZUOZK:W:_KQ5%%%?KQ^5!1110
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MJ2K8# U)[M-OYQ@>+D%.-',<;3@K)2LO12D?CE=?\G$3?]C4W_I77[%:[_R
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MXF^$J^,8X%76/#\T8,ZCYI+:1PC(?4!F5AGIAL=37;_\-S?!'_H=O_*3??\
MQBO,_P!I3]KGX4>.O@?XKT#0/$HU75[^W2*WM3IUU'N;S$).Z2(*, %N3VK@
MIT\1]?P]?"8*=%1:3^)IJ^M[I6TNF=ZJ4/JE:ABL9&KS)V^%6T]7ULUYH^+_
M -G7Q]X=^&/Q<T/Q)XHTN;5=-L7+A+<C=#(1A)MIX?83G;D<X.>,'Z)^*?\
MP4-U<_%;3;GP5&LG@O2Y"LMO<QE&U4'AV;/S1@#[G<'E@<[1\645^H8G*L)C
M*ZQ&(CS-)JSVU\N_G^MC\UP^98G"494*$N52:=^NGGV_KJ[_ $]^VG^T!X$^
M.EQX:E\+Z==OJ5E"3<:I<+Y7[MP#]GV8RQ5L_-G .[;N#9KYAHHKHP.#I9?0
MCAZ-^5=W??4QQF,JXZLZ]:W,[;*VRL%%%%=YPA7[ _!#[MK_ -@U/_9*_'ZO
MV!^"'W;7_L&I_P"R5^8<;_#A_67_ +:?HO!_QU_^W?U/7:***_*S]+"BBB@
MHHHH X#XC?\ (T^#/^OW_P!GBKOZX#XC?\C3X,_Z_?\ V>*N_H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /)_VL/\ DV?XG?\ 8OWG_HHU^6G_  3\\-Z3XL_:@\.Z
M;K>EV6LZ=):WC/::A;I/"Q%NY!*."#@@$<5^PWCKP;IWQ#\':SX9U82G3-6M
M9+.Y$+['\MQAMK8X.#UKQKX0_L-_#+X(^.K/Q;X:BU9=7M$DCC-U>^;'B1"C
M97:.S&O3P>)AAX58RWDK+[G_ )GCYA@ZF*G1E"UHR3?I>+_1GHO_  H'X8?]
M$X\)?^".U_\ C='_  H'X8?]$X\)?^".U_\ C==[17![2?=GJ>SA_*C@O^%
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MP(/Q&\6$?]ARZ_\ CE<,)7642!V$F=V_/.>N<^M5P_DE3)Y5)5)J7-;;RO\
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M+B_TN4J9+6.WAMTDP01N$2+N (!P>XKEOA_\3O%7PMU<ZGX4URZT6[8;7,#
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MR%?_ )']'_KV_P V?4T?^1'6_P :_)'R11117UY\L%%%% '[:_"O_DE_@_\
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ME0<=.!7!C\.\9A:F'B[.2:^\[<%76%Q-.NU=1:?W'Z8?\%#/^3=;G_L)VO\
M-J_+FNI\1?%3QKXNTTZ?KOC#7M:L"P<VNHZG/<1%AT.UV(R/7%<M7F9'ED\I
MPSH3DI-R;T]$OT/3SK,H9IB(UH1<;1MKZM_J?L/^RG_R;IX _P"P8G\S7YT?
MML?\G0>./^NEK_Z20UP&D_&;X@:#IMOI^F>.?$FG6%NNR&UM-7N(HHE]%57
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MR(^/1E?KZJWI7Y95T'@?X@>(_AMKB:QX8UBZT;45&WSK9\!UZ[74_*ZYQ\K
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M44 %%%% 'K?[)O\ R<=X!_["*_\ H+5ZY_P4N_Y+;X?_ .Q>A_\ 2FYKR/\
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M8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNJX7X&_\DE\,_P#7K_[,U=U0]P6P4444AA1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
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M %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_.;_XBC_AA[Q9_P!!W1?SF_\
MB*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC_6S-/YU_X"@_U8RW^5_>S\Q?
M^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\
M"*Z/_P! ZW_[XH_ULS3^=?\ @*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(
MH_X8>\6?]!W1?SF_^(K].O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/Y
MU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^
M$5T?_H'6_P#WQ1_PBNC_ /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[
MQ9_T'=%_.;_XBC_AA[Q9_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\
MT#K?_OBC_6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]
M!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\ @*#_
M %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\ A%='
M_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'
M=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_ /0.M_\
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M\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\
M@*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\
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M.O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\
MAA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_
M /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_.;_XBC_AA[Q9
M_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC_6S-/YU_X"@_
MU8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\
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MLS3^=?\ @*./_5C+?Y7][/S%_P"&'O%G_0=T7\YO_B*/^&'O%G_0=T7\YO\
MXBOTZ_X171_^@=;_ /?%'_"*Z/\ ] ZW_P"^*/\ 6S-/YU_X"@_U8RW^5_>S
M\Q?^&'O%G_0=T7\YO_B*/^&'O%G_ $'=%_.;_P"(K].O^$5T?_H'6_\ WQ1_
MPBNC_P#0.M_^^*/];,T_G7_@*#_5C+?Y7][/S%_X8>\6?]!W1?SF_P#B*/\
MAA[Q9_T'=%_.;_XBOTZ_X171_P#H'6__ 'Q1_P (KH__ $#K?_OBC_6S-/YU
M_P" H/\ 5C+?Y7][/S%_X8>\6?\ 0=T7\YO_ (BC_AA[Q9_T'=%_.;_XBOTZ
M_P"$5T?_ *!UO_WQ1_PBNC_] ZW_ .^*/];,T_G7_@*#_5C+?Y7][/S%_P"&
M'O%G_0=T7\YO_B*/^&'O%G_0=T7\YO\ XBOTZ_X171_^@=;_ /?%'_"*Z/\
M] ZW_P"^*/\ 6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO_B*/^&'O%G_
M $'=%_.;_P"(K].O^$5T?_H'6_\ WQ1_PBNC_P#0.M_^^*/];,T_G7_@*#_5
MC+?Y7][/S%_X8>\6?]!W1?SF_P#B*/\ AA[Q9_T'=%_.;_XBOTZ_X171_P#H
M'6__ 'Q1_P (KH__ $#K?_OBC_6S-/YU_P" H/\ 5C+?Y7][/S%_X8>\6?\
M0=T7\YO_ (BC_AA[Q9_T'=%_.;_XBOTZ_P"$5T?_ *!UO_WQ1_PBNC_] ZW_
M .^*/];,T_G7_@*#_5C+?Y7][/S%_P"&'O%G_0=T7\YO_B*/^&'O%G_0=T7\
MYO\ XBOTZ_X171_^@=;_ /?%'_"*Z/\ ] ZW_P"^*/\ 6S-/YU_X"@_U8RW^
M5_>S\Q?^&'O%G_0=T7\YO_B*/^&'O%G_ $'=%_.;_P"(K].O^$5T?_H'6_\
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M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
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M_P#T#K?_ +XH_P"$5T?_ *!UO_WQ7=_K9FG\Z_\  4<?^K&6_P K^]GYB_\
M##WBS_H.Z+^<W_Q%'_##WBS_ *#NB_G-_P#$5^G7_"*Z/_T#K?\ [XH_X171
M_P#H'6__ 'Q1_K9FG\Z_\!0?ZL9;_*_O9^8O_##WBS_H.Z+^<W_Q%'_##WBS
M_H.Z+^<W_P 17Z=?\(KH_P#T#K?_ +XH_P"$5T?_ *!UO_WQ1_K9FG\Z_P#
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M8MM:]S\T_P#AA[Q9_P!!W1?SF_\ B*/^&'O%G_0=T7\YO_B*_3K_ (171_\
MH'6__?%'_"*Z/_T#K?\ [XKN_P!;,T_G7_@*./\ U8RW^5_>S\Q?^&'O%G_0
M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
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M5_V>?A[\<+C3I_&_AR/79=.5TM6>YGB\M7*EA^[=<YVKUSTK@O\ A@/X!_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7F_P -O^1@OO\ KBW_ *&*](KS
M?X;?\C!??]<6_P#0Q2 ](HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7F]]_P E07_KK'_Z+6O2*\WOO^2H
M+_UUC_\ 1:T@/2****8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 8_B[_D6M0_ZY?U%8_PP_Y =Q_U\M_Z"M;'B[_D6M0_ZY?U%8_PP_Y
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<U\3?^2;^+/\
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M]FWL5QL^NQCBHEAZT%S2@TO1E1KTIOEC--^J-VBBBL#<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P""17_(P?$O_KUL?_0YJ_2FKQ>'^JU/9WOL1@\3];I>UM8****XSN"BBB@
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MO[C[1JKJFIVNBZ;=ZA?3I:V5I"\\\\APL<:J69C[  FOB/\ X)<_$3Q7\0-
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M5\.&(1:@;9;S43C#-=2@/(#Z[<A![(*]<IXF-.-:4:7PIBPDJDZ$)UOB:O\
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ML9) [VLZ'YHV( SP58' R&!P.E9/[6'PEA^-'P%\5>'S"LNH);->Z>QZK<Q
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M\$_U/,QF.C@Y1@XW<E?\;'[H45^+?_&6_P#U6G_RKU^H'[('_"5_\,[>$?\
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M44 %%%% !1110 4444 8_B[_ )%K4/\ KE_45C_##_D!W'_7RW_H*UL>+O\
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MQ]!6Q4J6,I8=K2:;^>O_ ,BS[IHHHKA/2"BBB@ HHHH **** "BBB@ HHHH
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M>]EY/_+796/FG]@G]MW4OC!J!\ >/)HYO%$<+2Z=JJJ$-^B#+QR*,#S5&6#
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MMJ.T,UI;J0I* \;V8X![!2>N"/K?2].L]'TVTL=/MX;2PMHEAM[>W4+''&H
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M:T@/2****8!1110 4444 <!\1O\ D:?!G_7[_P"SQ5W]<!\1O^1I\&?]?O\
M[/%7?T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHGA/_P '=M_\71_POGX9_P#11/"?_@[MO_BZ_%NBC_4K#_\ /Y_<@_UOK_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI_D[+\3X:_X)/_\ )>/$W_8NR?\ I1!7TU_P5%_Y-F3_ +#=K_Z#)6C^R?\
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M:UO;O*=0CB)QN\TMY;,!SM\M0>F1UK]"O&7A_3_BM\,]7T?S5DTWQ!I<D"3
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MJ-*5*,W:5^CZJW8^2KT<PQ%:%:5-7C:VJZ._<^W/A+\<O!'QTTJ^U+P/K?\
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M1PQ NY8]@0-OU8#O7N?A_P#X)+_$*YU!$USQCX9TZQ_BFT_[1=RCZ(\<0/\
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MS9 _V#Z5W/A#_@DKXSNM04>*?&VA:;8@@EM'CFNY&'<8D2(#ZY/T-?>_P+^
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MR#]X@]V\PU[3^R+\!=<^%'[/NH> /&<-N+F>\O4D-I,)8I8)5"AE. <$9X8
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M7S!]>%%%% !1110 5YO\._\ D9[_ /ZXO_Z&M>D5YO\ #O\ Y&>__P"N+_\
MH:T@/2****8!1110 4444 <!\1O^1I\&?]?O_L\5=_7 ?$;_ )&GP9_U^_\
ML\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"&XO@E_P!#L/\ P5WO_P 9H_X;B^"7_0[#_P %=[_\9KR/[*S#_H'G_P"
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M]_UQ;_T,5Z17F_PV_P"1@OO^N+?^ABD!Z11113 **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!C^+O\ D6M0_P"N7]16/\,/^0'<?]?+?^@K6QXN
M_P"1:U#_ *Y?U%8_PP_Y =Q_U\M_Z"M '84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\
M'O+_ +A_E4M17/\ Q[R_[A_E0!P'PL_X^=0_W$_F:]$KSOX6?\?.H?[B?S->
MB4D 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XCXI?\@^Q_ZZM_*NE\-_\B_IO_7O'_Z"*YKXI?\ (/L?^NK?RKI?
M#?\ R+^F_P#7O'_Z"*74#2HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;_#O_D9[_\
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M-_%G_8)N_P#T2]=+7-?$W_DF_BS_ +!-W_Z)>G'=">QE? W_ ))+X9_Z]?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7FOPY=4UZ^+,%'E-U./
MXQ7I5>->'_#C^(+^>V2=83&I?<RYSR!_6D![#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"O.;Z1?^%FJVX;?-CYSQ_JUJ7_ (59
M/_S_ ,?_ '[/^-<_-X;>'Q(-(,ZERRKYNWCE0>GXT >P_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
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M2^([*2X2Z6 )(8]K*3V!S^M 'JWVB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\
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MB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^_9_QH_X59/\ \_\ '_W[/^-
M'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\ G_C_ ._9_P :/^%63_\ /_'_
M -^S_C0!Z#]HB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^_9_QH_X59/\
M\_\ '_W[/^- 'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\ G_C_ ._9_P :
M/^%63_\ /_'_ -^S_C0!Z#]HB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^
M_9_QH_X59/\ \_\ '_W[/^- 'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\
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MH^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\
MGHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- '
MH/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_
M (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_
M ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5
MD_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G
M_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G
M_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"
MK)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^
MA7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T 7/BA(DEA9;65OWIZ'/:N
MD\.S1KH&G R*#]GC[C^Z*XYOA;<X^6^B)]T(I1\+;C S?Q@_]<S_ (T >@_:
M(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/
M^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_
M]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59
M/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&
MC_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_
M +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)
M_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7
MGW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$
M_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*
M/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GH
MG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:
M(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/
M^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_
M]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59
M/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&
MC_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_
M +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)
M_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*\[^'?_(SWW_7
M%_\ T-:?_P *LG_Y_P"/_OV?\:@^&L?E^(KM<YVV[+_X^M 'IE%%%, HHHH
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M/\."04445@=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5S7Q-_Y)OXL_[!-W_P"B7KI:YKXF_P#)-_%G_8)N_P#T
M2]..Z$]C*^!O_))?#/\ UZ_^S-7=5POP-_Y)+X9_Z]?_ &9J[JA[@M@HHHI#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q
M/''_ ")>O_\ 8/N/_1;5\>5]A^./^1+U_P#[!]Q_Z+:OCROYN\5?]\PO^%_F
M?K'!?^[UO5?D>W?LT_>\1?2W_P#:M>X5X?\ LT_>\1?2W_\ :M>X5^H< _\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>;WW_)4%_ZZQ_\ HM:](KS>^_Y*
M@O\ UUC_ /1:T@/2****8!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8_B[_D6M0_ZY?U%8_P ,/^0'<?\ 7RW_ *"M;'B[_D6M0_ZY?U%8
M_P ,/^0'<?\ 7RW_ *"M '84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\>\O^X?Y5+45S
M_P >\O\ N'^5 ' ?"S_CYU#_ '$_F:]$KSOX6?\ 'SJ'^XG\S7HE) %%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\W^'?_ ",]_P#]<7_]#6O2*\W^'?\
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M !7-?$W_ ))OXL_[!-W_ .B7KI:YKXF_\DW\6?\ 8)N__1+TX[H3V,KX&_\
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M'#HZ^H8<$?2K%<SNM&=&^J"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M22J3/;\@,[,?F)7<I='+?*05;@@^C]3ES>RYES_R_I?:_D>7]>CR^U4'[/\
MF_6V]O.Q]]44U'61592&5AD,#D$>M.KSSTPHHHH *BN?^/>7_</\JEJ*Y_X]
MY?\ </\ *@#@/A9_Q\ZA_N)_,UZ)7G?PL_X^=0_W$_F:]$I( HHHI@%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7F_P[_Y&>_\ ^N+_ /H:UZ17F_P[_P"1GO\
M_KB__H:T@/2****8!1110 4444 <!\1O^1I\&?\ 7[_[/%7?UP'Q&_Y&GP9_
MU^_^SQ5W] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!A>.O%EMX$\%:]XCO!NMM)L9K
MV1<XW"-"V/QQC\:_$O3])^(_[:'QJNOL^[6O$NI%[B1IY=EO9VZGU/"1)N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\W^&W_ ",%]_UQ;_T,5Z17F_PV_P"1@OO^N+?^ABD!Z11113 ****
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M)=I8_LX_$J:3[HT"\'7N8F _4UZ69-_69OJK?@E8\K*HQ^J0CT=_Q;N>5?\
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M/Q(C+*'9-.8+GD@&YR<?B/S%?>E?C=^S/XDO_"_Q\\!W.GW#P27&L6ME+L;
M>&:58Y$/J"K']/2OV1K/B["NCF'MKW51)^EDE^A?"V)5; ^QMK!M>MW?]0HH
MHKX@^Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O-_AM_P C!??]<6_]#%>D5YO\
M-O\ D8+[_KBW_H8I >D4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU3O)OOI;_-BI_6YS3J6C%=M6_P#)'YX?&S_E*3X&_P"NFG?^BVK]'J\WUO\
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MP+>"^<8#B)V/#!LJ%;!;@KG/'K/BWQUX>\!^'Y]<\0ZS9:/I,*;VNKN943Z
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M2G0QD:LJT^5R?F]%V6G_  Y[+I^L^#/C!X9O$L;[0O&WAZ9C;7*V\T-_:2$
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MT2O._A9_Q\ZA_N)_,UZ)20!1113 **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /:M>X5^H< _\DWAO^W_ /TY(^/XF_Y&U;_MW_TE!1117Z"?+A1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\W^&W_(P7W_ %Q;_P!#%>D5X[HM
M]JNAWT\UK:,TK@HP>%CCG/\ 2D![%17F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%%>;_P#";>)/^?%?
M_ =_\:/^$V\2?\^*_P#@._\ C0!Z117F_P#PFWB3_GQ7_P !W_QH_P"$V\2?
M\^*_^ [_ .- 'I%%>;_\)MXD_P"?%?\ P'?_ !H_X3;Q)_SXK_X#O_C0!Z11
M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%>;WW_)4%_ZZQ_\
MHM:/^$V\2?\ /BO_ (#O_C6)+?ZI-KPU-K1OM@96VB)L9"@#CZ"@#V.BO-_^
M$V\2?\^*_P#@._\ C1_PFWB3_GQ7_P !W_QH ](HKS?_ (3;Q)_SXK_X#O\
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MWB3_ )\5_P# =_\ &@#TBBO-_P#A-O$G_/BO_@._^-'_  FWB3_GQ7_P'?\
MQH ](HKS?_A-O$G_ #XK_P" [_XT?\)MXD_Y\5_\!W_QH ](HKS?_A-O$G_/
MBO\ X#O_ (T?\)MXD_Y\5_\  =_\: .P\7?\BUJ'_7+^HK'^&'_(#N/^OEO_
M $%:Y[4?%&OZC8S6TUEB*1<,5@8''YU6T'7-9T.T>"TLR\;.7)>%F.< =OH*
M /6J*\W_ .$V\2?\^*_^ [_XT?\ ";>)/^?%?_ =_P#&@#TBBO-_^$V\2?\
M/BO_ (#O_C1_PFWB3_GQ7_P'?_&@#TBBO-_^$V\2?\^*_P#@._\ C1_PFWB3
M_GQ7_P !W_QH ](HKS?_ (3;Q)_SXK_X#O\ XT?\)MXD_P"?%?\ P'?_ !H
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MS?\ X3;Q)_SXK_X#O_C1_P )MXD_Y\5_\!W_ ,: /2**\W_X3;Q)_P ^*_\
M@._^-'_";>)/^?%?_ =_\: /2**\W_X3;Q)_SXK_ . [_P"-'_";>)/^?%?_
M  '?_&@#TBBO-_\ A-O$G_/BO_@._P#C1_PFWB3_ )\5_P# =_\ &@#TBBO-
M_P#A-O$G_/BO_@._^-'_  FWB3_GQ7_P'?\ QH ](HKS?_A-O$G_ #XK_P"
M[_XT?\)MXD_Y\5_\!W_QH ](HKS?_A-O$G_/BO\ X#O_ (T?\)MXD_Y\5_\
M =_\: /2**\W_P"$V\2?\^*_^ [_ .-'_";>)/\ GQ7_ ,!W_P : /2**\W_
M .$V\2?\^*_^ [_XT?\ ";>)/^?%?_ =_P#&@#TBBO-_^$V\2?\ /BO_ (#O
M_C1_PFWB3_GQ7_P'?_&@#TBBO-_^$V\2?\^*_P#@._\ C1_PFWB3_GQ7_P !
MW_QH ](HKS?_ (3;Q)_SXK_X#O\ XT?\)MXD_P"?%?\ P'?_ !H ](HKS?\
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M%%, HHHH **** . ^(W_ "-/@S_K]_\ 9XJ[^N ^(W_(T^#/^OW_ -GBKOZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5S7Q-_Y)OXL_[!-W_P"B7KI:YKXF_P#)-_%G_8)N_P#T2]..Z$]C*^!O_))?
M#/\ UZ_^S-7=5POP-_Y)+X9_Z]?_ &9J[JA[@M@HHHI#"BBB@ HHHH ****
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M!_QU96L;375SH5]#%&HR7=K=PH'N2173A7:O3;[K\SGQ&M&:79_D?BE7[/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO_LS5W5<+\#?^22^&?\ KU_]F:NZH>X+8****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .(^-'_)
M,]9^D/\ Z.2OEBOJ?XT?\DSUGZ0_^CDKY8K^7O%'_D<TO^O2_P#2YG[%P;_N
M$_\ &_\ TF)]%?LY_P#(EWW_ &$'_P#1<=>J5Y7^SG_R)=]_V$'_ /1<=>J5
M^X<'_P#(@PG^']6?G>??\C.OZA1117V)X(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'RM_P4?L)[SX V,L,;/':Z[;S3,!PB&&= 3[;G4?B*_,NOW/UO0]/\2:
M3=:7JME!J.G72&.>UN8P\<BGL0>M>+3?L._!.>5I&\%A2QR0FIWBC\ )L"OT
M+(>(\/EF%^KUX2>K::MU]6CX3.L@KYAB?;T)):):WZ>B9^3?FO\ WV_.CS7_
M +[?G7ZP_P##"_P2_P"A,;_P:WO_ ,>KRC]JC]E#X6_#?X"^*?$?AWPR=/UF
MR%L8+G^T+J79ON8D;Y7E*G*LPY'>OJ\/Q9@,36A0A"=Y-):+J[?S'S-?AC&X
M>E.M*<;13>[Z*_8^'?AO\3/$'PM\56&NZ%J-Q:7%M,LCQQR$1SJ#\T;KG#*1
MP0?6OVR5MR@CH1FOPBK]VX?]4G^Z*\#C:G",L/-+5\U_ERV_,]S@^I)QKP;T
M7+^-_P#(?1117YB?HH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#_\ HN.O5*_<.#_^1!A/\/ZL_.\^_P"1G7]0HHHK[$\$**** "BBB@ HHHH
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M/:^)S?*YY3B/82ES75T]M-5M\C[#*\RCFF']O&/+9V:W_K<****\0]@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHK[$\$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN+>*\MY8)XDG@E4
MI)%(H974C!!!X(([5)10!X=J'[$WP6U.\EN9?!,4<DAW,MO?W4* ^R)*%4>P
M %5O^&%_@E_T)C?^#6]_^/5[U17J+-<P2LL1/_P)_P"9YKRW O5T(?\ @*_R
M/!?^&%_@E_T)C?\ @UO?_CU'_#"_P2_Z$QO_  :WO_QZO>J*?]K9A_T$3_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=11161L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1Z/^':?PT_Z#_BO_ ,"K;_Y'K]2GQ-DU5WJ*[\XW/S>'#N;4U:#LO*1\*?\
M#0'Q/_Z*-XK_ /!U<_\ Q='_  T!\3_^BC>*_P#P=7/_ ,77W7_P[3^&G_0?
M\5_^!5M_\CT?\.T_AI_T'_%?_@5;?_(]9_ZQ9'_)_P"2%_V#G'\W_DQ\*?\
M#0'Q/_Z*-XK_ /!U<_\ Q='_  T!\3_^BC>*_P#P=7/_ ,77W7_P[3^&G_0?
M\5_^!5M_\CT?\.T_AI_T'_%?_@5;?_(]'^L61_R?^2!_8.<?S?\ DQ\*?\-
M?$__ **-XK_\'5S_ /%T?\- ?$__ **-XK_\'5S_ /%U]U_\.T_AI_T'_%?_
M (%6W_R/1_P[3^&G_0?\5_\ @5;?_(]'^L61_P G_D@?V#G'\W_DQ\*?\- ?
M$_\ Z*-XK_\ !U<__%T?\- ?$_\ Z*-XK_\ !U<__%U]U_\ #M/X:?\ 0?\
M%?\ X%6W_P CT?\ #M/X:?\ 0?\ %?\ X%6W_P CT?ZQ9'_)_P"2!_8.<?S?
M^3'PI_PT!\3_ /HHWBO_ ,'5S_\ %T?\- ?$_P#Z*-XK_P#!U<__ !=?=?\
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M^&G_ $'_ !7_ .!5M_\ (]'_  [3^&G_ $'_ !7_ .!5M_\ (]'^L61_R?\
MD@?V#G'\W_DQ\*?\- ?$_P#Z*-XK_P#!U<__ !='_#0'Q/\ ^BC>*_\ P=7/
M_P 77W7_ ,.T_AI_T'_%?_@5;?\ R/1_P[3^&G_0?\5_^!5M_P#(]'^L61_R
M?^2!_8.<?S?^3'PI_P - ?$__HHWBO\ \'5S_P#%T?\ #0'Q/_Z*-XK_ /!U
M<_\ Q=?=?_#M/X:?]!_Q7_X%6W_R/1_P[3^&G_0?\5_^!5M_\CT?ZQ9'_)_Y
M(']@YQ_-_P"3'PI_PT!\3_\ HHWBO_P=7/\ \71_PT!\3_\ HHWBO_P=7/\
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M]<5V5<U\2O!T?Q"^'GB7PQ*PC36-.N+'>1D*9(RH;\"0?PJ)_"RX?$C\I?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B/C1_P DSUGZ0_\
MHY*^6*^I_C1_R3/6?I#_ .CDKY8K^7O%'_D<TO\ KTO_ $N9^Q<&_P"X3_QO
M_P!)B?17[.?_ ")=]_V$'_\ 1<=>J5Y7^SG_ ,B7??\ 80?_ -%QUZI7[AP?
M_P B#"?X?U9^=Y]_R,Z_J%%%%?8G@A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;_R27PS_ ->O_LS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZH>X+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHKX\^J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH X#XC?\ (T^#/^OW_P!GBKOZX#XC?\C3X,_Z_?\ V>*N
M_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N!^/OB34/!WP1\=ZWI19=2L-%NY[=ES
ME9%B8JP]P>?PKOJI:UI]EJVCWUEJ4<<NG7,$D-S'*<(T3*0X;VP343UBRXZ2
M1^#GP;^"OB_]H3QLWA_PK;)>ZD8VN[FXNYO+CAC# -)(YR?O,!P"23TKZ)_X
M=4_&#_H+>$?_  /N/_D>N;\)_$FQ_8?_ &F-1O\ PAK.E_$'P9=1- SZ;>I*
M9+-W#!"ZDA9HR@]FQV#<?<5K_P %+O@;<6L,LFL:K:R.@9H9-+E+1DCE25!&
M1TX)'O7U^(Q&(M">&C>+7;6_H?#X7"X7FG3Q<K23[Z6[WZGR#_PZI^,'_06\
M(_\ @?<?_(]?=G[%?P*\0_L\_!Z;PMXFN-/N=1?5)[T/ILKR1;'2-0,LBG.4
M/;TKEO\ AY1\"O\ H/ZE_P""J?\ ^)KVSX/_ !F\+_'3PF_B3PC=37FE+<O:
M&2>!H6\Q0I8;6&<88<UY5>OBYTW&K&T?0]G#X; TZL949IRZ:WZ'<4445Y![
M@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5S7Q-_Y)OXL_P"P3=_^B7KI:YKXF_\ )-_%G_8)N_\ T2]..Z$]C*^!
MO_))?#/_ %Z_^S-7=5POP-_Y)+X9_P"O7_V9J[JA[@M@HHHI#"BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!OVE?
MVM- _9]BAT];7^W?%-S'YD6FQR[%A0YQ)*V#M!(X4#)P>@YKWFOQJ_:2UZ]\
M1_'SQ_=7\K2S1ZU=6J[B?ECAD:*->?1$4?A7UO#>5TLSQ35?X(J]N_EZ'R_$
M&95,NPR='XI.U^Q[C;?\%+?B(FHB2X\/>&I;'<2;>.&X1]OH',IP??:>_%?9
MG[/O[1GAS]H3P[->:6K:=JUH0+[29W#209^ZP8 ;T.#A@!TP0*_'FOH/]@_Q
M!?:-^TMX=M;1V$&IPW5I=1J?OQB!Y1GZ/&C?\!K[G.N'<%]3J5</#DE!-Z=;
M:M,^,RC/L9];A2KSYHS:6O2^ET?JW17PA^V9^TS\2?A)\9/[#\*^)ET_2VTZ
M"Y^S?8+:;8[%PWS21LW.T'KWKPK_ (;H^-O_ $.2_P#@JLO_ (S7QF%X5QN+
MH0Q%.<;25U=N_P#Z2?78GB;!X6M*A.,KQ=M$O\S]9**_)O\ X;H^-O\ T.2_
M^"JR_P#C-6+#]O+XTV=W'-+XHM[Z-#DV]QI=J$?V)2-6Q]"*Z7P;F%OCA][_
M /D3G_ULP/\ +/[E_P#)'ZN45PWP0^)B?&#X5^'O%RVPM'U&!C-;J<K'*CM'
M( ?3>C8SVQ7<U\15ISHU)4IJSBVGZH^QIU(UH1J0=TU=>C"BBBLC0**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@/B-_P C3X,_
MZ_?_ &>*N_K@/B-_R-/@S_K]_P#9XJ[^@ HHHH **** "BBB@ HHHH ****
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M]WH^K_(W:***_I(_)@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;<PSVK\WQ^'JXG,Z].C%RDYRT7JS]!P5>EA\NHU*TE%<D=7Z(]9HKYH\#?\
M!0+X8>--=M]*ECUK09KAUBAFU*T0Q.[<!<Q.Y!)XY '(YKWOQIXXT'X=^'[C
M7/$FJ0:1I4& ]Q<$XR>BJ!DLQ[* 2?2N&O@,5A:D:5:FU*6RMOZ=SLHX[#8B
M#J4JB<5N[[>O8W**^4KG_@I%\+X-1-O'IGB6XMPP7[7'9PA"/[P#3!L?49Z\
M5[]\,_BQX5^+^@_VOX4U:+4[52$F4 I+ Y&=LB, 5/Z''!-:8C+<9A(*I7I.
M*[M&>'S#"8J7)1J*3[7.OHHHKS#T0HHHH **\F^,G[4'@'X&RK:>(-2EN-79
M!(NDZ=&)KG:<X8@D*@/;<PSVKS[P=_P4*^%?BK5H[&[.K^&_,("W6K6R"#)[
M%HY'*\]R />O5I95CJU+VU.C)Q[V_+O\CS:F98.C4]C4JI2[7_JQ]-45';W$
M5Y;Q3P2I-!*H>.2-@RNI&001U!'>I*\H](**** "BBB@ HKYX^)'[=GPO^'.
MLRZ5]JO_ !'>PN8YQHD*21Q,"009'=%8C'\)/\ZU_A#^V-\./C)JD6DZ=>W6
MCZU,=L.GZQ$L3S'GA&5F1CQTW9/I7JRRK'1H^WE1ER][=._H>9',\%*K[%55
MS=KGN%%%%>4>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!P'Q&_P"1I\&?]?O_ +/%7?UP'Q&_Y&GP9_U^_P#L
M\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<3\;?&%Q\/\ X/\ C3Q):#_2]+TB
MZNH?:18V*G\\5VU8?CCPI:^.O!NN>'+WBTU:RFLI3C.%D0J3^&<U$_A9<-))
MGXZ?L7_L_P!C^U!\9+^Q\4:C=KIEG:2:K?M#)BXNV,BJ%WD'&YGRS=< XP3D
M8/[1'@'1/A=^U-K?A;PY:M9:+INI6D=M \KRE08XF.68DG+,3R>]'ACQ1X^_
M8@^/5Z4MHX-;TQGL[JUND)M[ZV8@]B"4<!75@>"!Z$5S/QB^+[?%KXTZM\0'
MTH:6VH74-R=/6X\T(8TC7'F;5SG9G[O&>^*^]HN4L33JP?[KE_&ZMIZ'YIB%
M&.#JT)K]]S?.W*T]?7[]&?IQ_P %.-(TZ_\ V8+N[NU3[98ZI:2V3-][S&<H
MP'U1G_*N!_X)*^(+J\^&OCG1I&9K2QU2&YASV:6(A@/^_*G\:^/?VH/VQO%G
M[3T]E:7]G;Z%X<L9#-;:1:.TF9",>9+(0-[ $@8"@ GC))K]%?\ @GK\$=0^
M#?P(CEUNV:SUSQ%<G4Y[>1=LD$115AC8=CM!8@\@R$'D5XJHRPN J1K:.35E
M_P" _P"3/H77CC,RI3H:Q@G=]_B_^21]/4445\^?3A1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-?$W_ ))OXL_[
M!-W_ .B7KI:YKXF_\DW\6?\ 8)N__1+TX[H3V,KX&_\ ))?#/_7K_P"S-7=5
MPOP-_P"22^&?^O7_ -F:NZH>X+8****0PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ']I;[
MOAWZW'_M*O;J\1_:6^[X=^MQ_P"TJ_/^/O\ DF\5_P!N?^G(GT_#/_(VH_\
M;W_I+/#Z^P? ?_(D>'_^P?;_ /HM:^/J^P? ?_(D>'_^P?;_ /HM:_+?"O\
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M>F_'T\O\5_\ !1+XF>&?%&L:.VA>%7;3[R:T+-:7()\MRF?^/CVKVK_@G_\
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M+^+?C/P9J'@OP_H&LZAH6D7MO/=W$NGSO UQ(KJH1G4@D*#G;G&6!/05U?\
MP3D^+'C+Q_\ !'QM!XDU.]U9-$F\O3]2O)6DF :%F:/S"<ML(4C)R ^.@ '7
M]6E]4EB[Z*^GH[?F</UN'UV."MK*VO357_+\3Z,^-W[-_@']H+2XK7QAHRW-
MS I6VU*V<PW=OG^[(.H[[6#+GG%?)^K?\$C?#\VH%],^(VIVECGB&[TV.>7K
M_?5T'_CM?#O_  U%\8?^BH>+?_!S<?\ Q='_  U%\8?^BH>+?_!S<?\ Q=>W
M2P.)H:4ZECY^MF6#Q&M6E=_C]Y^HGP3_ .">OPM^#>L6VMRPWGBW7+=ED@N=
M:9&B@D'1XX54+G.""^X@@$$&OIVOP>_X:B^,/_14/%O_ (.;C_XNOT\_X)Q^
M./$/Q _9]N-4\3:WJ&OZB-;N81=ZE<O/*$$<)"[F). 2>/<URXS"5U!U:L[V
M.O X[#RJ*A1I\M_\KGU+1117AGT84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!YM_PT9\._P#H8A_X!W'_ ,;K#\=?
M'KP)K'@GQ#86>NB:[NM.N((8_LDZ[G:)E49*8&21UKV/:O\ ='Y5S?Q,4?\
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M4JU7>3B[OYQ/>Z***_'S]5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 <!\1O\ D:?!G_7[_P"SQ5W]<!\1O^1I\&?]
M?O\ [/%7?T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% %;4K/^T-.NK7?Y?GQ-%OQG;N
M!&<?C7YF^*O^"2_B;2[.>?1?B!I6IF)"^R^L)+3=CG&5:3G%?IW2$9&",BMJ
M5>KA^9T79O\ 2]OS.>OAZ.*48UHW2^6]K[>B/P&^$/PAU_XV>/K3P=X=^RKK
M%RDKI]LE,<>(T+ME@#V4]J^A/^'7?QH_O>'/_!BW_P ;K[X\<>,/V=/V8=>@
MU#5;'P?X1\1E6:+^R]&B_M *X()Q!$9%5AD;C@'D9KC+C_@IQ\$H9F1+S7)U
M'22/3&"GZ98']*]V6.Q%:TL/!V]+ZGSL,MPM#FCB:BO?36VGG^)\L^%?^"4?
MQ+U*^A&O>(_#NB6!/[V2WDFNIU'^S'Y:*?Q<5^C?P2^#/A[X"_#VP\(^'(Y/
ML=N3)-<S$&6YF;[\KD#J< >@  ' KP;_ (>>_!3_ )[Z]_X+/_LZ]W^"OQM\
M-?'SP<_B;PJUTVF)=/9DWD/E/YB!2?ER>,..:XL35QE2%JJ:CZ6/0PE' TJG
M[F2<GYW^X[ZBBBO)/:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N:^)O_)-_%G_8)N__ $2]=+7-?$W_ ))OXL_[
M!-W_ .B7IQW0GL97P-_Y)+X9_P"O7_V9J[JN%^!O_))?#/\ UZ_^S-7=4/<%
ML%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .'^.G_)$?B%_V+NH?^DTE?BS
M7[3?'3_DB/Q"_P"Q=U#_ -)I*_%FOUO@K_=ZWJOR/R_B_P#CTO1_F?L]^S[_
M ,D'^'7_ &+NG_\ I.E>@5Y_^S[_ ,D'^'7_ &+NG_\ I.E>@5^7XO\ WBI_
MB?YGZ-A?]WI^B_(****Y#J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK-,%E>+Q$\;54%**2OUU/ON*L'B,91I1P\')IO;T/9**\M_X:*\-?\^>J?\
M?F/_ ..4?\-%>&O^?/5/^_,?_P <K]W_ -;\A_Z"X_>?F_\ 869_\^)'J5%>
M6_\ #17AK_GSU3_OS'_\<H_X:*\-?\^>J?\ ?F/_ ..4?ZWY#_T%Q^\/["S/
M_GQ(]2HKRW_AHKPU_P ^>J?]^8__ (Y1_P -%>&O^?/5/^_,?_QRC_6_(?\
MH+C]X?V%F?\ SXD>I45Y;_PT5X:_Y\]4_P"_,?\ \<H_X:*\-?\ /GJG_?F/
M_P".4?ZWY#_T%Q^\/["S/_GQ(]2HKGO"/CS1_&T,KZ9.S21?ZR"5=LB^^.X]
MQ70U]-AL50QE*-?#34X/9IW1Y%:C4P\W3JQ<9+HPHHHKJ,0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B?C="]Q\%_'\4
M:EY'\/Z@JJO4DVT@ K\5Z_=R2-)HVCD571@596&00>H(KY?\2?\ !.OX6:]J
M]Q?6UQKVAI,Y?['I]U%Y"$]E$D3L![9P.U?=\-9UALKC4IXF_O---*Y\7Q!D
M^(S*5.IA[:733T/SYT[XW_$71]/MK&Q\>>);*RMHUA@MK?5[A(XHU&%55#X
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M"K;_ .1Z/^':?PT_Z#_BO_P*MO\ Y'H_UBR/^3_R0/[!SC^;_P F/A7_ (:
M^)__ $4;Q7_X.KG_ .+H_P"&@/B?_P!%&\5_^#JY_P#BZ^ZO^':?PT_Z#_BO
M_P "K;_Y'H_X=I_#3_H/^*__  *MO_D>C_6+(_Y/_) _L'./YO\ R8^%?^&@
M/B?_ -%&\5_^#JY_^+H_X: ^)_\ T4;Q7_X.KG_XNONK_AVG\-/^@_XK_P#
MJV_^1Z/^':?PT_Z#_BO_ ,"K;_Y'H_UBR/\ D_\ ) _L'./YO_)CX5_X: ^)
M_P#T4;Q7_P"#JY_^+H_X: ^)_P#T4;Q7_P"#JY_^+K[J_P"':?PT_P"@_P"*
M_P#P*MO_ )'H_P"':?PT_P"@_P"*_P#P*MO_ )'H_P!8LC_D_P#) _L'./YO
M_)CX5_X: ^)__11O%?\ X.KG_P"+H_X: ^)__11O%?\ X.KG_P"+K[J_X=I_
M#3_H/^*__ JV_P#D>C_AVG\-/^@_XK_\"K;_ .1Z/]8LC_D_\D#^P<X_F_\
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M-/\ H/\ BO\ \"K;_P"1Z/\ AVG\-/\ H/\ BO\ \"K;_P"1Z/\ 6+(_Y/\
MR0/[!SC^;_R8^%?^&@/B?_T4;Q7_ .#JY_\ BZ];_9B_:F^(.E_%[PSI.L>)
MM2\1:+K%_#IUQ;:K<-<E?-<(KHSDLI5F!X." 0:Z/]K?]D'PA\ _AK8>(M U
M36[V]N-5BL6CU*:%XPC12N2 D2G.8U[XY/%?/?P+_P"2V_#[_L8=/_\ 2F.O
M6C_9^:8"I5HTTXV:^%+9'F/Z]EN-A2JS?-==6]V?M-1117X&?MH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !7-?$W_ ))OXL_[!-W_ .B7KI:YKXF_\DW\6?\ 8)N__1+TX[H3V,KX&_\
M))?#/_7K_P"S-7=5POP-_P"22^&?^O7_ -F:NZH>X+8****0PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KQO]I#3IIM,T6]1&:"WDECD8#[I<+C/_?!KV2H;RS@U"UEMKJ%+
MBWE7:\<BAE8>A!KP,^RM9UEM; <W+SI6?9IIK\5J>GEN,_L_%T\3:_+T]59_
MF?$]%?4\GP7\&RR%SHX!/9;B4#\@]-_X4GX-_P"@0?\ P*F_^+K^?'X79STJ
MTOOE_P#('Z?_ *XX#^2?W+_Y(^6J*^I?^%)^#?\ H$'_ ,"IO_BZ/^%)^#?^
M@0?_  *F_P#BZ/\ B%V=?\_:7_@4O_D!_P"N.7_R3^Y?_)'RU17U+_PI/P;_
M - @_P#@5-_\71_PI/P;_P! @_\ @5-_\71_Q"[.O^?M+_P*7_R ?ZXY?_)/
M[E_\D?+5%?4O_"D_!O\ T"#_ .!4W_Q='_"D_!O_ $"#_P"!4W_Q='_$+LZ_
MY^TO_ I?_(!_KCE_\D_N7_R1\M45]2_\*3\&_P#0(/\ X%3?_%U\X>++&'2_
M%.L6=LGEV]O>311IDG:JN0!D\G@5\KQ!PCCN'*4*N+G!J;LN5M^?6*/9RS/,
M-FLY0H1DG%7U2_1LZ;X(W,EO\2-,1&PLRS1N/5?+9L?FH_*OJ*OECX+_ /)3
M-&^LW_HEZ^IZ_;/"^3>354^E67_I,#\]XQ26/A_@7YR"BBBOV ^%"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^4/\ @I/_
M ,D'T?\ [&&W_P#2>YKX(^!?_);?A]_V,.G_ /I3'7WO_P %)_\ D@^C_P#8
MPV__ *3W-?!'P+_Y+;\/O^QAT_\ ]*8Z_9N&_P#D2S_[>_(_)<__ .1Q'_MT
M_::BBBOQD_6@HHHH **** "BO)_VC/V@M)_9[\%KJEY";_5KQFATW3E;;Y\@
M +,S?PHN02?< =:_/[7OV\OC)K&J2W5KXBM]&@8Y2SLM.MVC09S@&5'8_BQK
MZ7+>'\;FE/VM*RCW?7TLF?/9AGF$RV?LJMW+LNGK=H_5FBOC#]EG]NFZ^(/B
M2S\'^/8;:'5+UA#8:M:IY:3RD\1RIT5FZ!EP"<# SFOL^O,Q^7XC+:WL<0K/
M\&O(]'!8ZAF%+VM!W7XKU"BBBO-/0"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!\L?\ !1ZPGO/@#92PQL\=KKMO-,P'"(8ID!/MN=1^
M(K\R>G(K]S];T/3_ !)I-UI>JV4&HZ==(8Y[6YC#QR*>Q!ZUXM-^PY\$YYGD
M/@O:6.2$U.\5?P FP*_0LAXCP^685X>O"3U;35NOJT?"9UD%?,,3]8H22TL[
MWZ>B9^3?G2?WV_.CSI/[[?G7ZP_\,+_!+_H36_\ !K>__'J/^&%_@E_T)K?^
M#6]_^/5])_KEE_\ )/[H_P#R1X'^J6._GA][_P#D3\GO.D_OM^='G2?WV_.O
MUA_X87^"7_0FM_X-;W_X]1_PPO\ !+_H36_\&M[_ /'J/]<LO_DG]T?_ )(/
M]4L=_/#[W_\ (GY/>=)_?;\Z]=_9'6*Y_:0\!I=L3%]OW@-R-ZQNR?\ CP6O
MT$_X87^"7_0FM_X-;W_X]5_P_P#L:_"'PKKNGZSI7A:2TU+3[A+JVG75+PF.
M1&#*<&4@\@<$8/>N7%<6X"O0J4HPFG)-;+JK?S'1A^%\;1K0JRE%J+3W?1_X
M3Y&_X*6W-X_QF\/6\A?[#'H4;PJ1\N]KB8.1[X5,_05\BU^LW[6G[-4?[07A
M&V;3YHK+Q3I.][&:48CF5L;H9#C(!P"#V(]":_.+7OV;?BEX<U26PNO 'B"6
M:,XWV6GR743<X^62(,K?@>XKTN&\SPM3 0H.:C*&C3=OF>?Q!E^)IXV=91;C
M+5-:_(\_TVXNK/4;6>R9TO8I5>!HQEA(""I'OG%?H-_P4N1#\-O!4\P":@NI
M.H"]E,)+@'TRJ5Q'[)_[$7B >+=-\7_$"P.D:=ITJW-II,^TSW,JG*F1>=B
M@':W)P!C%;?_  5"R+?X<'<V"VH97<=O MN<=,\GFN7%8[#X[/,)1H2OR<UV
MMM5M^'XG5A\'7P>3XFK6C;GY;)^3W_'\#RS]@7XG:_HOQRTGPNFHW$NA:U%<
M136,DA:)62%Y5D52<*V8\9'9C7Z?5^2O[$/_ "=%X(_WKO\ ](YZ_6JOE>,:
M<(9A%Q5KQ3?K=H^EX4G*>!DI.]I-+[D%%%%?"GV84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ' ?$;_ )&GP9_U^_\ L\5=_7 ?$;_D:?!G_7[_ .SQ5W] !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_V9J[JN%^!O_))?#/\ UZ_^S-7=4/<%L%%%%(84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KX4_X*A?\ 'O\ #;_?U'^5M7W77PI_P5"_
MX]_AM_OZC_*VKZCAG_D;4?\ M[_TEGSG$7_(KJ_+_P!*1X!^Q#_R=%X(_P!Z
M[_\ 2.>OUJK\E?V(?^3HO!'^]=_^D<]?K57K<9_[_#_ O_2I'E\)?[C/_&_R
MB%%%%? GVX45X/\ M*_M::!^S[##IZVW]N^*;F/S(M-CEV+"AR!),V#@$]%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCZ'J/B*_2QTK3[K4[UP2MM9PM+(P R2%4$G YKH?^%/>/?\ H2/$?_@IN/\
MXBO2Q.7T:DDTU#3]7K_78\K!YG7IQDI1<[O?MHM-OG\S]V?^%J>"O^APT'_P
M9P?_ !5;>CZ]IOB*T-UI6H6NIVH8H9K.=94W#&1N4D9Y''O7X%_\*>\>_P#0
MD>(__!3<?_$5^J7_  30\/:KX9_9TN;/6-,O-*N_[=NI/L]];O#)M,<.&VL
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MAL7.-9:MMI][O='O7[!_B"^T;]I;P[:VCL(-3ANK2ZC4_?C$#RC/T>-&_P"
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MC,-";3Y)7EULM-/GV.S(<#BI87$3BK<\;1Z7??Y=S\J?^&@/B?\ ]%%\5_\
M@ZN?_BZ/^&@/B?\ ]%%\5_\ @ZN?_BZ^Z?\ AVG\-?\ H/\ BO\ \"K;_P"1
MZ/\ AVG\-?\ H/\ BO\ \"K;_P"1ZZ?]8LC_ )/_ "0P_L'./YO_ "8^%O\
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M**C>*;MWNU^A]KPO7J5L%+VLF[2:5^UD_P!0HHHKXD^P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#@/B-_R-/@S_K]_]GBKOZX#XC?\C3X,_P"OW_V>*N_H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8P]K3ES1.[!YE]8J>QJQY9?F>PT445Y![84444 %%%% !1110 4444 %%%%
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MEZ^IZ[_"[_D35?\ KZ__ $B!S<9?[_#_  +_ -*D%%%%?L1\(%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !31&@<N%4,>K8Y_P \"G44 %%%% !3
M7C208=58>C#-.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OA7_@J%_QZ_#?_ ']1
M_E;5]U5\*_\ !4+_ (]?AO\ [^H_RMJ^HX9_Y&U'_M[_ -)9\YQ%_P BNK\O
M_2D?/W[$?_)T7@C_ '[O_P!(YZ_6NOR4_8C_ .3HO!'^_=_^D<]?K77K<9_[
M_3_P+_TJ1Y?"7^XS_P ;_*(4445\"?;A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!P'Q&_Y&GP9_U^_^SQ5W]<!\1O\ D:?!G_7[_P"SQ5W] !1110 4444
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M_P#2('-QE_O\/\"_]*D%%%%?L1\(%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6#4]'U&ZTK4K?)BO+*9H9H\J5.UU((R"1P>A-=A_PT!\3_\ HHOBO_P=7/\
M\77Z'GO#U7-L3&O3J**4;:W[M_J?"9+GM+*\/*C.#;;OIZ)?H?L_17XP?\-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKFOB;_R3?Q9_V";O_P!$O72US7Q-_P"2;^+/^P3=_P#HEZ<=T)[&5\#?^22^
M&?\ KU_]F:NZKA?@;_R27PS_ ->O_LS5W5#W!;!1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\?>//^1W\0?]A"X_]&-7V#7R1\2]
M.FTWQYKD<Z,ADNI)TR,95V+ C\#7XCXJ0D\!AII:*;_%'Z'P9)?6:L>O+^I'
M\/?$5MX3\8:?JMXDLEO;^9O6$ N=T;*, D#JP[U[3_PT5X:_Y\]4_P"_,?\
M\<KYSHK\=R7BW,\AP\L-@G%1;YM5?5I+]$?>9ADF#S*JJV(3NE;1VTU?ZGT9
M_P -%>&O^?/5/^_,?_QRC_AHKPU_SYZI_P!^8_\ XY7SG17O_P#$2,^_FA_X
M">9_JGEG:7WGT9_PT5X:_P"?/5/^_,?_ ,<H_P"&BO#7_/GJG_?F/_XY7SG1
M1_Q$C/OYH?\ @(?ZIY9VE]Y]&?\ #17AK_GSU3_OS'_\<H_X:*\-?\^>J?\
M?F/_ ..5\YT4?\1(S[^:'_@(?ZIY9VE]Y]&?\-%>&O\ GSU3_OS'_P#'*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <!\1O^1I\&?]?O\ [/%7?UP'Q&_Y
M&GP9_P!?O_L\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-DC2:-HY%#HP*LK#(
M(/4&G55U6[;3]+O+I%#/#"\@5NA*J3C]*F32BV]BHIRDDMS\HOVNOV _%/PX
M\3:CXD\ Z3<^(?!MU(TXM+",RW.G$G)C,:_,T8[,H.!PV,9/R#J&H7]WJ#W-
M]<W$U^" TUP[-*"H"@$GG@ #VP*_3+]G'_@H_JWQ<^*MAX<\3Z+H'AC1);>X
MGN-4:[>,0B.)G&6D;: 2 .?6OKOP_P"-_AM\2M29=#U_PKXJU")=S#3[RVO)
M44=SL9B!7TL<5B<&E3K0O9:.^MO/?L?)2P>$S"4JF'GRW=FK:7T>BT[GXO?!
MW]G7XC?M&>(D70=)O+NWGE_TK7K\.MI%S\S/,P^9N^U<L>PK]F_@;\'='^ _
MPRT?P=HQ,L%DA:>Z=0'N9V.9)6]R>@[  =JZ7QAXKTOP#X3U7Q#J\WV72=*M
M7NKB0#.V-%R<#N>, >N*_-G7O^"M/C)_$SR:+X+T*'P\LGRV]^\TEVZ9ZF17
M5%)'^PV/>N>=:OF/[JE&T5K_ )'53P^'RK]]6E>3T7ZZ?J?I_17C?[,?[3WA
MS]IOP?-JFDQ/IFKV++'J6CSR!Y+9F!*L& &^-L'#8&=I! (KV2O)J4YT9.$U
M9H]RE5A6@JE-W3"BBBLC4**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KFOB;_R3?Q9_V";O_P!$O72US7Q-_P"2;^+/^P3=
M_P#HEZ<=T)[&5\#?^22^&?\ KU_]F:NZKA?@;_R27PS_ ->O_LS5W5#W!;!1
M112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5B^(O!NC>
M+%0:KI\=V8QA'.5=1Z!@0<?C6U16%?#T<53=*O!3B]TTFG\F:TZM2C)3IR<6
MNJT9PW_"D_!O_0(/_@5-_P#%T?\ "D_!O_0(/_@5-_\ %UW-%>+_ *NY+_T!
M4O\ P7'_ "._^U<P_P"@B?\ X$_\SAO^%)^#?^@0?_ J;_XNC_A2?@W_ *!!
M_P# J;_XNNYHH_U=R7_H"I?^"X_Y!_:N8?\ 01/_ ,"?^9PW_"D_!O\ T"#_
M .!4W_Q='_"D_!O_ $"#_P"!4W_Q==S11_J[DO\ T!4O_!<?\@_M7,/^@B?_
M ($_\SAO^%)^#?\ H$'_ ,"IO_BZ/^%)^#?^@0?_  *F_P#BZ[FBC_5W)?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_(]'_#T./\ Z)JW_@\'_P CUX%_PP_\;?\ H2&_\&=E_P#'J/\ AA_XV_\
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M_HFK?^#P?_(]'_#T./\ Z)JW_@\'_P CUX%_PP_\;?\ H2&_\&=E_P#'J/\
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M  ]#C_Z)JW_@\'_R/1_P]#C_ .B:M_X/!_\ (]>!?\,/_&W_ *$AO_!G9?\
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MR8!=+K'EB5<!E;;Y!VY!!QDX]37G_P#P33^&E^WB+Q#X[N(7BTV.T.E6CNI
MFD=T>1EXYVB-03_M^QQRW[0'[*_QA^)/QG\7>)-.\&22Z=?7S&VD;4;-2\2
M(C8,H(RJ@X(R,\U^<U<+E5;.Z\<5RJ'*GK+E][2_5?/S/OJ6)S*ED]&6&YG*
M[VCS>[KY/Y>1WO\ P]#C_P"B:M_X/!_\CT?\/0X_^B:M_P"#P?\ R/7@7_##
M_P ;?^A(;_P9V7_QZC_AA_XV_P#0D-_X,[+_ ./5Z?\ 9G#/\T/_  8__DCS
MO[0XB_EG_P""U_\ (GOO_#T./_HFK?\ @\'_ ,CT?\/0X_\ HFK?^#P?_(]>
M!?\ ##_QM_Z$AO\ P9V7_P >H_X8?^-O_0D-_P"#.R_^/4?V9PS_ #0_\&/_
M .2#^T.(OY9_^"U_\B>^_P##T./_ *)JW_@\'_R/1_P]#C_Z)JW_ (/!_P#(
M]>!?\,/_ !M_Z$AO_!G9?_'J/^&'_C;_ -"0W_@SLO\ X]1_9G#/\T/_  8_
M_D@_M#B+^6?_ (+7_P B>^_\/0X_^B:M_P"#P?\ R/1_P]#C_P"B:M_X/!_\
MCUX%_P ,/_&W_H2&_P#!G9?_ !ZC_AA_XV_]"0W_ (,[+_X]1_9G#/\ -#_P
M8_\ Y(/[0XB_EG_X+7_R)[[_ ,/0X_\ HFK?^#P?_(]=9\*/^"@;?%3XC:!X
M3@\ &Q?5+D0&Z;6/,$2X+,VWR!NP 3C(SZBOE;_AA_XV_P#0D-_X,[+_ ./5
MZ!^S_P#LL?&'X;?&?PCXDU'P9)%I]C?*;F1=1LV*1."CM@2DG"L3@#)Q7+BL
MNX=C0J.C*',D[?O.MM/M=SHP^/SZ5:"JJ7+=7]SI?7[)Z+_P4>^,VI:/_8_P
M\TNYDM(+ZU_M#4VB;!FC+LD41/\ =S&[$=_E_'X%K[@_X*6?#?4?^$A\.>.H
M(I)M,:S&DW+*"1!(LCR1EO0/YK >Z>_/P_7O<-1HQRRDZ76]_6^M_P"MK'B\
M0RJRS&HJO2UO2VEOZW/2/@#\9-3^"/Q(TS7K*XD73S*D6I6JD[;FV+#>I'<@
M9*G'! K]+OVF/VC&_9UT'1-6'AW_ (2*WU*X>V.V^^S>4P3<I_U;[@0&],8[
MYX_+?X4?#G4OBQ\0-&\+Z9$[S7TZI+(BDB"'/[R5N. JY/Z=Z_0S]NCX3^-O
MBQX4\*:%X*\/MJ\5K=275RRW4$*P[8PD:_O'7.0[],XV^]>'G]' U<TPL<1;
M5/FN[:=+NZZWMKY'LY)6QE/+<3*A?2W+97UZV6O2US?_ &9?VLG_ &CM=UJP
M3PE_8$.F6R3O<'4?M)=F;:J[?*3' 8YSVZ>GQ1^VM\9M2^)GQDUG2/M,B^'_
M  [=2:?:68;Y/,C.R64CNS.&P?[H ^OT=^PK\$/B-\&?&'B7_A+?#,FE:7J5
MC&$NOMMO,/-CD^52L<C-RKN<XQ\OO7RO^U]\-]1^'/QX\4?:XI/L6L7DNK65
MPP.V6.9R[ 'N59F4_3W!K/*,/E]+.JL<-9Q45RV?-VYM;O7]"\TKXZKE%.6(
MNFY/FNK=[:66GZGB]?7W_!/'XS:EH?Q&'P_N[F2?0]9CEDM8';*V]RB&0LOH
M&1'!'<A3]?D&OJ/_ ()\?#2_\4?&R#Q1Y+KI'AV&622=E.QYI(VC2,''WL.S
M^VSW&?J\]C1EEM;V^R3MZ]/Q/FLEE5CF%'V.]U?TZ_@?3/[07[;;? 7XC3>%
MI?!/]LJMM%<QWBZKY&]7!_@\EL8(8=3T_"O-?^'H<?\ T35O_!X/_D>J'[8G
M[.GQ3^+_ ,;+S6?#WA*2^T6&SM[.WNC?VL?FA5+,0KRA@-SL.1VSWKQ'_AA_
MXV_]"0W_ (,[+_X]7R&7Y?D%3"4I8F4.=I7_ 'EM?3FT/J<=CL\ABJD<.I<B
M;M[E]/7E/??^'H<?_1-6_P#!X/\ Y'H_X>AQ_P#1-6_\'@_^1Z\"_P"&'_C;
M_P!"0W_@SLO_ (]1_P ,/_&W_H2&_P#!G9?_ !ZO0_LSAG^:'_@Q_P#R1P_V
MAQ%_+/\ \%K_ .1/??\ AZ''_P!$U;_P>#_Y'H_X>AQ_]$U;_P '@_\ D>O
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M ,>H_LSAG^:'_@Q__)!_:'$7\L__  6O_D3WW_AZ''_T35O_  >#_P"1Z/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR.#GM@^[?MK?MX>"?C9\)Y/!'@_3M2N'O+F&>YO]0@6%(DC;> @W%BQ( .0
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MNXTIS7O-:_UZMGJ93:,JT(?"I:?UZ)!1117AGT(4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\V_\
M@I=_R6CP[_V+\?\ Z4W%4O\ @FW_ ,EZU3_L7[C_ -'V]7?^"EW_ "6CP[_V
M+\?_ *4W%4O^";?_ "7K5/\ L7[C_P!'V]?LT?\ DF?^W/U/R67_ "47_;_Z
M'Z8T445^,GZT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <!\1O^1I\&?]?O\ [/%7?UP'
MQ&_Y&GP9_P!?O_L\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PS^TI_P3
M.T_XE>*+[Q1X UFV\-:C?2--=Z7?1L;.25CEG1T!:/)R2NUAD\;>E</\(/\
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MF?/4/;PV&IX6')304445S'4%%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /S;_ ."EW_):/#O_ &+\?_I3<52_X)M_\EZU
M3_L7[C_T?;U=_P""EW_):/#O_8OQ_P#I3<52_P"";?\ R7K5/^Q?N/\ T?;U
M^S1_Y)G_ +<_4_)9?\E%_P!O_H?IC1117XR?K04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!P'Q&_Y&GP9_P!?O_L\5=_7 ?$;_D:?!G_7[_[/%7?T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1U!X^S_^"?/BCP;XF_9YL?\ A$=&C\/RVMT\6KZ=%/+,JWNU-T@:1F;:ZA&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\M?&S_DIFL?2'_P!$I7U+7RU\;/\ DIFL?2'_ -$I7X_XH_\ (EI?
M]?8_^DS/N^#O^1A/_ __ $J)@^!_^1TT#_L(6_\ Z,6OL.OCSP/_ ,CIH'_8
M0M__ $8M?8=>;X5?[GBO\2_(ZN-/X]'T?YA1117[D?G04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** . ^(W_(T^#/^OW_ -GBKOZX#XC?\C3X,_Z_?_9X
MJ[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *9-,EO#)+*P2.-2S,>@ &2:CO;I+"S
MGN9 QCAC:1@O7 &3C\J^,M7_ ."I7PAOM)O;:/2_%@DF@>-2UA!C)4@9_?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?FW_ ,%+O^2T>'?^Q?C_ /2FXJE_P3;_ .2]
M:I_V+]Q_Z/MZN_\ !2[_ )+1X=_[%^/_ -*;BJ7_  3;_P"2]:I_V+]Q_P"C
M[>OV:/\ R3/_ &Y^I^2R_P"2B_[?_0_3&BBBOQD_6@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#@/B-_R-/@S_K]_]GBKOZX#XC?\C3X,_P"OW_V>*N_H **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\M?&S
M_DIFL?2'_P!$I7U+7RU\;/\ DIFL?2'_ -$I7X_XH_\ (EI?]?8_^DS/N^#O
M^1A/_ __ $J)@^!_^1TT#_L(6_\ Z,6OL.OCSP/_ ,CIH'_80M__ $8M?8=>
M;X5?[GBO\2_(ZN-/X]'T?YA1117[D?G04444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^;?_  4N_P"2T>'?^Q?C_P#2FXJE
M_P $V_\ DO6J?]B_<?\ H^WJ[_P4N_Y+1X=_[%^/_P!*;BJ7_!-O_DO6J?\
M8OW'_H^WK]FC_P DS_VY^I^2R_Y*+_M_]#],:***_&3]:"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\DW\6?\
M8)N__1+UTM<U\3?^2;^+/^P3=_\ HEZ<=T)[&5\#?^22^&?^O7_V9J[JN%^!
MO_))?#/_ %Z_^S-7=4/<%L%%%%(84444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'YM_\ !2[_ )+1X=_[%^/_ -*;BJ7_  3;_P"2]:I_V+]Q
M_P"C[>KO_!2[_DM'AW_L7X__ $IN*I?\$V_^2]:I_P!B_<?^C[>OV:/_ "3/
M_;GZGY++_DHO^W_T/TQHHHK\9/UH**** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
ME[XXV\D/Q(U%W7"S)"Z'U'EJN?S4_E7U#7.^+_ 6C^-X8DU*!C)%_JYX6VR+
MGJ,]Q[&OAN,<AK<0Y9]5P\DIQDI*^SLFK>6C^\^CR',J>5XOVU57BTT[?)_H
M?(=%?1/_  SGX=_Y_P#5/^_D?_QNC_AG/P[_ ,_^J?\ ?R/_ .-U^"_\0XS_
M /DC_P"!(_2O]:\L_F?W'SM17T3_ ,,Y^'?^?_5/^_D?_P ;H_X9S\._\_\
MJG_?R/\ ^-T?\0XS_P#DC_X$@_UKRS^9_<?.U%?1/_#.?AW_ )_]4_[^1_\
MQNC_ (9S\._\_P#JG_?R/_XW1_Q#C/\ ^2/_ ($@_P!:\L_F?W'SM17T3_PS
MGX=_Y_\ 5/\ OY'_ /&Z^=V&&(KYC.^&\PX?]G]>27/>UG?:U_S1[&7YMALT
MY_JS?NVO=6WO_D>M_LY:E/'XDU&P#M]FDM3,4SQN5U ./HQKZ"KYS_9U_P"1
MXO/^P?)_Z,CKZ,K^B_#F<I9!!2=[2DE]Y^5<5Q4<SDTMT@HHHK]//CPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK$?\_H_<P_UOH?\ /I_>C]GZJZIJ5KHNFW>H7TZ6UE:0O//-(<+'&JEF8^P
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M;Z'_ #Z?WH_9^BOQ@_X:"^*'_11?%7_@ZN?_ (NC_AH+XH?]%%\5?^#JY_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\DW\6?]@F[_\
M1+UTM<U\3?\ DF_BS_L$W?\ Z)>G'=">QE? W_DDOAG_ *]?_9FKNJX7X&_\
MDE\,_P#7K_[,U=U0]P6P4444AA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\1O]YOK7VY7Q&_WF^M?S]XL;8'_N)_[8?IW!/_,1_P!N_P#M
MQZA^SK_R/%Y_V#Y/_1D=?1E?.?[.O_(\7G_8/D_]&1U]&5]?X;_\B&/^.7Z'
MA\6?\C)_X4%%%%?J1\:%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIC%"=E&25FNGWGQ.#QU+ RG3NY0;NGU^YG[9T5^+?_#PW]H'_H?_ /RC:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7Q&_WF^M?;E?$;_>;ZU_/WBQM@?\ N)_[8?IW!/\ S$?]
MN_\ MQZA^SK_ ,CQ>?\ 8/D_]&1U]&5\Y_LZ_P#(\7G_ &#Y/_1D=?1E?7^&
M_P#R(8_XY?H>'Q9_R,G_ (4%%%%?J1\:%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?)G_  4L
M_P"2%:%_V,D'_I+=5\(? /\ Y+K\.?\ L9--_P#2J.ON_P#X*6?\D*T+_L9(
M/_26ZKX0^ ?_ "77X<_]C)IO_I5'7[-PY_R))_\ ;Y^2Y]_R.(_]NG[14445
M^,GZT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P'Q&_P"1I\&?
M]?O_ +/%7?UP'Q&_Y&GP9_U^_P#L\5=_0 4444 %%%% !1110 4444 %%%%
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M5W_7;[SV_P#9J&)A15-*33:=EY_Y,^DZ***X#T@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KFOB;_P DW\6?]@F[
M_P#1+UTM<U\3?^2;^+/^P3=_^B7IQW0GL97P-_Y)+X9_Z]?_ &9J[JN%^!O_
M "27PS_UZ_\ LS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7Q&_P!YOK7VY7Q&_P!YOK7\_>+&V!_[B?\ MA^G<$_\Q'_;
MO_MQZA^SK_R/%Y_V#Y/_ $9'7T97SG^SK_R/%Y_V#Y/_ $9'7T97U_AO_P B
M&/\ CE^AX?%G_(R?^%!1117ZD?&A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R9_P4L_Y(5H7
M_8R0?^DMU7PA\ _^2Z_#G_L9--_]*HZ^[_\ @I9_R0K0O^QD@_\ 26ZKX0^
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M_8R0?^DMU7PA\ _^2Z_#G_L9--_]*HZ^[_\ @I9_R0K0O^QD@_\ 26ZKX0^
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M_P#E>_\ N:C_ (>B?]4S_P#*]_\ <U?"%%'^K&4?\^?_ ":7_P D'^L6:?\
M/W_R6/\ D?=__#T3_JF?_E>_^YJ/^'HG_5,__*]_]S5\(44?ZL91_P ^?_)I
M?_)!_K%FG_/W_P EC_D?=_\ P]$_ZIG_ .5[_P"YJ^HO%7QLA\"_ I?B)XAT
MPZ=*VGPW7]D+/YK":4+Y<&_:N3N903MXPQYQ7XW5^E_[>L,GB#]EW2]1TD;M
M.BO[&]D,?*_9VB=$/TW21_I7R^;Y)@,/BL)0HT^55)6;NWHK::M[W/H\KSC&
MU\/B:U6?,X1NE9>>NB6UCX3^*WQ[\:_&+6KB^U_6KEK9V)BTV"1DM8%[*L8.
M.G\1R3W)H^%/Q[\:_!W6K>^T#6KE;9&!ETV>1GM9U[JT9..G\0P1V(KSRBOT
M7ZGA_8_5_9KD[6T/@OK5?VOM^=\_>^I^R'A7XV0^.O@4WQ$\/:8=1F73YKK^
MR&G\IC-$&\R#?M;!W*0#MYRIXS7R]_P]$_ZIG_Y7O_N:O0/V"X9/#_[+NJ:C
MJHVZ=+?WU[&9.%^SK$B.?INCD_6OS0K\ZRC),!B,3BZ%:GS*G*R=VM'?31K:
MQ][FF<8VAA\+6I3Y7.-VK+RUU3WN?=__  ]$_P"J9_\ E>_^YJ/^'HG_ %3/
M_P KW_W-7PA17U'^K&4?\^?_ ":7_P D?.?ZQ9I_S]_\EC_D?=__  ]$_P"J
M9_\ E>_^YJ/^'HG_ %3/_P KW_W-7PA11_JQE'_/G_R:7_R0?ZQ9I_S]_P#)
M8_Y'W?\ \/1/^J9_^5[_ .YJDM_^"H433()_AL\<.?F:/6P[ >P-N,_F*^#*
M*/\ 5C*?^?/_ )-+_,/]8\T_Y^_^2Q_R/V:^"/QT\-?'KPN^L>'I94DMV6*\
ML;E=LUM(1D!NQ!YPPX.#W! ]$K\[/^"9>GZFWQ&\67T:.-'32EAG?:=AG:9#
M&,],[5E_.OT3K\BSO T\NQT\/1=XJS]+K8_4LGQE3'X.%>JK2=_G;J%%%%>$
M>T?C[\!_^4RGB;_L-:U_Z3S5^AG[;7QVU_\ 9M_9U\0>/O#-IIM]K&GSVD44
M&K1226Y$MQ'&VY8W1LX<XPPYQUK\\_@/_P IE/$W_8:UK_TGFK[&_P""KG_)
MD7C3_K[T[_TMAK!R<<#A6OY8_P#I1LTGC<0GW?Y'CTW_  58UW7/ O@[1_ '
MP_;XD_%[5-+6^U6QT.WN'L--D;/RB-#)+(0-I9=P"[N7SE1R?AW_ (*P_%;X
M7^.[#2/C[\(E\,Z;>%3YMCI]WIUU#%G!E6*Y=Q.H/92O?G/%>U?\$A_AGI/A
M/]E&R\46]I&-9\47US<7=V5'F-'#,\$<>>NU?+8@>KL>]<S_ ,%I]%LKK]FS
MPMJDD"M?V?B>&&&; W(DEM<%USZ$QH<?[(]*Z<1_LT[VOJKKU>WRO;OH8T(^
MWCR;63UZ^ZGK\[>AK?'3_@I3J*^+KGP9^SSX"NOC#K]I"LM[JEE;SW5C:[L$
M*$@&Z3K@MN10>,L<@>9?#7_@K-XY\(_$ZS\(_M!?#2+P8EU(B27EI9W5A-9(
MYPLLEO<,[/'GJRL. 2 V,'Z7_P"":/P[T;P%^Q[X&N-,M8X[S78&U74+D(!)
M/-([8W'OM0*@]EKYK_X+?Z+9-X)^%^KFW3^T4U&[M1<;1N\IHD8J3Z;E!_/U
MJ:S6$FN;WE=)_-VT^?X:BH_[3"ZTNFU\E?7U/TWCD6:-9$8.C ,K*<@@]"*^
M#OVCO^"H]EX'^(DWPX^$'@Z?XH^,XI7M99+?S'MH[A<[HHXXE,EPRX.[;M Q
MPQP<>E?%#XL:G\./^"<)\:6MR\.M+X(L5@ND)W1W$\$,*R ]<AI0V?45^?G_
M  3;_:D^!W[+OAWQ+J_CA=2/CS5;KR$NK73C<>58JJD(KYX+2%RP'7:F>@JI
MPMB*E%RTA][=[6_5_P!74)-X>%:VL_N6B;_/^NGMU_\ \%%?VIOA+"FO_%']
MGN"#PE@-+<6=A>V/E D ;YWDG2,\XPZ@DU]T_LX?M*>#/VHOA_'XK\'74AC1
M_(O=/N@%N;&;&?+D4$CIR&!((Z'KCYTU#_@K9^SAJUA<V-]+KMY97,;0SV\^
MBEXY488964M@@@D$'KFOD7_@FA\1M'\._M[>)]"\#2W0^'_BI-0CL;6X0HRP
MQEI[8LI)PR*K(.<X<^M52O4FZ;71M/TUL_7^MM54]R"J)]4FO7JO3^O*#_@J
MKX\^-GB35H=(\?\ @K3- \ :;X@O5\,ZO9HPFOXQE4:0F=QDQA6^XG)_"OM'
M]@WXG?M%^*FT?1OB9\.]&\-?#NU\,PMI&LV*,)[EU$"P!R;J0?-$78_(O('3
MI7DG_!;W_DE_PS_[#-S_ .B!7WA\$9EM_@7X!E<X1/#FGL3["UC-8X62ITJS
M?V9)>ON;OS70K$>]6I)+>,GZ>\M%Y,\1_;'_ ."@G@W]DM[?1/L,GB[QU=1K
M-%H5K,(EAC8X5YY=K; <'"A68^@!S7S<O[>/[9+6O_"1?\,XQ'PMNW^3_8>H
M_:O*ZYSYN<8_C\K;WQ7RO^SG^TE\.[?]LSQ5\9/C1]NOP\]S?:3'%:?:O*NF
ME40DKG@11 A?0A2.5%?H5_P]\_9Z_P"?[Q%_X*&_^*H@G[.,V_>EK;HO+S?]
M>1I4TJ2II:1TOW\_3^O,[;]C?]OKP=^UQ#=:5'92>%/'%C&9KG0+J82B2,'!
ME@DPOF*"1N!564GH1ACYW_P6,_Y-%B_[&*R_] FKX1^+_P"T;\/[[]O;P5\6
MO@X+RPLYKRRGU:.6T^R^;<M,T=SA,\B6$C<>Y9CU)-?=W_!8S_DT6+_L8K+_
M - FK+%>]AX5;6;DDUYJ4=O)W+P_NXB=-.]HM_?&6GRL>L_\$Z_^3*_A7_V#
MI/\ THEKPKXY_P#!3[5[?XH:G\-O@/\ #JX^)OB33G>&YOQ'-/ )$(601P0#
M?(BD[3(709'&1@GW#_@GI$9_V(_A?&&*%]+E4,.HS<2C-?F=^SO\==;_ ."9
M/Q^\>^&_B!X)N=4M]49(9[B$B*Y,4<DABN;9G&V6*0.QVY&2%^8%2#VXFTL;
M.$G9>\_5WVOT_KS./"^[@H3BKNT?DK:O^O\ (^A=6_X*0?M,_!-H=5^,'P!M
MK3PT[*C75A:W=@JL3@ SN\\88\X4@$U]V_![X_:#^T)\&4\>^ 6:\2>"41V5
MTH6:"Z13FWE4-PP;'0X(((."#7S_ &?_  4$_9D_:@\"ZMX*\0^*9?"]OX@L
MY;&YL?$MM]C9$=2"WVCY[=6'#*2_! ..*]J_98_9Q\ _LW^ 9],^'5_?:GH>
MKSKJ)O+N_6[6=BBJ)$9 $P55>5&#@5GRN4)QGIV:_JWG<TNE*+B[]TS\>_VH
M/B'\>?$W[6/P]USXB>!-)\/?$NS&G_V-HEFC"WNMEV[6^\&XD/S2EE/[Q>!V
MZU^N/[)/C[XW^/O#>O7'QO\ !.E^"=6M[M$T^WTM&59X2F69LW$W(;CJ/I7P
ME_P4._Y26?!#Z:'_ .G.6OU:UO3Y=6T6_L8;N2PFN;>2%+N$ O"S*0'7/&1G
M(SZ4H2:PO,E?WIZ>C7XOJ75C_M"BWTB[^J?X+H?"WQ]_X*C1^&OB9=_#;X-^
M KSXI>+K:62VFF@\QH%G3[Z111*TD^TA@Q!0#;P6'->8^)/V_OVP_AE9G7?&
MOP TVT\,PCS;F>+1[^,11C&2\WVB18N#U=<9_*O;OV<OV=?A%_P3JU3Q-J7B
MCXJZ*VL>(51;:Y\1S6^GW,5LA+-&@:4F3<Q!8J!G:O'%=3X[_P""F?[-GAJS
MO;:X\=1^(9/+97L=*TVXNA.",%0_EB(YZ<N!S6?P07+*\K:]K]K?U\]ROBD[
MQM'IWMWO_7RV.F_8W_;0\,?MA^$=0OM+T^?0/$&DM&FJ:+<2B4P[P2DD<@ \
MR-MK#)52"I!4<$_ /_!6;QW\:=:DDT'Q=X+TS2/A98>(]WA_7K=&%S>N() H
MD)G88*F0_P"K3[H_$_X(XZI:W'[3WQ+&DQO:Z-=:+--;V\@ 9(Q>1>6" 2,A
M6QU/UKW3_@ME_P F]^!_^QH7_P!)+BEB8KDI5DK<R6GK)+[U;\14&^>I2O?E
M;U_[=O\ C<Z3_@GI\3/VB=>TSP3X>\;?#S1]%^$]KX7@72?$%JC"YN52*);8
MN?M+CYX\L?W:\_W>E?=M>4?LF?\ )KGPB_[%+2__ $DCKU>N[%:5IQ[-Z]]7
MJSFH?PT^Z7RT"BBBN4W"BBB@ HHHH **** "BBB@ HHHH **** "OB-_O-]:
M^W*^)9XVAFD1QM=6*D'L0:_G_P 6-L$_^OG_ +8?IW!6^(_[=_\ ;CT3X#ZM
M9:/XPNIK^\M[*%K%T$EQ*L:EO,C.,D]>#^5>]?\ "=>&_P#H8-*_\#8O_BJ^
M/:*^*X?XZQ/#^"6"I48R2;=VWU/H,SX<I9GB/K$ZC3LEHET/L+_A.O#?_0P:
M5_X&Q?\ Q5'_  G7AO\ Z&#2O_ V+_XJOCVBOI/^(J8W_H&C][/*_P!2\/\
M\_G]R/L+_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BI
MC?\ H&C][#_4O#_\_G]R/L+_ (3KPW_T,&E?^!L7_P 51_PG7AO_ *&#2O\
MP-B_^*KX]HH_XBIC?^@:/WL/]2\/_P _G]R/L+_A.O#?_0P:5_X&Q?\ Q5'_
M  G7AO\ Z&#2O_ V+_XJOCVBC_B*F-_Z!H_>P_U+P_\ S^?W(^PO^$Z\-_\
M0P:5_P"!L7_Q5'_"=>&_^A@TK_P-B_\ BJ^/:*/^(J8W_H&C][#_ %+P_P#S
M^?W(^PO^$Z\-_P#0P:5_X&Q?_%4?\)UX;_Z&#2O_  -B_P#BJ^/:*/\ B*F-
M_P"@:/WL/]2\/_S^?W(^PO\ A.O#?_0P:5_X&Q?_ !5'_"=>&_\ H8-*_P#
MV+_XJOCVBC_B*F-_Z!H_>P_U+P__ #^?W(^PO^$Z\-_]#!I7_@;%_P#%4?\
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MR/L+_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BIC?\
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M .A@TK_P-B_^*KX]HH_XBIC?^@:/WL/]2\/_ ,_G]R/L+_A.O#?_ $,&E?\
M@;%_\51_PG7AO_H8-*_\#8O_ (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]R/L+
M_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BIC?\ H&C]
M[#_4O#_\_G]R/L+_ (3KPW_T,&E?^!L7_P 51_PG7AO_ *&#2O\ P-B_^*KX
M]HH_XBIC?^@:/WL/]2\/_P _G]R/L+_A.O#?_0P:5_X&Q?\ Q5'_  G7AO\
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MPG7AO_H8-*_\#8O_ (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]R/L+_A.O#?\
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M_%4?\)UX;_Z&#2O_  -B_P#BJ^/:*/\ B*F-_P"@:/WL/]2\/_S^?W(^PO\
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M]#!I7_@;%_\ %4?\)UX;_P"A@TK_ ,#8O_BJ^/:*/^(J8W_H&C][#_4O#_\
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M!H_>P_U+P_\ S^?W(^PO^$Z\-_\ 0P:5_P"!L7_Q5'_"=>&_^A@TK_P-B_\
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MFW?SYHQT/QK.\=EN*IPC@7.Z>O.HI6\K29_0YI__ !XVW_7-?Y"K%?BMIO\
MP4"^/.DV$%G;^.<00((XQ)I5DY"CH-S0DG\37U__ ,$[_P!IKXC_ !W\9>+K
M#QOX@76;6PL(I[=!8V]OL<R;2<Q1J3QZYJJF7UZ-+VE2VF]FW^B_0[J.:4*]
M54J:>O=+_-GW51117FGL!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^7X'B?ZL9?[7VEG;M?3_ #_$XW7?A3HVK_"VX\ 6CW.@Z!-8C3A_9;(DL<&
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M,B@@@R0M%"LI! /SN>><U]M?LL_LG^"OV3? \F@^%8Y;N^O&674]:O,&YO9
M,#.!A47)VH.!D]22QBFK2<Y/2VB\^[]/Z\KGK%1BM;ZOR[?/^O/X]_X+>_\
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M7DG[8_\ P3O\%?M97$>OK?R^$/',,2PKK5K )H[E%^ZMQ%E=^!D!@RL.,E@
MM?.*?L%_MEV>G'PW:_M%6X\, ^6KMKVI+<"+H !Y)*C&!L$NWM1"3]E&$E[T
M5:_1^?E_7J[J).K*I%Z2=_1]O3^NMEU7C;XY_L\>#OVL-*^#7AC]G'P7XMU2
M2\MK*36-*TC3T^R7CO\ .FS[.<^4,,S!QM(88!4UUW_!8S_DT6+_ +&*R_\
M0)JZS]C3_@G3X1_93U"3Q/>ZG)XR\>31M$-6N(!##:(WWA!%EB&8<-(S$D9
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M5)XR;F-"BLKIC8>JGIQ7/:4\+.BG:2<VO^WK6_S-Y2BL1&K:\;13^6Y\4_\
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M_0+_ .3U/_D@_P!9LV_Y_?\ DL?\CQ#_ (9I_P"IC_\ )'_[91_PS3_U,?\
MY(__ &RO;Z*/]0>&_P#H%_\ )ZG_ ,D'^LV;?\_O_)8_Y'B'_#-/_4Q_^2/_
M -LH_P"&:?\ J8__ "1_^V5[?11_J#PW_P! O_D]3_Y(/]9LV_Y_?^2Q_P C
MQ#_AFG_J8_\ R1_^V4?\,T_]3'_Y(_\ VRO;Z*/]0>&_^@7_ ,GJ?_)!_K-F
MW_/[_P EC_D>(?\ #-/_ %,?_DC_ /;*/^&:?^IC_P#)'_[97M]%'^H/#?\
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M_D]3_P"2#_6;-O\ G]_Y+'_(\0_X9I_ZF/\ \D?_ +91_P ,T_\ 4Q_^2/\
M]LKV^BC_ %!X;_Z!?_)ZG_R0?ZS9M_S^_P#)8_Y'B'_#-/\ U,?_ )(__;*/
M^&:?^IC_ /)'_P"V5[?11_J#PW_T"_\ D]3_ .2#_6;-O^?W_DL?\CQ#_AFG
M_J8__)'_ .V4?\,T_P#4Q_\ DC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\
M/[_R6/\ D>(?\,T_]3'_ .2/_P!LH_X9I_ZF/_R1_P#ME>WT4?Z@\-_] O\
MY/4_^2#_ %FS;_G]_P"2Q_R/$/\ AFG_ *F/_P D?_ME'_#-/_4Q_P#DC_\
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M .V4?\,T_P#4Q_\ DC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\ /[_R6/\
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MV4?\,T_]3'_Y(_\ VRO;Z*/]0>&_^@7_ ,GJ?_)!_K-FW_/[_P EC_D>(?\
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M^?W_ )+'_(\0_P"&:?\ J8__ "1_^V4?\,T_]3'_ .2/_P!LKV^BC_4'AO\
MZ!?_ ">I_P#)!_K-FW_/[_R6/^1XA_PS3_U,?_DC_P#;*/\ AFG_ *F/_P D
M?_ME>WT4?Z@\-_\ 0+_Y/4_^2#_6;-O^?W_DL?\ (\0_X9I_ZF/_ ,D?_ME'
M_#-/_4Q_^2/_ -LKV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S^_\ )8_Y'B'_  S3
M_P!3'_Y(_P#VRC_AFG_J8_\ R1_^V5[?11_J#PW_ - O_D]3_P"2#_6;-O\
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M3_U,?_DC_P#;*]OHH_U!X;_Z!?\ R>I_\D'^LV;?\_O_ "6/^1XA_P ,T_\
M4Q_^2/\ ]LH_X9I_ZF/_ ,D?_ME>WT4?Z@\-_P#0+_Y/4_\ D@_UFS;_ )_?
M^2Q_R/$/^&:?^IC_ /)'_P"V4?\ #-/_ %,?_DC_ /;*]OHH_P!0>&_^@7_R
M>I_\D'^LV;?\_O\ R6/^1XA_PS3_ -3'_P"2/_VRC_AFG_J8_P#R1_\ ME>W
MT4?Z@\-_] O_ )/4_P#D@_UFS;_G]_Y+'_(\0_X9I_ZF/_R1_P#ME'_#-/\
MU,?_ )(__;*]OHH_U!X;_P"@7_R>I_\ )!_K-FW_ #^_\EC_ )'B'_#-/_4Q
M_P#DC_\ ;*/^&:?^IC_\D?\ [97M]%'^H/#?_0+_ .3U/_D@_P!9LV_Y_?\
MDL?\CQ#_ (9I_P"IC_\ )'_[91_PS3_U,?\ Y(__ &RO;Z*/]0>&_P#H%_\
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M_P"2/_VRO;Z*/]0>&_\ H%_\GJ?_ "0?ZS9M_P _O_)8_P"1XA_PS3_U,?\
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MPW_T"_\ D]3_ .2#_6;-O^?W_DL?\CQ#_AFG_J8__)'_ .V4?\,T_P#4Q_\
MDC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\ /[_R6/\ D>(?\,T_]3'_ .2/
M_P!LH_X9I_ZF/_R1_P#ME>WT4?Z@\-_] O\ Y/4_^2#_ %FS;_G]_P"2Q_R/
M$/\ AFG_ *F/_P D?_ME'_#-/_4Q_P#DC_\ ;*]OHH_U!X;_ .@7_P GJ?\
MR0?ZS9M_S^_\EC_D>(?\,T_]3'_Y(_\ VRC_ (9I_P"IC_\ )'_[97M]%'^H
M/#?_ $"_^3U/_D@_UFS;_G]_Y+'_ "/$/^&:?^IC_P#)'_[91_PS3_U,?_DC
M_P#;*]OHH_U!X;_Z!?\ R>I_\D'^LV;?\_O_ "6/^1XA_P ,T_\ 4Q_^2/\
M]LH_X9I_ZF/_ ,D?_ME>WT4?Z@\-_P#0+_Y/4_\ D@_UFS;_ )_?^2Q_R/$/
M^&:?^IC_ /)'_P"V4?\ #-/_ %,?_DC_ /;*]OHH_P!0>&_^@7_R>I_\D'^L
MV;?\_O\ R6/^1XA_PS3_ -3'_P"2/_VRC_AFG_J8_P#R1_\ ME>WT4?Z@\-_
M] O_ )/4_P#D@_UFS;_G]_Y+'_(\0_X9I_ZF/_R1_P#ME'_#-/\ U,?_ )(_
M_;*]OHH_U!X;_P"@7_R>I_\ )!_K-FW_ #^_\EC_ )'B'_#-/_4Q_P#DC_\
M;*/^&:?^IC_\D?\ [97M]%'^H/#?_0+_ .3U/_D@_P!9LV_Y_?\ DL?\CQ#_
M (9I_P"IC_\ )'_[91_PS3_U,?\ Y(__ &RO;Z*/]0>&_P#H%_\ )ZG_ ,D'
M^LV;?\_O_)8_Y'B'_#-/_4Q_^2/_ -LH_P"&:?\ J8__ "1_^V5[?11_J#PW
M_P! O_D]3_Y(/]9LV_Y_?^2Q_P CQ#_AFG_J8_\ R1_^V4?\,T_]3'_Y(_\
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MFW_/[_R6/^1XA_PS3_U,?_DC_P#;*/\ AFG_ *F/_P D?_ME>WT4?Z@\-_\
M0+_Y/4_^2#_6;-O^?W_DL?\ (\0_X9I_ZF/_ ,D?_ME'_#-/_4Q_^2/_ -LK
MV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S^_\ )8_Y'B'_  S3_P!3'_Y(_P#VRC_A
MFG_J8_\ R1_^V5[?11_J#PW_ - O_D]3_P"2#_6;-O\ G]_Y+'_(\0_X9I_Z
MF/\ \D?_ +91_P ,T_\ 4Q_^2/\ ]LKV^BC_ %!X;_Z!?_)ZG_R0?ZS9M_S^
M_P#)8_Y'B'_#-/\ U,?_ )(__;*/^&:?^IC_ /)'_P"V5[?11_J#PW_T"_\
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M\TE'D3T.[V<+\UE<****DT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** . ^(W_(T^#/\ K]_]GBKOZX#XC?\ (T^#/^OW_P!GBKOZ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\ )-_%G_8)N_\
MT2]=+7-?$W_DF_BS_L$W?_HEZ<=T)[&5\#?^22^&?^O7_P!F:NZKA?@;_P D
ME\,_]>O_ +,U=U0]P6P4444AA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAO\ Y\M5_P"_47_QRC_AHOPW_P ^6J_]^HO_ (Y1_KAD'_07'\?\A_V%F?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#Y,_X*6?\ )"M"_P"QD@_]);JOA#X!_P#)=?AS_P!C)IO_ *51
MU]W_ /!2S_DA6A?]C)!_Z2W5?"'P#_Y+K\.?^QDTW_TJCK]FX<_Y$D_^WS\E
MS[_D<1_[=/VBHHHK\9/UH**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#@/B-_P C3X,_Z_?_ &>*N_K@/B-_R-/@S_K]_P#9XJ[^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:^)O\ R3?Q9_V";O\
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M_P CQ"OSO_;C^*/C/PE\=);#0_%VNZ-8C3K=Q:Z?J4T$6X[LMM1@,GUK]?\
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MFK6OZ[W/$**]O_X9I_ZF/_R1_P#ME'_#-/\ U,?_ )(__;*^'_U!XD_Z!?\
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ML_\ \FJ:'_V-=K_Z375<6(DO91A%62<;+_MY'?A8OVLIR=VU+_TEGO/[ _\
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MLKVVCN8)4.0\;J&5@?0@BIP_\"53[3DT_1:+[U^1=?\ BPAT4;KS;M?[MO\
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M@;\=/@;X*\=?\)7XV^TZSIL4]W'9ZA9"**Y VSQJ#:$@+(KK@DGCK7<>(/\
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M]OGY+GW_ ".(_P#;I^T5%%%?C)^M!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <!\1O^1I\&?\ 7[_[/%7?UP'Q&_Y&GP9_U^_^SQ5W] !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'R9_P %+/\ DA6A?]C)!_Z2W5?"'P#_ .2Z_#G_ +&33?\ TJCK
M[O\ ^"EG_)"M"_[&2#_TENJ^$/@'_P EU^'/_8R:;_Z51U^S<.?\B2?_ &^?
MDN??\CB/_;I^T5%%%?C)^M!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <!\1O\ D:?!G_7[_P"SQ5W]<!\1O^1I\&?]?O\ [/%7?T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7Q-_Y)OXL_[!-W_Z
M)>NEKFOB;_R3?Q9_V";O_P!$O3CNA/8RO@;_ ,DE\,_]>O\ [,U=U7"_ W_D
MDOAG_KU_]F:NZH>X+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "LSQ'XCT[PEHMQJVK7'V33[?;YLVQGV[F"CA02>6 X'>M.O-OVC/\
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MG;2XNHZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS-<\2:=X;6Q.HW'V<7MU'96_R,V^9\[%^4'&<'DX'O6G7FOQO_U/@?\ [&JP
M_F]>E4[:)BZA1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9A\2:<OB0:";C_B;&U^VBWV-_J=^S=NQM^]QC.?:M.O-9/^3CH?^Q6;
M_P!*Z]*IM6$@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME278R9*L5;A@#U![5IUYK^SK_P DETG_ *ZW/_I1)3MI<76QZ51112&%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#S7_A=O\ U(7CC_P3?_9UA^.OB_\ VGX)\0V?_"$^,+3[1IUQ%]HNM)V1
M1[HF&YVW\*,Y)[ &O9JYKXF_\DW\6?\ 8)N__1+U::OL2T[;GCWPS^/&E>%?
M >BZ5<Z!XAN)K6 *TMM9HT;9)(*DN,C!]*Z?_AIC1/\ H6O%'_@ G_QRNZ^&
M7_)-_"?_ &";3_T2E=+0VK[ KVW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\
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MH_\  !/_ (Y1_P -,:)_T+7BC_P 3_XY7K]%%UV"S[GD'_#3&B?]"UXH_P#
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M'_@ G_QRC_AIC1/^A:\4?^ "?_'*]?HHNNP6?<\@_P"&F-$_Z%KQ1_X )_\
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MM>*/_ !/_CE'_#3&B?\ 0M>*/_ !/_CE>OT4778+/N>0?\-,:)_T+7BC_P
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M.4?\-,:)_P!"UXH_\ $_^.5Z_11==@L^YY!_PTQHG_0M>*/_   3_P".4?\
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M%'_@ G_QRC_AIC1/^A:\4?\ @ G_ ,<KU^BBZ[!9]SR#_AIC1/\ H6O%'_@
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MBC_P 3_XY1_PTQHG_0M>*/\ P 3_ ..5Z_14W78=GW/(/^&F-$_Z%KQ1_P"
M"?\ QRC_ (:8T3_H6O%'_@ G_P <KU^BBZ[!9]SR#_AIC1/^A:\4?^ "?_'*
M/^&F-$_Z%KQ1_P" "?\ QRO7Z*+KL%GW/(/^&F-$_P"A:\4?^ "?_'*/^&F-
M$_Z%KQ1_X )_\<KU^BBZ[!9]SR#_ (:8T3_H6O%'_@ G_P <H_X:8T3_ *%K
MQ1_X )_\<KU^BBZ[!9]SR#_AIC1/^A:\4?\ @ G_ ,<H_P"&F-$_Z%KQ1_X
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M $_^.5Z_11==@L^YY!_PTQHG_0M>*/\ P 3_ ..4?\-,:)_T+7BC_P  $_\
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M.4?\-,:)_P!"UXH_\ $_^.5Z_11==@L^YY!_PTQHG_0M>*/_   3_P".4?\
M#3&B?]"UXH_\ $_^.5Z_11==@L^YY!_PTQHG_0M>*/\ P 3_ ..5D>,/VA]'
MUCPEK=A'X>\1PR75C/ LDUDBHI:-E!8^8< 9YKW:N=^(W_)/?%'_ &"[K_T2
MU--7V#7N>3^!_P!H31]#\&:%ITOA_P 13RVEC# TL%DC1N50 E3Y@R#CCBMO
M_AIC1/\ H6O%'_@ G_QRNW^%O_)-/"G_ &"[;_T4M=10VK[ KVW/(/\ AIC1
M/^A:\4?^ "?_ !RC_AIC1/\ H6O%'_@ G_QRO7Z*5UV"S[GD'_#3&B?]"UXH
M_P# !/\ XY1_PTQHG_0M>*/_   3_P".5Z_11==@L^YY!_PTQHG_ $+7BC_P
M 3_XY1_PTQHG_0M>*/\ P 3_ ..5Z_11==@L^YY!_P -,:)_T+7BC_P 3_XY
M1_PTQHG_ $+7BC_P 3_XY7K]%%UV"S[GD'_#3&B?]"UXH_\  !/_ (Y1_P -
M,:)_T+7BC_P 3_XY7K]%%UV"S[GD'_#3&B?]"UXH_P# !/\ XY1_PTQHG_0M
M>*/_   3_P".5Z_11==@L^YY!_PTQHG_ $+7BC_P 3_XY1_PTQHG_0M>*/\
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MM>*/_ !/_CE>OT4778+/N>0?\-,:)_T+7BC_ , $_P#CE'_#3&B?]"UXH_\
M !/_ (Y7K]%%UV"S[GD'_#3&B?\ 0M>*/_ !/_CE'_#3&B?]"UXH_P# !/\
MXY7K]%%UV"S[GD'_  TQHG_0M>*/_ !/_CE'_#3&B?\ 0M>*/_ !/_CE>OT4
M778+/N>0?\-,:)_T+7BC_P  $_\ CE'_  TQHG_0M>*/_ !/_CE>OT4778+/
MN>0?\-,:)_T+7BC_ , $_P#CE'_#3&B?]"UXH_\  !/_ (Y7K]%%UV"S[GD'
M_#3&B?\ 0M>*/_ !/_CE<9XL^.6E:MX^\%:K'H>O10Z6]V9(9K1%EE\R(*/+
M&_YL$9.2,"OI*O-?B!_R5SX8?]=-1_\ 2<546K["=^YE?\-,:)_T+7BC_P
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M   3_P".5Z_14W78=GW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\ H6O%'_@
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M%'_@ G_QRC_AIC1/^A:\4?\ @ G_ ,<KU^BBZ[!9]SR#_AIC1/\ H6O%'_@
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M:8T3_H6O%'_@ G_QRO7Z*+KL%GW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\
MH6O%'_@ G_QRO7Z*+KL%GW/(/^&F-$_Z%KQ1_P" "?\ QRC_ (:8T3_H6O%'
M_@ G_P <KU^BBZ[!9]SR#_AIC1/^A:\4?^ "?_'*XSX0_'+2_!_@&PTJYT/7
MKN:&29C-9VB/$=TKL,$N.@.#QU!KZ2KS7]G7_DDND_\ 76Y_]*)*JZY7H+6^
MYE?\-,:)_P!"UXH_\ $_^.4?\-,:)_T+7BC_ , $_P#CE>OT5-UV'9]SR#_A
MIC1/^A:\4?\ @ G_ ,<H_P"&F-$_Z%KQ1_X )_\ '*]?HHNNP6?<\@_X:8T3
M_H6O%'_@ G_QRC_AIC1/^A:\4?\ @ G_ ,<KU^BBZ[!9]SR#_AIC1/\ H6O%
M'_@ G_QRC_AIC1/^A:\4?^ "?_'*]?HHNNP6?<\@_P"&F-$_Z%KQ1_X )_\
M'*/^&F-$_P"A:\4?^ "?_'*]?HHNNP6?<\@_X:8T3_H6O%'_ ( )_P#'*/\
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MEC)!!*NJ C@D<'O7VN6<14\!@)8.5-MN^M^Y\AF&0U,;CHXI5$DK:6[''_\
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M $_^.5Z_11==@L^YY!_PTQHG_0M>*/\ P 3_ ..4?\-,:)_T+7BC_P  $_\
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M%%% !1110 4444 %%%% !1110 4444 %%%% 'GTFF7G_  OR+4/LD_V >&S
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MX\1W4\)FC9/-C(3#KD<J<'!'%>@T4[Z6$%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y]\!M,O-'^&&F6M_:3V-TDMP6@N8VC=<
MSN1E2 1D$'\:]!HIWTL+K<****0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#@OCMIMWK'PIUZTL+6:]NY%BV06\9DD;$R$X4#)X!/X5W
M-N"MO&",$*/Y5)13OI876X4444AA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'GWQ@TR\U/_A"?L=I/=_9_$]C<3>1&S^7&N_<[8'"C(R3
MP,UZ#113OI804444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1117*=84444 %%%% !1110 4444 %%%% !1110 4444 %%>*?M4>-/BMX/\
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M?K7@?[8_[66K_"74]%^'OP\LDU;XDZ^46!602+9J[;$.P\-(S9VAOE !+9&
M<%2E*K[*&KO;3K_P#I=:,:/MJGNJUW?=>7KT/JJBOAZT_9!_:*UW31KFL?M&
M:OI?B>1?-.DV;W!L4?J$+)*B >NV$CTS7O/[+T?QDMO">IV?QC?3;C4K2\:W
ML+RTV^=<PKP9)-@"8)QM.%8C.X9ZZSHQC%M5$VNFOX::F-/$3E)*5-I/9Z?C
MKH>T4445R':%%%% !1110 4444 %%%% !1110 4444 %%%% !17P?X__ &C?
MBA^TQ\9M2^&/P*OH= T/2=RZIXJ<#+!6VLROABB;OE38-[$9R%SBUKO[+W[2
MGPNL&\0^"OCQJWCC5[<>8^BZR9/+F Y*QB>:6-C_ +P3Z@UV1P_NQE4DH\VU
M[_>[;'!+%/FE&E!RY=[6^Y7>K/N:BL/P._B&3P?H[>*X[&+Q(ULAU!--+&W6
M;'S!-W.,UKW%Q%9V\L\\BPP1*7DDD("JH&223T %<DER-IO8[8OG2:6Y+17Y
M9?%__@H-\3=;^+#S_#_6VT3X?'45TVR)TZVF^UE"OF2;Y8V8%@ZG (PK)P":
M_4VNFKAJE&G"I/[5].NEM_O.2CBZ=>K.E#[%M>CO=:?<PHHHKE.T**** "BB
MB@ HHHH **** "BBB@ HHHH ***\>_:+\,_&;Q)I^BI\'O%NC^%+N*60ZC)J
M\2R+,A"[ NZWFP0=V>%Z]Z<5S22VN3*7+%RM>Q[#17Q;_P *M_;=_P"BP^"_
M_ .+_P"5M>-_$[XJ?M9?#'XH>'?A[)\3]%\1^+-<VF&PT+3;64PAFPIE,ED@
M4'#-WPJDG QGOA@_:24(5(MOS?\ D>=4QWLXN<Z4DEY+_,_3:BO(/C#\0_&/
MP3^ HUNUT2?X@^+K&T@AN39Q!$><J%DN7C3#>7NRQ6,9Y'W1EA\[Z!^SG^TO
M\:-/7Q'XW^-FI_#B\NAYL&AZ&DB^0AY"2+#+"JD>A+M_>.<BL(45+F;DE%.U
M_P#);LZ*F(<>51@W)J]NWJ]E]Y]ST5^?OA/XZ_%C]DGXYZ+\.OB_KP\9>$-;
M9$L=?FRTL2LVP2^81N(#$!T<L0.5./O?H%15HNFHS3O&6S7EO\UU'1Q"JN4&
MK2CNGY[?)] HHHKF.H**** "BBB@ HHHH **** "BBB@ HHHH ***\(_;$_:
M2'[-7PM_M>SMXKWQ%J4WV/2[>?)C\S:6:1P.2J 9QD9)49&<TXIR:C%7;T)E
M)1BY2=DM3W>BOA+PO^S'^T9\5/#MKXM\3?'W6O"&M:A$MU%HFG"988E8!D60
M131(AP1E0C8]2<UT/[+G[1'Q"T;XUZI\#/C#+#J'B2UC:33-:C4*;I53?M)"
M@.&CRZO@-\K!LGIW/"_%&,TY13;6O3>SV=C@6,^&4H-1DTDW;KM=7NKGV917
MGWQX^,>E_ ;X7ZSXQU5#.EF@2WM5.&N9V.(XP>V3U/8 GM7QY\-/AG^T1^UC
MX='Q"UCXPZE\-M.U M)I.E:*LT:/$"0&*1RQX0XX9B[,.3P1G"E1=12FW:*W
M?GV\W^AO6KJDXP2YI2V2[=W?9>??0_02BOB7]G7]HCX@?#CXZ7'P+^-%\FKZ
MG*!_8OB# !GRI9%9L#>K@':Q&X."I)R-OVU2K472L[W3U374=&NJUU:SB[-/
MI_71A1116!TA1110 4444 %%%% !1110 4444 %%%% !117R=^VA^U!XF^&N
MN>&OAI\-H(Y_B#XF9!%<2(K_ &1'?RX]JM\N]F!Y;*J%)(Y&-*=.56:IP5VS
M.I4C1IRJ3=DCZQHKX=N/V0OVB['2CKUI^T7JUWXL5?/_ +'DDN/L#2]=@9I2
MA7/ S"![ 5Z+^Q+^TYK7QQTCQ!X:\:VL=GX\\+S""_,:",7*[F3>4'"NKHRL
M%^7.",9P.B6'7+*5.:ER[[_?KNCDCBGS1C4@X\VS=ON=GH_4^G:*^<OVUOVH
M+C]G'P-I\>A6T5[XPUZ5K?38IE+I$%QOE91][&Y0%[EAU (KR;2OV2_VC?%F
MBQ>(M>_:%UG0?%%Q&)SHMHTWV2)B,B-S%*D8(Z$+$P!SC=UJ*='GA[6<N6-[
M7[OR2[=32KB.2?LH1<I6O96T7FWWZ'W-17R%^R#^TEXVUKXC>)?@W\6%AD\;
MZ"KR0:E&JI]KC0C<K!0%)VLKJP W*3D9&3]>U-:BZ+2;NFKIK9I]2Z-:->+:
M5FG9I[IKH%%%%8'0%%%% !1110 4444 %%%% !1110 4444 %%%?!7BKXV?%
M3]K;XV:Y\.O@_KP\&>#=!9H]3\30@B:3#%"RN/F&6#!%0J6"EBV.FU*E*M+E
MCTU;Z)&%:M&A'FEU=DENVS[UHK\_OB)X6_:(_8STV/QO8?$Z\^+/A.UD7^UK
M'7$D9XXR0-V)))65,G&]'!!(RI&:^S?@Y\5-)^-7PWT3QEHNY;+4H=YA<Y>"
M0$K)$WNK C/?&>]:5*'+#VD)<T;V]'YIF5/$<T_95(N,K7UMJO)H[2BOF[]L
MK]JYOV>-!TW2?#UFFK^/->)33;-U+K"N0OFNHY;YB%5?XCGL"*\KT7]E']H_
MQ]I<?B#Q;^T#K'A3Q!<*)1HVEF7R(<C(1_)FBC5AT(5&'N:5.CSP]K-\L=K]
M_1+>W4=7$<D_90BY2WLNB\V]K]#[EHKP/]EO3?CGH*^(M'^+U]INL65A*D.E
M:M 0;B[&,LQ*@ QX( +J'W;LY'->^5G4@J<K)I^AM2J.I'F<6O)A11161J%%
M%% !1110 4444 %%%% !1110 445Y5^TE^T%I?[-GP\7Q5JNEWFKI+=I8PVM
MFR*3*R.PW,Q^5<(<D GD<&FDVTEU$VHIM[+7[CU6BOR\\&_\%#?BC\6_VB?!
M6F64]IX6\*:CK%I93:-:VT5PTD+RJK!YY$+EB"1E-GL,\U^H==5?"U,/&+J=
M?T.+#XREBI2C2UY;:^O;KT"BO$OVMOVCK;]FOX6RZXD,=[KU])]DTJSESL>8
M@DN^.=B 9..O R,YKYV\)_LY_M)_%SPI!XXUSXZ:OX1UW48A>6GA^V,T=NBL
M-T:RK%(B1DC&5$;X!YR<BII4>>+J2?+%:7\_)(TK8CV<U2A'FD];*VW=MZ(^
M]J*^1/V._P!IWQ7XF\:^(/A#\5@B_$'06D\J]5%3[;&A =6"@*7 (8,H 9#G
M&02WUW4UJ,J,DGJFKIK9I]450KQKQ;2LT[-/=-=&%%>/?M4?M 6/[.OPFU#Q
M#(8YM9N/]$TFS8_ZZY8'!(_NJ,LWL,=2*^</V _VC_BM\7/BYXL\.?$37GU&
M+3-+:86<FGVULT,XGC0Y,4:MD!F&"?UJZ.'G6A.I':/_  ^G]=3.OBZ>'G"G
M+>7;S=E?^NC/O"BBBN4[ HHHH **** "BBB@ HHHH **** "BBOG+]K;]LG3
MOV6UTFR?PY=>(-8U:"2:U19U@MT",%)=\,V<L. O/J*J,95)*$5=LB<XTX.I
M-V2W/HVBOSS_ &+_ -L;XF_'S]I"?2/$FK6R>')M/N;J/1[.RACBA9=FW;)M
M,IQD_><YS7Z&5T8C#SPSC&INU?\ K[CGPV*IXJ+E3V3M_7WA17C'[47[36E_
MLP>#K#6]1T:\UR;4+AK6UMK61(U\P(7^=VSM7 ZA6/M7QK\$?V]?BC\:OVHO
M".CS7EIH?A+4KPP2:'9VD4BF,1NPW3.AD+9 R591QP!58?"5<3=P6BZD8C&T
M<*U&;U?1'Z8T45\I_M+?$KXXZM\3K#X7_"7PX^BF\MA=3^,;Y%:!8\@.48AE
M0*2 <@R$D;5'!;FIP=2:A'=]]#JJ5%2@YRV7;5]CZLHKX:UK]D#]H?P]I,FN
M:%^T7KFM^)($\Y=)NY+A+65P,E%+SNAST&Z( ]\"O0?V'_VJM4^/6D:UX;\8
MV\=IX[\.,%NS'&(Q=1[BAD*#A75AM<#C)4@#.!U/#IQE*G-2Y=]_UW1R1Q34
MXQJP<>;9Z6]-'H_4^I****XCO"BBB@ HHHH **** "BBB@ HHHH ***^,?VL
MO^"A0^!'B_5? _A[PNVI>);2*,OJ&HRA;2(R1K(I5%.Z3 89!*<]S6E.G*K-
M4X*[,JE2%&#J5'9(^SJ*^-/^"=?[0WC[X^0^/9?'&N+K!TZ6S^QJMG!;B$2"
M8L!Y2*6'R+][)X^M?8]Q(T-O+(D33NBEA%&0&<@?=&2!D^Y K3$498:;ISW5
MMO-7,L+B(8NFJE/;5:^3L245\*12?M*_M:>*M8%GJ=U\#/ >GW4EFN(V6^E=
M&(."I5Y&!')5TC[ L0:YOXJ>%_VB/V+].A\<V'Q5OOB?X6@F1-3M=<$LFQ68
M ;DEDD(0D@;HW# D<8S6L<,M(RFE)VLM]]KM:(QEBI+FE"FW&-[O1;;V3LV?
MH?17$_!?XJ:;\:_ACH'C/2D:&VU2#>UNS9:"525DC)[[75AGOC/>OGK]L7]I
M[Q7X5\9>'_A%\*D23X@Z\4\R\**_V.-R0@4,"H<@%BS A5&<<@C%4*CJ^PM[
MU['0\125'ZPW[MKGUW17P3XM_9Q_:3^$_A2X\;Z'\=M7\5Z]I\)N[K0;@S26
M[*HRZQ++(Z2$#. 8TSVP<"OHC]D?]I"V_:6^%L>MO!'8Z_8R?8]6LXL[$F"@
MATR<[''(ST.X9.W)UEA[0<Z<E)1WM?2_Z>9C#%7G&G4@XN5[7MK;?;KY'MU%
M%%<9W!1110 4444 %%%% !1110 4444 %%%?G;^T=_P4[U/0]6U[PG\/O#QT
M[4;"ZFL)=<U8I(R/&[(S10#*]5R&=B/5*VI49UY<E-79A6KT\/#GJNR/T2HK
MYX_83^*WBGXR_ 6'Q'XQU3^V-9;4KFW-S]GB@^1"NT;8E5>,GG&:]F^('B2^
M\'^"=:UO3=$NO$=]8VKSPZ59%1+<L!D*N?Z9.!P"< JO3>'FX3Z!AZT<33C4
M@M&=#17P;X3^'O[3/[55J?%7B'XC7GP<\.W?[S3=)T>*2.X\O^%F1)(WVD=Y
M)"QZA0"*YSQ?X\^.7[!?C'0KCQ=XPN/BG\.-4G\F2>_+-< CE@&D9GCD"Y91
MO9& .>>G6L)>2IN:YWT_2^USD>-M%U53?(NOZVWM\MC]%:*I:+K%GXAT>QU7
M3YEN;"^@CN;>9>CQNH96'U!%?$WQ>^//Q-^//[0E_P#!?X.:K'X8LM)#C6O$
M>/WJ["!*5;!*JK,J )AF?^(+S7+3HSJ5/9K1J][]$M[G54KPI4U5>J=K6ZM[
M)>I]S45\!_$;X,_M$_LS^&;KQ]X<^-NJ_$*#2D^TZCI.M)*ZF <N526:4, .
M3@HP&2#FOJ[]F_XV6G[07PCT;QC;VZV5Q<!H+VS5MP@N$.'4'T/##/.UA6LZ
M"4'4IR4DM'Y?)]/,RIXARFJ=2#BWJMM?FNOD>G4445R':%%%% !1110 4444
M %%%% !1110 45F>)M>@\*^&]5UJZ226VTZTEO)4A +LL:%R%R0,X'&2*_,7
MXT_\%3/&7B>06GPXTV/P99H^3J%XL5Y=RCL-CJ8XQZC#GT85T4*%3$2Y::VW
M\CEQ&)I86"G5>^WG8_4VBN'^!OB34?&/P7\":]J]Q]KU74]#L[R[N-BIYDLD
M*,[;5 49))P !Z"H/CMXL\7^"/A;K>M>!O#B>*?$EK'NM].9FRPS@L$4;I"H
MY\L$%L8!S6=2FZ=1TWNG;]#6G456FJBV:O\ J=_17PWHG[-'[2WQ<L5U_P <
M?'+4_ %_<#S(M%T(2 0*>0D@@EA12/JY]3FN7T+X^?%S]D#XY:-\/_BUKX\;
M>#M7:,6NM3#=-'&[[!,)"-YVMC>CEL ?*>A/9'"<\O9PFG/MK^#VN<,L;[./
MM9TVH=W;3S:O=(_0RBBOA3XF?M(_$W]H;XU7_P */@1>0Z+I^EEUU;Q3(!_"
M=KLKD-L0,=HV#>QY!"YKDI4I5I<D?7R2[L[:U:%"'//TTW;?1'W717PSKG[+
M/[27PUTU_$/@WX^:QXSUJW7S&T;6#+Y4V.2D8GFEC8^@95'N*^Q?A])XEF\$
MZ+)XQBL8/%#6R'4(]-+&W6;'(3))_4C.<$BM*E*$8\T)J7WW_'H9TJTYRY9T
MW'KT:_#KY'0T445S'4%%%% !1110 4444 %%%% !1110 45Y_P#';XRZ9\ _
MAGJ?C35[&[U&SLFBC-M9;?,=I'"+]X@ 989/IV-?G-XB_P""EGQ/^(/Q(T*W
M\,FU\$Z!)>PP/91017DTR-(H/F2RQGG&<;%3&>_6NS"X2KBY6IK3:_0X,7C:
M."C>J];7LMVC]6:***XSO"BO#OVO/VB8/V=?A3<:G;%)O%&I$V>C6C#=NG(Y
MD*]U0'<?4[1_%7B'_!/G]H7XG_&+QMX[T?XB:ZVJ-HUO"([=[&VMV@E\UT<'
MR8U)/RXYSTKJI8>=:$JD=H_C;>WI^IR5L53HU(4I;R_#U]=?N/N"BBO/?CU\
M9=)^ OPOUCQ?JQ#BU39:VN<-=7#<1Q#ZGJ>P!/:N7T.OS9Z%17YX_L4_M4_%
M[XL?M$MX:\<Z]Y^DR:7-?KIO]G6T 3(C>(ADC#XVN,98Y!&<U^AU=6(P\\,U
M&?57T_KR./#8J&*BY4[V3MK_ %YA1117*=@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUXBK2G%5HI*3LFG>SZ)Z+?R/N:BBBN$]$**** "BBB@ HHHH **** "BBB@
MHHHH *\N_:@\;3_#O]GWQYK]K)Y-Y;:7*EO)W660>6A'N&<'\*]1KY[_ &_8
M)KC]DOQX(3@K%;.P"YRHNHB?IZ_A2LI-1>S:7WNP[N/O+='FG_!,_P ,Z3\/
M_P!FN^\8ZG<6VG?VWJ$T]Q?W<BQ(L$)\I SL0 H82GD]6-?4_A3XI>"_'EQ+
M;^&O%^@^(IXANDBTG4X;ID'J1&Q(%?!O['?[+,O[0GP=\,ZK\2]:O+SP'IK3
MPZ#X5T^Y,$+XFD\V>X*?,6,A<#!#87KCBM+]KS]B#PI\(_AW/\2?A3]N\):S
MX;>.[DA@OYI \>\*71Y&9T=20V0V" 1C.*]S&1HRQ4E5FTV[:+;HK_KV/GL#
M*O#"0=&":2OJ[-]7;1_*^Y^A%?&/[>7QDUC6K[1_@-X )N?%_BQDCU Q'_CW
MM6_@8_P[P"S'M&IS]ZNM\#?M>06?[%UA\6O$NVYU:"V:SEA0;?M=\DC1*,#[
MN\J'.. &/I7S3^QW\>OA%X-U_P 3?%'XI^.4?XF^(;B3,1TN\F%A 6Y"LD++
ME\ ?*3M157C+"N>CA)1JS<XW5-[+J^B].K\K=SIKXV,J,%3ERNIU>G*NK]>B
M\^NA@_MK_"/3?@/IOP$\$Z45DBLUNI;JYV@-<W+2V_F2GOR>@[*%':OU5K\H
M?V_/VA_A]\;/&GPWO_!?B#^V;32//^VR?8KB#RMTD++Q+&I;A&^[GI7Z+_"'
M]HCX>_'AM57P+X@_MPZ6(C=_Z%<6_E>9NV?ZZ-,YV-TSC'/:ML1&M/!TYU(N
M]YMZ;7DK7[7Z'/A94*>/K0IR7+RTTM=[1=[=]=_/<]'HHHKQCWPHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH YWXA^.-.^&O@;7?%.JMMT_2;22[EQU8*
MN0H]V. /<BOCS_@GSX)O_B;XF\8_M >+D\_6]<O);32]XR(8A@2LGL/EB4]A
M&X[UI_\ !4[X@2^'?@?I'AFVDV2^(M2595!P6@A'F,/^^S%7TK\!? D7PS^#
M/@SPS'&(FT_2X$F &,S%0TK?B[,?QKOH_NL/.MUD^5>F\OOT3/-K?OL33H_9
MBN=^M[1^[5G>T45P?QM^,OA_X$_#W4O%?B&=5AMT*V]JK 2W<Q'R0QCN2?R&
M2> :X#TO4^(O^"HU]%XN^)7PI\$Z0!<>)"TC;(N9%^T2Q1PKZ\M&Q%?HK#&8
MX8T)W%5 )]>*_/C]B7X6>(?C]\8M5_:'\?Q,83<.=$MY!\CRC*!D!_Y9PJ-B
M^K<]5.?T+KTL2O8T:>&?Q1NWY.6MOD>5A7]8K5,4OA=E'S2Z_-]PHHHKS3U0
MHHHH **** "BBB@ HHHH **** "BBB@ KXT_X*>?"O6_'/PCT7Q%HELU[_PB
M]W)=7EO&NYA;N@#28[A2JY'H2>@-?9=?+G[97[2&O_#N\\.?#;X>P177Q%\6
MNL-O)(JNMG$[;!)M;(+,V0-P*@*Q(X%;4/:>VA[+XKJW]?F88CV:HS=;X;._
MST^_MYG>_LW?M/\ @W]H3PC8SZ5J5O;>(HK=?[0T.60+<6\@ #E5/+QYZ.O&
M",X.0/FWPF4_:#_X*17/BWPVWVCPQX(LA;W6IQ8,4THBDC"JPX.9)'QZK$Q'
M&*?K7_!*G1[CP?:3:9XVU"S\>(AEN=0DC4V4\YR2%C4*\:Y. 0QP.=IZ5B?L
M>_%37OV7OBBO[/WQ&T*QTS[?=%].U>S15,TTG^K+N /.23 57(W*<*>.$]>$
M:+J3J8=WE9VCZZ-I];*]EN>).=>-*G2Q,;0NKR]-DUTN[7>QJ?\ !67Q!<-X
M;^'7AB%RL6H7]Q=R+S@M&J(F?^_S5]S>$=!MO"OA71M%LT"6FG6<-I$H& $C
M0*/T%? 7_!5NW:T\4?"356_U$;W:'L,A[=NOTK]$(Y!)&CCHP!KBEI@:=NLI
MW^327X'?&[S"I?I&-OG=O\3\]/\ @I]"_@KXE?"'Q]8CRK^UFD0RJ"#F"6*:
M/)^KO^9K]"K>=;JWBF0@I(H=2#D8(S7Y^?\ !6ZX632?AE8I\T\MW>.J@]@L
M*_S:OOO1;=K/1[&!CEHH(T)'J% I2UP-*_24_P U^HXZ8^I;K&-_E=+\"Y11
M17 >D%%%% !1110 4444 %%%% !1110 4444 %?G]^W7H^L?"']I+X<?'1--
MEU;PWIYM[2^6-0?)>.1SM/H721MI/&Y?I7Z U\4_M(?%/Q-\?/C0?V=/A_<0
M6%B\!/BK6I8%F\J#:"\:AN  &09')=U4%<$GKPCFL1!PW6NNUK:W\K?C8XL:
MH2PTXU'9.RTWO?2W=WZ=K[;GTMX+^/?@'Q_X!N?&6B^)[&YT"T@-Q>3M*$:S
M4+EA,A^:-@!T8<]L@BOE7_@GYHMYXZ^,'Q@^,:6TEGX?UZ^FM=.61=OG;IS*
MS8_V0(QGU9AV-8'Q<_X)56D.ARW7PP\47D6I+ $ETO7'5H[S &0)45=A)7.&
M5E)(Y4"O0?V#?VCKOQ +OX-^+M#M_#?B_P *0&&&&V@6!)XHF"2 QK\JRJ2"
M2O#!BP P<]L84E&K/#.[M:SW2ZOSV7H>?.I6E.E3Q<;*][K5.27NKRW?J8G_
M  4W^'>O76E^!OB3HUFVHV_A&Y=KZ )N$<;/$ZR,.Z!H]K>FX'IFOI'X'?M(
M>"/CYX4CU?P]J]NMW'")+_2KB0)<V1Q\PD0\[0<X<?*<<&O'?VOOV@/$UKXU
M\/?!/X9B ^-_% "W5[/&)$L;9\@_*P(R55V)(.U%) R01YQXN_X)1Z,OA&U;
MPAXSU"R\6P6^V:;4%4VEY(0=W" /"#G'!?"C&"<DY4^5X51KNRN^5[[_ !77
M:_S[:&U5SCBW/#KF=ESK;;X;/O;Y6WU)?@"O_"]_V_O'7Q1T++^$-!@-C'J"
M#]W=2^0MNH4_Q A9'SZ!/45][5\#?L0_&C6?@[XZ/[.OQ"T&TT/5+9Y#IM[:
MQJGVB0@R;9"ORR;TY27J<!3DXQ]\U&,CR>SA'6"BE%]UW^^Y> ESJI.6DW)N
M2[/16^22UZA1117GGJ!1110 4444 %%%% !1110 4444 %%%% &9XH\\^&=7
M^RY%S]DF\K;UW[#MQ^.*^%_^"2<]H?!WQ$A./[674;9Y]WW_ "S&X3/_  (2
M?G7WW7PCXT_9+^+/P)^,6J_$/X 7EC>VFKN[WGAN_D2,?.V]H\2%4>/=RIWH
MRYP/4]N%G%*K2D[<Z5GYIWU]3S\9";=*M!7]FVVNZ:MIYH^S/B-I.G:]\/\
MQ)IVL&%=+NM.N(;IK@@1K&T;!BQ/  '.>V*^+_\ @DSXGN+KP#X\\.22^;;:
M;J<-U!SD#SHV5L>V80?Q-;]U\.?VB/VAM/DM?C+=Z/\ #GP#;@S:EHOAN0-<
MZFB?-L:1990J'!S^\_X >"./_P""2NGE='^)U_$A6REO;.&$G_969B,^P=?S
MKIHTU3H8A.2;M';6WO=_/4Y*]:57$89J+2O+?1N\==.RLM7U>AF^'81\</\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO%WP;UG6-=\):'K6KVGB21;?4-0TV&>XA"V]NRA)'4LH#$L,'@DFND_X*?\
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MH **** "BBB@#\X/^"ELS>)OV@OA#X5W,R,B$QC/6>Z6//\ Y#K]'E4*H &
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MFE^'O'/AO7M2=6=;/3-7M[F8J!DD(CDX ZG%>2?\.\OV?O\ H0/_ "LZA_\
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MM)M]*T73;/2-+M@5@LK"!((8@220J* JC))X'4FN*T/]GOP!X:^*.H_$73=
M^S>,M1$@NM2^V7#>9OQN_=M(8QG:.BCI7HM=%>O[6%*"O[L4GZJ^IRX?#^QJ
M59M+WI-KR3MI_6@4445QG<%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% &3XG\7:%X)TMM3\1:UI^@Z:KK
M&;S5+J.VA#'HN]R!D]AFL+PW\:/A[XRU:+2O#_COPSKFJ2AFCLM-UBWN)G"C
M+$(CEB  2>. *\Z_;D\)#QA^RSX]MMF^6TLUU&/ Y!@=9#_XZK#\:_+G]B'Q
M$/#'[5'P\NF?8DU^;)O?SHWB _-Q7IX+"1Q49W=FMONT_'0\C'XV6#G3LKQE
MO]^OX6/V[FFCMX7EE=8HHU+.[D!5 &223T%</I/Q[^&6O:G:Z=IGQ%\)ZCJ%
MU(L5O:6FN6LLLSDX"HBR$L2>@ S7.?M<>./^%>_LW^/M867R;C^S)+2!LX/F
MS8A3'OE\_A7XC>"O$T_@OQCH>OVI(N-+OH+V/']Z.17'\J> P:QCES.R5O\
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M)E8892.0.E>/AJ<*M7DJ2Y59Z_<>]BJLZ-%SI1YG=:'WS_PTE\)/^BI>"_\
MPH;3_P".4?\ #27PD_Z*EX+_ /"AM/\ XY7XK?%[X ^/?@/<:9!XYT'^PY=2
M21[5?MEO<>8J%0Q_<R/C&Y>N.M3?"']G7XA?'B/5'\"^'_[<73#&+L_;;>W\
MLR;MG^ND3.=C=,]*]I9;0E#VBJ>[WTMVW]=#YYYMB(S]FZ7O=M;]]O34_;;P
MW\:/A[XRU:+2O#_COPSKFJ2AFCLM-UBWN)G"C+$(CEB  2>. *L>+/BSX'\
MWT5CXF\9>'_#E[+'YT=OJVJ06LCQY(WA9'!*Y!&>F0:_/S]B7]C[XN_"+]H;
M0O$WBWPE_9.AVUO=)+=?VE9S;6>!U4;8YF8Y8@<"N8_X*Q?\EU\+_P#8NQ_^
ME,]<,L+2^L4Z-.=U):O33?\ R_$]&GC:_P!5JUZM/E<&K)WU7NZ_B_N/TX\)
M^._#7CZRFO/#'B'2O$=I#)Y4MQI-[%=1H^ =K-&Q ."#@^HK=KX<_P""3/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D>,-!C\5>$]:T6
M8!H=1LIK1P>A$D;*?YU^!_@W49OA_P#%#0[Z?,5QHNL032<X*M#,I/ZJ:_H'
MK\)_VKO"?_"#_M'_ !"TI5*1KJ\UQ&,?P3'S5_205[>3U.3$N+ZJ_P!S_P""
M?/9[3Y\+&79V_P# E_\ :H^^?^"K'C@:5\%_#?AV&4!];U03.N>6AA0L?PWO
M'^5?G5XR^&[^%_AC\/\ Q4P<#Q,E\WS=/W$_EC%>Z_\ !0'XECQ]J/PGA1]R
MP^#[._< Y DN5#,/R1*]6_;$^#K>&?V&?@Y.EOLN?#RVZW0QRGVJ$O+_ .1=
MOYUUX?\ V.C&^\JC3_&/Z(X<5_MU:7:---?A+]6CV_X=_%HZE_P3?F\1^=F\
MT[PM=:8S9Y$L*O;IGW("'\:^ OV%_"O_  EW[5'@*W9-\5I=OJ$G&0/(C>52
M?^!*H_&NY^&?Q+:U_P"">OQ5\-&7]]%KUFD:YP1'<-&Q'T_T>3\ZZO\ X)0^
M%?[2^-7B;773='I>C&)6_NR32H!_X[')71"/L*F*J_U?EYE^,CGJ3^LTL'1?
M]+FY?_;6?;W[8?[1T?[-WPIEU>U2*X\2:C)]CTFWF!*>:1EI&'=47G'<E1WK
M\M/AM\(/BM^VGX[U6^M[MM8OX\2:AK>M7++;P;B=B%@&(S@[413@ \ "OH3_
M (*V:I<2_$3P)IS,WV2'2YIT7/&]Y=K'ZXC6OE[X2_M0?$SX&Z+=Z3X(\2+H
MEA=W'VJ>/^SK6<O)M"Y+2Q,W11QG'7CDURY;1_V=UH6YW>U^EG;]+G5FV(3Q
M2H5&^2-F[=;J_P"J7W]SHOBU\ OBC^QEXJT'5[N_CL;J9F?3]<T"[=H_,7&Y
M,LJ,#@C*LN&!/49K]4/V0?CTW[0_P5TWQ'>+''KEM(VGZI'& %^T( 2X'8.K
M(^.VXCM7Y&?%K]I_XF?'/1K/2O&_B7^V["SN/M4$7V"UM]DFTKNW11(3PQ&"
M<<U]O?\ !)NZNX/AO\2&*YM8K^"2+KS)Y+[Q^0CK7&4Y_4IU,19RAJFNUU_F
M8X&M3CCH4\+=1GHT^]F_T_$\]_X*#_MC:UK?C+4OAGX.U.73= TQC;ZK=V<A
M22]N!]^+>.1&GW2!]XALY %>;>!?^";OQ@\=^";;Q)%%HVD)=0B>WT[5+N2*
M[E0C*G:L;*NX8P'93SSBOFS7-6N=0\27^ISOYEY/=R7,CN VZ1G+$D'KR>]>
M\K_P4+_: 50J^/L #  T73__ )'K>GAJF'P\84+<SW;_ *_X9&%?%4J^*G+$
MW<5I%+^E_P %FQ^R+^T1XJ_9C^,T/A#Q#<7,'AB?43INL:/=292RF+^69T&2
M%9&Y8KPR@YS\I'Z%?M^?\FD>/_\ KE:_^E<-?C9XP\9:QX^\5ZCXCUV[^W:U
MJ,YN+FY$21>9(?XMJ *.G8"OV!_;8:>3]B;Q4UT,73:?8&4?[?VB#=^N:X<R
MIZ4*L[<_-%.WJORU_ ]+**OOU:4&^3=7WZ_GI\[GYU_\$^_^3N_ /^_>?^D4
M]>X?\%$/VQ_^$JO;SX6^"K_.BVS^7K>H6[\7<JG_ (]U8=8U(^8_Q,,= <_#
M_A3Q;J_@?6H]7T.^DTW4XXIH8[J$X=%EB:)]I[$H[#(Y&<CFM7X3ZOX;T/XF
M>&]0\8Z:VL^&;>^CDU&S5B#)%N^;_> ZE?XL8R,YKUZV%CB*\*D]HK;SNW^'
MY^FOAT<9+#X>=*&\GOV7_!_+UT^W?^">7[&"ZLVG_%;QQ9$V<;B;0=+N$XF(
MZ74BG^$'E!W(W=-N?2/^"FG[0_B#X8^&]!\&>&;V;2KS7TEGO;^W<I*MNA"B
M-&'*[V)R1SA<=S7VAH-]I^J:'I]YI$L,VE7%O'+:26V/*:$J"A3'&W;C'M7R
MY^W]^RGJO[0GA32M:\+!)?%6@+(([&1@@O8'P6C5B<!P5!7/!R1D9%?,U<3]
M8Q495U:">W;U^=K_ .6A]92PCPV#G##.\VM^_I\KV_SU/SZ_9]_8S\??M+:!
MJFN^&KK1K+3[&Y^RO-J]U)&99MJN54)&YX#J<M@?-U/./=_V3?V3_CG\+_VB
M(+2ZN-0\&:#9!;K4]1LIEEL]1A!(6%>J2,YSPPW(,M@';GYF\!_%GXJ_LJ^*
M[RUTJ[U+PGJ&X?;='U&V(CEQT\R"08Z<!@ <'@BOT!_93_X*-67Q@\1V'@[Q
MSI=OX?\ $=ZPBLM0LF/V.[E.<1E6):)SP!\S!CQ\IP#[V(EB=9T;2@UM\M_/
M^M#YS"1PC:A7;C-/?Y[>7X>I]L5#>7D.GV<]U<R+#;P(TLDCG 15&23[ "IJ
M\?\ VOM2N=*_9C^)-Q:.T<W]C31[EZA7PC?^.L:^-=[.Q]XK7U/R[_:R_:Z\
M3_M%>,KW3;"]N;/P-#<&+3M(MRRBY4-A99@/ONW! /"Y  SDG3UK_@G/\8M"
M^&\OB^XL]+?R;;[7-HD-TS:A'&!N;*;-A8#DJ')XP 3Q7EO[,.EV^L_M%?#:
MSNXQ+;R:_9[T/1@)E.#[<5^\3*'4JP#*1@@]Z^IQ51Y?2A3PZ[[^5M_7J?&X
M.FLTK5*F);TMHNE[[>G0_(#]B;]LK7?@SXRTOPOXBU.:_P# &H3+;/%=2%O[
M,9CA9HB?NH"1N7IC) SU^M/^"CGP/^('QHT7P6W@;2'U:'2S>RW^R^@MPB,L
M6TGS)%W9"/TST]Z_,+XI:=;Z/\3O%UA:;1:VNL7D$.P878LSJN/; %?N'\-]
M4N=;_9Y\,ZA>.9;NZ\,6\TTAZL[6JEC^)-<^8N,*=/'TU[RU];IVO^)U94G.
MM4RZI)N.WIK9V^\_!FUMY+RYBMX5WRRN$1<@98G '/O7Z9_\$\?V7_B;\#/B
M9XDU;QOX:_L33[S2/LL$WV^UN-\GG1MMQ%*Y'"DY(QQ7YM>&?^1DTK_K[B_]
M#%?T/5WYG7E1I14?M<R?X?YGEY1AX8BM)S?P<K7WO?[@HHHKY ^[/S5_X*[?
M\C%\-/\ KUO_ /T."MG_ ()$?\>/Q._ZZ:?_ "N*QO\ @KM_R,7PT_Z];_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M75L\#;XGB.X);JQ^5SC##G'TKZ \>^!](^)7@W5_"^O6_P!JTG5+=K:>,<,
M1PRGLP."#V(!KT<7F"E5IU*#TCNN^NOX?B>3@\L<:-2G72O+9]OZ?W['PA_P
M3&_:;^V6[?"/Q%=YFA5[C0)I6Y9!EI;;)[CEU'IO'8"O=/VLOVVM'_9FUG0-
M&@TQ?$>M7CBXO;%9_*-M:<C=NP<.Q^Z".BMG&0:YCP[_ ,$P?AIX3U[3]:TC
MQ;XXL=4T^=+FVN(KZT#1R*05(_T7U%>M?'3]D?X<?M"(L_B?2Y(=;CC$2:YI
MKB"\"CH&."KCT#J<=L5CB:N&JXB-57:^TOZ[]?\ @G3A*.+HX:5%V37PO?\
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M[1@NCJ/J[>V!4WPK_P""6/@'P?JD.H>+=>OO&\D+ATL_(%E:-CM(@9W;GMO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHRQCD*#DKAW!V@GD<'%?1X/][ETZ,/B5_P#TKF_%:?@?*8[]SFE.O4^%V_\
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MXL>,K^[=I+FXUF\DD9CDY,SUZO8_\% /CUIEC;V=KXZ6"VMXUBBC71M/PB*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 456DU.SAF,
M,EW!'*.L;2*&'&>F:3^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^
M?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_
M\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/
M^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?
MQ?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!
M:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[
M4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_
MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
MY^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _
M<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+
M_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?
M\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6
MJ*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U
M+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG
M_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J-JUC&,M>VZCWE4?UI1JEDP!%Y
M 1_UU7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@
M_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7
M_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_
MXT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U1
M57^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9
M_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/
M_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U15-M8L%8*;VW#'H#*N?YT[^U+/_G[
M@_[^+_C0!:HJK_:EG_S]P?\ ?Q?\:/[4L_\ G[@_[^+_ (T 6J*J_P!J6?\
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MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
MY^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _
M<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+
M_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?
M\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6
MJ*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJFNL6$F=M[;MCTE4_UIW]J
M6?\ S]P?]_%_QH M455_M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2
MS_Y^X/\ OXO^-']J6?\ S]P?]_%_QH M455_M2S_ .?N#_OXO^-']J6?_/W!
M_P!_%_QH M455_M2S_Y^X/\ OXO^-']J6?\ S]P?]_%_QH M455_M2S_ .?N
M#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\ OXO^-']J6?\ S]P?]_%_
MQH M455_M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\ OXO^
M-']J6?\ S]P?]_%_QH M455_M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M45
M5_M2S_Y^X/\ OXO^-(VK62KEKRW4>IE7_&@"W151=6LF7*WENP]1*O\ C2_V
MI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U
M+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/
MW!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@
M_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7
M_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_
MXT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U1
M57^U+/\ Y^X/^_B_XTUM8L(\;KVW7ZRJ/ZT 7**J_P!J6?\ S]P?]_%_QH_M
M2S_Y^X/^_B_XT 6J*J_VI9_\_<'_ '\7_&C^U+/_ )^X/^_B_P"- %JBJO\
M:EG_ ,_<'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?
MN#_OXO\ C0!:HJK_ &I9_P#/W!_W\7_&C^U+/_G[@_[^+_C0!:HJK_:EG_S]
MP?\ ?Q?\:/[4L_\ G[@_[^+_ (T 6J*J_P!J6?\ S]P?]_%_QH_M2S_Y^X/^
M_B_XT 6J*J_VI9_\_<'_ '\7_&C^U+/_ )^X/^_B_P"- %JBJO\ :EG_ ,_<
M'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\
MC0!:HJK_ &I9_P#/W!_W\7_&FMK%@K!3>VX;T,JY_G0!<HJK_:EG_P _<'_?
MQ?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!
M:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[
M4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_
MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
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M_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\
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MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
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MXT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\
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M'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\
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M]_%_QH M455_M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\
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MM2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\ OXO^-']J6?\
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M_C1_:EG_ ,_<'_?Q?\: +5%5?[4L_P#G[@_[^+_C2-JUDJY:\MP/4RK_ (T
M6Z*J+JUBXRMY;L/42K_C2_VI9_\ /W!_W\7_ !H M455_M2S_P"?N#_OXO\
MC1_:EG_S]P?]_%_QH M455_M2S_Y^X/^_B_XT?VI9_\ /W!_W\7_ !H M455
M_M2S_P"?N#_OXO\ C1_:EG_S]P?]_%_QH M455_M2S_Y^X/^_B_XT?VI9_\
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M .?N#_OXO^- %JBJO]J6?_/W!_W\7_&C^U+/_G[@_P"_B_XT 6J*J_VI9_\
M/W!_W\7_ !H_M2S_ .?N#_OXO^- %JBJO]J6?_/W!_W\7_&C^U+/_G[@_P"_
MB_XT 6J*J_VI9_\ /W!_W\7_ !H_M2S_ .?N#_OXO^- %JBJO]J6?_/W!_W\
M7_&ECU.SFF$,=W!)*>D:R*6/&>F: +-%%% !1110!Y'K>G_;_&EW:^9L\R4_
M-C./ESTJY_P@/_3]_P"0?_LJ+O\ Y*)+_P!=3_Z!76T@.2_X0'_I^_\ (/\
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MG&1]:N^._P#CRMO^NA_E6UHG_('LO^N*_P J .?_ .$!_P"G[_R#_P#94?\
M" _]/W_D'_[*NMHHL!R7_" _]/W_ )!_^RH_X0'_ *?O_(/_ -E76T46 Y+_
M (0'_I^_\@__ &5'_" _]/W_ )!_^RKK:*+ <E_P@/\ T_?^0?\ [*C_ (0'
M_I^_\@__ &5=;118#DO^$!_Z?O\ R#_]E1_P@/\ T_?^0?\ [*NMHHL!R7_"
M _\ 3]_Y!_\ LJ/^$!_Z?O\ R#_]E76T46 Y+_A ?^G[_P @_P#V5'_" _\
M3]_Y!_\ LJZVBBP')?\ " _]/W_D'_[*C_A ?^G[_P @_P#V5=;118#DO^$!
M_P"G[_R#_P#94?\ " _]/W_D'_[*NMHHL!R7_" _]/W_ )!_^RH_X0'_ *?O
M_(/_ -E76T46 \XU;1?[+U**T\[S/,"G?MQC)(Z9]JVO^$!_Z?O_ "#_ /95
M!XK_ .1CM/\ =3_T(UVE ')?\(#_ -/W_D'_ .RH_P"$!_Z?O_(/_P!E76T4
M6 Y+_A ?^G[_ ,@__94?\(#_ -/W_D'_ .RKK:*+ <E_P@/_ $_?^0?_ +*C
M_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\ (/\ ]E1_P@/_ $_?^0?_ +*NMHHL
M!R7_  @/_3]_Y!_^RH_X0'_I^_\ (/\ ]E76T46 Y+_A ?\ I^_\@_\ V5'_
M  @/_3]_Y!_^RKK:*+ <E_P@/_3]_P"0?_LJ/^$!_P"G[_R#_P#95UM%%@.2
M_P"$!_Z?O_(/_P!E1_P@/_3]_P"0?_LJZVBBP')?\(#_ -/W_D'_ .RH_P"$
M!_Z?O_(/_P!E76T46 Y+_A ?^G[_ ,@__94?\(#_ -/W_D'_ .RKK:*+ ><6
MNB_:-;?3_.V[69?,VYZ9[9K:_P"$!_Z?O_(/_P!E4&F?\CM-_P!=)/Y&NTH0
M')?\(#_T_?\ D'_[*C_A ?\ I^_\@_\ V5=;118#DO\ A ?^G[_R#_\ 94?\
M(#_T_?\ D'_[*NMHHL!R7_" _P#3]_Y!_P#LJ/\ A ?^G[_R#_\ 95UM%%@.
M2_X0'_I^_P#(/_V5'_" _P#3]_Y!_P#LJZVBBP')?\(#_P!/W_D'_P"RH_X0
M'_I^_P#(/_V5=;118#DO^$!_Z?O_ "#_ /94?\(#_P!/W_D'_P"RKK:*+ <E
M_P (#_T_?^0?_LJ/^$!_Z?O_ "#_ /95UM%%@.2_X0'_ *?O_(/_ -E1_P (
M#_T_?^0?_LJZVBBP')?\(#_T_?\ D'_[*C_A ?\ I^_\@_\ V5=;118#DO\
MA ?^G[_R#_\ 94R;P+Y,+O\ ;<[5+8\KT'^]785#>?\ 'I/_ +C?RHL!P.@:
M#_;AG'G^3Y6W^#=G.?<>E:__  @/_3]_Y!_^RI/ 7WK[Z)_[-774 <E_P@/_
M $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\ (/\ ]E1_P@/_ $_?
M^0?_ +*NMHHL!R7_  @/_3]_Y!_^RH_X0'_I^_\ (/\ ]E76T46 Y+_A ?\
MI^_\@_\ V5'_  @/_3]_Y!_^RKK:*+ <E_P@/_3]_P"0?_LJ/^$!_P"G[_R#
M_P#95UM%%@.2_P"$!_Z?O_(/_P!E1_P@/_3]_P"0?_LJZVBBP')?\(#_ -/W
M_D'_ .RH_P"$!_Z?O_(/_P!E76T46 Y+_A ?^G[_ ,@__94?\(#_ -/W_D'_
M .RKK:*+ <E_P@/_ $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\
M(/\ ]E5+6/"?]E6$ES]J\W:0-OEXZG'7-=U6-XN_Y ,_U7_T(4 <[H_A3^UK
M%;C[5Y6XD;?+ST]\U>_X0'_I^_\ (/\ ]E6EX/\ ^0''_OM_.MN@#DO^$!_Z
M?O\ R#_]E1_P@/\ T_?^0?\ [*NMHHL!R7_" _\ 3]_Y!_\ LJ/^$!_Z?O\
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M^RKK:*+ <E_P@/\ T_?^0?\ [*C_ (0'_I^_\@__ &5=;118#DO^$!_Z?O\
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M0?\ [*C_ (0'_I^_\@__ &5=;118#DO^$!_Z?O\ R#_]E1_P@/\ T_?^0?\
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M^_\ (/\ ]E1_P@/_ $_?^0?_ +*NMHHL!R7_  @/_3]_Y!_^RH_X0'_I^_\
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M?O\ R#_]E76T46 Y+_A ?^G[_P @_P#V5'_" _\ 3]_Y!_\ LJZVBBP')?\
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MX0'_ *?O_(/_ -E1_P (#_T_?^0?_LJZVBBP')?\(#_T_?\ D'_[*C_A ?\
MI^_\@_\ V5=;118#DO\ A ?^G[_R#_\ 94?\(#_T_?\ D'_[*NMHHL!R7_"
M_P#3]_Y!_P#LJ/\ A ?^G[_R#_\ 95UM%%@.2_X0'_I^_P#(/_V5'_" _P#3
M]_Y!_P#LJZVBBP')?\(#_P!/W_D'_P"RH_X0'_I^_P#(/_V5=;118#DO^$!_
MZ?O_ "#_ /94?\(#_P!/W_D'_P"RKK:*+ <E_P (#_T_?^0?_LJKZAX-^P6,
MUQ]LW^6N[;Y6,_K7:UG>(?\ D"WG_7,T6 Y'0O#/]M6KS?:?)VOLV[-W8'/4
M>M:7_" _]/W_ )!_^RJUX%_Y!<__ %V/_H(KHZ .2_X0'_I^_P#(/_V5'_"
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MK:*+ <E_P@/_ $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\ (/\
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MJ\KYBNWR]W3\:O\ _" _]/W_ )!_^RJ_X+_Y O\ VT;^E;U ')?\(#_T_?\
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M[J?^A&NTKB_%?_(QVG^ZG_H1KM* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#B],_Y':;_KI)_(UVE<7IG_ ".TW_723^1KM*2
M****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0WG_'I/_N-_
M*IJAO/\ CTG_ -QOY4 <OX"^]??1/_9JZZN1\!?>OOHG_LU==20!1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\7?\@&?ZK_ .A"MFL;
MQ=_R 9_JO_H0H ;X/_Y <?\ OM_.MNL3P?\ \@./_?;^=;= !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7)^/?NV/U?_ -EKK*Y/Q[]V
MQ^K_ /LM)@=)I_\ QX6W_7)?Y"K%5]/_ ./"V_ZY+_(58I@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<7K7_(Y6O_72+^8KM*XO6O\
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M** "BBB@ HHHH **** "BBB@ K.\0_\ (%O/^N9K1K.\0_\ (%O/^N9H S?
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M;_R'+O\ ZYM_Z$*[2N+\&_\ (<N_^N;?^A"D!VE%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LGQ5_R +K_@/_ *$*UJR?%7_( NO^ _\
MH0H K^"_^0+_ -M&_I6]6#X+_P"0+_VT;^E;U !1110 4444 %%%% !1110
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MATX2@\/14&[OKZA1117*=@4444 %%%% '%^*_P#D8[3_ '4_]"-=I7%^*_\
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MS-I+WI;OY[+?Y'T3^R'X&\;>"_A%:R?$#Q#JVN^)-5D^WR1ZM>27+V2,JA(
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M^/(I5W&WM$O$]FBE1\_H?SK _P"">VO2:W^RYX<CE?>UA<75F">RB9F4?@'
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MX#_X]KO_ 'U_E6]K'_()O?\ K@__ *":P? ?_'M=_P"^O\J .IHHHH ****
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M1^.OA7XFN_$NOZIXANX=9,4<^JWDERZ)Y$9VJSL2!DDX'K7UU7Q5_P $K_\
MDCWBS_L.G_TGBK[5KT,R2CBI)+M^2//RN3EA(-OO^;/E3]JSX_?&7P+XCD\-
M?#7X;ZEJ\+6B2GQ)!I=S?(C-NRJ*B; RX'WBPYY6O-O^"</Q.\;?$'QW\0$\
M7^)M9UQX;:&1;?4[N21()#*^[9&QVQ^F% QC':OO-_NM]*_/7_@FC_R5WXL_
M[J?^E$E5A90E2JPY5=1O?J9XN$XUJ53G=G)*W38_0NBBBO*/8"BBB@ HHHH
M**** .+N/^1Z'_71?_0!7:5Q=Q_R/0_ZZ+_Z *[2D 4444P"BBB@ HHHH **
M** /C7]LKXS>,M1^*'A3X)?#W49-#U?7A&]]JD3%)$21F545Q\R@*K.Q7YL
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M_:GQ:^*OBF_M=.5YHXI-1OIEC2/S7>:7+,<#)\K\A7TUI/[;'P1UK61I=O\
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MN/SE8_C7UC7%BZ2HUY0CMT]-T=^"K/$8>%26[6OJM&%%%%<AVA1110 4444
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M_I.E?''PA_Y2<^,?]^__ /1*U]C?LW_\F^_#;_L7=/\ _2=*^)IO$5C\!_\
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M7+"C3[07WZW9PX)\\Z]1]9O[E9)?(****\\],**** "BBB@ KD_'OW;'ZO\
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M*347WBMOU"BBBO./4"BBB@ HHHH **** .+\%_\ (7NO^N9_]"%=I7%^"_\
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M?^0+>?\ 7,UHUG>(?^0+>?\ 7,T 9O@7_D%S_P#78_\ H(KHZYSP+_R"Y_\
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MWWUO<_2L$, 1R**;'&(XU1?NJ !3J\8]Q7MJ%%%% PHHHH **** "N+\9?\
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M75I.*YO\74Y\ODY1J6=X*347_=Z?J%%%%><>H%%%% !1110 5Q?@W_D.7?\
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M:'5E]*5'"PA+>WYZA1117$>@%%%% !1110 5R>D_\E%3_KHW_H!KK*Y/2?\
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MBHKEBK(YSQ3\-_"7CBXMKCQ)X6T7Q!/:@K!+JFGPW+1 D$A"ZDKR!T]*Z,#
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MU:"ZC1U2,*"& SP2?6N@_P"$ZLO^>%Q^2_XT@.CHKG/^$ZLO^>%Q^2_XT?\
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M_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: .CHKG/^$ZLO\ GA<?DO\
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M'Y+_ (T?\)U9?\\+C\E_QH Z.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\
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M+_GA<?DO^- '1T5SG_"=67_/"X_)?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\
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ME_SPN/R7_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: .CHKG/^$ZLO\
MGA<?DO\ C1_PG5E_SPN/R7_&@#HZ*YS_ (3JR_YX7'Y+_C1_PG5E_P \+C\E
M_P : .CHKG/^$ZLO^>%Q^2_XT?\ "=67_/"X_)?\: .CHKG/^$ZLO^>%Q^2_
MXT?\)U9?\\+C\E_QH SO!?\ R%[K_KF?_0A7:5YYX?UF'2;Z::5'=74J @&>
MH/K70?\ "=67_/"X_)?\:2 Z.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\
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MPN/R7_&@#HZ*YS_A.K+_ )X7'Y+_ (T?\)U9?\\+C\E_QI@='17.?\)U9?\
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M'_7;_P!E-+_PG5E_SPN/R7_&LGQ'XBM]8M(XH8Y$97W$N!CH1V/O2 ZGP_\
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M.?\ "=67_/"X_)?\:/\ A.K+_GA<?DO^- '1UQ?C+_D-6O\ US7_ -"-:/\
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M\)U9?\\+C\E_QH_X3JR_YX7'Y+_C0!T=%<Y_PG5E_P \+C\E_P :/^$ZLO\
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M?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\ /"X_)?\ &C_A.K+_ )X7'Y+_ (T
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MUZ12 R/^$1T?_H'P_E1_PB.C_P#0/A_*M>BF!D?\(CH__0/A_*C_ (1'1_\
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M /0/A_*C_A$='_Z!\/Y5KT4 9'_"(Z/_ - ^'\J/^$1T?_H'P_E6O10!D?\
M"(Z/_P! ^'\J/^$1T?\ Z!\/Y5KT4 9'_"(Z/_T#X?RH_P"$1T?_ *!\/Y5K
MT4 >>?$+1;'2["U>TMHX&:4@E!U&*W=!\,:5<Z)8RRV,3R/"C,Q'))'6L_XI
M?\@VR_Z['_T&NC\,_P#(O:;_ ->Z?^@BEU C_P"$1T?_ *!\/Y4?\(CH_P#T
M#X?RK7HI@9'_  B.C_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\
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M!\/Y4?\ "(Z/_P! ^'\JUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\
MA$='_P"@?#^5'_"(Z/\ ] ^'\JUZ* ,C_A$='_Z!\/Y4?\(CH_\ T#X?RK7H
MH R/^$1T?_H'P_E1_P (CH__ $#X?RK7HH R/^$1T?\ Z!\/Y5!?>%=(CLKA
MUL(0RQL0<=#BMZJ^H?\ (/N?^N3?R- 'G?PZTFSU1K_[7;I/Y8CV[QTSNS_(
M5VO_  B.C_\ 0/A_*N6^%?WM3^D?_LU>@4@,C_A$='_Z!\/Y4?\ "(Z/_P!
M^'\JUZ*8&1_PB.C_ /0/A_*C_A$='_Z!\/Y5KT4 9'_"(Z/_ - ^'\J/^$1T
M?_H'P_E6O10!D?\ "(Z/_P! ^'\J/^$1T?\ Z!\/Y5KT4 9'_"(Z/_T#X?RH
M_P"$1T?_ *!\/Y5KT4 9'_"(Z/\ ] ^'\J/^$1T?_H'P_E6O10!D?\(CH_\
MT#X?RH_X1'1_^@?#^5:]% &1_P (CH__ $#X?RH_X1'1_P#H'P_E6O10!D?\
M(CH__0/A_*C_ (1'1_\ H'P_E6O10!D?\(CH_P#T#X?RK#\:>'M-T_P[<3V]
MG'#*I3#J.1E@*[.N<^('_(K77^\G_H0H S/!'A_3M0\/Q37-G'-*78%F'/!K
M?_X1'1_^@?#^54/AW_R+,/\ UT?^==-0!D?\(CH__0/A_*C_ (1'1_\ H'P_
ME6O10!D?\(CH_P#T#X?RH_X1'1_^@?#^5:]% &1_PB.C_P#0/A_*C_A$='_Z
M!\/Y5KT4 9'_  B.C_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\
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MKT4 9'_"(Z/_ - ^'\J/^$1T?_H'P_E6O10!D?\ "(Z/_P! ^'\J/^$1T?\
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M]#%(#L?^$1T?_H'P_E1_PB.C_P#0/A_*M>BF!D?\(CH__0/A_*C_ (1'1_\
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MD!T7_"(Z/_T#X?RH_P"$1T?_ *!\/Y5KT4P,C_A$='_Z!\/Y4?\ "(Z/_P!
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MUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\ A$='_P"@?#^5'_"(Z/\
M] ^'\JUZ* /+;K2[5/B MDL""U\U!Y6/EP4!_G7=_P#"(Z/_ - ^'\JXZ\_Y
M*@O_ %VC_P#18KTBD!D?\(CH_P#T#X?RH_X1'1_^@?#^5:]%,#(_X1'1_P#H
M'P_E1_PB.C_] ^'\JUZ* ,C_ (1'1_\ H'P_E1_PB.C_ /0/A_*M>B@#(_X1
M'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z!\/Y4?\ "(Z/_P! ^'\JUZ*
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MC_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\ A$='_P"@?#^5:]%
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M/I=KJ&O7D-S DT21L55AP#O KU*O-_AU_P C+?\ _7)__0UI =C_ ,(CH_\
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M /0/A_*M>B@#(_X1'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z!\/Y4?\
M"(Z/_P! ^'\JUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\ A$='_P"@
M?#^5'_"(Z/\ ] ^'\JUZ* ,C_A$='_Z!\/Y4?\(CH_\ T#X?RK7HH R/^$1T
M?_H'P_E1_P (CH__ $#X?RK7HH R/^$1T?\ Z!\/Y4?\(CH__0/A_*M>B@#(
M_P"$1T?_ *!\/Y5Q.GVL5I\2%AAC6.))6"JO0?(:]-KS>W_Y*@?^NS?^BS2
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MNJZ;<KO@O+&99H95SC*NI(89!Y!J]3::=F)--704444AA1110 4444 %%%%
M'G7Q2_X_+#_KFW\Q7H4/^IC_ -T?RKSWXI?\?EA_US;^8KT*'_4Q_P"Z/Y4@
M'T444P"BBB@ HHHH **** "BBN>\6?$3PIX#^RCQ-XGT?PZ;HE;?^UK^*U\X
MCJ$\QAN/(Z>M-)MV0FU%79T-%(#D9'(I:0PHHHH **** "BBB@ HHHH \WO/
M^2H+_P!=H_\ T6*](KS>\_Y*@O\ UVC_ /18KTBD 4444P"BBB@ HHHH ***
M* "BBN>N/B+X4M/%4/A>?Q/HT/B689BT:34(EO)!@ME82V\\ G@= ::3;LA-
MI*[.AHHHI#"BBB@ HHHH **** "BBB@#S?X;?\C!??\ 7%O_ $,5Z17F_P -
MO^1@OO\ KBW_ *&*](I( HHHI@%%%% !1110 4444 %%)7/^'?B)X4\8:C?:
M?H/B?1];O[ XN[73K^*XEMSDC$BHQ*<@CG'(--)O83:6YT-%%%(84444 %%%
M% !1110 5D>+O^1;U#_KD:UZR/%W_(MZA_UR- &+\+_^0'<_]?!_]!6NQKCO
MA?\ \@.Y_P"O@_\ H*UV- !1110 4444 %%%% !1110 455U+5+/1=/N+_4+
MN"PL;=#)-<W,BQQ1*.K,S$  >IJCX5\9:!XZTPZEX;US3?$&G"0Q&[TJ[CN8
M@X )7>A(R 1QG/(IV;U0FTFD^IL4444AA1110 4444 %%%% !7&_%#_D"VO_
M %\#_P!!:NRKC?BA_P @6U_Z^!_Z"U)@;GA/_D6]._ZXBM:LGPG_ ,BWIW_7
M$5K4P"BBB@ HHHH **** "BBB@ HKQSX@?MA?!WX7Z])HOB/QU96NJ1-MEMK
M6&>[:)O[K^0CA#[-@UWW@'XE>%OBGH*ZSX2UVRU_32VPS6<H;8V,[77[R-@@
M[6 /(XK3V<^7GY7;OT,_:PY_9\RYNW7[CI:***S- HHHH **** "BBB@ KS?
MXC?\C)8?]<E_]#:O2*\W^(W_ ",EA_UR7_T-J3 ](HHHI@%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5YO\.O^1EO_ /KD_P#Z&M>D5YO\.O\
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MQD^7T>J_K[@HHHKS3U@HHHH **** "BBB@#S?1?^2E7'_7:;^35Z17F^B_\
M)2KC_KM-_)J](I %%%%, HHHH **** "BBB@"IJVJV>AZ7=ZCJ%Q'9V-I$T\
M]Q,VU(XU!+,3V  )K\??VG/%^N_M/?\ "8_%QVDL_ OA^]@T+0;>3(\TNQ8D
M _Q%!YC]QOC'05]8?MN_$K6_BSXXT3]G7X?2^9JVL2)+K]U&QV6T'WA&Y'10
MH\Q_8(.=V*H?MU?"[1?@S^Q)H?A#0(?+T_3M6M$,C ;YY"LI>5_5F;)/UP.
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M9U\/?!O0]"^+/PVLH_!FLZ;J<4,\>D 01?,"8Y4C7Y4964 [0 0W(XK]#Z^
M/^"FOQ.?Q5=>$O@MX:4ZCK^HWT-W=V\)RP8Y2WB/NS.6]@JGO7I4*U>MBJ?+
M+5M>ENOE:W]7/*Q&'PU'"5+Q5DGZWZ:[[V/LOX+^.I/B;\)?"'BN9%BN-7TR
M"[F11A5D9!O ]MV<>U=I7*?"GP/'\-/AGX6\*1N)1H^FP632J,"1D0!F_%@3
M^-=77+7Y/:S]G\-W;TOH=F'Y_8P]I\5E?UMJ%%%%8'0%%%% !1110 5SGQ _
MY%:Z_P!Y/_0A71USGQ _Y%:Z_P!Y/_0A0 SX=_\ (LP_]='_ )UTU<S\._\
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M*YSXI?\ (-LO^NQ_]!KH_#/_ "+VF_\ 7NG_ *"*74#3HHHI@%%%% !1110
M4444 9/BKPGH_CCP_>Z%K^FV^K:1>Q^7<6=TFY'7^A!P01R" 1S7RO=?\$M_
M@S<:Y]O2;Q+;6N_?_9<6HQFWQ_=RT1EQ_P #S[UZ]^TY\1OB'\,? =OK'P[\
M&_\ "97T=VAO8!N=H;8'+E8E^=RWW?ESMSNP<5X"W_!4KPY<6'V"R^&_BR?Q
MH1L&BF./R_._N>8&,A&?^F6?:NW#QQ%G.A\[/]/U//Q4L-=0Q*\U=?K^GH>:
M?MI?#WPY;_&#X&_!GP/I-MI=I#-YKV5FN2GVB>-/,<DDLVV%V+,22!DFOTH
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MPM_X\[__ *Z+_(UU/B#_ ) .I?\ 7M)_Z :Y;X6_\>=__P!=%_D: .YHHHH
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MB@ HHHH **** "BBB@ HHHH *\W^'7_(RW__ %R?_P!#6O2*\W^'7_(RW_\
MUR?_ -#6D!Z11113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK \=?\BK??1/_0UK?K \=?\ (JWWT3_T-: *GPW_ .1;_P"VS?TKJJY7X;_\
MBW_VV;^E=50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MY[\5/]=IO^[)_-:[NR_X\X/^N:_RKA/BI_KM-_W9/YK7=V7_ !YP?]<U_E2
MGHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO;_\ )4#_
M -=F_P#19KTBO-[?_DJ!_P"NS?\ HLT@/2****8!1110!YO'_P E0/\ UU/_
M *+KTBO-X_\ DJ!_ZZG_ -%UZ12 ****8!1110 4444 %%%% !1110 4444
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MN?\ KDW\C0!P_P *_O:G](__ &:O0*\_^%?WM3^D?_LU>@4D 4444P"BBB@
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M;_\ ZY/_ .AK7I%>;_#K_D9;_P#ZY/\ ^AK2 ](HHHI@%%%% !1110 4444
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MXJS_ ,)%XN_Y\I__  #/^%(#TBBO-_\ A(O%W_/E/_X!G_"C_A(O%W_/E/\
M^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*?_P#/^%%P/2**\W_
M .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F_P#PD7B[_GRG_P#
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MX2+Q=_SY3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[_GRG_P#
M,_X47 ](HKS?_A(O%W_/E/\ ^ 9_PH_X2+Q=_P ^4_\ X!G_  HN!Z117F__
M  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBBO-_\ A(O%W_/E/_X!
MG_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*
M?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F
M_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\
MX!G_  H_X2+Q=_SY3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[
M_GRG_P# ,_X47 TOBE_R#;+_ *['_P!!KH_#/_(O:;_U[I_Z"*\ZUB;Q'KL,
M<=W87+)&VY=MJPYQ]*M6>L>*K&UBMXK&X$<2A%!M&)P/PH ].HKS?_A(O%W_
M #Y3_P#@&?\ "C_A(O%W_/E/_P" 9_PHN!Z117F__"1>+O\ GRG_ / ,_P"%
M'_"1>+O^?*?_ , S_A1<#TBBO-_^$B\7?\^4_P#X!G_"C_A(O%W_ #Y3_P#@
M&?\ "BX'I%%>;_\ "1>+O^?*?_P#/^%'_"1>+O\ GRG_ / ,_P"%%P/2**\W
M_P"$B\7?\^4__@&?\*/^$B\7?\^4_P#X!G_"BX'I%%>;_P#"1>+O^?*?_P
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MX4?\)%XN_P"?*?\ \ S_ (47 ](JOJ'_ "#[G_KDW\C7G_\ PD7B[_GRG_\
M ,_X4V77O%LT;QM93[6!4_Z(>A_"BX%KX5_>U/Z1_P#LU>@5Y)HO_"0Z"9C9
MZ?<KYN-VZU8],X[>YK3_ .$B\7?\^4__ (!G_"@#TBBO-_\ A(O%W_/E/_X!
MG_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*
M?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F
M_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\
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M35Y9I=]XGT>S6VMK"X6)22 UJQ//X5;_ .$B\7?\^4__ (!G_"@#TBBO-_\
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M_P#"1>+O^?*?_P  S_A1_P )%XN_Y\I__ ,_X47 ](HKS?\ X2+Q=_SY3_\
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M!G_"C_A(O%W_ #Y3_P#@&?\ "BX'I%%>;_\ "1>+O^?*?_P#/^%'_"1>+O\
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M S_A1<#TBBO-_P#A(O%W_/E/_P" 9_PH_P"$B\7?\^4__@&?\*+@>D45YO\
M\)%XN_Y\I_\ P#/^%'_"1>+O^?*?_P  S_A1<#N/$'_(!U+_ *]I/_0#7+?"
MW_CSO_\ KHO\C67=:UXKO+:6"2QN#'*A1L6A'!&#VJGHTGB/08Y4M+"Y59""
MVZU8]/PH ]9HKS?_ (2+Q=_SY3_^ 9_PH_X2+Q=_SY3_ /@&?\*+@>D45YO_
M ,)%XN_Y\I__  #/^%'_  D7B[_GRG_\ S_A1<#TBBO-_P#A(O%W_/E/_P"
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M;>QN%ACSM#6C$\DGT]Z /4:*\W_X2+Q=_P ^4_\ X!G_  H_X2+Q=_SY3_\
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MA\7*H LI\ 8_X\S_ (4 >DT5YO\ \)%XN_Y\I_\ P#/^%'_"1>+O^?*?_P
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M#/\ A1<#TBBO-_\ A(O%W_/E/_X!G_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\
MPD7B[_GRG_\  ,_X4?\ "1>+O^?*?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G
M_"C_ (2+Q=_SY3_^ 9_PHN!Z117F_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__
M  #/^%%P/2**\W_X2+Q=_P ^4_\ X!G_  H_X2+Q=_SY3_\ @&?\*+@'PV_Y
M&"^_ZXM_Z&*](KR'28]?T6ZDGM=/NEDD7:Q:V8\9SZ>U:W_"1>+O^?*?_P
MS_A0!Z117F__  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBBO-_\
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M^$B\7?\ /E/_ . 9_P */^$B\7?\^4__ (!G_"BX'I%%>;_\)%XN_P"?*?\
M\ S_ (4?\)%XN_Y\I_\ P#/^%%P/2**\W_X2+Q=_SY3_ /@&?\*/^$B\7?\
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M*/\ A(O%W_/E/_X!G_"BX'I%%>;_ /"1>+O^?*?_ , S_A1_PD7B[_GRG_\
M ,_X47 ](HKS?_A(O%W_ #Y3_P#@&?\ "C_A(O%W_/E/_P" 9_PHN!Z117F_
M_"1>+O\ GRG_ / ,_P"%'_"1>+O^?*?_ , S_A1<#TBBO-_^$B\7?\^4_P#X
M!G_"C_A(O%W_ #Y3_P#@&?\ "BX'I%%>;_\ "1>+O^?*?_P#/^%'_"1>+O\
MGRG_ / ,_P"%%P/2**\W_P"$B\7?\^4__@&?\*/^$B\7?\^4_P#X!G_"BX'I
M%%>;_P#"1>+O^?*?_P  S_A1_P )%XN_Y\I__ ,_X47 ](HKS?\ X2+Q=_SY
M3_\ @&?\*/\ A(O%W_/E/_X!G_"BX'I%>;_$;_D9+#_KDO\ Z&U'_"1>+O\
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MX2+Q=_SY3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[_GRG_P#
M,_X47 ](HKS?_A(O%W_/E/\ ^ 9_PH_X2+Q=_P ^4_\ X!G_  HN!Z117F__
M  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBO-_AU_R,M__P!<G_\
M0UH_X2+Q=_SY3_\ @&?\*R=*CU_1[R2YMM/NEED4JQ:V8C!(/I[4 >O45YO_
M ,)%XN_Y\I__  #/^%'_  D7B[_GRG_\ S_A1<#TBBO-_P#A(O%W_/E/_P"
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M_P#0UKEO^$B\7?\ /E/_ . 9_P *K:EJ7BC5;*2UN+&X:&3&X+:,#P0?3U%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !116;/XETBUUZVT2;5;*+6KJ)IX--DN$
M6XEC7AG2,G<RCN0,"C<6VK-*BBB@84444 %%%% !1110 4444 %%87B3QYX:
M\&W&GV^O^(M)T.?49/*LHM2O8K=KE\@;8P[ N<LO"Y^\/6MVG9VN*ZO8****
M0PHHHH **** "BBB@ HHHH **** "BBHH;J&Y,@AECE,;%'V,#M8=0<=#[4
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M0 4444 %%%% !1110 4444 %%4-=U_3/"^DW&J:SJ-II&F6R[I[V^G6&&(9
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MB@ HHHH ***CN+B*UA>:>1(84&6DD8*JCU)/2@"2BD5@RAE.0>012T %%%%
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M-.BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZN/C&I'E?);O]IZ_U8]EHKY+_P""8?\ R:[;_P#88O/YI7 _MU?\G:?LX_\
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M"ZCH7@/XB:#)\!O ]U>1SW5UKMG>22SE6X4.8%Z9R 55<C+. *^R?VD-0M/
M/[&?BC_A%+E'TVU\.QV.GW%O*'4V[*D*LKCAOD;((ZUSXF,_JZE52YV]&K;>
M=M+W_ Z,)*F\2XT6_9J*NG?>_1/6UOQ/"[_XY?%_]L3XB:UX;^"VIQ>"_A_H
M\GDWGBJ1?WUP22,HV"PW8)5$P< %G7< -34/V:?VD?A#:MXB\%_'+4?B#J5L
M/,DT'Q DABN5')1/.GE7)Z?\LSZ,#7I?_!/'PQ9^'?V4O"4]M$J3ZH]S?7,@
M',DAG= 3]$C1?^ U])45ZGU6HZ%)*T='=)W:WO?S_ ,/3^N4HXBLW>6JLVDD
M]K6\K;F1X1N=9O/"^E3^(K.VT_79+:-[ZULY3+#%,5&]48@9 .?\3UK@/VAO
M@_XE^,GAG3=,\,?$;5?AM=VMY]IEU#21*9)TV,OE-Y<T1QE@W)(RHX[UZM17
MG<WO\Z5M;GJ<BY.23OI8_,+]J[X2_%S]F+P'IOB3_AHGQIXE^V:@MA]E^UW=
MILS&[[]WVM\_<QC'?K7L6F_L0?%S4-.M;K_AJGQI'Y\2R[-MV=NX XS]OYZU
M+_P5;_Y(1X<_[&&+_P!$35]B>&_^1=TO_KUB_P#0!7J?6:GU;VFE^9K9;63[
M>9Y+P='ZS[.SMRI[O>[7?R/G3]O+Q!X@^'?[*MU=:)XAU+3=9M;BQ@.JV%U)
M;7#_ #JK'>C;ANYR,]^]>N?L\ZI>:U\!OAWJ&HW<]_?W7A^PFN+JZD:26:1K
M="SNS$EF)))).237C/\ P4M_Y-3UK_L(67_HX5ZK^SM;O>?LS?#J"*=K:27P
MK8HLR?>C)M4 8>XZUS7O@ZD[7?/_ .VG5;EQ\(7LO9_^WL]2HKY=_8Q_97\8
M_LY:IXUN?%'BRWU^+6ID:"&TDF<,59R9Y?, Q*VX @;NGWC7U%7/5A&$K0ES
M(Z:,YU(WG'E?8*^4/VD/VDO'UK\7M,^#GP>TJSN_&EW;"[O=3U !HK&,@D$
MG:"%&XLP(Y4!6)KZOKX:_; FNOV<_C]X:^-?A?4-/U#7=2A71[WPC=2'[1J,
M7"[H%4%NR G'#*A^;)6KPRC*M&,]G?[[:7\K[_Y$8J4XT)2@[6M]UU>U^MK_
M /#E/Q9\4/VI/V58;3Q7\2;[P]\1O!37$<.H#2XDCEM%8X!#+!"02> 2KKG
M.,@U]P>'=>L_%/A_3-9TZ3SK#4;:.[MY,8W1R*&4X^A%? /Q2_:XM?VRO#>F
M?!KP;HUSX;U_Q+>1P:K-XAEABBLXXG61EC.[,K%DX7:K':0%R>/O?P?X9M?!
M?A/1?#]D6:STJRAL86?[Q2- BD^^%KIQ$6J2=6"C*^ENL;;_ '[/J<>%FI56
MJ,W*%M;ZVE?;77;==-.]C8HHKX7UZ'_A2W_!3/1M14?9])^(&F&"1NBM,4V8
M^IE@B/\ P/WKCHT_;3]G>VCMYM*]OGJ=V(J^PI^TM=)J_DF[7^5T?=%%?'?_
M  4*AOOB1_PK?X1:1<>5J'BC4Y;N7"[BL-O$QR1W&6)_X!7>_L)_$$^,OV7?
M#,E[)MO-"272+O>>8_L[$)G_ +9>75*C?#NO?9[>7?[TT2Z]L0L/;=;^?;[M
M3Z'HKXI_X)^V[?$+Q_\ &?XNW"[_ .W-::QL9B.D*L9"![;6@'_ *Q=07Q;^
MWM\8/%^@V?BJ^\(?"#PE<_V?,NEMMFU6?+!LGH0=K$;MRJ-GRDL36CPS4U!N
MUHJ3\KI:>>Z7J9K%)P<TKWDXQ_O6;U\MF_)'WA17Y\_%;]FW5/V&/#L7Q0^$
MWC/79]/TJZA.LZ#K4Z207D#N$Y$:(I&6 Y7(W95@1S])?M _M+6OPI_9Q7XC
M:9"MS=:K;6_]CP3?=::X0/&6]0J[F([[<=ZF=%<JG2?,F^7:SOI9?.^A5.O+
MF<*T>5I<V]U;J_EUT['NE%?"OA7_ ()\7GQET.S\6_&?XA>)]2\7ZE$MW]GL
M+B)([#>-PB'F(XXR,A B@\#@9/3_ +,_B#Q;\%?VA->^ OBOQ'<>+-)&G#6/
M#NJ7S%KA8<@&%B23C&[C. 8SC ; T>&CK",[R5W:VFF]GU,HXJ3Y9RIVA*UG
M?77:ZZ7]?4YKXC_\I4OAO_V F_\ 2>^K[HKX7^(__*5+X;_]@)O_ $GOJN_'
MWQIKG[7'Q6D^!?P_NVMO".FR+)XQ\1P?,@"MG[.C="01C;_$XQ]U&)UE3=:%
M""_E=WV7/*[_ *]#*-54:M>;[QLN[Y59+^O,^VZ\X^/7PPU_XM^!1H7ASQUJ
M7P]U$74=Q_;&EB0R[%# Q_)+&<'(_B[=*Z;P!X#T3X8^#]+\,>'+)-/T?3HA
M#!"O7U+,?XF8DL6/)))KH:\]VC*\7>ST^7D>FKRA::M=:_/?7]3\U/VG/@9\
M7/V<?A;-XR_X:/\ &GB'R[N&U^Q?:;NVSYA(W;_MC],=-M=_X)_8W^+GC'P9
MH&O_ /#4?C2T_M73[>^^SYNW\KS8U?9N^W#=C=C.!G'05W?_  4X_P"36[S_
M +"UG_Z$U>^_!/\ Y(SX"_[ %A_Z3QUZ<<35>&E4=KJ5MEMRI]NYXLL)26,C
M25^5PON]^:W?L>4?M67'B#X7_L9:Z++Q/J3>(=(TZQMCX@MYY(+N:19H(WFW
MARZL_P Q/S$_,<DUU?[(>N:EXF_9K\ :IJ^H76JZE<Z?OGO+Z9III6\QQEG8
MDL< <DUSG[?G_)I'C_\ ZY6O_I7#6K^Q1_R:M\./^P;_ .U'KFB^?"U)O?G7
M_I)V6Y,53A'90E^#@>W5^:7A7PS\3_VB?VHOC!X7TWXV^+?!-AH.I74L$=K>
MW4\0C^TLBQI&MQ&$4#ICCC&*_2VOS2^!_P =/ _P+_;(^/&H>.-;_L2SOM0N
MK>WD^R3W&]Q=LQ&(D<CCN0!3P5_:RY5=\KMUUNA9A;V,.9V7/&_32TNIW7CC
M]F_]HOX)^';_ ,7>$_CYK'C2;2X'NI]-UD2D21H-S!$FEG1FP#P=OL<U]'_L
MF_'EOVBO@SIWBJYMHK/5HY7L=1@@SY8N(\$E,DD*RLC $G&[&3C->,_&;_@H
M=\.=0\$ZEH?PXGU#QOXMU>WDL;&UL]-N(U2212H9O-16;&<A4#$G XZCMOV.
M/AE>?LR_LQNWC ?8;W-SKVI09W&U3RP=A_VA'$I([$D=JVJ.?U><\3&UK<KM
M9];_ "L8TE36(IPPDKIWYE>ZZ<O5ZMGTI17Y]_#WX2^*O^"@\>H^/_B%XMU?
MP]\/I;N2WT3PQHTJH#'&V#(Q8,F0<@L49F(;[H !NW_@G6O^"?WQ0\!SZ!XN
MU77OA9XGU)='O]'UF4.;21R,2IM"H"!ELJJGY"#G(QFL*N94I2M-]//LWW_"
M^ES9XQ\KJQA>FNM^BW:7;\;=#[WHKXP_X**?$;Q-H<WPY\%Z7XAE\%Z!XIOW
M@U;Q#&[1B&,/$NUG&"$ D9V (R%P3C-5=/\ ^"<.G>$X;+Q#\+/BOXFT'Q)E
M)EU22>*>WN5.">(E0E6Z_,SJ1P00:SIT(RIJK4ERIMI:7VWOV-*N(G&JZ5*'
M,TDWK;?:W?\ (^V:*^=OV\(9+?\ 8]\<133M=2QVUHKSR*JM(PNH06(4  D\
M\ #FO!?@C^R1XD_:6^#_ (4U?XI_$;6D\,?V9!#HGASP_*D,<%O&@2.28NC*
MTA"Y/RD_[?\ ")I454IRJ2E91=OPOI_E^)57$2ISC3C"[DF_NMO]_P#P&?H'
M17YTZ+8^)_V _P!I3P;X2B\47WB'X6>,)5MX[6_;/V9FD$98*/E5T9XV+(%#
MJV"../=_VZOVB-=^#?A'0_#G@O\ Y'CQ;<FSL)%4,\" JK.@/&\LZ*N>A8GM
M52PS;I^Q?,IZ+IJMU\NOD3#%)*I[9<KAJ^NC5TT_/IYGT_17PWIG_!,6QUS1
MX]7\8_$GQ1>_$*5!++JEO<(\,4Y&>/,4R.%/\7F*3C.%K5_9!^,7C?PG\8?$
MWP$^)VJ/KNL:1&T^D:Q.Q:2XB4!BC.?F<&-ED4MDC#@DX&*^KPES*G.\DKVM
MT6]GUM\B%BIQ<75I\L9-)._5[772_P ]3[/HK\__ -MFZ\6VO[97PA'@6XM;
M3Q9<::]I87%X,PQ/*\T9=A@Y 5V/0].AZ'9\??\ !-N/Q!X5U#Q#JOQ,\4:_
M\2HK9[E-3O)D-J\R@L%$94R(N1@8DXZ@=JSC1@J4:U2=D[]+O1M?\'_,TE7J
M.M*A2AS25NMEJD_U_P"&/N>BOES_ ()U_%W6_BQ\ V'B*]FU'5M"U&33#>7+
M%I98@B21EV/+, Y7)YPHSSR?%?$5]XS_ &^/V@O%/@S2_$MYX7^$WA24V]ZU
MBQ!O&#E.0" [.R.5W9557.">#I+"2C7E1;^'5ORTU_%:$1QD)8>-=)^\[)=;
M]OP>I]+?MS?\FH_$/_KRC_\ 1\=6?V*/^35OAQ_V#?\ VH]?*O[1G[%,O[/7
MP-\5:Q\/OB#KRZ#]F5=9\/ZU)'-!>1-(@W+L155U)!!*D]<,._U%^QSJ$&D_
MLB^ ;ZZD$5K;:0TTLAZ*BO(6/X &JE&G3PM1PE=<RZ6M[K,H2J5,93C.%GRR
MZWZP_K8]VHK\_?!/@'Q3_P %$M2USQAXM\5ZMX8^%=O>O8Z1X=TB0(UP$P3(
MY8%<\C+,K$DL!M"\N\6?#K5_^">?BSP=XF\)>+M8UKX9ZKJ<>E:SH6LRB3RO
M,!/FIL54W;58@A5(* '<&("CA5S*G.5INVGF]DWW_4N6,?+*K"%Z:O=WZ+=I
M=4OD?H!17R%_P5#;_C&:-AS_ ,3NT(_[YDK#T#]C74_VE]$TGQU\8_&FN#4[
MZ"*[T[0=%GCCM-,@(#1QG>C[F*[2S+M.2<D]:SHT8U(.I.7*E*SZ]$]/O_#?
MH:UL1*G45*G'F;CS;VZM?I^.W4^V:JZKJ5OHNEWFH7<@AM+2%YYI&Z*BJ68_
M@ :GCC6&-(T&U% 4#T KYJ_X*%?$Q_A_^SEJUA9N?[5\32IHMLBYW%9,F7&/
M^F:L/JPKE495&H0W;LO5Z(ZW.-.+G4V2N_1:L^6OA/\ 'OXD6'QB\$_%+Q'X
MHUF;X=>./$M_I,>CW5[*UG:Q%E2)A&6**%:3C"C'DMZFOT]KXM_:/_9S&B_L
M#Z9X=M(@-7\%V=OJH= <^<@)NF&/7S)F_ 5]$?LW_$Q?C!\#_!_BLR"2ZO;%
M%N\=KB/]W,/^^U;\"*]/$\E2FW36D'R^J^R_S/)PCJ4ZB55ZU(\WI*_O+\8G
MI5%?FWXFTGX@>*O^"A'Q*\-?#[Q%%X3O-7TZ&'4-89"TEK9K%;,[1 '_ %F0
MJC&#\QY7[PN_M&?L&VWP;^'&J_$[P?X]\57'C'0PM]<WFH7:EYQN D='1%=&
M&=W+-T(]ZQ6'@HTYU)VYTGM??]//\#HEB:CG4A3IWY&UO;;]?+\3]%Z*\M_9
MA^)%[\7/@'X,\5:DP?4[ZRVW<@4+OFC=HG?'0;F0M@<<UX5XF_8:U?XKZEJV
ML?&GXO:WJEG]HD:SL-(DCM+2TA#'RR1(C(&V[<X08.?F;K63HJG5E3JRMR_H
M[:?TC6-=U*,:M*-^:S73=7U_IGV/7P[_ ,%8O^2-^#?^QA7_ -)YJX3X*ZM'
M^R[^UYH'PX\(_$%?'7PY\3QF(VJW\=T;&<APH81G:D@=%R0%W*_(X&.[_P""
ML7_)&_!O_8PK_P"D\U=M"C[+$T)1=U*4?+[6IR5*[K8>O"2M**=];[QNM3[;
MLO\ CS@_ZYK_ "J>OF?]O#X1/\5/V;;Z>QA\S6_#H36+,J#OQ&O[U1CUC+'Z
MJ*]"_9:^*R_&CX#^$O$[RB6_EM!;7_/(NHOW<I([;BNX>S"N'V?-3E43V=FO
M79_FOD=-.KRRITFMXW3\UNOQ3_X8]6HKXC^$,7_"_/V^_'?CI\7&@^ K8:-I
M[]5^T'=&2.W7[2?Q6N)^(6EW7[5G[9OBKX8^.O&]]X3\(Z'$%TW0[.=8'U!M
MJ$% X*,[;V?)5CM&%&,D:PPW-*$;[QYGY+]7:S^9,\6H1G+EO:7(O-_HKW5]
M=C]$J^>/VCOV/[7]H;X@>#?$\WBV^T ^'R UK;0"3SE$@DS&V]?*?(QOPW0<
M<5E_!/\ 8UOOV?/B/9ZAX2^)6OR>!_)D%[X9U/9,)Y"/D8, J#GG*HK?+C<0
MQKS+]N[_ ).@_9I_[#:?^EEI5X>FOK5*-&>K>CMMH^G];F>(J-X.M+$4]$E=
M7WU75:[OMT/NBBOF7_@H3\4_%/PI^ $E[X3N)].O=0U"*PFU.V)$EI$RNS,K
M ?*6*A=W!&[@YQ7D_@W_ ()U>%O$G@_3?&'AGXO>(YO&%U MS%XGT^[CDMFF
M(R64*!+C.1_K=P[\\5C2HQE3=6I*R3MM?6U_U_X!O6KRA45&G&\FK[VTO;^O
MS/O*LGQ=XFL_!?A76-?U%BEAI=I+>SE>NR-"S8]\"J?P[T/6/#/@?1-+\0ZW
M)XDUNUM4BO-5DC5#<2 ?,V !QV&>2!DY.35WQ9X;L_&7A?5]!U%2]AJ=I+9S
MJO79(A5L>^#7+47+S*+N=E*7-RN:MW1\(?#>T^//[<=IJ'C./XGW/PH\%?:Y
M+?3+'0U?S6V8SDQR1,P&0"S.<L&PH%>E_#WX<_M*_!/XB^'].;QG;?%GP#?7
M'E7]QK3F*ZLDP2TNYR\F<#"@/("3@JN=U>.^%=4^-G_!/,ZEHUYX3/Q#^%)N
M7NH;^QW!K93U<NH8PY&"RR*5+?=;DD_57P'_ &R/AI^T%*ECH6JR:;X@*[CH
MFK((;EL D^7@E9. 3\C$@#) KVZG,ES8>*E2]+].OVK^9X%'DD^7$R<:M^[7
M7[/V6O(]QHKYQ_;2^/.O?";PKX?\.>"E5_'GC&^&F:6[ '[/DJK2@'@MET49
MXRV><8KS*S_X)DZ;K5FFL>+?B=XMU/Q\Z^8^L6]PGEI-U&!(K2,%/?S%)Q_#
MT'FTZ490]I4E:.RZWMO]QZE6M*,_94X\TK7>MDD]M>_D?;=?,.O?&SQ;;_M[
M^'/AK;:L(_!\^@O>76G?9HCOG\N=@WF%/,'W$X# <=.M9O[)/C7Q/XHM_B;\
M%OB)JTNL:[X2E.GC6@Y,]U9S*ZJY9LY8 9#-DX=<Y()/R???L9>"X_VV[/X0
M_P!K>('\-W&F&^>\:Y@-[YGD/)C?Y.S&Y1_!G'>NNA0A&LXS=URMK3=.+=_D
MM?70X<5B*CH1E35GS)/6S34XJWS>C\M==C]8**\,\ _LIZ3\'O@CXO\ A]X'
M\0:Q9G7A<RQZIJ,L<D]M/+ L093&D? V*>F>O/3&5^Q5^SIXH_9O\ :QHGBC
MQ!:ZS<7M^;J&"PDD>WMEV@':9%4[F/)^4#@=:XW3I^^XSVM;3>^_I8[U4J^X
MI0WO?7:VWK<^B*^+-'\?>)Y/^"FFL>%G\1ZL_AF/2A(FBM?2FR5OL43;A#NV
M [B3G'4DU]IU^9WQ8^)&N?"G_@I!XC\0>'O!>H>/M2CTZ&)=%TPR"9U:RB!<
M;(I#A1R?E_*M,%'FKN/]R?WZ&..ER45+M*'W<RN?IC7QOX;\>>)9_P#@I9XG
M\+R>(M6D\-0Z(LL>C->RFS1_LUN=RP[M@.68Y ZD^M5?^&Z_BY_T:IXT_P"^
M[O\ ^0*\T_9M\?:Q\3O^"B6M>(M>\(WW@;5+K0G670]2+F>#9# BEM\<;?,%
M##*CAAUZUTX?"U(5)2FE;DGU3Z>ISU\92J1C&#=W*/1K[2\C]':*\P_:!\!^
M._B-X/MM&\!^-?\ A!;N:[47^HK#OE-J58.(R/F5\[2"I4G&-PKY)^*_[ GP
M^\!^'+W7Y_C'J^E>/(86N;;4_$&KVT,<TZ@L.JK(-Q& 1(2,YYKAIQIR5ZD[
M?*[/0JSJQ:5*'-\TE_7X>9^@M%?-W[ ?QGUGXU? "VO?$-S)?:UH][)I,][*
M<O<A$1T=SW;9(H)ZDKD\DUY[\0_^";?P:A;Q'XQ\0>*O%FFVI>XU.^F^W6BQ
M0@EI'(S;$@#)P,D_6M*E&-&K*G6E:W6U_P"M#&GB)5Z,:M"-[]&[?Y]3[3HK
M\V?^">/[.-GK7Q4U'XM:?'J5EX*TFXN+7PXFI2*US>,RM&TLA5%4JJ,PX4#<
MV.=AS]6_M"? GQW\;O$>DV.G?$J\\&> EMV_M.QTN/;=W,V[@"08^0J2"&)
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M39M84WZP:QX7NM4@FGECP2?,CB"@QD!ERR95BI!ST^U_VQKI+[]DWXA7$?\
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MMX@_8A\ ?\*@\7> O!D=QX)MO$CP2W%U;S2W9#PL&3(ED+,G7*;@.3TKT/\
M9_\ @]%\!OA/HO@F'5[C7%TX2$WUPGEEV>1G.U,G8H+<+DX]37AWQU^"VB?
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MBOA_QYI/Q2_8[TXZCHOQOT7Q%X;0,T/ASXC2XNG4#A()0?,D8#HJE%'I7?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]E#J.EWT+07-K<+N26-A@J16#J*%?VM)62E=+T=['4J3E0]E5=VXV;\[6O\
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MM(L8A#;6ENN$C4?S)ZDGDDDG)-:U>?+EYGR;=#TH<W*N??K;:Y\4_P#!5O\
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MIQ_R:W>?]A:S_P#0FKWWX)_\D9\!?]@"P_\ 2>.N:_:<^ __  T=\+9O!O\
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M[_*WS/';[]@?XIZE9SVEW^U)XPN[2XC:*:">&Z>.1&&&5E-_@@@D$'KFJ?\
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M6WZIGCT\#-X2E"I%.4&W9[-/=77R:/.I/^"4OP@A4-)XE\91@L%!:_LQDDX
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MLK*WW@2D\:'/J8_SKZ(^ /[.'@W]G'PS-I7A6UE>>Z97O=3O&#W-TPSC<P
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M".U9?BS_ ()TZ?;>*KS7?A9\1?$'PGGO23<6VE%WAY.=L>R6)U7.3M+,!GC
MXKO_ (!_LA6OP=\72^,M;\<>(O'WC26V:S;5-5N7$8A)!*B,NQ/('WW8 @$
M'FNRIB^=NI"JU?[-OP[6_0X*6"5/EISHIV^U?3UMO?Y;GC7[=W_)T'[-/_8;
M3_TLM*^VM;UW3?#.EW&IZQJ%KI6FVZ[YKR^G6&&)<XRSL0 /J:\5_:F_93L_
MVEK3P[-'XCN?"6OZ#.TUEJMK!YQ0,5)&T.ASE%(8,""*;\>/@?9^-OV77\&>
M,?&\]JNDV-O-=^*KB/+226Z@F>5&?YMV"2-^<GKFO/E4A]5IP;LXR=_23O?Y
M+IN>FJ=18NK42NI1C;UBK6^?<]NTG6+#7]-MM1TN]M]2T^Y0207=I*LL4JGH
MRNI(8>X-/U+4K31]/N;Z^N8K.RMHVFGN)W"1QHHRS,QX  &<FOFG_@G%H^I:
M/^R_I(OVE:VN;^[N-/\ .4H?LIDPIVDG 9@[#_>_&OH;QEX/TCX@>%]3\.Z]
M9KJ&CZE"8+FV9F4.A]U((/<$'((K/$4U1J2IQ=[&N%JNM2C4DK7_ *_X8^=O
MB!^PK\-?B9J"^-/!.J7O@3Q#=?Z7;ZWX5NL02LPR)0@.,'KF)DSG.3FL7]C/
MXQ>.KKXG?$#X/^/-9B\6WOA'YK;Q!'R\J*X0I(W\1^93EOF!#@EL#&3-_P $
MZ=7\.S3VGP^^.GC#P3X<F8NVD1M)(O)Y&Z*>$$=N5)]2:]Q_9S_9?\*?LV:+
M?P:'+=ZIJ^INLFH:QJ#!I[@KG"@  *H+,0.OS<DUV^TIQIRBY\RMHFM4^FO2
MWEN>?[*K*K&2I\KO=M/1KJK=;^:T/GB&XCM_^"K4JRN(VFT+9&&XWM]C!P/P
M4_E7UO\ &3_DD7C?_L"7O_HAZ\C_ &DOV,=*^/?BG2O%^E^)]0\#>--/18H]
M8T]#)N522A*AT8.I)PRN#@\YXQT7PN_9ZUGP+\*?%?A'7?B-K'CB_P!?2=7U
MC6%:1X#)#Y7R*\CL5  .TOU],UQUN2KA8Q4O>C'EMWU?7;J=N'52CBY-QO"3
M3OVT2M;?H>;?\$P_^37;?_L,7G\TJ_\ \% _CAXF^#_PST6Q\(W0TO6?$FH?
MV>-4W!6M8PN6*D_=8Y4;OX1DCG!'I?[,/P%_X9P^%T?@[^W/^$AV7DUW]M^R
M?9<^9CY=F]^F.NZK_P"T!\ O#?[1?@-_#/B/SX$247-I>VI FMI@" ZY!!!!
M((/4'L<$=&(JTZF*]I\4;KYK2YSX6C6IX+V7PSL[>3=['@'AS_@G#\-=)T^3
MQ!\3O$6L>--7\GS]3U'4M2:WML@99]P(D"@?Q/(>!GBN%_X)<PZ;;^.?CA%H
MQ4Z/'>6BV1C<NOD"6[$>&))(VXY)R:[GPW_P3KNG6VTOQS\9?%GC3P?;%?*\
M-^9+:VQ"G*HP,\@V\8^0*?0BO5?V=?V5=._9U\8?$'5M)U9+G3/%%S%+;:5'
M9>2NG1QM,5B#^8WF#$N,X7[OOQU2Q$>2K%U.:ZT5K+XD_OM\M-]3DCA9<U.4
M:2C9ZNZ;>CZ]OG?R/"OC=/':_P#!3;X1O,XB1M+5 S' +,+M5'U)('XU]P:M
M_P @J]_ZXO\ ^@FO#_VGOV1=#_:2.CZDVL7GA;Q5H_%EK5DGF,J[MP5DW*3A
MOF4AE()//-:/[/\ ^S_X@^#NF^(8?$7Q.USXC7FK+&@N-8WD6P0.!Y8>61AG
M?S\V/E' KSJKA5PBA>THJ2MWN[[_ #ZGIT_:4\8Y\MX2Y=>UE9W7RZ'AG_!*
M;_DD?C7_ +&-_P#T1%57XS?\I.?A+_V"?_9+RO>?V4_V:?\ AF/PCK>A_P#"
M1_\ "2_VEJ)U#S_L/V7R\QHFS;YCY^[G.1UZ5#XS_9B_X2[]ISPE\7_^$E^R
M?V!:?9?[&^P;_/XF&[SO,&W_ %W38?N^_'H3Q%)XWVR?NV_]LM^9QQH5%@G1
MM[U__;[_ )#/VYO^34?B'_UY1_\ H^.L3]G/0;CQ3^PAH.C6C,EUJ'ABZM(F
M4X(=Q*JX/U(KU?XY_"__ (71\*/$7@K^T_['_M>%8?MWV?S_ "L.KYV;EW?=
MQ]X=:D^"?PU_X4[\*_#?@S^T?[7_ +'MOL_V[R/(\[YBV[9N;;UZ;CTKS$XO
M#5*3>KDG\K-'=RR6*IU4M$I?>W%K\F?FU^QK^Q_\+_VB/"NLP^)M=\1Z5XWT
M:]>"]TFQNK>+;#P$D"20.WWMRGG@KVR*^B?^'5/P@M9(F?Q)XR!9P%5[^T&X
M]<?\>OL>E=M\:_V#_#/Q*\9/XU\+>(=3^&WC.1C)+J>BYV2N>LC(&1@Y[LCK
MG))!/-4?AM^PK-H7C71_%/C[XL>+/B1J>BW"W6FI>7,L,,,BG()#32N>W =0
M>A!'%>L\:ZC5157!]K7U\O\ @V/&C@%13INBI]G>VGGZ>5SSC_@IG!)X:UKX
M+^+I(&FTC1M6=;C S@AH9%4_58G_ "K[ET;6++Q%I%EJFFW45[I]Y"EQ;W,+
M!DEC8 JRD=0016!\4OA=X=^,G@F_\*^*++[;I-X!N"MMDC<<K(C?PLIY!_/(
M)%?*>C?\$X=6\/E](T[X[>,-/\#2.V_P_9[X=Z-]Y2RS>62>Y\GGTKAIRA4H
M*C4ERN+;3WO??;K?\#TJD*E&O[6E'F4DDULU:]GKTLS#^#^M6&O?\%/OB+=:
M;>07]K_8\D7G6\@=-Z):HZY'&0RD'T((K[TKYR^$?[%?ASX(_&P^-_"NHFST
MD:+_ &2NAM;%W+DH6G:X,A+,Q3)&P=>" ,5]&U.(G"4:4:;NHQ2^YO\ X<O#
M0J1=2516<I7[[I?\,?"__!3RYBL[GX-7$\BPP1:[)))(YPJJ#"22>P K[AM+
MZVO[*&\MKB*XM)HQ+'<1.&C=",AE8<$$<Y%>+?M*_LOV/[2=YX(_M36/L&F^
M']0-Y<V)M#+]OB8IOAWB1#'D(1N&[[W3BO'M>_X)QW*K<:1X2^,_BSPQX&N"
MWF^&6>2X@VL<L@Q-&NWG'S(Q]2:<'3GAXTIRLTY/:ZUM_E_G8SG&M3Q$JL(\
MR:BM[/1RV^__ ".6^$&I0_&'_@I7XQ\6:"RW.@:!I[VTE] <QRN(4MQ\PX.6
M\PCU$>>U>C_\%$/ =]<?#G0OB7H"%?$G@+48M1BF0?-]G+KO_!66-C[*U>T?
M 7]GSPC^SKX0;0?"MM)^^<2WFH7;![F[D P&=@ , <!0 !D\9))Z'XJ:AH&E
M_#7Q/<^*FC7PXFG3_;_./RM"4(9?J0< >I%*MB%3E3E1_P"725O.VOXW:]"J
M&&=2%2-?3VK=UVNDE]R2^9\@>*_%%I^UK^UA\&M+TX^?X6T#1H_&%\@.Y5DD
M"2)&X]01 I!_OM7W37P]_P $L_A3_P (_P##GQ#X[N()(Y/$-W]EL#-RPLX"
M1G/^U(6!_P"N8K[AK7&J-*2H0VC?[V[O[M%\C+ .=6#Q%3>5ONBK?B[R^9X]
M^V%_R;!\2_\ L"S_ ,A7)?\ !/?4;2^_9-\%Q6US#<2VOVJ&=(I S1/]IE;:
MX'W3M93@]F![UUO[87_)L'Q+_P"P+/\ R%?)'[-'[&*_$+]G_P )>-/!OQ$\
M2?#/Q5J<,R:A=:3/(T-TJ7$J*6C62-@=H X?''W<Y-%!1EAZBF[*\?RE^ L0
MYQQ5)P5W:>FW\OXG0?\ !2W5H/'WBKX6?"W1G6\\37FJ?:'AA8%X%DVQ1[O[
MN[<S<]DS7IW_  4HC\K]D[5DSG;?V(S])16U^SS^Q#X8^!OB:;Q?J6LWWCGQ
MQ-NSK6J#'E%AAFC0LQ#L#@LSL<< C)SWG[2WP-_X:(^%-[X+_MO_ (1_[3<0
MS_;OLGVG;Y;AL;-Z9STSNXJ95*<%2IP=U&7,W\U^27S*C2JU/;59JSE%Q2^3
MW>UVW\NYJ_L^_P#)!_AU_P!B[I__ *3QU\K?MW?\G0?LT_\ 8;3_ -++2OLC
MX?>%?^$$\!^'/#?VK[=_8^G6]A]J\OR_-\J-4W[<G;G;G&3C/4UY7\=OV8?^
M%V?%#X:>,/\ A)?[&_X0R]6\^Q?8//\ MF)HI=N_S5\O_58SM;[V<<8-TZT(
MX^-=OW>9N_DT_P#,FI1J2RUX=+WN6*MYIQOY=&>2_P#!4_PI?:W\!=(U:T1I
M;?1=9CGNE7HL;QO&'(]F91_P*OJ#X2^.])^)GPV\.^)=%GBGT_4+*.11"1B-
MMH#QD#HR,"I'8@BM[Q!H&G>*M$OM'U>RAU'2[Z%H+FUN%W)+&PP5(KX^O/\
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M57"QHSE9QYNE[IN^GGZF_P"^H8N5>G'F4E'K:SBK:^3WT.0_X),_\D7\7?\
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M[=Y [ #BNX^ _P"Q[;?"/QD?&OB#QWXC^('C/[.]H-2U6Z=8UB;JOEEW9O\
M@;L,X( (!KMJ8OG;J0JM7Z6_#M;]#SJ>!5-*G.BI6^U??SMO>W3N>/?MW?\
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MI_X9C\(ZWH?_  D?_"2_VEJ)U#S_ +#]E\O,:)LV^8^?NYSD=>E1?#[]F/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%?*?CK6K_XW?ME^&_ NG7UQ;>&/A["-?UIK29H_.O6 $$+,I!P
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MB@ HHHH **** "BBB@ HHHH **** "BBL3QQ'KLG@W7$\,200^(VLIAITET
M8EN-A\LMGC&['7BDW97&E=V-NBO#OV2K'XRV/@/44^--Q'/KAOF-DNZW>5;?
M:/OM!\A!;<1U('7L![C6U2G[.;C=/S6QC2J>U@I\K7D]PHHHK(U"BBO/_CU;
M^/+KX3^((OAI-#!XT:)?L#S>6!G>N\*9/D#%-P!;C..G6@#T"BO,OV<;7XC6
M?PCT>+XJSPS^,P9/M+1F(L$WGRPYB^0N%QDKQTY)R:Q? O[1J^-OVC?''PJ3
M0#:?\(Q9QW1U8WF_[06\KY?*\L;<>;UWG[O3GC=T7[25.+O9-Z;66[.=5X^S
MC4FG'F:6N]WLCV>BBBL#H"O-OVB/@[_POOX2ZSX(_M?^PO[1,)^W?9OM'E^7
M*LGW-Z9SMQ]X=:])HIK1IKIK]P/5-/J<I\*/ O\ PK#X:^&?"7V[^TO[%L(;
M'[9Y/E>=L4+OV;FVYQTR?K75T454YRJ2<Y;O4B$(TXJ$=EH%%%?GQ-JWQ:_;
M"_:/^(7AGP[\2]1^&?A+P=.UJG]DF19'82-&I81R1LY<H[$L^%   JZ-)UI.
M-[))MOR7_#F=>M[&"E:[;22\W_PQ^@]%<I\+?"NL>"?A_HNAZ_XAN/%>L6<)
MCN=8N@1)=-N)W$$D]"!R2>.2>M>1?M9:?\?;ZX\(GX*7=M;P+._]JB1K96ZI
MY;-YXP8P-^53+'(X-"IJ554U)6;M?9>HW4<:3J2B[I7MN_3S9]$5X9\/OV8_
M^$$_:2\;?%C_ (27[=_PDML;?^R/L'E_9LF(Y\[S#O\ ]5TV#[WMS[=:B86L
M(N"C7&P>88P0I;'.,]LU+4QG*E)N+W37R>XYTXUHQ4ULT_FMOS"BBBLS4***
M* "BBN0^+WQ!7X4_#'Q-XP:Q_M(:+8R7GV/S?*\XJ,A-^UMN3WP<>E '7T5Q
M'P3^)7_"XOA7X;\9_P!G?V1_;%M]H^P^?Y_D_,5V[]J[NG7:.M=O5SA*G)PE
MNM#.G4C5@JD'=-77S"BBFR<1L1Z&LI2Y8N78T'45\<_\$UO'?B7QWX)\>3^)
M?$.J^(9[;7/)@DU6]ENFB3R@=JF1CM&>PXK[&KJKT70J>S;OM^*N8T:BJQYD
MNK7W-K] HHKQG]I7]HQ?V>+#PG<'0/[??7]7CTL1_;/LWD!@29,^6^[''R\=
M>M90A*I)0CN]"JE2-*#J3=DE=_(]FHHHJ#0***YOXD>,D^'?P_\ $GBB2U-Z
MNCZ?/?FV$GE^;Y<9;9NP=N<8S@XST-)NRN-)MV1TE%>>?L__ !:_X7I\(] \
M;_V5_8G]JK*WV'[1]H\K9*\?^LV)NSLS]T=:]#K6I"5*;A-:K0RIU(UH*I!W
M3U04445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?&GPB\
M>>)M2_X*+?%/PU>>(M6NO#EGI!EMM'GOI7M('Q9?,D);8I^=^0/XCZFOLNMJ
ME-TXPDW\45+[S"G55252*7P2<?N"BBBL3<**** "BBB@ HI&^Z?I7QU_P3G\
M=^)?'%E\46\1^(=5U]K/7%AMCJE[+<F!,/\ *F]CM' X''%:TZ;J*;7V4G][
ML8U*JIRA%KXG;\&_T/L:N&^+'P9\,_&S2=.TKQ7!<WNEV=XEZ;*&Y>&*X900
M$E"D;TR<[?51^/<T5FFXM-;HU:4DXO9D%C8V^F65O9V<$=K:6\:Q0P0H$2-%
M&%55'     %3T447OJP225D%%%>-?M66?Q:OOABL?P;GCA\3_;(S-EX4D:WP
MVX1M-\@.[83D@X!P:(KF:7<)/EBY=OZ^_L>RT5S'PPB\40_#OP['XUF@G\6+
M8Q#4Y+8*(VN-HWD;0%Z]=HQG..,5T]5./+)QO>Q,)<\5*UK]]PHHHJ"PHKQ?
M]LK7]3\+_LS^.]4T;4;O2-3MK1&@O;&=H9HCYT8RKJ0RG!(X/>K'[(>N:EXF
M_9K\ :IJ^H76JZE<Z?OGO+Z9III6\QQEG8DL< <DUK&FY4Y5.S2^]-_H8RJJ
M-6-*VZ;^YI?J>P4445D;!1110 4444 %%%% !1110 4444 %%?&OB?QYXFM_
M^"EGA?PO%XBU:/PU-HK2RZ,E]*+-W^S7!W-#NV$Y53DCJ!Z5]E5M.FX1A+^9
M7_%K]#"G652<X)?"[?@G^H5\H_$K]AG4OC#\2-2U?Q;\7/$5_P""[R]^UCP?
M KQP1  ;41FF9 !CJ(@>O0\U]745-.I*E+GAN55I0K0Y)[?UV]3.\.^'M-\)
MZ#8:+H]G%I^EV$*V]M:PC"1QJ,!1^%:-%%0VY.[W-(Q44HI:(X[XP?#W_A;'
MPO\ $O@_[?\ V5_;5D]G]M\GSO)W?Q;-R[OIN'UK-_9_^$O_  HOX1Z!X(_M
M7^V_[*65?MWV;[/YN^5Y/]7O?;C?C[QZ5Z'7C'[/_P"T:OQV\2?$72DT Z,O
MA#5?[,$YO//^U_/*OF;?+7R_]5TRWWNO%:P]HX2C';1OY:+_ -*_$PJ>SC4A
M*?Q.Z7S5W^$?P/9Z*\:_:LL_BU??#%8_@W/'#XG^V1F;+PI(UOAMPC:;Y =V
MPG)!P#@UWWPPB\40_#OP['XUF@G\6+8Q#4Y+8*(VN-HWD;0%Z]=HQG..,5*A
M[CG=;VMUVO?T_4T<[5%3L]KWZ;VMZ]?0Z>BBBLS0***\S_:-M?B->?"/6(OA
M5-%!XS)C^S-(8E)3>/,"&7Y Q7."W'N#@T=4A/1-GIE%>?\ P$M_'EK\)?#\
M?Q,FAG\:B)OM[P>7C.]M@8Q_(6";02O&0<9ZUZ!6E2/LYN-[VZK8BG/VD%.S
M5^CW"BBBLS0**^-/A%X\\3:E_P %%OBGX:O/$6K77ARST@RVVCSWTKVD#XLO
MF2$ML4_._('\1]37V76U2FZ<82;^**E]YA3JJI*I%+X)./W!1116)N%%%% !
M1110 4444 %%%4/$$CPZ#J4D;-'(EM(RLIP00AP0?6IE+EBY=BX1YY*/<OT5
M\A_\$R_''B/Q[\$?$%_XFU_5/$5]%X@EACN=6O9+J5(Q;VY"!I&)"Y9CCIDG
MUKZ\KJQ%%X>HZ;=[?Y7.+#5UB:2JI6O_ )V"BBBN<Z@HHHH **** "BBB@ H
MHKQGX%_M&)\;/'/Q*\/1Z =)3P;J0T\71O/.^V9>5=^SRU\O_5=,M][KQS<8
M2E=KHKOTNE^;1$IQA;F>[LO6S?Y)GLU%%%06%%%% !117C/P[_:,7X@?'[X@
M?#-= ^Q#PG%')_:GVSS/M1;9D>5Y8V8+?WFSBKA&51M1Z*_R7_#F<ZD::3D]
MVE\WM^1[-17G/[0EM\0;OX2:[%\+IH8/&K*GV-IC&,C>OF!3)\@<IN +<9[C
MK2?L]6_Q"M?A'H47Q1FAG\:JLGVQH3&2!O;RPYC^0N$V@E>,^O4N,+P<[K1V
MMU]?0)3M-0L]5>_1>3\ST>BO@+Q9KGQ7_:J_:I\:?#[PO\1;_P"&OA7PBI5I
MM*9UED92J%CY;QLY9R>"X554<9Z^E_%CX>_M'^#?A)X&T#X:^,9/%?B*RNYA
MK6LWQMX[BYC+[H6/VDL-B@D,-Q8X'WN:W]@N6FW))SLUZ/JWLCF^LWG4C&#:
MA=-Z;KHENSZRHJEHJWR:/8+JCPR:F+>,73VX(C:7:-Y4'^'=G'M5VN62LVCK
MB^9)V"BBBD4%%(WW3]*^.O\ @G/X[\2^.++XHMXC\0ZKK[6>N+#;'5+V6Y,"
M8?Y4WL=HX' XXK6G3=13:^RD_O=C&I55.4(M?$[?@W^A]C445\:^)_'GB:W_
M ."EGA?PO%XBU:/PU-HK2RZ,E]*+-W^S7!W-#NV$Y53DCJ!Z4Z5-U9<J[-_<
MF_T%7K*A#G:OJE][2_4^RJ***Q-PHHHH **** "BBB@ HHHH P?'?@G2?B1X
M/U?PQKMO]JTG5+=K:XC!P=I'53V8'!![$ T_P3X1L? /A'1_#>F/<2:?I=JE
MI;M=S&67RT&%W,>O _PXK;HI\S2<>C)Y4VI6U7Z_\,@HHHI%!17SK^W]XIUK
MP;^S#XBU7P_J]_H>J17-FL=[IMR]O,@:X0, Z$,,@D'GD&O2?V>=4O-:^ WP
M[U#4;N>_O[KP_837%U=2-)+-(UNA9W9B2S$DDDG))K:--RHNM?:7+^%S"551
MKJA;5QYOQL>@T445B;A17C7Q)_:*7X>_'?X>?#8:!_:#^+5D8ZE]L\K[($SC
M]WY9WYVG^)<5[+5\DE!3Z.]OEHR%.+G*"W5K_-77X!1114%A1110 45S?Q(\
M9)\._A_XD\426IO5T?3Y[\VPD\OS?+C+;-V#MSC&<'&>AK _9_\ BU_PO3X1
MZ!XW_LK^Q/[565OL/VC[1Y6R5X_]9L3=G9G[HZU:A)Q<ULK?C>WY,ASC&48-
MZN]OE:_YH]#HHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$\<?\B5X@_[!]Q_Z+:O
MD/\ X)/_ /) ?$G_ &,LW_I+;5]>>./^1*\0?]@^X_\ 1;5^8/[$G[$W@?\
M:4^%^K^(_$VJ^(+"^M-7DT^./2;B".(QK#"X)$D+G=F1NX& .*]'!J+I8A2=
ME:'YL\O'.4:N&<%=WGIM]F)]/?\ !23XF>%=,^ .J^$+F^M;OQ/J\]LMEID<
M@>="DRNTI0<J %(R>I8"NUTOPSJ/@W]@V71=7C>#4[/P)/'<0R9#1/\ 8W)0
MYZ%<[2/:OE+]D?X8^$O@C^UMKWPX^(/A^SO_ !+"_P!H\+ZY>;BK;<NNU"?+
MW.F&5MNY61E!SBOO;X_?\D*^(G_8NZA_Z325&*4:&%]E!W4_?O\ *VB_._4U
MP4IXC%^UJ+E</<MOUO=OSZ6TM\SXI_83_:W^$_P:^ L/ASQCXK_L?65U*YN#
M;?V==S_(Y7:=T43+S@\9S5?]I[XP:=^W3JWA3X7_  DTV^UT6^HK?WVOSVCP
MV]I'M:/<=P#!0'))8+G"A0Q-=Q_P3K^#G@'QM^SC!J?B+P/X;U_4CJMU&;S5
M-)M[F8J"N%WNA.!V&:W?VQOV7?A[X:^$.N^/_"&CVO@/Q;X;B6_LM1\/C[$-
MRN 4*1X7)SPP (..<9!]&O4P]+&<\T[IKTZ6=M]/4\G"T\34P*A!KE:?>^[N
MKZK7T/5/VO/'-S\'_P!EWQ9J.FSR17T=C'IMK<+PR-*RPAQZ$!B?J!7._P#!
M/OX6:=\.OV;_  ]J$,"_VMXDC_M6^N<?/)O)\I<^BQ[>/4L>]>??$35->_:,
M_P"":S:Y>*\^O-ID=]<E4P9S:7/[R3 _O+$S\=S7JO["/CRR\=?LO^##;3(]
MSI-O_95W$I&8I(3M ([938WT85R.$J5&O!_$II/T2?X<USMC4A6KX><?@<&X
M^KM?Y\MOQ/?98DGC:.1%D1A@JPR#^%$L:31O'(H='!5E89!!ZBGT5Y35U9GL
MGR%_P3SN'\/VOQ;^'[$B+POXKN$MXVZI%(64*/;,+'ZL:^O:^0?V*I5OOCM^
MTM?01A;63Q,D:LO0LKW(/^/XU]?5V8EN4HR>[C!_?%'#A-(SBME.:7HIL\"_
M:"\=?&VU\5:;X3^$W@NRN?MEK]HG\5ZM*/LEI\Q4ILX&\?*W.XD'A#@D?/\
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MQZK\6?$#:IXCU0BX73!9V]NFF1$96(^5&I9SG+;B<< ="3\)>(_&'Q&7X@>
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M^&?Q TOXJ^ ="\6Z,S-IVK6JW,2O]Y">&1O]I6!4^X-<5^UQ<65M^S-\2GU
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M3S5]H^&_^1=TO_KUB_\ 0!6K_P!S7^)_DB%_OK_P+\V:$DBQHSNP5%&2S'
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MA3^VQX/\+ZQK?G?#3Q=;B*SLY+6!1!=$&, 2A!(?WHCX9CQ-["OI;QKXJL_
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MF3^)M-^)OQ2OD/VOQ=X@E,3/][R8RS\'TW3,O_ *P?B/_P I4OAO_P!@)O\
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M*2,<-*I'?::]E_94_:)U#XW:1K^D>*M'7P[X_P#"]T++6M-C!$>X[@LB DD
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M'B/]I+PM\3OB?XT\,>(1I%K/92-IH:.=H7BE54"+:Q(</+G).<?@*ROVH/\
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M14;NVC;;:W[*W3N?,?[-7[6'BCQ%\3-0^$?Q<T.#P]\0[-&>VGMOE@OU5=Q
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M=^)U@T+]D%X,?^/&1$_[_FIF@/Q]_P""BQ+@S^'?AAIP/(RAO&Y'_ @\F?\
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M0Q7<&4[<'!(KMOBS^TO\4/B%\;=5^$/P,TW3X=1TA/\ B;>)=5 :.U;@-M#
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M-;DL#H^NV%R^G:OIC9_T>Z0 L%SSM(((SR.0<D9KPO\ X5;^V[_T6'P7_P"
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MN6+5M==4GJ]W;I^IO_!'XHVOQH^%/AKQI:0?94U:U$LEONW>3*I*2)GN%=6
M/< &OG#QU^T?\5OC7\3M<\!?L_V6G6]GH+^1JWC#5E#0Q39(VQA@RX!5A]QR
MV"0 !D]3^P;]I_X8G\,_8_\ C[\G4O)Z_?\ M5QMZ>^*^1?V*_"?[0WB7P+X
MA?X4>/\ PYX7T^+5G&HV.KVZ/<M<F-/WA+6DQVD8 ^8<JW'<Z?5Z:Q-=:6AM
M?;5V5_2WWM&;Q-1X6ANW/>V^BUMV;_),]]7XV_'O]EWQ-H/_  O*;1?&'@;6
M+M;*3Q%HL:H]A*WW=P6.(;<9)!CY .&R,';_ ."B&D_%2X^&6L:EX9\2:38?
M#J'2PNN:7<1AKJ[9I@!Y;&%L##)TD3H?QX/XF?LM_M:_&+PK+X;\7_$WP5J^
MC22I,UMY7D_.ARIWQV"L,'T->Y_M?:=<Z/\ L5^+;"\F6XN[71[:":9,X=UD
MB5F&>Q()K"LX14)^ZY*739I]UMIK^!M04YN5.TE!I:O=._1W;U5OQ/#_ -C[
MP1^TG-X)^&VJ6'Q!\.0?"[,,IT22W0W?V(2GS(MWV,G<0&P?-[CYA7N'[4/[
M3>J_"S6-!\!^ -#3Q5\3O$7-EI\F3%;Q<CS9 ",_=; +* %9F( YW/V*/^35
MOAQ_V#?_ &H]?(GQ<TOXG:U_P48URR^'_B+2_"_BJ32H_P"SKW6(P\1MA;(7
M1 T,OS'$AX7L_(KHJ)8C&RIS22BYOM>W=[^OE<YJ+>&P$*L&VY*"[VO;9/3K
MHMKV/2-8G_;/^%^D7/C/5=9\)^,=-LXS=77AJVMT\U(@,N 4@C8E1G[LK'CH
MU?4GP5^+FE_'+X6:-XSTB-H+?486\RVD.6MYE)62,GOA@>>XP>]?,T_PF_;9
MNH9(9?B_X*>.12C*;2+D$8(_Y!M>M_L;? GQ)^SQ\'[OPMXHU#3=0OGU*>]C
M;2Y)'A2-TC 7+HASN5CC;CFN7%J$L-4<G&ZVY?Q3T]'WW.C#RJ1K048SL[WY
MK?)K7U7;8\8_X)5_\B#\1?\ L8/_ &D*M>-OCY\;/C=\<_%?PX^"4FD>&K'P
MJYAU'7]6C5RTH8JP^>.0 %PRJ%C8G83D#@5?^"5?_(@_$7_L8/\ VD*[GXK?
ML@^)[?XF:E\3?@OXX/@;Q?J0)U"PO(_,L+YSC+,-K;<]2"CC=R-IYKJQ#A'&
MMU-N56[7Y8VOY;_Y!&-26%:I;\\KVT=N:5[>>W^9K_ ?4OVD/#_Q!'ACXJV&
MA^)?#TEK)<+XMTN183&ZXQ&45$W$D@;3&G&3N.W%?+'_  4&T/XPV?C[PS)K
M_BC1[SPQ?:_(?"UE;1*);%@4VM.?(4G 9?XI!P?Q^@_A7^U9X^\,_%[2OA3\
M</"MIHNOZL-NE:[I+9M+P\A05W,/F((W*1AB 47.:Y'_ (*9?\A+X*_]A]O_
M $*&IH\T<91DTK2=KK9Z[^36W2QA7Y98*O!2E>*;L]U[NS[I[]4SV/\ 9[\&
M_M#^'?%M]<?%SQWX?\4Z ]DR6UKI,")(EQO0AR5M(?EVAQ]X]1QW',?$SQ9^
MTUX\\?ZYX;^''AW1_ OA_3)O)3Q1KSB4WIP&#Q*4<;2&[1/@@@L#Q7U.3@9/
M2OAN;]H;XW?M3>.O$>A? U-+\)^$=$N/LL_BG54#O,X)'R[D<#< 2%6,D#!9
MEW 5RTY2KU>;ECHO1+7=_EY]M#NJ1CAZ7+SRU?K)Z;*_I?I;OJ-T'X^_'/\
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M]);:O2C&$98IN*?+:W_@37]>AY3E4E3P:4VG)2N^_NQ?^>^U[[G.P_'WX_\
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M>K5XI_.S>GW'D7C&']M7P3H-[XSN/%'A/4;*QC-Y<>&["UB=Q&HW.HS;J6
M.=LV[C@DU])_LS?'*#]H;X/Z3XOCMDL;Z0O;7]I&25AN8SAPI/.T@JPSSAAG
MFOF_7O@!^T]X\\,ZGJ?CGXUQ>&(5M99SI/AV$_*H0DQ.8O)!X^7[S_4UH_\
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MO$T!<W("E8VA1#B-E7F,<@_6M+X4^)OB%\5_V1-#UK2M=M(OB+JVE>9!JU_
MB0"X\PC>Z)&5 VC& A^E._;F_P"34?B'_P!>4?\ Z/CJS^Q1_P FK?#C_L&_
M^U'KATJ4*E1I7YU\KIZ+LCT-:>(ITTVURRW>]G#5]V?!GP.\'?M!ZE^TA\4[
M#P?XYT#2O'EJS?V_JEW C6]V?- /E VK@?-SQ&G'Y5]1_ML?&;XD_ ?X4_#6
M?1_$<5EXEO+R&RUB\@M()H[EQ!F0JLL1"@N"1A5..PZ5S/[)7_)\W[0O_71_
M_2D4O_!5;_DG_P //^Q@_P#:35Z$9JK4PL915FH/;OT]/(\SV;HTL7.,G=.H
MMWTZ^OGN?8OC'QII?P_\&ZGXFUVY^RZ5IEJUU<S8R0JC. .Y)X [DBOC?0OB
M-^U/^T];OXH^'$F@_#+P3)(PTUM8C26>]C!(W$M#,3R.H1%[ MC->A?\%'OM
MO_#)>N?9-WE_:K+[3MS_ *KSE].V[97DGPC^'G[7FJ?"WPE=^$_BSX,L_#,V
MEVS:;;-:Q%H;?RUV(W_$O;YE& ?F/(/)KEPM.+ISK.UT^57VVO\ ?_D=>*K3
MYZ=%*5G'F?+OO;?\_5'K?[/G[0GCZ'XL7?P>^,VFV5IXS2T^VZ9JVF@"WU.%
M0=QP.-V S J%&%8%5*\Z/[7G[5]W\"?[#\+>$=)3Q%\0_$+!;"Q=6=(5+;%=
MD4@L6;Y54$9())XP?._ _P"S!^T%?_M">!_B)\3?''A;Q!'X=,D>[3PT4_DN
MCJ454M(E;)?^(\ GZ5A:]Y%Q_P %6]%75L,D>DC[ )@-H<6<A7;_ ,",A'O6
MGLJ52M"]GI)R4=GRW>G:ZM^)'MJU*C4LFM8J+ENN9I._>S;^5KF[IL7[:G@^
MS7Q3JE[X5\86RIYL_A!4BCN0G5D5XX4&\#.,2OSV;H<S_@EA=-?:%\5+EK=[
M1IM<CD-O(<M$2KG:3@<C..@Z=*^Z'^ZWTKX>_P""7_\ QX?%S_L8%_E)44ZW
MM:==<J7NK96^TOZ[EU*'LJU!\[?O/=W^Q+7R_(^XZ^&?%G_*5;PC_P!@%O\
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M^+?$=QY-A9^%]."1*1YEQ*;9-D48[LQ_+DG@$US_ /P4B_Y-+\3_ /7U8_\
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MCAZB<5=26ZO_ #;W[=.QC6IQK8JE)3=I1EL[;<NUN^[[GT+1117DGMA1110
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MKNI%0226]EW[ETL.J<G-R<G:UWV['GG[07PFC^./P?\ $G@MKH6,NI0 07+
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M[7[?Y[GQEK7P1^+7P]_;?N?B=X*T2PU_PKXE%O::M)<7,2/9VQ,"SD(TB,7
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M-;T3QMH_]BZG<ZY)>10?:H;C=$8($#;HG91\R,,$YXZ5]0T5T>WE^\_OVO\
M)WT^\YUAH)4E?^'>WS26OW>1\I_M[_!'QK\:M)\ 0^#-%_MF72]7:ZO%^U00
M>5&54;OWKKGH>!DU]6445FZC=-4^B;?WV_R-%2C&K*MU:2^Z[_5GDW[5G@;6
M_B5^S[XS\->'++^T=;U"U2.VM?-2+S&$J,1N=E4< ]2*G_9=\%ZS\.O@!X)\
M-^(;/^S]:TZQ\FZM?-27RWWL<;D8J>".A->I44HS<:;IK9M/[E;]1NFG457J
MDU]]G^A\H_$SX(>-?$'[=?P[^(>GZ+]H\'Z3IWD7NI?:H%\I]MR,>6SB1O\
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M=1NG&G;:_KKW_0V5-*K*K=W=E;IIV7GU"BBBLC8**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_-C&<<].:Z6G9V3[BNFVET"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M*2T7:<-F4-L&#P>>*\[^%7Q8_P"%W?LP6WC)XUAN]0T:X%W'']U;B-7CEQZ
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MWMM;7OJD?HGX3\?>&?'EO+<>&?$>D^(K>([9)=)OHKI4/H3&Q -;U?FA\==
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MU<K;*EJ2X$1D9@ &$;_*2-Q*+T)!Q]0_9C_8XN/"4FEVGCSPW9ZMY.R/7/\
MA,XGN!)CAV0S>4>>H" >F*RIT(^S56I>SO9)7>FE_O\ O-ZN(DJKHT[75KMN
MRUUML^GW'WE6!I?C_P +ZY'JLFF^)-(U"/29&BU%[6^BE%FZYW+,58^61@Y#
M8(P:^?/^"?'Q5U7X@_"'5-%US55US4O"FJ2:2NI+()/M-N #"^_)W<;@&[A5
MY/6OF+]G#X)R_M ?&SXU>&]9UJ[LO -EXDDO]5TNQE,4FI3_ &FX$$;N.1&
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M&Z'J[^(_&$%[?6$%VWEWEKL1WC5C@?9LX!/'.?>L[X-WGCC]EC]K[1_@S?\
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MK[1\-_\ (NZ7_P!>L7_H KF?^YK_ !/\D=:_WU_X%^;-*BO//CK\$-"_:"\
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MY[<$\U\*?L^_LI_LP_&GX3Z3!IMX=8\62V"-?W$>KRPZC;SE1YA^S;]BA6R
M3&RD <MU/UUX'^&\'PC^#,7A*VU34-9@TS3Y8EO-3F,LSC:Q R>BC. HX
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MG"6ZT/1IS52"G'9ZA1114%A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_9^%_Y]HYKX;^ M/^%W@/0_">E37-QIVCVJVD$MXRM,R+T+E54$_0"OF_\
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M^S\ ^"=#\+Z?+/-I^CV,.GP27+*TK1Q($4N5 !; &< #/85BY+ZG.C]IRO\
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M&?$NE0:UHLZ".2VNP6SCHP;.X,.H8$$'D&OF"7_@EI\&I-:^VK=>*(K;?O\
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M6NW%OX9\,1$:1X>2Y-NMVP$>0O.<L'9V*_.0  0%X_0^*)((DCC4)&@"JJC
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MH?#J]_X*1^ 8/AC!I,/AVQA-I(=$MUBMGN%@N2[*5 $G#*-XSG'4XKW[4_\
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M/:J7Q4^$7A/XT^%I/#_C#2(M6TYF\Q Q*20R 8#QNI#*W/4'D<'(XKP#P?\
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MXA^&/PS\,_MU>-=%^->E(_AOQ06U'1M2NKV>T@CFE</EI(Y$PI/FH2QP&4=
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M[0,G&,UWQK8?ZU'%MM.]VO-[Z]M7;0\]T,5'#2PD4FK63OTZ:=^F_P!YB?\
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MX  '  KHJ*=VMA63W"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MS1_AUX9\/^*M9\3:?H=E:>(-8V_;]2CB'GSA550"W4#"KP, D9Z\UT=%%.[=
MO(5DKVZA1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5SB_#KPROCF3QE_8=F?%+VJV9U9H@9Q"I.$5C]T?,<XP2, Y %='133:V$TG
MHPHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MO*?&7[-_AKQQ\;/"WQ1OK[5HM?\ #L @M+:WFB6U=09#F13&6)_>MT<=!^/J
MU%5&4H24HNS1,HJI%PDKI_\ #A1114E!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img175210594_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" >3#-@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTV*:1G+."QSP1_A3?[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H
MNT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15
M+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[
M15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O
M[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%
M4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_L
MF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52
M_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8
M?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^
MR8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_
MO/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)
MA_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\
M_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'
M^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_
M )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[
MS_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\
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M\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\
M"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_P
MH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P *
M/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C
M^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_
MLF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[
M)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R
M8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF
M'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A
M_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?
M[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^
M\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O
M/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S
M_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_
MYC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^
M8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F
M/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC
M_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_
MPH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\
M* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"
M@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH
M NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\*
M+M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"
M[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH N
MT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M
M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[1
M5+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT5
M2_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4
MO[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+
M^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_
MLF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[
M)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R
M8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF
M'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A
M_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?
M[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^
M\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O
M/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S
M_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_
MYC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^
M8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F
M/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC
M_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_
MPH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\
M*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"
MC^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH
M_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/
M[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^
MR8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_L
MF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)
MA_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8
M?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'
M^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_
MO/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[
MS_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\
M_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/
M^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_
M )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_Y
MC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\
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M!SE4A:U]WKZ:'R6$\0,!C:\:%+#UKN2C\$;)MVU]_2W4^FZ***^;/TX****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@
MX7_ OR1^7<&_[[FW_7^7YL****^9/U$**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\
M08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL**
M**^9/U$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\
MT&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G
M86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_
M[[FW_7^7YL****^9/U$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_
MR=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\
M,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S
M'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q
M_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?
MX4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^
M%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A
M1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4
M?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%'
M]DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_
M9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V
M3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']D
MP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,
M/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#
M_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_
MWG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_9,/]
MY_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V3#_>
M?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG
M_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_
MS'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\
MQ_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,
M?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_9,/]Y_S'
M^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_
MA0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X
M4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^%
M %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0
M!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4
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MG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\
M>?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?
M\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y
M_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S
M'^% %VBJ7]DP_P!Y_P Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_
M #'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?
MX4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\
M,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A
M0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q
M_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^%
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M5\^#WA#PC=-\.[J[\>>)IHV6TB%A/9VD,F.'F>=$8J.N$5B<8RN<CT[XY?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'R#\2/\ D["T_P"PKIG_ *#!7U]7
MR#\2/^3L+3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_+N#?]]S;_K_+\V%%%%?,GZB%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?(/Q(_P"3L+3_ +"NF?\ H,%?7U?(/Q(_Y.PM/^PKIG_H,%?7U?39
MQ_!PO^!?DC\NX-_WW-O^O\OS84445\R?J(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT45O5Q%:NTZLW*W=M_F<]'#T</=48*-][)+\@HHHK Z HHHH **** "BBB@
MHHHH ^0?B1_R=A:?]A73/_08*^OJ^0?B1_R=A:?]A73/_08*^OJ^FSC^#A?\
M"_)'Y=P;_ON;?]?Y?FPHHHKYD_40HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #7=8T9W8*JC)9C@ >M?E=^T=\7/$?\ P4;^/EI\!_A5?20?
M#/2;CS]?\00@M#<^6WS3$C[T2'Y8ESB1R&Z!2NK_ ,%1OV[ETW[9\$? 6K);
MWEQ_H_B?6XF8K:QMP;12@)W$']X5!('R#)+ =#^R#^TY^R#^R;\*[;PYIGQ,
MCO==NMMQK6L?\(]J8>\N,=O]&R(TR51>PR3RS$Q2Y:C]I+X8[+^9_P#R*_%_
M)EU.:DN2/Q/=]E_F_P /P/+?V0_AMHGP?_X*L>*/!GAR&2#1=&TVZM;999#(
MY MH"69CU9F)8]LG@ <5]S?\%"O&=QX%_8W^)VHVCM'<SZ<NG*RY! N)4@;!
M[?+(U?G3\+_VJOA;X=_X*:>-?BQJ'BC[/X U&&X2UU?^S[IO,+01(H\E8C*,
MLK#E!TK[M_X*&W%O\2_V!/&FL>'YC?:=>6%CJ]M,$9/,MOM$$N_:P##Y/FP0
M".XK.MS2P--S_E2EY7;O?MI<>&48XV27\VGG91_"YY3_ ,$7_AS::#^S[XB\
M8&%/[3\0:R\!FP-WV>W151,^F]Y3^(K]"*^%_P#@CGXCM=6_9+FTV%O])TG7
M[N&=<\_.L<JGZ$/C\#7W17H8CXUZ1_\ 24<6'^%^LOS9^+G[4^D)^SW_ ,%4
M?#FO:(!90ZIJ^EZTT<:X %Q((KD<#^,K,3_OFOVCK\:?V_KM/B!_P4V\$Z%I
MA\V[LYM"TN38,[9&N/._19UK]EJYJ'^Z0712G;TTM^!TU;_6I-]8Q^_6X5^-
MWP[TM/VA?^"P&MW&LJMW8Z+KMY<"*7E=FGH8K<8/H\<38^M?LC7X[_LOW*_#
M_P#X*[^,=,U3]U+J6KZY;0EN,F7S)XS_ ,"51C_>%%'_ 'N#ZJ,VO72WXA6_
MW2?FXI^CO?\  _8BO@O_ (+'_#>S\3?LQV7BLQ*-2\,ZO"T<^WYO(G/DR)GT
M+&)O^ "OO2OBS_@KKXDM=%_8WU6PG<+/K&K6-I;KW9EE\\_^.PM7-B/@7K'_
M -*1T4+\SMVE^3.D_P""7?C&Z\8?L7>"3>2F:?2WNM,#-U\N*=_+'X(4'X5]
M7U\>?\$G=%N-)_8M\,2SJ5%]?W]U&&&/D^T,@/X["?QK[#KTL1_%=]]+^MM?
MQ//P_P##MYO[KNWX!1117,= 4444 %%5);.621F%RZ G[HSQ^M-^PS?\_;_K
M_C0!=HJE]AF_Y^W_ %_QH^PS?\_;_K_C0!=HJE]AF_Y^W_7_ !H^PS?\_;_K
M_C0!=HJE]AF_Y^W_ %_QH^PS?\_;_K_C0!=HJE]AF_Y^W_7_ !H^PS?\_;_K
M_C0!=HJE]AF_Y^W_ %_QH^PS?\_;_K_C0!=HJE]AF_Y^W_7_ !H^PS?\_;_K
M_C0!=HJE]AF_Y^W_ %_QH^PS?\_;_K_C0!=HJE]AF_Y^W_7_ !H^PS?\_;_K
M_C0!=HJE]AF_Y^W_ %_QH^PS?\_;_K_C0!=HJE]AF_Y^W_7_ !KP?_AM;X+?
M]% ?_P %-]_\9KJH87$8J_L*<I6WLF[?<<U;%4,/;VU11OM=I?F?0M%?/7_#
M:WP6_P"B@/\ ^"F^_P#C-'_#:WP6_P"B@/\ ^"F^_P#C-=7]E9A_T#S_ / 9
M?Y'-_:>!_P"?\/\ P)?YGT+17SU_PVM\%O\ HH#_ /@IOO\ XS1_PVM\%O\
MHH#_ /@IOO\ XS1_968?] \__ 9?Y!_:>!_Y_P /_ E_F?0M%?/7_#:WP6_Z
M* __ (*;[_XS1_PVM\%O^B@/_P""F^_^,T?V5F'_ $#S_P# 9?Y!_:>!_P"?
M\/\ P)?YGT+17SU_PVM\%O\ HH#_ /@IOO\ XS1_PVM\%O\ HH#_ /@IOO\
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M )^W_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\
MG[?]?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?
MM_U_QH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W
M_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]
M?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_
MQH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&
M@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MYOXE?\DY\5?]@JZ_]$O7A'[&/^L\7_2T_P#:U>[_ !*_Y)SXJ_[!5U_Z)>O"
M/V,?]9XO^EI_[6KZ7"?\BG$^L?S1^79Q_P E?E?^&I_Z3(^FZ***^:/U$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O\
MDG/BK_L%77_HEZ\(_8Q_UGB_Z6G_ +6KW?XE?\DY\5?]@JZ_]$O7A'[&/^L\
M7_2T_P#:U?2X3_D4XGUC^:/R[./^2ORO_#4_])D?3=%%%?-'ZB%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X0U^[U?A#7Z
MCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110 4444 %%%% 'MOA;_
M )(W-_UYW?\ .2O$J]M\+?\ )&YO^O.[_G)7B5<6'^*IZGS>4_QL5_C?YL**
M**[3Z0**** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;^)7_ "3GQ5_V
M"KK_ -$O7A'[&/\ K/%_TM/_ &M7N_Q*_P"2<^*O^P5=?^B7KPC]C'_6>+_I
M:?\ M:OI<)_R*<3ZQ_-'Y=G'_)7Y7_AJ?^DR/INBBBOFC]1"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(
M_P"8G_MS_P!N/S?C'_F'_P"WO_;0HHHK]2/S<**** "BBB@ HHHH ]M\+?\
M)&YO^O.[_G)7B5>V^%O^2-S?]>=W_.2O$JXL/\53U/F\I_C8K_&_S84445VG
MT@4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O^2<^*O^P5=?\
MHEZ\(_8Q_P!9XO\ I:?^UJ]W^)7_ "3GQ5_V"KK_ -$O7A'[&/\ K/%_TM/_
M &M7TN$_Y%.)]8_FC\NSC_DK\K_PU/\ TF1]-T445\T?J(4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445YG^TEIOB[5/@AXNB\"ZG=:5XH2R::SFL@/.<IAFC0D$
MAG4,H*X()&"*0!\7/VD?AQ\#X<^+_%%II]X5W)IT1,]VX[$0H"P!_O$!?>OD
MCQO_ ,%;M%M;AX?"/@&]U*+HMUK%ZMKSZ^5&LF1_P,5XS\)_^";?Q3^+,W]N
M>-K]?!MK>,9I)-5#76I3%N=[0[A@D]?,=6![5]6^"_\ @E_\'/#L:MK(UKQ7
M-@;_ +=?&"+/^RL 1@/JQ^M>W['!X?2M+F?9?U^I\_[?'XK6A#DCW>_]?+YG
MS+??\%8_BA)*39^%O",$>>%G@NI3CZB=?Y5IZ!_P5J\<6\P.M^"/#^H1<973
MY9[5O?EVE_E7V;9_L-? JQMUAC^'6G,B]#--/*W_ 'TTA)_.J6L?L"? ;6E/
MF> 8+9\8#V=]=08]\+* 3]0:?UC [>R=OZ\Q?5<QW]LK_P!>7Z'FGPT_X*E_
M#+Q7)%;>*M-U3P5<OUFD7[;:+[>9&!)_Y#Q[U];>%?&&A>.M&AU;P[K%CKFF
M3?<N]/G6:,GN,J3@CN.HKXI^(G_!)[P=JD,LW@OQ7JF@W9RRV^J*EY;_ .Z"
MH1U'N2WT->/_  1_9-^/?P&_:,\+6%M/=Z7H=[>+]NUS1)C-836T8+R)*I&
M2H95$J#YF&WUI>QP>(_A3Y'V>W]?-^A2KX_#/]]#GCW6_P#7R7J?J=1117BG
MOA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?A#7[O5^$-?J/!'_,3_ -N?^W'YOQC_ ,P__;W_ +:%%%%?J1^;A111
M0 4444 %%%% 'MOA;_DC<W_7G=_SDKQ*O;?"W_)&YO\ KSN_YR5XE7%A_BJ>
MI\WE/\;%?XW^;"BBBNT^D"BBB@ HHHH **** /W>HHHK^7#^D HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#F_B5_R3GQ5_P!@JZ_]$O7A'[&/^L\7_2T_]K5[O\2O^2<^*O\ L%77_HEZ
M\(_8Q_UGB_Z6G_M:OI<)_P BG$^L?S1^79Q_R5^5_P"&I_Z3(^FZ***^:/U$
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** //_ (E?&S0_A9?65KJUKJ%Q)=1F
M5#9QQL  <<[G7FN-_P"&O_!O_0-US_OQ#_\ ':]'\9?"WPQ\0+JWN-?TS[?-
M;H8XF^T2Q[5)R1A&&>?6OF[]IKX:^&_A[%X=/A_3OL!NVN!-^_EDW;?+V_?8
MXQN/3UKZC+:.78IPP]2,O:.^O3J^_;R/RCBC&<2Y1"OF&'JT_J\;633<]6H]
MK;OOL>E?\-?^#?\ H&ZY_P!^(?\ X[7M=A>)J%C;W4898YXUE4-U 8 C/OS7
MC?P_^ /@+6_ OA[4+W0?.O+K3X)YI/MEPNYVC4L<"0 <GL*]FM;:.SM8;>%=
MD,*"-%R3A0, 9/M7G9A]2BU#"QDFF[W_ $U/I>'?[<J0=;-JE.49*+CR7NKZ
MN]TO+N2T445Y!]D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
MU?MF_P"I\(_[UW_*&OI6OFK]LW_4^$?]Z[_E#7NY'_R,*7S_ /26? <>_P#)
M.8K_ +<_]+B>U_"K_DF7A/\ [!5K_P"BEKJJY7X5?\DR\)_]@JU_]%+755Y6
M(_C3]7^9];EO^XT/\$?R04445SGI!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W_7_&C[#-_P _;_K_ (T
M7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\ G[?]?\:/L,W_ #]O^O\
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M^O\ C0!=HJE]AF_Y^W_7_&C[#-_S]O\ K_C0!=HJE]AF_P"?M_U_QH^PS?\
M/V_Z_P"- %VBJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W_7_&C[#-
M_P _;_K_ (T 7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\ G[?]?\:/
ML,W_ #]O^O\ C0!=HJE]AF_Y^W_7_&C[#-_S]O\ K_C0!=HJE]AF_P"?M_U_
MQH^PS?\ /V_Z_P"- %VBJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W
M_7_&C[#-_P _;_K_ (T 7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\
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M )^W_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\
MG[?]?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?
MM_U_QH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W
M_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]
M?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_
MQH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&
M@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\:
M+M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_QH N
MT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&@"[1
M5+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\: +M%4
MOL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_QH NT52^
MPS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&@"[15+[#
M-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\: +M%4OL,W
M_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_QH NT52^PS?\
M_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&@"[152*SECD5
MC<NX!^Z<\_K5N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE/BK\1-/
M^$_PZ\0>+]4&ZSTBT>Y,>[:96 PD8/JS%5'N:ZNL#QUX#T#XF>%[WPYXGTN#
M6-%O%"S6LX.#@Y!!!!5@0"&!!!'!I#/!/@S_ ,%"/A-\5[>"#4-67P3KC#Y[
M'7G$46[ SLN?]6PSP-Q5C_=KZ4L[R#4+6*YM9X[FWE7='-"X='!Z$$<$5^='
MQJ_X)2S?:)]0^%_B&-H6)8:+KK$%.^([A0<^@#J/=S7R]?\ P6_:#^ =Y.;?
M0O&7AO'S27F@23-"<=S-;,4_,U[?U?"8C6C/E?9_U_F?/?6L;A=*]/F7=?U_
MD?M]17X8K^UE\;]'7[))\1O$T31Y!6ZNW:0<]R^6_.I(?CQ\>_B-,MK8^,_'
M&L2,-OV?2KJY)8>ZPXS^55_953?F5B?[:I;<CO\ (_:CQI\1/"_PYT_[=XH\
M0Z9X?M,'$FHW20[\=E#$%C[#)KYWT3_@HI\-_%WQF\.^!?#T5YJ-GJMR;1M?
MF7[/;I*RGRE1'&]]SX3+!,;@>:^"_ G["?QT^+VH"]OM N=$BN#F74_%4[0/
MGU:-LS$_\ _&ON/]GW_@F_X$^$E[9:YXFN7\;>)+9UFA:>/RK*WD!R"D.3O(
M/=R1P"%4U/U;"X?6M4YGV7]?Y%K%XS%:4*?*N[_K_,^NZ***\4]\**** "BB
MB@ HHHH **** /RN_:J_;*_:$_9 _:V-MKFLOXA^%EU=#4-.TN73+.%+NQ?A
MX%N$A$@DB)*Y+$Y5"V0W/TCI/_!6#]F[4/#\6H7/B[4-+O&BWMI-UHEVUPC8
M^X6CC:+/;B0CWKZ/^*GP>\%_&[PK+X<\<^';+Q'I#G>(;M#NB?!&^.12'C?!
M(W(0<$\\U\AZM_P1J^ VHZP]Y;ZAXRTNV9]PT^TU2!H%']T&2W>3'U?/O40Y
MHP5.73KU^?\ 3+GRRE[1?=T^7](^(/C7\2M8_P""GW[7?A71O!VAW>G:!;(E
MC;?:%!E@LQ)ON+R?;E4X/W<D<(H)+<_L!\?O&GBKX2_!37O$'@3PHOC/7M)M
M ]OI#3,A=%P&<!06DV+\WEKAF"D @D4SX%_LT_#C]F_1)M-\ >&K?11<[3=7
MC,TUU=$=/,F<EF ))"YVC)P!FO3ZN45&BJ--VW=_-[_UYO;I"DY5?:U%?96\
ME_7X=3\Q/V6?^"Q&CZA:3Z1\<XFTC41-))!XATFR:2U:-F)$4D" NA0$*K*'
MW #=@@EO2OCA_P %?/@]X0\(W3?#NZN_'GB::-EM(A83V=I#)CAYGG1&*CKA
M%8G&,KG(].^.7_!-KX&_'C6;O6]2\/W/AO7KM_,N=3\-7 M7F8DDLT;*\18D
MDEO+W$GDFN7^&G_!)CX ?#O5XM1N]-UGQI-"ZR11>)KY9858'(S%#'$CCU5P
MP/<4G^\5I>[Z?U_D/2F[QU]?Z_S/G3_@DC\ _$_B;XC>)/V@/%T4R17RW$&F
MSW";6O[F>3=<W"C^Z.5R."78#[IKZS_X*+?M*>)OV8?V?QXA\(0PC7]3U*+2
MK>]N(A*EGOCD<R[#\K,!&0H;(R<D$#!^G;.SM]-LX+2T@CM;6!%CB@A0(D:
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M*[3Z0**** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;^)7_).?%7_8*N
MO_1+UX1^QC_K/%_TM/\ VM7N_P 2O^2<^*O^P5=?^B7KPC]C'_6>+_I:?^UJ
M^EPG_(IQ/K'\T?EV<?\ )7Y7_AJ?^DR/INBBBOFC]1"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYJ_;-_U/A'_ 'KO^4-?2M?-7[9O^I\(_P"]=_RAKW<C
M_P"1A2^?_I+/@./?^2<Q7_;G_I<3VOX5?\DR\)_]@JU_]%+755ROPJ_Y)EX3
M_P"P5:_^BEKJJ\K$?QI^K_,^MRW_ '&A_@C^2"BBBN<](**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_"&OW>
MK\(:_4>"/^8G_MS_ -N/S?C'_F'_ .WO_;0HHHK]2/S<**** "BBB@ HHHH
M]M\+?\D;F_Z\[O\ G)7B5>V^%O\ DC<W_7G=_P Y*\2KBP_Q5/4^;RG^-BO\
M;_-A1117:?2!1110 4444 %%%% '[O4445_+A_2 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "OFK]LW_4^$?\ >N_Y0U]*U\U?
MMF_ZGPC_ +UW_*&O=R/_ )&%+Y_^DL^ X]_Y)S%?]N?^EQ/:_A5_R3+PG_V"
MK7_T4M=57*_"K_DF7A/_ +!5K_Z*6NJKRL1_&GZO\SZW+?\ <:'^"/Y(****
MYST@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWPM_R1N;_KSN_P"<E>)5Q8?XJGJ?-Y3_ !L5_C?YL****[3Z0**** "BBB@
MHHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OFK]LW_4^$?\ >N_Y0U]*U\U?MF_ZGPC_ +UW_*&O
M=R/_ )&%+Y_^DL^ X]_Y)S%?]N?^EQ/:_A5_R3+PG_V"K7_T4M=57*_"K_DF
M7A/_ +!5K_Z*6NJKRL1_&GZO\SZW+?\ <:'^"/Y(****YST@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M17:?2!1110 4444 %%%% '[O4445_+A_2 4444 %%%% !1110 4444 %%%%
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M0\"5QCG."%'N_M7T17AWB?\ 9F_X3?X]Z7\1-?\ $G]H:?I6S[%X?^PE4B*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O^2<^*O^
MP5=?^B7KPC]C'_6>+_I:?^UJ]W^)7_).?%7_ &"KK_T2]>$?L8_ZSQ?]+3_V
MM7TN$_Y%.)]8_FC\NSC_ )*_*_\ #4_])D?3=%%%?-'ZB%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7S5^V;_J?"/\ O7?\H:^E:^:OVS?]3X1_WKO^4->[
MD?\ R,*7S_\ 26? <>_\DYBO^W/_ $N)[7\*O^29>$_^P5:_^BEKJJY7X5?\
MDR\)_P#8*M?_ $4M=57E8C^-/U?YGUN6_P"XT/\ !'\D%%%%<YZ04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^8O_!0?]K_QE:_$[4?ASX0U
MJZ\.Z/I"QQWUQITIBN+J=D#E3(N&5%#!=JD9.[.> /TZK\C?^"B/PAN_A_\
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MT2\^P4445P'I!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %?A#7[O5^$-?J/!'_ #$_]N?^W'YOQC_S#_\ ;W_MH444
M5^I'YN%%%% !1110 4444 >V^%O^2-S?]>=W_.2O$J]M\+?\D;F_Z\[O^<E>
M)5Q8?XJGJ?-Y3_&Q7^-_FPHHHKM/I HHHH **** "BBB@#]WJ***_EP_I **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBODS_@I9_R0K0O^
MQD@_]);JN_ 87Z]BJ>&YK<SM??\ R.+&XGZGAIXBU^57ML?6=%?A#17Z%_J1
M_P!1/_DG_P!L?"?ZX_\ 4/\ ^3?_ &I^[U%?A#11_J1_U$_^2?\ VP?ZX_\
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MFV7?V7BGAN?FT3O:V_S9]EE>/_M+#+$<O+JU:]]OD@HHHKQCU@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFK
M]LW_ %/A'_>N_P"4-?2M?-7[9O\ J?"/^]=_RAKW<C_Y&%+Y_P#I+/@./?\
MDG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\ 12UU5<K\*O\ DF7A/_L%6O\ Z*6N
MJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YST@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9MIUXQM[V_EFC)$?!VLQ&17ZRUSVC^#?"FB:HTNE:%H]AJ,*#<]G:11S(K9
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MC:7LUK)=#]Q**^!_^"9O[>>I_M$6=[\/_']S'<>.M+@^TVFI!!&=3M00&WJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KY,_X*6?\ )"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);J
MO>R'_D9T/\1XF=_\BZMZ'YJ4445_0I^%!1110 4444 %%%% &KX5_P"1HT?_
M *_(?_0Q7H?QU^[HGUF_]DKSSPK_ ,C1H_\ U^0_^ABO0_CK]W1/K-_[)7#4
M_P!XA\SYO%?\C7#>DOR9Y/1117<?2!1110 4444 %%%% 'UG_P $T_\ DNNN
M_P#8MS_^E5K7Z5U^:G_!-/\ Y+KKO_8MS_\ I5:U^E=?A_%O_(S?HC]CX7_Y
M%R]6%%%%?&'UH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7S5^V;_J?"/^]=_RAKZ5KYJ_;-_U/A'_ 'KO^4->
M[D?_ ",*7S_])9\!Q[_R3F*_[<_]+B>U_"K_ ))EX3_[!5K_ .BEKJJY7X5?
M\DR\)_\ 8*M?_12UU5>5B/XT_5_F?6Y;_N-#_!'\D%%%%<YZ04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5^8O_!2W]IC7+[QS-\*M OIK'1;
M"*,ZM]F<JUY-(H<1.1U159?EZ$L<]!7Z=5^-'[=FBW_P_P#VP/$&JW,'FQW=
MQ:ZO:>8#LFCV(,?0/&RGZ5Z.74X5,7&-3;5_/3]+OY'E9I4J4L'.5+?1?)_\
M&R^9P'Q4_9=\>_!?P#H/BOQ?96VE6VM3>3;V+3[KM#L+@R(!A.!T+;@3@@<U
M^B7_  3ET^YU7]C^YLK*^ETR\N+_ %"*&]A"EX'95"R+N!&02#R.U>$_M^?M
M%>!_C]\#/ 5]X6UJWGOAJ;2W>DR.%N[0F!@0\9YP&.-XRI[$UO\ [)/[5W@3
M]GK]D.4:OJT%UXF&H7DEIH%NV^YF<A=F]1_JT)'WFP, XR>*]3$2K8C"554C
M[U[67R/%PT*&&QU)TY7C:]WMU^[T/+OV%_BIXC\&_MA3:/XAU6ZU.X\0R7&D
M:G/>3M,\MQ'N:-RS$DD/'M!/9S7ZV5^,'[#^B:G\3?VO_#>ILIDD@O+C6[^5
M1P@568D^@,C(O_ A7[/URYG'E]ES?%RZV_KU/0RF?-[5Q^'FTO\ UVL%%%%>
M(>^%%%% !1110 4444 %%%% '$:G\#_AQK7BY?%>H_#_ ,+7_BE9H[A=<NM%
MMI+T21X\MQ.R%]R[5P<Y&T8Z4WXH?'+X??!:SBN?'7C'1O"ZS1O+!%J-VD<U
MPJ8W^5%G?)C(X12>1ZBNYKY#_;T_8/N_VRIO"M[8>,H?#%WX>@NHX[>XTXW$
M=R9C&1EQ(IC \K^ZWWO;G.3E%)1V_+3_ (8N*4FW+<^#/[:'[=/_  4UT?Q+
M\/\ 2[A?#EAJ5A>3:A)"4/V.R,9>YE'\&\IM0'GYHP0#D#]-OV[/B!<?#']D
MGXF:Y9RF"]_LMK*"13AD>X=;<,/<>;G\*_.W]ECXW>+_ /@G+\>9/@K\4=#T
MF+PYJUW%YNLV-NBRKYAVQ7:W 56G@R2")/F3YL;2I0_<?_!3RQFU']B+XB"W
M4R&);*=MO/R+>0EC^ Y_"EB(PC@HPIN\'>[\W;F]+?UV5X=REC+U-)::>2^'
M[_Z[OP?_ ((L_"2RT?X3>*_B+/;*=7UG4CI=O<,/F2U@5&(4]@TCG/KY:^E?
MI!7Q!_P1[U:VU#]D".UADW36.O7L,Z_W6;RY!_XZZU]OUW8CXDO*/Y+_ (<X
M*'PM^<OS:_(_%3XQ:#'^RA_P55T._P!!1+'2M0URQU*.&/Y52"]/E7*8[#<\
M^!T QZ5^U=?C9_P48N%\4?\ !2?P'I5@5EN[<:'8N@/25KII #_P&5#^-?LG
M7-0_W2"Z*4DO16L=-6_UF3?6,7\W=L*_&?\ L6/]JW_@KEJ-AK<?V_0M(UJ9
M)+>3YH_L^G1E50C^Z\L0R._F'UK]F*_'G]D>=?#/_!6[QU8Z@?)N+S5/$$$(
M;^)F>25?S12111_WN#[1DUZI*S^05O\ =)VZN*?H[W_KR/V%Z<#@5^>?_!9K
MX1V/B+X%Z'X_B@1=8\.:E':R7&,,UI<94H3WQ*(B/3+>IK]#:^-O^"MFKV^F
M_L6^(;:9PDNH:EI]M I/WG%PLI _X#$Q_"N;$?"GYQ_-+_@&]'XFO)_DSJO^
M":OCZY^(7[&G@"YO9/-N]-BFTAFSD[;>5HX\_P#;,1U]/U\:_P#!)/3YK/\
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MJ7V&;_GZ?]?\:/L,W_/T_P"O^- %VBJ7V&;_ )^G_7_&C[#-_P _3_K_ (T
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M )^G_7_&@"[15+[#-_S]/^O^-'V&;_GZ?]?\: +M%4OL,W_/T_Z_XT?89O\
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M^.OW=$^LW_LE<-3_ 'B'S/F\5_R-<-Z2_)GD]%%%=Q](%%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*H(HV)0D\;GVJ.Y%'[4W[#?PV_:RM[>Y\2VUSI7B6TC\JV\0:2RQW*QYR(Y
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MIS=23G+=DPBJ<5%;(****@L**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\
MVT****_4C\W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBB
MOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_X*6?
M\D*T+_L9(/\ TENJ^LZ^3/\ @I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\
MR+JWH?FI1117]"GX4%%%% !1110 4444 :OA7_D:-'_Z_(?_ $,5Z'\=?NZ)
M]9O_ &2O//"O_(T:/_U^0_\ H8KT/XZ_=T3ZS?\ LE<-3_>(?,^;Q7_(UPWI
M+\F>3T445W'T@4444 %%%% !1110!]9_\$T_^2ZZ[_V+<_\ Z56M?I77YJ?\
M$T_^2ZZ[_P!BW/\ ^E5K7Z5U^'\6_P#(S?HC]CX7_P"1<O5A1117QA]:%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC)-:'[#/P_O]8;Q#\7?$H:?6O$4\D=G))G(AWYE<9Z!G&T>@C]#7FUJWF_\
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MI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?FI1117]"GX4%%%% !1110 4444 :OA7_D:-'_Z_(?\ T,5Z'\=?NZ)]9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7R9_P4L_Y(5H7_ &,D'_I+=5]9U\F?\%+/
M^2%:%_V,D'_I+=5[V0_\C.A_B/$SO_D75O0_-2BBBOZ%/PH**** "BBB@ HH
MHH U?"O_ "-&C_\ 7Y#_ .ABO0_CK]W1/K-_[)7GGA7_ )&C1_\ K\A_]#%>
MA_'7[NB?6;_V2N&I_O$/F?-XK_D:X;TE^3/)Z***[CZ0**** "BBB@ HHHH
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M.TXSUP:]O)</6ACZ<I0:6O1]F?!<=5Z53AW$QA)-^YU_OQ/HSX5?\DR\)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 %%%% !1110 4444 %%%% !7R9_P4L_Y(5H7_8R0?\ I+=5]9U\F?\
M!2S_ )(5H7_8R0?^DMU7O9#_ ,C.A_B/$SO_ )%U;T/S4HHHK^A3\*"BBB@
MHHHH **** -7PK_R-&C_ /7Y#_Z&*]#^.OW=$^LW_LE>>>%?^1HT?_K\A_\
M0Q7H?QU^[HGUF_\ 9*X:G^\0^9\WBO\ D:X;TE^3/)Z***[CZ0**** "BBB@
M HHHH ^L_P#@FG_R777?^Q;G_P#2JUK]*Z_-3_@FG_R777?^Q;G_ /2JUK]*
MZ_#^+?\ D9OT1^Q\+_\ (N7JPHHHKXP^M"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MS^_;^_8_\7?%SXN>&/$?@323J-QJT'V#4F+K'%;-%RDTC'HI0D>O[L  D@5^
M@-<I\2OBGX5^$'AF77_%^M6^BZ9&=@DF)+2/C(2- "SMP?E4$\&MJ-25&K&I
M#=?KH85Z,:]*5*>S_37]#CF^#6I^-?V:4^&_CS4K?4M8N-&73[S4K-6*&90/
M+E&[EBI5&)(&2I.!G%?C7\5?@7XY^"OB:ZT7Q+H5[9R([1Q7D<3-;72?WXI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\ VT****_4C\W"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110!]9_\$T_^2ZZ[_V+<_\ Z56M?I77YJ?\$T_^2ZZ[_P!BW/\
M^E5K7Z5U^'\6_P#(S?HC]CX7_P"1<O5A1117QA]:%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_7Y-_Z&:QZV/&'_ "-FL_\ 7Y-_Z&:QZZ(?"CU,/_!AZ+\@HHHJSH"BBB@
MHHHH *_6;]AG_DUGP3_V_?\ I=<5^3-?K-^PS_R:SX)_[?O_ $NN*^"XS_Y%
M\/\ &O\ TF1]MPE_OT_\#_.)[Q1117XR?K04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%%% !1110
M4444 ?(/Q(_Y.OM/^PKIG_H,%?7U?(/Q(_Y.OM/^PKIG_H,%?7U?39Q_!PO^
M!?DC\NX-_P!]S;_K_+\V%%%%?,GZB%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5\F?\%+/^2%:%_V,D'_I+=5]9U\F
M?\%+/^2%:%_V,D'_ *2W5>]D/_(SH?XCQ,[_ .1=6]#\U****_H4_"@HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N1^+OC
MK_A67PN\5>*Q$DSZ/IL]Y'%)G:[HA*J<$'!; X/>NNKB/C=X'F^)?PA\8^%K
M=@EUJVEW%K S' $C(=F?;=BIELRH[H\$_8R_;7U7]IW7M4T+5?"=KH]UIEB+
MR;4+.\9HI"75 @A9=RYR3G>W2NX^,_[:WPW^ _C1O"_BF354U06\=UBSL_-3
M8^=OS;ASP:_(CX>_$[QW^SEX[O+[P[?3^'/$-OYEA>0S0H^0&&^*2-P0<,H[
M9!&1BJ_QA^,GB7XZ>,#XF\5SP7&K&W2VWV\"PKL3.T;1QGDU]34RV%2K&4-(
M-:V_3?R/C:>;5*5&4*FM1/2Z]-]O,_>S1-6@U_1K#5+7=]EO;>.YBWC#;'4,
MN1V."*NU^-FC?\%&OC5H.CV.F6FJZ6MK9P1VT*MID9(1%"KD]^ *N?\ #S#X
MY?\ 06TG_P %<5<4LKK<SY;6]3T89SA^5<][]=#]AZ*_._\ 8K_;3^)_QN^.
MUAX6\4ZA87&D365S.\=O8I$VY$ROS#GK7Z(5Y^(P\\-)1GU5_P"ON/3PN*IX
MN+G3V3M^"?ZA1117*=@4444 %%%% !1110 4444 ?-MQ^P3\/;_]IX?'6_U/
MQ#J/BQ;I;Q+"ZN+=M.2181#'B/R ^$ 5E_><,H//2OI*BOG?]L[]LCPW^R/\
M/6OKHQ:GXPU%&31=#W?-,XX\V3'*PJ2,GO\ =')XB4U2IJ/1;(M1=2;EU>[/
MA+_@ME'HTWQ.^%Z:<(G\6-I]RMTL(!F,!E3[-NQS]_S]O_ J_6/PVMS'X=TM
M;W<;Q;6(3;NN_8-V?QS7Y7_L&_LI^,/VG/BP/VD?C1+->6;7@OM*M;M-IU*=
M/]7+LZ);1$+L4<,4'\(^;]8JVA%T:"IR^)MMKM?IZZZ_(RG)5JO/'9*R\_ZM
MH?DK_P %N/B5]J\4?#KP%!-\MG:SZS=1 _Q2MY4)/N!%-_WU6A\"/^"P_@WP
M#X9\+>"M4^%NJ:1X;T73[?38]0T_5H[V;;%&J!S"T40YQDX<GD]:^Z]>_8Y^
M&/CCXN:Q\1O&OA^W\;:]?116UO!KD2W%G8V\:!1'' P*$DAF+.&.6.-HXKC?
MCI_P3E^"7QD\(W>GV/@O2/!&MB)OL.L>&[*.R:"7'REXX@J2KG&589QG!4\U
MA3<J--JU[N[7WV^Y.QM-1JS6MK*R?W7_ !U/>?AI\3/#/Q@\%Z;XL\(:O!K>
M@Z@F^"Z@)[<,K*<%'4\%6 ((P1745^/O_!)WQQXB^$/[47C3X*:M.7L;H7D<
MMJK%HXM0LWVM(GH&19 3WVIZ"OV"KHDHVC.'PR5U_7R.>+ES2A+>+L_S_4*_
M&?\ L6/]JW_@KEJ-AK<?V_0M(UJ9)+>3YH_L^G1E50C^Z\L0R._F'UK]F*_'
MG]D>=?#/_!6[QU8Z@?)N+S5/$$$(;^)F>25?S1216='_ 'N#[1DUZI*S^1I6
M_P!TG;JXI^CO?^O(_87IP.!7YY_\%FOA'8^(O@7H?C^*!%UCPYJ4=K)<8PS6
MEQE2A/?$HB(],MZFOT-KXV_X*V:O;Z;^Q;XAMIG"2ZAJ6GVT"D_><7"RD#_@
M,3'\*YL1\*?G'\TO^ ;T?B:\G^3.J_X)J^/KGXA?L:> +F]D\V[TV*;2&;.3
MMMY6CCS_ -LQ'7T_7QK_ ,$D]/FL_P!B_P /RRKM2ZU/4)HO=?/*9_-&K[*K
MTL1K5;>[LWZM7?XG!A_X=NS:^2;2_ ****YCH"BBB@ HJI+'=F1BDB!,\ __
M *J;Y=]_SU3\O_K4 7:*I>7??\]4_+_ZU'EWW_/5/R_^M0!=HJEY=]_SU3\O
M_K4>7??\]4_+_P"M0!=HJEY=]_SU3\O_ *U'EWW_ #U3\O\ ZU %VBJ7EWW_
M #U3\O\ ZU'EWW_/5/R_^M0!=HJEY=]_SU3\O_K4>7??\]4_+_ZU %VBJ7EW
MW_/5/R_^M1Y=]_SU3\O_ *U %VBJ7EWW_/5/R_\ K4>7??\ /5/R_P#K4 7:
M*I>7??\ /5/R_P#K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_K4
M7:_"&OW1\N^_YZI^7_UJ_"ZOU'@C_F)_[<_]N/S?C'_F'_[>_P#;0HHHK]2/
MS<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]WJ*I>7??\ /5/R
M_P#K4>7??\]4_+_ZU?RX?T@7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=HJ
MEY=]_P ]4_+_ .M1Y=]_SU3\O_K4 7:*I>7??\]4_+_ZU'EWW_/5/R_^M0!=
MHJEY=]_SU3\O_K4>7??\]4_+_P"M0!=HJEY=]_SU3\O_ *U'EWW_ #U3\O\
MZU %VBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M0!\G?$C_DZ^T_["NF?^@P5]?5\
M>?$591^U1:AF!E_M33?F[?=@Q7UMY=]_SU3\O_K5]-G'\'"_X%^2/R[@W_?<
MV_Z_R_-EVBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M7S)^HEVBJ7EWW_ #U3\O\
MZU'EWW_/5/R_^M0!=HJEY=]_SU3\O_K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^
MM1Y=]_SU3\O_ *U %VBJ7EWW_/5/R_\ K4>7??\ /5/R_P#K4 7:*I>7??\
M/5/R_P#K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_K4 7:*I>7??
M\]4_+_ZU'EWW_/5/R_\ K4 7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=HJ
MEY=]_P ]4_+_ .M1Y=]_SU3\O_K4 7:*I>7??\]4_+_ZU'EWW_/5/R_^M0!=
MHJEY=]_SU3\O_K4>7??\]4_+_P"M0!=HJEY=]_SU3\O_ *U'EWW_ #U3\O\
MZU %VBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M0!=HJEY=]_SU3\O_K4>7??\]4_
M+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_ *U %VBJ7EWW_/5/R_\ K4>7??\
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M4_WB'S/F\5_R-<-Z2_)GD]%%%=Q](%%%% !1110 4444 ?6?_!-/_DNNN_\
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M^7_UJ +M%4O+OO\ GJGY?_6H\N^_YZI^7_UJ +M%5(H[L2*7D0IGD#_]56Z
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M3FZDG.6[)A%4XJ*V04445!84444 %%%% !1110 4444 %%%% !1110 4444
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M^Q;G_P#2JUK]*Z_-3_@FG_R777?^Q;G_ /2JUK]*Z_#^+?\ D9OT1^Q\+_\
M(N7JPHHHKXP^M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% 'UG_P33_Y+KKO_ &+<_P#Z56M?I77YJ?\ !-/_ )+KKO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /W>HHHK^7#^D HHHH **** "BBB@ HHHH **** "BBB@#Y!^)'_ "=?:?\
M85TS_P!!@KZ^KY!^)'_)U]I_V%=,_P#08*^OJ^FSC^#A?\"_)'Y=P;_ON;?]
M?Y?FPHHHKYD_40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MABU(W%W+^+I)$/\ QVOLS]E?]HK4/C%\ ;CXA>,8+#2GM)[I;G^RX)?*2&$
MEPA9W)QD\$].E?%O[=W[*O@+]G3X0^"9/#%A,=:N-0-M?:M<W,DDET!"S$E"
MVQ/F&<*H_&OI?_@F7''-^RK'',JO"VJWJNKC(*G;D'VQ7IXB.&EA)U*$;6TN
M_D>1AZF+AC84\3*_,KV7S\M]#L?@+^VQX*_:&^)6N^$O#UK>VWV&U%U:7E\
MGVY0VV0K'U4+E",G)#'(7;7T-7XO_LHZA'X9_;?\.IH+;M/;7;JRA\LY#6SB
M5!]1L(/X5^T%<>,P\**IRIWM)==[_P!6/0P.)J5W4A5M>,K:;6_JX4445YIZ
MH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7X0U^[U?A#7ZCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?N]1117\N'](!1110 4444
M%%%% !1110 4444 %%%% 'R#\2/^3K[3_L*Z9_Z#!7U]7R#\2/\ DZ^T_P"P
MKIG_ *#!7U]7TV<?P<+_ (%^2/R[@W_?<V_Z_P OS84445\R?J(4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !7X0U^[U?A#7ZCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?N]1117\N'](!1110 4444
M%%%% !1110 4444 %%%% 'R#\2/^3K[3_L*Z9_Z#!7U]7R#\2/\ DZ^T_P"P
MKIG_ *#!7U]7TV<?P<+_ (%^2/R[@W_?<V_Z_P OS84445\R?J(4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R9_P4
ML_Y(5H7_ &,D'_I+=5]9U\F?\%+/^2%:%_V,D'_I+=5[V0_\C.A_B/$SO_D7
M5O0_-2BBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS
M_P"":?\ R777?^Q;G_\ 2JUK]*Z_-3_@FG_R777?^Q;G_P#2JUK]*Z_#^+?^
M1F_1'['PO_R+EZL****^,/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\
MVT****_4C\W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBB
MOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** /D'XD?\G7VG_85TS_T&"OK
MZOD'XD?\G7VG_85TS_T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U
M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M))ZG:T445Q'MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^3/^"EG_)"M"_[&2#_TENJ^LZ^3/^"EG_)"M"_[&2#_ -);JO>R'_D9T/\
M$>)G?_(NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?DI_P4N^-VJ^,OC5=>!H;R6/PYX;6-#:(Q"373H'>1Q_$0'"C/3!QU-?K77X
MS?MS:,W@K]LCQ%>7\'GV=U=6FJ+&PR)8C''N'TRCK^%>GED8SQD5/L[>NGZ7
M/(S><Z>"FZ>]U?TU_6R^9X]XK^"?CKP+X-TOQ5XA\,WVC:%JDHAL[J]41F9B
MI<8C)W@%02"5 (Z&M=?V:?B9+\,X_B##X3NKKPA)$9QJ5M+%-B,,59S&CF0
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M'EWW_/5/R_\ K4 7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=KY,_X*6?\
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M %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_ )ZI^7_UJ +M%4O+OO\
MGJGY?_6H\N^_YZI^7_UJ +M%4O+OO^>J?E_]:CR[[_GJGY?_ %J +M%4O+OO
M^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\ UJ/+OO\ GJGY?_6H NT5
M2\N^_P">J?E_]:CR[[_GJGY?_6H NT52\N^_YZI^7_UJ/+OO^>J?E_\ 6H N
MT52\N^_YZI^7_P!:CR[[_GJGY?\ UJ +M%4O+OO^>J?E_P#6H\N^_P">J?E_
M]:@"[15+R[[_ )ZI^7_UJ/+OO^>J?E_]:@"[15+R[[_GJGY?_6H\N^_YZI^7
M_P!:@"[15+R[[_GJGY?_ %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_
M )ZI^7_UJ +M%4O+OO\ GJGY?_6H\N^_YZI^7_UJ +M%4O+OO^>J?E_]:CR[
M[_GJGY?_ %J +M%4O+OO^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\
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M[_GJGY?_ %J +M%4O+OO^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\
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M %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_ )ZI^7_UJ +M%4O+OO\
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MR#W'F.^/;%>JT45I4FZDW-[LB$53BHKH%%%%9EA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?A#7[O5^$-?J/!'_,3_P!N
M?^W'YOQC_P P_P#V]_[:%%%%?J1^;A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?N]1117\N'](!1110 4444 %%%% !1110 4444 %%%% 'R#\
M2/\ DZ^T_P"PKIG_ *#!7U]7R#\2/^3K[3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_
M+N#?]]S;_K_+\V%%%%?,GZB%%%% !1110 4444 %%%% !1110 4444 %%%%
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MM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /D'P5_R=I<?]A?4/\ T":OKZOD'P5_
MR=I<?]A?4/\ T":OKZOI<]_BT?\ !']3\NX _P!UQO\ U_G^40HHHKYH_40H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M***XCO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *_"&OW>K\(:_4>"/^8G_MS_ -N/S?C'_F'_ .WO_;0HHHK]2/S<
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]WJ***_EP_I ****
M"BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G7VG_ &%=,_\ 08*^OJ^0?B1_
MR=?:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY
M,_X*6?\ )"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);JO>R'_D9T/\1X
MF=_\BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?6?\ P33_ .2ZZ[_V+<__ *56M?I77YJ?\$T_^2ZZ[_V+<_\ Z56M?I77
MX?Q;_P C-^B/V/A?_D7+U84445\8?6A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?FW^W]^VGXQ\.?$6^^''@;
M59?#UIIB(NHZE9';=33.@?8DG6-5#+RN&)SSCBOTDK\@_P#@H5\*[KP)^TY<
M>(]5MYI/"_B:6&]CN(N^U42>('LXVY^CK7?E\*=3%1A5VU^_3]+OY'F9G4J4
ML'.=+=6O;>W6WSLOF?.%]\3O&.J7!GO?%FN7D[=99]2F=CWZELU7_P"$]\3?
M]#%JW_@=+_\ %5^X_P .O 'PEUWP5I.H>$/#'A>[\/7$"O:36FG0,C+CN=N=
MV>&W?-D'/.:Z/_A5?@K_ *$_0?\ P60?_$UZLLRA!N/LMOZ['CPRFI4BI^VW
M^?ZGY;_\$WO%6M:M^U!I=O?:Q?WMN=.O"8KBY>1<B/@X)Q7ZXUA:3X$\-:#>
M+=Z9X=TK3KM05$]I9112 'J-RJ#S6[7DXS$K$S4HQM96_%O]3VL#A98.$H2E
MS7=_P2_0****X3T0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OPAK]WJ_"&OU'@C_F)_[<_P#;C\WXQ_YA_P#M[_VT
M****_4C\W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBBOY
M</Z0"BBB@ HHHH **** "BBB@ HHHH **** /D'XD?\ )U]I_P!A73/_ $&"
MOKZOD'XD?\G7VG_85TS_ -!@KZ^KZ;./X.%_P+\D?EW!O^^YM_U_E^;"BBBO
MF3]1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *^3/^"EG_ "0K0O\ L9(/_26ZKZSKY,_X*6?\D*T+_L9(/_26ZKWL
MA_Y&=#_$>)G?_(NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'UG_ ,$T_P#DNNN_]BW/_P"E5K7Z5U^:G_!-/_DNNN_]BW/_
M .E5K7Z5U^'\6_\ (S?HC]CX7_Y%R]6%%%%?&'UH4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?DS^W-_R=-XV_[<?_2&WKP>O>/VYO\ DZ;Q
MM_VX_P#I#;UX/7]'95_R+\/_ ((_^DH_ <S_ -^K_P".7YL****]4\T****
M"BBB@ HHHH **** "BBB@ HHHH **** "OUF_89_Y-9\$_\ ;]_Z77%?DS7Z
MS?L,_P#)K/@G_M^_]+KBO@N,_P#D7P_QK_TF1]MPE_OT_P# _P XGO%%%%?C
M)^M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'R#X*_P"3M+C_ +"^H?\ H$U?7U?(/@K_ ).TN/\ L+ZA
M_P"@35]?5]+GO\6C_@C^I^7< ?[KC?\ K_/\HA1117S1^HA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)G_!2S_DA6A?\
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M _W7&_\ 7^?Y1"BBBOFC]1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,_\ 08*^OJ^FSC^#A?\  OR1^7<&_P"^YM_U_E^;"BBBOF3]1"BBB@ HHHH
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M\EUUW_L6Y_\ TJM:_2NOP_BW_D9OT1^Q\+_\BY>K"BBBOC#ZT**** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH ^0?!7_ "=I<?\ 87U#_P! FKZ^KY!\%?\
M)VEQ_P!A?4/_ $":OKZOI<]_BT?\$?U/R[@#_=<;_P!?Y_E$****^:/U$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_3\SP/\ 8Y_8_P!/_9C\/75W?W,.K^--414OK^%3Y4,8P1!#D [<\EB 6('
MP!7T?7Q?^S+_ ,%!)/CY\>+[P?>Z%!H6CWML[Z)\Y>Y,D0+.LS9VDM&&8!0-
MNS&6SFOM"N'&*O[12K[M7^1Z>"EA_9N&&VB[?,****X3T HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OPAK]WJ_"&O
MU'@C_F)_[<_]N/S?C'_F'_[>_P#;0HHHK]2/S<**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#]WJ***_EP_I **** "BBB@ HHHH **** "BBB@
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M=8_LV[-S-<K@R?9XPRQ9&1N)(['/&:G\>:;'XY^'MZFGLMSY\*W%LR<[RI#
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MPMZ?)6O\PHHHKZ,\4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3K[3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_+N#?\ ?<V_Z_R_-A1117S)^HA1110
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MBBB@#\F?VYO^3IO&W_;C_P"D-O7@]>\?MS?\G3>-O^W'_P!(;>O!Z_H[*O\
MD7X?_!'_ -)1^ YG_OU?_'+\V%%%%>J>:%%%% !1110 4444 %%%% !1110
M4444 %%%% !7ZS?L,_\ )K/@G_M^_P#2ZXK\F:_6;]AG_DUGP3_V_?\ I=<5
M\%QG_P B^'^-?^DR/MN$O]^G_@?YQ/>****_&3]:"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSX^.W
M_!1KQM\%_C[XJ\)+X8T35- TJX2*%9A-#=,IB1B3('*\EB1\G0BOT'K\V_\
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M)^M_ZLYM_P ^?_)H_P"9[G17AG_#2DO_ $+Z?^!9_P#B*/\ AI27_H7T_P#
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M\Z]_YXI^?_UZ +M%4O.O?^>*?G_]>CSKW_GBGY__ %Z +M%4O.O?^>*?G_\
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M\4_/_P"O0!=HJEYU[_SQ3\__ *]'G7O_ #Q3\_\ Z] %VBJ7G7O_ #Q3\_\
MZ]'G7O\ SQ3\_P#Z] %VBJ7G7O\ SQ3\_P#Z]'G7O_/%/S_^O0!=HJEYU[_S
MQ3\__KT>=>_\\4_/_P"O0!D?$K_DG7BK_L%77_HEJ\(_8Q_UOB[_ ';3_P!K
M5[9\1I;P_#WQ0&A4+_9=UDY_Z8M[UX;^QV\RR^+/)0/\MKG/_;:OI<)_R*<3
MZQ_-'Y=G'_)7Y7_AJ?\ I,CZAHJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KU\T?J)
M=HJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KT 7:*I>=>_\\4_/_Z]'G7O_/%/S_\
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M=HJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KT 7:*I>=>_\\4_/_Z]'G7O_/%/S_\
MKT 7:*I>=>_\\4_/_P"O1YU[_P \4_/_ .O0!=HJEYU[_P \4_/_ .O1YU[_
M ,\4_/\ ^O0!^4W[<W_)TWC;_MQ_](;>O!Z]T_;?9V_:A\:&10K_ .A9 _Z\
MH*\+K^CLJ_Y%^'_P1_\ 24?@.9_[]7_QR_-A1117JGFA1110 4444 %%%% !
M1110 4444 %%%% !1110 5^LW[#/_)K/@G_M^_\ 2ZXK\F:_5W]B"2Z7]E[P
M6(XE9/\ 3<$_]?L_O7P7&?\ R+X?XU_Z3(^VX2_WZ?\ @?YQ/H&BJ7G7O_/%
M/S_^O1YU[_SQ3\__ *]?C)^M%VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#KT 7:
M*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_ /KT>=>_\\4_
M/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\
M/%/S_P#KT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_
M /KT>=>_\\4_/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/
MS_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*
MI>=>_P#/%/S_ /KT>=>_\\4_/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *]
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MU S(^XA(Q@?Q$!>/4U[K=?\ !./X@)>LMMKOA^6TSQ+++-'(1Z[!&P_\>KZ
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M,[1[*M>4_ .SOOVDOVCM=^*VH6QET'0Y!!I44H^42 $1  ]U4F0^C.IKZ_\
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M5+SKW_GBGY__ %Z/.O?^>*?G_P#7H NT52\Z]_YXI^?_ ->CSKW_ )XI^?\
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M7_X'7?\ \BUK>)/^"M'C^YU!F\/^#?#>G6/\,6I&XNY?Q=)(A_X[7V9^RO\
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MS>[(A%4XJ*Z!1116984444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\F?VYO^3IO&W_;C_Z0V]>#
MU[Q^W-_R=-XV_P"W'_TAMZ\'K^CLJ_Y%^'_P1_\ 24?@.9_[]7_QR_-A1117
MJGFA1110 4444 %%%% !1110 4444 %%%% !1110 5^LW[#/_)K/@G_M^_\
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M/_0)J^OJ^ESW^+1_P1_4_+N /]UQO_7^?Y1"BBBOFC]1"BBB@ HHHH ****
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KBO%_C[X=JMSX=\4>)/#*?:U,$^E
M:M?VX,JMP4:)VY!Z8(KXJ_X*6?M3:YX4U6U^&'A/4I])>2V6ZUF]M)"DK*^=
MD"L.5!4;FQU#*.F0?S\\-_#CQ=XUM9[OP_X7UK7K:%MLL^FZ?-<HC8SAF12
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M44 ?N]1117\N'](!1110 5\>^.O^1V\0_P#81N/_ $:U?85?'OCK_D=O$/\
MV$;C_P!&M7X=XJ?[EA?\3_(_1>"_]XK>B_,PZ***_FT_6 HHHH **** "BBB
M@#C-4_Y&]/\ KK%_):[.N,U3_D;T_P"NL7\EKLZ_=_$K_D5\/?\ 8+#_ -)B
M?S]X7?\ (VXD_P"PNI_Z5(****_"#^@0HHHH **** "BBB@#["\"_P#(D^'O
M^P=;_P#HI:W*P_ O_(D^'O\ L'6__HI:W*_O/+O]RH_X8_DC^;,5_O%3U?YA
M1117H'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@#-\22O!X=U22-VCD2UE974X*D(2"#V->#_P#"4ZU_T%[_ /\
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M_P!?=Q_)Z];KKQ-.$G&\5L?"\)5)JAB?>?\ %E^434_X2G6O^@O?_P#@2_\
MC1_PE.M?]!>__P# E_\ &LNBN3V-/^5?<?=>UJ?S/[S4_P"$IUK_ *"]_P#^
M!+_XT?\ "4ZU_P!!>_\ _ E_\:RZ*/8T_P"5?<'M:G\S^\U/^$IUK_H+W_\
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M7&?_ "+X?XU_Z3(^VX2_WZ?^!_G$]XHHHK\9/UH**** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XO
MXT_8U^#GQ"\4:AXB\0^"X=1UG4)/-N;IKZZ0R-@#.U90HX Z 5B?\,!_ /\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^L_^":?_)===_[%N?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#+
M\4_\BSJ__7G-_P"@&OG6OHKQ3_R+.K_]><W_ * :^=:^RR+^'/U/E,Y_B0]
MHHHKZ8^="BBB@ HHHH **** /)-%_P"2K2?]?=Q_)Z];KR31?^2K2?\ 7W<?
MR>O6ZZL1O'T/AN$_X&)_Z^R_*(4445RGW(4444 %%%% !6IX6_Y&;2/^OR'_
M -#%9=:GA;_D9M(_Z_(?_0Q65;^'+T9K2_B1]4?15%%%?EA^D!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?A#7[O5
M^$-?J/!'_,3_ -N?^W'YOQC_ ,P__;W_ +:%%%%?J1^;A1110 4444 %%%%
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M2 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3.<E!<SV[GZ84445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\
M/%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_ /KT>=>_\\4_/_Z] %VB
MJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#K
MT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_ /KT>=>_
M\\4_/_Z] %VODS_@I9_R0K0O^QD@_P#26ZKZF\Z]_P">*?G_ /7KY1_X*227
M#? W0Q+&J+_PD<'(]?LUU[U[V0_\C.A_B/$SO_D75O0_-RBBBOZ%/PH****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS_P"":?\ R777?^Q;G_\
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MM\7?[MI_[6KVSXC2WA^'OB@-"H7^R[K)S_TQ;WKPW]CMYEE\6>2@?Y;7.?\
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M>*?G_P#7H NT52\Z]_YXI^?_ ->CSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\
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M]_YXI^?_ ->CSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\ ]>CSKW_GBGY__7H
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MO1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\
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M0!=HJEYU[_SQ3\__ *]'G7O_ #Q3\_\ Z] %VBJ7G7O_ #Q3\_\ Z]'G7O\
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M%_):[.N,U3_D;T_ZZQ?R6NSK]W\2O^17P]_V"P_])B?S]X7?\C;B3_L+J?\
MI4@HHHK\(/Z!"BBB@ HHHH **** /L+P+_R)/A[_ +!UO_Z*6MRL/P+_ ,B3
MX>_[!UO_ .BEK<K^\\N_W*C_ (8_DC^;,5_O%3U?YA1117H'*%%%% !1110
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M% !7S5^V;_J?"/\ O7?\H:^E:^:OVS?]3X1_WKO^4->[D?\ R,*7S_\ 26?
M<>_\DYBO^W/_ $N)[7\*O^29>$_^P5:_^BEKJJY7X5?\DR\)_P#8*M?_ $4M
M=57E8C^-/U?YGUN6_P"XT/\ !'\D%%%%<YZ04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &7XI_Y%G5_^O.;_P! -?.M
M?17BG_D6=7_Z\YO_ $ U\ZU]ED7\.?J?*9S_ !(>@4445],?.A1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWB'_ +"-Q_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444
M%%%% '&:I_R-Z?\ 76+^2UV=<9JG_(WI_P!=8OY+79U^[^)7_(KX>_[!8?\
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M17]"GX4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]9_P#!-/\
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M9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?DS^W-_R=-XV_P"W'_TAMZ\'KWC]N;_DZ;QM_P!N/_I#;UX/7]'95_R+\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-3_TF1]-T445\T?J(4444 %%%% !1110 4444 %<?\6M5?1_A]J\L3;9)(Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU?'05*48Q@G>T597[OS"BBBOICQ0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /R9_;F_P"3IO&W_;C_ .D-O7@]>\?MS?\
M)TWC;_MQ_P#2&WKP>OZ.RK_D7X?_  1_])1^ YG_ +]7_P <OS84445ZIYH4
M444 %%%% !1110 4444 %%%% !1110 4444 %?K-^PS_ ,FL^"?^W[_TNN*_
M)FOUF_89_P"36?!/_;]_Z77%?!<9_P#(OA_C7_I,C[;A+_?I_P"!_G$]XHHH
MK\9/UH**** "BBB@ HHHH **** "BBB@ KYJ_;-_U/A'_>N_Y0U]*U\U?MF_
MZGPC_O7?\H:]W(_^1A2^?_I+/@./?^2<Q7_;G_I<3VOX5?\ ),O"?_8*M?\
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MW_K_ #_*(4445\R?J(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5^$-?N]7X0U^H\$?\ ,3_V
MY_[<?F_&/_,/_P!O?^VA1117ZD?FX4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% '[O4445_+A_2 4444 %?'OCK_ )';Q#_V$;C_ -&M7V%7Q[XZ
M_P"1V\0_]A&X_P#1K5^'>*G^Y87_ !/\C]%X+_WBMZ+\S#HHHK^;3]8"BBB@
M HHHH *RM1\26VF7)@E25G !R@!'/XUJU1O-#LKZ8RSP[Y,8SO8?R-?4\.5<
MCHXURX@IU)T.5Z4[<W-I;=Q5K7ZGR?$U+/ZV!4>'*E.%?F6M6_+RZWVC)WO:
MVG<XZ\U2*XUY;U5<1!T;:0-W&,]_:NBC\8V4DBH(I\L<#*K_ (U9_P"$7TS_
M )]O_(C?XTJ^&=-C8,MMAE.1^\;_ !K]OSOB[P^SS#8;#XC"XG_9Z:IT_@5D
MDDK_ +S79:GX+D/!GB1D.*Q6(PV+PO\ M-1U*GQN\FVW;]UIN]#3HHHK^9S^
MI@HHHH **** "BBB@#["\"_\B3X>_P"P=;_^BEK<K#\"_P#(D^'O^P=;_P#H
MI:W*_O/+O]RH_P"&/Y(_FS%?[Q4]7^84445Z!RA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7R9_P4L_Y(5H7_8R0?^DMU7UG7R9_P4L_Y(5H7_8R0?\
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M^]=_RAKW<C_Y&%+Y_P#I+/@./?\ DG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\
M12UU5<K\*O\ DF7A/_L%6O\ Z*6NJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YS
MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OPAK]WJ_"&OU'@C_F)_P"W/_;C\WXQ_P"8?_M[
M_P!M"BBBOU(_-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /W>H
MHHK^7#^D HHHH *^/?'7_([>(?\ L(W'_HUJ^PJ^/?'7_([>(?\ L(W'_HUJ
M_#O%3_<L+_B?Y'Z+P7_O%;T7YF'1117\VGZP%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!]A>!?^1)\/?\ 8.M__12UN5A^!?\ D2?#W_8.M_\
MT4M;E?WGEW^Y4?\ #'\D?S9BO]XJ>K_,****] Y0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5A_^(KAZ*/\ 6+.?^@VK_P"#)_YA_9> _P"@>'_@,?\ ([C_ (75XS_Z#/\
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M8?\ XBC_ (75XS_Z#/\ Y*P__$5P]%'^L6<_]!M7_P &3_S#^R\!_P! \/\
MP&/^1W'_  NKQG_T&?\ R5A_^(H_X75XS_Z#/_DK#_\ $5P]%'^L6<_]!M7_
M ,&3_P P_LO ?] \/_ 8_P"1[#\+_BAXF\1>.M,T_4-3^T6<WF[X_(B7.(G8
M<JH/4#O7OM?+/P5_Y*9HW_;;_P!$R5]35_1OAQC<5CLIJU,75E4DJC5Y-R=N
M6&EW?35GY3Q7AZ.'QL(48**Y%HDEUEV"BBBOU4^+"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#\F?VYO^3IO&W_;C_Z0V]>#U[Q^W-_R=-XV_P"W
M'_TAMZ\'K^CLJ_Y%^'_P1_\ 24?@.9_[]7_QR_-A1117JGFA1110 4444 %%
M%% !1110 4444 %%%% !1110 5^LW[#/_)K/@G_M^_\ 2ZXK\F:_6;]AG_DU
MGP3_ -OW_I=<5\%QG_R+X?XU_P"DR/MN$O\ ?I_X'^<3WBBBBOQD_6@HHHH
M**** "BBB@ HHHH **** "OFK]LW_4^$?]Z[_E#7TK7S5^V;_J?"/^]=_P H
M:]W(_P#D84OG_P"DL^ X]_Y)S%?]N?\ I<3VOX5?\DR\)_\ 8*M?_12UU5<K
M\*O^29>$_P#L%6O_ **6NJKRL1_&GZO\SZW+?]QH?X(_D@HHHKG/2"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R_%/
M_(LZO_UYS?\ H!KYUKZ*\4_\BSJ__7G-_P"@&OG6OLLB_AS]3Y3.?XD/0***
M*^F/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U/"W_(S:1_U^0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M444 %%%% !1110 4444 %%%% !1110!]A>!?^1)\/?\ 8.M__12UN5A^!?\
MD2?#W_8.M_\ T4M;E?WGEW^Y4?\ #'\D?S9BO]XJ>K_,****] Y0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ^LZ^3/\
M@I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\ R+JWH?FI1117]"GX4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!]9_\$T_^2ZZ[_P!BW/\ ^E5K
M7Z5U^:G_  33_P"2ZZ[_ -BW/_Z56M?I77X?Q;_R,WZ(_8^%_P#D7+U84445
M\8?6A7#_ !J_Y)GK/_;'_P!'1UW%</\ &K_DF>L_]L?_ $='7S_$7_(FQO\
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M\C"E\_\ TEGP''O_ "3F*_[<_P#2XGM?PJ_Y)EX3_P"P5:_^BEKJJY7X5?\
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M?^19U?\ Z\YO_0#7SK7V61?PY^I\IG/\2'H%%%%?3'SH4444 %%%% !1110
M4444 %%%% !1110 4444 %:GA;_D9M(_Z_(?_0Q676IX6_Y&;2/^OR'_ -#%
M95OX<O1FM+^)'U1]%4445^6'Z0%%%% !1110 4444 %%%% !1110 4444 ?(
M/@O_ ).TN/\ L+W_ /Z!-7U]7R#X+_Y.TN/^PO?_ /H$U?7U?39[_$H_X(_J
M?EW '^ZXW_K_ #_*(4445\R?J(4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P""G6L:?K<DEUX0TF^GCEAW8 TVQ8H(UQT$LF,XY_?,:_:=ONGZ5^/W_!)
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M_GU?]?\ "C[?+_SZO^O^% %VOPAK]T?M\O\ SZO^O^%?A=7ZCP1_S$_]N?\
MMQ^;\8_\P_\ V]_[:%%%%?J1^;A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?N]15+[?+_SZO\ K_A1]OE_Y]7_ %_PK^7#^D"[15+[?+_SZO\
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MQ?QDO))?AOJZM R ^3\QS_SV3VKY_B+_ )$V-_Z]5/\ TAGJ97_O^'_QQ_\
M2D?,5%%%?PX?T2%%%% !1110 4444 5M4_Y!EW_UQ?\ ]!-<]X'^]>_\ _\
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M ))EX3_[!5K_ .BEKJJXKX6WLB?#7PJHMG8#2[89YY_=+[5U'V^7_GU?]?\
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M"X/E^LU8PYG9<S2N^RONSY2CAZV(;5&#E;LF_P CB/BM\8+RQNM6\-V=DD!
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M](WAO55-LZ@VDHSSQ\A]J\ K[+(OX<_4^4SG^)#T"BBBOICYT**** "BBB@
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ME_Y]7_7_  H ^3O!?_)VEQ_V%[__ - FKZ^KX\\&S,O[5EQ((R6_M:_.SO\
M=FKZV^WR_P#/J_Z_X5]-GO\ $H_X(_J?EW '^ZXW_K_/\HEVBJ7V^7_GU?\
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M4 7:*I?;Y?\ GU?]?\*/M\O_ #ZO^O\ A0!=HJE]OE_Y]7_7_"C[?+_SZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS_X)I_\
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M^]=_RAKW<C_Y&%+Y_P#I+/@./?\ DG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\
M12UU5<K\*O\ DF7A/_L%6O\ Z*6NJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YS
MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^$-?N]7X0U^H\$?\Q/_ &Y_
M[<?F_&/_ ##_ /;W_MH4445^I'YN%%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^L_^":?_)===_[%N?\
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MJ?\ VAZ_^I/_ %$?^2__ &Q]O45\0T4?\18_Z@?_ "I_]H'^I/\ U$?^2_\
MVQ]O45\0T4?\18_Z@?\ RI_]H'^I/_41_P"2_P#VQ]O45\0U]%_LZ?\ (DWO
M_81?_P!%15]1PWQY_K!CU@?JWL[IN_/S;>7*OS/&S;AK^R\,\1[;FU2MRVW^
M;/4Z***_63XD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P !8\%_"N/P3=7'B3Q%J"WU[ CREQEDCX)9RS<LV,]J]4KR?XX>()[I=/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?\ MS_VX_-^
M,?\ F'_[>_\ ;0HHHK]2/S<**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#]WJ***_EP_I **** "OCWQU_R.WB'_ +"-Q_Z-:OL*OCWQU_R.WB'_
M +"-Q_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?87@7_D2?#W_ &#K?_T4M;E8?@7_ )$G
MP]_V#K?_ -%+6Y7]YY=_N5'_  Q_)'\V8K_>*GJ_S"BBBO0.4**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_ -);JOK.ODS_ (*6
M?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ4445_0I^%!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?6?_!-/_DNNN_\ 8MS_ /I5:U^E
M=?FI_P $T_\ DNNN_P#8MS_^E5K7Z5U^'\6_\C-^B/V/A?\ Y%R]6%%%%?&'
MUH5P_P :O^29ZS_VQ_\ 1T==Q7#_ !J_Y)GK/_;'_P!'1U\_Q%_R)L;_ ->J
MG_I#/4RO_?\ #_XX_P#I2/EFBBBOX</Z)"BBB@ HHHH **** *VJ?\@R[_ZX
MO_Z":Y[P/]Z]_P" ?^S5T.J?\@R[_P"N+_\ H)KGO _WKW_@'_LU?N_#O_)N
ML]_QT?\ TN!_/O$W_)S,@_P5_P#TW,ZJBBBOP@_H(**** "BBB@ HHHH [CX
M*_\ )3-&_P"VW_HF2OJ:OEGX*_\ )3-&_P"VW_HF2OJ:OZB\+O\ D35?^OLO
M_2('X[QE_O\ #_ O_2I!1117["?"!1110 4444 %%%% !1110 4444 %%%%
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M9?\ 8.3_ -&RUY97J?[1?_([67_8.3_T;+7EE?Q;QA_R/\7_ (OT1_0&1?\
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M,Y_B0] HHHKZ8^="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K4\+?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?\ MS_VX_-^,?\
MF'_[>_\ ;0HHHK]2/S<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#]WJ***_EP_I **** "OCWQU_R.WB'_ +"-Q_Z-:OL*OCWQU_R.WB'_ +"-
MQ_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?87@7_D2?#W_ &#K?_T4M;E8?@7_ )$GP]_V
M#K?_ -%+6Y7]YY=_N5'_  Q_)'\V8K_>*GJ_S"BBBO0.4**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS:NGNKK6+:V\S^K,DSS+^(L%',<KJ>THRND[2CL[/223W78****\0]T****
M"BBB@#N/@K_R4S1O^VW_ *)DKZFKY9^"O_)3-&_[;?\ HF2OJ:OZB\+O^1-5
M_P"OLO\ TB!^.\9?[_#_  +_ -*D%%%%?L)\(%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'Y,_MS?\G3>-O^W'_TAMZ\'KWC]N;_ ).F\;?]N/\
MZ0V]>#U_1V5?\B_#_P""/_I*/P',_P#?J_\ CE^;"BBBO5/-"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K]9OV&?^36?!/_ &_?^EUQ7Y,U^LW[#/\
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M15^H^&__ "/X_P"&1\=Q9_R+'ZH]3HHHK^LC\3"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#+\4_\BSJ_P#UYS?^@&OG6OHKQ3_R+.K_ /7G-_Z
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M &X_-^,?^8?_ +>_]M"BBBOU(_-PHHHH **** "BBB@ HHHH **** "BBB@
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M:%</\:O^29ZS_P!L?_1T==Q7#_&K_DF>L_\ ;'_T='7S_$7_ ")L;_UZJ?\
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M;]AG_DUGP3_V_?\ I=<5^3-?K-^PS_R:SX)_[?O_ $NN*^"XS_Y%\/\ &O\
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MC;?]\M_\51_PGVH?\\;;_OEO_BJYJBC^UL=_S]8?4L-_(CI?^$^U#_GC;?\
M?+?_ !5'_"?:A_SQMO\ OEO_ (JN:HH_M;'?\_6'U+#?R(\3\+Z^\/[14U\M
MI;_:#J-XV[Y\9*RY.-WO7TC_ ,)]J'_/&V_[Y;_XJOEGPW_R7F;_ +"%U_Z#
M)7T#7Z%QICL3A\1A%2J-7HP;];R/QSPSP]*M@\>YQ3MB:B_"!TO_  GVH?\
M/&V_[Y;_ .*H_P"$^U#_ )XVW_?+?_%5S5%?GO\ :V._Y^L_8_J6&_D1TO\
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M"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?87@7_D2?#W_8.M__ $4M;E8?@7_D2?#W_8.M_P#T4M;E?WGE
MW^Y4?\,?R1_-F*_WBIZO\PHHHKT#E"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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MEP1\['NS9+$DDDFOR _X*0?LZQ_L?_'3PE\4/AFA\/Z5JUT;RVM[1=L6G:A
MRNRQ@<+&X(8)TXD ^7 '[4U\ _\ !:2U@E_9@\-SN%,\7BJW$9.,@-;7.['Y
M"LJLY0E&LG[R:_%V_P"#ZFM&$9QE1:]UI_@FS[.^#OQ$MOBU\*?"7C.T41PZ
M[I=O?^6/^6;21AF3_@+$C\*["OF?_@FU<27/[$_PP:5R[+:7" G^ZMU, /P
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M/?\ Q%'_  E6H_\ 0 NO_'O_ (B@#IJ*YG_A*M1_Z %U_P"/?_$4?\)5J/\
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M^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\
M$4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\ H 77_CW_ ,10!TU%<S_P
ME6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X
M2K4?^@!=?^/?_$4 =-7R9_P4L_Y(5H7_ &,D'_I+=5]&_P#"5:C_ - "Z_\
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MHKTG_A2>H_\ /2Z_\ 6_^*H_X4GJ/_/2Z_\  %O_ (JC_4'B3_H%_P#)Z?\
M\D'^LV4_\_O_ "67^1YM17I/_"D]1_YZ77_@"W_Q5'_"D]1_YZ77_@"W_P 5
M1_J#Q)_T"_\ D]/_ .2#_6;*?^?W_DLO\CS:BO2?^%)ZC_STNO\ P!;_ .*H
M_P"%)ZC_ ,]+K_P!;_XJC_4'B3_H%_\ )Z?_ ,D'^LV4_P#/[_R67^1YM17I
M/_"D]1_YZ77_ ( M_P#%4?\ "D]1_P">EU_X M_\51_J#Q)_T"_^3T__ )(/
M]9LI_P"?W_DLO\CS:BO2?^%)ZC_STNO_  !;_P"*H_X4GJ/_ #TNO_ %O_BJ
M/]0>)/\ H%_\GI__ "0?ZS93_P _O_)9?Y'FU%>D_P#"D]1_YZ77_@"W_P 5
M1_PI/4?^>EU_X M_\51_J#Q)_P! O_D]/_Y(/]9LI_Y_?^2R_P CS:BO2?\
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MX]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\
MPE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\
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M1#_5W-/^?7_DT?\ ,^-J*^R?^'<NH_\ 0VW7_@A;_P"/T?\ #N74?^AMNO\
MP0M_\?H_UGRC_G]_Y++_ .1#_5W-/^?7_DT?\SXVHK[)_P"'<NH_]#;=?^"%
MO_C]'_#N74?^AMNO_!"W_P ?H_UGRC_G]_Y++_Y$/]7<T_Y]?^31_P SXVK]
M9OV&?^36?!/_ &_?^EUQ7S%_P[EU'_H;;K_P0M_\?KZS^!OAG4?@O\+=$\&_
M8[K6/[-\_P#TWR&@\SS)Y)?N?-C'F8^\<XSWQ7R/$V<8',,'&EAJG-)23V:T
MLUU2[GU/#N4XS XN57$0Y4XM;IZW79OL>Q45S/\ PE6H_P#0 NO_ ![_ .(H
M_P"$JU'_ * %U_X]_P#$5^9GZ&=-17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U
M_P"/?_$4 >-?M%_\CM9?]@Y/_1LM>65[G\1O!>H^/];@U#[-=6'EVZV_E_9V
MDSAF;.>/[W3':N5_X4GJ/_/2Z_\  %O_ (JOYBXDX-SW,,WQ&*PV'YH2E=/F
M@KKT<DS]@RG/\MPV!I4:M6THK727Z(\VHKTG_A2>H_\ /2Z_\ 6_^*H_X4GJ
M/_/2Z_\  %O_ (JOFO\ 4'B3_H%_\GI__)'K?ZS93_S^_P#)9?Y'FU%>D_\
M"D]1_P">EU_X M_\51_PI/4?^>EU_P" +?\ Q5'^H/$G_0+_ .3T_P#Y(/\
M6;*?^?W_ )++_(\VHKTG_A2>H_\ /2Z_\ 6_^*H_X4GJ/_/2Z_\  %O_ (JC
M_4'B3_H%_P#)Z?\ \D'^LV4_\_O_ "67^1Y!XBM[ZXAA%B9 X8[O+DV<8^HK
MG9]"UJZV^<DDNWIYDRMC\S7T#_PI/4?^>EU_X M_\51_PI/4?^>EU_X M_\
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ML^:X@SK 8[ NCAZG-*ZTM)?FD>H45S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
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M (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\
MH 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<
MS_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\
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M_M7!_P _X/\ R#^S<7_)^*_S.6HKJ?\ A7^H_P#/&Z_\!6H_X5_J/_/&Z_\
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M']AYA_S[_&/^8?VCA?Y_P?\ D>L45S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
M%U_X]_\ $5^L'Q)TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"S_P#%K_A>GPCT#QO_ &5_8G]JK*WV'[1]H\K9*\?^LV)NSLS]T=:^#_\
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M\1C0Y]11Y+5/L=Q<&14(#']S&^,%AUQGMTKTNOCW]N+]C^Y^.EQ<>.9/&O\
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MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+-"^'T^U-W,"_'(=^57TY;L,ZW_!7+_D=?AW_P!@^Z_]&)7S1\0/V?;[P_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<=\9/^21>-_^P)>_^B'KL:X[XR?\DB\;_P#8$O?_ $0]
M95?X<O1FM'^)'U1^/?[!_P#R=G\/?^OJ?_TFEK]M:_$K]@__ ).S^'O_ %]3
M_P#I-+7[:U]-G'Q4_1_F?*9'_#GZGY??\%5_BU<:O\0-!^'UM*1I^D6PU"Z1
M3P]S+D)G_=C''_70UY%\'_V!/BO\8_ B>*]*CTO2-+NT+VD>KW3PRWJ#HR*D
M;84D<%RH/4<8-6?^"CFB7ND_M7>)9[I7\K4+>TNK9VZ-'Y")Q[!HV'X5^FW[
M,OQ8\*?$+X%^&-2T74K-(-.TN"VOK;S55K"2*)5=)!QL *D@G (P1P:=.I+"
MY="I26KW?:][_=L14HQQF9SIUGHEHN]K?GN?EK\%?VC/B/\ LA?$Q]%U234&
MTJPNC:ZOX7O92T8 .&,0)(1\<JZ\-QG*FOUWO_C)X&T;P_HFMZOXNT70M-UJ
MW6ZT^?5M0AM!<QLJME/,8;L!USCID5^.7[:WQ"T/XG_M)>+=<\.2QW6E,\-M
M'=P\I<-%$L;2*>X+*<'N #WKZL_:(_9?^)GQ1_9S^ 6C^%_#S:SJ.AZ.1J,4
MEY;VS6YDAM]JGSG3)&UAQG&WFGB(1Q%&C6JKEE*U_FF_S77N+"3EAJ]>A2?-
M&*;7JNG_  V]M#[-_P"&DOA)_P!%2\%_^%#:?_'*^5_^"CGPWT7XR_!K3/BG
MX.O[#7SX>=HI[[2KA+B*:S9]KX="0?+DP>O 9Z^2?^'>7[0/_0@?^5G3_P#Y
M(K](/V1?@QJ_@G]EVQ\!>/M&6SO)?MT-[I[S13@Q32N<%HV93E6['O7)6H4L
M+%5Z-2\HM65U\_\ +YG;0Q%;&2=#$4G&$D[NS_7MNO,\3_X)8_'#_A(O!6K?
M#74KC=?:&QOM-#GEK21OWB#_ ')#GZ2CTKYD_P""C'Q=_P"%F?M#7VEVL_FZ
M3X7C_LN$*P*F;.Z=ACOO.S_MF*XR^F\3_L2_M-7XT_+WV@W,L</G9"7EI*AV
M%L=0T;*?9A[5ZS^P/^SROQ_U7XC^)/$B-<VG]G7&G17,O.Z^ND;=*#_>123]
M9%->E*%/VCS%:Q4;_P#;ST_%:>K/)C4JNDLKEI)RY?\ MU:_@]5Y(^LO^"=/
MQBM_%W[,\=IJ=VJ7'@^22RN9)&^Y; &2)SZ*$)7_ +9&O@/QAJFK_MK?M;>7
M9-((M<U%;.RR,_9;"//SX[;8U:0CU)]:X?P[\2?%?P3TWXC^"+<FT.NP_P!C
MZI&20T;13?,1[D>;'])#7VY_P2I^"/V73==^*.I6^)+HMI6DEQ_RS4@SR#ZL
M%0$?W''>K=.%"K4Q^ZMIZO?[W^%R(U*F(I4LNV:;4O1;?<K_ #2/5OVUOC@?
MV4?@;H/ACP0$TW5]0B&EZ8ZX)LK:%%#RJ.[ %%!/=L]J^/?V<?V"O%'[3WA.
MX\=ZQXO70+*^N)1;W%S;/?7-ZZL1)(V9$PN\,-Q8DE6XZ$^K?\%<]%N_[2^'
M&K[6:P\J\M"W\*R;HF ^I&?^^:\P_9E_8#L/VDOAA;^++3XEII%U]HEMKO2U
MT;[2UK(K?*"_VA,[D*M]T?>QSBN3!VCA)8ARM*3=W:]M;?\ !^?FCLQRE/&0
MPRAS0BE:-[)Z?IM\CG_!7C?QS_P3]_:(N?#VHWK7FC0W$8U.QA9C;7]JX!$Z
M*>D@4Y!Z@J5)(SG[G_;N_:@NO@G\(=,_X1.[5/$/BG*6%ZN";>W"AI)U!_BP
MR!?0OGM7RH/^"?/P\_X3J\\&/^T7H\'BBT9$ETRXT58I=[ $(NZ[ =L$9522
M.X%:O_!3;X?7W@KPQ\%[5KI]2L])TF31FO3'L$DL:0C=MR=I8*3C)Z=3BBM[
M#$RH*4KMO5V:NK-^FZ2^8Z'UC"0Q$HQY8I72YD[.Z7KHFW\CA_V<?V"O%'[3
MWA.X\=ZQXO70+*^N)1;W%S;/?7-ZZL1)(V9$PN\,-Q8DE6XZ$XW@KQOXY_X)
M^_M$7/A[4;UKS1H;B,:G8PLQMK^U< B=%/20*<@]05*DD9ST'[,O[ =A^TE\
M,+?Q9:?$M-(NOM$MM=Z6NC?:6M9%;Y07^T)G<A5ONC[V.<5N#_@GS\//^$ZO
M/!C_ +1>CP>*+1D273+C15BEWL 0B[KL!VP1E5)([@5W2K0C7E3G.\;?#RO\
MU_PVIYT,/4G0C5IT[2O?GYEOZ/\ X?\ $^UOVV+Z#4OV0_'=Y;2+-;7&G0RQ
M2+T96EB((^H(KX&_X)]_%S1/@?<?%#Q=KTN+6ST2(16X8![F8S#9"F?XF/Y#
M)Z U]Q_M4^&6\$_L,>(O#SWAU!M)T*SL#=F/R_.\IH4W[<G;G;G&3C/4U^9'
M[/\ \ ;OX]Z#\0;?2#(WB#0],CU.QMU/%R5DVO$1ZLI.W_: '0FO+P2I^SQ"
MYO=OOY6W^X];'2J.IAI<OO\ ;STT^\WO WA7QG^WA^T=/-J$\@:^E^U:E> %
MHM-LE. B=A@81%[L<GN:_9+P7X-TCX>^%-+\.:#9I8:1IL"V]M;I_"H'4GNQ
M.22>222>37Y<?\$U_C]9_"OXF7W@?78X;33_ !3)'%#>2(%>&\3*QQNV,[7W
M%<'HQ'3+&OUBIYFY4^2C%6@EIY_\-_P>I64*-3GKS=ZC>OE_P_\ P.@4445X
M1]$?@K\2/^3BO%/_ &-5U_Z6-7[U5^"OQ(_Y.*\4_P#8U77_ *6-7[U5[N._
MW3#>C_*)\SEO^_8OU7YS/S"_X*W?\E(\!_\ 8)F_]'5]0?\ !-__ )-,\,?]
M?5]_Z4R5\O\ _!6[_DI'@/\ [!,W_HZOJ#_@F_\ \FF>&/\ KZOO_2F2E#_D
M5+_$_P#TJ1K+_D<2_P *_P#28GT[1117AGT(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XM\
M!^&O'UG#9^)_#ND^([2&3S8K?5K**ZC1\$;E612 <$C(]36[11MJA/569S/A
M[P7X/^%NEW\F@Z!HGA+3R#<7C:;90V<1"*?GDV*H.!GD]!7X\?MB?'*7]ISX
M[--H,,UUH]H5TC18(T)>X&\_O O7,CMP.N-HZU]&_P#!2']KC[5)=?"3PC>_
MNHVQX@OK=S\S#_ET!'8<%_?"]F%<3_P3O\#_  W\/ZT?B7\0/''A72;ZS=HM
M&T?4]9MH9D?HUS)&[@KCD("/5O[I/O8"CRIXVMK;;N^E_GLO*[V/F\QK\\E@
M*%E?XNRZV^6[\[+>Y]P?"O1M)_8[_95TY?$T_DPZ!8&\U22(;RUS*^]T3'WC
MYCB-?7BOSS\,^(+/]M3]I"?Q+\5/&&C>$O!NGLLGV/5=4BM!]F#'R[2 .ZDL
MW)=QTRQX)45^C/QV\-V_[4'[//B;P_X!\1:%JK:KY4,&I1WPFLP\<\<CJTD(
MDY 4\ 'DBO@K_AT_\7/^AB\%_P#@==__ "+4X.K!U:E>N^6;>GE?JOR^7J7C
M:514*5##QYH+>W6UK)O^M?D:O_!33QKX'\46WPSL/ _B#0-8L-+@NX/L^@WT
M-Q':IB$1J1$Q"#"D <=/:O;O^"7/C;P[!\$7\,R:_I<?B2;6KN>+1VO(Q>/'
MY41WK#NWE<*W(&/E/I7P9^T9^RUXK_9CO-#MO%.H:/?R:Q'-) =(FED"B,H&
MW^9$F#\XQC/>OHK_ ()F_L]^(M1\;Z7\7([W2U\-V$M[ILMJTLGVPR&#;E5\
MO9MS*O)<'@\5W^RI+ RBIWCJ[^=V[??H>6ZU=YC3DZ=I>ZK>5K7^47<_0C5/
MC[\,-#U*ZT_4OB/X2T^_M9&AGM;K7+6*6&13AD=&D!5@>"",BH[+]H/X6:I>
M065G\2O!]W=W$BPPV\.O6KR2NQPJJHDR220 !US7YK?'C]ACXW^-/C5XYU[1
MO!/VS2=2UFZN[2X_M:Q3S(GE9E;:TX89!'! -9GPK_8,^.OAOXG>$=6U'P-]
MGT^PU>TNKF;^U[!MD:3(SMA9R3@ G !->=0P>&J0A*=5)M*ZNM#UZ^.Q5.K.
M$*+:3:3L]==S#_:^^&FH?LP?M/-J_A[=865S=)K^BS1C"Q-YFYHQ[)(",?W2
MOK7Z7W?[2NC-^RW+\7[=D%L='-VEON'RW>-GD9/<3?)^%<'_ ,%$/@?_ ,+:
M^!5UJ]A;^;K_ (6+:C;[%R\D&/W\?K]T;\>L8K\LH?C5XBB^"=Q\+Q-GP]+J
MRZMC)W*P0J8_]PMM?']Y<]ZNE#^T,(J+?O0:7_;KT_+\8^9E6J?V9C95K>Y4
M3?\ V\M?S^Y2\B/X:?%74_ GQDT3Q\\TEQJ%IJJZA<OGYIPSYF!_WU9P?]ZO
MUA_;<_:!MOA?^SC=:CHUZIU/Q3"MCI,T3<[)4W/,O^[&20?5EKXU_:!_90/P
MW_8M^'/B86?E:_9W!NM:./F"WH4J&_ZYE(4^I-?.?C#XG^*OC38_#[PI<A[U
MM LDT32[:+):5FE(4X_O$&*/Z1K7?6HT\?RPAM"7*_3_ "V7S9YM'$5<MYIS
M>M2/,O6_Y[OY(^K?^"6'P0_X2#QGJ_Q+U&WW66B*;#32XX:ZD7]XX_W(SC_M
MK[5@?MU?M#>*/C;\:)?A1X6N9E\/V5_'I26-M)M&I7Q<(3(1U4.=JJ>!MW=3
MQ^C/[/WPEM/@?\(?#?@^V"-+8VP-W,G2:Y?YIG^A<G'L .U?C'\5/"(@_:5\
M3^']?O\ ^QH9O$\\%UJ,L?F?9XI+DYG*[AN 5M^,C([]ZQI5(8S,+O6,5HO1
MK7\6_GY'36ISP.6)+24VN9^J>GX)?)]SZ,^(7_!+GQ5X'^%M_P")[;Q?9:SK
M>G6K7=SHL%BZ*51=SB*<N2[  X!C7..U>J_\$T?VH]9\:37OPQ\5W\NIW-G:
MF\T>^N7+RF)2!) S'EMNX,N>0 PS@*!R6O?\$JM)\+^';W7]5^-,%EHUG UU
M/>R>'OW:1 9+9%WR,>G7M7:_L:_L?^$?"/Q*TGXB>$/C1IOCRWT^*99;"PTY
M8GQ+$R 2?Z2[1D;@<,F>.U$J]*I2J1JU.;33W6K/6WWO]11P]:C6I3HTN377
MWT[K2_W+]-CQG]NK]H;Q1\;?C1+\*/"US,OA^ROX]*2QMI-HU*^+A"9".JAS
MM53P-N[J>+/Q"_X)<^*O _PMO_$]MXOLM9UO3K5KNYT6"Q=%*HNYQ%.7)=@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?[K?2G4U_NM]*B?
MPL:W/P=^'_\ R<KX<_[&VW_]+%K]Y*_!OX?_ /)ROAS_ +&VW_\ 2Q:_>2OH
MLR_@4/G^43YW+/\ >,3Z_K(XOQ'\:_AYX/U>;2M>\>>&=$U2$*9;'4M8M[>=
M-P#+N1W##(((R.016;_PTE\)/^BI>"__  H;3_XY7PA^VC^QS\7_ (L_M$^)
M/$_A3PC_ &KH=Y':K!=?VG9P[REO&C?)),K##*1R.U>(+_P3S_:!W#_B@/\
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M9?[QAO\ %^L3];Z***\,^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /A']K[_@G7=?%+Q=>^-OAW>65EJ]^QEU'2+]FCBGE[RQ.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K \?:#<>*O OB+1;1XX[K4=.N+2)YB0BO)&R*6(!(&2,X!K?H
MJ9)233ZE1DXM270_.[]FG_@G;\1_@W\</"WC+6M;\+76EZ5-))/#87=R\S!H
M70;0UNJGEAU8<9K]$:**[,1B:F):=3H<.&PM/"IJGU/G_P#:V_9(T?\ :>\-
MVO\ I8T;Q5IBM_9^I[-R%6Y,4JCDH2,Y'*GD9Y!_.S6O^";OQXTO4GM;;PQ9
M:Q IP+VSU:V6)O<"5T?\UK]DZ*TP^,JX5<L-NS,L5@*.+:E46O='Y[?LO_\
M!,RX\,>)+#Q1\4[JRNVLI%GMO#MBYEC:08*FXDP 0I_Y9KD' RQ&5/Z$T45G
MB,34Q+3J/8UPV$I82+5);[OJ%%%%<IV'R%^W!^Q/JG[26L>'_$'A*]TG2]?L
MXFM+UM5DDCCG@SNC(,<;G<K%AR.C=>*]?_95^!?_  SS\&=)\)W$MM<ZN'DN
MM2NK/<8YKAVY*E@"0%"("0.$' KUZBNA8BHJ/L+^[>_]?,Y?JU)U_K-O>M;^
MOEH?GM^TQ_P3@\7_ !6^-FN^+?".L>'=.T?5W2YE@U*>=)DF*@2D*D+*02-W
MWNK'I7W)\-_ >F_"_P !Z%X4TA-FGZ3:1VL9Q@OM'S.?]IFRQ]R:Z6BG+$5)
M48T&_=C_ $ON%#"TH5I8A+WI;_K]YYS\??@;H/[0GPYO?">N[H5D836E]$H,
MEI.H.V1<]>I!'<$CWK\W[K]@[]I+X0ZU?1> ;Z>[M+H>6]_X<U]=.,\8)VB5
M9)(F_P" _,!GJ>M?K-13P^)J8>ZAL]T]B<3@Z6*LYZ-;-;GYN_LX?\$S=>_X
M2VT\3?%V>U%G!*+G^P89_M,UU(#G%Q(/E"9Y(5F+<@D=_MKX]? KP_\ M ?#
M>[\(ZVIMXV*RV=Y"HWV<Z@A)$'? )!7N"17I%%.OBJN(:<G:VUN@8?!TL*FH
M*]][ZW]3\F;K]@[]I+X0ZU?1> ;Z>[M+H>6]_P"'-?73C/&"=HE622)O^ _,
M!GJ>M>B?LX?\$S=>_P"$MM/$WQ=GM19P2BY_L&&?[3-=2 YQ<2#Y0F>2%9BW
M()'?](J*ZO[2KVZ7[VU./^R<-S7UMVOI_7S/,_VC?AEJ7Q<^!_BGP9HDUG9Z
MCJELD%O)>LR0(1(C?,45B!A3T4UX'^PW^QOXT_9G\8>)-6\4:GH-_;ZE8):P
MKI%Q/(ZL) Q+"2% !CT)K[(HKBIUYTHSA':6YWU<-3K3A.6\=C\_OVG/^";>
MN_$;XL7GBSX<ZIH6BV>I?Z3=V>IS30F*ZS\[Q>7$XVMPW.,,3Z\?9_P?T_QE
MH_PZT73_ !]<Z=?^*;2$075[I<TDD-SMX60ET0AV7!88QG..M=E13EB)RHQH
MRU2V%'"TX5I5XZ2EOV"BBBN8ZS\S?%O_  3,^*&O?%;6?$]OKWA%+"]UN;4H
MXY+RZ$HC>=I "!;$;L'IG&>]?IE11734Q$ZL(4Y;1V_#_(XZ.%IT*DZL-Y[_
M (O]6?'/[<G[''C3]IGQ;X9U3POJ>@V%OIEC);3+J]Q-&[,TFX%1'"X(QZD5
M[)^R7\'=:^ _P/T;P;K]S87FJ6<UQ))-ILCO"1),SK@NB-T89^7K7L5%"Q$U
M0^K_ &=_Q;_4KZM3>(>)^UM^%OT"BBBN8Z@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>FV6HIJDUD(]*BDCBV(D; X=W.<N>^.G%>\5O5I2HS=.>Z.:A6AB*:J0V?\
MPP4445D;A1110 4444 %%%% !15'7-7A\/Z)J&J7"R/;V-O)<R+$ 7*HI8@
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M=@JC9&K,<DCH*-W9";LFWT.HHJKI>IVVM:79ZA92>=9W<*7$,FTKO1U#*<$
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M5YHT5F)Z ')[4X4YU+\D6[=B9U:=.RG)*_=GME%%%9FH4444 %%%% !1110
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M<']TW1#U%>MT.$E%2:T?Z#4XN3BGJM_GJ%%%%06%%%% !1110 4444 %%%%
M!1110 445'<3K:V\LS E8U+D+UP!FDVDKL:5W9$E%>4?L]_M)>&?VDM$U?5/
M#-CJUC;Z7=BSF75H8HW9RH;*B.1P1@]R/I7J]:SIRIRY9JS,X5(U(\T'=!11
M169845QFB?&#PAXB^(VM^ ].U<7/BO185N+_ $\6\R^3&VS!\PH$;_6)PK$\
M_6NSIN+23:WU)4E)M)[:/R?8****104444 %%%% !1110 4444 %%%% !17@
M/[:GQ^\0_LX_">R\4>&K/3+Z_FU6*Q:/58I)(A&T<K$@1R(=V4'?')XKU'5/
M&EQH_P *[CQ8=-DU2[M](.I'3[($/.XA\SRTZGD\#K^-7ROV;J]$[?A<CG3J
MJBMVK_C;\SK:*\._9*_:.O/VF/ >H^(+SPM)X8:SOFLU7SS-%< *&W(Q13D9
MVD8ZCKS@>XU52G.C-PFK-$TJL*T%4INZ84457U"^@TNQN;VZD\JVMXVFED()
MVHH)8X'H :Q;MJS9)MV18HKE?AG\4/#'Q@\*0^)?".I_VOHLTCQ)=?9Y8<LA
MPPVR*K<'VKJJN490?+)69$91FN:+N@HHHJ2@HHILDBQ1L[L$11DLQP /6@!U
M%>6S?M0?"R/X@Z=X(C\::?>^)[^4006-@)+H>9DC8TD2M&C<='8&O4JIQE%)
MM:,A3C)N*>JW"BO O@3\9?$>K?%[XD?#'QW+;/XBT.Z_M#2Y[:#R4NM,DQL(
M7G)0E03D_?QS@U[[3E!QLWU2?W_U9^8HS4[I=&U]W]77D%%%%0:!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QM_P53_ .3<=+_[&*V_
M]$7%?9-?&W_!5/\ Y-QTO_L8K;_T1<5K1_BT_P#%'\T8U_X%7_#+_P!)9]/_
M  SA2X^%OA..5%DC;1[0,K#((\E.HKXE^.'A?1OA?_P4&^$%QX&LK?2-1UAH
MSJMGIRB-'5Y'C=V11@;H]Y/'.S)YR:V/!WPM_;*O_!NAG3OBYX1L]'FL(#;1
M&UC\V*$QJ44G^S\[@N!][MU[UZA^SW^Q>/AGX]G^(WCOQ9=?$#XA3*RI?W(8
M16NY=K%-Q+,VW*AC@!3@*.M>I:&'Q,JTIK[6BO=WOH]-O\CQKSQ6$C0C3:NH
MZNUE:SNM;]-#Z<KD/B[XXOOAK\-/$7BK3]%_X2&YT>T>\_LW[08#,B<OA]CX
M(7<?NG.,<9S7D'QX_:>\??"7QX=!\.? SQ'\0=.%K'/_ &QI;7 AWMG,?R6L
M@RN!_%WZ"MW]GWXV>*?CQ;^)K3QC\)-9^&]O:1Q1QKK1F(OUE$@=5\RWB^Z%
M&<;OOCIW\SV%5TG5BM%YKTVW/7^L4E55*3=_1_G:QU7[/?QHLOV@/A1H_C2S
MLO[,-Z9(Y[#S_.-M*CE60OM7=T!SM'#"N5_:)_::_P"%&^(_ OAS3_#?_"5>
M(/%E]]CMK(7WV7REW(GF%O+DR-S@8P.A.>*\5_83DF^#WQD^+GP0OG81:?>_
MVOI2N?O0-M4D?5&MSQ_M4O@N,_'[_@H=XC\0L?M'A[X:V(L+8YW(;L[D^F=[
M7!_[9+7=[&D\2I)?N[<__;MMOO:1P>WJK"N+?[U2Y+_WKVO]UY=OR/HKX]?M
M%>$OV=/#EKJOBE[R26]=H;*QL+<RS74@ )5>BC&1RS#\3Q7SMJ7_  49\0^&
M3'J?B/X ^+]"\(-(JG6KII$^4G (5[=8R3Z>;^->Z_M)?'[X?? '1=*UCQI
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M91TM>UF^C^>_0^__ -H#]H3PO^SEX+7Q#XF:XF\^7[/9V-FH:>ZEP3M7)
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M2\86\=I_P5&^'\$*+%#%X99$11@*H@O  /;%=6&IO#N<9?$^=?*,9+\97_\
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MAXZ^TQ+(;:&"YB8CE)%GCP1^!(^A-;7[&-S+=_LM?#9YG+N-*5 3_=5F51^
M 'X5S/V52BZL8V<9);[IJ_Z6T.F+K4Z_LI3NI1;6B5FFE^J>I\'?LN_M+>.?
MA_XZ^+&K:)\&M?\ '5UX@U87=[:::TV_2W\R=A%)LMI.<NPY"?ZL\>GZ1Z7\
M4;:U^$=GX[\8V;^"8/[.2_U"SU$MOL"5!:)\HK%@3MQM!)XQGBOE#_@G#_R4
M;]H'_L/1_P#HZ[I?^"I_B:]L_!GP^\.0V]S>6&K:NTMU9VQ*M=>2$V0Y )RQ
MEXX/(!P<5TXA1K5:=&,;.2AKKMRKIY+\CDPDIT:56M.3DDYZ::M-ZW\_N5S3
MD_X*+:KK\\][X&^!OB_QAX4A=D?7(ED1?E/)VQP2J/7EP?7%?0WP$_:"\*_M
M%>#WUWPQ+-&UO)Y%[IUXH2YM),9VNH)&".0P)!P>X('S9HO[:7Q-\.Z39Z7I
MG[)/B^QTZSB6"WMH/M:I%&HPJJ!8<  55_8YF\:ZQ^U9\1O%>I?"[7OAKX=\
M2:6+F6SU*TF2#[6DD0R)'AC#,VZ9\!<_,W7K52PT>62Y.5)-I\R;TZ-7ZKMU
M%#%RYHOGYFVDURM)7[.W1]]T2V?_ "E8N_\ L ?^VBU]R5\-V?\ RE8N_P#L
M ?\ MHM?<E<-;^#0_P '_MTCOP_\6O\ XO\ VR!\4?\ !5W_ )(-X=_[&"/_
M -$35]=^!O\ D2?#_P#V#[?_ -%K7R)_P5=_Y(-X=_[&"/\ ]$353\-_\$L?
MA1K'AW2[^;Q!XR6:ZM8IW6.]M H9D#$#-KTR:Z*482PC4Y67/VO]E&-:52.,
M7LX\SY.]OM/R9=_X*M_\D(\.?]C#%_Z(FKZ_T>[BT_PE8W5P_EP0V,<DCX)V
MJ(P2<#V%?E_^VQ^Q/X'_ &;?AKI'B+PSJOB"^O;O54LGCU:X@DC"&.1R0(X4
M.<H.^.O%?IYINH6ND>#+6^OIX[6RMK!)IYYF"I'&L8+,Q/0  FIK*$,(O9RO
M[SW5OLHJC*I/&?O86?*M$[_:?D?*^M?\%$%US4+J'X5?"?Q9\4+*U?RYM2LK
M>6&#/7Y=L,K8Q_?5#[5Z+^S3^V!H/[1&H:KH,FBWWA'QCI2F2[T/46W-L#;6
M9&PI.TE0P95(+#@]:\H7]NN;6[J;PY\ _@[JGC+3[%S"+^& VEA$Q)((1$.U
M3R?G:,^U>0_"SQ'\0+S_ (*/>&+[X@^&+#P?XEU6PF6XT_3'!22'['-L=R))
M,L?+&<D?=' KIIX:,XN+ARZ-IM^]HK[?+L<E3%3IR4XU.;5)I1]VS=GKKMZL
M^]_C/\;/"OP%\%S^)O%EZUM9JWE0V\*[Y[J4@D1Q)D98X/4@ #)('-?,J_\
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M_P"0*[7]E+]LK4OVF_%FO:0_P[G\+6FCVWF7%^^IFY"S%PJP,I@CVL1O/7^
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MJ_*_;H=1H>N6'B71[+5M*O(=0TV]A6>VNK=@R2QL,JRGN"#7RG8_\%%/#O\
M9OBL7_A:]7Q#I>MOHFEZ!I=S]LNM6=2PWJ!&OEKE>>&QD8W$XJE_P2T\67^O
M?L\ZAIMY(TL.C:S-;6A8YV1/''+L'L'=S_P*N+_X)U^%]+O/C7\<]?GLHYM7
ML=6-K:W3C+0QR3W!D"^F[8F3UP,=S71+"PI5:L)ZJ*OY[QM^#L_O.6.,J5J-
M&I#1S=GVVE^JNON/J3]GGXQ>)?C-X<U34O$OPZU3X<7%I>?9HK'5GD,LZ[%;
MS 'AB('S =",@\\5V/Q,\9_\*Z^'GB3Q1]C_ +0_L?3Y[_[)YOE>=Y:%MF_!
MVYQC.#CTKIJ\T_:8_P"3>?B1_P!B_>_^B6KRZLE)N4%9'L4827+&<N9]_P#A
MCP'3O^"DNB^)/">BMX8\ ZYXM\=ZA!)/-X5T/?<_8E61D_>3K%DY #?+&<!A
MG'&=[X,_M]:1X^^(4/@3QKX-U7X9>*[IQ%:6FJ,725S]V-F:.-D=OX04P>F<
MD M_X)I>'],TW]F'2=3M;"W@U'4;NZ:\NXXP)9]D[HF]NI"J, 'ISZUP'_!5
M?1+6Q\$^ _%]L$MO$&GZS]F@NTXEV-&TF >^'B4CTY]:]B=/#QQ7U?DT;M>^
MU^WDO/7J>'3J8J6$6)YU=*]K:.W=]WY6]#ZC_:(^,7_"A/A+K/C;^R/[=_LX
MPC[#]I^S^9YDJQ_?V/C&[/W3TKP_Q%_P4"BFM],M_A]\-=>^)6MMI]M?:I:Z
M+YCP::98U?RFFCAD+.N<'Y ..N<@;/[>-])J7[%WB&\E79+<0Z?*ZD8P6GA)
M'ZUVG[&/A?2O"O[,O@!-+LH[,7VF0W]RT8^::>50SR,>I))[]  !P!7+3IPA
M1G4J*[C.WX7^[?S\SMJ5*E2M"%*5E*+?X_G^'D9'QW_:LN/@;I'PWNKOP<U]
M=>+ID@ELY-1\AM/=EC+ GRF\PJ9".B_=]Z]YU35+/0]-NM1U"YBLK&UB:>>X
MG<*D4:@EF8GH  3FOB7_ (*9?\A+X*_]A]O_ $*&NN_X*<>++_PW^S2]G9/)
M$NLZK;V-R\?'[K:\I4GT)C4>XS63IJ=*G*"LY2DOQBE]URHU94ZM2,W=0@G_
M .E7^^WH9&J?\%&FU[6KZV^%WPB\4?$O3;%]D^I6:RQ(/]H*D$K!3VW[#[5Z
MM^SK^V#X/_:&NKS1K:VO/#7B^Q4M=:!JJA90%.&,;?QA3P00K#NH'-=E^SSX
M#TKX:_!7P?H6CPQ1VT6FP2R21 ?OYG0/)*3W+,2<^X]*^1_VU-/@^%O[7/P4
M\>>'XTLM:U:]6VO_ "?E-RJRQ1DL!U+1S,A/< >E=<:="I7^J1CJVTI7ZJ^Z
MVL[')*IB*>'^N2EHDFXVTL[;/>ZN?2_[4?[1B_LT^#='U]] _P"$@2_U./3F
MA^V_9?*#([>9N\M\XV=,#KUKSKQ!^W5+?>-GT7X;?"_Q#\2],M;Q;&^\0:>)
M([*"4L =KK#(&"YY9B@XR"1S7*?\%7.?@/X<'_4P1?\ HB:OK#X9^%]+\%_#
M[P]HNBV46GZ99V,4<-O", #:"2?4DDDD\DDD\FL*<:4:"K3C=\S5N^B>OIKM
MW\CIK.M*O[&G+E3BG>UVG>2T]=-^VVITM?!W[=7_ "=I^SC_ -A6#_TN@K[R
MK\]?^"CEKK5]^T)\#;?PW=PZ?XAFG$>FW=P 8H;DW4(B=P5;*A]I/RMP.AZ4
ML!_OM'U?_I+'F7^XUO1?^E1/T!U#3;35K.2TOK6&]M9!M>"XC$B,/0J1@BO@
MG]GG0]/^'_\ P4<^)'AKP8BVOA<Z9))<V-J,00/BW<J%!P LKLH]-Q P.*Y/
M]HSQ!^UO\"?"MCJ7C'XFV-WX>U"Y%G<7OABR@\VTR,@LWV6%E)&[:58<C&1D
M5]7?LC_L\^#?@]X/_P"$AT#6)O%^J^)H8[VZ\3W8_>7:.-ZA1D[%);<026)/
MS$X&-Z=-8:,ZSFI)IQLK[NV^FEMUWZ'-4JO%3A14'%IJ6MMEVUUOMV[]#PO]
MIK_E(O\  W_KUM__ $HN*^T/'DOA:'PO?-XR;2E\/B-OM7]L^7]FV8YW>9\N
M*^"OVY/ &G_%3]MKX4^$M6FNK?3=7TR"UGELV59E4W%QDH65@#QW!KN]0_X)
M.?"^2SD6Q\4^+K:Z(^22XN+65%/J5$"D_P#?0J.6G+"4O:2M\72_VO5%N=6.
M-K>SA?2'6WV5Y,R/^"9MBG_"6_&C4/#T<\?@";58X]),@(C;:\Y4+GG(B://
M?#+FJ_[24E]^U-^V)X>^"*7LUOX,\/QKJ&M) Y4RN$$CD^^UHXU/\)D8UU?[
M,/Q"\3_!3XY7/[.?B_\ LN_M(+1KO0-7TRPCLO-39YFV2.,!264.2WWMR-EG
MSD<M\)9E\-?\%1_B-:Z@HBFU;391:;N-^8[:8$?\ C?\C77I+%*INE3<HOOR
MI)-^>]UW7D<=^7".D]&ZBC)+2W,[M*W397OJGYV/MCP?\/\ PUX \.Q:%X<T
M.QT?2(TV"TM8%1&&,$M_>)[LV2<DDFL7P/\  _P-\-_%.N^(O#/ANRT;5M;V
M"\FM4V!@O95^Z@)^8A0-QY.37=45XO/*[=]7OYGO>SA91LK+;R([B1H;>614
M,C*I8(O5B!TK\KOBA^TMXU\0?M>> /%T_P '?$&G:WH=F\-GX2N#,+O4%83Y
ME3-L' PQZ(P_=GGKC]5:^&/C-_RDY^$O_8)_]DO*[<!RK$+F5]';R]V5_OV.
M+,%*6&ERRMM?S]Z/Y/4^A/@!\</%/Q=\/:_J/BCX8ZQ\-I]-D58;35VEW7:E
M"Q9?,@BX!&. >M>-^'?^"D.B>(/A_%J4'@G4K[QI>:C/8:?X/T>X-[<7 C1&
M,S.(@40[\?<8Y4X!P<?7FK?\@J]_ZXO_ .@FOAC_ ()1^%]*7P7XZ\1_8HSK
M4FK_ & WC#+B!8T<1@]@6<DXZX&>@HI1I5?;5'&RBHM)/N[?C_PPJKK4O8TX
MSNY.2;:7:^R[=-O,^C_ '[0TNI?!?4OB)\0_">H?#&VTZ65;G3]1$LTZ1H5
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MDTQT^V_9O(#(S&3/EONQM^[QUZU\U?MJ:?!\+?VN?@IX\\/QI9:UJUZMM?\
MD_*;E5EBC)8#J6CF9">X ]*V_P#@K(-WP;\' ]/^$@'_ *3S5T0HTZLJ%2*]
MV<K->DK/7L_O.>=:M3A7I2E[T(W3MWC=:=U]QW&J?MT3ZSX\70_AQ\+_ !#\
M1-$BOTTZ\\368DBL89"X5BKK#(&5<YW,4'&1Q@U]55B>"?"^E^"_".D:'HMG
M'I^E6%M'!;V\(PJ* /S)ZDGDDDGDUMUQ573TC!;=>K_1?([:'M)+VE26]M.B
M^>[^?X'RWXS^*'[1'P?\8:U=7GP^L?B;X >[EELI?#LI34K6W9R8T>,#,A5,
M#"QG..7[UU/PQ_;>^%'Q*O!IK:XWA/7U?RY-'\3Q_89T?.-FYCY;-GC:&+>U
M2_%G]M;X5?"+4I](O=;DU[Q'%(83HF@0F[N?,!P8V((1'!XVLP/M7A?Q&\/?
M%;]M"U^S)\'/#O@#0)%*)XB\;1^9JRIGK"BJ)(CCG!4J>/FKHI0]I!<\++^:
M]OST?RU.:K4]G4E[.I>7\MK_ ):Q^>A]E>/O&5IX!\":_P")[OY[32;":^<
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M._X*;_\ (U? W_L,3_\ HRUK[QJ7"/U6G4ZMS3^35BXU)/$SIMZ*,7][E?\
M)'@W[-_[4G_#07B[XAZ'_P (S_8/_")7B6GG_;_M/VK=),F[;Y2;/]3G&6^]
M[<YOQ6_;1\._!CXZP^ O%.GKI^CMHYU63Q"UV3L;$FV$6XC)8L8\ A\DL.*\
M8_X)O_\ )7?VA?\ L+P_^E%[5?XT>'-+\6?\%/OAUINLV%OJ>GOHRRO:W2!X
MV:.*\D0E3P<.JG!]*ZU0INO&#6CA?Y\G-?[]>WR.&6(JK#U*B>JG9>G.E;[M
M._S.@\1?\%(]3T6&/7(_@;XM_P"$#D93'XCOR]LCQL<!E'DM&<]AYO/K7UC\
M,/B1HGQ=\!Z/XN\.SM/I.IP^;%YB[70@E61QDX96!4C)Y'!(YJO\8](M=<^$
M?C/3KR%9K2XT:[C>-@",>2W\OZ5\Z_\ !+NZEN/V8V21RZ0:Y=QQ@_PKMB;
M_%F/XUC:E5I3<(V<+=;W3NOT-G*M1KTXSGS*?-TM9I)_=KUN>D_!?]IO_A;W
MQB^)'@3_ (1O^R?^$.N6M_[0^W^=]KQ,\>?+\M?+^YG&YNN*^.?V[_COXIU_
MXF>$-%N_AEK.CV?AGQ))+IMY<^:$UYHY$5?(S .#A<%2_P#K!UXSZG^Q?_R>
M)^TA_P!A&3_TKFH_X*/?\E"_9^_[#\G_ *.M*Z,-&$<5AM/B47\[7O\ AML8
MXF4ZF&Q*YK<KFODKZ?\ !W/:/V>?VC/&WQD\3:EIGB?X-:_\-K2UL_M,6H:L
MTYCG?>J^4OF6T0SABW!/"GCO7GWC3_@H1&/&FJ>'/AE\,?$/Q4FTF0Q7UUI8
MD2)&!()3RX969<@C<0H.#C(YKZZGA6XADB?[LBE3CT(Q7P-X!TWXJ?L!ZEXE
MTZ+X?2_$GX;:E?F^CU?0S_IUN" N9$"LV%11D,H7.2'&2*YZ7L:M1WC:RT5]
M&[]WMI]YO5]O1IJTV[O5V5TK=$M]?+0^COV<_P!JC1_V@IM7TH>']9\*>*-%
M53J6D:K;L/)W' Q)@#KV8(W!PN 37M]>/_ ']I;X>?M#0WUWX3N&M]:A13?Z
M9?P+#?1J"0I< D.H)/*LP&[!P3BO8*PKQY9VY>7R.G#RYZ=^?F\_\_/[O0\-
M_:,_:Z\'_LY_8M/U&*ZU[Q1?KNM-"TP!IF4G 9R>$4G@=23G .#CR+3_ /@H
MU/X>U2R3XG?!WQ5\.=&O7$<&JW2RRH2>Y62"(D <G9N.!P#7)_LHV$'Q7_;C
M^,WC/7XQ=:CX?N)+338K@9-N/.:%64'H5CAVY_Z:'UK[%^-7@32/B5\*_$_A
M[6[:.YL;JQE_U@!\IPA*2*>S*P# ^U;2]CAJ<)5(\S:4GK:U^B^7?J81]OBJ
MLXTI\J3<5I>[75^5^W0=XP^)']E_"N]\:>%M+F\<JMDM[86.DL7?4%;&T1E5
M8G(.>%/3I7YI? []HSQMX-_:0^*?BO2_@SK_ (EUG7&8WOART:?[1I>90V)=
MML[=?E^9%YKZ:_X):>++_7OV>=0TV\D:6'1M9FMK0L<[(GCCEV#V#NY_X%6%
M^R5_R?-^T+_UT?\ ]*177"G'"XFK2:O:+^[W7;YW5_30X*M6>+PM"LGRWFOO
M][7Y6=O74^T/"^K7.O>&=(U.\T^72;N]LX;F;3Y\^9;.Z!FB;(!RI)4Y .1T
M'2ODK_@JG_R;CI?_ &,5M_Z(N*^R:^-O^"J?_)N.E_\ 8Q6W_HBXKS*;3KP:
M5O>C_P"E(]>JG'#5$W=\DO\ TEGU!\,8UD^%_A)'4.C:/: JPR#^X2OB/]H+
MPOHWPY_;\^#%WX)M+?2-7U:>(ZI:Z=&(U=&F,;2,BX +QF0,<<A<FLOQ-:_M
MA?#'X'Q>+X?B/H5[X;L=+M[A;'2[*![N*U*+@X>R7.Q""QWD@ GFO2OV$_@U
MX<\6V-K\<M6\4WWC_P <ZDKQ276I@*=+E V21!=S'>!\H8D#8PVJH->LJ:HU
MYXIR346[I7N[IV3\O/R/%=1XC#PPB@TY)6;M96M=K7?RWU,/_@K-_P DO\"_
M]AM__1#5]N2-:+HH-\819^2/-^T8\O;CG=GC'UKXB_X*T#=\+? P]=;<?^0&
MK4C_ ."4?PGFM$=?$?C))'0')O+0@$CT^S?UKFC&$L)%5)6]Z72_2/H==252
M.-;IQYO=76W5^3..^"MIX=U#_@I%KMY\+4M_^$/MM+E_M2320!9&1HE#!"OR
M[3-Y9^7@LK$<"NV_X**?$+7=0?P-\&O"]RUKJ/C:\6.\D5MN8#(L:1DCG:SL
M2WM'CH37*^%5U[_@GS\8_"/@B6\L/$?PU\;77D1WITZ*VO[:;>J9DE09EVF5
M/OEAM)VA,8J;]KR9?#G[>7P'UR^"IILGV:V$K<*'%VX)_#SD-=$8QJ5\,E[T
M-EY\MWKVL^G;J<LI3HX;%-^[/1M=N;EC==[K6_>^B/K+X*? 7P?\!O"=IHWA
MG2;>"9(E6ZU)HA]JO' ^9Y).IR<D+G S@ "K+? OP&WQ,M/B OABPB\6VT3Q
M)J,401CO !=@.&< %0Y&X!B,XKO**\F56<INHWJ^OJ>W&C3A!4U'W5T]#P?]
MI#]KKP[^SS>:7HC:5?\ BKQAJH#66@Z8/WCJ6*JSM@[0S J %9B1P.]<%X!_
M;XFU#QIH_AKXB?";Q5\-KO6IUM=-FNX)IXYI&( !#0Q/R2!E5?J,X'-5_P!I
M;X)?$/1?C[X<^.?PTTNS\6:EI=I]CO?#UXP1W0*ZEXB2,DI(PX.X$ @-DBMK
MX:_MU^#/&OBRQ\(>/?#6J?#3QBTJ^38^([?]SYQ)"!)652K') +H@.< DG%=
MU&G3E234.=ZWULUKT7IK?4\^O5J1K-2GR1TMI=/36[]=+:?,^HZ^5_AOGXK_
M +<GQ!\4M^]TKP'I</ARQ8\K]JE)>9E]QB13]17T5X]\6VO@+P3KWB2^8)::
M38S7LA8]HT+8_'&/QKQ']@OPG=:+\ [7Q%JBYUOQC?7'B*]D;JQF?]WSZ%%5
MO^!&N6C[JG4[*R]9:?\ I*E]YV8CWG3I=W=^D=?_ $KE/&OVR--TWQ3^V)\(
M="^(MPUK\,)K5V'G2F*UENLR95WR-N6%NI/&%;J,YKM_VR?V;/A%I?[.OBG6
M;7PGH7A;4-)M/M-AJ&E6D5I(TP($<;% /,#DA<-G[V>H!K-_:?U2Z_:?^*P_
M9[\-6.FB/3XH]4U_Q)J$'GOIB_*0MNN1B4AT&<\^9C@!C7D/QB_8\^(OP1T7
M3]9MO$%Q\7_ACX9N%U&?P=K%S/$(XD'.(E<HRJN22N/]QAN%=E*WL:493Y-6
MUYIN]_+LKZ.W1'GUK^WJRA3]IHD_)I6MY]&[:J_5GVQ^RWJ6MZQ^SO\ #Z\\
M1--)J\VD0-+)<$F1UQ\CL3R24VDD\G-:/Q\^*-W\%_A1KOC2ST+_ (2-M)1)
MI-/^U_9BT9=5=M^Q\;0V[&WM5CX)_%;1/C5\,M$\7>'T:#3[Z+'V5P UM(A*
MO$<<?*P(XX(P1P:W?''A6V\<>"]=\.WBAK75;&:RD#?W9$*Y_6N'%2DJTY2C
M9W;M\[V_0]'"1C["G&,KJR5_E:_ZF-\%_B=:_&;X6^'/&EG;?8HM7M1.UKYO
MF^1("5>/?@;MK*PS@9QT%>/?#W]MC2_'W[36M?"2/0/LL=E)=6]KKGV_S!=S
M0 %T$7EC;P).=Y^YTYX\N_8/^*1^'O[-OQ+TC6W$=Y\.[V]DEB8_=C*,X7\9
M4F'XUY!8^%KOX/\ P7^ ?QKNE8:@?%D^J:S,!@M;WK@9/L8H1_W\KTEAJ7UF
M<?L.RCZSUAZVL>8\56^JPDOC5W+TI_'Z7Z'W5^T_^T%;?LU_#(^+)M)_MV=[
MR*RM].^U?9C*[Y)^?8^,*K'[ISC%=O)XXM=#^'L?BOQ5Y/AJVAT]+[4$FFWI
M9Y0,Z%]HW;2=O"@D]!SBOD[]L[;\6/VC/@5\+(BMQ937IUO4(UYS"IZG_MG%
M/^=5_P#@JCXFOM/^%_@WP_;1SRV6KZSFZ@@X,ZQ)E8L@'DLX(X/*CTKCA14Z
M=-?:G)KT2LMO6[^1V5,0X5*DOLTXIV[MWEOZ67;4NW'_  46U+Q!=7%UX!^"
M'B[QMX7MW9'UN%9(U^4\D+'!* ,<_,ZGU KZ!^ '[1'A7]HSPK-K'AM[BVN+
M.3R+_2[Y0ES9R=@Z@D%3@X8'!P>A! ^;?#_[9GQ+\*Z'8Z/I/[)'C"PTRQA6
MWM[:$W:I'&HP !]@]*J?LDW?C?Q!^U[XX\8:C\*O$'PU\/\ B/1]]S:ZC:SI
M;_:D>$!A*\,:L[?O&P!GYF//-=DL-&TER623:?,F].ZOU7;9G#3Q<^:+Y^9M
MI-<K2U[.W3SW5]CW_P#:(_:S\)?L\-8:=>V]YXA\5:D,V7A_2E#SR G 9S_
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MO&MHFMS;M$A@*;#$5&W;C&,=,8[5\'?L)6B>!_VJ_CSX+TH;- M[AY(H8_\
M5Q&.Y9$4>A"RLO\ P'VK6"HUHSA&-FE=.][VM>_W]#.I*OAY0G.?-&346K6L
MVG:W7IUN>Z?';]LSPU\&O%2>#K#0=:\;>.9(Q(FAZ-:L6 9=REGP>H_N*Y'<
M"O/?"?\ P4.\GQQI?AWXF_"W7_A:NJ2"*TOM49VCW$@!G$D,15,D LN[&1G
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M(!&.17Q1^R'^T-XQ^#?PDM[+PO\ LZ^)?&:W]Q+=77B;3S<;+]][*.4M)!A
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MU[M;MWZ7VL,\&^,M%^(7A?3O$7AW4(M4T;4(A-;74.=KKT/!Y!!!!4@$$$$
MBOG'4/V_?#/AOQ7\2]#\0Z%<64_A._CTZPBLKD75SK4SM(H2.+8NP_(#]YA@
M]>@/!?\ !+G6+VTT/XF^#9+AKG3-!UE#:,QSCS/,1P/0'R5; [L3WK+_ &7?
M"VE:U^W]\;M4OK*.ZOM)FGDLI)!GR'>8(SKZ-MR,^A/K6OU>G'$3IO6/)S+O
M]EK\';\;&+Q566&A45E-S47V^TG\KJ_?I<^D?V=?CMXI^-AU]O$7PNUGX;QZ
M<8?LQUAI-UZ)-_*J\,>-NP9QN'S#FO7=6_Y!5[_UQ?\ ]!-6ZJ:M_P @J]_Z
MXO\ ^@FO+Q,HRC)QC96_0];#1E!Q4Y<SOOMU/B+_ ()0_P#)-_'_ /V'5_\
M1*UZQ\2/VW/#/PB^.&J>!/%EA_9FE6.D+J?]N"Z+M-(P!6W2W$>2QR<$/VZ
M9(\G_P""4/\ R3?Q_P#]AU?_ $2M4/&'AO2_%'_!4[1;35["WU*UCT=+E8+J
M,.GF1VLC(VT\$JP!'N :][$PC4QLHSVY;_="_P"AX-&K*C@HRAOS6^^I;]3;
MU_\ X*2:IX=\C6+WX&>+;+P/.Z^5X@OV>W\R-NC*IA,9)[ 3<^M?2U[\9K;4
MO@B_Q'\&:1>>,X); 7UCI=BK"XNLD Q *KD.#D$!3@J13/VE-)MM;_9]^(UI
M=QB6 Z!>R;2/XDA9U/U#*#^%>2_\$U[F6X_91T!9'++#?7L: _PKY[''YL?S
MKAM2JT9RA'E<;=;W3NOONCN3K4:T(SGS*=^EK-6_#7_@GR1\*_VEO'&@_M6?
M$KQM8?!G7]?U[6+407?A:U:?[5IJJ81NDVVS-_RS4<QK]X?C^COPG^)5_P".
M?A79>+_%/AJZ^'UU(D\EWI.K.RR6:1R.NYVDCC(!5 ^2HX;OUKY7_9E_Y2%?
M'G_KVD_]'P5W?_!2OQ9?^&?V8-0@L7DB_M;4+?3YWC[1'=(P)[ ^6%/UQWK7
M$2C4IT(0A9RC"SUTOI;TU]3EPD9TZF)J3FVHRG=66ME=OU?W&%K7_!1)M:UN
M]M?A=\)/%'Q/TVQD,=QJM@DL<61W4)!*=I[;]A]J]A_9V_:D\,?M$6^I6UA:
M7F@>)M)(74M U10EQ!SC</[R[OE)P"#P0,C/S+\)?VL/B#\,_AOX>\-^'OV4
M_%S:38V<:13VYN@MP=H+3<6)R7)+DY.=W6H_A+XB^(/Q(_;C\.^/KKX,^)?A
MOIUYI<^FZQ+>VEP8)ML,C)))*]O$H)985 .22B\]JZ)82"YH<MDD_>YE?17U
M5^NVVES&&-F^6ISW;:]WE=K-ZV=NE[[ZV/H?XM?M<:/\&OCEX?\  >OZ;';:
M1J6D3:M<>(9+W:MJL:SML\GRR7)\C PX)+@ 'OD?!W]KW6_C-\2K#2--^$?B
M33/!-\DLMOXPU,210.B(65@OD[#N( &)2>?PKQK]JOPQIGC+_@H-\&-(UFSC
MO]-N-/A,UM,,I)LFN7"L.XRHR#P1P:^^%4(H50%4#  & *X>6E"A"HXW<N9?
M<WK^7EIUN>C)UJF)J4XRM&/*]M=8IM?GW>NEK'RMKG_!03PGX+^(7Q#\+^)]
M'N-/E\,7$=K8?8KC[5<ZQ*Q(V1P[%V$<=7(YY(XSR:?\%)9/#?BS3K'XA?"#
MQ+X!T34'VP:IJ#/O*9 \SR7@CRHR"VQF('3/0\_^SOX=TS6O^"C'QGO+^P@O
M+K38Y;BSDF0,;>0R0H73/1MK,,]<$^M>B?\ !3C2K6^_9?O+J:%7GLM4M)8)
M"!E&9BAP?=6(K6,:$/8*4+\ZC?6V^EU^?;R.>4\14^L.$^54Y3MI?X=;/RMI
MW\Q_Q"_;\L+'7K_2?AAX!UWXO2Z9_P A"^T-7^Q0=>DJ12ENAYVA?1C7H7[,
M/[57AW]IS0M1GTZQN=#UO2G5-0TB[8.T6[.UT< ;U)5AG (*G('&=G]EOPKI
M'A']GWP%;:/I\&GPW&C6EY,L*X\V:6%'DD8]2S,3R?8= *^9OV:;.'1O^"BG
MQOL;)%M[1[*68PQC"[VFMG)Q_O.Q_$TU2HN=2@EK%-WO_*U?3;7\/,GVU=0I
M8ERTFXKEM_,G;7>Z_'R/JWXV?'+PG\ ?!LGB3Q9>-!;;O*M[6W4/<74N,B.-
M<C)P.I( '4BOFE/^"C.M64:ZUK'P&\8Z9X&;#_\ "0XD9?*/W7VM L?/_77'
MO7F_[8WC_4X/VXO!MN/!-]\1[7PWIJ7=EX7M ^ZYF<2.90%CD)"E8V/R'_5<
M\9KT6^_;<^*>IV-Q9W?[)OC&XM;B-HI89#=LKHPP5(-AR"#11P_[I5.3F<K[
MNR5G;UN[>B'7Q7[Z5+GY%&VT;MMJ_9I)7]6?77@/QUHGQ,\(Z9XF\.7R:CHV
MHQ":"X3C(S@J1U5E(*E3R""*^=OC)^WSH7@'QY+X'\%^$]5^)OBZW<QW%EI!
M*QQN/O1AE21G=>X5"!T)R"!P_P"QJ_C/X5_LL_%>;6/#.K>$Y-+GU#4](L=9
MMI8'C3[*'"J)%4LH9?O8P235_P#X)=>!].M/@WJWC61%N?$6NZI-'<WTGS2^
M5'MPF[K@L6<^I89Z"AX>G3J57+6,$G;OS;)M=NMB_K%6I2I*.DIN2O;91W:3
M[Z6N>&_MI?M7V_QG^"L'A/7?!NN?#SQK::M;W[:/K4#XE@$<R%HW9$/!89#(
MOMGFOT5TW6?^$=^$MIJWD_:/L&B)=>3NV[]D ;;G!QG&,X-?+G_!5?3[67]G
M[1;Q[:)[N'7X(XYV0&1%:&;<H;J =JY'? ]*^D=4_P"2 W?_ &++_P#I*:QK
M3C]1G*G'E][UUY3>A3FL?&-67-[JZ6TYGO\ CV.?_9:_:"_X:6^&<OB[^P/^
M$<V:A+8_8_MGVK.Q4;?O\M.N_ICMUKC_ (T?MM^'_AEXTN/!'AWPQKWQ"\<6
MXS-H^C6KXARH8!GVDGY6!^1''/)%<?\ \$M?^39[G_L/W7_HN&MOXR?MG>$_
MA7\1M0\*^"_!=[\0_B//M2]M=#@"G<B_+'+*J,[LBGHJL%Y!*G(K6M1C'%NE
M"-UV7HNNNG?\SFP^(G/!1K5)I-]6O-]-->WY,S/AK_P4 BUKXC:9X+^(OPWU
MSX6ZIJKK%82:H[M'(['"AQ)%$R!FPH8*PR1G YKM_P!LCXR^(OA/\/9H-"\
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MC<?,GB.Y4_40P5Q&J6/CK]@KXU>+?%&D>%;OQC\(_%4_VNZCTX$RZ>^YFR<
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MC(#9YQ7SQ\-_V]-0_9_\(V'@7XS^ ?$UEXCT6%;&WN[."-A>1H-J,?,= 3@
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M(_\ RE2^&_\ V F_])[ZONBBM?K;=557'[-O_)>6_P"MOD9?4TJ,J*EN[_\
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M>U_Q37ZG5B*2Q%&5%NW-;\&G^A\/^(O^"F45KI\F@Z?\+/%4'Q,9?*70KZW
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M"%)SC!<8Z,:@_8I\(^(O&?[0OQ$^-,_A*X\"^%-=MC;:?IMQ&8FN6=XF,H7
MR,1;BP&TM*<$X)K[BHKI6(A%2<(6DTUOI9[V7_!.5X6<W%5*EXQ::5E>ZVN_
M^ C\^?'?ASQW^Q'^T9XB^)?ACPS=>+?AKXI9IM4M;%6+6K,Q=MQ .PJY9E<C
M:0Y4D'D=UIO_  42?XIZIIVC?";X6^)?$VKRW$:W?]HI'!!;1;AO8O&[@<9
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MFFKH**^<-%_:0\2ZC^VMKGP@DL=)7PU8Z8+V.Z6&7[87,,,F&?S-F,R-T0<
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MA*(653OM(URQ 4?,.3WZ5YBP]62D[;7OJNFYZ;Q=&/*K_%:VCZ[;(Z']G_\
M:@/QJ^('Q!\'7_AG_A%]8\(W7D-&;_[3]J7S)(V<?NDV@%%XY^^.:R?VM/VQ
MK/\ 9;NO#5JWAMO$UUK FD>)+[[,;>*,H-_^K?=DL0!Q]T\UY5>0_P#"E_\
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MVAO&GQFUW5K'Q1\'=>^&MO9VRSPWFKM.4N6+;3&OF6T0R!SP3]*\0_X*#?\
M)<?V=?\ L.?^W-K7W/6SE!8*E[F[GU>Z:5_F8QIU/KM3]YHE'HMG=V^7WGAO
MP7_:;_X6]\8OB1X$_P"$;_LG_A#KEK?^T/M_G?:\3/'GR_+7R_N9QN;KBNB^
M/O[1G@_]G+PO%K'BJYE:6Y8QV6FV:A[F[<#)"*2  ,C+$@#([D _-7[%_P#R
M>)^TA_V$9/\ TKFK*\3Z?!\8/^"GUGHOB)!<Z1X5TU)[2QN1F-W2!9E(4\']
MY*']Q&*B.'A.=*.R<.:7R5W;U+EB)TX59;M3<8_.5E?T.@7_ (*/ZQI,<.L>
M)O@3XNT'P9*PVZ\6=U*,?E8!X(XSGT$OXFOK7X=_$;P]\5O"%AXG\+ZC'JFC
MWJ[HYD!!!!PR,IY5@>"#R*V=8T>Q\0:3>:9J5K%?:?>1-!<6TZADEC8896!Z
M@@U\-?\ !.&XF\)_$WXV_#VVF:70-'U3S+-"Q81LLTL)(]V5(\_[E)1I5X3Y
M(\KBKK6]UUO?KU&Y5L/.'//FC)V>EK.UU:W33K]YZ;XJ_;Z\)_#WXM>/_!OB
MS2Y-*@\,0QO;7MO<_:)M4E=8R(8X-B[6_>=2Y&%)) KB-6_X*2:CX2U*SN/%
MGP/\6>&?"=W+LAUF^9XWD4\@K$\"HQQSM$I^IK ^%OAO2O$/_!4/XFR:GI]O
M?OIVG?;;3[1&'\F<)9JLB@]& =L'MGUKZ#_;FTFUUC]E3X@I=1+*(+);F/<,
ME9$E1E8>AR/U-4U1HPHRE"_-&+>O?=^OX&<7B*U2O&,^51G)+1/;9>GX^9[/
MX?UZP\5:#IVLZ5<I>:9J%O'=6UQ']V2-U#*P^H(K0KPK]ANZEO/V3_AU),YD
M<6,D8)_NK/(JC\  /PKLOVB/%5[X'^!?CS7=-9DU"QT:ZFMW7JC^60K?@3G\
M*X\33]C5G3CKRMK[CNPE7ZQ0IU9:<R3^]'B_Q6_;\T7PKXZNO!7@'P=K'Q4\
M3V;,EU;Z+N$,;*<.H=$D9V4\':FT'C=G(JQ\'_V]- \=>.(/!/C;PIJWPO\
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MU+^T<G[,_@O2?$,F@_\ "01WVIQZ>T/VW[+Y09'8R;O+?.-G3 Z]:\M\8_\
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ML,\C&">L^"OBR_\ &O[ =MJFIR-->_\ "*WUL\KG+.(4FA5B>Y*QKD]ZY/\
MX)<^&]*L?V>9M9@T^WBU:^U6XCN;U4'FRHFT(I;KM7)P.G)/<U,:$*<J\:FO
M(UY=9+\="I8B=6.'E2=O:*5^O2+_  N_^";/P5_;UM/B)\4(?A]XS\!ZK\-?
M$]W\MG;ZE*T@D?:6"/OBB9&8 [<J03QG)&?:OCI\=/#'[/?@67Q/XHEF^S^8
M(+>TM5#3W4Q!(C0$@9P"220  :^5/V^K./3_ -H[]G?6+<>3J#:ND+3*!N*I
M=V[*">X!=_\ OHU['^VU^SOK?[0'P_T@>&+BV7Q'X?OO[0M+6]P(;OY<-&2>
M 3@$9X.,' .0IPI3A1JI<JDVGUM9V;^XN$Z].5:E?G<4FNE[J]G;S/,[?_@H
MWK&G1PZSXF^!/B_0?!,NUE\0#S)$*-]UP'@CC(.1TE^F:^P-$\6:9K_A6S\2
M6UP8]'N[1;Z.XNHV@Q"R;P[*X!4;>?F Q7RAI7[>$W@VX@\.?'GX::QX"NYO
M]&DU*.W-UIEQQ\[ 8SLZ\(9?K6U_P4 ^(2V_[(-_J'AF^CN=.UZ2TM$O;)@T
M;VLAW$AAQM95V_1L45Z?PJ$+7:2=[K73^MO06'K/WI3J7Y4VTU9JVO\ P-;^
MIC>(/^"B*ZKK]]8_"SX4^)OBE96$ACN=3TY)8X<^J!(96*^[!,_3FO6OV=?V
MJO#7[0PU/3[:QOO#?BO2?^0AX?U50L\0S@LO]Y0WRDD @XRHR,_,?P8_:K\?
M_"_X7>&_#?AS]E?Q9<:59V482\M3=!+QBH+7'%B03(27SD_>ZFD^'/BCXA_$
M_P#;>\&^/KCX*^)OAS926$^F:Q/>6MPT$Z^3*4DDE>WB53GRUYSG8HSTKLEA
M(IRI\NB3][F5]%U5^NVVESAACIR4:G/=NWN\KM9O6SMNEK>]G8^N_CQ^T/X/
M_9U\+)K/BN[D#7#&.ST^T4/<W;@9(120,#C+$@#(YY /SG!_P4>U>UABUS6O
M@3XNTOP+(01XB4NZ>6?NN T"1G/IYOXFN:\7:3;_ !H_X*<VF@^)$^U:)X6T
MY)[73[D9CE9(%F'RG@@R2ACZA!GBOOFXMH;NWD@GB2:"12CQ2*&5E(P00>""
M.U<,8TZ-*$ZD>9S5][)*^FW5V^1Z#E5KU9PIRY8P=MKMNR;WZ*_S/*OC)^T#
M:?"[X"S_ !0L-(FUVQ$%M<06-P[V,DB3.BJ6WQLR$!P<%>V*ZGX/?$+_ (6Q
M\+_#7C#^S_[*_MJR2\^Q>=YWD[OX=^U=WUVCZ5X]_P %#@%_9)\8@# #6>!_
MV\Q5V'['O_)K_P -/^P+#_(U,80EAIU4M5-)>G+>QHYSCB84F]'!M^MTKF3J
M'[4?V#]J_3_@K_PC._[79_:_[<^WXV?N'EV^1Y7/W,9W]\^U?.W_  4R^,GB
M(>%]3^'Q^'^JQ>'6N+.?_A,F\P64CXW^2O[K:6SD?ZS/RGBM'Q#_ ,I7O#W_
M &!S_P"D,U=G_P %1?\ DV9/^PW:_P#H,E:*,*<L/*U[VOZ\[2?RLCGE.I4A
MBH<UN5.VVW(FU\]?OT+/[,O[3GCWQMJG@_P?JOP-\1^&-#.GK%_PE%XUQ]FV
MQ6^4?YK5%Q(5 'S_ ,0P3W]!N?VG/L_[5MI\%O\ A&]WGV!OO[<^WXVXA:7;
MY'E\_=QG?WSCM7I?PM_Y)EX1_P"P/9_^B4KY"U+_ )2M:5_V &_](Y:UDJ=;
M$RCRVLI]7JTI._Y>1A&56AA(2Y[W=/HM$Y137W-Z[GMU_P#M0'0_VIK+X.:M
MX9^PQZE9_:M.U[[?N6X/ELP0P^4-IRDB_?/*CUX]OO[Z#2[&YO+J18;:WC::
M61NBHH))/T -?'/_  4<\+WGAW3? 7QAT6,_VMX,U>(S,O&8'=67=["157_M
MJ:ZW]M?XVVNC?LDW.K:+<;Y?&=O;V&FE#\SQW*;W(QW\G?\ B17(Z7M*%.5)
M>\WROUOH_FFON/05;V=>I&J_=24E_A^U]S3^\[?]EO\ :,G_ &EO"VM^(D\+
MMX<TFSU!K"SEDOOM#7FU0S/M\M-F R<9;DD9XYX+XK?MZ:3X6\<7G@SX?^"M
M:^*OB:Q8K>0:(&\F%@<,N](Y&9E/!PFT'C=G(&O8^&;O]F3]AF^LM/7R=;T7
MPS/<RR1CE;R1&>1_^ NYY]%%?)_[(?[0WC'X-_"2WLO"_P"SKXE\9K?W$MU=
M>)M/-QLOWWLHY2TD&$ V8WGD,>"37:L/3J5:CIJ\8V25]WWN^FE_GI8X)8JI
M3HTE4E:4[MNU[+>R2ZZI:]M;GUE\"?VTM(^+'C(^"/$OA;5OAQXY,9EBT;6U
M($Z@9(C9E1BV 3M9%R <9P<?1U?FK\6OBA\4OCS\1_A?K,7[/'B[P=JWAK6X
M;@:J]K=3[H3(A:-R;6,*F5SDD@<^IK]*JY\315.,9VY6[Z7OM;7YW^^YTX2N
MZDI0YN9*VMK;WTZ;6Z=SPGQU^T^?A_\ M*>$?A7J/AG%CXE@62U\0_;\ 2'S
M (_)\KD[T5?O_P 8..U=G\?OC%:? ;X4:WXUN[+^TQIZQB*Q\[R3<2.ZHJ;]
MK;>6SG:>AXKYO_X*7:#<Z'X?^'GQ0TR/.H^$M<C+.#C$;LKKGV\R)!_P.MC]
MK?7(/B[X@^ WP_TV7S[+Q;K,.MW*J,[K&!!(2?8J['_@%*G1C6A2MNY.,OEK
M?_P'\AU*\J-2LGLHJ4?Q5O\ P)?B>T?LU_':U_:*^%EIXPM],_L69[B:UN=-
M-QYYMY(VQM+[5SE2C?='WJQ=+_:4.N_M1:I\'].\.?:8M*TX7]_KOV[ A)1"
M(_)\KDYDC&=XZGCC%>6_LG7:_##]H;X\_#2Z;[/:IJ(\36",<#R9@#(1[ /
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M ,>V\#$A;_5GA3SW'ZLU\-:E_P I6M*_[ #?^D<M+ RC&I+F5_=E_P"DRO\
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M/_T)J]\^"JB3X+^ U8!E;P_8 @C((^S1UPQO]2G;^?\ ]M1VRM_:,+_\^_\
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M5L'$5J"C4II1^+>*=W?71/7LGZ7-:.(<J51N7P[2:LK:;K35:KIK;T/(I/\
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M6OAK_@J5_P @'X5_]A]O_0%K'!?[U2_Q1_-!F7^Y5_\ !+\F?<M?&W_!5/\
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M^V-\4M>^&OPKO8M#\":IXV&L6MW974FF^9MTZ,PD&>79$_R@$]=HXZU\K_\
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MU.:[I86'O1Y;))V?,KZ:ZKS\MCS(8V;<).=VVDX\KLKZ:.W3S>I[I\7/VRM
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M 'A#P5X,USXI^+['1(&O].T")VCLN.DLB1R$-ST"''0D'BO;?V_/^32/'_\
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MT)##. <J<@<9\.M?VYO%GCP'3O@;\$=5\0Z-:_Z-!JMXIMK--O 0(B[% &,
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M2DOC-/\ A&?^$=_X1R\CM,_;_M7VC=YGS?ZI-F/+Z<]?:O3_ (8?\DO\)?\
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MX#?"74O'<5G*PEOK& VM@CLQ)D"I&WRLVX[G\O)R>>M8X>'/)^[S6\[+YO\
MX*-\54]G!>_RW?:[^2_X#/2OV;_VRM%^/GB'4O"M_P"'M0\$>-M/C,TVBZDV
MXL@(#;&*HVY<C*LBG!R,@''@O_!3+XR>(AX7U/X?'X?ZK%X=:XLY_P#A,F\P
M64CXW^2O[K:6SD?ZS/RGBN$T#Q1\1]0_X*&?#?6/B+X3L/!GB&^@\K[%IL@8
M36S0W"*\A$DF6ZCD@X1>!P:]_P#^"HO_ ";,G_8;M?\ T&2NRI3A2JT*B2M)
MK2]TGS):/RT?KH<$*M2M0Q%-R=XIZM6=N6^J\]5?MJBS^S+^TYX]\;:IX/\
M!^J_ WQ'X8T,Z>L7_"47C7'V;;%;Y1_FM47$A4 ?/_$,$]_K2N7^%O\ R3+P
MC_V![/\ ]$I745S8N495I<L;6;^>NYUX&,XT(\TKW2MMIHM HHHKC.\****
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MCU6X>T@E.$DF#VI16Y'!; ZCKU%?>M?#7_!1[_DH7[/W_8?D_P#1UI79@?\
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MNZ%XUUJ8(:[!96;:2 '9P@4! 0F22QR*_1*BM_K5.-3VT*?O;IMWL^]K'/\
M4ZLZ?L:E2\-FDK77:]W\SQ;]K3]G>#]I'X3W/A])H[/7+207NE7<N=B3J"-K
M8YV."5/ID'!QBOF_P'^W%XK_ &<]%MO!GQV^'_B**^TN,6MMKFGQ))]M1  I
M)D94<@8_>)(=W< Y)^^:*YJ5;DBZ<U>+UMY]TSJK4/:252$N62TOY=FCX^\"
M?M8_$G]HKXD^'8OACX N='^'UO<B76->\31[%N(.0T<97*AN<@(SL6"YVJ&S
M]@T45-2<)64(V2^;^;+I4YPNZD^9OY+Y(^6/^"CGPMU_XG?L_K_PCEC-J=[H
MVI1ZC)9VZ%Y9(0DB.44<L5WAL#G -5_V:?VZ] ^,FM>&O L?A7Q!8^)3:^7?
MW$ENALK>2*$ECO#E@&*8&Y%Y(%?5]%73K1C2E2G&Z;NM;6=K$5:,I58UH2LT
MK/2]U>_WGPQ\-?\ E*5\1/\ L!_^TK2OL3XD>'[KQ9\._%&AV,H@O=2TNYLX
M)2<!))(F13GV)%='165:?MJ<*;7PQ4?SU-J,'1J3J)_%+F_+3\#\T/V7_P!J
M[3OV1?!]W\,?'?PZ\26?BB'4)95_LVTC:2\9R -X=T)Q@*K+O!4+BJGCKQ7\
M0/B-^V'\#?%_C3PBW@G3=0U6&WT32[ELW8MXYT+/.#@JS-)P"%X[?Q'].J*[
M_KL?;*NX>]UU\K:=OQ['F2R^3H2PRJ6@]M%WOKW_  /BG_@JW_R0CPY_V,,7
M_HB:OL3PW_R+NE_]>L7_ * *TJ*XO:?N?96ZW_!+]#T?9_OO:WZ6_%O]3X9_
M9]_Y22?&S_L&O_Z':5W7Q9_:\\:? #XF:Q!XV^&&H7?PX+*=,\1:$?.8+M&?
M-W$)N+9^5FC(Q_&.:^K**OVR?LU*-U&*CZVZ^3^\Q6'E'VKC.SG)R]+]/-?<
M?FO\4OB--^W]\1_A]8?#;P+K&GV6B:@MQ?>+-3MTB:VCW*67?&S*H 4L%W[F
M8# '?U__ (*I_P#)N.E_]C%;?^B+BOLFBJE7C^[C"-HP=][ZW3>OR)CAI?O)
M5)7E./+>UM+-+3YOJ8?@<;O!&@ ]].M__12U^<WPI^+MW_P3\^+7Q#\,>._"
MVL77AG6K[[5IU_IL"DR!6?8T>]D1U9' .&!4KC'I^FM%*.(4:DYN-U/=?.ZU
M\F54P[E3A&,K2A9I_)K;S3/RQ_;>^(7CWX]_#O2O&T_A6Z\'?#33]3CMM,MM
M73;?ZA-*CDW+*!\D85-HYP2_!;^'[Z^/'C+Q_P" _AG#K'P[\*0^,-7MY86N
M=/D=@YM0,R&-%Y=R!@ <C=D!L8/JE%.>(4J<:<8V46W^6C[[?<[*U@AAW&I*
MK*=VU;\]5V_'75WN?#6O?\%+O"FL^'[[PY>?"WQ3<>+;J!K63PY=VL3P/(PP
M8F);S"N3C_59/I7H/_!/7X0^)OA'\"KR/Q59RZ3?ZSJ4FI1Z7,"KVL31HBAU
M/W6.PG:>0" ><BOJ2BIJ5H.E.E3AR\]D];[=A1P]3VD9U9\W+>VB6^FO](^'
M?^"5?_(@_$7_ +&#_P!I"LWXM>$O''[(W[2VK_&3PAX;N?%O@7Q(C?VYIUB&
M,ENS$-(Q !*_.OF*^"/F93C()^]**TGBG*O[=+=6:[JR3_*X_JJ='V4GU<D^
MSNVONO;S/@7XB?M\:A\>O"E]X'^"W@+Q/>^)]8B-E/=7EO&JV4;C:[#RY' .
M"1O<HJYR>F*^E?V2?@.?V=_@OIGABYDCGUF61[[4YH3E#<2  JI[A55$SWVY
M[U[+142KQY'3I1Y4]];MVV7H$,//VBJ5I\SC>VEDK[OU/AG_ ()P_P#)1OV@
M?^P]'_Z.NZZG_@J+_P FS)_V&[7_ -!DKZ]HJ*E;GJ0J6^'E_P#);?G8JGA_
M9TJE*_Q<_P N:_Y7^9R_PM_Y)EX1_P"P/9_^B4K6\2?\B[JG_7K+_P"@&M*B
ML*S]LY/;FO\ B=6'7U=06_+;\#XH_P""3_\ R0'Q)_V,LW_I+;5%^U%\+_'7
MP@_:"TK]H#X;Z))XEC$*V^OZ+:JS2R($\MFVJ"2K(%Y .QD5B",U]N45W5,7
M*6(^L15NEM]+6:?J>?2P<8858:3O;KMK>Z:WV/A;Q!_P4L3QMH,^@_#/X=^*
M+_Q_=1F"*VN;5'CM9",%\1NSOM/."J#CDBO6_P!AW]G;4_@'\,KR3Q*5;QAX
MBN?M^IJ'#^3QB.(L.&899B1QN<@$@9/T=142KP4)0I0Y>:U];[=/2Y<</-SC
M.M/FY=M+;Z7\W;3]#X:_9E_Y2%?'G_KVD_\ 1\%?<M%%8U*GM(PC;X8I?=U-
M:-'V4JDKWYY.7I?H<!\?O!NH_$+X*>-O#6D,%U34]*N+:V#-M#2%#A2>V>GX
MU\/?LS?MG:1^SC\.++X6>*/AMXHM_&.FSS(+73;)"]Y(\C,&=7='#\A> ^0H
M(]!^D%%71K*G&4)J\96\M5?_ #)KT'4E"I"5I1OTOH[7T^1^:6FZQX^\8?\
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M@=S;, KC"\C<IS]XD5[)15U*U.:;]G:3\]/DO^#8QI4*M-I>TO%>2O\ -_\
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M:^2OAK^VAXA_99\,V7P]^-W@+Q!%<:)&+.PUG3(DD2[@0809D=$?:N '1SD
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M/A]/JSM=:SHBB2:QN!&F5="0NPKLP6*#.>3T'ZDZM_R"KW_KB_\ Z":^+?\
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M^$_A607%A'J2E9+Y@ROP"!O+LB;BN555(W$]?T#HK?ZVN?VRA^\[]+OK;O\
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M,L%7,;,I5@Q&X'-+\4/B7XR_X*(7VB^"?A]X5U;P]\.H[M+K5?$&L1! Q7@
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M])[ZNV_;F^ GBOQI-X1^)?P[A-SXV\&SB=+-!E[F%7$@V#^)E92=G\0=@.<
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M?, 5F4J=W4,>AKB_VX?AOKWQ4_9O\2Z)X;@>\U56@NTLXN7N%BD5V11W; )
M[D =:]ZHKDE)<ZE35K--==M3LC%^S<*CO=-/IOI^1\ _!7_@H!H_A#X;^'_A
M[9_"SQ3=>.M'LDTY=$TRU3RI9HUV[B<^:A8C<W[HD%CUZG)_9=C\9R?\%!O%
M6H^/M+M]$\3:IX?DOI]/M7#I CBV\M,@GD(%!YZ@U^BE%=WUN*G.I&&LDT]>
M_;YZ]3SXX*?)"G*I>,&FE;MM?OI==-]CX:_:\_Y/@_9U_P"OF+_TJ%?<4O\
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MOP?\+]+U&)+"/64"7VI7$J,//V@';&JY48."7X+=%^[?BYXM\>^"?@U8ZO\
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M!XW?3/[8&DQQN+$3^1YI>5(P-^UMO+Y^Z>E;?PS\9?\ "Q?AUX8\5?8_[/\
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MXZD_8W[(O[-GB;X3ZMXO\<?$'6+?6/'OBR59+O['S%;H&+%=V "Q8C( VJ$
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M]3_9G_Y-U^&/_8M:=_Z3)1^T=\'E^/'P;\1>"Q=+8W%]&KVURX)2.:-UDC+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %?/'[1_B']HBU\16NE?!_PMHM]HEU9!
M;G6M1GB$UK<%F!**\Z\*NT\QOR>G:OH>BJC)1DI-7\GL1.+E%Q3M?JMSPO\
M9-_9O/[/?@[43J^HKKGC37[G[=K>J*25DDY(1"P!*J68[B 278X&0![I115U
M*DJTW.6Y-*E&C!0C_7F%%%%9&H4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img175210594_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" >#"DP# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY)_X
M*?\ C+4="_97U3PYH5I=ZCXA\8WMOH5E96$+33S!F,LJHB@LV8XG7 '\5?6U
M4&NM,FUI;4RVCZO! 9EA+*9XXF.TL!]X*2N,]"5]JSJ052/(^O\ P[7S1I"?
MLWS+I^?1_>?F)^SC^WS_ ,,C_#KP)\-?B=\#?&'P_P! M(/LX\0WD4JM<S,Y
M>:;[/+!$=NYV8A'=@.@)K]-_#/B;2O&?AW3M=T._@U31]1@2YM+RV;='-&PR
MK ^X-<-^TMX%\-_$;X#^.-%\66]O-HS:3<SR27 &+9HXF=)U)^ZR$!@W;%?+
M7_!&O7M6U;]E;4K._,CV&F^(KFWT]GS@1-%#*RK["21S]6-=$9NO*KS?%%*5
M^]W;[[F#A[&--QV;:MZ*Y]XT445F6%%%% !17-R^%]0DD=AKMR@8DA1NX]OO
MTW_A%=1_Z#]U^3?_ != '345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\
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M345S/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\
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M'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (174?\
MH/W7Y-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW_P 70!TU%<S_
M ,(KJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC
M_A%=1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T
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M\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#BZ/\
MA%=1_P"@_=?DW_Q= '345S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_ !=
M'345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\ Q= '345S/_"*ZC_T'[K\
MF_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (174?\ H/W7
MY-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW_P 70!TU%<S_ ,(K
MJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC_A%=
M1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T =-17
M,_\ "*ZC_P!!^Z_)O_BZ/^$5U'_H/W7Y-_\ %T =-17,_P#"*ZC_ -!^Z_)O
M_BZ/^$5U'_H/W7Y-_P#%T =-17,_\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q
M= '345S/_"*ZC_T'[K\F_P#BZ/\ A%=1_P"@_=?DW_Q= '345S/_  BNH_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN0_9(\'GQU^TG\/=**>9%_:T5W*N,@QP9F8'VQ&1^-?:825!TU.DK1^[;?\
M(_/\9'$*JZ=:5Y:>>ZNOS/VW\">&8O!?@GP_X?@ $.E:?;V28](XU3^E;M%%
M?#SDYR<I;L_1:<%3@H1V6@4445!84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_DF?6?\ P2I^'*>(?C%KWBVXB#P^'=/\N!B/NW%P2H(_[9I*/^!5^JM?#O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU;-W9,>OW6;>F?9R!V6OA_XP?L/_ !<^#?GW-_X<?7='CR3JN@DW4(4<EF4
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M=OPO_F=]_P %5/C=!;Z+HGPOTZX#W=S(NJ:HJ'_5Q+D0QM[LV7Q_L+ZU\)_
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M9$-P(]>UZ-]*TZ-3A\R+B20>R(6.?4J.]?BU;V\MU<1P0QM+-(P1(T&69B<
M =R37HWQZ^/_ (J_:(\:-XA\3W"#RU,5GI]N"MO9Q9SL0$GD]2QY)]@ /IK_
M ()R_LG77C;Q59_%#Q-9-%X:TF;S-*AG3'VZZ4\2 'K'&><]W '\+"L\'06
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !15'7-<T_PSHU]JVK7D.G:98PO<W-W<N$CAC0%
MF=F/   )S7-?!WXIZ7\:_AQH_C70XYH]'U82R6GGC#M$DSQJY';<$W8[;L4=
M_+^OT?W!V\_Z_5'9T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB(5SPJKG<"<\5]74549./-9[V_"_YW5_1$2CS.+[7_&WY6T]6%%%%(H****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \-_;<_P"37O&_^Y:?^ED%=C^SU_R0;X=?]B]8?^DZ5QW[;G_)
MKWC?_<M/_2R"NQ_9Z_Y(-\.O^Q>L/_2=*]^7_(GC_P!?9?\ I,3Q(_\ (UE_
MU[7_ *5(]!HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /DSXI?\ *0SX3_\ 8!F_] OZ^LZ^3/BE_P I#/A/_P!@&;_T
M"_KZSKW\T_AX3_KVO_2I'B9;_$Q/_7Q_^DQ"BBBO /;"BBB@ KY>_;7_ &GO
M^%0^&_\ A%_#EVH\8ZK$=TD9^;3[<\&3V=N0OIRW89]2_:&^.>E_ /X?7&NW
M@2ZU*8F#3=/+8-S,1QGOL7JQ[#CJ1G\A_%WBO5/'/B;4M?UJZ:]U34)FGGF;
MNQ[ =@!@ #@  =J^[X9R3Z]4^MUU^[CLOYG_ )+K]W<^+XBSCZG3^K4'^\EO
MY+_-]/O[&?;6UQJ=[%;P1275W<2"...,%GD=C@ #J22?UK]6?V1?V;(/@/X,
M-WJ2)-XOU:-7OYA@_9TZK;H?0=6(ZMZ@+7CO[!?[+YTN"V^)OBFT7[5.F[0[
M.9>8D/\ R\L/5APGH"6[KC[@KKXISOV\G@,._=7Q/N^WHOS]#EX;R?V,5C:Z
M]Y_"NR[^K_+U/#?VW/\ DU[QO_N6G_I9!78_L]?\D&^'7_8O6'_I.E<=^VY_
MR:]XW_W+3_TL@KL?V>O^2#?#K_L7K#_TG2OF)?\ (GC_ -?9?^DQ/HX_\C67
M_7M?^E2/0:***\ ]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **XOXG?&3P?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '#?';_DA_Q#_P"Q=U'_ -)I*\^_87_Y-<\&_P"]>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\3^"?
M#OC:W@@\1:!I>OPP,7BCU2SCN5C8C!*AU.#CN*^1/^"@7PQ\'>#/@KI=]X?\
M):'H5Z^NP0M<Z;IL-O(R&"X)4LB@E254XZ<#TK[5KY0_X*3?\D'TC_L8;?\
M])[FOH\AK5%F%""D[<VU]#P,[I4W@*TW%7MO;4]OM_@)\,FMXB?ASX3)*C)_
ML.U]/^N==KI.D6&@Z;;Z?IEE;Z=86Z[(;6TB6**-?144  >P%36O_'M%_N#^
M52UX=2M5J:3DWZL]FG1IT]812]$%%%%8&P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'R9\4O\ E(9\)_\ L S?^@7]?6=?)GQ2_P"4AGPG_P"P
M#-_Z!?U]9U[^:?P\)_U[7_I4CQ,M_B8G_KX__28A117@G[7'[24'P%\%BWTY
MXYO%^K(T=A"2#]G7HUPX]%Z*/XF]@V/+PN%JXRM&A15Y2/2Q.(IX2E*M5=HH
M\=_;T_:@.CVUQ\-/"UX/MEPFW6[R%N88R/\ CV4_WF'+^@(7N<?"GA3PMJ?C
M;Q)IV@Z-:O>ZIJ$RP00)U9CW/H ,DD\  D]*H7=W<:I?37-S+)=7=Q(TDDLA
M+/([')8GJ22?UK],_P!B7]F'_A4GAS_A*_$=JH\7ZK$/+BD7YM/MR,B/VD;@
MMZ<+V.?V6I/#<+9<HQUF_P#R:7?T7Y:;GY+3AB.),>Y2TBO_ "6/;U?YZ['J
M?[._P)TSX!?#^#0[1DNM4G(GU+4 N#<38[=]B]%'ISU)KU&BBOQ:O7J8FK*M
M5=Y2U9^NT:,,/3C2I*T5L%</\8_'VL?#7P5+K6A>$;[QM?I/'$-)T\N)65C@
MO\D<AP/]VNXHJ:4HPFI3CS)=-K_=J54C*<'&$N5OKV^\^$_C=\>OB=\9/A?K
MG@[_ (9_\6Z1_::Q#[;Y5U/Y>R9)/N?9%SG9C[PZYK8^'O[3GQ.\!^ _#OAK
M_AG?Q;??V1I]O8?:MMU'YOE1JF_;]C.W.W.,G&>IK[4HKZ'^UL+[%8?ZHN1.
M]N:>]K=[[(\'^S,3[7V_UI\UK7Y8[7OV.'^#GC[6/B5X*BUK7?"-]X)OWGDB
M.DZ@7,JJIP'^>.,X/^[7<445\]5E&<W*$>5/IO;[]3WJ<91@HSES-=>_W!11
M161H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!#>3_9;6:;&?+1GQ]!FOYK/ACX='QP_:3\-Z/K,K%/
M%'B>&*^D#$,5GN1YI!]2&;\:_I7DC62-D895A@@]Q7\U_CC2]7_9G_::U.!(
M/+U3P=XE^T6R2@@.(9Q)"W^ZRA&^C5-%PCC(.IM^B:O^AI44I82HH;W_ $=C
M^D30]$L/#>C6.DZ59PZ?IEC EM;6MN@2.&-%"JBJ.   !BOS^_X*R_LW_$G]
MH"X^&A^'_A6Y\2C2UU 7GV>:*/R?,-OLSYCKG.QNF>E?9WP)^.7A7]H;X;Z7
MXR\)7\=W8W<8\ZWW#SK.; WP2J#\KJ3T[C!&003Z#55J;<_?W3N9T:BC&\-F
MK'R#_P $O_@UXS^!O[.^H>'O'6A3>'M9DUZXNUM9Y(W8Q-%"%;*,PP2K=^U?
MG3_P5T\"V7@_]KV\OK%%B'B#2+75)U7@>=EX6/XB%3]2:_<+Q)XETKP?H-]K
M6N:C:Z1I%C$9KF^O)5BBA0=69B< 5_/1^W'^T);_ +3W[1NN>+-)CE&A1I'I
MFDK(A$CVT60KE>H+NSOCJ X!Y%9UINM7A9:K\DK?B[>MO(THQ5*E.^S_ #;O
M^&O],_9[_@GAKD_B#]B_X67-R2TD6FM: DY^6&:2)/\ QU!7T77E'[*/PYN/
MA+^S?\.O"=ZACO\ 3M&@%W&?X)W7S)5_!W8?A7J]=N):=>;7=_F<>&O[&%^R
M"BBBN8Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#AOCM_P D/^(?_8NZC_Z325Y]^PO_ ,FN
M>#?]Z]_]+9Z]!^.W_)#_ (A_]B[J/_I-)7GW["__ ":YX-_WKW_TMGKWX_\
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MU1116!L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5P_P =/^2)?$'_ +%[4/\ TFDKN*X?XZ?\D2^(/_8O:A_Z325U
M87_>*?JOS.?$_P "?H_R/._V%?\ DUWP?_O7O_I9-7OE>!_L*_\ )KO@_P#W
MKW_TLFKWRNO-O^1AB/\ '+\V<N6?[C0_P1_)!1117E'I!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_IJ_2(?7YO137YS_ !O_ &H/&_QUNGBU>^^P:$'W1:+8DI;K@\%^<R,/5OP
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MAB]O;G0;&:>YN-'MY))9&@0L[,4RS$DDD\G-?2O#Y2L*L5RU+.3C;FCT2?\
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MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\
M%T?VAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#
M_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_
M - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?V
MAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+
MH Z:BN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - V
MV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_
M .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:
MBN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z
M'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;
M;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_
MM#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=
M']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\
M?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/
M_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>
M)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^
M+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P!
MVV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\
MH&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z
M:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[
MZ'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW
M_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z:BN9
M_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q
M=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_
M^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q
M/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q=']H
M>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H
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M'Z)X#T&VT7P]IEOI.EVXQ';6R;5'J3W+'NQR3W-;-<S_ &AXG_Z!MM_WT/\
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M_M#Q/_T#;;_OH?\ Q=?+7[5G[(^I_%9KCQ;X<T>WLO%2)NN;>!U1-1 '4Y;
MEQT;^+H>Q'Z/P]Q'["V#QK]S92?3R?EY]/3;X'/L@]M?%X1>]U7?S7G^?KO-
M^Q_^V?'XYCL_!7CN[6+Q(H$5AJTQ 6_[".0]IO0_Q_[WWOL6OPHNK6YTN^EM
M[B*6TO+>0I)%(I22-U.""#R"".G;%?=7[*O[;&IZL-/\$>,+BWEU([8-/UB\
M;'V@]%BF8L!O[!C][H?FY;7B#AODOC,"O=W<5T\UY>73IIMGD7$'/;"8QZ[*
M3Z^3\_/[]3[MHKF?[0\3_P#0-MO^^A_\71_:'B?_ *!MM_WT/_BZ_,S]#.FH
MKF?[0\3_ /0-MO\ OH?_ !=']H>)_P#H&VW_ 'T/_BZ /G+_ ()L_P#)%O$?
M_8R3_P#I-;5]9U\:?\$[[K68?@]X@73[2&>'_A(9BS2$ AOL]OQ]X=L5]2_V
MAXG_ .@;;?\ ?0_^+KWL^_Y&=?U/$R7_ )%U'T.FHKF?[0\3_P#0-MO^^A_\
M71_:'B?_ *!MM_WT/_BZ\$]LZ:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;
M;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_
MM#Q/_P! VV_[Z'_Q=?-OQ"_8;T?XE>-=7\3ZG-K<%_JDYGFCM+RV6)6( PH:
M-B!QW)KLPM/#U)-8BHX+NH\WZHY,34KTXIT*:F_-V_1GUQ17YB>*OV3='T#]
MI7PA\-XY]6-AK6G/>R/)<P&X#*MR?E8)M _<#JI/7VKZ#^'O[#>C_#7QKI'B
M?3)M;GO]+G$\,=W>6S1,P!&&"QJ2.>Q%>SBLMP.&A&3Q+;E'F7N;[I?:TU1Y
M.'S#&8B<HK#I*,N5^_ML_P"771GUQ17,_P!H>)_^@;;?]]#_ .+H_M#Q/_T#
M;;_OH?\ Q=?-'T)TU%<S_:'B?_H&VW_?0_\ BZ/[0\3_ /0-MO\ OH?_ !=
M'345S/\ :'B?_H&VW_?0_P#BZ/[0\3_] VV_[Z'_ ,70!TU%<S_:'B?_ *!M
MM_WT/_BZ/[0\3_\ 0-MO^^A_\70!YC^W!_R:[XW_ -VS_P#2R"NU_9]_Y(/\
M.O\ L7=/_P#2>.O+?VSKS7I?V:?&2WEC!#;%;3>Z,,C_ $N''\1[X[5V/P'O
MO$2?!'X?K!I]N\ T"P",S#)7[.F#]_TKWI?\B>/_ %]E_P"DQ/$C_P C67_7
MM?\ I4CV"BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+KP3VSIJ*YG^T
M/$__ $#;;_OH?_%T?VAXG_Z!MM_WT/\ XN@#IJ*YG^T/$_\ T#;;_OH?_%T?
MVAXG_P"@;;?]]#_XN@#IJJ:O>2Z;I-[=P6SWLT$#RI;1YW2LJDA!@'DD8Z'K
M6)_:'B?_ *!MM_WT/_BZ/[0\3_\ 0-MO^^A_\736^HGMH?.7_#9'Q._Z-M\6
M_P#?5U_\A5D:/^WMXQ\1:AJ5AI7P'US4[[39/)OK:SO9I9;5\L-LJK:$H<JP
MPV#E3Z&OJ3^T/$__ $#;;_OH?_%U\M?LFW6LQ_'3]H-K2TAEG;75,ZL1A&^T
M7G ^8=\^O2OK\/4R^MAZ]9X17II/XIZWDEW\SY:O3QU&O1I+%/WVU\,-+)OM
MY'LWP*^.'BSXKZMJEIXB^%NL_#^&T@66*YU0S%;ABV"B[X(^0.>":]EKF?[0
M\3_] VV_[Z'_ ,71_:'B?_H&VW_?0_\ BZ^8Q%2G5J.5*'(NR;?XO4^BH4ZE
M."C4GSOO9+\M#IJ*YG^T/$__ $#;;_OH?_%T?VAXG_Z!MM_WT/\ XNN8Z#IJ
M*YG^T/$__0-MO^^A_P#%T?VAXG_Z!MM_WT/_ (N@#IJ*YG^T/$__ $#;;_OH
M?_%T?VAXG_Z!MM_WT/\ XN@!GB'XK>"?".I-I^N^,- T6_50YM=0U.""4*>A
MV.P.#ZXK,_X7Y\,?^BC>$O\ P>6O_P <K@_B%^SCX;^*OB1]>\4^"+;5-6>-
M(6N/[1N8<HHPHVQW"KQ]*^8?VBOV>?"?@'XB?"+2]*\)0Z5:Z_K!M+RW6_N)
M1=)YULNPL\S%.)&&5*GYNO Q]+E^#R[&2C1<YJ;3;TC;1-OK?IIH?/8[%8_"
M1E54(.":2UE?5I+I;KKJ?;UO\=/AM=W$<$'Q"\*S32,$2./6K9F=B<  !^23
MVKN*^:=/_8W^'^EWUM>VOP[MHKFWE6:)_P"UKP[74@@X-S@\@=:]P_M#Q/\
M] VV_P"^A_\ %UY&*6$37U1R??F27W6;/4PSQ33^LJ*[<K;^^Z1TU%<S_:'B
M?_H&VW_?0_\ BZ/[0\3_ /0-MO\ OH?_ !=<)VG345S/]H>)_P#H&VW_ 'T/
M_BZ/[0\3_P#0-MO^^A_\70!TU%<S_:'B?_H&VW_?0_\ BZ/[0\3_ /0-MO\
MOH?_ != '35P_P =/^2)?$'_ +%[4/\ TFDK2_M#Q/\ ] VV_P"^A_\ %UQ?
MQJOO$;?!OQXLVGVZ0G0+\.RL,A?L\F3]_P!*ZL+_ +Q3]5^9SXG^!/T?Y'._
ML*_\FN^#_P#>O?\ TLFKWROF?]B>\UV+]FGPFME9036P:\VN[#)_TN;/\0[Y
M[5[E_:'B?_H&VW_?0_\ BZZ\V_Y&&(_QR_-G+EG^XT/\$?R1TU%<S_:'B?\
MZ!MM_P!]#_XNC^T/$_\ T#;;_OH?_%UY1Z1TU%<S_:'B?_H&VW_?0_\ BZ/[
M0\3_ /0-MO\ OH?_ != '345S/\ :'B?_H&VW_?0_P#BZ/[0\3_] VV_[Z'_
M ,70!TU%<S_:'B?_ *!MM_WT/_BZ/[0\3_\ 0-MO^^A_\70!TU%<S_:'B?\
MZ!MM_P!]#_XNC^T/$_\ T#;;_OH?_%T =-17,_VAXG_Z!MM_WT/_ (NC^T/$
M_P#T#;;_ +Z'_P 70!TU%<S_ &AXG_Z!MM_WT/\ XNC^T/$__0-MO^^A_P#%
MT =-17,_VAXG_P"@;;?]]#_XNC^T/$__ $#;;_OH?_%T =-17,_VAXG_ .@;
M;?\ ?0_^+H_M#Q/_ - VV_[Z'_Q= '345S/]H>)_^@;;?]]#_P"+H_M#Q/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^
M;?B%XY_:9TWQKJ]MX0^'GAO5/#4<Y6PO+NX1998\##,#>)SG/\(^E>8ZE^TY
M^TGH_P 1=*\"7G@#PE#XKU2W:[L]/W%O-B D);S!>E!Q#)P6!^7W&??HY+6K
MQYJ=2GM?XU=+=W72W7L>'5S>E1E:=.>]O@=F_+O?IW/N"BOFWX>^.?VF=2\:
MZ1;>+_AYX;TOPU).%O[RTN$:6*/!RR@7C\YQ_"?I7TE7F8K"O"R47.,K_P L
ME)?@>CAL0L3%R491M_,FOS"BBBN,ZPHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /DS]CS_DOG[2'_8PK_Z4WU?6=?)G['G_ "7S]I#_ +&%?_2F
M^KZSKWL\_P!^E_AA_P"D1/$R;_<H^L__ $N04445X)[84444 %%%% !1110!
M\F?MF?\ ):OV<O\ L9#_ .E-C7UG7R9^V9_R6K]G+_L9#_Z4V-?1_C[XC>&_
MA?H$NL^)]7M](L(P<-,WSR'^[&@^9V]E!-?0XN$JF"P4(*[:GHO\;/!PLXT\
M7BY3=DG'_P!(1TE>-?'/]JSP1\"[>2WO[O\ M;Q#MS'HM@P:;GH9&Z1#_>YQ
MT!KY%^/?_!07Q!XQ-QI'P_2;PSHYRC:FY'VZ<9ZJ1Q"/IEO]H=*^19IIKVY>
M65Y)[B9RS.Y+.[$Y))ZDDU]1E7",ZEJN/?*OY5O\WT^6OH?.9EQ3"G>E@5=_
MS/;Y+K^7J>N?'']J;QO\=;F2'4[S^S- W9BT6P8K ,=#(>LC>[<9Z 5YOX1\
M&ZYX]UR#1O#VEW.L:G-]RVM8RS8'5CV51W8X [FOHWX"_L%^*_B4MOJWBUIO
M"/AYL,L<B?Z=<J1G*(>(Q_M/SZ*17Z#_  S^$?A/X0:&-+\*Z/#IL) \V8#=
M-.P'WI)#\S']!G@ 5[N-X@P&3T_JV!BI271?"O5]7_3:/&P>1XW-9_6,9)Q3
MZO=^BZ+^DCY:^ O_  3OT[1A;:Q\2YDU6^!#KH=HY^S1GJ/-D&#(?51A?=A7
MV;I^FVFD6,%E8VL-E9P*$BM[>,1QQJ.@50, >PJS17Y9CLRQ695.?$3OV71>
MB_IGZ3@LOPV7PY,/&W=]7ZL****\P]$X;X[?\D/^(?\ V+NH_P#I-)7GW["_
M_)KG@W_>O?\ TMGKT'X[?\D/^(?_ &+NH_\ I-)7GW["_P#R:YX-_P!Z]_\
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M &+NG_\ I/'7O2_Y$\?^OLO_ $F)XD?^1K+_ *]K_P!*D=_1117@GMA1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY0_X*3?\
M)!](_P"QAM__ $GN:^KZ^4/^"DW_ "0?2/\ L8;?_P!)[FO>R'_D9T/\1XN=
M?\BZMZ'U5:_\>T7^X/Y5+45K_P >T7^X/Y5+7A/<]E;!1112&%%%% !1110
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MHH **** "BBB@ HHHH ^3/V//^2^?M(?]C"O_I3?5]9U\F?L>?\ )?/VD/\
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M$QO^^83UE_Z0SZSHHHKP3VPHHHH **** "BBB@ KY,_;._Y+-^SI_P!C(?\
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M5ES2[VM^&H4445@;!1110 4444 %%%% !1110 4444 %%%% !1110 5\H?\
M!2;_ )(/I'_8PV__ *3W-?5]?*'_  4F_P"2#Z1_V,-O_P"D]S7O9#_R,Z'^
M(\7.O^1=6]#ZJM?^/:+_ '!_*I:BM?\ CVB_W!_*I:\)[GLK8****0PHHHH
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M-/X>$_Z]K_TJ1]KEO\3$_P#7Q_\ I,0HHHKP#VPHHHH **** "BBB@ HHHH
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M4 %%%% !1110 5\F?$O_ )2*?"K_ +%Z;_T7J%?6=?)GQ+_Y2*?"K_L7IO\
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M</\ Z+T^O?RKX,5_UZ?_ *5$\3,_CPW_ %\7_I,CZSHHHKP#VPHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /%OVE/V9=#_:"\._/Y>F^*;2,BPU
M8+^/E2XY:,G\5)R.X/Y4^.O NM_#?Q1?>'O$-A)IVJ6;[9(GZ$=F4]&4CD,.
M"*_;^O*/C]^S?X8_:"T.&WU</I^K6H/V/5[509H<]48'[Z$\E3^!!YK[;(.(
M99<UA\1K2?WQ]/+NOFO/X_.\ACCU[>AI4_"7KY^?W^7YV_L[?M<>)/V>=/N]
M)LM,L=:T*[N?M<MK<;HY5D*JA*2+TRJ*,,K#CC'.?LKX>_\ !0GX:>+O*@UO
M[=X1O6X/VV/SK?/M+'DX]V517PK\/?V9_'?Q6\$WWB?PII\&KVEG>O8RVJ7"
MQW&]41RP5\ C$@Z-G(/'3/!>)_!VO>"M0-CX@T:^T6\&?W-_;O"QQW 8#(]Q
MQ7WV,R?*<TK3NTJO7E>OS7_ /B,+FN9Y;2C97I]+K3Y/_@G[8>&_%FB>,=/6
M_P!"U>QUFR;I/8W"3)]"5)P?:M:OPST#Q+J_A74$O]%U2\TB]3[MQ8SO#(/^
M!*0:^AOA[_P4"^)_@[RH-7FL_%MDO!74HMDX'M+'@D^[AJ^0Q?!F(IWEA:BD
MNST?^7Y'U6%XMH3TQ,'%]UJO\_S/U&HKY4^'O_!13X=^*/*@\16FH>$;ML O
M,GVJV!/821C=^)0#WKZ/\)^.?#OCJQ%[X=US3];M>\EC<)*%]FVGY3['FOB\
M5EV+P3MB*;CY]/OV/KL-C\+C%>A44OS^[<W****\X[PHHHH ^3/B=_RD1^%/
M_8OS?^@:A7UG7R9\3O\ E(C\*?\ L7YO_0-0KZSKW\U_AX7_ *]K_P!*D>)E
MOQXG_KX__28A1117@'MA1110 4454U35K'1+1KK4;VWL+5?O374JQH/JS$"F
MDV[(3:2NRW17B_B[]L7X0^#=Z7'C*TU&=>!#I*M>%CZ!HP4'XL*\2\7_ /!3
M7P_:>9'X8\'ZAJ3=%FU.X2U7Z[4\PD?B/PKVL/DN8XK^'1=O/1?C8\BOG& P
M_P#$K+Y:_E<]A_;@_P"37?&_^[9_^ED%=K^S[_R0?X=?]B[I_P#Z3QU^<'QD
M_;6\>?&;PS?^&[ZVTG2]!O=GG6UE;L7<(ZR*#([,?O*I^7'2KO@']O+XE_#_
M ,/Z5HEO'HNHZ;IMM'9V\=[9MN6*-0JC=&ZDD #DU]>^&<>\NCA].93<M^CB
MEVWT/EEQ%@ECW7UY>11VZIM_J?JC17Y_:)_P4\U>':-7\!V5W_>:QU!X/Q 9
M'_G7H&B?\%,/ MUM&J^&->T]CU-OY-PH_$NA_2OFZG#>:TMZ-_1I_J>_3X@R
MVIM5MZIK]#[!HKY]T3]O#X-:QM$OB.XTN1NB7VGSC_QY%91^==_HG[0_PQ\1
M;18^/?#\CMTCDU".)S_P%R#^E>54R[&T?XE&2_[=9Z=/'X2M_#JQ?S1Z'157
M3]4LM6A\ZQNX+R'_ )Z6\JR+^8-6J\]IIV9W)IZH****0PKY,_8^_P"2_?M'
M_P#8P+_Z4WM?6=?)G['W_)?OVC_^Q@7_ -*;VO>P/^XXS_#'_P!+B>)C?]\P
MGK+_ -(9]9T445X)[84444 %%%% !1110 5\F?MG?\EF_9T_[&0_^E-E7UG7
MR9^V=_R6;]G3_L9#_P"E-E7OY%_O\/2?_I$CQ,Y_W*7K#_TN)]9T50US7M-\
M,Z7<:EJ]_;:9I]NN^6ZNY5CC0>I8G KX[^-G_!1C2=%^T:7\.;$:U>#*'6+Y
M&2V0\C,<?#2?4[1[,*X\#EN*S&?+AH7\^B]6=6,S##8"/-B)V\NK]$?7/B[Q
MIH7@+19=6\1:M:Z-IT7WKB[E"*3V4=V8]@,DU\4_&O\ X*.D^?IGPST_:.5_
MMW4XN?K%"?YR?]\U\<?$#XF>*/BEK;:MXIUJZUB\.=AG;Y(@>2L:#"HOLH K
M2^%OP5\9?&35/L7A719[]4;;->,/+MH/]^4_*#CG'4]@:_3<#PO@\!#V^824
MFN^D5_G\_N/SO&<28O'2]A@8N*?;63_R^7WG/^+/&.N>.M:FU?Q#JMUK&I2_
M>N+R4NV.RC/11V P!VKM/@_^SGXZ^-UXJ^'=(9=-#;9=7O,Q6D?.#\^/F(_N
MH&/M7VW\%/\ @GKX4\%^1J7C>=?%VKKAOL:@I81'TVGYI?\ @6!_LU]86=G;
MZ=:Q6MI!':VT*A(X84"(BCH HX ^E89AQ=1H1]CET;VZO1+T77\/F;8'A>M6
M?M<?*U^F[?J_^'/FSX)_L'^!OAG]GU'Q H\8Z\F&\R\C M(6X/R0\AL'NY/J
M *^EXXUC1410B*,!5& !Z"G45^9XO&XC'3]IB)N3_K9;(_0\+@Z&#A[.A!17
M];]PKA_CI_R1+X@_]B]J'_I-)7<5P_QT_P"2)?$'_L7M0_\ 2:2HPO\ O%/U
M7YFF)_@3]'^1YW^PK_R:[X/_ -Z]_P#2R:O%/VZ/V46O/MWQ,\(VNZ909=;T
MZ%?O@=;I ._]\=_O?WL^U_L*_P#)KO@__>O?_2R:O>F59%964,K#!4C((]*]
M^IF%;+,XKUZ/\\KKNN9Z'AT\#2S'*J-"K_)&S[.RU/PW\+^)M3\&>(=/US1K
MN2PU2QF6>WN(S@JP_F",@@\$$@\&OUL_9K_:&TG]H'P4M]#Y=GX@LE6/5--#
M<Q.1Q(G<QM@D'MR#R*^+?VUOV4_^%4ZI)XS\+VQ_X1&_F_TBUC'&G3,>GM$Q
M/R_W3\O]W/@OPB^+&N?!?QQ8^)M!E N(#LFMW)\NYA.-\3CT./P(!'(%?HF/
MP>&XFP,<1AW[ZV?GUB_Z\]M_@L#B\1P]C'0KKW'O^DE_7EN?M517%_"+XL:'
M\:/ ]CXFT&4FWG&R:W<CS+:88WQ./49_$$$<$5VE?BU2G.C-TZBM):-'Z[3J
M0JP52#NGLPHHHK,T"BBOE?6/^"<WPVUK5KW4)];\5)-=SO<.L=W;!0SL6(&;
M<\9/K7=A:6&J-_6:KAVM'FO^*L<6)J8BFE]7IJ?>\N6WX,^J**_-SX#_ +(?
M@[XH?%#XL^&]5U+7+>Q\)ZF+*QDLYX5ED0RW"9E+1,"<0K]T+R3QZ?5'P;_8
MQ\$_!#QK%XGT+5-?N[^."2W$>H7$#Q;7&"<)"ISQZUZN.R[!8-RI_6&YI)I<
MF]TFM>;S/-P>/Q>+49^P2BVU?GVL[/3E\CWNBBBOG#WPHHHH **** "BBN=\
M3_$;PGX)N((/$7B?1M FG4O%'JFH16S2*#@E0[#(SW%7"$JCY8*[\B)3C!<T
MG9'145P?_"_/AC_T4;PE_P"#RU_^.4?\+\^&/_11O"7_ (/+7_XY6_U7$?\
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M-=^-XEP.60^KX"*DUVTBOGU^7WG#@^'\9F,_;XV3BGWUD_\ +Y_<?G+^R_\
MLCZ?\6/&WCK1?&&H7FG2>$KF.TN+;3&3,LI>9''F,& 4&$C@<[NHQ7VUX+_9
M!^$G@?RWM/!UGJ%RO/VC5BUXQ/KMD)4'Z**\P_8\_P"2^?M(?]C"O_I3?5]9
MU\AGV:8V6+E255J-HZ)V6L4WMYOJ?59)EN$CA8U'33E>6K5WI)I?@B"SLK?3
MK:.VM+>*UMXQA(84"(H] !P*GHHKXW?5GUNP4444@"BBB@ HHHH ^3/VS/\
MDM7[.7_8R'_TIL:^LZ^3/VS/^2U?LY?]C(?_ $IL:^LZ]['?[A@_2?\ Z6SQ
M,'_ON+]8_P#I""BBBO!/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *^3/ '_*1KXE?]BW#_Z+T^OK.ODSP!_RD:^)7_8MP_\ HO3Z]_*O@Q7_
M %Z?_I43Q,S^/#?]?%_Z3(^LZ***\ ]L**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^3/^";/_ "1;Q'_V,D__ *36U?4FM^']+\3:>]CJ
M^FVFJV,GW[:]@6:-OJK @U\M_P#!-G_DBWB/_L9)_P#TFMJ^LZ^@SR3CFE9K
M>YX>2I2RVBGV/FWXA?L!_"WQIYLVF6EUX3OFY$FERYA+>\3[E ]DVU\Q_$+_
M ()S_$#PUYL_AJ^T_P 6VJY*QJWV2Y(_W'.S\G_"OTNHK;"<1YE@[)5.9=I:
M_CO^)CBL@R_%:NGROO'3\-OP/Q \7> /$O@&^^R>)-!U#1+C.%6^MVC#^ZDC
M##W!-9ND:UJ'A^^CO=+O[G3;V/[EQ9S-%(OT92"*_<;5-)L=<L9+/4;.WU"S
MD&'M[J)9(V^JL"#7@7Q"_81^%7CGS9K32YO"U\W/G:++Y<>?>)@R >RA?K7V
MF%XRH5%R8RDX^:U7W;_F?(XGA.O3?-A:E_)Z/[_^&/C;X>_MZ?%3P3Y4-_J%
MOXKL5X,6KQ;I<>TJ;6)]V+5]-_#W_@H[X$\1>5!XITS4/"ERV TRC[7;#WW(
M X_[X/UKQ+XA?\$W?'&@^;/X4U?3_%-L,E;>;_0[D^@ 8F,_4N/I7S7XU^&/
MBWX<W7V?Q-X=U'1')PK7=NRQO_N/C:W_  $FO0> R'.E>C92?\KY7_X#_FCA
M^O9WE.E:_*OYM5]__!/V4\&_$;PO\0[/[5X:\0:?K<(&YOL=PKLG^\H.Y3[$
M"NCK\*M/U*[TF\BN[&ZFLKJ([HY[>0QNA]0P.17O'P]_;F^*_@/RXI]:C\3V
M*X_T?7(_.;'?]Z"),_5B/:OGL7P76C>6$J*7D]']^WY'O87BZE+3$TW'S6J^
M[?\ ,^JOB=_RD1^%/_8OS?\ H&H5]9U^7.N?MCIXB_:$\&_%&Y\+M#)H6F26
M,NF17N1.Y6Y 99"GRC]^."#C:>M=!XN_X*2^/]7WQZ#HNC^'X6Z22*]W,O\
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M\>-?&'@?0?$NC>(-#DBU;3X+]+:\::%T$L:N%RJ,"1NQGBOL3]N#_DUWQO\
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M5\,/^@+XK_\  .V_^2*/^'E7PP_Z OBO_P  [;_Y(KX,_P"%#_$O_HG?BO\
M\$ES_P#$4?\ "A_B7_T3OQ7_ ."2Y_\ B*X_]7,D_G_\G.O^W\X_E_\ )3[S
M_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\ \ [;_P"2*^#/^%#_
M !+_ .B=^*__  27/_Q%'_"A_B7_ -$[\5_^"2Y_^(H_U<R3^?\ \G#^W\X_
ME_\ )3[S_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\ \ [;_P"2
M*^#/^%#_ !+_ .B=^*__  27/_Q%'_"A_B7_ -$[\5_^"2Y_^(H_U<R3^?\
M\G#^W\X_E_\ )3[S_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\
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MJ2OQX_5@HHHH ^3/V0/^3@/VCO\ L/K_ .E-[7UG7R9^R!_R<!^T=_V'U_\
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M **** "BBB@#Y,_X)M_\D=\3_P#8R3?^D]O7UG7R9_P3;_Y([XG_ .QDF_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFP\U+\_NW+U>%?MQ?\FM^-OI9_\ I;!7NM>%?MQ?\FM^-OI9_P#I;!6N5?\
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M_I9!7:_L^_\ )!_AU_V+NG_^D\=<5^W!_P FN^-_]VS_ /2R"NU_9]_Y(/\
M#K_L7=/_ /2>.O>E_P B>/\ U]E_Z3$\2/\ R-9?]>U_Z5([^BBBO!/;"BBB
M@ HHHH **** "ODS]C[_ )+]^T?_ -C O_I3>U]9U\F?L??\E^_:/_[&!?\
MTIO:][ _[CC/\,?_ $N)XF-_WS">LO\ TAGUG1117@GMA1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^\,Z[?:)<YRS6<S(K^SK]UQ[,"*_:;Q-X2T3QIICZ=KVDV6LV+];>^@65/J
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M $#4*^LZ]_-?X>%_Z]K_ -*D>)EOQXG_ *^/_P!)B%%%%> >V%%%% !1110
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M7'1D<?Q*PR"/0U^NOP%^-VC?'CP';:]IK+!>)B+4-/WY>TGQRI]5/56[CW!
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M?WD?[NYM')$5U"2-T3^QQP>Q (Z5^L9A@L/Q+@HXG#/WUL_SB_ZTWVW_ #+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3]0**9#-'<0QRQ.LL4BADD0@JRD9!!'44^OQX_50HHHH ^3/^";?_)'?$_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \LT#_DX/Q+_ -@Y/_0;>O4Z\LT#_DX/Q+_V#D_]
M!MZ]3KX[AG^%B_\ K_6_]+9[V;_'1_Z]T_\ TE!1117V)X(4444 %%%% !11
M10 4444 %%%% !1110 4444 %<Y\0/B#H/PP\+7?B'Q)J$>G:9;#EWY9V/1$
M7JS'' %<]\;/CKX8^!/A=]5U^ZW7,@(L],A(-Q=N.RCL!QECP/K@'\J_C;\>
M/%'QW\3-JFOW.RTC9A9:9"2(+1#V4=V/&6/)]A@#ZO),@K9K+VD_=I+=]_)?
MY[+\#YC.,\I9;'DA[U1].WF_\NIV'[2O[5WB#X_:B;*,2:/X1MY-UMI:M\TI
M'22<C[S>@^ZO;)R3Y?\ #[X;^)/BEXBAT3PQI4^JWTA&X1KA(E_OR.?E1?<D
M5V?[/G[./B3]H'Q$;;35-AH=LX^WZQ,A,4 Z[5'\<A'11]20.:^S?^":=O%'
M\%_$<JQJ)F\0RHTFT;F5;:W*@GN 6;'^\?6OTK&X[#Y'@YT\%%-T[:=N:]F_
M/2_<_/L'@Z^<8N$\7)VG?7ORVNE]_H:7[._["?AOX8BUUOQ=Y'BCQ.H5UB=-
MUE9N#G**1^\8?WF'T4'FOJ:BBOQC&8[$8^K[7$2YG^7HNA^N87!T,%3]E0C9
M?GZ]PHHHKA.P**** "BBB@ HHHH **** "BBB@ HHHH **** "O"OVXO^36_
M&WTL_P#TM@KW6O"OVXO^36_&WTL__2V"O4RK_D88?_''_P!*1YN9?[C7_P $
MOR9V_P"S_P#\D)^'/_8N:?\ ^DT==]7 _L__ /)"?AS_ -BYI_\ Z31UWU<V
M+_WBI_B?YG3A?X%/T7Y!1117(=(4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?)GQ._Y2(_"G_L7YO_0-0KZSKY,^)W_*
M1'X4_P#8OS?^@:A7UG7OYK_#PO\ U[7_ *5(\3+?CQ/_ %\?_I,0HHHKP#VP
MHHHH **** "N+^)WQD\'_!NQLKWQAJ_]D6UY*T,#_9II][@9(Q$C$<>M=I6+
MXG\$^'?&UO!!XBT#2]?A@8O%'JEG'<K&Q&"5#J<''<5O1]E[1>W3<>MK7^5[
MHQK>UY'[%KFZ7V_"Q\E?M4?M7?"SXD? 7Q3X<\.^*?[1UF]%L+>V_L^ZBW[+
MF)V^9XE4856/)[5U'P=_;'^#_A7X2^"]%U3Q?]EU+3M&L[2Z@_LR\?RY4A17
M7<L)!P01D$BO:_\ A0?PQ_Z)SX2_\$=K_P#&Z/\ A0?PQ_Z)SX2_\$=K_P#&
MZ^C>,RIX987DJ<JDY?%&]VDOY=M#P/JN9K$/$\]/F:Y=I6LFW_-YG2^$_%>E
M>./#=AKVB77VW2;^/SK:X\MX]Z$XSM<!AT[@5KU4TG2+#0=-M]/TRRM].L+=
M=D-K:1+%%&OHJ*  /8"K=?,3Y>9\FW2^]CZ*'-RKGWZV"BBBH+"BBB@ HHJI
MJ^I1:+I-[J$ZNT-I \[K& 6*JI8@9(YP/6FDV[(3=E=ENODS]C[_ )+]^T?_
M -C O_I3>T?\/+/AC_T O%O_ (!VO_R37A_P'_:\\'?"[XG_ !9\1ZKINN7%
MCXMU07MC'9P0M+&@FN'Q*&E4 XF7[I89!YZ9^VP>3YA3PF*A*BTY*-O.TD_R
M/C\5FV!GBL-.-5-1<K^5XM?F?I'17C7P*_:H\)_M!:MJFG^'=/UFRFT^!9Y6
MU2"*-65FV@+LE?G/J!7LM?(XC#U<+4=*O'EDNC/J:&(I8F"JT97B^H4445S'
M0%%%% !1110 5\F?MG?\EF_9T_[&0_\ I395W'QD\8?M Z+XUEMOASX&T#7_
M  T((V2\U"=$E,A'SK@W4? ./X?Q->"?$[PK^T_\5O$W@O7=6^&^AV]WX3O?
MM]BEE?6ZQR2;XGQ*&O&)7,*_=*G!//3'U^3X-4:\,34K4U&TMYQOK%I75^[/
MELVQ3JT9X>%*;=X[0=M))O7Y'WM17ROH_P 0OVL)M6LH]0^&/A6"P:=%N)8[
MF,LD98;V'^G'D#/8_2OJBOGL5A)81I.<97_EDI??8]S#8I8I-J$HV_FBU]UP
MHHHKA.T**** "BBB@ HHHH **** "BBB@ HHHH **** "N(^,7PBT+XV>![S
MPWKT7[J3]Y;W48'FVLP!VRH?49Y'0@D'K7;T5K2JSHS52F[26J9G4IPK0=.H
MKI[H_(+0?V6?&OC3QAXY\/\ A:&VUNY\)7QL;HF=+<RGS)45D$A Y\EC@MQD
M5A^*/V=?B;X.WG5? VMPQ)]Z:&T:>(?5X]R_K7W-^R!_R<!^T=_V'U_]*;VO
MK.OTW&<4XK XET7",HI1?5/6*;\MWV/SK"<-X;&8=55-Q=Y+HUI)I?EW/PDF
MADMY6CE1HI%.&1P00?0BGVMW/8W"3VTTEO,ARLD3%67Z$5^WWB+P3X=\71&/
M7=!TS68\8VZA9QSC'_ @:\E\4?L3?!WQ1O=O"::7.W_+72[F6#'T0-L_\=KK
MH\:8:>E>DUZ6?^1S5N$<1'6C53];K_,_.+PQ^TS\5/!^P:;X[UD1I]V*[N#=
M1K[!)=R@>V*]<\+_ /!1KXG:/L35;31=?C_B::V:&4_0QL%'_?->R^*/^"97
MA>\WMX>\8:KI9/*IJ%O'=J/;Y?+./S_&O(_$_P#P3=^(VE;WT?5=#UV(=$$S
MV\I_X"Z[?_'ZZ_K_  [C_P"(HI^<;/[[?J<OU+/L#_#<FO)W7W7_ $/4_"__
M  4XT*XV+XB\%:A8GHTFF727(^H5Q'CZ9->N^%_VYO@[XFVJWB631YVZ1:I9
MRQ8^K@,@_P"^J_//Q1^RM\6O".\W_@35I$3K)81B\7'KF$MQ7F6H:;=Z3=-;
M7UK-9W"_>AN(S&X^H(S4OAK)L8KX:5O\,K_G<:XAS;".V(C?_%&WY6/VS\-?
M$7PKXS56T'Q)I.L[AD"PO8YC^(5B1715^$2L48,I*L#D$<$5W?A?X\?$7P;M
M&C^-=<LXEZ0?;7>+_OVQ*_I7D5^"9;T*_P!Z_5/]#U:/&$=JU'[G^C_S/N_]
ML_\ Y+)^SK_V,A_]*+*OK.OQT\7_ +3/C_Q]JWA+4_$&JPZE?^%[O[;IT[6D
M<9$FZ-OG"*H89B3J/7UJ'QM^TO\ $_XA>8NL^,]3>W?[UK:2?982/0I$%!'U
M!K2KPKBJ]##T)3BN123>KWDWIHNGH13XEPU&O7K1A)\[C9:+:*6NO^9^K_C3
MXR^!OAVK_P#"1^*]*TJ5>MO-<J9S](AES^ KP'QM_P %'OAWH.^/P_I^J^*)
MQ]V18Q:0-_P*3YQ_WQ7YI,Q9BS$DDY)-=-X/^&'B[X@2A/#?AK5-:YP9+.U=
MXU_WG VK^)%=U'A' 8://BJCE;SY5_G^)Q5N*<=B'R8:"C_Y,_\ +\#Z(\;?
M\%'/B-KV^/P_8:5X7@/W9$B-U.O_  *3Y#_WQ7@/C3XQ^./B(S_\)'XJU75H
MFZV\URWDCZ1 A!^ KW+P3_P3O^)WB3RY=9?3/"UNW++=W'GS8]DBW+GV+"O?
MO!/_  39\#:/Y<OB77-5\1SK]Z*';9P-]0-S_DXKH_M'A_*OX*BVOY5S/_P+
M_@F'U#/,S_C<R3_F=E]W_ /S>KT'P3^S]\1OB)Y;:!X.U6\@DQMNI(#! ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZM:FXQE)V?XG5E^.PV)IQIT9IR25T=%1117B'L!1110 4444 %%%% !1110
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M$KZY^(?A&Q T*Y??JMC;KQ9RD_ZY5'2-B>1_"Q]#\OZAPQGBDEEV+>FT6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/^$KU#_H W7_ (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4
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M_P )7J'_ $ ;K_Q[_P"(H_X2O4/^@#=?^/?_ !% '345S/\ PE>H?] &Z_\
M'O\ XBC_ (2O4/\ H W7_CW_ ,10!TU%<S_PE>H?] &Z_P#'O_B*/^$KU#_H
M W7_ (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4 =-17,_\
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M7J'_ $ ;K_Q[_P"(H_X2O4/^@#=?^/?_ !% '345S/\ PE>H?] &Z_\ 'O\
MXBC_ (2O4/\ H W7_CW_ ,10!TU%<S_PE>H?] &Z_P#'O_B*/^$KU#_H W7_
M (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4 =-17,_\ "5ZA
M_P! &Z_\>_\ B*/^$KU#_H W7_CW_P 10!TU%<S_ ,)7J'_0!NO_ ![_ .(H
M_P"$KU#_ * -U_X]_P#$4 =-17,_\)7J'_0!NO\ Q[_XBC_A*]0_Z -U_P"/
M?_$4 =-17,_\)7J'_0!NO_'O_B*/^$KU#_H W7_CW_Q% '345S/_  E>H?\
M0!NO_'O_ (BC_A*]0_Z -U_X]_\ $4 =-17,_P#"5ZA_T ;K_P >_P#B*/\
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M0_Z -U_X]_\ $4 =-17,_P#"5ZA_T ;K_P >_P#B*/\ A*]0_P"@#=?^/?\
MQ% '345S/_"5ZA_T ;K_ ,>_^(H_X2O4/^@#=?\ CW_Q% '345S/_"5ZA_T
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M?_$4?\)7J'_0!NO_ ![_ .(K])2459'RC;>K.FHKF?\ A*]0_P"@#=?^/?\
MQ%'_  E>H?\ 0!NO_'O_ (BF(Z:BN9_X2O4/^@#=?^/?_$4?\)7J'_0!NO\
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M]B>"%%%% !1110 4444 ?)O_  4J_P"2$Z)_V,=O_P"DUS7UA'_JU^E?)_\
MP4J_Y(3HG_8QV_\ Z37->T?&SX]^%_@/X7_M+7KGS+V5"++2X6'GW;@=%'90
M<9<\#W. ?I:E&IB,OPE*E&\G*I9+_MT^>IUJ=#'8JI5=HJ,-?_ CI?B%\1-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y,_9 _Y. _:._[#Z_^E-[7
MUG7R9^R!_P G ?M'?]A]?_2F]KZSKWL\_P!^?^&'_I$3Q,F_W-?XI_\ I<@H
MHHKP3VPHHHH **** "BBB@#R3XU?\C=X!_Z_'_\ 1D%>MUY)\:O^1N\ _P#7
MX_\ Z,@KUNOD,I_Y&^9_XJ?_ *:B>YC?]QPGI+_TMA1117UYX84444 %%%%
M!116?KVI3Z1H]W>6UE)J,\*;DM8L[I#Z# )_0UG5J1HTY5)[13;ZZ+R6OW%P
MBZDE".[.7^.?_)$_B#_V+VH?^DTE>=_L*_\ )KO@_P#W[W_TLFJS\0O'^O\
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MOV? 8O YHEBZ*3DE9WW76S^:NOP/R7&X7&9:WA:K:BW=6V?2Z^3U_$W?AWX
MUGXH>,M,\-:#;&YU&^E"+_=C7JTCGLJC))]!7[!_!OX2Z-\%? .G^&-&7='
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M)<?$/5I9KN]T/57M;*QP!"LJ1QNL['J6!DX'0$ \]OT$KY,_X)M_\D=\3_\
M8R3?^D]O7UG7T'$5>I6S*JJDKJ+LO)'A9#1ITLOIN"LY:OS84445\T?0A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR<DJK!22202<U.&FHTZE/N[I_-W7WO\ !?+3$1<I4ZC[;?<D_P /S/Z)  H
M P!T%+7XFK_P6@^.BJ ="\#,?4Z;=<_^35+_ ,/HOCG_ - 'P+_X+;O_ .2J
MHS/VQHKD?A#XLO/'GPI\&^)=12&._P!8T:SU"X2W4K&LDL*.P4$DA<L< D\=
MZZZKJ0=.;A+=:$0DJD5-;,****@L***S/$?B;1_!^CSZMKVK6.B:7!M\V^U*
MY2W@CW$*NYW(49) &3U(H TZ*SO#_B+2?%FD6^JZ'J=GK.EW )AOM/N$G@E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZO82#9M$<D:A2JE"0&4@%B>N"/L33+-]/TVUM9+J>^>")8FNKHJ99BH WOM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !117GGQ._:!\ _!N^LK/QAKW]D7-[&
MTT"?8[B?>@."<Q1L!SZUM2HU:\_9THN4NR5W^!E5JTZ,>>K)17=NR,?XU?\
M(W> ?^OQ_P#T9!7K=?+?C3]HSX>?$;5M#U7P]XA_M"P\/2-=:G-]BN(OL\9:
M-@V'C4MQ%(<*"?E]QGK/^&YO@C_T.W_E)OO_ (Q7S649=C99SFD(T9-J5*ZY
M7I^ZB]=-#T\=C\)'+\'*5:*34[>\M??>VI[Q15?3[Z#5+&VO+5_-MKB-9HGP
M1N1@"#@\C@CK5BOH'=:,X+WU04444AA1110 4444 8OC;_D3=>_Z\+C_ -%M
M7/\ P3_Y)II/UF_]'/70>-O^1-U[_KPN/_1;5S_P3_Y)II/UF_\ 1SU\?4_Y
M*6E_UXG_ .G('O1_Y%$_^OD?_29'=4445]@>"%%%% !1110 4444 %?)G@/_
M )2-?$;_ +%N+_T785]9U\F> _\ E(U\1O\ L6XO_1=A7OY5\&*_Z]/_ -*B
M>)F?Q8;_ *^+\I'UG1117@'MA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'R9_P3;_ .2.^)_^QDF_])[>OK.ODS_@FW_R1WQ/_P!C)-_Z
M3V]?6=>]GW_(SK^OZ'B9+_R+J/H%%%%>">V%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0@KM[$RE&G%SD[)&=\6OBQH/P9\%7GB3Q!/LMX1MAMXR/-N92#MBC'=CCZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU'WG48SGGZU]"+^W)\$0H!\;=O\ H%7W_P 8KO?^%!_#'_HG/A+_ ,$=K_\
M&Z/^%!_#'_HG/A+_ ,$=K_\ &Z^AJ8S*JE"GAW"I:#;7O1O[UKW]WR/"AA<S
MIUIUU.G>=D])6TO;[7F=II]]!JEC;7EJ_FVUQ&LT3X(W(P!!P>1P1UJQ4=O;
MQ6MO'!!&D,,:A$CC4*JJ!@  = !VJ2OEG:^A](KVU"BBBD,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRM]N7?\ PKITW?I^PY#EM/)\++'8O235W_=7;U?7Y(YBO</V>_&7$_ARY?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKRS0?^3@_$?_ &#D_P#08*]3KRS0?^3@_$?_ &#D_P#08*^/XB_BY?\ ]?X_
M^D3/>ROX,5_U[?\ Z5$]3HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'0?[/7_/CXB_\&[?_$T?\.@_V>O^?'Q%_P"#=O\ XFO$_P#@I5^W-\1?@/\
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M&O\ P4F_:L^,5K)=>"O@AH_B2RC8H][8Z5?M;AAC*^;]HV;N1\N<^U-^)?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\?\ TB9[F5_!B?\ KV__ $J)ZY1117UYX84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\F?\$V_P#DCOB?_L9)O_2>WKZSKY,_X)M_\D=\
M3_\ 8R3?^D]O7UG7O9]_R,Z_K^AXF2_\BZCZ!1117@GMA1110 4444 %%%%
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MJ5%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,7":OR*G;R^+F_0]+-H8+"U:F%HTFI1=N;FO^%OU"BBBONSYL**** "BBB@
MKDM4^*WA;1=0GL;W5/)NH&V21_9Y6VGTR%(KK:R+KPCH5]<27%SHNG7$\AR\
MLMI&S,?4DC)KR\P6/E37]GR@I7UYU)JWERM:G9A7AE)_6E)K^ZTG?YIG/?\
M"ZO!G_09_P#)6;_XBK>E_%;PMK6H06-EJGG74[;(X_L\J[CZ9*@5P_B#PWI,
M/QO\.6$>EV4=C+9,\ELMN@B=L3<E<8)X'Y"O3K7PCH5C<1W%MHNG6\\9RDL5
MI&K*?4$#(KY++,;Q!CJU6,Y45&E4Y)6C.[LHMM>_II+2_4]S&8?+,/3@XJI>
M<>9:QTU:U]WR->BBBOT$^7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_)L\K#/$N+^LJ*?]UM_FD%%%%<9UA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?)G_!-O\ Y([XG_[&2;_TGMZ^LZ^3/^";?_)'?$__ &,DW_I/
M;U]9U[V??\C.OZ_H>)DO_(NH^@4445X)[84444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBON#YT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O+-!_Y.#\1_]@Y/_08*]3KRS0?^3@_$?_8.3_T&"OC^
M(OXN7_\ 7^/_ *1,][*_@Q7_ %[?_I43U.BBBOL#P0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#RS]G?_ )$[4/\ L(O_ .BXZ]3KRS]G
M?_D3M0_["+_^BXZ]3KX[@_\ Y$.$_P /ZL]W/?\ D95O4****^Q/""BBB@ H
MHHH **** /*_$G_)?_"__7@_\IZ]4KROQ)_R7_PO_P!>#_RGKU2OC^'OXV8_
M]?Y?^D4SWLT_AX7_ *]K_P!*D%%%%?8'@A1110 4444 %%%% !1110 4444
M%%%% !1110 445%=6ZWEK- Y(25&1BO7!&.*4KI-I:C5KZDM%>6?\,Z>&_\
MG]U7_O[%_P#&ZXOP/\*-(\3>)?%.GW5Q>QPZ5<^3"T+H&9=\@^;*')P@Z =Z
M^ KY]G.'KT</4P$>:JVH_ONJBY._[OLCZ:GEN JTZE6.)=H6;_=]W;^;NSZ'
MHKD/!/PQTOP'=7,^GW%Y,]P@1A<NC  '/&U177U]E@ZF)K45/%TU3GUBI<WX
MV7Y'@8B%*G4<:,^:/>UOPNPHHHKN.<**** "BBB@ KRSXP?\CA\/_P#L(_\
MM2&O4Z\L^,'_ ".'P_\ ^PC_ .U(:^/XM_Y$]3_%3_\ 3L#WLC_W^/I/_P!(
MD>IT445]@>"%%%% !1110 4444 8OB[PG:>--';3;V2:*!G5RUNP#9'3J"/T
MKS7Q%\!?#^D^']3OH;S4FFM;66=%DEC*EE0L <1],BO9*Q?&W_(F:_\ ]@^X
M_P#1;5\GG>19;CZ=3%8J@I5%%V;WT3:/;R_,<7AIPHT:C47):>MCR+X=_!C1
M/%WA"QU6\NM0CN)S)N6"1 @VR,HP"A/0#O7KOA'PG:>"]'73;*2:6!79PUPP
M+9/7H /TK ^"?_),](^LW_HYZ[FN#A7)LOPN7X7&T**C5E3A>75WBF_O9TYU
MF&*K8JMAZE1N"G*R]&[!1117W9\V%%%% !1110 4444 >6?"?_D?/B%_U_#_
M -&35ZG7EGPG_P"1\^(7_7\/_1DU>IU\=PE_R*8_XZO_ *=F>[G?^^O_  P_
M](B%%%%?8GA!1110 4444 %%%% 'EGQ@_P"1N^'_ /V$?_:D->IUY9\8/^1N
M^'__ &$?_:D->IU\=E/_ ".,S_Q4_P#TU$]['?[A@_2?_I;"BBBOL3P0HHHH
M **** "BBB@#%\;?\B;KW_7A<?\ HMJY_P""?_)--)^LW_HYZZ#QM_R)NO?]
M>%Q_Z+:N?^"?_)--)^LW_HYZ^/J?\E+2_P"O$_\ TY ]Z/\ R*)_]?(_^DR.
MZHHHK[ \$**** "BBB@ HHHH *\LT/\ Y.#\0_\ 8.7_ -!@KU.O+-#_ .3@
M_$/_ &#E_P#08*^.XB_B9?\ ]?X_^D3/>ROX,5_U[?\ Z5$]3HHHK[$\$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".XN(K6WDGGD2&&-2[R2,
M%55 R22>@ [UP_\ POSX8_\ 11O"7_@\M?\ XY7::A8P:I8W-G=)YMM<1M#*
MF2-R,"",CD<$]*\/_P"&&?@C_P!"3_Y5K[_X_7H858)I_6W)=N5)_?=HX<2\
M6FOJRB^_,VONLF>/?L ?$[P=X-^%7B*T\0>+-#T*[EU^::.#4M2AMW>,P0 .
M%=@2N01GIP:^M_#'Q&\)^-KB>#P[XGT;7YH%#RQZ7J$5RT:DX!8(QP,]S7E/
M_##/P1_Z$G_RK7W_ ,?KM?AC^S]X!^#=]>WG@_0?[(N;V-89W^V7$^] <@8E
MD8#GTKU<TQ&78RI4Q-)SYY:V:C;[^9L\S+J&/PE.GAZBAR1ZIRO^5CT.BBBO
MFCZ$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS?\
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MPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\
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MX3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!._P">5S_WPO\
M\51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\ /*Y_
M[X7_ .*H Y+X2_\ (\_$/_K_ !_Z,FKU.O%/AGXHM--\8>-YY4F*75Z'0*H)
M \R4\\^XKT7_ (3_ $[_ )Y7/_?"_P#Q5?'<)?\ (HA_CJ_^G9GNYW_OTO\
M##_TB)TU%<S_ ,)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%5]B>$=-17,_P#"
M?Z=_SRN?^^%_^*H_X3_3O^>5S_WPO_Q5 '345S/_  G^G?\ /*Y_[X7_ .*H
M_P"$_P!._P">5S_WPO\ \50!TU%<S_PG^G?\\KG_ +X7_P"*H_X3_3O^>5S_
M -\+_P#%4 =-17,_\)_IW_/*Y_[X7_XJC_A/]._YY7/_ 'PO_P 50!TU%<S_
M ,)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%4 =-17,_\ "?Z=_P \KG_OA?\
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M7/\ WPO_ ,57Z'&49Q4HNZ9\LTXNS6ITU%<S_P )_IW_ #RN?^^%_P#BJ/\
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MYXAMU/SRMZ >GJ>@KF?%?QHTKP[9N(H9I[]E_=0, !GU8@\#^=?._B#Q%?\
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M_GE<_P#?"_\ Q5'_  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\
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M_A/]._YY7/\ WPO_ ,51_P )_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\
M?"__ !5'_"?Z=_SRN?\ OA?_ (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*
MY_[X7_XJ@#IJ*YG_ (3_ $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN
M9_X3_3O^>5S_ -\+_P#%4?\ "?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_
M 'PO_P 51_PG^G?\\KG_ +X7_P"*H Z:BH+&\34+2*XC#!)!N 8<U/0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'+[*G?1W^%7MK]USJ-H]*-H]*6BO<.,3:/2O$/VA/!F/(\1VT?I!=[1^"/\
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MC8-T_P"5[6[PE_2[JYQ8K+LNXBI?6,/*T^ZW])+^GV=C[9VCTHVCTKPWX?\
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MU3^0-9EQ^TG=MGR-"AC_ .NEP7_DHKR:O'O#M+_F)OZ1F_\ VVQVPX:S6?\
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MH]*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGWMKZA11161H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2T45^EQ322;N?)/?0****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOMZ=GU7G='Y!FF6U<KQ#HU-5T?=?UN%%%%?3'D!1110 4444 %%%% !1110
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MI^#?BMKG@W9#%-]LL!_RZ7!)4#_9/5?PX]J]X\&_%G0_&.R%)OL.H-Q]DN"
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M4OC/+K#3:5H,K0Z?RDMVO#S>H7T7]3].N)\3/BQ=^-)WL[,O::,IXCSAIO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,D1^8'&/>I/VO/V<- _8%_:2\&Z[8:+;>.?A[JFZ\BT+Q&HG5@C!;BV<XPV
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MUZ/H_-!1117O'FA1110 4444 %%%% !1110 4444 %%%% !1110 5Y3\5OC
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M6Q-;$.]:;D_-MA1117<<X5Y9\8/^1P^'_P#V$?\ VI#7J=>6?&#_ )'#X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?E#_ ,%KO@WJ<FL>"?B?96CSZ6EHVAZC/&N1 XD:2 MZ!O,E&?50.XKT
MS_@E-^U1XC^.7@J_^%/B31;>XL?".CQPPZY',5>2W)\J*WDBVX+! PWAAD(
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MG1I4_A<IM>2?+I\A:***_8SX,**** "BBB@ HHHH *\L_9U_Y$V__P"PB_\
MZ+CKU.O+/V=?^1-O_P#L(O\ ^BXZ^.S#_D?9?_AK?E3/>PO_ "+,5ZT__;CU
M.BL37O&NA^&5/]I:G!;.!GRMVZ0_\ &3^E>:^(/VC+2'='HVFR7+=!-='8OU
MVC)/YBNS,N),IRFZQ>(BI+HM9?<KO[S#"93CL=K0I-KOLOO>A[+6%K_CG0?#
M(;^T=3@@D'_+$-OD_P"^1D_I7S9X@^*WB?Q%N6?4GMX&_P"6-I^Z7Z<<G\2:
MY(L6)).2>IK\HS+Q3A&\,MP]_P"]/3_R5?\ R2/M<'P;)VEBZMO*/^;_ ,CW
M;Q!^T;;Q;H]%TQYV[37AVK_WR.3^8KS3Q!\4O$WB3<MSJ<D,#?\ +"U_=)CT
M..3^)-5/#_P_\0>)]K:?I<TD+=)Y!LC_ .^FP#^%>E^'_P!G&1MLFM:H$'>"
MR7)_[[8?^RFOD?;<8\6?!S^S?;W(6]=.;[VSW.3(<E^+EYE_V]+];?@>*5T?
MA_X=^(O$VUK'2YFA;_EO*/+C^NYL9_#-?27A_P"&GAOPUM:TTN%IE_Y;W \U
M\^H+=/PQ745]1EOA8])YGB/^W8?_ "3_ /D?F>-B^,EK'"4OG+_)?YGA_A_]
MG$_+)K6J8]8+)?\ V=A_[+6#\0/AK;0>/-+\/:!$(&N+ RCSI"=[CS2<D]"0
M@'I7T=7EGB/_ ). \,?]>#_^@W%?09WPCDV!P5&A0HVYZM*+EO*TI)/5WMIV
MLCS,OSS'XC$5*E6I?EA-I=+I76BW^9\]WUC<:9>2VMW"]O<0MM>.08*FO5/A
M;\9I=%:'2M=E:;3^$BNFY>#T#>J_J/IT]0^(?PST_P =VI<A;75(UQ%=J.OH
MK^J_J.WH?F77_#]_X9U.6PU&!H+B,]^C#LRGN#ZU^99AEF;\ X]8O"RO2;TE
MT:_EFN__  \7=:?7X7&8'B;#.A65IK==5YQ?]=F?94,T=Q$DL3K+$X#*Z'(8
M'H0>XI]?,7PS^*]WX*G6SO"]WHSGYHLY:'_:3^J]_:OI+2]5M-:L8KVQN$N;
M64922,\'_ ^U?OO#?%&#XCH<U+W:B^*#W7FNZ\_OL?F6;9/7RJI:>L'M+^MG
MY%NBBBOLCP0HHHH **** "BBB@ HHHH ***:[K&K,S!549+,< #UH =7AWQ:
M^,7F>=HF@3_+RES?1GKZHA_FWY>M4/BM\9&U<S:/H4I2QY2>[4X,WJJ^B^_?
MZ=?*=/T^YU6]AM+2%[BYF;;''&,EC7\]<8\<2Q#EE632O?24UN^G+#\KK?9:
M:O\ 4<AX=5)+&X];:J+Z><O\NG4;:6D]_=16UM$\\\K!$CC&68GH *^C?A;\
M(X?",<>I:FJ7&LL,J.JV^>P]6]3^ ]3<^&'PLMO!%J+NZ"7.LR+\\O580?X4
M_J>_TKOZ][@S@>.6J.89E&];>,>D/-]Y?EZ[>;G_ !$\6WA<([4^K_F_X'Y^
MAY9\)?\ D>?B'_U_C_T9-7J$T,=Q&T<J+)&PPR.,@CW%>7_"7_D>?B'_ -?X
M_P#1DU>IU]MPFD\H@G_-5_\ 3LSY[.],<VNT/_2(GGWB3X(^&]>WR00-I-R>
M=]IPF?=#Q^6*\J\2? CQ%HNZ2R$>KVXYS;_+)CW0_P!":^EJ*X<UX'R7-;R=
M+V<WUA[OWKX7]U_,Z,%Q%F&"LE/FCVEK^._XGQ-=6LUE,T-Q#)!,IPT<JE6'
MU!K5\/\ C/6O"T@;3-1FMESDQ9W1GZJ>/TKZQUOPUI7B2#RM3L(+Q<8!D7YE
M^C=1^!KR_P 2?LZV=QNET2_>T?J+>Z^=/H&'(_'-?D>.\/,YRJI]8RJKSVVL
M^2:_&WW/Y'W&'XIP&-C[+&PY;]US1_KY?,H^&_VC&&R+7=.W=C<67\RA/\C^
M%>J>'?&^A^*E!TW489Y,9,).V0?53S7S'XD^'/B'PKN:^TZ3[.O_ "\0_O(_
MKD=/QQ7.([1LK(Q5E.0RG!!K/!\>Y]DE3ZMFE/GMTFG&?WV_%I^I=?AK+<PA
M[7!SY;_RN\?N_P FC[<HKY<\-_&?Q+X=V1O=#4[9>/*O,N<>S_>_4CVKU7PW
M\?-!U;9'J*2:1<'@F3YXL_[PY'X@5^LY5Q]DN9VA.I[*;Z3T7_@7P_>T_(^)
MQO#688.\HQYX]XZ_AO\ F1?%_P#Y''X??]A'_P!J0UZG7DGQ2O[;4O%'P\N+
M2XBNH&U#Y9(7#J?WD'<5ZW7J9/*,\VS*47=.5/\ ]-1./'IQP6$36MI_^EL*
M***^R/ "BBB@ HIC2HGWG5?J<5$VH6J?>N85^L@%0YQCNRE%O9%BBJ3:YIR?
M>O[5?K,O^-0MXFT=/O:M8K];E!_6L7BJ$=ZB^]&BHU7M%_<5_&__ ")>O_\
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M2S7VF09_++Y+#XAWI/\ \E_X'=?->?D'PE^+3^&I(](U>1GTECB*9N3;D_\
MLG\J^B8Y$FC62-E=& 964Y!!Z$&OC/7-#O?#>J3:?J$+07,1P5/0CL0>X/K7
MH?PE^+3^&I(](U>1GTECB*9N3;D_^R?RKX?@WC*IEM19/G#:BG:,GO![<LO+
ML_L[/3;Z+/LACBX_7L#JWJTOM>:\_P _7?W'QM_R)NO?]>%Q_P"BVKG_ ()_
M\DTTGZS?^CGK>\92)-X)UR2-E=&TZ=E93D$&)L$&L'X)_P#)--)^LW_HYZ_7
M:COQ+2:_Y\3_ /3D#X>/_(HG_P!?(_\ I,CNJ***^Q/!"BBB@ HHHH ****
M"O+-#_Y.#\0_]@Y?_08*]3KRS0_^3@_$/_8.7_T&"OCN(OXF7_\ 7^/_ *1,
M][*_@Q7_ %[?_I43U.BBBOL3P0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** "O+/$?_)P'AC_ *\'_P#0;BO4Z\L\1_\ )P'AC_KP?_T&XKX[B;^#A?\
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M'J2:Q%1P7=1YOU1G^)/^2_\ A?\ Z\'_ )3UZI7EG_#.GAO_ )_=5_[^Q?\
MQNK^@? [0O#NL6FI6UWJ+SVS[T662,J3[X0']:^/RJ.>8*O6=3!QY:U3G;]K
M\*:C%Z<FMN6_2^Q[V->78BG34:[O3AR_!O9M_P VF]NIZ)1117Z(?*E35-+M
MM:TZXL;R(36TZ%'1NX_QKY5^(7@.Z\!ZT;:0F:SERUM<8^^OH?\ :'?\^]?6
MM8GB[PG9>,]%ETZ]7AOFCE4?-$_9A_GD5\!Q?PO3XBPO-3TKP^%]_P"Z_)].
MSU[W^GR+.)956M/6G+=?JO/\U\CYT^%OQ&E\"ZL4G+2:3<D">,<E#VD4>H[^
MH_"OJ&UNH;ZVBN+>19H)5#I(AR&4C((KX[\3>&[SPGK-QIM\FV:(\,/NNO9E
M]C7H?P8^*!T&YCT/5)?^);,V()G/^H<]C_LD_D?J:_*N".**F3XAY+FGNPO9
M7^Q*^S\F_N?DW;[/B+)XXZE_:&#UE:[M]I=UYK\4?0U%%<UXVL?$U]:VR^&=
M1MM.G5R9FN5!#+C@#*-W^E?T3BJ[PM&5:-.4VOLQLY/TNTOQ/RNC35:HH.2C
M?J]EZVN=+17C'B<_$_PGH=UJMWXCT^2WM]NY884+G<P48!A ZD=ZLZ38_%+6
MM*L[^#Q+IJPW4*3HLD2A@K $ XA//-?(?ZU7KO#?4:_.ES6Y87LVU?\ B=TS
MW?[%_=^V^LT^6]KWEOO;X3UZBL_08=0M]'M(]5GCN=15,3S1#"LWJ.!_(5H5
M]K2FZE.,W%JZ3L]UY/S74^?G'DDXWO;JM@J&\O(-/M9;FYE2"WB4N\DAPJ@=
MR:CU35+71K&:\O9TMK:%=SR.>!_]?VKYH^)WQ2NO'%T;:VWVVC1MF.'HTI'\
M;_T':OD.)N*,+PYA^:?O59?#'OYOLO/KLCW,HR>MFM6T=(+>7Z+S+GQ0^+D_
MB^233]-9[?1E.#V>XQW;T7T7\_;AM!T&^\2ZI#I^GP-/<R'@#HH[L3V ]:L>
M%?"FH>,-62PTZ+>YY>1N$C7NS'L/YU]0>!? 6G^!=-\BU7S;J0 SW3#YY#_1
M1V%?@^3Y+F?'6/>/Q\VJ5]9?^VP7]);N[W_2L=F&#X<PRPV&C>?1?K+^M?0K
M?#WX<V/@/3\(%N-2E'[^[(Y/^ROHO\^_MU]%%?T]@L%A\NP\<+A8*,([)?UJ
M^[W9^/8C$5<55=:M*\F%>6?";_D>_B%_U_C_ -&35ZG7EGPF_P"1[^(7_7^/
M_1DU?.9O_P C;+/\=3_TU(]7 _[CC/\ #'_TM'J=%%%?8GA!1110 4444 %%
M%% !7EGQ@_Y'#X?_ /81_P#:D->IUY9\8/\ D</A_P#]A'_VI#7Q_%O_ ")Z
MG^*G_P"G8'O9'_O\?2?_ *1(]3HHHK[ \$**** "BBB@ HHHH AO+.#4+:2W
MNH8[B"08>*50RL/<&O&_B)\#=/M]/OM6T:<V0MXGGDM),LA"J6.T]0>.AR/I
M7M58OC;_ )$S7_\ L'W'_HMJ^7X@R? 9K@ZGUNDI.,6T^JLKZ-:_+8]C*\?B
M<'7C[";2;5UT?R/,/@C\-=.N-+M?$E\!=SR,WV>%E^2+:Q7<?5LCCT^M>TUP
MWP3_ .29Z1]9O_1SUW-8<)X'#X+)<-]7@H\\(REYR<4VW_6FRT-<[Q%7$9A6
M]K*_+)I>23V"BBBOKSP@HHHH **** "BBB@#RSX3_P#(^?$+_K^'_HR:O4Z\
ML^$__(^?$+_K^'_HR:O4Z^.X2_Y%,?\ '5_].S/=SO\ WU_X8?\ I$0HHHK[
M$\(**** "BBB@ HHHH \L^,'_(W?#_\ ["/_ +4AKU.O+/C!_P C=\/_ /L(
M_P#M2&O4Z^.RG_D<9G_BI_\ IJ)[V._W#!^D_P#TMA1117V)X(4444 %%%%
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M% !1110 5Y9^SK_R)M__ -A%_P#T7'7J=>6?LZ_\B;?_ /81?_T7'7QV8?\
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MO+==--OU/).(X8F*P>8;O1-[/RE_GUZ^?<_#3XJ6GCBW%K<;+36(UR\&?EE
MZLG]1U'ZUWM?$UO<RV=Q'/!(T,T;!DDC)#*1T(-?0?PM^,D7B!8M*UN18-3^
M[%<'"I<>Q]&_0]O2OH>#^/(9ARX#-)6J[1ELI>3[2_!^3W\S/>&Y86^)P:O#
MJNJ].Z_+T/5JXCXT?\DSUGZ0_P#HY*[>N(^-'_),]9^D/_HY*_2N(?\ D38S
M_KU4_P#2&?(Y7_O^'_QQ_P#2D;7@/_D2/#__ &#[?_T6M;M87@/_ )$CP_\
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M_P"11#_'5_\ 3LSW<[_WZ7^&'_I$0HHHK[$\(**** "BBB@ HHHH \L^+_\
MR./P^_["/_M2&O4Z\L^+_P#R./P^_P"PC_[4AKU.OC\I_P"1OF?^*G_Z:B>]
MCO\ <<'Z3_\ 2V%%%%?8'@A1110 4444 %%%% &)XW_Y$O7_ /L'W'_HMJP?
M@G_R3/2/K-_Z.>M[QO\ \B7K_P#V#[C_ -%M6#\$_P#DF>D?6;_T<]?'U/\
MDIJ7_7B?_IR![T?^11/_ *^1_P#29'<T445]@>"%%%% !1110 4444 <7<?&
M3P?:SR0R:OMDC8HR_9IC@@X(^Y7GND_$+P_:_&+6M<EU#;I=Q9K%%<>3(=S
M0C&W;N'W&ZCM7KDG@GP[+(SOH&EN['+,UG&22>Y^6F_\(+X;_P"A>TK_ , H
MO_B:_/L=EO$&.G2E.K17LIJ<?=GNDTK^_M9]+'U&&Q>68:,U&%3WX\KUCLVG
MI[OD5=!^)/ASQ1J L=,U'[3=%2XC\B1.!U.64"NFK,T_POHVDW N++2;&SG
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M85[V7QS2+E_:,J;6EN127K?FD_P/-Q3P;2^JJ2[\S3^ZR0ZBBBO://"BBB@
MHHHH BNKN"QMY+BYFCMX(QEY96"JH]23P*R/^$Z\-_\ 0P:5_P"!L7_Q5:.J
M:7;:UI\]C>Q>=:SKLDCW%=P],@@UR7_"E?!G_0&_\FIO_BZ\+,)9O&HO[/A3
M<;:\\I)W\N6+T/2PJP+B_K4II_W4FK?-HY+X#^)-(T?PI?0W^J65E*U^[K'<
M7"1L5\N,9 )Z9!_*O6=-UG3]9C=]/OK:^1#AFMIED"GT.TG%<G_PI7P9_P!
M;_R:F_\ BZZ#PWX1TGPC!-#I-I]DCF8.Z^8[Y(&,_,37B<.X'.<KH4<#BE2=
M*"M>,IN7EHXI;^9Z&:8C 8RI4Q%%SYY.]FHV^]-LV****^X/G0HHHH ****
M"BBB@ HHHH **** "BBB@#COB7\/[?QWHI10L>IP M;3GU_N-_LG].M?+-]8
MW&F7DUI=1-!<0L4DC<8*D=J^UZ\Q^,7PQ_X2JS.JZ;&/[6MU^:-1S<(.W^\.
MWKT]*_'./.$?[4IO,\#']]%>\E]M+_VY?BM.Q][PWGGU.:PF(?[M[/\ E?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.MA%&$JSE!*R345MMJE<****\8]8**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#RS]HK_D2++_L(1_\ HN2O4E^Z/I7EO[17_(D67_80C_\ 1<E>
MI+]T?2OCLO\ ^1_F'^"C_P"Y#W<5_P BS#?XJG_MHM%%%?8GA!1110 4444
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MB7!?]>J?_I*.O-?^1AB/\<OS84445]">6%%%% !1110 4444 %%%% !1110
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M4445F=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHDY2>^NMEV2_'=GGYYFU?,<1*$](1;27ZONPHHHK[P^:"BBB@ HHHH ****
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M[>)88(U"I'&,*H'0 5+117[I&*BE&*LD?G+;;NPHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L7QM_R)FO\
M_8/N/_1;5M5B^-O^1,U__L'W'_HMJX,P_P!SK?X9?DSIPO\ 'I^J_,P/@G_R
M3/2/K-_Z.>NYKAO@G_R3/2/K-_Z.>NYKS>'?^1+@O^O5/_TE'7FO_(PQ'^.7
MYL****^A/+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \L^,'_(
MW?#_ /["/_M2&O4Z\L^,'_(W?#__ +"/_M2&O4Z^.RG_ )'&9_XJ?_IJ)[V.
M_P!PP?I/_P!+84445]B>"%%%% !1110 4444 8OC;_D3=>_Z\+C_ -%M7/\
MP3_Y)II/UF_]'/70>-O^1-U[_KPN/_1;5S_P3_Y)II/UF_\ 1SU\?4_Y*6E_
MUXG_ .G('O1_Y%$_^OD?_29'=4445]@>"%%%% !1110 4444 %>6:'_R<'XA
M_P"P<O\ Z#!7J=>6:'_R<'XA_P"P<O\ Z#!7QW$7\3+_ /K_ !_](F>]E?P8
MK_KV_P#TJ)ZG1117V)X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!>JG_I#/3RO_?\/_CC_P"E(VO ?_(D>'_^P?;_ /HM:W:PO ?_ ")'A_\
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M_P!@Y?\ T&"OCN(OXF7_ /7^/_I$SWLK^#%?]>W_ .E1/4Z***^Q/!"BBB@
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M\)YH7_/]_P"09/\ XF@#H**Y_P#X3S0O^?[_ ,@R?_$T?\)YH7_/]_Y!D_\
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M@R?_ !-'_">:%_S_ '_D&3_XF@#H**Y__A/-"_Y_O_(,G_Q-'_">:%_S_?\
MD&3_ .)H Z"BN?\ ^$\T+_G^_P#(,G_Q-'_">:%_S_?^09/_ (F@#H**Y_\
MX3S0O^?[_P @R?\ Q-'_  GFA?\ /]_Y!D_^)H Z"BN?_P"$\T+_ )_O_(,G
M_P 31_PGFA?\_P!_Y!D_^)H Z"BN?_X3S0O^?[_R#)_\31_PGFA?\_W_ )!D
M_P#B: .@HKG_ /A/-"_Y_O\ R#)_\31_PGFA?\_W_D&3_P")H Z"BN?_ .$\
MT+_G^_\ (,G_ ,31_P )YH7_ #_?^09/_B: .@HKG_\ A/-"_P"?[_R#)_\
M$T?\)YH7_/\ ?^09/_B: .@HKG_^$\T+_G^_\@R?_$T?\)YH7_/]_P"09/\
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M>'_^P?;_ /HM:W:X?P9XTT:U\'Z'!+>;)8[&%'7RG."(P"/NUL?\)YH7_/\
M?^09/_B:[\M_W*A_@C^2.;%?[Q4]7^9T%%<__P )YH7_ #_?^09/_B:/^$\T
M+_G^_P#(,G_Q->B<IT%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_
M !- '045S_\ PGFA?\_W_D&3_P")H_X3S0O^?[_R#)_\30!T%%<__P )YH7_
M #_?^09/_B:/^$\T+_G^_P#(,G_Q- '045S_ /PGFA?\_P!_Y!D_^)H_X3S0
MO^?[_P @R?\ Q- '045S_P#PGFA?\_W_ )!D_P#B:/\ A/-"_P"?[_R#)_\
M$T =!17/_P#">:%_S_?^09/_ (FC_A/-"_Y_O_(,G_Q- '045S__  GFA?\
M/]_Y!D_^)H_X3S0O^?[_ ,@R?_$T =!17/\ _">:%_S_ '_D&3_XFC_A/-"_
MY_O_ "#)_P#$T =!17/_ /">:%_S_?\ D&3_ .)H_P"$\T+_ )_O_(,G_P 3
M0!T%%<__ ,)YH7_/]_Y!D_\ B:/^$\T+_G^_\@R?_$T =!17/_\ ">:%_P _
MW_D&3_XFC_A/-"_Y_O\ R#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G
M^_\ (,G_ ,30!T%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_ !-
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M3_XFC_A/-"_Y_O\ R#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G^_\
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M ,30!T%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_ !- '045S_\
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M_P#2V=!17/\ _">:%_S_ '_D&3_XFC_A/-"_Y_O_ "#)_P#$U]B>"=!17/\
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MD_\ B:/^$\T+_G^_\@R?_$T =!17/_\ ">:%_P _W_D&3_XFC_A/-"_Y_O\
MR#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G^_\ (,G_ ,30!T%%<_\
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M3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\
MZ!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M
M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9
M_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#
M/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^
M$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?
MA/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1
M_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH
M_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^
M@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B
M@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_
M *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_
M .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_
MPH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!M
MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?
MTO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X
M1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\
MZ!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M
M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9
M_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#
M/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^
M$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?
MA/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1
M_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH
M_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
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M*T**H1G_ /"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^_"?X5H44 9__  C^E_\
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M &?_ ,(_I?\ T#;/_OPG^%'_  C^E_\ 0-L_^_"?X5H44 9__"/Z7_T#;/\
M[\)_A1_PC^E_] VS_P"_"?X5H44 9_\ PC^E_P#0-L_^_"?X4?\ "/Z7_P!
MVS_[\)_A6A10!G_\(_I?_0-L_P#OPG^%'_"/Z7_T#;/_ +\)_A6A10!G_P#"
M/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^%:%% &?_PC^E_] VS_ ._"?X4?
M\(_I?_0-L_\ OPG^%:%% &?_ ,(_I?\ T#;/_OPG^%'_  C^E_\ 0-L_^_"?
MX5H44 9__"/Z7_T#;/\ [\)_A1_PC^E_] VS_P"_"?X5H44 9_\ PC^E_P#0
M-L_^_"?X4?\ "/Z7_P! VS_[\)_A6A10!G_\(_I?_0-L_P#OPG^%'_"/Z7_T
M#;/_ +\)_A6A10!G_P#"/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^%:%% &
M?_PC^E_] VS_ ._"?X4?\(_I?_0-L_\ OPG^%:%% &?_ ,(_I?\ T#;/_OPG
M^%'_  C^E_\ 0-L_^_"?X5H44 ,AACMXUCBC6*-1A40  ?04^BB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\;?\B;
MKW_7A<?^BVKG_@G_ ,DTTGZS?^CGKH/&W_(FZ]_UX7'_ *+:N?\ @G_R332?
MK-_Z.>OCZG_)2TO^O$__ $Y ]Z/_ "*)_P#7R/\ Z3([JBBBOL#P0HHHH **
M** "BBB@ KRS0_\ DX/Q#_V#E_\ 08*]3KRS0_\ DX/Q#_V#E_\ 08*^.XB_
MB9?_ -?X_P#I$SWLK^#%?]>W_P"E1/4Z***^Q/!"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q?&W_(FZ]_UX7'_HMJ
MY_X)_P#)--)^LW_HYZZ#QM_R)NO?]>%Q_P"BVKG_ ()_\DTTGZS?^CGKX^I_
MR4M+_KQ/_P!.0/>C_P BB?\ U\C_ .DR.ZHHHK[ \$**** "BBB@ HHHH *\
MLT/_ ).#\0_]@Y?_ $&"O4Z\LT/_ ).#\0_]@Y?_ $&"OCN(OXF7_P#7^/\
MZ1,][*_@Q7_7M_\ I43U.BBBOL3P0HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** ,7QM_R)NO?]>%Q_Z+:N?^"?\ R332
M?K-_Z.>N@\;?\B;KW_7A<?\ HMJY_P""?_)--)^LW_HYZ^/J?\E+2_Z\3_\
M3D#WH_\ (HG_ -?(_P#I,CNJ***^P/!"BBB@ HHHH **** "O+-#_P"3@_$/
M_8.7_P!!@KU.O+-#_P"3@_$/_8.7_P!!@KX[B+^)E_\ U_C_ .D3/>ROX,5_
MU[?_ *5$]3HHHK[$\$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#%\;?\B;KW_7A<?^BVKG_@G_ ,DTTGZS?^CGKH/&
MW_(FZ]_UX7'_ *+:N?\ @G_R332?K-_Z.>OCZG_)2TO^O$__ $Y ]Z/_ "*)
M_P#7R/\ Z3([JBBBOL#P0HHHH **** "BBB@ KRS0_\ DX/Q#_V#E_\ 08*]
M3KRS0_\ DX/Q#_V#E_\ 08*^.XB_B9?_ -?X_P#I$SWLK^#%?]>W_P"E1/4Z
M***^Q/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Q?&W_(FZ]_UX7'_HMJY_X)_P#)--)^LW_HYZZ#QM_R)NO?]>%Q
M_P"BVKG_ ()_\DTTGZS?^CGKX^I_R4M+_KQ/_P!.0/>C_P BB?\ U\C_ .DR
M.ZHHHK[ \$**** "BBB@ HHHH *\LT/_ ).#\0_]@Y?_ $&"O4Z\LT/_ ).#
M\0_]@Y?_ $&"OCN(OXF7_P#7^/\ Z1,][*_@Q7_7M_\ I43U.BBBOL3P0HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,
M7QM_R)NO?]>%Q_Z+:N?^"?\ R332?K-_Z.>N@\;?\B;KW_7A<?\ HMJY_P""
M?_)--)^LW_HYZ^/J?\E+2_Z\3_\ 3D#WH_\ (HG_ -?(_P#I,CNJ***^P/!"
MBBB@ HHHH **** "O+-#_P"3@_$/_8.7_P!!@KU.O+-#_P"3@_$/_8.7_P!!
M@KX[B+^)E_\ U_C_ .D3/>ROX,5_U[?_ *5$]3HHHK[$\$**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\;?\B;KW_7
MA<?^BVKG_@G_ ,DTTGZS?^CGKH/&W_(FZ]_UX7'_ *+:N?\ @G_R332?K-_Z
M.>OCZG_)2TO^O$__ $Y ]Z/_ "*)_P#7R/\ Z3([JBBBOL#P0HHHH **** "
MBBB@ KRS0_\ DX/Q#_V#E_\ 08*OZ_\ ''0O#NL7>FW-IJ+SVS[':*.,J3[9
M<']*\\TWXKZ19_%+5?$KV]Z;&ZM5@2-43S0P$8R1NQCY#W]*_+.(.(LIE7PE
M-8B-Z==.7DE&:=_1NQ]GE>58U4Z\G2=ITVEYW<6OP/H>BO.] ^..A>(M8M--
MMK344GN7V(TL<84'WPY/Z5Z)7W^7YI@\TINK@JJG%.S:[GS&*P>(P<E#$0<6
M]=0HHHKU#C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBHKJ[@L;>2XN9H[>",9>65@JJ/4D\"E*2BG*3LD-)MV1E>-O^1-U[_KP
MN/\ T6U<_P#!/_DFFD_6;_T<]6/%WC/P_=>$]:AAUW3999+*=$C2\C+,QC8
M  \DFL/X0>*M$TSX>Z9;7FL6%I<(9=T,]TB.N97(R"<C@BO@ZF.PO^L=*?M8
MV]C-7YE:_/#S/I8X>M_9,X\CO[2/1_RR/3J*IZ;K.GZS&[Z??6U\B'#-;3+(
M%/H=I.*N5]S3J0JQ4Z;33ZK4^;E&4'RR5F%%%%:$A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NU4U32[;6M/GL;V+SK6==DD>XKN'ID$&F_P!M:?\ \_\ :_\
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M_MK3_P#G_M?^_P O^-;F9=HJE_;6G_\ /_:_]_E_QH_MK3_^?^U_[_+_ (T
M7:*I?VUI_P#S_P!K_P!_E_QH_MK3_P#G_M?^_P O^- %VBJ7]M:?_P _]K_W
M^7_&C^VM/_Y_[7_O\O\ C0!=HJE_;6G_ //_ &O_ '^7_&C^VM/_ .?^U_[_
M "_XT 7:*I?VUI__ #_VO_?Y?\:/[:T__G_M?^_R_P"- %VBJ7]M:?\ \_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,>3PCI,CL[6F68Y)\Q_\:;_ ,(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
MC1_PA^D?\^G_ )%?_&MJB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :
MVJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\ QK:HH Q?^$/TC_GT_P#(
MK_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\ C1_PA^D?\^G_ )%?_&MJ
MB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_
M^-'_  A^D?\ /I_Y%?\ QK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&M
MJB@#%_X0_2/^?3_R*_\ C1_PA^D?\^G_ )%?_&MJB@#%_P"$/TC_ )]/_(K_
M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
MC1_PA^D?\^G_ )%?_&MJB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :
MVJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\ QK:HH Q?^$/TC_GT_P#(
MK_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\ C1_PA^D?\^G_ )%?_&MJ
MB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_
M^-'_  A^D?\ /I_Y%?\ QK:HH BM;:.SMTAA79$@PJY)Q^=2T44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%17-S#9V\MQ<2I!!$I>261@JHH&223P !W
MH EHI <C(Y%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445%<74-HBO/-'"K.L:M(P4%F(55&>Y)  [DT
M2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%12W4,$D,<DT<<DS%(D9@#(P4L0H[G )X[ F@"6BBB@
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ML*IV_0_BK]D_PE\/_P!C'QO\*/!6EK#:SZ#=[99 &GO+P1%EGF?'S.71.>@
M     YIO]R\0]EK%=[=7V7;S.FGI5C16[:3?:_1>?Y'JOP%\<#XE_!+P'XJW
M!GU?1+.\DP<XD>%2X_!MP_"N\KX^_P""4?CK_A,_V-?#=H\WG7.@7EWI,N3R
MH$AEC'X1S(/PK[!KTL0DJTFMGJO1ZK\#SL/_  HKMI]V@4445S'0%%%% !11
M10 5P>L?';P#X?\ BII'PWU#Q186OC75K=KJSTB1_P!Y(B]L]%9N2JD@L%;
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M[> ?$WQ0UKX=:7XHL+SQGHT"W%[I,;YDB5NP/1F7C<JDE=R[@,BNA\;:+?\
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MZ/8O>C2=,4-<3A<#('4*"06;!VJ"<'&*B<E"+E+9%1BYR48[LY;]I_\ :?\
M"/[*_P .9_$_B>?SKN3=%IFD0N!<7\^.$0=E'!9SPH]20#^>G[('Q]^*/BG_
M (*#:!KOQ5@NM*D\?^&[E='TZ;*00V)+36XAC)RJEK5L%L,V=W.X$^B_LP_L
MP^+_ -K[XCP_M#?M#0F739"LOACP?,I$ A!W1N\9Z0CJJ'F0_.V5(#ZO_!2)
M3\+_ -I;]FGXKP@6]O9:Q_9=]< 8Q")HW"GV\N2Y_6MJ<'2K4_:_%)\MOY5)
M-?.3;7IMU9G4DJE*HJ6T5>_\SBT__ ='Z[]C]$:*0'(R.12U!04444 %%%%
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MMXHXG88P&E;*YR >AQG%U8>PCHK6UV2=_P NQK&2A/VTM[WTW;5OS[_,[/\
MX(K66I0? 'QI<3+*FD7'B1C9>8#@E;>(2$=L?<''=37Z&UR/PG^%GAWX*_#W
M1?!GA2R^P:'I4/DPQDY=SDEI';^)V8EB>Y)KKJ[*TE*5X[))?<K'+3BXQUW;
M;^]W"BBBL34**** "J^H:?;:M87-C>0)<VES$T,T,@RLB,"&4CN""15BBDTI
M*SV&FT[H_-&?]BW]HK]D/XA:SJ_[,^OV.M^"]8G$TGA?6)XU,7)PKB8A&"C
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ME/VL857]J,7\[*_XW%&*ISG3723_ #NOP84445F6%%%% !7E/[4WQ'UOX/\
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MKW@F-G73IM1,1:T1FX8)/$S1D=?+5I$&3@$FO+_VP/V$_$?P_P#V:_%'Q?\
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MI^TA)QWDFU9=KM?C^(OA;X)_M^?#C0X_ VA?$'PQ>:!;JMM9:U>2Q326T(X
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M4M;1+[O^'^X****D8445YY^T!\7XO@-\'_$OCN;1;_Q FCVQG_L_3HRTDAR
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M/O'V@?"_P=JOBKQ1J<.D:#I<)GNKR?.U%'& !RS$D * 220 "37P/KW_  6
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M72K+7=,N]-U*TAO]/NXF@N+6YC$D<L; AD93P002"#ZU^<O[=7[$<OPLN/\
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M<X R<#A0  !@5Z/111*3D[L:2BK(****D84444 %%%% !1110 4444 %%%%
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M^[_1=C+64N=JW9=E^K_I>91114E!1110 4444 1Q6\4#2M'$D;2MOD*J 7;
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MX$LEU:QG9'+-M&T,<'!!^9=I8*Q(KW"BBMI2<WS/<QC%07*M@HHHJ"PHHHH
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M&.T4E]RL8QYFY3EO)M_>%%%%9EA1110 4QHT:17**74$*Q'(SUP?P'Y4^B@
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M$K_^S5T=?.W_  3[N/$+?LB_#ZR\4Z/J6A:UIMK)I\EGJEI);3".*5TA;9(
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M72O 'PXCEC;4M)\/O";G40A!Q^Z+@Y(_CDVJ<,(V(%?HU12@E!*.Z6R>J7_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR5-;6U2V6UK>=KW^7H<G^SO^R]\/?V7_  O+HO@72&M3=%6O=2NY/.O+UE&
M99,#@<X50JC)PHR:]8HHIRDY.[!1459!1114C"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE
MC_@IM\/#\0_V-?'"Q1B2[T58=:AR,[?(D!D(_P"V1EKZGK%\;>%[7QOX-UWP
M[?*'L]6L)["92,Y26-D;]&KGQ$7*E+EWW7JM5^)M1DHU(N6W7TZ_@?A#_P $
MN_'_ /P@?[9G@U'D\NUUQ+C1IN>OFQEHQ^,J1U^].O:U:^&]#U'5KZ18;*PM
MI+J>1C@+&BEF)^@!K^9SPCJE]\%OC1I&H3JT>H^%=>BEF0<$26UP"R_FA%?N
M;_P49^+$/@/]B[QGJ5G<#S?$-K%I%FRG[XNB%<@_]<?-/X5TXBI?!QJP>NJ7
MSLX_>VS"C3MBW3GMHW\M)?<DC\'?B)XRNOB)X^\2>*;W/VO6M2N-1E!.<-+(
MSD9]MV/PK[^_X(H_$G^Q_BYXW\$32$1:YI4>H0*3QYUM)@@#U*3L?^ 5XK_P
M3G_9O@_:*^('CRSOK<2V.G^$[Y(I&&1'>7"&"!OJ-TC#W2N"_8I\?R_!G]KC
MX>:M>;K1(=873+Y9/EV1SYMY-V?[OF$G_=K;#15.I"@MI1T^;<5]S2?W&6(D
MZD)UG]F6ORM+\4VOO/W:_:L\??\ "K_V;OB1XF67R9['0[K[._I.Z&.+_P ?
M=:_!G]BOX=_\+3_:J^&GA]H_-MWUB*[N%QD&&WS/(#[%8B/QK]5?^"P_CX>%
MOV48]"1\3^)=9MK0J#@F*+=.Q^FZ*,?\"KY*_P""+7P\&O?'OQ7XNECWP^'M
M&\B-B/NSW,@53_W[BF'XUA@]<5.I_+_[:N9?>W8VQ?\ NT8?S?\ MS4?PM<_
M9RBOF?\ ;P_;#M/V1?A;%?V<$&I>,M:=[;1;"<_NPRC+W$@!R8X\KP.69E&1
MDD?CAI>E_M#_ +>GB[43:/X@^(U];_OYUFNUAL;/<?E4>8R00YP<(-N<$@'!
MJ(R<Y.,%>VY<HJ$5*3M?8_HGHK^>6U\6?M%_L!^/+*PNKG7/!5V +A=(O)Q<
MZ9>Q\ _(K-#*/X2RG<N>"IK]K?V0?VG-*_:N^#=AXPLH%T_5(Y#9ZMIBON^R
MW2@%@#U*,"KJ3V;!Y!K:,5.#G!WMO_7KH8N3C)1DK7/;:*_/O_@I=_P4!U/X
M 2P_#CX=W,4'C:\MQ<:AJQ59#I<+?<5%((\YQSE@=JX."6!'YO\ @G]FO]HK
M]K>SG\::5H6O^.8%D9#K6L:I&OFLIY$<EU*IDP>#L)P1CK6$).I=Q6BZFTHJ
M%N9ZOH?T245^ OP2_;*^-W[%WQ(/A[Q!<ZQ>:7ILZV^J>#?$4KLJ(.HAWY,#
M;3N5D^5OE)#+BOW7^'/C_1OBIX%T+Q=X>N?M>BZS:1WEK+C!VL,[6'9@<J1V
M((KHY4X*I!W7]?F8\S4^22LS^<K]J7_DY;XK?]C3J?\ Z525_1?\*_\ DF'A
M#_L#V?\ Z(2OYT/VI?\ DY;XK?\ 8TZG_P"E4E?M?\>/VNO#_P"R5^S#X6UB
M[:&_\57^BVT.AZ*S_-<S>0G[QP.1$F06;Z*.6%84)J&!3?\ =_)FN(BYX]I?
MW_S1]4T5^!WP-\>_M0?M?_&8Z'X<^*OC2TGOIVO-0N[77+RWL-,@+99_+B<+
M&@SA44#)PHK]D=<UG3?V1?V;M3UC5]9UOQ9;^%M,>XFU#7=0DN[[4)NP:60D
M@O(P4 ?*NX # JY?NZ7M:FG]:_UU)C[]7V5/7^M/Z_X![!17\]GB?XT?M"?M
MX_$R?1K"]UK7[F\WS0>%]&G:WT^UA4YR4W",*NX#S)3DY +$D5#XN_8E_:0_
M9^T.?QIJ'@O6/#UEIP\Z75-'U2WGDME'61OLLS.B@=6(  ZD4E=14IJR*:3?
M+!W9_0S17Y2?\$P_V_\ Q=XF^(-G\)/B5K,_B*+4XW&B:UJ#F2[CG12_V>60
M\R*RJQ5G)8, ,D, OZMUK.'*D^C,HRYFUU04445F6%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5\Q?%C_@I!\!?@]XHG\.ZKXO;4]7MI/*NH=$M)+Q
M;9@<%7D4;-P((*ABP(P0*N_M^:)\7-?_ &==;MO@_="'5\$ZC;VZL+^XLMI\
MQ+5P?ED]L;F7(4AL _,O_!.GPU^S#\5?@+?Z!?>!]#/C32[5V\4)XH@BN+T@
M##W44SJ&CAXZ1[?*(&><.T1;ESM:<NOKY^BZO_ARY)14;_:T]/\ @OHC] ?A
MG\3O#'QB\%Z=XL\':O#KF@7ZEH+N#(Y!PRLK ,C @@JP!!ZBOSW_ ."S%K/#
M=_!'5-3CEG\&6^JW,>I1J"4+$P, <'J8TF [\-7CW[%/[:47[.O@_P >>#/
M7PW\5?%::3Q)=:EI]KINX0V^G[4C21W2.5PQ$>3F,#H<YR*^Q_A5^T!\(_\
M@IM\,_$OP]\1:#=Z/J\$:RW^@7D@^T6Q!PMS:S #.QSC)52"<,FUOFN2YG"K
M15[<LK/[VOEK\T3%\G-3JNU^:-U\TGY7W/K;PKK6D>(O#.E:GX?N;:\T.[MH
MYK&XLV#0O"5!0H1QC&*_,?XD? [6OVD/V[OB'XP^!?B^T\,>)O!-SHT5YJBY
M,$D[I)'=,&4$.R+$JM&00^V12:V(_P#@E'\5O![7.@>!OVC-8T/P+<R,6T]6
MN[<A&)R&ABF$<AQU/R[O05]G?LJ?LL^%OV3?ALOA?P[)+J%W<2?:=3UBZ4+-
M?3XQN('"(!PJ G [DDL;7*ZGMKVMMWOYOM:]^[L1K&FZ5M]'VMY+N_PU/8+&
M.XALK=+N9+BZ6-1+-''Y:NX'S,%R=H)R<9./4U/114MW=QI65@HHHI#"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH _GJ_X*,?#O_A6_[8WQ$M(X3#::E=KK%OZ,
MMR@E<CV\QI!^%>I_MM?M$?\ "Q_V1OV:/#,5UY\[:0U_J0W98RVP-E&2/=H[
M@UZ5_P %M_AY]@^(7P[\;Q1$+J6G3Z5/(!QO@D$B9]R)V_[Y]J_-:>]N;R*V
MAFFDFCMD,4".Q(C0LSE5'8;G9L#NQ/>N:C[U!4.TE_Y+=+\T_P#ASHK:5O;=
M7'_TJU_Q31^R_P#P1?\ AG_PCGP#\2^,IX0ESXDU<Q128Y:WMEV+_P"1'F_*
MOSI_;X^&\OP?_:^^(%A;(UK;W&H_VS9,GRX2X G!7V5V9?\ @-?N/^R?\-/^
M%0?LW_#SPFT7DW-CH\+728QBXD'FS?\ D1WK\Z_^"VWPP^Q^+/A[\08(ODOK
M6;1;N0= \3>;#GW(DE_[XKJQDO9XJ,XOX?=O\K7^;BOO.;"+GH23^U[WZ_@F
M_N/-_P#@I]^T%%\9_#7P#2VFW>?X577[N-3PL]SMC*GW5K>0?C7UU_P1H^'7
M_",_LUZQXHFBVW'B;6I'C?'+6\"B)?\ R)YU?B]?ZQ>ZK%8Q7=S)<I90?9;9
M9#GRHM[.$7VW.Q_X$:_I!_9*^'?_  JC]FKX<>%WB\FYL]%MWN4QTN)%\V;_
M ,B.U;TTHPK37VI?@Y.2^Y)(PFW*5*F_LK\E9_>W<_*#_@LCXJN]9_:JL='D
MD;['H^@6T<,9/RAI'DD=@/4Y4?\  17<_L-?\%&/@Y^RS\ ]/\':QX8\67'B
M-[NXO=3O-)L;1X9Y'D(C(9[E&.(EC7E1@@_4\A_P67\#WNA?M-:1XC>-O[.U
M[0H1#-CCS8'=)$^H4Q'_ (&*]=_X)S?LK_LV?M+_  $@NO$G@^'5_'VD7,MM
MK7_$ZOX)"&D9H)?*CN%4*T9500H!,;=P:Y,'S>QG;N[^G,_^!<Z\5R^TAS=E
M;_P$\S_X*!?M\?"/]K;X1Z9H/AWP[XIL/$VF:HE[:WNL6-K'$L11DECWQW#L
M-P*G&W!*#/2NF_X(B^,KFU^(WQ'\*EV-G>Z5!J03/"R0R^7D#U(G_P#'17KW
M[3/[/W[#_P"R?'X?/C;X<7\DVMS/';VVEZQJ,\J(@&^9U:\4B,$J,C))/ /.
M/4?V%/#_ .RKJ_B#7O%'[/VBW5EK5G9K8ZE/</JA\N&9PXC_ -*=HR2T(/R9
M(V]@>=L-RQE.2U3O?UM9?<[&.(YI1A%Z6M;[[_CJC\@/VP/%EWXV_:D^*FJW
MCL\K>(KRV7=VCAE:&-?P2-1^%?I%\+?^"N'P$^&'PW\,>$M/\(>.X+31=.@L
M46'3K':2B!2W_'YSD@G)Y)))K\Z/VT? UY\._P!JOXH:1?(RNVNW-]$6!&^&
MX<SQL/JLB_K7ZJ_ ;]A/]DOXY?"/PQXTT;X?QWEOJEE')-Y?B'4B89]H$L3@
M77#(^Y2/:L<+S?5(VV]W\G_P37$V^M.^_O>FZ_I'YX_\%#_VH/AU^U=\0/#7
MBKP-HFMZ1>VNGO8ZF^M6L$+3A7W0E?*FDW8#2 YQ_#U[?H7_ ,$<?&5UXB_9
M2N])N6+)H.OW5G;Y.<1.D<^/^^Y9/SKR7XW^"_V OV??BFW@+Q9\/]4&JPVT
M=Q<W.GZGJ5S;VQ?)6.0K>;P^T!L!#\KKSSBOLO\ 8Q\,_!/2OA3)J_P(TZ:Q
M\':U>/.[S-?$S3Q@1,P%VQ? V;?E^7*GOFML/RPI34=4_P ^:_\ FC.OS2J0
MYMU_\C9?@?A%^U+_ ,G+?%;_ +&G4_\ TJDK#^+7Q@\3_&SQ1'KWBF^^UW4-
MI#86T,8*PVUO$@6.*-23M4<GKDEF)R236Y^U+_R<M\5O^QIU/_TJDK]"?B/_
M ,$O_#VF_L+VM_X4@?5OB;9VT?B2?4MA$E^C1!I;1%R<(L9RBCDN@_O&N.E[
MN$C5>T5'\M_DK_TSJK>]C)4UO)R_/;YNWY]#Z._X)9Z1\.;;]E71-1\"6OE:
MG>.4\1S7#*]TVH(,.KL.B $&->@1P>I8GU_]K_X1ZA\=?V:_'G@G22O]K:E8
MAK)78*LD\4B31H2> &:,+D],U^1'_!+O]J;_ (4'\<H_#6MWAA\&^,'CL;GS
M&_=VMWG%O/[#),;'T<$_=K]GOC-\;?"'[/\ X)D\6>.-1FTO0HYTMFN8;.:Y
MQ(^=@*Q(Q )&,D 9P,\BN[&)58\[=E+\'M9>FEEVL<F%E*E/EBM8N_KUO_GZ
M,_GB^%?Q;^(W[)7Q4N=6\.RS>&?%5B)-/OK._M0VY-RF2":)QT)1?0@@$$'F
MON?P%_P6NU2XL_[-^)7PPTS6[2X!ANY]#NF@5HF&&!MIA(),@X(,B@Y[5]$Z
M7\</V3/^"@7Q(D\"ZAX637-?-HTMKJVJV L)KE8R"8H+E)%N-P!+[.!M5CV-
M<;\7?^",GPPO]+U+4?!GB[6O!]RB-,D6I/'>V,04$X.0DBKQ]XR-CK@]*QE.
M<*:=575OPZ^??0T482F_9NSO_P -_P .?07[(_[4'P#^-UJ=-^%UMIWA;6(8
MS+)X9?38M.NXT[LJ1_)(!W,;-C(SC-?3%?S-?L_^(M8\%?'KP'JF@32#5K77
M;00&W;F4F94*#U#@E2.X8BOZ9:Z)13A&HNMU]UO\S&+<:DJ3Z6_&_P#D%%%%
M8&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLW^)/VE/V?[;2?!NEC6/%6E:O!?V=I]HA@,J%7BE7?*RH,+)NY89V>M?G/\
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M \F[22&20+)PAR>?,0G&"*^CZ*F,5&BZ&\7_ %^6G_!U*E)RJJMM)?U^>O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _%W_A?GQ._P"BC>+?_!Y=?_'*
M/^%^?$[_ **-XM_\'EU_\<K@Z*_IGZKA_P#GVON1_/'UJO\ \_'][.\_X7Y\
M3O\ HHWBW_P>77_QRC_A?GQ._P"BC>+?_!Y=?_'*X.BCZKA_^?:^Y!]:K_\
M/Q_>SO/^%^?$[_HHWBW_ ,'EU_\ '*/^%^?$[_HHWBW_ ,'EU_\ '*X.BCZK
MA_\ GVON0?6J_P#S\?WL[S_A?GQ._P"BC>+?_!Y=?_'*_3G]C?7]4\4?LW^$
M-3UG4;O5M2G^V>;>7T[332;;R=5W.Q).%  R>  *_(JOUF_89_Y-9\$_]OW_
M *77%?"\84:5/ 0<()/G6R_NR/L^%:U2IC9J<FUR/=^<3WBBBBOR _5 HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \>_:$UW4M%_L#^S]0NK#S/M&_[+,T>_'EXSM(SC
M)_.O'O\ A.O$G_0P:K_X&R__ !5>I_M+?\RY_P!O/_M*O$*_DGCK&XJCQ%B8
M4ZLDER:)M+X(G[?PWAZ,\KHRE!-^]T7\S-S_ (3KQ)_T,&J_^!LO_P 51_PG
M7B3_ *&#5?\ P-E_^*K#HKX/^T<;_P _I?\ @3_S/I?JN'_Y]K[D;G_"=>)/
M^A@U7_P-E_\ BJ/^$Z\2?]#!JO\ X&R__%5AT4?VCC?^?TO_  )_YA]5P_\
MS[7W(W/^$Z\2?]#!JO\ X&R__%5V'PB\6:WJ7Q#TFVO-8U"ZMW\[=#/=.Z-B
M%R,@G!Y /X5YG7<?!7_DIFC?]MO_ $3)7O</X_%SSC!QE6DTZM/[3_F7F>9F
M>&H1P-=J"OR2Z+LSZFHHHK^U#^?@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTMW,4JE3'-;2@ M%+&>489'L0002""?!_P!LS]OG_AD;QYX0\-_\(+_PE?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]KBP_9#^%4>O_8$UGQ'JDYLM(TV1RD;RA2S22$<^6@P2!R2RKD;MP^-_ ?\
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MU&';^J)_WZB_%$U?]ZDO[L/R84444RPHHHH \0_:6_YES_MY_P#:5>(5[?\
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M2""""U8CB3RXI)3(0?X<J#Z]J^W/^&0/@9_T1WP+_P"$]:?_ !NMOPG^SO\
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M4.&QD=1R*AIU%1H/WHN37KN^6_E;\[[FD;0E5K[-13_)7M\^G96V/K#]F_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^3C_ ()_]>P_]+%K]8Z**FG^[HJE_>D__ G?\!27-5=7NHK_ ,!O^=S\BO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXY'\->)M'\0I']]M*OXKH+]3&QQ5<K:YDM">9)\K>IT%%%%24%%%% !1110
M4444 %%%% !116)XO\;>'_A_HSZMXEUJPT'3$8(;K4+A88]QZ*"Q&2>P')H
MVZ*YSP/\1_"WQ*TV2_\ "GB'3?$-G$_ER2Z=<I,(VQG:VT_*<<X.*Z.FXN+L
MT3&2DKQ=PHHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA_:.^%%]XG\2V>F6-_!JLMBL>E121Q&-8XF!(DD<[LN>^.G%-8:HZ/M_L_\
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M8T'B8N\5^?\ PY\;Z/IWC7]I3XM6MC]KF\0>+O$%SM^T7LW4X+,S'^%$4$X
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MW'9E8%3].,C!KY1_:^_X* ZY\!_&UWX*\/>#%_M:&))?[5UQR;>1'&0T44;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7D_[6'_)L_P 3O^Q?O/\ T4:]8KR?]K#_ )-G^)W_ &+]Y_Z*-)[#6Y^4
M'["UX+3]JSP"'4/%<7$]K(C?=99+:5"".X^:F?M#?#K6/V3_ -I2Y31GDLDL
MKU-8T*Z'3R2^^,>^T@H1WVGUK-_8W_Y.B^&O_88B_D:_1C_@HU\ _P#A:_P;
M?Q+IEMYOB+PH'NTV#+36A'[^/WP ''^X1WK[#%XCZMB:51[.Z?I?1_)O[FSX
M7!8?ZWA:M);JS7K9Z?-?C8^1O^"A7CJR^+EC\'O'^G@+;ZYH$NZ,-GRI8Y1Y
ML9]U=V7\*^HO^"57_)NFK?\ 8Q7'_HBWK\N;WQI>ZAX'TOPQ<?O+/3+VXO+5
MRQRGG+&)$QZ9B5OJ6]:_4;_@E5_R;IJW_8Q7'_HBWJ,115#!5*:VN[>CE?\
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MFD^([:$^;%#JUC%=)&Y&-RB12 <'&17X">*H8[?Q1K$42+%%'>3*B( %4!R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?4$M)+^Z%PQ4!1<''/3OBM#[+XI_Y^[C_P "?_KT@/4J*\M^R^*?^?NX_P#
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M^[C_ ,"?_KT?9?%/_/W<?^!/_P!>@#U*BO+?LOBG_G[N/_ G_P"O1]E\4_\
M/W<?^!/_ ->@#U*BO+?LOBG_ )^[C_P)_P#KT?9?%/\ S]W'_@3_ /7H ]2H
MKRW[+XI_Y^[C_P "?_KUGZC?Z]ILR1W%_=([#("W!]?8T@/8J*\M^R^*?^?N
MX_\  G_Z]'V7Q3_S]W'_ ($__7I@>I45Y;]E\4_\_=Q_X$__ %Z/LOBG_G[N
M/_ G_P"O0!ZE17EOV7Q3_P _=Q_X$_\ UZ/LOBG_ )^[C_P)_P#KT >I45Y;
M]E\4_P#/W<?^!/\ ]>C[+XI_Y^[C_P "?_KT >I45Y;]E\4_\_=Q_P"!/_UZ
M/LOBG_G[N/\ P)_^O0!ZE17EOV7Q3_S]W'_@3_\ 7JCJ=YK^F>7]IO[I-^=N
MVX)Z8ST/O2 ]@HKRN.'Q1)&KK>7!5@"/])_^O3OLOBG_ )^[C_P)_P#KT >I
M45Y;]E\4_P#/W<?^!/\ ]>C[+XI_Y^[C_P "?_KTP/4J*\M^R^*?^?NX_P#
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M^O1]E\4_\_=Q_P"!/_UZ /4J*\M^R^*?^?NX_P# G_Z]'V7Q3_S]W'_@3_\
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MWQ6A]E\4_P#/W<?^!/\ ]>D!ZE17EOV7Q3_S]W'_ ($__7H^R^*?^?NX_P#
MG_Z],#U*BO+?LOBG_G[N/_ G_P"O1]E\4_\ /W<?^!/_ ->@#U*BO+?LOBG_
M )^[C_P)_P#KT?9?%/\ S]W'_@3_ /7H ]2HKRW[+XI_Y^[C_P "?_KT?9?%
M/_/W<?\ @3_]>@#U*BO+?LOBG_G[N/\ P)_^O1]E\4_\_=Q_X$__ %Z /4J*
M\EOF\26-LTT][<K&N 2+@]S[&BQ?Q'?VZS07MRT9) )N#_4T@/6J*\M^R^*?
M^?NX_P# G_Z]'V7Q3_S]W'_@3_\ 7I@>I45Y;]E\4_\ /W<?^!/_ ->C[+XI
M_P"?NX_\"?\ Z] 'J5%>6_9?%/\ S]W'_@3_ /7H^R^*?^?NX_\  G_Z] 'J
M5%>6_9?%/_/W<?\ @3_]>C[+XI_Y^[C_ ,"?_KT >I45Y)J$OB+3K?S;B^N4
MCW;<K<$\_@:?9_\ "2WMLDT-[<-$W0FX/KCN:0'K%%>6_9?%/_/W<?\ @3_]
M>C[+XI_Y^[C_ ,"?_KTP/4J*\M^R^*?^?NX_\"?_ *]'V7Q3_P _=Q_X$_\
MUZ /4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#U*BO+?LOBG_G
M[N/_  )_^O1]E\4_\_=Q_P"!/_UZ /4J*\BU*X\0Z;"KW-]<HC-M!6X)Y_ U
M-:KXFNK>.6*\N&C<94FX[?G2 ]7HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\
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MC[+XI_Y^[C_P)_\ KT >I45Y;]E\4_\ /W<?^!/_ ->C[+XI_P"?NX_\"?\
MZ] 'J5%>/ZE>Z_IC1BYO[I"^=NVX)Z?0U=6W\4.H87EQ@C(_TG_Z](#U.BO+
M?LOBG_G[N/\ P)_^O1]E\4_\_=Q_X$__ %Z8'J5%>6_9?%/_ #]W'_@3_P#7
MH^R^*?\ G[N/_ G_ .O0!ZE17EOV7Q3_ ,_=Q_X$_P#UZ/LOBG_G[N/_  )_
M^O0!ZE17EOV7Q3_S]W'_ ($__7H^R^*?^?NX_P# G_Z] 'J5%>.ZC?Z]ILJ1
MW-_=([#("W!/'X&M#[+XI_Y^[C_P)_\ KT@/4J*\M^R^*?\ G[N/_ G_ .O1
M]E\4_P#/W<?^!/\ ]>F!ZE17EOV7Q3_S]W'_ ($__7H^R^*?^?NX_P# G_Z]
M 'J5%>6_9?%/_/W<?^!/_P!>C[+XI_Y^[C_P)_\ KT >I45Y;]E\4_\ /W<?
M^!/_ ->C[+XI_P"?NX_\"?\ Z] 'J5%>.WE_KUG>);S7]TLS8PHN#CDX'0UH
M?9?%/_/W<?\ @3_]>D!ZE17EOV7Q3_S]W'_@3_\ 7H^R^*?^?NX_\"?_ *],
M#U*BO+?LOBG_ )^[C_P)_P#KT?9?%/\ S]W'_@3_ /7H ]2HKRW[+XI_Y^[C
M_P "?_KT?9?%/_/W<?\ @3_]>@#U*BO+?LOBG_G[N/\ P)_^O1]E\4_\_=Q_
MX$__ %Z /4J*\=GO]>@U!+22_NA<,5 47!QST[XK0^R^*?\ G[N/_ G_ .O2
M ]2HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\ @3_]>F!ZE17EOV7Q3_S]W'_@
M3_\ 7H^R^*?^?NX_\"?_ *] 'J5%>6_9?%/_ #]W'_@3_P#7H^R^*?\ G[N/
M_ G_ .O0!ZE17EOV7Q3_ ,_=Q_X$_P#UZ/LOBG_G[N/_  )_^O0!ZE17CK7^
MO+J7V,W]U]ISC;]H..F?7%:'V7Q3_P _=Q_X$_\ UZ0'J5%>6_9?%/\ S]W'
M_@3_ /7H^R^*?^?NX_\  G_Z],#U*BO+?LOBG_G[N/\ P)_^O1]E\4_\_=Q_
MX$__ %Z /4J*\M^R^*?^?NX_\"?_ *]'V7Q3_P _=Q_X$_\ UZ /4J*\M^R^
M*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#U*BO'8[_ %Z3439K?W1N02-O
MV@XX&3WQ6A]E\4_\_=Q_X$__ %Z0'J5%>6_9?%/_ #]W'_@3_P#7H^R^*?\
MG[N/_ G_ .O3 ]2HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\ @3_]>@#U*BO+
M?LOBG_G[N/\ P)_^O1]E\4_\_=Q_X$__ %Z /4J*\M^R^*?^?NX_\"?_ *]'
MV7Q3_P _=Q_X$_\ UZ /4J*\=MK_ %ZZOGM8K^Z:=2P*FX...O>M#[+XI_Y^
M[C_P)_\ KT@/4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>F!ZE17
MEOV7Q3_S]W'_ ($__7H^R^*?^?NX_P# G_Z] 'J5%>6_9?%/_/W<?^!/_P!>
MC[+XI_Y^[C_P)_\ KT >I45Y;]E\4_\ /W<?^!/_ ->C[+XI_P"?NX_\"?\
MZ] 'J5%>.V-_KU_<O#!?W3RJ"6!N#V..Y]ZT/LOBG_G[N/\ P)_^O2 ]2HKR
MW[+XI_Y^[C_P)_\ KT?9?%/_ #]W'_@3_P#7I@>I45Y;]E\4_P#/W<?^!/\
M]>C[+XI_Y^[C_P "?_KT >I45Y;]E\4_\_=Q_P"!/_UZ/LOBG_G[N/\ P)_^
MO0!ZE17EOV7Q3_S]W'_@3_\ 7H^S>*1_R]W'_@3_ /7H ]2HKQ[3;[7M2D=;
M:_NG91D[K@C^9J_]E\4_\_=Q_P"!/_UZ0'J5%>6_9?%/_/W<?^!/_P!>C[+X
MI_Y^[C_P)_\ KTP/4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#
MU*BO+?LOBG_G[N/_  )_^O1]E\4_\_=Q_P"!/_UZ /4J*\M^R^*?^?NX_P#
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M_P#KT?9?%/\ S]W'_@3_ /7H ]2HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\
M@3_]>@#U*BO+?LOBG_G[N/\ P)_^O4%\WB2QM7FGO;E8EQDBX/<X[&D!ZS17
MDFGR>(]0MQ-;WMR\>2,FX/\ 4U9^R^*?^?NX_P# G_Z] 'J5%>6_9?%/_/W<
M?^!/_P!>C[+XI_Y^[C_P)_\ KTP/4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/
MW<?^!/\ ]>@#U*BO+?LOBG_G[N/_  )_^O1]E\4_\_=Q_P"!/_UZ /4J*\M^
MR^*?^?NX_P# G_Z]5M0D\1Z?;F:XO;E(\@9%P?Z&D!ZW17DUBWB2^M4F@O;E
MHFS@FX/8X[FI_LOBG_G[N/\ P)_^O0!ZE17EOV7Q3_S]W'_@3_\ 7H^R^*?^
M?NX_\"?_ *],#U*BO+?LOBG_ )^[C_P)_P#KT?9?%/\ S]W'_@3_ /7H ]2H
MKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\ @3_]>@#U*BO+?LOBG_G[N/\ P)_^
MO574IO$6FP++<WURB%MH*W!/.">Q]J0'KE%8_A&::X\.V4D\C2RLI)=SDGYC
MC)^E;%, HHHH **** /*?!?_ "%[O_</_H0KLZXSP7_R%[O_ '#_ .A"NSI(
M HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% '%ZQ_R.=O_P!=(OYBNTKB]8_Y'.W_
M .ND7\Q7:4 %%%% !1110 4444 %%%% !1110 4444 <GX]_U=E]7_\ 9:Z3
M3?\ D'VO_7)?Y"N;\>_ZNR^K_P#LM=)IO_(/M?\ KDO\A2Z@6****8!1110
M4444 %%%% !5;4O^0;=_]<G_ /035FJVI?\ (-N_^N3_ /H)H YWP'_JKS_>
M7^M=77*> _\ 57G^\O\ 6NKI( HHHI@%%%% !1110 4444 %%%% !7%^./\
MD)6O_7/_ -F-=I7%^./^0E:_]<__ &8TF!VE%%%, HHHH **** "BBB@ HHH
MH *Y+Q]_RX_]M/\ V6NMKDO'W_+C_P!M/_9:3 Z:Q_X\K?\ ZYK_ "%3U!8_
M\>5O_P!<U_D*GI@%%%% !1110 4444 %%%% %35O^05>_P#7%_\ T$U@^ _^
M/>[_ -Y?Y&M[5O\ D%7O_7%__036#X#_ ./>[_WE_D: .IHHHH **** "BBB
M@ HHHH H:]_R!KS_ *Y-_*LGP+_R#[C_ *Z_T%:VO?\ (&O/^N3?RK)\"_\
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MHHI@%%%% !1110 4444 <7-_R/0_ZZ+_ .@"NTKBYO\ D>A_UT7_ - %=I2
M****8!1110 4444 %%%% '%V/_(\/_UTD_\ 037:5Q=C_P CP_\ UTD_]!-=
MI2 ****8!1110 4444 %%%% '%Z#_P C==?[TO\ .NTKB]!_Y&ZZ_P!Z7^==
MI20!1113 **** "BBB@ HHHH XOP?_R'KO\ ZYM_Z&M=I7%^#_\ D/7?_7-O
M_0UKM*2 ****8!1110 4444 %(WW3]*6D;[I^E '&^ _^/NZ_P!P?SKLZXSP
M'_Q]W7^X/YUV=) %%%%, HHHH **** "H+[_ (\KC_KFW\C4]07W_'E<?]<V
M_D: .9\ _P#+]_VS_P#9JZVN2\ _\OW_ &S_ /9JZVD@"BBBF 4444 %%%%
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M:_S=D93JQIRA"6\KV^2NSZ*HHHK(U"BBB@#B]8_Y'.W_ .ND7\Q7:5Q>L?\
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M** "BN%^,WQF\-_ CP1/XH\32S"SCD6&.WM%5Y[B1CPD:LR@G )Y(  )K)^
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M<?\ /[MSFCC,/*7(I;Z>7W[?B>ZT445R':0WO_'G/_US;^5<OX!_Y?O^V?\
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M"I (((-:U,/5I1YI+3[_ ,C*EBJ-:7+!Z]M5^9NT445S'48WB[_D!3_[R_\
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MB;4-VV6U\-K'=&#_ 'W,BH#D8V[BP]*]XTO4(]6TRTOH598KJ%)D5P P5E!
M..^#6KISC!3:T9DJL)3=-/5%JLWQ'_R [S_<_J*TJS?$?_(#O/\ <_J*R-3/
M\#?\@F;_ *[G_P!!6NBKG? W_()F_P"NY_\ 05KHJ "BBCIR: "BOE7X@?M\
M:1IGC*Y\*_#KP7K'Q3UFT+"X&D;EA&TX;8R1R,^#P2$V^C&M;X-_MQ>&OB-X
MP3P;XGT'4OAWXQD<1Q:;K'W)9",B,.50ASV5T7.0 23BNJ.%K2CSJ.F_R]-S
MCEC*$9\CEKMY7[7VOY'TI1117*=@5D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\
M ?\ T,4 0^#?^0*O_71JW:PO!O\ R!5_ZZ-6[0 444V21(8WDD=8XT!9F8X
M ZDF@!U%?)7BS_@H)83>*KO0?AC\/]<^*=Q9$BXN-+#I#@'!9-D4K,N>-Q50
M>Q(YKKO@;^VIX5^+_B9_"6J:7?\ @?QHI*C1]8&/-8#)2-R%)<#G:RJ?0'G'
M5]5K<O/R^?G;TW./ZY0Y^3FUV\K]K[7/H>BBBN4[ K"\9?\ (%;_ *Z+6[6%
MXR_Y K?]=%H F\)_\@"V_P"!?^A&M>LCPG_R +;_ (%_Z$:UZ "BBH[FX6UM
MY9W^Y&A=OH!DTFTE=C2;=D245\>/_P %2/A2CLO]@>,#@XRMG:8/_DS3K?\
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M>5S[RHK\^OBIX+_:(_9+TT>--)^*>H?$3P[;.G]H1:MYDQC4L "\4LDF(R2
M6C<,,]AR/K[]GWXS6/QZ^%FD^+K.'[)+/NAO+/=N^SW"'#IGN.C _P!UEJ9X
M?EI^UIR4H[/R]453Q7-4]C4BXRM=7MKZ-&]\3OB-H_PF\"ZOXJUR;RM/TZ$R
M,H(W2MT2-?5F8@#ZU^6GQ,\+:Y\2/@[XM^/?C19%U'Q!K$%CHENV=L-L&8LR
MY_@ 01K_ +KG^+-?0_Q?U"]_;6_:*M/ACH=S*GPY\)3?:->OX#\D\RDJRANA
M/6-/<R-R!78_\%&M)L]!_9;L-,TZVCL["SU2SM[>WA7"1QJDBJH'H  *Z*'^
MSJG+[<W&WE'F7_I7Y'+BO]J]I#[%-2OYRY7_ .D_GWL>U_LM_P#)N?PX_P"P
M%:_^BQ7J->7?LM_\FY_#C_L!6O\ Z+%>HUSXS_>:G^)_F=N#_P!VI_X5^05R
M7C[_ )<?^VG_ ++76UR7C[_EQ_[:?^RUQLZSIK'_ (\K?_KFO\A4]06/_'E;
M_P#7-?Y"IZ8!7R#^W3\9=4G&E?!;P,6NO&'BMDANQ ?F@M7.-A/\)?!R>R*Q
M/4&OH+XW_%W2?@?\-M6\6:L0R6J;;:VSAKF=N(XE^IZGL 3VKY^_8A^#>K:C
M>:K\</'JFX\8>*BTMBDRX-K:O_& ?NEP %':,#^\177AX1NZU1>['\7T7ZOR
M]3AQ526E"D_?G^"ZR_1>?70\*^"?PYL/A'_P4&T#P?IS&6+2;'R99V&#-,=-
M+2R?1G9B!V! [5^F5?GUI_\ RE4G^C_^FROT%KHQDY5*="<MW!/[VSFP%.-*
MI7IP5DI67RB@KX=_:L\2:E^TA\=O#WP"\-73PZ3:RK>^([R'H@4!BI['8A!P
M>"[J.U?87Q"\86WP_P# NO\ B6\(^SZ58S7C _Q;$)"_B0!^-?(O_!-?PE<:
MWI_CGXJ:S^_UGQ!J3VR3N/FV@^;,0?1I' _[95EA(I2E7DM(*_S>B^[=_(WQ
MDFU##Q>M1V_[=6LOO6GS/L7PKX7TOP3X;T[0=%M(['2M/@6WM[>,<(BC ^I[
MDGDDDFM6BBN*4G)N3W9W1BH)1BK)%35O^05>_P#7%_\ T$U@^ _^/>[_ -Y?
MY&M[5O\ D%7O_7%__036#X#_ ./>[_WE_D:11U--EE2&-Y)'6.- 69F.  .I
M)IU?)?[<'QAU9H]*^#/@7=<^-?%S+#.(#\UM:,2""?X=^&R>R*Y..#5TZ<JL
MU3AN_P"OPW,ZE2-&#J3V7]?>]D>-^/M8G_;4^,GB2_B,K_"GX>:==7",N?+O
M)UC8J?<R,N?^N<?8M7H?_!*__DCWBS_L.G_TGBKV/0?@OI7P%_9;\0>%-,VR
MR1:)>37MYMPUU<M WF2'VX  [*JCM7CG_!*__DCWBS_L.G_TGBKV%4BZ%>E2
M^&*C;S?,[OY_Y'B^SFL1AZU7XYN=_)<JLOE^=SZ5^(GP%\#?%7Q'H&N>*-!M
M]5U#17+VS2_=8'/R2+TD0-\P5N,CT)![]45$"*H50,!0. /2EKE?BA\2-&^$
MO@75?%.O7"P:?81%RN0&E?\ @C3/5F. ![UXKD^51Z+IZ_YGN<L>9SMJ]WZ=
MWY'P[X?L8/A;_P %.7TGPTJVVFZP'%W9VX"HHEM#,ZX'0"10^.U?H97P-^PC
MX+UKXO?&+Q;\>?$T!19YIH--##AI7^5RGJL<6(P>^X]U-??->AC$X*E2E\48
MI/U[?(\W OVCJUH_#*3:\^E_F4->_P"0->?]<F_E63X%_P"0?<?]=?Z"M;7O
M^0->?]<F_E63X%_Y!]Q_UU_H*\X]0Z6BBB@!'=8T9W8*JC)9C@ >M?GC\0M:
MG_;6^.VK16K22?"GX>VD]U+)'GR[V948@^A,C)@?],T8\;J]B_;A^-&J:=IV
MF?"3P1YEUXY\8$6S);M\]O:N=I)/\)?D9[*'/& :[_X?_!'3/@#^S;J_A>PV
M3W:Z5=3ZA>JN#=7+0MO?Z# 51V51[UUP_<498E[ZJ/KUE\MEYG%4_P!HKQPJ
MVNG/TOI'Y[OR]3P[_@E7_P DQ\:?]AA/_1"UVG_!2JZU&W_9M=;)I%MYM6M8
M[WR^GDX<@-[>8(_QQ7%_\$J_^28^-/\ L,)_Z(6OI[X^:QX(T;X3>()?B(T1
M\*2P&&YBD&7E+?=2,#DR9QMQR",\8S77F,N7&\UKV<']RCH<661Y\O4+VNI*
M_:[DK_(R_P!E>RT.Q_9Y\ IX>$/]GOI,$CM  -\Y4&8MC^/S-^[W!KYD_:<T
MR#PS^W?\'-4\-Q"'7]3EMO[16W !DC\\Q,[ >L1D4GT3VKRKX*+^T!\'?#MU
MXQ^%_A_5=8^&5Y<R36FC:RB3RRP9^6;[.C"0$C^*+AMN3D8KT#]BOQQX=^,O
M[0?B'QOX\UC_ (NC)OATC19X?*M[> +AO())W.J[EV'! WM\Q)*]?L7#%2Q*
M=TKMKKJOA:^>OH<7ME4PD<))6;LD^FC^)/Y:==3]!:***^>/IR&]_P"/.?\
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MTOB[_D!3_P"\O_H0I/!__(#B_P!YOYTNH&U63XL\5:9X'\,ZGK^LW*V>EZ=
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M./\ D(VO_7/^IKM*Q-R*ZM8;VVEM[B))[>9#')%(H974C!!!Z@CM7/\ P_\
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M1KCP5X<D;[9?0G,;(&7[3.".,'"QH>YP>C5^C5M;Q6=O%!"@CAB0(B+T50,
M#\*[ZB=/"4X3W;;2[+_@[GF4K5,;4J0V247YO_@+0^$OV=4&O?\ !13XMZB1
MN6SM[R,$<X8301>GH#7WC7PCHG['/QHM?C9\0]=TOQS9>!M*\074[G5[ ?:K
MN:&24RJB*=K1D'&X[U.0,%A67\5/ /[1'[*>DMXUT7XKZE\0M"LV5M0AU;S)
M3$F0,M#-)+\F>"R.&&<\#)&DX4ZT:,?:)-1BNN_GIH9TYU:$ZTO9MISD^FWE
MK=GZ!45YE^SG\;;+]H#X5Z;XKMH!9W3LUM?6:MN$%PF-Z@_W2"&&><,,\UZ;
M7G5*<J4W":U1ZE*I&M!5(.Z9Q>K_ /(YV_\ UTB_I7:5Q>K_ /(YV_\ UTB_
MI7:5D:G*?$[X7^'/C!X/N_#7BBP%_I=P0VT,5>-Q]UT8<JP]?<CH2*U?"GA/
M1_ WA^RT/0-.M]*TFS01P6MLFU%']23R2>222<FM:F3SQVL,DTTBQ0QJ7>1R
M JJ!DDD] !5<S47&^FY/*G)2MKM_P#\_O^"FND6O@_Q?\-_'6D%;#Q-YTBF>
M$!7D\AHWB<D<DJ21GT(':OO3^UTM?#_]J7@\B..U^TS!OX $W-^7-?GAKE_+
M^W3^V)IMGIJM/\//"; R7&/W<D".&D?/K,X"+_L@'L:^V_VB;Z32_@)\0KB'
M<)(]!O-OECD?N6''YUW8A2IX.E3?Q>\_1/;^NAY^%<:N-JU(_#[L;]VM_NVO
MU/CW]C+PZ?VE/V@/&_QC\5PB_BTZY5-+M[A0T<4K9\O /'[J)5Q[N&ZC-?H!
M>6<&H6LUK=0QW%M,ACEAE4,CJ1@J0>"".U?F?^QC\5O&^F_"^\\!_";PM'K'
MC&\U.6_U#5]2.RPTVW9(HXV8Y&YCL<A<]C@-R!Z7X^\9?M:?L[Z:?%_B;5?#
MGCOPW;L#>VUE;)MMT)QEMD,,@'.-P+ <$\5V8S#\U14DU&*244WY?Y]]S@P.
M)4:3K.+E*3;DTMM?T717L?;^CZ/8^']+M-,TRTAL-/M(UAM[6W0)'$BC 55'
M  %7*X+X'?&#2OCI\-=+\7:1&UO%=!HY[21@SVTRG#QD]\'D'N"#@9Q7>UY%
M2,X3<9[K<]RE.%2"G3V>QQ<W_(]#_KHO_H KM*XN;_D>A_UT7_T 5VE9&IQG
MQ6^#_A7XU^&1H/BW3%U&P29+B/#F.2)U/5''*Y&5..H)%=+H>AZ=X9TBTTK2
M;*#3=-M(Q%!:VL82.-1T"J.!5ZJVI:E:Z/I]S?7UQ':65M&TTT\S!4C11EF8
MGH !5\S4>6^FY/(G+FMKMY^A^?7[>]C!\.?VE/A;XT\/QBUU^[D26X^SC:TS
M0S1A&;'4LKE#ZA0*_0ZOSE\%27?[;7[9R^*DAD_X0'P@\<D+2 A6CB<M"I_V
MI9<N1_=!':OT#\7>*],\"^&-3\0:S<K9Z7IL#7-Q,W\*J,\#N3T [D@5WXB]
M/#4:4_B5WZ)O1?=T/,PO[W%5ZT/A?*EZQ5F_F^IX?^VE^T,WP3^'(T[1)&D\
M:^(=UGI<,(W21 X#S@=<KD!?5F'H:^']4^"[? WXY_ #1K_<WB34+K3]5U=V
M.<3RWX CSWV*@4^I#'O7T-^S#X-U3]IOXT:I\?/&5JR:-9SFV\,:;,,JNPD*
MX'0B/GD=9&8\;:YW]LS_ )/D^"O^_I?_ *<7KNP:^K5Z5'[4G>7E[KM'Y;OS
M.#&_[5AZM?[$4E'S]Z-Y?/9>7J?H'1117@'TAQ=C_P CP_\ UTD_]!-=I7%V
M/_(\/_UTD_\ 037:4@.&^*WP4\'_ !LTW3['Q?I":I!8W*W4!W%'1@1N7<.=
MK 89>X]P".QT[3K72+"WL;&VAL[*WC6*&WMT"1QH!@*JC@ #L*L5G^(?$&G>
M%-#OM8U:[BL-,L86GN+F9MJQHHR235<S4>6^FY/*N;FMKL? ?[3UA!\,OV]/
MAEKWAQ5M-1UB:RDO8;<!3*SW#02$@=Y(SM/K@U]^>(/#^G>*M$OM'U>SBU#3
M+Z%H+BUF7<DB,,$$5^?OP!L]1_:]_:_U+XK7UK)#X1\-2*;)91QN0$6T7^\"
M3,WH>/XA7Z)5Z&*BZ=&C1G\23;\DW=+Y(\W"252O6KP^%M)>;2LVO5]3%\&^
M"]#^'OAVST'PYIEOI&DVB[(;6W7"CU)/5F/4L223R2:^%O\ @JEI>DVC?#_6
M(%C@\3/)<0^;%\LKP($922.?E=N/3<:^B_VDO%GQV\.WNGQ_"3PEI6OZ=);.
MU[=7K)YT,N["A%:>//R\_=;G\J^-/ACJ^DZU^T/:ZC^T_?>(+/Q=#+'_ &99
MZS8K;:6F&_=ER#PF[D ((\@EF.2*TP5.4ZL<0Y;.]K^\]^GG^1ECZL*=&6&4
M=TE>UHK;KMI^9^EG@^:]N/"6B2ZB&74'L8&N0PP1*8U+Y]\YK7I P8 @Y!Z&
MEKS9RYI.5K7/6IQY(*-[V.+T'_D;KK_>E_G7:5Q>@_\ (W77^]+_ #KM*S19
MP/Q0^!?@GXR7&B3>+M$AU:31[C[1:LY(^L;X^]&Q )0\' KNK>WBM+>."")(
M88U")'&H554#   Z #M4E8?C;QII'P\\*:GXCUV[2RTK3H6GGF<]AT4#NQ.
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M](UPXR"IXBI&.UV>E@9RGAJ<I;V05D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\
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M(U'PKXCMVGTR]4;C&VV2)P<K(C8.&4C(X/N".*Z*V(3J4FGS<BBF^KL[M_\
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M:A=?M)^+=3M;33[B>6RF6ZV7"+&S&-LWI&& P<@]>AKR']A?X$>+OB;X7O\
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MYKDK4^7WG-2;[7_'0[</4YER*FXI=[?A9E'7O^0->?\ 7)OY5D^!?^0?<?\
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M>3:7;U\WU,#QM_R!Q_UU7^1JUX7_ .0#:?1O_0C57QM_R!Q_UU7^1JUX7_Y
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M*Y_QY_J;/_>;^0KH-*_Y!=G_ -<4_P#012 M5';W$5W!'-!*DT,BADDC8,K
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MKMK?Y]/GL8'_  2VLIIO$7Q0U2UC:'1I#:Q1+CY2V^9E /JJG_QX5^@M>??
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MK\2CX]G\7^"[_P 4_:?MGVV_EGN )?X6V/:%?EXV\87 QC KU/\ X5E^V?\
M]%;\'?\ @)'_ /*ZNF,:=*CRTZBYI;O7;LM-N_?\#DE.I6K\]6E+DC\*LM_Y
MGKOV73\7]BT5XW^SWX7^-/AQ]=/Q=\7:-XI680_V:-)A5/((W^;OVV\.<YCQ
M][[IZ=_9*\FI#V<N5-/T/:IU'4CS.+7J<7XH_P"1EM/]V/\ ]"-=I7%^*/\
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MU251[MM_>=]&DJ-*-*.T4E]P5D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\  ?\
MT,5D;$/@W_D"K_UT:MVL+P;_ ,@5?^NC5NT %%%<_P#$#0]6\3>"]8TK0M:;
MPYJ]W;-%;:HD(E:V<C[P4D9_/(SD<TF,A\4?"_P;XVNDN?$7A+0M?N(QM2;5
M--AN74>@+J2*^5_^"D'BC3_"_P %] ^'NC6L,-YKE_$MOIME&%"P0G=A8U'
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MG_LM=;7)>/O^7'_MI_[+28'36/\ QY6__7-?Y"IZ@L?^/*W_ .N:_P A4],
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M+\<?\A&U_P"N?]37:5Q?CC_D(VO_ %S_ *FNTH **** "BBB@ HHHH ****
M.+\4?\C+:?[L?_H1KM*XOQ1_R,MI_NQ_^A&NTH **** "BBB@ HHHH ****
M.+U?_D<[?_KI%_2NTKB]7_Y'.W_ZZ1?TKM*0!1113 **** "BBB@ HHHH XN
M;_D>A_UT7_T 5VE<7-_R/0_ZZ+_Z *[2D 4444P"BBB@ HHHH **** .+L?^
M1X?_ *Z2?^@FNTKB['_D>'_ZZ2?^@FNTI %%%%, HHHH **** "BBB@#B]!_
MY&ZZ_P!Z7^==I7%Z#_R-UU_O2_SKM*2 ****8!1110 4444 %%%% '%^#_\
MD/7?_7-O_0UKM*XOP?\ \AZ[_P"N;?\ H:UVE) %%%%, HHHH **** "D;[I
M^E+2-]T_2@#C? ?_ !]W7^X/YUV=<9X#_P"/NZ_W!_.NSI( HHHI@%%%% !1
M110 5!??\>5Q_P!<V_D:GJ"^_P"/*X_ZYM_(T <SX!_Y?O\ MG_[-76UR7@'
M_E^_[9_^S5UM) %%%%, HHHH **** "J>L_\@B]_ZXO_ .@FKE4]9_Y!%[_U
MQ?\ ]!- &'X#_P"/6Z_WQ_*NHKE_ ?\ QZW7^^/Y5U% !1110 4444 %%%%
M!6;XC_Y =Y_N?U%:59OB/_D!WG^Y_44 9_@;_D$S?]=S_P"@K715SO@;_D$S
M?]=S_P"@K714 %%%% !1110 4444 %9'BS_D 77_  '_ -#%:]9'BS_D 77_
M  '_ -#% $/@W_D"K_UT:MVL+P;_ ,@5?^NC5NT %%%% !1110 4444 %87C
M+_D"M_UT6MVL+QE_R!6_ZZ+0!-X3_P"0!;?\"_\ 0C6O61X3_P"0!;?\"_\
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M_P *OL/^?NY_\=_PH_X5?8?\_=S_ .._X4 +_;VG?\_D/_?5']O:=_S^0_\
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M_P *OL/^?NY_\=_PH_X5?8?\_=S_ .._X4 +_;VG?\_D/_?5']O:=_S^0_\
M?5)_PJ^P_P"?NY_\=_PH_P"%7V'_ #]W/_CO^% "_P!O:=_S^0_]]4?V]IW_
M #^0_P#?5)_PJ^P_Y^[G_P =_P */^%7V'_/W<_^._X4 <YXSU"VOEM/L\R3
M;2V=ISCI6[8ZY81V-NK7<2LL:@@MT.!6#XR\*V_AM;0P322^<6!\S'&,>@]Z
MW;'X;6-U8V\[75P&DC5R!MP,@'TH L?V]IW_ #^0_P#?5']O:=_S^0_]]4G_
M  J^P_Y^[G_QW_"C_A5]A_S]W/\ X[_A0 O]O:=_S^0_]]4?V]IW_/Y#_P!]
M4G_"K[#_ )^[G_QW_"C_ (5?8?\ /W<_^._X4 +_ &]IW_/Y#_WU1_;VG?\
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M=_S^0_\ ?5']O:=_S^0_]]4G_"K[#_G[N?\ QW_"C_A5]A_S]W/_ ([_ (4
M+_;VG?\ /Y#_ -]4?V]IW_/Y#_WU2?\ "K[#_G[N?_'?\*/^%7V'_/W<_P#C
MO^% "_V]IW_/Y#_WU7*>+KV"\U"W>"5955,$J<XY-=5_PJ^P_P"?NY_\=_PK
ME/%WAV'P_?V\$,LDBR)N)DQD<D=J .L_M[3O^?R'_OJC^WM._P"?R'_OJD_X
M5?8?\_=S_P"._P"%'_"K[#_G[N?_ !W_  H 7^WM._Y_(?\ OJC^WM._Y_(?
M^^J3_A5]A_S]W/\ X[_A1_PJ^P_Y^[G_ ,=_PH 7^WM._P"?R'_OJC^WM._Y
M_(?^^J3_ (5?8?\ /W<_^._X4?\ "K[#_G[N?_'?\* %_M[3O^?R'_OJC^WM
M._Y_(?\ OJD_X5?8?\_=S_X[_A1_PJ^P_P"?NY_\=_PH 7^WM._Y_(?^^J/[
M>T[_ )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\ '?\ "@!?[>T[_G\A
M_P"^JYGQI?V]]]C^SS)-MW[MISC.VNE_X5?8?\_=S_X[_A7->,O"]OX;^Q^1
M+)+YV_/F8XQM]![T =!9ZYIZ6D"M=Q!@B@C=[5-_;VG?\_D/_?506?PUL;BT
M@E:ZN 9$5B!M[C/I4W_"K[#_ )^[G_QW_"@!?[>T[_G\A_[ZH_M[3O\ G\A_
M[ZI/^%7V'_/W<_\ CO\ A1_PJ^P_Y^[G_P =_P * %_M[3O^?R'_ +ZH_M[3
MO^?R'_OJD_X5?8?\_=S_ .._X4?\*OL/^?NY_P#'?\* %_M[3O\ G\A_[ZH_
MM[3O^?R'_OJD_P"%7V'_ #]W/_CO^%'_  J^P_Y^[G_QW_"@!?[>T[_G\A_[
MZH_M[3O^?R'_ +ZI/^%7V'_/W<_^._X4?\*OL/\ G[N?_'?\* *^I:U82Z;=
M(EW$SM$X"AN22#6-X-U"VLH;D3SI$692-QQG@UL:E\.+*RTZZN%NKAFAB>0!
MMN"0"?2L;P=X3M_$D-R\\TL1B90/+QSD'U% '1_V]IW_ #^0_P#?5']O:=_S
M^0_]]4G_  J^P_Y^[G_QW_"C_A5]A_S]W/\ X[_A0 O]O:=_S^0_]]4?V]IW
M_/Y#_P!]4G_"K[#_ )^[G_QW_"C_ (5?8?\ /W<_^._X4 +_ &]IW_/Y#_WU
M1_;VG?\ /Y#_ -]4G_"K[#_G[N?_ !W_  H_X5?8?\_=S_X[_A0 O]O:=_S^
M0_\ ?5']O:=_S^0_]]4G_"K[#_G[N?\ QW_"C_A5]A_S]W/_ ([_ (4 5-8U
MFQFTJZCCNHG=HR H;DUF>#]2M;*RG6>=(F,F0&..PK2UCX=V6FZ7=727,[/#
M&7"MMP<?A69X/\(6WB*SGFGFEB:.38!'C'0'N* .@_M[3O\ G\A_[ZH_M[3O
M^?R'_OJD_P"%7V'_ #]W/_CO^%'_  J^P_Y^[G_QW_"@!?[>T[_G\A_[ZH_M
M[3O^?R'_ +ZI/^%7V'_/W<_^._X4?\*OL/\ G[N?_'?\* %_M[3O^?R'_OJC
M^WM._P"?R'_OJD_X5?8?\_=S_P"._P"%'_"K[#_G[N?_ !W_  H 7^WM._Y_
M(?\ OJC^WM._Y_(?^^J3_A5]A_S]W/\ X[_A1_PJ^P_Y^[G_ ,=_PH 7^WM.
M_P"?R'_OJC^WM._Y_(?^^J3_ (5?8?\ /W<_^._X4?\ "K[#_G[N?_'?\* (
M[O7-/>UF5;N(L48 ;O:N>\%W]O8_;/M$R0[MFW<<9QNK?N_AK8V]K-*MU<$Q
MHS ';V&?2N?\&^%[?Q)]L\^62+R=F/+QSG=ZCVH Z?\ M[3O^?R'_OJC^WM.
M_P"?R'_OJD_X5?8?\_=S_P"._P"%'_"K[#_G[N?_ !W_  H 7^WM._Y_(?\
MOJC^WM._Y_(?^^J3_A5]A_S]W/\ X[_A1_PJ^P_Y^[G_ ,=_PH 7^WM._P"?
MR'_OJC^WM._Y_(?^^J3_ (5?8?\ /W<_^._X4?\ "K[#_G[N?_'?\* %_M[3
MO^?R'_OJC^WM._Y_(?\ OJD_X5?8?\_=S_X[_A1_PJ^P_P"?NY_\=_PH 7^W
MM._Y_(?^^J/[>T[_ )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\ '?\
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MY#_WU1_;VG?\_D/_ 'U2?\*OL/\ G[N?_'?\*/\ A5]A_P _=S_X[_A0 O\
M;VG?\_D/_?5']O:=_P _D/\ WU2?\*OL/^?NY_\ '?\ "C_A5]A_S]W/_CO^
M% "_V]IW_/Y#_P!]4?V]IW_/Y#_WU2?\*OL/^?NY_P#'?\*/^%7V'_/W<_\
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M 7^WM._Y_(?^^J/[>T[_ )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\
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MK[#_ )^[G_QW_"@!?[>T[_G\A_[ZH_M[3O\ G\A_[ZI/^%7V'_/W<_\ CO\
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MJD_TKJ_^%7V'_/W<_P#CO^% "_V]IW_/Y#_WU1_;VG?\_D/_ 'U2?\*OL/\
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MK[#_ )^[G_QW_"@!?[>T[_G\A_[ZH_M[3O\ G\A_[ZI/^%7V'_/W<_\ CO\
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M_?5<[X/\)6_B.VN))YI8C&X4"/'/'N*Z'_A5]A_S]W/_ ([_ (4 +_;VG?\
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M %R/_H0KTBO-_AK_ ,AZ^_ZY'_T(5Z120!1113 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /-_$'_)1K/\ ZZP?S%>D5YOX@_Y*-9_]=8/YBO2* "BBB@ HHHH ****
M "BBB@ HHHH **** ."^*G^KTWZR?^RUV.C_ /((L?\ K@G_ *"*X[XJ?ZO3
M?K)_[+78Z/\ \@BQ_P"N"?\ H(I 7****8!1110 4444 %%%% !5+6O^0-?_
M /7O)_Z":NU2UK_D#7__ %[R?^@F@#D?A7_J-1_WD_DU=W7"?"O_ %&H_P"\
MG\FKNZ2 ****8!1110 4444 %%%% !1110 5YO\ $S_D-6/_ %R_]F->D5YO
M\3/^0U8_]<O_ &8TF!Z11113 **** "BBB@ HHHH **** "N ^*O_,+_ .VO
M_LE=_7 ?%7_F%_\ ;7_V2DP.UTO_ )!MI_UQ3_T$5:JKI?\ R#;3_KBG_H(J
MU3 **** "BBB@ HHHH **** *&O?\@/4?^O:3_T$UROPL_X]+_\ WU_D:ZK7
MO^0'J/\ U[2?^@FN5^%G_'I?_P"^O\C0!W-%%% !1110 4444 %%%% &5XI_
MY%W4?^N#?RK ^%__ "";O_KO_P"RBM_Q3_R+NH_]<&_E6!\+_P#D$W?_ %W_
M /910!VE%%% !1110 4444 %%%% !1110!6U+_D&W?\ UR?_ -!-<3\*O^8I
M_P!LO_9Z[;4O^0;=_P#7)_\ T$UQ/PJ_YBG_ &R_]GI =_1113 **** "BBB
M@ HHHH **** /-_$W_)0['_KK!_Z$*](KS?Q-_R4.Q_ZZP?^A"O2* "BBB@
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MB@ HHHH **** /-]-_Y*=)_UVE_] :O2*\WTW_DITG_7:7_T!J](I %%%%,
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M "+.H?\ 7/\ J*V:QO&'_(LZA_US_J* ,CX8?\@&X_Z^6_\ 0$KL*X_X8?\
M(!N/^OEO_0$KL* "BBB@ HHHH **** "N?\ 'O\ R*E[_P!L_P#T-:Z"N?\
M'O\ R*E[_P!L_P#T-: *_P .?^1;7_KJ_P#2NHKE_AS_ ,BVO_75_P"E=10
M4444 %%%% !1110 5R_Q&_Y%M_\ KJE=17+_ !&_Y%M_^NJ4 3^ ?^15LOJ_
M_H;5T-<]X!_Y%6R^K_\ H;5T- !1110 4444 %%%% !7'_$__D V_P#U\K_Z
M ]=A7'_$_P#Y -O_ -?*_P#H#TF!K^#_ /D6=/\ ^N?]36S6-X/_ .19T_\
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M754&Z:^UI]]M[?(_06BFQR+-&LB,'1@&5E.00>AIU>>>GOJ@HHHH \W\3?\
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M-K]FO]N;XH?'/]JSPUHFHZA::7X2U)[D/H5G9Q% J6TSIF9E,I.Y5)(8 XZ
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MY&FM[VZ[=6;%%%%<AVG"_%/_ (]M/_WW_D*ZS0_^0)I__7O'_P"@BN3^*?\
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M ,AZ^_ZY'_T(5Z120!1113 **** "BBB@ HHHH *^;O^"A__ ":7XR_W[/\
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MFMVBBN24G.3E)W;.V,8TXJ$59(*X#XJ_\PO_ +:_^R5W]<!\5?\ F%_]M?\
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M7*_"S_CTO_\ ?7^1K$W.YHHHH _.'_@H?_R=C\&_]VT_]+J_1ZOSA_X*'_\
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MI_Y%W4?^N#?RK ^%_P#R";O_ *[_ /LHKSCU3M**** "OSA_X*7?\G"?!_\
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MOO\ KJO\J[>N(^%O_'A??]=5_E7;T %%%% !1110 4444 %8WC#_ )%G4/\
MKG_45LUC>,/^19U#_KG_ %% &1\,/^0#<?\ 7RW_ * E=A7'_##_ ) -Q_U\
MM_Z E=A0 4444 %%%% !1110 5S_ (]_Y%2]_P"V?_H:UT%<_P"/?^14O?\
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MD1J?^^CEB!P!W6I?L!? 75M0NKZ[\">;=74K32R?VQ?C<[$EC@3X&23TJO\
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M"P]%TE)S=Y2=V_-]O);(****YCK/-_$'_)1K3_KM!_,5Z17F_B#_ )*-:?\
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M9WB+_D7]2_Z]I/\ T$U!J<S\+?\ CPOO^NJ_RKMZXCX6_P#'A??]=5_E7;T
M%%%% !1110 4444 %8WC#_D6=0_ZY_U%;-8WC#_D6=0_ZY_U% &1\,/^0#<?
M]?+?^@)785Q_PP_Y -Q_U\M_Z E=A0 4444 %%%% !1110 5S_CW_D5+W_MG
M_P"AK705S_CW_D5+W_MG_P"AK0!7^'/_ "+:_P#75_Z5U%<O\.?^1;7_ *ZO
M_2NHH **** "BBB@ HHHH *Y?XC?\BV__75*ZBN7^(W_ "+;_P#75* )_ /_
M "*ME]7_ /0VKH:Y[P#_ ,BK9?5__0VKH: "BBB@ HHHH **** "N/\ B?\
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M_P! :O2*\WTW_DITG_7:7_T!J](I %%%%, HHHH **** "BBB@#S?PK_ ,E
MOO\ ?G_]"->D5YOX5_Y*!??[\_\ Z$:](I( HHHI@%%%% !1110 4444 >;_
M  ]_Y&J__P"N4G_HQ:](KS?X>_\ (U7_ /URD_\ 1BUZ120!1113 **** "B
MBB@ IK_=;Z4ZFO\ =;Z4 >=?"W_C_OO^N2_SKT>O./A;_P ?]]_UR7^=>CTD
M 4444P"BBB@ HHHH *K:E_R#;O\ ZY/_ .@FK-5M2_Y!MW_UR?\ ]!- '$_"
MK_F*?]LO_9Z[^N ^%7_,4_[9?^SUW]) %%%%, HHHH **** "L[Q%_R+^I?]
M>TG_ *":T:SO$7_(OZE_U[2?^@F@#F?A;_QX7W_75?Y5V]<1\+?^/"^_ZZK_
M "KMZ "BBB@ HHHH **** "L;QA_R+.H?]<_ZBMFL;QA_P BSJ'_ %S_ *B@
M#(^&'_(!N/\ KY;_ - 2NPKC_AA_R ;C_KY;_P! 2NPH **** "BBB@ HHHH
M *Y_Q[_R*E[_ -L__0UKH*Y_Q[_R*E[_ -L__0UH K_#G_D6U_ZZO_2NHKE_
MAS_R+:_]=7_I744 %%%% !1110 4444 %<O\1O\ D6W_ .NJ5U%<O\1O^1;?
M_KJE $_@'_D5;+ZO_P"AM70USW@'_D5;+ZO_ .AM70T %%%% !1110 4444
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M?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\ X6HG_0-;_O\
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M .%J)_T#6_[_ '_V-'_"U$_Z!K?]_O\ [&NP_L;3_P#GQMO^_*_X4?V-I_\
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M]_\ 8T?\+43_ *!K?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H
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M/_Y\;;_ORO\ A2 Y#_A:B?\ 0-;_ +_?_8T?\+43_H&M_P!_O_L:[#^QM/\
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M\+43_H&M_P!_O_L:[#^QM/\ ^?&V_P"_*_X4?V-I_P#SXVW_ 'Y7_"@#C_\
MA:B?] UO^_W_ -C1_P +43_H&M_W^_\ L:[#^QM/_P"?&V_[\K_A1_8VG_\
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M*_X4?V-I_P#SXVW_ 'Y7_"@#C_\ A:B?] UO^_W_ -C1_P +43_H&M_W^_\
ML:[#^QM/_P"?&V_[\K_A1_8VG_\ /C;?]^5_PH X_P#X6HG_ $#6_P"_W_V-
M'_"U$_Z!K?\ ?[_[&NP_L;3_ /GQMO\ ORO^%']C:?\ \^-M_P!^5_PH X?4
M/B4E]87-L-/9/.B:/=YN<9!&>E9/A3Q<OAJ&X1K4W'FL&R'VXP/H:]-_L73S
MP;"V(_ZXK_A0NAZ<OW=/M1](5_PI <A_PM1/^@:W_?[_ .QH_P"%J)_T#6_[
M_?\ V-=A_8VG_P#/C;?]^5_PH_L;3_\ GQMO^_*_X4P./_X6HG_0-;_O]_\
M8T?\+43_ *!K?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\
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M?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\ X6HG_0-;_O\
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M9P ,]*[5M#TYOO:?:GZPK_A2_P!BZ>.!86W_ 'Y7_"D!R'_"U$_Z!K?]_O\
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MW_?[_P"QH_X6HG_0-;_O]_\ 8UV']C:?_P ^-M_WY7_"C^QM/_Y\;;_ORO\
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MI_\ SXVW_?E?\*/[&T__ )\;;_ORO^% ''_\+43_ *!K?]_O_L:/^%J)_P!
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M .%J)_T#6_[_ '_V-'_"U$_Z!K?]_O\ [&NP_L;3_P#GQMO^_*_X4?V-I_\
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M/_Y\;;_ORO\ A2 \J\*^)1X;N)Y&MS<>:H7 ?;C!SZ&NE_X6HG_0-;_O]_\
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M^%J)_P! UO\ O]_]C78?V-I__/C;?]^5_P */[&T_P#Y\;;_ +\K_A0!Q_\
MPM1/^@:W_?[_ .QH_P"%J)_T#6_[_?\ V-=A_8VG_P#/C;?]^5_PH_L;3_\
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M-M_WY7_"C^QM/_Y\;;_ORO\ A0!Q_P#PM1/^@:W_ '^_^QH_X6HG_0-;_O\
M?_8UV']C:?\ \^-M_P!^5_PH_L;3_P#GQMO^_*_X4 <?_P +43_H&M_W^_\
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M9\OR?+X_UG7>>G3FO9ZIQ<5&3VDKKT)C.,FTNFC^Z_ZA1114%A1110 4444
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M6GV+[7]JQY>/FW^6G7/3;7K5:U*<J4G":LT8TJL*T%4INZ8445R/BSXL>%?
M_BOPUX:UO5?L6M>))7@TJU^SRR?:'7&X;D0JF-P^^1UJ(IR:BM6S24E%.4G9
M(ZZBBBD,**** "BBB@ HHHH **** "BBB@ HHKQCX;_M&?\ "P/CY\0/AI_P
MCWV#_A$XT?\ M3[;YGVK=MX\KRQLQN_O-TJX1E4;4>BO\E_PYG.I&FDY/=I?
M-[?D>ST445!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFMO6_6^WGI:_9R_:-T;]HKPSJ-[9:==:#K.DW/V/5=%OL&6TFYXS@;E.& )
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M8XE&P8R3EL\' 8\5[;\8/BE%\+?A'K_CJ"R77(-,LOML=LEQY2W"DKC$FUL
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MY ?3]U&/^V8KBH4U-RE+:*OZZI)?>]3OQ%65-1C#>3MZ:-M_<M//[CVOX?\
MQ\\>ZMX\T_POXW^"NN>"Y=11Y+;4K348-5LE"*2WGRQA1%V '))(XKY_^*/Q
M!TCX8_\ !2&UUW6GG^RQ^%EAC@M(&GGN)G5UCBBC49=V8@ #U[#FOO.OBS5+
M>*X_X*E:498DD,?A4NA=0=K>7(,CT.">?>NC#RC*KI&WNRO;_#+O?^ON.;%1
ME"C9RO[T+7M_/'M8ZWQE^V7XJ^%=U8:GX_\ @KK7A7P->7*VZZ\=6M[N:'=]
MUI;:($QG'52^>"!D\5]#>)/&VG^&_ ]]XK*7.I:7:V1O\:;$9I9H@N_,:C[Q
M*\BO#/\ @HE&LG[)?C#<H;;)9D9&<'[5%S74?#;XF:+\,_V1_!'B_P 4WWV/
M2['POITL\V-S,3;QA55?XF8D #U-9.,:F'=6*LU+EZZW5_O]#:,IT\2J4I73
MCS:VTL[=.GK]YQU[^U-\4IM'F\0Z-^SGXBNO"\2&8W&IZQ;V5\8QR6%D5>0G
M&2 ,Y[5ZW\#/C=X>_: ^']KXL\-F9+621H)[6Z4+-;3+C=&X!(S@@@@\A@:\
M?\/_ !^^-WQFT^/5/AW\)]-T#P[=#?9:UXXU(I]IC/1_LT(\P CD$$J1R":X
M;_@F6M[:V?Q?LKX6\=Q;^)2)8;+=]G27#A_+W<[<J ,\X S71*BO9U.:*BXI
M-:W>Z6NOGY'-&O)5::C-R4FUM9;-Z.R[=W<[CP_^W-:^(_%GC+PE8>!=5U7Q
MAHNK2Z98:+I,WVA[Y(V96N9)&1([:,$ $LQQN'6KWAG]K[5;'XL:+X ^*'PT
MO?AIJFO?+I-TVJ0ZC;7+YP$,D:A5).%X+8++G&0:X']@^-?^%W_M)/M&_P#X
M2-5W8YQYUWQFH_\ @HE(;7QI\ ;J,!9XO% *28Y'[RW/7Z@?E3A3I>WI47'X
MU&[UT;BG=?/O?Y"G5J^QJU5*W(YV5EJHR>C^2MI;YGTM\;OC?X:^ 7@F3Q+X
MFEF,)D6WMK.T0/<7<S9VQQJ2 3@$\D  &O O'W[:7Q2^&_A$>+-;_9TU*P\,
MMM*WEQXDB\R-6^Z9H4@9X<Y ^<#!('6I_P#@HIX7OF\#>#?'MHUO/#X)UR'4
MKG3[F=8A<QET&U=W#/N50%ZD,< GBL7XV_M@^#_C1\(==\"> ],U[Q)X[\16
M;:</#RZ3/'/8M(-K-.S+L 3)Y5F&0.0,D8T:?-34XPYWS6:UT6G;O?=Z(VKU
M>6KR2GR+ENGIJ[OO?:RT6K/?/@7\6/%/Q.\*W'B'Q7X&A\!Z8\,-WI]P-?M]
M2CO;=T+F7=$J^6%&W[W7=[&O.H?VP/$'Q U+4Q\(?A+JGQ(T+39FMY]>DU6#
M2[65QU%N95/G8]L'D<8()P/C1X9USX'_ /!.N]\.+*9=7T[0[>PO)87R$\R5
M%G"GNH#NH]JQ_P!G?XD?&+P=\#_!6E>%_P!G5-4T*+3(7MM1C\;6$ O Z[VG
M,93*%V8L5/(W8-;>RIRE5J02Y8RY4KV7K=N^UNN[?1&"K58PI4ZC?-)-MVN^
MFB25MWU6R75W/?\ X&?M :-\<+/5X8-/OO#WB30YQ:ZQX?U1-MS92'.,XX93
MM;##KCD"N U?]K;6?$7CK7_"_P )_AC?_$V?P]+]GU74/[5@TRSAER1Y:22A
MA(0588X^Z<9'-<S\$?!GQ4OOVMO$7Q)\4_#H?#[0M8T 6-S;C7+74!+<QO%L
M;,1#9*J>JX&#SR*R&^#GQG_9=\?>+/$7PHM-,\?^"_$5\VIWOAF^E$%[#(S%
MF,3D@$C) .3D8!0D F/9THS7,UK&]KW7->UFUTM=K7M=FGM:TJ;Y4])6O:TN
M6U[I-;WLGIW:7;Z#^"_Q<U3XH6^KPZWX"U[P)JVDS+!<VVK*K0R.P)_<3*<2
MJ!C+!0.1US7:^*M1U/2/#>IWNC:0=?U:WMWDM=+%REO]JD RL?FO\J9/&X\"
MO*?V=?VI-$^/[:OI1TB_\)^,=%(&J>'M47$L&3C<K8&Y0>#E5(.,J,@GVNN6
MM!PE9QM_73<[*$U.%U+F_!^C6FOR1^:?[+OQ$^)VD?M$?&Z^T/X3'Q)K&H:F
M&U;2SXEMK;^R6\^;Y/-=2L^"67*8^Y[BOK3XU_M9:+\"?BGX4\+>([!+?1]8
MT^YO[C7'N]HL_*1V""$1GS"Y4*,,#EA@&O'?V*_^3KOVE_\ L,?^W-S3/VL/
M#^G>*?VW_@#IFK6<6H:?-'*TEM.NY'VNSJ&'<;E'!X.,'BO0:A6K8>FXV3BM
MK_R-KKT>WXW/-O4H4<34C)MJ3WM_.D]EUOKT[)'K7P%_:DUWXZ>-[FP7X4^(
M?"_A+[$U[9>)M8WQQW:AD555/*"98.3\LC<*:IZM^U]>>)/&>K^&/A'\.M1^
M*=YHS^7J-_#J$.G:?"_(*+<2@AFR#Q@9P<$XKT_]H#6-0\._ SQ]J6D[AJ-I
MH=Y+ T?#*PA;##W'7\*\D_X)R:+8:7^RCX9N;-5\_4+B\NKN11R\OVAX^?<)
M&@_"N:*IRC*KRV4;*U]V[ZOY+I8Z9.K"4*3G=SN[VV22T7S?6^G<ZKX0_M3:
M?\0O&]WX"\3>'-0^'WQ#MH_..@ZJZR+<1@9+6\RX64 <]!P"1D D._:*_:BT
MS]G/Q#X#M-:TP3Z3XDNYH+K4S<M'_9\<?EYD\M8W,O\ K/N@J>.^:\5_;V4>
M'_C5^SYXDTL^3XA&O?9%>,X>2$RP?(>Y7YV'_ R.]6OV\HUE^-7[-".H=&\5
M %6&01]HL^*THTH5IT)6LIMIKTOMU[?YDU*M2E&M&]W&-T^NJ>_2Z:?JK:'6
M>./VQ/&7@W1'\7-\"O$+_#N,JSZY>:E!;W:Q$X\TV.UI%7D$;RO!&<5M?\-?
M+X\MX1\'? VJ?%.[^S1W-VT5S%IMG9;U#"&6YF^7SP#S&H8CGGBO1_VAK>.Z
M^ OQ&BF021GP]?DJ?:W<C]17EO\ P3J@CA_9&\&LD:HTDM\[LJ@%V^V3#)]3
M@ ?0"LX^SE2G/E^%KJ];WW^[I8N?M8580Y])WZ+2UMOOZW.K_9W_ &FK'X\3
M>(=(NM O?!_C'P[,(=5T&_D$C0Y) 9' 7>N5(/RC!QV()]EN))([>5XHO.E5
M24CW!=YQP,GIGUKXR^#:B'_@I3\8DC^1'T*)V5> S8L^37VC66(A%1A."MS1
M3]+^IKAJDG*I">O))KU6^MK=^A^;=_\ %+XH77[>UCK'_"H<>,;7P\UJGA/_
M (26URT)5V\XW6WRQPY.S&>*^F?CMXB\3^*/V-?B+?\ B[PE_P (1K3:3=*^
MD?VE%J&Q0<*WG1@*=PYQVKS)_P#E*A'_ -BS_P"T#7N_[87_ ";!\2_^P+/_
M "%;8B<72II12]U]]/>EY_F<V%A)5JS<V[2\M?<CY?D>&?LQ_'[6K3]G7P5X
M?^'/P\U+XE:SI-@L>IM%>Q:;8VCEF;RC<S</+M()1 V 1DCI7M/[/'[3EC\=
M+SQ#H=[H%YX.\9^'I?*U/0+^02-$"2 Z2 +O7(P>!CCL03!^Q%;Q6_[*OPZ$
M421!M/+L$4#+&5R2<=R>]>,?"*0P?\%./BU#'A(Y?#ZNZJ,9(%ES^IKIJQA5
MQ->FUJN>5^MT_NM\K^9ST)5*6$P]12T?(K=+-???YV\CW?XW?M+:/\']8TCP
MU9Z1J'C+QUK/.G^&]' ,SKS^\D8\1Q\'YB#T)Q@$CE-+_:RUKPUXNT30OBW\
M,-0^&":[.+33=4_M2#4[*2<_=CEEB $3'MG/J< $CY_\'^,O'EE^W'\:-:\.
M_#;_ (6/K=F$T^.*77K?3386N5"LIF4[@X1?N],G/WJ[#]I%?CY^T-\++WP?
M)^SY_84LMQ!<P:D/&FGW!@>-PV0F$SD;E^\/O5E3HP4:3DDU))MMI-)]E=;+
MNG=FM3$3E.JHMIP;22BVFUW=GN]-&K(^W:\6_:0_:6L/V<9/!<NJ:4+W3=?U
M06%U>M=&(6$7REYRHC<R;02=HP3CK7JOA>._A\,Z0FJC&IK9PK=@,&_?!!OY
M'7YL\U\B_P#!1I%DO_@@CJ'1O%L8*L,@C,?!KFHTU+$1I/5.27XV.NO5E'#2
MJQT:BWZ:'7>-/VP/&'A[P_/XPTSX'>(-2^'<"^;)KUYJ,-G<&#/^O6R*M+Y>
M/F#-MX.3@5JVO[9%I\0M/LQ\(O!>K?$W5Y;1+NZM8IXM/M].#=(KFYE^1)>#
M\B[B=I/3!KV+XJ6\=U\,/%\,J!XI-'O%93T(,+Y%?/O_  3.@CB_97TITC5'
MEU*\:1E4 N1)@$^IP /H!6E/V4Z=27+\%NN][K7[NEC.I[:G5IQY_CYKZ+2U
MMOOZW.[_ &??VH+7XU:]XC\+:MX:O?!/CGP\W_$PT&^F6;"$XWQR +O )7/R
MC[RD9!S4^J?M'?V;^U-H_P &_P#A'O,_M#2FU/\ MK[;CR\+*VSR?+Y_U77>
M/O=..?&O"BBW_P""H?C#RQY?G>%$,FWC>=MMU]>@_*H_%/\ RE*\'_\ 8JR?
M^B[JM(TJ<Y0E:RE!RMYJ,OGNKF%2M5ITY+FNXSBKZ;.4-^FTK;>9[!^T'^U1
MI7[._C+P+I6N:9YND^(Y)UN=6-RR?8$CV?-Y2QL9<[^@*].]<EXT_:Z\<^%-
M"F\6Q_ ?Q#+\/X )9=8O=3@M;Q8<X,IL<-(JXY^8KQR<5QG[;D:R_M)?LTHZ
MAU.OG*L,@_Z1:U]0?&B-9?@_XY1U#HVAWP*L,@CR'XKG?)2PL*SC=MR[]'Y?
MUZG6O:5L5.@I<J2CT5]5Y_UZ%CP'\2-&^)?P\TWQEX?E:ZTG4+4W4.\;7&,A
MD8=F5@5/7D'K7#?LM_M#?\-*?#^_\3?V!_PCGV74Y=.^R_;?M6[8D;;]WEIC
M._&,=NM>:?\ !.VXDF_8[TU7;*Q7&H(GL/-<X_,FLC_@EO\ \F_Z[_V,MU_Z
M)@KIJ8>%.>(C_+RV^;_R.6GB*E2&&D_MWOYVC_F=+I?[<5KJWCSQSX)LO VJ
M:MXMT'59--T[2=)F\]]25&=7N'=D1+:-2J[B['&\8S45G^W$/!OCQ?"WQD\!
M7?PFN)[5[NTOI]2CU&UF50209(D !.T@!=WS8'!(SRO[$\:G]IK]IYRHWC7H
MP&QR ;B\R/T'Y5#^WM86US\;_P!FMIH$E\SQ,(7$B[@R&XM,J0>".313ITI5
MJ5%Q^-1N^S<+W7S[W^05*E54ZU12^"4K*RU2EL_EHK6\[G8>,OVRO%OA'0QX
MQD^!WB(_#8,I?7KK4((+M8F; E-CAI%4Y!!=E!!&2,U[FOQ0TO4OA++\0-%_
MXFFE-I#ZO;+N\LS(L1D"$X.T\8/!P<\<5A_M.Q)-^SK\24D4.A\/WORD<<0L
M:\9_9GD:3_@G7 68L1X>U<#)SP'N<"N2IR/#5*D59Q:_%2W\].EO0[*?/'%4
MZ<Y74T_DTX[>3OU;?F>S?LW_ !J_X:"^$NE^-O[&_L'[;+/']A^U?:=GER,F
M=^Q,YVY^Z,9K!;]I/;^U0OP:_P"$=ZZ9_:/]M_;O^F>_9Y'E_AG?^%<=_P $
MW_\ DTSPQ_U]7W_I3)7"/_RE0C_[%G_V@:[*E&G'%SI):)2_"+:_$XH8BH\)
M3JM^\W&_SDD_P/8/CQ^UEH_P ^)7@WPWKVELVDZ_!<33:PD[%K3RQ\JB!8V,
MI=MJ@!AR>]<AXZ_;+\8?#C3XO$^O_ KQ#IGP]DE13K5QJ=N+R)'.%:2R4%HR
M20,.Z\D#()KEOVK(UD_;6_9Q#J&'VB4X89Y$BD?K7M?[8\*7'[+OQ*610ZC1
MY7 /J,$'\P*PC[.G0IU91NVY7WZ2\NMM/T-Y.I4Q%6E&7*HJ-M%NXI]>E_\
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MLW>DWZ%D+KMDC8'#1NO\+*001[<$C!KI[BXBM+>2>>1888U+O(YPJJ!DDGL
M*^+_ /@E_(\/@3XC:?;L9-&M/$T@LVS\N#&H./P5#U[_ )^N?MT:SJ&A_LJ^
M/[C3=ZSO:1V[O&<%8I)HTD/_ 'PS#\:QQ5-4ZO)3V=K7_O6M?TN=6%J2J4E*
MINKIV\FT[>MCG+?]L37?B)J6II\'_A/JOQ)T;39FM[C7)=4@TJTD<<D0-*#Y
MO4<<'D'&"">Y^!O[36A?&C5-7\.RZ9?^$O'&B_\ (2\-:NH6>(9 WHPXD3)
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M OPR\"ZA\4?$^E@'4Q:7D5E8V1/\$EU("H?@_+CJ",Y! U?A'^TPGCKQS=^
M?%OA/4/AYX_M[?[6NC:A,EQ%=0]WM[A %D [X [XSM;'RG^PK\0/BAX8^$-_
M=>$/@L/'L>J:M<7-[X@;Q99V,D\_R@HT4JEQM'J>=Q(ZUZ3X@T'XV_%G]H;X
M2>,M1^#W_"!VWA>]D2^O_P#A*+*_\RUEVK(-J%6X7?P V=_0=_0EA84YJC*U
MK:RYE>]K[7VOI:U[:W/-CC)5:;KPOOI'E;35^]M[:WO:^ECUOXL?M0GP;\1[
M;X<^#/!U_P#$7Q]+;?;)=+L[J.T@M8>S37$@*H2"#TQRN2-PSH?"GXY>+/%_
MC*7PKXR^$VO> ]56U:\6Z:YBO].:,$#'VJ/"[R6'R@'\*\Z^,_P"^)?AOXXS
M_&;X.W^F7>O7EBMCJOAW6_EBO(T"@"-\@ D1Q\%DP5SNY(K<^#'[7Q\9_$0?
M#?Q_X.O_ (<_$$QF2"QNW$UM>JJEB8I<#J%8@8*D*<.3Q7+3IQE23@E*5G?7
M5/79=4M.C\['7.I*%9^TDXQNK:*SVW=G9WNMUY7/HN9F2)V1/,<*2J9QN/89
M[5^;WB;XI?$^\_;X\-ZJWPCV>+K'0I+>W\*'Q):DSPE)SYQNMOEKPS'9C/RX
M[U^DE?$FO?\ *5+PY_V+3_\ I//1@VE5=U?W9?\ I,OSV?X68LPNZ*L[>]#_
M -+C^6Z\][K0]-^.7B3Q3XJ_8W^)-]XQ\'?\(-K)TNZ0Z3_:D6H80 ;7\V(!
M>>>.HQ7G/[,?Q^UJT_9U\%>'_AS\/-2^)6LZ38+'J;17L6FV-HY9F\HW,W#R
M[2"40-@$9(Z5[G^V%_R;!\2_^P+/_(5G?L16\5O^RK\.A%$D0;3R[!% RQE<
MDG'<GO3A*/L*DG'K'3IM+Y_C\Q3C+ZS3BI:\L]=+[P^5_E\B?]GC]IRQ^.EY
MXAT.]T"\\'>,_#TOE:GH%_()&B!) =) %WKD8/ QQV()M?%CX^ZGX#\6VWA/
MPU\./$GCOQ'<6PNT6QC2WL(XRQ4>;=.=J'*GL?U%>#_"*0P?\%./BU#'A(Y?
M#ZNZJ,9(%ES^IKUWXN?M61>"_B%%\._!?A+4/B-\07B$\FE6$JV\%I&<$-/.
MP(CX(/3 R,D9&5*DG*E*$?CBI6^7?MU_4N%648U8U)?!)J_W6T[ZVT^XQO#_
M .U_JNC_ !.T+P1\5?AG?_#/4-?<1:5>'5(=2M+B0D (TL:J%))5>-V"RYP#
MFN)_X*5>-/%NE_!G6-"MO!?VGPE?"U^T^*3JD2"WF^T!A#]EQYCYV+\P.!N]
MJ\C_ &W]5^,>I:%\/M7^(&@^%?#.G1>(H?L%OI%W-<ZA#,5+8DD/[HKA?X><
MA>U?0'_!2W_DU/6O^PA9?^CA6KIQBZ-3E5W.S2=UHXVZ[Z][:=M#G5:<EB*7
M,_=AS)M)/52\EI[O:^O?4WOV8?B'\3M:\.^#-'U[X1_\(WX5CT.W6'Q+_P )
M+:W7FJD"")OLR*'7S  <$_+GFO>?$%_<Z5H.I7ME9C4+RVMI)H;0R>7Y[JI*
MINP=N2 ,X.,]#7-_!/\ Y(SX"_[ %A_Z3QUVE<V,?-6FHJSN_P WKK_PQU9>
MN7#TW)WT7Y+33_@OS/)OV8_C_;?M(_#%/%D.DG0KA+R:RN=-:Y^T&&1""/GV
M)G*LC?=&,X[9KD/!'[8>G^,_VFM<^$B^'VM8; W$-MKWVW>MW<0*C2Q"+RQM
M*AGYWG[@X^;CRC]G'Q!;_L]?&3]H[P9?'R=+TW?XLLHVX46Y4N^/^ R0K_P&
MO,;#P[>?"[X,_ WXVW:&/4W\83:QK,W.?LNHOM8GV,<:?]]UV0HTIU>9+W)*
M-O\ %->[]S3N<DZ]:%'EO[\92OIO&&_EJG&WKZGV7\?OVA#\%=8\!:-9Z /$
MFL^+M673+:T^V_9?*4E0TI/EOD NG&!UZ\5H?'7]H;P[\!]-TW^TH+S6M>U:
M;[-I7A_2H_-O+Z3(&$7LH) +>X !) KQ/Q(@^+'_  44\-Z?Q/I?P_\ #[ZC
M(.JBYFX7\?WL+#_<KS[XD>)O%T/_  4:O+G0_ O_  L+4M"\/1C2])EUB'3A
M$CQJ7G5Y05)!FD7:!D[L_P -8TJ,:BIQENU*3]%>R[:VW[._0VJXB<'5E'9<
ML5ZNUWIJ_BVZV\SV6Z_:\\4> +BPN_BO\'M5^'WA:^F2W37H=6@U.*!G/RFX
M2)0T0^N3VP:](_:+^.,?P$^#^H>.XM)7Q'%:R6ZK:)=_9Q*)9%0,)-C\#=G[
MIS7B'QH\2?'KXQ?"WQ)X,N/V<18)K%HUNMV?&^GS>0^04DV;5W;6 .,CIU%8
MO[4NA:]X7_X)P:?HWBB'[/K^GV>DVEY"95E*.DT2X+J2K$ #D$BB5.+Y&TD^
M:*LG>Z;]6_\ AT$:TUSI-M*$G=QM9I:=$GZ>76YUTO[=C>)?%VFZ/\.?AIKW
MQ"L6GM[;4M<T\NMC8R2;<CS%AD#!-W);8.#@XYKTCXV?M,:3\)?$&D^$]-T7
M4/&WCW5P6L?#>D8\W9S^\E<\1)P?F(/ )Q@$CH?V=?#^G>&?@3X!L=*LXK&T
M_L2TF\J%< R20J[N?5F9F8D\DDU\9_#?QIX^L?VS/CGKGASX9?\ "Q]<M[E=
M. DU^WTUK"U#E4V^<IWAUBC^[]W;S]ZM/94IUY4HJRAS/?>S22UT6K^[SU,E
M6JQP\:\I7<^5)6VNFV]-6[+[^EM#Z&T/]J_6-"\9Z)X;^+'PSU#X83:],+;2
M]1;4X=3L9ICC$3S1 "-B2, @^^!S7T57P]^TI#\??VB/AG)X4/[/_P#PC]P+
MR"]M]2'C/3[@P21MG(3Y.2I89W#&?PK[4T47:Z/8"_ %]Y$?VC!!'F;1NZ>^
M:YZU.*IJ>B=VK)WTTL]WYIZ]#IH5).HX7;C9.[5M;NZV5^C6G4X/XS_&C_A4
M5OI$=OX1\1>,M5U>9X+*PT"T\TEU4$F1R0(UP>ISP"<8!QY#X@_;*\7?"RZT
MR[^*OP5U3P/X6OIUMAKEKK=OJ:PLWW3+'$HV#&2<MG@X#'BO1?CY^TQHGP+F
MT?2?[*U#Q5XPUQBFE>'=)3=/<$'&YC_ N>,X)ZX!P<?-/[7WB#XZ^-OV<_%%
MWXK\">$_!GA*,6\MQ9W&IR7VJ+BXC"&-HAY0.XKG=V)[T8>*:BYQ33=KMVZV
MTU6OWZAB)M-QA-J26R5_2^CLG\M-CZ"_; \6>(--_9]\22^%O#(\566I:7=1
MWMW'J<5JMA:M Q-R X/G  _<3DUXS^P#X\^(UK\"?#.CVGPL^W>%((-1EMO$
MP\0VT?VF833NL7V8KO3=+^ZW$X'WNE>E3327'_!/1)96+R-\.T+,>I/V 4O_
M  3N_P"30_!'^_??^EL]=+BJ-&O3M>TDK_\ @:O\NGKK<YG*5:IAJM[73=M/
M[K:VZ[/RVL]3YL\'_%;XHR_MW>--:L_A!]N\7CP\MG<^%/\ A)K6/[+"#;'S
MOM17RW_@^51G]Y_LFONO3?B1<:+\*V\8?$728OA_+:P27&HZ?-?QWJVBJQ"C
MSHQMD+ *0%&<L%ZU\N_"?_E)_P#%3_L71_*QJ]_P5%U2_M_@[X3TRWC::PU+
MQ%#%>1+*(A*JQNR1ECPH+#.3P"H-%2*JQPU*,4N:,===+M^?G?OYA3;H/$59
M2;4'+336T5Y>5NWD=9I_[77CSQ=I+>)_"'P$\0:]X%Y>/5Y]5M[2ZGB'62*S
M92\@(Z;2<U[7\'_C!X=^.'@6T\5>&9Y)+&9FBD@N$V3VTR_?BD7)PPR.A(((
M()!!KR#3?C!\>-*T^ULK/]F%+>SMHEAAAC\>:<%1% "J!LZ  "JG[&?PY\?^
M!=<^+&H>,?"?_"&:?XCUA=6T[2O[2M[T1,_F&8!X6(X_=C)"YP..*QK4X*G4
M:25E=>\FWJE9J[Z.^B6QI3K5.>%VW=Z^ZTEHW=.RZJVK=[G,:?\ \%'=+U;P
MW<?V=X#U/6O'!U6YTZS\):-<-=SS1PA";AW6(%$.X@ (QRIZX)'TI\'_ !QJ
MWQ(^'>D>(]<\+7?@S4[T2&71+YV::VVR,@#;D0Y(4-@J.&%?*W_!,?P_IT>A
M_$[7!9Q?VO)XCELVO-N9/)55<1@]AN=C@=3C/05]N48F-*E^[C'6R=[]U>WX
M_P!(UP[JU&YSEI>2M;LVE=_U]YR?Q.^%7A;XR>%G\.>,-+_M?1GF2=K;[1+!
METSM.Z)E;C/K7QW^R7X$T/X9_MV_&/PSX:L?[-T/3](C2VM?.DE\M2UJY&Z1
MF8_,Q/)/6OO"OBWX#_\ *1KXZ?\ 8*A_E:4L'*2E4@GIR2=O/W=3/,(1<*4V
MM?:05^MO>=O2Y]HLP522< <DFOSS^.&M3?M@>)O'VHP2O_PJ/X9:5?213)GR
M]4U86[[&&/O*IP1_LC_II7OW[=?BSQ[HGP?_ +%^'OAW6M:U37YFL;JZT2RE
MNI;*VVYD;;&I(+#Y03CJ><XKQ*Z^+&C?#7]E/7OAUH?P7^+6E6HT*ZMY=5U3
MPKY$!FDB827,[^:=JEB23SM QT J:%.7)*M'=:+UMK+Y=//7H:UZL?:PHRTB
M]9>E_A^?7RTZGN_[ '_)I'@+_KG=?^E<U?0M?(7_  3I^*7]K?!GPQX+_P"$
M1\56?]GV=U<?\)#=Z;Y>D7/^E-\D-QN^=_WG3:/N/Z5]+?%'5+S0_AGXMU'3
M]WV^TTF[GM]O7S%A9EQ^(%/,KT\15DUU;_%D95:IA:44^B1XMXF_;"GU+XB:
MGX(^%/@#4/BIK>D';J<]O?Q6%C:L"04-Q(&4L"",8 )!P3@X^??C_P#%2_\
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M>TG4 E6P>00<AN_< @@>4^'?VDOB[\;+7^T?A9\*+:R\,S$BT\1^--1^SQW
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M=?M#> =+M=*UD:%XFT6]35-*O)%+0B=00%D !(!S]X D$ X/(/E4?[6WQ,^
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M-EYM+]7=G;7G[7'Q"T70SXLUC]GWQ%8^!%3SY-335K>2^C@Z^8]CM#K@<G+
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MOJVM3W&H:^WBJTT^22?:O[MHI5+_ "[B<DX)D)KTOQAH?QO^,'QR^$?BF_\
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M )8O$<+(V.5/D3=*B_X*474]_P"%/A1H-S*\.A:MXAB74'#84@*H ;\'<_\
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MO_F;RIJ<X3>\;_C;_(^8_AQ\&_&&@_MP_$?X@7^D>1X1U?2([6RU'[3"WFR
M6V5\L.9%_P!6_+*!Q[BOIRBBG*HYQA%_927R0H4U3E.2^T[O^OD?*?QT^#'Q
M#T']I'P]\:_AKHUEXLNH+ Z;J?AZZO4LY)DPR[TE?"CY6').04'# D#M?B#8
M_$/XR?LP^.-*U7P1'X9\8ZI97%K::#'JT%WN! V9G&V,$\]2 ,5[O13=1RIJ
MFUML^N]R514:CJ1;5]UT;M:_?9+9GEO[+O@O6?AU\ /!/AOQ#9_V?K6G6/DW
M5KYJ2^6^]CC<C%3P1T)KRSX>_!;QGH?[=_C_ .(E[HWD>#M4T46EGJ7VJ%O-
MEQ:?+Y8<R#_52<E0/E]QGZEHJ_K$O:SK6UDI)_\ ;VYFL-!484+NT>6W_;NW
M_!/F;XO_ +/WC31/C/%\8_A#=Z<OB>6V%GK6@:LQCMM5A  !#C[KX5.N!E%.
M1@AM/2_B-^T9XIU*PM!\(/#_ ((MEGC:\U#6O$T=\DD(8;UB2V7<KD9 +9 S
MS7T-12C6:BHRBG;:_3RTMIY.Y4J%Y.49.-][6UZ7U3U\U8*^9OVT/@[XO^+-
M]\*I/"FD?VJFB>(H[_4#]IAA\F %,O\ O'7=T/"Y/M7TS16=.HZ4XU([II_<
M:5::JTY4Y;--?>8?CG3;G6/!/B"PLX_.N[K3[B"&/<%W.T3*HR2 ,DCKQ7CO
M[#OPO\3_  ?_ &?M,\->+M,_LC6H;RZE>U^T1385Y"5.Z-F7D>]>_440J.$9
MQ7VK?A?_ #"=-3E";^S>WSM_D?,NA_!WQ?9_MY>(/B+-I&SP;=>'EL8=2^TP
MG=,%A&SRP_F#[C<E<<=:9KWP;\87O[?'AOXCPZ/O\&6?A][&?4OM,(V3%+@!
M?*+^8>9$Y"XYZ]:^G:*TC7E'EM]F+C\G?\=693PT*BDF]Y*7SBXM?+W4?,?[
M47P;\8?$;XW_  -\0>'M(_M#2/#>K_:M5N/M,,7V>/SH&W;7=6?A&X0$\?2O
M=_B7I%WX@^'/BG2["+S[Z]TJZMK>+<%WR/$RJN20!DD<D@5TM%92DYT51>RO
M^.YO"*A6==;NW_DNQ\\_L6_"GQ3\)?V;[;PMXKTO^RM>2XO':T^T1385W)0[
MXV9>0?6J/[!/PA\7?!;X/ZMHGC/2?[&U2?7)[R.#[3#/NB:.)5;=$[*,E6X)
MSQTKZ4HKHGB9SE4DU\=K_+L<T,+"G&G%-^Y>WS5M3YE_9=^#OB_X<_'#X[^(
M/$.D?V?I'B;5X[K2;C[3#+]IC$MRQ;:CLR<2)PX!Y]C1^UG\'?%_Q,^*7P-U
M?PUI']I:=X:\0"^U6;[3#%]FA\ZV;=B1U+\1N<(">.G(KZ:HJ(UY1JTZJWA9
M+Y+EU^1<L/&4*D'M-MO_ +>WL</\<O#>H^,/@WXVT+2+?[7JNI:/=6MK;[U3
MS)7B957<Q"C)(Y) KA/V7OA/J_@_]EG0O ?C+3SIVI?8[RTOK031RE%EFE.-
M\;,IRC@\$]:]SHK+F?LY4NDK7^5_\V:N"=2%7K&]OG;_ "1\7_ CPA^T!^S#
MH]]\/-,^'^D^/O#27TDVE^(#K\5@ENDAR?-B8-(PS\Q55R"6 +#%7_ G[._Q
M*T']LS3/B/XEN$\0V5UH<JZGJUO)%%;6MTP=5MK>$OYOE*HC 8J<\L3DD#[!
MHKJ>*FY.;2YFFF^]U;^K6\SD^IP45!-\J::7:SOZ_??38^9/V@/@YXP\;?M1
M?!7Q=HND?;?#WAV:1M4O/M,,?V<%U(^1W#MP#]T&O4OVD?".K>/O@/XX\.Z#
M:?;M8U+3);>UMO,2/S)".%W.0H^I(%>DT5S.HW3C2Z1O^+N=2IJ-6=7K*WX*
MR/+?V7?!>L_#KX >"?#?B&S_ +/UK3K'R;JU\U)?+?>QQN1BIX(Z$UYQ\ _@
M[XO\%?M2?&KQ?K.D?8_#OB*2)M,O/M,,GV@*Q)^17+K_ ," KZ9HK7V\O:SJ
M]9)I_-W9DL/"-*G1OI"S7_;J:5_O"OF3X*?!SQAX1_:[^,'C75M(^R>&=?AB
M73;[[3"_GD&//R*Y=?NG[RCI7TW165.HZ;;75-??;_(UJTU648RZ-2^:O_F5
M]0B>?3[F-!N=XF51ZD@@5\U?L _!OQA\$OA3XAT?QII']C:E=:]->PP_:89]
MT+0PJ&W1.P'*,,$YXZ5].TC#<I'K1&I*G"<8KXDOP=PG3524)/[+;7S5CX3^
M&/B;XA>#?V@/C?JWPQ\%0?%_PYJFL1_:KY=7BTPVUT@8M;K+,-LHCWE2$! &
MSGG%>B>*OVQ/'?PE@M=5^*'P+U+PEX7EG6WEU;3_ !#:ZIY+-TW1QJN!]6'M
MDX%87PZ^'/QO_9-O?$&B>#O">E_%;P-J.HRZC9Q?VO'IE_:M)@%9'F&TC"CI
MNSC.1G%6_B#\,?C3^UI#I_A_QUH>D_"GX?1W4=UJ&GV^I)J>IWI0Y5%DC7RU
M7WX(.#AL8KT5[.3IW47%**;;:=DDGHGNNFC^>YY;]I#VG*Y*3<FDDFFVVUJT
MUKN]5UV+'[4/P9\<_&KXN?!CQ7\/I+>WL-&$]\VO7!B>&U8^5+ S0LZO(KE
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MN$FDW>RM:][OI=7\FD>!>--<_:$\$^/]7OM"\,>'?B5X+NV4V.DPZ@NEW]D
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M#8!(4E=I(!P&Z'I7JE%3*LY1C!*RB[JW?3_+K^5D5##QC.51MMR23OU2O_\
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MJ<<@'.#_  GI7I7[,O[/VG_LY_#>/P]!>-JNJW4[7NJ:FZX-U<, "0"20H
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M?1)IVZO7H;WP7_:G/Q%^(^J?#OQ5X,U#X?\ CO3[;[8VF7=REU#+#\OS1S(
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M ^EZ*B-9Q7NQ2=K7ZVZ^7X&DJ'-*\I.U[VZ7W[7^5[!7YV?LRWGQ*T?XX?M
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M*"C)],Y//RY(/V!16JK<LFXQ23W6MG^-_P 3&5#FBE*3;6STNOPM^&O4^6O
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MHIE&03C.[&>0:]1\/?LYV&@_LPGX/_;VF@?1YM.DU IC,LH9FE"]AYCD@9Z
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M/G#]G[]G?Q+H_P 3-?\ B[\4+ZRO_B!K$7V:"QTTLUKI5M@#RT9OO-A57(X
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M! !N%A 5\_\ 74!J]?HK-U9.BJ'3\>K_  ;=O4TC1C&N\1U_#HORBE\CX_\
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M6VJN !DDUJ?L_6DW[/O[:7B?X.Z/J=Y/X$U#2!JFGZ9>3M*+*7"/A"V2!@R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M? [6]3GCLM+FL'M$NIFVIYN;A=I)X&3-&/\ @0KZ<^/<R2? SXCJCJS)X>U
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M.[.5 ^P_ 7P6\&?#'Q!XFUSPUHW]FZIXDG%SJL_VJ:7[1(&=@VV1V5.9'.$
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MX]JFGB&J2IN3C:^JZW=]5=>>O;T'5PJE5E54(RYK73Z65M'9[JVG?6^IZ?\
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M[!HVFPK;VMMYCR>7&.@W.2Q^I)-;-%%5*3DW*3NV3&*BE&*LD%%%%24%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC?O6O;K;?TVUM>_D="Q,'JD^6]K]+[>N^E[6\RAH?QB\7WG[>7B#X=3:OO\
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M7<2C1E4,9Q')_$W*XYSFKO[:VH:SI'[5OP!NM"TQ->UR$S&UL9)Q;I<2^8@
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MWM=I?>[&TI<L7*U[)O[E<^@**\G\>_&RWT+]F?4?B=92*BMX?74[,G!'FRQ
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M$V,A49,2W,F9><8!*CZCK2Y%>7-))+KK^B97M)6CRP;;Z:?JTCZDKR+X2_M
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MMG@C4KO6+[3*'</MXY##/&['-;'["_C+XA_%SP8/'7BSXEOXGL9A-82>'Y-
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M_O;6[LM+=;;JU];?25%>"?L;?'_5OC[\-;ZZ\26<-EXIT/4)-*U);<;8Y'4
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M/9>'])LM+TZVCL]/LH4M[>WB&%BC10JJ/8  5I6J1E3]YJ4K[I6TMUT5W?\
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MCY%. 1FNR=>G+%3FG[LHN-_5+_(Y%AJGU2%.WO1FI6[I2>G;9W.>_P""EO\
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M]U(0C%O-C7D\9R.E>N7GP%^/E_:3VUQ^TJ)8)D:.1#X"T_#*1@C[_H:ZK4O
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M^Y 523[!F0_A6I\._A?\;/%/@'P[J^A_M,1C1[S3X)K1(_ FGLJ1E!M3._\
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ME%J_)RJ/FH2YEZ73Y?Q."_X)]^&[V[^!_B7QK=#RM9\<ZQ>ZGYS?>"[FC3\
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ME5LX+F37-%NRML]]EYZ%1HWC4?(TW&25Y7W6RU>[MKH?!W_"&_&/0/!/@?\
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MSWA\:?%2?XAV[P)!;0S:+!8?9]I^^6C9FD8C@ECFLS]F3]G7_AG/0?$NF_\
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M79Z&,<+4Y:J2M><9QUWM&.[\[-==>ZLSU^OB?_@H0C?\+3_9T?:=@\2D%L<
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MWMYOH?;5?%_[!W_);/VDO^QD7_T==U]H5XO\!_V<O^%)>-OB3X@_X2'^VO\
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MP?\ "0_\(_\ V!JR:IN^Q?:?/VC'E_ZQ-O\ O<_2MC]I'X*?\-!_"74_!/\
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M'RIRYKJ/AW^R0-)^)4'Q#^(OC;4/B?XRLUVZ?<WUJEI:6(_O16R%E5ADX(.
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M%*",A<9(('7!Q77_ !*_9-M?$?Q!E^(/@;Q;J?PS\=3Q^7=:CI<23V]Z./\
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M8OQB_8UTSQWXYE\?^#/%6K?#;Q](N)=5TALQ71&!^^BRN[(4 X8 X^8-7.?
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M34O[)UU+NU@@NO)BFVAY0'&R164Y4,.GO7L_A6]FU+POH]W<OYEQ<6<,LCX
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M 49))P !Z"NXIU(.E.5-[IV^X*=1581J1V:O]X4445F:!1110 4444 %%%%
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MC0:Y86=VE]%;7.[R_-0$*6 (W#DY5LJ>X->:_&_]F$_&;XH> O&(\9:EX?\
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MB'W6 ./K7T?6C@XPC/I*_P"#:_-&:J*525/K&WXI/]0HHHK,T"BBB@ HHHH
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MY]ONIMRR*C.-DDK*,E0>!QCBO//^"G6FW%]^R_<S0QETM-6M)IB!]U"63/\
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MX*;:1:>'_P!EWPUI>GPBWL+'7+*VMX02PCC2WG55R22<  <G-?9EE_QYP?\
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M2O<O^"BVL7&L?#+PA\/]+?=J'C?Q!:V$84_>B5@Q/TWF+\ZYKX6?!^X^(/[
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MSK@?VC_A;I'[(?CWP-XF^"^J7F@>(];U>*RF\'PW;SP:A$2<GRF);;N(7!R
M7&W:0*[[]N[/_"[/V9LC!_X2I>/^WBSK:C>6)P]7F;3DUKNK+7\S.I:%&O2Y
M%%J-]-FG>W:ST?X:L3]N>QD^%/Q0^$WQRL8V"Z+J2:7J[1CEK60L>?\ @)G7
MZNM>Z_M/?%:+X5_L^^+/%5O<)Y_V Q6$BG(::;"1$>O+AOH*T_VBOAA'\8_@
MKXM\)LBM<7UDQM"PSMN$^>(_]]JOZU\*Z+X\F_:@\(_LZ_!Z=WDNK6]D?Q/
MQ^9(+#**L@]7B!Z_Q$5RT::Q5)49?9EK_@EJ_NM+[T=->H\)6E77VH_^3QTB
MOG=+Y'K_ (9UJ;]B?]@?3]8CM5?Q5?Q)=+'.O'VZ[(*[QW\N/;D=_+QWK>\
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MM8&7]W]KN8T(R/[JEBV/1<4O[?G_ ":1X_\ ^N5K_P"E<->8?%[X8ZG\4O\
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M5^!?Q[UGQ/\ L7Q?$?4(CJ7B#3='O'FXYN9K7S%#MC^_Y:L<>IKBOB5^S_\
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M9A4EM"$)?="-O_)FON.B3?U6I3CO.<X_?.5__)4SM?VD[D? W]LKX2?$M?\
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M;K2?@Q=>,]77.O\ CK4I]<NI&'S>6S$1#/IC<X_ZZ5Y5X=\.V7[6G[5GQ/\
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M5/R>NG6R/=OA%^S7X6^ NO:MJ'A34-;L=$N[=4'AZXU*6?3[5@<M*B.2=Q
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MWWQQT6W\-_MK?LUZ3:;OLMA8O:P[SEMB*ZKD]S@"O5OV /\ DTCP%_USNO\
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M4U@_M5?"'X=?L_WGA2'X'RWOA[XN76K0PVVEZ+JUQ<S31'=GS8WD<A2VT8.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!(KZ5^&_Q+\-_%SPE:^)O">I?VMH=TSI%=>1+#N*,58;9%5A@@CD5C_L^_\
M)!_AU_V+NG_^D\==_1BW3]K423O=]=-^UOU)P*J^PIMR5N5=-=N]_P!#)\6:
M;JFL>&=3LM$UC_A']7N+=X[35/LJ7/V60C"R>4YVO@\[3P:\)_X4?^T#_P!'
M,?\ EA:?_P#%U[MXLTW5-8\,ZG9:)K'_  C^KW%N\=IJGV5+G[+(1A9/*<[7
MP>=IX->$_P#"C_V@?^CF/_+"T_\ ^+K"B[7]Y+U5_P!&=%>/-;W9/T=OO]Y?
MJ;/@WX1_&K1?%&FWVO\ Q]_X231H)@]UI/\ PAME:_:D[IYJ.63/J.:]SKPS
MP;\(_C5HOBC3;[7_ (^_\))HT$P>ZTG_ (0VRM?M2=T\U'+)GU'->YT5G>WO
M)^BM^B"A'EO[LEZN_P"K/BB'Q'XD_:7_ &HOB%X"U'XE:Y\.M \)E8=/T?PO
M>+87^H-SOF,I4LRC )&",.F,<D^]_"GX.>+?AW<:]8ZK\4M>\9>&[JW6/3H=
M86-K^R<Y#N;K&Z0]-N0 /3UQOB]^RW\+OVC=0EU>ZW6WB>QE^S'7_#UX(KN"
M6/'R2$94LO'#J67H"*\M_9^\9_$#X5_M0:M\#?$_BR?XA:&NEG5+#5KX%KRT
M'!"2N22<@D$,3SL(P"171&U6DJ<'9J.JMO97;3[O?\F<TKT:SJ35TY:-/:[L
MDUV3TZ^:/&M/^ KW?[?>J>"6^)/Q!7R="%R/$2:[C5R#'&WE&X\O_5Y8_+MZ
M 5]RVOPU\0^#?A#>>%_"GC;5KSQ$L<OV'Q%XNF&I7"R,Q8&0E0' S@?+P,<'
M&#\WZ<IM/^"INI>=B+[3X8!AW$#S/W,?3U^XW_?)KV3]L[XW:Q\ _@;J'B/0
M(HGUF:YBL+6:=0Z0-)G,A4\-@*< \9(SD<4ZTZE2G0ANY)??S-!AZ=.G4K3_
M )7^"A%LY'6OV2?'-YX?NK\_M _$*;QJ(FDBFM[];32VF RH-F@P$)X(W_X5
MN_L/_'+6OCG\&WO/$Y63Q-HM_+I6H3J@3SV0*RR%0  2K@'  RI.!G%<KH_[
M'NBZ[X33Q!\9_B%XC\>7$EK]LOA?:U)::1;@KO)CCC9=J*.^X XSA<XKF/\
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M_'/Q$^+U]K\LT$HN/"=DDD>FPR.,+L'F!"$R<?N@<@'/<^??ML?\G*?LS_\
M8?/_ *46U?:%<D9^SPE-Q6K<U?RO_7F=DJ:JXR:DW:*@TK];?\#T"BBBN ](
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8#'W6W+Z@UW_ ,%?@+X<^ MEXAM/#4M\]MK6J2:K-%>/&RPR. /+B"(NV,
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img175210594_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_4.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =>#*H# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\
MXBC_ (2K4?\ H 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_
M (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C
M_P! "Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B
M*/\ A*M1_P"@!=?^/?\ Q% '345S/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\
MCW_Q% '345S/_"5:C_T +K_Q[_XBC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_
M $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\ PE6H_P#0 NO_ ![_ .(H
M_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/
M?_$4 =-17,_\)5J/_0 NO_'O_B*/^$JU'_H 77_CW_Q% '345S/_  E6H_\
M0 NO_'O_ (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_
M (2K4?\ H 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_
M\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P!
M"Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\
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M (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\
MH 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<
MS_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\
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M_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\ A*M1_P"@!=?^/?\
MQ% '345S/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\ CW_Q% '345S/_"5:C_T
M+K_Q[_XBC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^
M@!=?^/?_ !% '345S/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$
M4 =-17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 N
MO_'O_B*/^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
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M^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\
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MM1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !%
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MS/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0
MNO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 NO_'O_B*/^$JU'_H
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MX]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\
MPE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\
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M/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4
M=-17,_\ "5:C_P! "Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\
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MOSA+^5-?>[EFBBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[Z?<C[O^('_!2'X*^!;Z2SM]4U'Q7/&VR3_A'[02QJ?:21HT<>Z,PJ?X:_\
M!1;X,?$;4H=/?5K[PK=S/LB7Q%;+!&Q]Y4=XT^KLM?E5\*/@'\0/CA<W4/@C
MPQ=:Y]E'[^96CA@C)Z*TLC*@8]EW9/I6!X\^'_B+X8>)KKP]XITFXT76+;!D
MM;@#.#T92"0RGLRD@^M?0++<,G[-R][U5_N/F'FV+:]K&"Y?1V^_N?T'(ZR*
MK*P96&0RG((]:=7Y_P#_  2__:,O_$EGJ'PLU^[>[ETVW^VZ--,Q9Q;@A9+?
M)ZA"RLH[ L.B@#] *\'%8>6%J.F]>WH?2X/%1Q=)5(JW==F%%%%<AVA117YX
M_P#!0+]MJ_T'4[WX8> +]K.YB7R];UBV?$B,1_Q[1,#\I ^^PY&=HQS6M*G.
MM-4X+5_U?T,:U:&'INK4=DOZLO/^MCZ:^+W[:WPD^"]]/INL^)!J&M0Y$FEZ
M/$;J9".JL1\B-_LNP/M7F_AO_@J-\&-<U%;:\C\2>'XF_P"7O4M.1HA]1!+(
MW_CM?E1X+\#^(?B1XDMM"\-:3=:YK%T?W=K:H78^K$]%4=V) '<UTWQ9_9\^
M(7P-:R'C?PS<:&E[G[/,98IXI".JB2)F7=CG:3GVKZ..6X>G:%67O/SM]R_X
M<^5EFV*J7G2A[J\F_O?_  Q^['A?Q7HWC;0K36M U2UUC2;I=T-Y9RB2-QT.
M".X/!'4$$&M6OQS_ & ?VC+_ .#GQ@T[P]>7;MX1\37"65U;.Q\N"X<A8KA1
MT4[MJL>ZGG[HQ^QE>/C<(\+-).\7M_D>[@,:L9!MJTEO_F%%%>?_ !S^-7A_
MX!_#O4/%?B";$4(\NUM%(\R[G(.R)!ZG')[ $G@5Y_H>GYLJ?%S]I+X;_ NZ
ML+;QQXGBT2YOD:2W@%M/<2,JG!8K"CE1GC) !P<=#7GW_#PW]G[_ *'_ /\
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M/W_0@?\ E9U#_P"2*7UW _\ /K\$']GYC_S^_P#)I?Y'YS_\/#?V@?\ H?\
M_P HVG__ "/7V=_P3D_:(^(7QXF\?+XZ\0?VX-+6Q-I_H5O;^5YAGW_ZF-,Y
MV+USC''>O2O^'>7[/W_0@?\ E9U#_P"2*]%^$/[._P /?@,VJMX%\/\ ]AG5
M!$+O_3;BX\WR]VS_ %TCXQO;IC.>>U8UL7A)TI0A3M)[.R[HZ,/@L=3JQG4J
MWBMU=GS=_P %0OC9-X)^%VG>!M-G,6H>*'8W;(V&6SC(W+_P-RJ^X5Q7YC>
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MGCY%?EJ+I=?U^04445\\?4'EG[3GQ>7X&_!'Q-XL4J;^W@\BP1OXKF0[(_J
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M"=F/XU]9FE10P_*]Y/\ +7_+[SXG)Z,JF)Y^D5^>G^?W'<4445\@?=!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5^1__!43QB?$'[1D.CI)NAT/28+<J.TDA:5O_'73\J_7
M"OP>_:>\8?\ ">?M">/]:#;XYM7GBB;.<QQMY2?^.H*]/+8<^*3?1-_I^K/'
MS>IR8.2_F:7Z_H>84L<;2.$12['@*HR37WU_P23\(_:O&WCSQ.Z<6-A!I\;8
M[S2%V_2!?SK]-:]S%Y@L+4]GRWT[_P# ['SN"RQXRE[7GMKVO^O<_!/P3^SM
M\3OB+/#'X>\":[J"3'"W/V)XK?\ &9P(U_%A7W-^S#_P3)7P_J=CXF^+$UK?
MSP,)H?#-JWFPAA@C[3)T?!_Y9KE3@99@2M?H-17E5<TK35H+E_,]NCDU"F^:
MH^;\B&::'3[225\100H6; X50,]!["OGG_AX;^S]_P!#_P#^4;4/_D>O?];M
MY+S1;^"%=\LMO(B+D#+%2 .:_&C_ (=Y?M _]"!_Y6=/_P#DBN3!TJ-:4U7E
MRI6MJEO>^_R.W'UJ^'A!X>',W>^C=K6MMZO[C]&/^'AO[/W_ $/_ /Y1M0_^
M1Z/^'AO[/W_0_P#_ )1M0_\ D>OSG_X=Y?M _P#0@?\ E9T__P"2*/\ AWE^
MT#_T('_E9T__ .2*]3ZE@?\ G[^*/&_M#,?^?/\ Y++_ #/T8_X>&_L_?]#_
M /\ E&U#_P"1Z]%^$/[1'P]^/#:JO@7Q!_;ATL1&[_T*XM_*\S=L_P!=&F<[
M&Z9QCGM7Y1?\.\OV@?\ H0/_ "LZ?_\ )%?9W_!.3]G?XA? :;Q\WCKP_P#V
M&-46Q%I_IMO<>;Y9GW_ZF1\8WKUQG/'>L:V$PD*4IPJ7DME==T=&'QN.J58P
MJ4K1>[LS\Z?VC-4;6OC[\1;QSDR:_?#\!.Z@?D*^[_\ @D?HJ0^"?B#JVW]Y
M<:C;6N[VCC9L?^1:^$/VC-'FT#X^?$2QG!$D>OWK<CJ&F9@?Q# U]^?\$E-6
M@F^&/CC3%<?:K?6([AUSSLDA"J<?6)ORKT)?\BOW=N6/YQ/,I_\ (W?/OS2^
M_P!X^\*_)+_@J)X[3Q-^T);:'!*LD/A_3(K=PISMFD)E8?7:T?Y5^HOQ-^(F
MD?"CP'K/BO79Q!INF6[3/S@R-T6-?5F;"@>I%?@Q\0O&VH?$CQSKOBG5&W7^
MK7DEW*,Y"[F)"CV48 ]@*\C*Z3J8CGZ1_-Z?E?\  ]O.*ZIX;V?6?Y+5_C8^
MC_\ @F7X-?Q+^TY9:GL+0:#IUS?,V. S+Y"C_P BD_A7[ 5\6_\ !+WX.R^"
M?A#J/C._@,5_XJG4VX<8(LXMRH?;<[2'W 4U].?%;XS>#/@GX?&L^,]=M]%L
MW;9"KAGEG;^['&H+.?7 XZG J\TJ>TQ"A'[*M\]_UL1D]+V6%]I+3F=_EM^E
M_F=M17B?P=_;&^%GQSU]M"\,Z\_]M;6>.PO[9[>295Y)CW#:W S@'=@$XX->
MV5Y4Z<Z;M-6]3V:=6G55Z<DUY'Y/_P#!5C5&NOV@M$LB?DM- A('N\TQ)_0?
ME7+?\$TM%35?VJM(N'7=_9^G7ET/8F/RL_\ D6NI_P""J^CS6?[0&B:@P/D7
MN@0JC8XRDTP8?J/SK#_X)AZM!IO[4$%O,X5[_1[NWAR<9<;),#_@,;?E7U&"
M_P"1>^7M/_VX^/Q^N:+G[P_*)^OE?#W_  5;\=IH_P (/#GA:.51<ZUJ?VAX
M\\^3 A)/TWR1_E7V^\BQHSNP5%&2S'  ]:_%C]NCX[P_'3XZ7]SID_G^'=%3
M^S-.=3E955B9)1[.Y.#W4+7@8*DZV(@NBU?RV_&WXGTN85E0PLY=6K+YZ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .9^)OBJ/P/\ #GQ/XAE?8FEZ;<7F[W2-F'Z@5_/Q//)=3232L7ED8NS'
MJ23DFOZ!/BA\/+#XL> -;\(ZI=WECIVK0?9[B;3W1)PF02%+JRC.,'*G@FOE
M;_AT_P#"3_H8O&G_ ('6G_R+7JY=B*6&E.53K;\+_P"9XN:8:MBXPA2Z7O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8GB1_P"1K+_KVO\ TJ1WU%%%> >V%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M8WC3_D3]=_Z\)_\ T6U<[\$?^2:Z5_O3?^C7KHO&G_(GZ[_UX3_^BVKG?@C_
M ,DUTK_>F_\ 1KU\?5_Y*6E_UXG_ .EP/>A_R*)_]?(_^DR.[HHHK[ \$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!Q/QH_Y)GK/TA_]')6QX#_Y$?P__P!@^#_T6M8_QH_Y)GK/TA_]
M')6QX#_Y$?P__P!@^#_T6M?'P_Y*:I_UXA_Z<F>]+_D41_Z^2_\ 28F]1117
MV!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG)@F7B2,_1@?J,'O795^*5*<Z,Y4ZBLT[,_7J=2-6"J0=T]4%%%%9F@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$_&C_DF>L_2'_T
M<E;'@/\ Y$?P_P#]@^#_ -%K6/\ &C_DF>L_2'_T<E;'@/\ Y$?P_P#]@^#_
M -%K7Q\/^2FJ?]>(?^G)GO2_Y%$?^ODO_28F]1117V!X(4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>8W?[07AVSNIK=[
M+5"\3M&Q6*/&0<<?O*\C,,VP.5*,L=54%+:_6VYW87 XG&MK#P<K;V/3J*\L
M_P"&B_#?_/EJO_?J+_XY72>"?B=I?CRZN8-/M[R%[= [&Y1%!!..-K&N#"\3
M9/CJT</AL3&4Y;)=>ITULHQ^'INK5I-16[.OHHHKZ8\@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH QO&G_(GZ[_UX3_\ HMJYWX(_\DUTK_>F_P#1KUT7C3_D3]=_
MZ\)__1;5SOP1_P"2:Z5_O3?^C7KX^K_R4M+_ *\3_P#2X'O0_P"11/\ Z^1_
M])D=W1117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$?&C
M_DF>L_2'_P!')6UX#_Y$CP__ -@^W_\ 1:UB_&C_ ))GK/TA_P#1R5M> _\
MD2/#_P#V#[?_ -%K7QT/^2FJ?]>(?^G)GNR_Y%$?^ODO_28F[1117V)X1'/!
M'=0R0S1K-#(I1XY%#*RD8((/4$5^0G[4WP3E^!OQ8U#2H8V&A7N;W2Y3D@P,
M3^[SZHV5/? 4]Z_7^O"_VPO@;_PNSX3W,=A;^;XDT?=>Z9M&6D('[R$?[ZC
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M#_T6M?'P_P"2FJ?]>(?^G)GO2_Y%$?\ KY+_ -)B;U%%%?8'@A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45F:AXHT;2;@V][JU
MC9S@ F*XN41L'H<$YJM_PG7AO_H8-*_\#8O_ (JN&6.PE.3C.K%-?WE_F=$<
M/7DKQ@VO1FY16+'XV\.RR*B:]I;NQPJK>1DDGL/FK:K:CB*.(NZ,U*W9I_D1
M.E4I_'%KU04445T&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >6?";_ )'OXA?]?X_]&35ZG7EGPF_Y'OXA?]?X_P#1DU>IU\=P
ME_R*8_XZO_IV9[N=_P"^O_##_P!(B%%%%?8GA!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &-XT_Y$_7?^O"?_ -%M7._!'_DFNE?[TW_HUZZ+QI_R)^N_]>$__HMJ
MYWX(_P#)-=*_WIO_ $:]?'U?^2EI?]>)_P#I<#WH?\BB?_7R/_I,CNZ***^P
M/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .)^-'_ "3/6?I#
M_P"CDK8\!_\ (C^'_P#L'P?^BUK%^-3*OPTU@$@%O) R>I\U#6M\/;B*X\#Z
M%Y4J2[+*%&V,#M8( 0?0BOC827^L]17U]A'_ -.3/?DG_8\7_P!/'_Z3$Z*B
MBBOLCP HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?7Y?D_(^"X:QTL)B)8"OHF]/*2Z?/\ ,^WZ***_(C]2"BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M75Y[=8ODG]U_RD_0^RH<3Y;CH^RQD.6_=<T?Z^1%X=_:-'RQZWIF.QN+(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q'QH_Y)GK/TA_]
M')6UX#_Y$CP__P!@^W_]%K6+\:/^29ZS](?_ $<E;7@/_D2/#_\ V#[?_P!%
MK7QT/^2FJ?\ 7B'_ *<F>[+_ )%$?^ODO_28F[1117V)X050UK0[#Q%8266H
MVT=U;/U1QT/J#U!]Q5^BLZE.%:#IU(IQ>C3U3]47&<J<E*#LT?.GC_X'7V@^
M;>Z+OU'3QEFAQF:(?3^(>XY]N]>7QR26\JR1LT<B'*LIP5([@]C7VW7GWC[X
M.Z7XP\R[M=NFZJ>3,B_)*?\ ;7^HY^M?A'$GAPI-XO)-'O[-O_TE]/1Z=FMC
M](RGBMJU',-5_-_FOU7W'$> /CU+:^78^)-T\/1;]!EU_P!\#[P]QS]:S_VP
M_@U;?';X/MJFB".]UW15:^TZ6##&>/'[V$'_ &E&0/[R*.YK@/$WA35/"-^;
M34[5H'ZH_5)!ZJW>KG@[Q[J_@F[\RPGS QS+:R<QR?AV/N.:\_A;Q&S+AO%P
MH9M&4O9O=_''R=_B7>^MNKV-L\X1P>=8:4L&TN=;+X7YKL_P/SBL[R?3[N"Z
MMI7@N8762*6,X9&4Y# ]B"*_8+]F;XTP_'+X4Z;KCO&-9@'V35(4P-EPH&6
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MMUZ1PH%7\A5FOT[)_#7+L%:IF$G6GVVC]V[^;L^Q\AC^+<5B+PPJ]G'ON_\
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MOCO5M!U'09_)U&RGLY.PF0KGZ'O^%0Z?J5WI5PL]E<S6DR])(7*-^8KT<O\
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M117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /S _X*K?L>^%--\%^+OCLVO^)+[Q?<7ME;BSNKF!
MK"*-F2$(D8A#@!1Q\YYR3G-?='[)G_)KGPB_[%+2_P#TDCKPW_@K7_R9;XB_
M["6G_P#I0M>Y?LF?\FN?"+_L4M+_ /22.GAM*%:*V4XV_P# 6%;6K3D]W%_^
ME(]7HHHI %%%% !16=K&N0:''&\ZR,)#M'E@'^9%97_"?Z=_SQN?^^%_^*H
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M_P 57U=*G"C3C2IJT8I)+LEL>).<JDG.3NWJ=-17,_\ "?Z=_P \;G_OA?\
MXJC_ (3_ $[_ )XW/_?"_P#Q5:D'345S/_"?Z=_SQN?^^%_^*H_X3_3O^>-S
M_P!\+_\ %4 :^M:'8>(K"2RU&VCNK9^J..A]0>H/N*\#^('P.OM \V]T7?J.
MGC+-#C,T0^G\0]QS[=Z]E_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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MG_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\ A/\
M3O\ GC<_]\+_ /%4 =-17,_\)_IW_/&Y_P"^%_\ BJ/^$_T[_GC<_P#?"_\
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MPO\ \51_PG^G?\\;G_OA?_BJ .FHKF?^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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M_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*H Z:BN9_X3_3O^>-S_P!\+_\
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M_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*H Z:BN9_X3_3O^>-S_P!\+_\
M%4?\)_IW_/&Y_P"^%_\ BJ .FHKE7^)&DQ_?$R_[P0?^S5 _Q7\/Q_?N"O\
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M_A/]._YXW/\ WPO_ ,51_P )_IW_ #QN?^^%_P#BJ .FHKF?^$_T[_GC<_\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M ,)_IW_/&Y_[X7_XJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\
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MHYVD0RY**".9&/K[U\?4_P"2EI?]>)_^G('O0_Y%$_\ KY'_ -)D>K45S/\
MPG^G?\\;G_OA?_BJ/^$_T[_GC<_]\+_\57V!X)TU%<S_ ,)_IW_/&Y_[X7_X
MJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\ XJC_ (3_ $[_ )XW
M/_?"_P#Q5 '345S/_"?Z=_SQN?\ OA?_ (JC_A/]._YXW/\ WPO_ ,50!TU%
M<S_PG^G?\\;G_OA?_BJ/^$_T[_GC<_\ ?"__ !5 '345S/\ PG^G?\\;G_OA
M?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\ A/\ 3O\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M ,)_IW_/&Y_[X7_XJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\
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M]2OWA^&:]0TC7M.U^V$^G7L-Y%W:%P<>Q'4'ZU^R97G^69Q&^"K*3[;2_P#
M79_A8^"QF68S .V(IM+ONOO6A>HI:*^@/+$HI:* $HI:* $HI:* $HI:* $H
MI:* $HI:* $HI:* .)^,W_)--9^D7_HY*V/ 7_(C^'_^O"#_ -%K6/\ &?\
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M )12T4 )12T4 )12T4 )12T4 8OC3_D3M=_Z\)__ $6U<]\$?^2:Z5_O3?\
MHUZZ+QI_R)VN_P#7A/\ ^BVKGO@C_P DUTK_ 'IO_1KU\?4_Y*6E_P!>)_\
MIR![T/\ D43_ .OD?_29'<T4M%?8'@B44M% "44M% "44M% "44M% "44M%
M"44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M%
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M?_29'=44M%?8'@B44M% "44M% "44M% "44M% "4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]>(?^G)GO2_Y%$?^ODO_ $F)O4445]@>"%%%% !1110 4444 %%%% !1110
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MX*L,$'T(KQ\/Q9Q-PS46'S&+E'M43O\ *>[];R1WU,DRC-XNKA6D^\?UCT_
M^V^O(I:^1_#7Q&\0>%-BV.H2?9U_Y=IOWD7TP>GX8KUCPS^T1876V+6[)[&3
MH;BWS)']2OWA^&:_5,I\1,GS"T,2W1G_ 'OA_P# E^J1\9CN%<=A;RI+VD?+
M?[O\KGL%%4-'U[3O$%OY^G7L-Y%W,3@D?4=0?K5^OTZG5A6@JE*2E%[-:I_,
M^0E"5.3C-6:"BBBM" HHHH **** "BBB@ HHHH XGXS_ /)--9^D7_HY*V/
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M1110!C>-/^1/UW_KPG_]%M7._!'_ ))KI7^]-_Z->NB\:?\ (GZ[_P!>$_\
MZ+:N=^"/_)-=*_WIO_1KU\?5_P"2EI?]>)_^EP/>A_R*)_\ 7R/_ *3([NBB
MBOL#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WC3_D3M=_Z\)_\
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M *4>[F_QT/\ KW#_ -)"BBBOL3P@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH QO&G_(GZ[_UX3_^BVKG?@C_ ,DUTK_>F_\ 1KUT
M7C3_ )$_7?\ KPG_ /1;5SOP1_Y)KI7^]-_Z->OCZO\ R4M+_KQ/_P!+@>]#
M_D43_P"OD?\ TF1W=%%%?8'@A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOC^+?^1/4_Q4_P#T[ ]W(_\ ?H^D_P#TB1ZG1117V!X04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EGPG_ .1\^(/_ %_#
M_P!&35ZG7EGPG_Y'SX@_]?P_]&35ZG7QW"7_ "*8_P".K_Z=F>[G?^^O_##_
M -(B%%%%?8GA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^(_\ @HK\"_[3TFU^)>DV^;JR"VFKK&.7A)Q%,1_LD[2?1E[+7Q+\
M,?B%J?PK\=Z/XITAL7FG3B3RRQ"S)T>-L?PLI*GZU^U&N:+9>)-'OM*U*V2\
MT^]A>WN+>0962-@593]037XX?'CX2WGP3^)VK^%[K?)!"_FV5PXQY]LQ)C?Z
MXX/^TK#M7ZYPKF$<9AI9=7U<5I?K%[KY?D_(_+>)L#+"XB./H:)O7RDNOS_,
M_8#P-XRTWXA>#])\2:1+YVG:E;K<1-W&>JGT93E2.Q!K=K\^_P#@G7\=#I6L
M7?PUU:X M+YFN]):0_<G S+%D]F4;@/56[M7Z"5^>9ME\LLQ<J#VW3[I[?Y/
MS/O,KQT<QPL:ZWV?D^O^?H%%%%>,>L%4-:T.P\16$EEJ-K'=6S]4<=#Z@]0?
M<5?HK.I3A6@Z=2*<7HT]4_5%QG*G)2@[-'SIX_\ @=?:!YM[HN_4=/&6:'&9
MHA]/XA[CGV[UY;7V[7C/C#PSI>H?''0[.>QB:UO+1I;B-1M$C@3'<<8Y^5?R
MK^?.+. L-0G3Q.6RY%4G&'*]DYNR:>Z5]UKY=C]/R3B6K4C*EBUS<L7*ZWM%
M7L_/S^_N>$5M:7X)U_6L&ST>\F4])/)(3_OH\?K7U?I?A?1]%Q]@TNTM&'\4
M4*JWYXR:U*Z,'X51T>,Q7RC']6__ &TRK\:/:A1^;?Z+_,^:M+^ /BB^P;@6
MNGKW\Z;<WY(#_.NNTO\ 9NM$P=1UF:;U2UB$?ZL6_E7L]%?;8/P]R#"V<Z3J
M/^])_DK+\#Y^OQ1F=;::BO)?YW9PVE_!?PEIF#_9INW'\5U*S_ID+^E=;I^C
M6&DIML;&WLUQC$$2I_(5<HK[7"97@,!_NM",/2*7XV/GJ^,Q.)_C5'+U;844
M45ZAQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 >6?"7_D>OB%_
MU_C_ -&35ZG7EGPE_P"1Z^(7_7^/_1DU>IU\=PE_R*8?XZO_ *=F>[G?^_2_
MPP_](B%%%%?8GA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Y9\8/\ D</A_P#]A'_VI#7J=>6?&#_D</A__P!A'_VI#7Q_
M%O\ R)ZG^*G_ .G8'O9'_O\ 'TG_ .D2/4Z***^P/!"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \L^$W_(]_$+_K_'_HR:
MO4Z\L^$W_(]_$+_K_'_HR:O4Z^.X2_Y%,?\ '5_].S/=SO\ WU_X8?\ I$0H
MHHK[$\(**** "BBB@ HHHH **** "BBB@ HHHH **** "L7Q!X-T7Q5&5U/3
MX;EL8$N-LB_1AR/SK:HK"OAZ.*INE7@I1>Z:37W,UIU:E&2G3DTUU6AX?XF_
M9T/SRZ#J&>XMKW^0<#^8_&O*O$'@_6?"\I34]/FM1G D*YC;Z,.#^=?8M,FA
MCN(FCEC66-AAD< @CT(K\KS;PWRK'7G@VZ,O+6/W/5?)I>1]E@N+,;A[1KI5
M(_<_O_S1\5V=]<Z;<+<6EQ+;3K]V2%RC#Z$5Z1X9^/FNZ3LBU)(]7MQQN?Y)
M0/\ >'!_$?C7IGB;X'>'->W26T3:1<GG=:_ZO/NAX_+%>3^)O@?XCT'?);1+
MJ]L.=UKG?CW0\_EFOS&KP]Q5PG-UL%)N'>F^9?.#_6+7F?80S3)LZBJ>(24N
MTM'\I?\ !.T\<?%;0?&7P[U6UMII+:_=8\6MPN&.)4)P1D'@'OGVKTGP%_R(
M_A__ *\(/_1:U\A30R6\C1RHT<BG#(X((/H15RPU[4]+P++4;NT Z""=D_D:
MVR[Q"KT<P>-S"CSRY%#W?=VDY7:=]=?(SQ7"].IA5A\+4Y5S.6NNZ2MT[>9]
MGT5\HV/Q=\7:?C9K4T@])T23/XL":Z&Q_:&\1V^!<6]C=KW+1LK?F&Q^E?H^
M'\3<EJZ58SAZI-?@V_P/E*O"&80^!QE\VOS1]&T5XG8_M)H<"\T)E]6@N,_H
M5_K706/[07ABZP)EOK,]_,A##_QTG^5?38?C3A_$_!BHK_%>/_I21Y%7A_,Z
M/Q46_2S_ ";/3**Y2Q^*GA/4,>5KELF?^>Y,7_H8%=!9:M8ZD,VE[;W0_P"F
M,JO_ "-?38?,,'B_]WK1G_ADG^3/(JX7$4/XM-Q]4T6Z***] Y0HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\L^,'_(V^ /^PC_ .U(:]3KRSXP?\C;
MX _["/\ [4AKX_BW_D3U/\5/_P!.P/=R/_?H^D__ $B1ZG1117V!X04444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EGPG_Y'
MSX@_]?P_]&35ZG7EGPG_ .1\^(/_ %_#_P!&35ZG7QW"7_(IC_CJ_P#IV9[N
M=_[Z_P###_TB(4445]B>$%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &-XT_Y$[7?^O"?_P!%M7/?!'_DFNE?[TW_ *->NA\:?\B=
MKO\ UX3_ /HMJY[X(_\ )-=*_P!Z;_T:]?'U/^2EI?\ 7B?_ *<@>]#_ )%$
M_P#KY'_TF1W5%%%?8'@A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5Y9\8O^1L\ ?]A'_P!J0UZG7EGQB_Y&SP!_V$?_ &I#7Q_%
MW_(GJ?XJ?_IV![V1_P"_P])_^D2/4Z***^P/!"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \LT7_DX/7O\ L'+_ .@PUZG7
MEFB_\G!Z]_V#E_\ 08:]3KX[AG^'B_\ K_6_]*/=S?XZ'_7N'_I(4445]B>$
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%17%S#9PM+
M/*D,2]7D8*H_$TFU%7>PTFW9&7XT_P"1/UW_ *\)_P#T6U<[\$?^2:Z5_O3?
M^C7JOXZ^*/AB+P_JMC'JL5U=7%K+"B6P,@W,A ^8?+U/K5'X#^*-.N_"MOHB
M38U*U$CO"PQE6D8Y4]^HS7YZ\TP-7B>C&G7BW[*<=))^\YP=O6R;MOH?4+!X
MB&3U'.FU[\7JGMRR5_37<]1HHHK]#/E@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK1Q&&PT8SCLUTZ&];-\?B*;I5:K<7N@HHHKZ8\@**** "BBB@ HHHH ****
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MB>I_BI_^G8'NY'_OT?2?_I$CU.BBBOL#P@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /+/A/_R/GQ!_Z_A_Z,FKU.O+/A/_
M ,CY\0?^OX?^C)J]3KX[A+_D4Q_QU?\ T[,]W._]]?\ AA_Z1$****^Q/""B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&\:?\B=K
MO_7A/_Z+:N>^"/\ R372O]Z;_P!&O70^-/\ D3M=_P"O"?\ ]%M7/?!'_DFN
ME?[TW_HUZ^/J?\E+2_Z\3_\ 3D#WH?\ (HG_ -?(_P#I,CNJ***^P/!"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRSXQ?\C9X
M_P"PC_[4AKU.O+/C%_R-G@#_ +"/_M2&OC^+O^1/4_Q4_P#T[ ][(_\ ?X>D
M_P#TB1ZG1117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'EFB_\G!Z]_P!@Y?\ T&&O4Z\LT7_DX/7O^P<O_H,->IU\
M=PS_  \7_P!?ZW_I1[N;_'0_Z]P_])"BBBOL3P@HHHH **** "BBB@ HHHH
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MOX.%_P"O]'_TM'O9/_$K?]>ZG_I+/4Z***^P/!"BBB@ HHHH **** "BBB@
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M=6_\[3MZ6C$\_%8J.)::I1A;^5-7];MA1117KG"%%%% !1110 4444 %%%%
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M=7CMW/\ #<HT6/Q(Q^M?9X3BK),;;V.+A?LWRO[I69X%;)<QP_\ $HR^2O\
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MD2/4Z***^P/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M# _6NYT?]G_PY8;6O7NM3?N)'\M/R7!_6O3J*_0L#P+D.!LU0YWWF^;\/A_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%>J5]7E^/ECXR<L/.E;^=)7]+2D>-BL,L,TE5C._\K;MZW2"BBBO6.(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO4Z^.X2_Y%,?\=7_ -.S/=SO_?7_ (8?^D1"BBBOL3P@HHHH **** "BBB@
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M':UT+;3(SU\Z3>_Y+G]2*[G1_P!G32+7:VI:A<WS]UB B3^I_45ZW17Z'@>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ%?.Y/\ Q*W_ %[J?^DL]_-?@H_]?(?^E(^LZ***\ ]L**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH XGXS_P#)--9^D7_HY*V/ 7_(C^'_ /KP@_\ 1:UC_&?_ ))IK/TB_P#1
MR5L> O\ D1_#_P#UX0?^BUKX^'_)35/^O$?_ $Y,]V7_ "*(_P#7R7_I,3>H
MHHK[ \(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:_S:KT/P+\7R?>L88O\ ?N4_H31_;7'>(^&%2WE22_'D#^S^&Z6\H?\ @?\
M]L;,W[1NNM_JM-T]/]\2-_[,*I3?M!>*)/NI81?[D!_JQI8?V>_$\GWI=/B_
MWYF_HIJ]#^SCK;?ZW4[!/]S>W_LHHMQ[B/\ GZONC_D'_&-4OY/Q?^9A3?'+
MQA)]W4(HO]RVC_J#5&;XO>+Y_O:W,/\ <CC7^2UW$/[-=RW^MUZ)/]RV+?\
MLPJ]#^S7;+_K=>E?_<M@O_LQH_L/CO$?'.I;SK)?ASA_:/#=/X8P_P# /_M3
MRR;XC>*)_O:_J _W)V7^1JE-XLURX_UNLZA)_OW3G^M>VP_LXZ*O^MU._?\
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MNI+\CYFMB:^)?-6FY/S;84445WG,%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!C>-/^1/UW_KPG_P#1;5SOP1_Y)KI7^]-_Z->NB\:?\B?KO_7A
M/_Z+:N=^"/\ R372O]Z;_P!&O7Q]7_DI:7_7B?\ Z7 ]Z'_(HG_U\C_Z3([N
MBBBOL#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[TY/UD_TL>)+BK,Y;22^2_4\/A_9J;_EKXA ]DL\_KOJ[#^S;IZ_ZW6KE_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +X7_P"*KIJ2@#FO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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MG_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*KI:*
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M?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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MX3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_WPO\
M\51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\ /&Y_
M[X7_ .*KI:* .:_X3_3O^>-S_P!\+_\ %4?\)_IW_/&Y_P"^%_\ BJZ6B@#F
MO^$_T[_GC<_]\+_\51_PG^G?\\;G_OA?_BJZ6B@#FO\ A/\ 3O\ GC<_]\+_
M /%4?\)_IW_/&Y_[X7_XJNEHH YK_A/]._YXW/\ WPO_ ,51_P )_IW_ #QN
M?^^%_P#BJZ6B@#FO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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M%_\ BJZ6BOL#PCFO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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MO^>-S_WPO_Q5=+10!S7_  G^G?\ /&Y_[X7_ .*H_P"$_P!._P">-S_WPO\
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M_P#A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJOG7P_P#%;Q-X=VK!J3W$"_\
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M:J\L^,/_ "-G@'_L(_\ M2&OC^+O^1/4_P 5/_T[ ][(_P#?X>D__2)'7?\
M"?Z=_P \;G_OA?\ XJC_ (3_ $[_ )XW/_?"_P#Q5=+17V!X)S7_  G^G?\
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M_P!T?^ <#J6K7NL7!GOKN:\F/\<\A<_K45K9SWLGEV\,DS_W8U)-?1_A_P"
MOAS2=KWOG:M,.?WS;(\^RK_4FO0+'3;32[<06=K#:PKTCAC"+^0KU<O\,LPQ
M4O:YG74+[I>]+YO;YW9Q8KB_"T5R8.FY6[Z+[M_R/E?2/AS?7DBF]D%A">IP
M)'_[YR!^9%>C>'_!/@G1]KW5K?:K./XKD*$S[(& _/->U45^JY9P-D>66DJ/
MM)+K/WOP^'\#XS&<19CC+IU.5=HZ?CO^)REGXRT;3[=8+6RDMH5Z1PPHBCZ
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M/_?"_P#Q5=+10!S7_"?Z=_SQN?\ OA?_ (JC_A/]._YXW/\ WPO_ ,572T4
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M?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8_XZO_IV9[N=_P"^O_##_P!(B%%%%?8GA!1110 4444 %%%% !1110 4444
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MEGB%DF/M&K-T9=I+3_P)77WV/C\7POF&&NX14UY;_<]?NN>O5Y9\8O\ D;/
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MC'M33T]9N[7WH^IADN393%3Q33?]Y_E'K]S..UCQ!J6OS>;J-]<7KYR/.D+
M?0=!^%5K.RN-0G6"U@EN9FZ1PH78_0"OH7P_^S[H6F[7U*>;591U4GRH_P @
M<_K7HNEZ+I^AV_DZ?906<7]V&,+GZXZ_C7?@?#7-,=/VV:5E"^_VY?/6WXLY
ML3Q;@\/'V>#I\UO^W5_G^"/G/P_\"O$NL;7NHX]*@/\ %<ME\>R#)_/%>E^'
M_@#X?TO:^H/-JTPZB0^7'_WRO/YDUZ=17ZIEG >1Y;:3I>UDNL]?PTC^!\9C
M.)<QQ=TI\B[1T_'?\2IINDV6CVX@L;2&SA'\$$80?I5NBBOT"$(TXJ$%9+HC
MYB4I2?-)W844459(4444 %%%% !1110 4444 %%%% 'D&B_\G&:]_P!>J_\
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M0P/((/<5^58W+\3E]3V6(A9_@_1GZ9@\=A\=3]IAY77XKU0^BBBO/.X****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK%\7
M>++3P9H[:E>QS2P*ZH5MU!;)Z=2!^M<^(Q%+"TI5ZTN6$5=OLD:TJ<ZTU3IJ
M\GHD8?QG_P"2::S](O\ T<E;'@+_ )$?P_\ ]>$'_HM:\H^('QJT3Q7X0U#2
MK2UU".XN FUIHT"#$BL<D.3T![5?\,_'C0-%\.:7I\]GJ336MK'"[1Q1E2RJ
M 2,N..*_+X\3Y,L_GB?K,>1T8QOTNIR=ON:/L)9/C_[,C1]B^;VC=O+E2N>S
M45B^$?%EIXST==2LHYHH&=D"W"@-D=>A(_6MJOU##XBEBJ4:]&7-"2NGW3/C
MZM.=&;IU%:2T:"BBBN@R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** ,_4O$&EZ-(B:AJ5G8NXRJW,Z1EAZC<1FO*OBIXDTC4?%'@B6TU2R
MN8K>_P!\SPW".L2[XCEB#P.#U]#7HWB3P'H7BZ:&;5K'[7)"I1&\Z1, G./E
M85C?\*5\&?\ 0&_\FIO_ (NOA,^P6=YG3J83#QI*DW%IN4^;W91EJE!K=6WV
M/I,MQ&78.<:]5SYTG=)1MJFOYD]F;T?C;P[+(J)KVEN['"JMY&22>P^:MJN+
MM_@WX/M9XYH](VR1L'5OM,QP0<@_?KM*^DR^6924O[1C!/IR.3];\T4>3BEA
M$U]5<GWYDE]UFPHHHKUSA"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#RSX3_ /(^?$'_ *_A_P"C)J]3KRSX3_\ (^?$'_K^'_HR
M:O4Z^.X2_P"13'_'5_\ 3LSW<[_WU_X8?^D1"BBBOL3P@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH QO&G_(G:[_ ->$_P#Z+:N>
M^"/_ "372O\ >F_]&O70^-/^1.UW_KPG_P#1;5SWP1_Y)KI7^]-_Z->OCZG_
M "4M+_KQ/_TY ]Z'_(HG_P!?(_\ I,CNJ***^P/!"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 1E#*589!X(-<AX@^$OACQ%N:73EM9V_Y;6?[I
MOK@?*?Q!KL**X<9@<+F$/98NE&<>TDG^9TT,36PTN>A-Q?D['@GB#]G.^M]T
MFC:C'=IU$-T/+?Z!AD'\<5YKKW@[6O#+$:GIMQ:KG'F,N8S]'&5/YU]BTUE6
M12K*&5A@J1D&OR_,_#3*L7>6#E*C+_P*/W/7_P F/L,'Q=C:-E72J+[G]ZT_
M ^)HY7AD62-VC=3D,IP1]#6Q/XSUJ[DTV2YU"6Z?3I?.MFN#O*-E3U/)^Z.#
MZ5]'^(/A!X7\0;G?3Q93M_RVLCY1^NW[I_$5XSX[^$C>$]:T:SMM0%RFJS^1
M$98]IC.Y!\V,Y'SCH.W2ORC->#<\R"E*K3GS4KJ[C*WVERWB[?:M:U[.S/M<
M%GV79G-0E&T];75^CO9Z]+]CD=<\6:QXDDW:GJ-Q=\Y"._R#Z*.!^ K-AADN
M95BAC:61CA4122?H!7O_ (?_ &=]*L]LFK7LVHR=XHOW4?T_O'\Q7I&B^&=*
M\.Q>7INGV]F,8)B0!F^K=3^)KV\%X<YQF4_;YI64+[W?//\ .W_DWR//Q'%>
M PD?9X.'-;LN6/\ G^!\X>'_ (*^*-=VN]HNF0'_ ):7IV'_ +X&6_,"O3/#
M_P"SUHMAMDU2ZFU20=8U_=1_D#N/YBO5J*_4LL\/\DR^TITW5EWGJO\ P%6C
M]Z9\;C.)\QQ5U&7(O[O^>_W6,_1_#^FZ!#Y6G6,%DG0^3&%)^IZG\:T***_0
MZ=*G1@J=**C%=$K(^6G.523E-W;[A1116I 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'D&B_\ )QFO?]>J_P#HF&O7Z\@T7_DXS7O^O5?_ $3#
M7K]?(<-_P\7_ -?ZO_I1[F;?'1_Z]P_])"BBBOKSPPHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH QO&G_ ")^N_\ 7A/_ .BVKG?@
MC_R372O]Z;_T:]=%XT_Y$_7?^O"?_P!%M7._!'_DFNE?[TW_ *->OCZO_)2T
MO^O$_P#TN![T/^11/_KY'_TF1W=%%%?8'@A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >6?"?_D?/B#_U_#_T9-7J=>6?"?\ Y'SX@_\ 7\/_ $9-
M7J=?'<)?\BF/^.K_ .G9GNYW_OK_ ,,/_2(A1117V)X04444 %%%% !1110
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MH]S-OCH_]>X?^DA1117UYX84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8WC3_D3]=_Z\)_\ T6U<[\$?^2:Z5_O3?^C7KHO&G_(G
MZ[_UX3_^BVKG?@C_ ,DUTK_>F_\ 1KU\?5_Y*6E_UXG_ .EP/>A_R*)_]?(_
M^DR.[HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% 'EGPG_P"1\^(/_7\/_1DU>IUY9\)_^1\^(/\
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MP0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>VQX^4T:M6G'$5*\V[RTNK:-KM?IWW"BBBOE#Z8**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ->$_P#Z+:N=^"/_ "372O\ >F_]&O7Q]7_DI:7_ %XG_P"EP/>A_P BB?\
MU\C_ .DR.[HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^*OP9\(_&C
M0SI?BG2H[Q5_U%U'\EQ;GUCD'(^G(/<&NWHK6G5G1FJE.34EU1G4IPK0<*BN
MGT9^6/[0'[$GB[X/_:=6T82>*?"J?,;JWC_TBV7_ *:Q#L/[ZY'<[>E?/>DZ
MO?:#J5MJ.FWD^GW]LXDANK:0QR1L.A5@<@U^Z5?+_P"T!^PIX5^*7VG5_"_D
M^$_$SY=O+3%E<L3DF2-1\C'^^GN2K&OTW*N+5)*AF*_[>_S7ZK[C\[S/A=Q;
MK8!_]N_Y/_/[SRK]GW_@H;)#]ET/XGH9(\K''XBM8_F4>L\:]?\ >09]5/)K
M[FT/7M.\3:3;:II-];ZEIUT@DANK6021R+ZAA7XO?$KX4^*?A%K[:1XITF;3
M+GDQ2,-T4Z@XWQN.&'TZ9YP>*V_@S^T%XR^!FK"Y\.:B38R.&N=*N<O:W'^\
MN?E/^TI!]\<5UYEPOA\='ZSETE%O6WV7Z=OR]#DR_B/$8.7U?'IM+2_VEZ]_
MS]3]E:*\(^ 7[7_@SXXQ06!E'A_Q25 ?2+R0?O6[^0_ D'MPWMCFO=Z_+,3A
M:V#J.E7BXR7?^M3]*P^)HXJFJM"7-%A1117*=)\F?L>_\E^_:/\ ^Q@7_P!*
M;VOK.ODS]CW_ )+]^T?_ -C O_I3>U]9U[V>?[]+_##_ -(B>)DW^Y1]9_\
MI<@HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>)_^EP/>A_R*)_\ 7R/_ *3([NBBBOL#P0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D/QP_Y&OP'_P!?4G_H
MR"O7J\A^.'_(U^ _^OJ3_P!&05\AQ9_R**G^*G_Z=@>YDO\ OT?27_I$CUZB
MBBOKSPPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO^>5S_WPO_Q5 '345S/_  G^G?\ /*Y_[X7_ .*H_P"$_P!._P">5S_WPO\
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M?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%4?\ "?Z=_P \KG_OA?\
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MX3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!._P">5S_WPO\
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MPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\
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MG?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y_P"^%_\
MBJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\ A/\ 3O\
MGE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\ WPO_ ,51_P )
M_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\ OA?_
M (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_ (3_ $[_
M )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%4?\
M"?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_ 'PO_P 51_PG^G?\\KG_ +X7
M_P"*H Z:BN9_X3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!.
M_P">5S_WPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_
M  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y_P"^
M%_\ BJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\ A/\
M3O\ GE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\ WPO_ ,51
M_P )_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\
MOA?_ (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_ (3_
M $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%
M4?\ "?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_ 'PO_P 51_PG^G?\\KG_
M +X7_P"*H Z:BN9_X3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$
M_P!._P">5S_WPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\
MQ5'_  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y
M_P"^%_\ BJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\
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MF?\ A/\ 3O\ GE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\
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M*Y_[X7_XJOKSPSIJ*YG_ (3_ $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOG;3;22,-@;&N)#MD4Y5HV?=E<@8.!XA^V=\1M _;6_::^#7PS^$MQ'XKNM
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M;1Z4M% ";1Z4;1Z4M% ";1Z5Y#\;Q_Q5?@/C_EZD_P#1D%>OUY#\</\ D:_
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MZIJ5KHNGSWU[)Y-K N^23:6VCUP 35NN8^)C:ZG@+6V\-:39ZYKPMS]CT[4
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MT[:LY?:4ZOOTDU%[*7Q)>>VHFT>E&T>E+15@)M'I1M'I2T4 )M'I1M'I2T4
M)M'I1M'I2T4 )M'I12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ'W9$/*G]#C@D5V5?B!X(\>:_P##CQ!;ZWX;U2XTG4X?NS0-]X=U93PRGNK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8D'X* *O445XS;D[L]9)15D%%%%(84444 %%%% !1110!\F>!_\ E(U\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHK,\0^)]'\(Z:VH:[JUCHM@K!#=:A<I!$&/0;W(&3Z9JHQ<G
MRQ5V*4E%7;LC3HK@_P#A?GPQ_P"BC>$O_!Y:_P#QRC_A?GPQ_P"BC>$O_!Y:
M_P#QRNCZKB/^?<ON9S_6J'_/Q?>CO**S/#WB?1_%VFKJ&A:M8ZU8,Q076GW*
M3Q%AU&]"1D>F:TZYY1<7RR5F=$9*2NG=!1114C"BBB@ HHHH **** "BBB@
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M,KQ+>;'\2>,-,TM>K1Z;;R73?3+>6 ?S_&O9?"?_  3H^&&B;'U>?6/$<O\
M$MQ=""(_18@K#_OHU]3T5\YB.(\TQ&]5I>5E^*U_$]ZCD&74-J5WYZ_GI^!Y
M_P"$_P!G_P"&_@C8=&\$Z+:RI]VX>T6:8?\ ;1]S?K7?JH50J@!0, #H*6BO
M J5JE9\U63D_-W/<ITJ=%<M.*2\E8****Q-0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /DSP/_ ,I&OB#_ -BW%_Z+L:^LZ^3/ _\ RD:^(/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\D'^'7_8NZ?_ .D\=<5^W!_R:[XW_P!VS_\ 2R"NU_9]_P"2#_#K_L7=/_\
M2>.O?E_R)X_]?9?^DQ/$C_R-9?\ 7M?^E2._HHHKP#VPHHHH **** "BBB@
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MZ][//]^?^&'_ *1$\3)O]S7^*?\ Z7(****\$]L**** "BBB@ HHHH ****
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MJUI.4FIZO_!(^RS.A3P^7.E1C:*<=%_CB?6=%%%?,GT04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R9X'_ .4C7Q!_[%N+
M_P!%V-?6=?)G@?\ Y2-?$'_L6XO_ $78U]9U[^<?'0_Z]4__ $D\3*OAK?\
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M?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<_[E+UC_ .EQ/K.BBBO!/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR**G_7R/_I,CQ)_\C6'_ %[E_P"E1/?J***\ ]L**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAZ3_ /2)'B9S_N4O6/\ Z7$^LZ***\$]L**** "BBB@ HHHH **** "BBB@
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M-\DQ&4SO+WH/:7^?9_TC]$RO.*&9P]W2:WC_ )=T=/1117SI[P4444 %%%%
M'%?&[_DB_C[_ +%_4/\ TFDKS;]A+_DU_P )_P#72]_]*YJ])^-W_)%_'W_8
MOZA_Z325YM^PE_R:_P"$_P#KI>_^E<U>_#_D45/^OD?_ $F1XD_^1K#_ *]R
M_P#2HGOU%%%> >V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >%_MP?\FN^-_]VS_]+(*X7PK^QU\-/BY\$? FH7FDMHVM
MW'A^QDDU/2'$,DCFW0EG3!1R3R25R>>>:[K]N#_DUWQO_NV?_I9!7:_L^_\
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M .E%E7O9'_O\/2?_ *1(\3.?]REZQ_\ 2XGUG1117@GMA1110 4444 %%%%
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M0=0;A@?E'^PO/J1R*^A_V>?V2/"?P'M8K[8NN^*V3$VK7*#]T>ZP)_RS'O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS]DU*&VN$W*^^1/D#$;QF)ON\].*XOQ-X-U[P7>FTU_1=0T6YSCRK^V>%C]
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M7]0_])I*\V_82_Y-?\)_]=+W_P!*YJ])^-W_ "1?Q]_V+^H?^DTE>;?L)?\
M)K_A/_KI>_\ I7-7MP_Y%%3_ *^1_P#29'D3_P"1K#_KW+_TJ)[]1117@'MA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1RW,4
M#Q))*D;3-LC5F +M@G ]3@$X'8&H-6U:RT'2[S4M2NH;'3[.%I[BZN'"1Q1J
M"S.S'@  $DGTK\SOAI^V1J7[4G_!2'P+:Z8;BT^&^D1:G_8=O(C1B^/V6>-[
MU@>I8JRK_=4$<,7RX?O*BIK>S?R2;_&UE_P&$O<INH]E^;_K^M#]/****0!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI_P3?^%U]DVU_P"(].;L(;R)U_)XB?UKD=4_X)B:#-G^SO'6HVOI]JL8Y_\
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MO77:7_P4[T&;']H^!=1M?7[+?1S_ /H2)7!/AG-8?\NK^CC_ )G=#B++)_\
M+VWJG_D?;%?)G[:'_)8OV=_^QD/_ *4656=+_P""D'PNOL"YL/$>G-W,UG$Z
M_FDI/Z5Y#^TI^TYX ^)7Q ^#>M:%J=Q<6?AW6C>ZD)+.6-X8O.MFR 1\QQ$_
M"YZ>XKKRG*<?A\;&56C)*TM;:?#)'+FF9X+$8.4:=5-WCU_O(_0BBOD_7/\
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M1_CA_P D5\?_ /8OZA_Z325YQ^PG_P FO>$?]^]_]+)J]^'_ ")Y_P#7R/\
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MV>?^QD/_ *46=>_D7^_P])_^D2/$SK_<I>L?_2XGUG1117@'MA1110 4444
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MM"O;>SU14VPW[FW<*C@<)*3@#^%B>QP#[S^PE_R:_P"$_P#KI>_^E<U? 8O
M8C+LMJ4<1&S]I'T?NRU1]OA<=0Q^84ZM!W7LY>J]Z.C/?J***^0/J@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*KI=H]*-H]* .:_X3_3O^>5S_P!\+_\
M%4?\)_IW_/*Y_P"^%_\ BJZ7:/2C:/2@#FO^$_T[_GE<_P#?"_\ Q5'_  G^
MG?\ /*Y_[X7_ .*KI=H]*-H]* .:_P"$_P!._P">5S_WPO\ \51_PG^G?\\K
MG_OA?_BJZ7:/2C:/2@#FO^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJZ7:/2
MC:/2@#FO^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\ OA?_ (JNEVCTHVCTH YK
M_A/]._YY7/\ WPO_ ,51_P )_IW_ #RN?^^%_P#BJZ7:/2C:/2@#FO\ A/\
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M_P 51_PG^G?\\KG_ +X7_P"*KI=H]*-H]* .:_X3_3O^>5S_ -\+_P#%4?\
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M[7UGM'I7O9Y_OS_PP_\ 2(GB9-_N:]9_^ER.:_X3_3O^>5S_ -\+_P#%4?\
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M?3[5%;S_ /H(2ONS:/2C:/2O0IY]F=/:O+YZ_G<X9Y+EU3>BOEI^1^<NJ?\
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MC]R?YGFVAV?P_P##.W^R/"&G:7MZ&STR"(C_ +YQ72?\)_IW_/*Y_P"^%_\
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M"_XGU.&SC 8K2G55^ST?XG?_ /"?Z=_SRN?^^%_^*H_X3_3O^>5S_P!\+_\
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M"_\ Q5'_  G^G?\ /*Y_[X7_ .*KI=H]*-H]* .:_P"$_P!._P">5S_WPO\
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M=_SRN?\ OA?_ (JC_A/]._YY7/\ WPO_ ,572[1Z4;1Z5X![9S7_  G^G?\
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M +X7_P"*H_X3_3O^>5S_ -\+_P#%5TNT>E&T>E '-?\ "?Z=_P \KG_OA?\
MXJC_ (3_ $[_ )Y7/_?"_P#Q5=+M'I1M'I0!S7_"?Z=_SRN?^^%_^*H_X3_3
MO^>5S_WPO_Q5=+M'I1M'I0!S7_"?Z=_SRN?^^%_^*H_X3_3O^>5S_P!\+_\
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M97UNYCFMYT*NC#L0:^P_V"OVDM0T'5K?X::M%]KT299YM.DC4"6VD :5T/\
M>1OG;GD'O@X'TG^UM\ O"7Q,^'/B#Q#?V?V7Q#HNF7%Y;:G:@+*PBB9Q%)Q\
MZ''0\C/!'.?,?^"??P%T+3O!^G_%&>66\UW4$N+:WBD4".S59GB8KW+,$ZGH
M"1CG-?I6-SK!YIDU2I7A:6UNT[.S3[;_ "NO7\^PF48K+LVA"C.\=[_W;JZ:
M[_\ #GU+_P )_IW_ #RN?^^%_P#BJ/\ A/\ 3O\ GE<_]\+_ /%5TNT>E&T>
ME?DI^GG-?\)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%5TNT>E&T>E '-?\)_I
MW_/*Y_[X7_XJC_A/]._YY7/_ 'PO_P 572[1Z4;1Z4 <U_PG^G?\\KG_ +X7
M_P"*H_X3_3O^>5S_ -\+_P#%5TNT>E&T>E '-?\ "?Z=_P \KG_OA?\ XJC_
M (3_ $[_ )Y7/_?"_P#Q5=+M'I1M'I0!S7_"?Z=_SRN?^^%_^*K5T?7(-<CD
M>!9%$9VGS !_(FM#:/2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\^U#X!^ ]
M4^,FG?%6ZT+S?'VG69T^UU;[9./+@(D!3RA)Y1XEDY*$_-UX&/0:*-G=?UT_
M(-U9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%</\8_ .L?$KP5+HNA>+K[P3?M/'*-6T\.9553DI\DD9P?]ZM:48SFHSERI
M]=[?=J9U)2C!RA'F:Z=_O.#_ &X/^37?&_\ NV?_ *605VO[/O\ R0?X=?\
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M*?*C/^Q&,(O_  $"L/0O#^J>*-2BT[1M-N]5OY?N6ME"TTC?15!-?H5\,?\
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MBTW]9<7VY4U]]VR2BBBO/.X**** "BBB@ HHHH **** "BBB@ HHHH ****
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M][:)XEUO2';HMR(KJ-?H-J-CZM7D_B7_ ()G^-+'>VA>*=%U9%Z+=I+:.WT
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M_!=]O;0_%.M:2[=%NTBND7Z ",X^K5]BT5[%'.LQP_\ #KR^;O\ G<\JME&
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MB@ KY,_;0_Y+%^SO_P!C(?\ THLJ^LZ^3/VT/^2Q?L[_ /8R'_THLJ][(_\
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M;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XKXW?\D7\??]B_J'_I-)7FW["7_)K_A/_KI>_P#I7-7I/QN_Y(OX
M^_[%_4/_ $FDKS;]A+_DU_PG_P!=+W_TKFKWX?\ (HJ?]?(_^DR/$G_R-8?]
M>Y?^E1/?J***\ ]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^3/VSO^2S?LZ?\ 8R'_ -*;*OK.ODS]L[_DLW[.
MG_8R'_TILJ]_(O\ ?X>D_P#TB1XF<_[E+UA_Z7$^LZ***\ ]L**** "BBB@
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M?\C6'_7N7_I43WVBBBO /;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH XKXW?\ )%_'W_8OZA_Z325YM^PE_P F
MO^$_^NE[_P"E<U>D_&[_ )(OX^_[%_4/_2:2O-OV$O\ DU_PG_UTO?\ TKFK
MWX?\BBI_U\C_ .DR/$G_ ,C6'_7N7_I43WZBBBO /;"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-7];MG?AL,\.FG4E._\ -;3TLD%%%%<)VA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\F?L?_P#)P'[1W_8?7_TIO:^LZ^3/V/\
M_DX#]H[_ +#Z_P#I3>U]9U[V>?[\_P###_TB)XF3?[FO6?\ Z7(****\$]L*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#B?CA_R17Q__P!B_J'_ *325YQ^PG_R:]X1_P!^]_\ 2R:O1_CA
M_P D5\?_ /8OZA_Z325YQ^PG_P FO>$?]^]_]+)J]^'_ ")Y_P#7R/\ Z3(\
M27_(UA_U[E_Z5$]]HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .*^-W_ "1?Q]_V+^H?^DTE>;?L)?\
M)K_A/_KI>_\ I7-7I/QN_P"2+^/O^Q?U#_TFDKS;]A+_ )-?\)_]=+W_ -*Y
MJ]^'_(HJ?]?(_P#I,CQ)_P#(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3/
MV/\ _DX#]H[_ +#Z_P#I3>U]9U\F?L?_ /)P'[1W_8?7_P!*;VOK.O>SS_?G
M_AA_Z1$\3)O]S7K/_P!+D%%%%>">V%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/QP_P"2*^/_ /L7]0_]
M)I*\X_83_P"37O"/^_>_^EDU>C_'#_DBOC__ +%_4/\ TFDKSC]A/_DU[PC_
M +][_P"EDU>_#_D3S_Z^1_\ 29'B2_Y&L/\ KW+_ -*B>^T445X![84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'%?&[_DB_C[_ +%_4/\ TFDKS;]A+_DU_P )_P#72]_]*YJ])^-W_)%_'W_8
MOZA_Z325YM^PE_R:_P"$_P#KI>_^E<U>_#_D45/^OD?_ $F1XD_^1K#_ *]R
M_P#2HGOU%%%> >V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS36'<9M)7Y[I626W*NB[GG8' 8K!\L'74H)MVY+;MO?F?5A1117SQ[P4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%</\8_ .L?$KP5+HNA>+K[P3?M/'*-6T\.9553DI\DD9P?\ >KN**UI5)49J
MI#=:]_P>AG4IQJP=.>S^7Y'R+??L4_$75+*XL[S]HKQ1=V=Q&T,UO/#<O'*C
M AE93>8(()!!X(-5M!_87\=>%M+ATS1?V@/$.D:;#N,=G86L\$*;B6;:BW@
MR22<#J37V'17M_V]F%N7G5O\$/\ Y$\;^Q,#?FY'?_%/_P"2.'^#G@'6/AKX
M*BT77?%U]XVOUGDE.K:@'$K*QR$^>20X'^]7<445XE6I*M-U)[O7M^"T/9IT
MXTH*G#9?/\PHHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#BOC=_R1?Q]_V+^H?^DTE>;?L)?\FO^$_^NE[_ .E<
MU>D_&[_DB_C[_L7]0_\ 2:2O-OV$O^37_"?_ %TO?_2N:O?A_P BBI_U\C_Z
M3(\2?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#BOC=_R1?Q]_V+^H?^DTE>;?L)?\FO^$_^NE[_ .E<
MU>D_&[_DB_C[_L7]0_\ 2:2O-OV$O^37_"?_ %TO?_2N:O?A_P BBI_U\C_Z
M3(\2?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /R__;)\&P?MB_\ !1+P-\&+F\N[?PUX?T=Y]5GT
MYU6: R(T\A4LK*"5%JHRIY;I7JWA'_@CS\&?!OBK1?$%EXF\=2WFDWL-_!'<
M7]D8VDBD5U# 6@)7*C."#CN*3QO_ ,$H/!_QD\?>+O''C_QSXEG\1>(-0FN_
M+T)H+>VMHB<0PXEBD:38BHN[*YV]!7E'PK\3?$;_ ()W_M5>%_@]XM\4W/C7
MX3^,GC@T6[O&;=9L[B-"@8GRRDA5713L*N'&#Q1AO=5.GM-W?K)MRM\MEZ!B
M/>YY[Q22^2TO\]WU\KGZA4444 %%%% !16=K.N0:''&\Z2.)#M'E@'^9%97_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_
M  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_W
MRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '345S/
M_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4 =-17,_\+ T__GC=?]\K
M_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^>-U_WRO_ ,51_P + T__
M )XW7_?*_P#Q5 '345S/_"P-/_YXW7_?*_\ Q5'_  L#3_\ GC=?]\K_ /%4
M =-17,_\+ T__GC=?]\K_P#%4?\ "P-/_P">-U_WRO\ \50!TU%<S_PL#3_^
M>-U_WRO_ ,51_P + T__ )XW7_?*_P#Q5 '35SOQ"\#V'Q*\%:OX8U.6X@L-
M4@-O-):,JRJI(.5+*P!X[@U'_P + T__ )XW7_?*_P#Q5'_"P-/_ .>-U_WR
MO_Q57"<J<E.#LUJB91C4BX25TSYR_P"':?PQ_P"@[XM_\#+7_P"1J/\ AVG\
M,?\ H.^+?_ RU_\ D:OHW_A8&G_\\;K_ +Y7_P"*H_X6!I__ #QNO^^5_P#B
MJ]S^WLS_ .?\CQO[$R[_ )\HS?@Y\(='^"/@J+PQH5S?7=A'/).)-0D1Y=SG
M)&411CCTKN*YG_A8&G_\\;K_ +Y7_P"*H_X6!I__ #QNO^^5_P#BJ\6K5G6F
MZE1WD]6SUZ=.%&"ITU9+8Z:BN9_X6!I__/&Z_P"^5_\ BJ/^%@:?_P \;K_O
ME?\ XJLC0Z:BN9_X6!I__/&Z_P"^5_\ BJ/^%@:?_P \;K_OE?\ XJ@#IJ*Y
MG_A8&G_\\;K_ +Y7_P"*H_X6!I__ #QNO^^5_P#BJ .FHKF?^%@:?_SQNO\
MOE?_ (JC_A8&G_\ /&Z_[Y7_ .*H Z:BN9_X6!I__/&Z_P"^5_\ BJU=&UR#
M7(Y'@21!&=I\P ?R)H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBU[2-9JSB[I+:_\ EY&4D_9RI)W4E9M[V_S\SIZ***@H**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJLUJR;J]@HKSCXQ?M%_#;]G_ $^"[^('B_3_  VMP"8()BTEQ, <$QP1AI'
M)&2JD#/-8WP=_:[^#WQ^OWL/ GCS3M:U)06_L]UEM+IE R66&=$=E'<JI I1
M]Z_+K8<O=WT/8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBL[4?$&FZ3J&EV-Y>PV]YJDS064$C8>XD6-I&51WPB,Q] * -&BB
MO.=<_:2^$?AG6;O2-8^*7@O2=6M)##<6-]XAM(9X9!U1XVD#*P]",T;NW4/,
M]&HI%8,H(.0>012T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$/PIX9U7RUF^PZQK=M:3[&SM;9(X;!P<'&#@UA_\-8_!#_HLGP__ /"HL?\
MX[2O?8#U6BO,;#]J+X-:K?6]E9?%OP+>7ES(L,%O;^);)Y)9&("HJB7+,20
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHX1M07,4C12E1V4LA8#L&%=3DJRFUIKJNFM[?+=',HRI.";OV?FM_GU/-?\
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M%O5?^O27_P! -? ?_!%#_DW?QG_V-#_^DMO4X?25=+;E7_I9=;6-)O\ F?\
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M !1110!\)?\ !5OXO^)/#7@7P/\ #'PI>OIFH_$34FT^YO(V*L+93&C1;AR
M[S(#CJJL.AKV'X7_ /!/_P"!GPY^']GX:G^'GA_Q-<+ $N]8US3HKJ\N9"N'
MD\QU+1Y.2%0J%[5R_P#P4:_99US]I#X4Z5?>#& \=^$;PZEI46\1FX4@>9"K
M$@*Y*1LI/&8P"1G(\3\*?\%?K#P#X<BT/XR?#/Q=HGQ!L8A%=0V=I&D5PX4#
MS&2>2-XMQY*[7 SP3TK.FXJ,XOXF]?.-E:WDM;KOKZ74YFX-?"E]TKN]_56L
M_*QG_"32G_8A_P""C,'PA\,7MU+\,_B!8_;X-'GF:06$Q24H5+$DE6MV3<>2
MCKN+%0:^K_B?^P/\"/C+XXU+Q?XQ\"_VQXBU$H;J\_M>_@\S8BQK\D4ZH,*J
MC@#I7Q]^Q;#XK_;?_;"U+]I#Q-IBZ-X5\,Q'3M%LE<NHF\ME2%6P-^Q97D=L
M#YY%P,<#]0>G)K;E<:5/VGQ)/U2;T3\[?A;<S<DZL_9_"[>C=M?E?\;GPQ\=
MOV'_ -D3]G_X5Z_XZ\1_#?;8:7 72!?$&IB2YF/$<*9N?O.Q 'IDD\ UY[_P
M2B_9)M]-CO?CMX@T.+2KG6&E7PMI/SNMA9N2&F4R%G.X?(C,2VP$Y._-5/B1
M?77_  4J_:]M_A_I4\C? _X<W'VC6;R!B(]1N02I"L.N\AHD(Z()7!^8"OTM
MT_3[;2;"VL;*WCM;.VC6&&"%0J1HH 55 Z    >U*BW&+K/[7P_X>_K+IY>H
M5DG+V/\ +\7KT7RW?GWL6****0PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMYA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y/\
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MD>FF]F>V((>*/]]%Y9;@%LD[<@ 9R/4Z*F45-<LMBHR<7=;GYR>#_P#@E/\
M$KX=Z/\ V3X5_:O\5^&=*\QI?L.CZ=<VD&]L;FV1ZB%R<#)QVKYZ\3?LG_$3
M2_V_/"7PUN/V@/$]]XKOM!:^@\>2+<_;K6()<G[.H-V7VD1N.)0/WAXZY_:"
MN>N/AWX5N_&5MXNG\,Z/-XLMH?L\&O26$37T46&'EK.5WJN';Y0<?,?4UI&3
MC.,GTO\ DTOQM\M#-KW'%;O_ #3-JR@>ULX(9)6GDCC5&E;JY P6/UK\[/\
M@M=_R1WX<?\ 8QM_Z3O7Z-5SGC;X;>$?B59VUIXO\+:+XJM+:3SH(-;TZ&\2
M*3&-ZK(K!6P2,CGFE>\XS?247]TD_P!#2FU3T\FOPL;EE_QYP?\ 7-?Y5/2*
MH50 , < "EH>KN90CRQ4>P4444BPHHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\[_:&^%*_''X(^,_
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MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S?Q)\(_\)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ:OEGX*_\E,T;_MM_P"B9*^IJ_J+PN_Y$U7_ *^R_P#2('X[QE_O\/\  O\
MTJ04445^PGP@45^7_BK_ (+9?\(SXHUC1_\ A3/VG^S[R:T\[_A*=GF>6Y3=
MM^QG&<9QDUE_\/SO^J)_^77_ /<51"<:D5..SU*E%PDXRW1^JE%?G/\ #/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/\ @I9_R0K0O^QD@_\
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MXD_6HP_\2IS=E?TYM+>?X&F(O[&GR_S2MZ\JO?R_$_56BBB@D**** "BBB@
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MX(L_$#4O$/P*\7>%[V:2>T\/:NK66\Y$45PA=HU]MZ.WUD->$_M:?\%0+O\
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MD=20P]P:^:-5_P""8O[.6I>$9-!A\ )IY,96/4[:_N?MD3D$"02-(=Q!.=K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5\F?\%+/^2%:%_V,D'_I+=5]9U\F
M?\%+/^2%:%_V,D'_ *2W5>]D/_(SH?XCQ,[_ .1=6]#\U****_H4_"@HHHH
M**** "BBB@#]WJ***_EP_I *_([_ (+>?\E ^%'_ &#KW_T;%7ZXU^1W_!;S
M_DH'PH_[!U[_ .C8JR_Y?T?\7Z,VA\$_3]4?J]H/_(M:=_UZ1_\ H K\K/\
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MMN/_ $DM*^5O^"B?@>;Q=_P4ATC0KW7)/#,&OC1[>VUE8S(;-7Q$)0NY,[9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP#D$8XR>A8>JZ7M[>[W_  .7ZU15;ZOS>_V^5_38]GHHHKG.H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\G?\%./^36[S_L+6?_ *$U?)'_  2QF7_AH;6K.5/,AN_#
MES&\; %3^^@//MC(_&OK?_@IQ_R:W>?]A:S_ /0FKY!_X)9_\G+7?_8 NO\
MT9#7OY<D\'B$_P"]_P"D(^9S/_?\-Z1_]+9YW^T[\*=3_95_:,E&BM)96<=U
M'K6@72@_+'OW(H/<QN"A_P!T'O47[9OC6P^)_P 5].\<:< D/B30;&_>,'/E
MRA##*G_ 7A9?^ U^BG_!0GX!?\+D^"L^KZ;;>=XE\+A[^UV+EY8,?OXAW.5
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MK#_TF1^P'[,__)JOP_\ ^Q:M_P#T2*_#BX_Y"$O_ %U/\Z_<?]F?_DU7X?\
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M.!N#+C)(PN<;L5G]8E14VL/RZ:]/+MKN:K"PK2AS8KFUT6_GWTV/ES_@KO\
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MI&K860J,[@2O+ 9RI!\S_:O_ &F?V:?C9\(]7=&&L^-C:8TIDTB>"]MY_P"
M-.T878#]Y=[ C. 3BN/"5*U.C&,Z?/3>WW_EVVTZG9C:.'J5Y3A5Y*D=];+;
M^D[7]+GMG[)/[<.A_M*2RZ#?Z>/#GC.WA\XV0E\R"[C&-SPL<'(ZE#R <@M@
MD?3M?BS_ ,$_-#U/6?VKO!DFFK)ML3<7=W(@XC@$#JV[V)95^KBOVFK',L/3
MP]2/L]+J]CIRK%5<32E[75IVN%%%%>0>V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAB@50J*N0#PN>!DG%>V45USQF(J1Y93T.*G@,-2ESPAK]_YGC/[1G[*OA/\
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M8\F_:(_9K\,?M,>']*T?Q/?:M86VG71NXFTB:*-V<H5PQDC<$8/8"L#]G?\
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M85*DZLN:;NSIITX48J%-604445F:!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\
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M_P"_R?XT9\6_\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^-
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M^- 'J-%>3WUWXGL[=I;BZN(XA@%A,OK['-%C>>)KVW66WNKB2(D@,9E_J<T
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MV?%O_/:?_O\ )_C1GQ;_ ,]I_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?%O\
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M_D_QHSXM_P">T_\ W^3_ !H ]1HKR[/BW_GM/_W^3_&C/BW_ )[3_P#?Y/\
M&@#U&BO+L^+?^>T__?Y/\:,^+?\ GM/_ -_D_P : /4:*\N+>+5!)GGQ_P!=
MD_QJCINJ^(-09UM;VXE*C+9E''YF@#U^BO+L^+?^>T__ '^3_&C/BW_GM/\
M]_D_QH ]1HKR[/BW_GM/_P!_D_QHSXM_Y[3_ /?Y/\: /4:*\NSXM_Y[3_\
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M\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\
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MO_/:?_O\G^-&?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]I_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!72US7@7_D'7'_77^@KI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK;U##H1FEKA/0WU"BBB@ HHHH **** "N+\#_P#(2NO^N?\ [,*[2N+\#_\
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M^A&M6F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5\V?\%$/^35O$O_7U9?\ I3'7TG7S9_P4
M0_Y-6\2_]?5E_P"E,=:4_P"+3_Q1_P#2D95OX%7_  R_])9K?L'_ /)J?@;_
M *YW/_I5-7%_&C]M"[^"?[2EGX.UJVTZ/P-_9OVVZO%MY7O@YBE950B3:=SH
MB@%/XNHZCM/V#_\ DU/P-_USN?\ TJFKYQ^/]A;:I_P4D\ 6UY;QW5NZZ>6A
MF0,K8,A&0>#R ?PKUI4XU,QJ0GLW+]3PX5)T<KISANE'\T>C:YK'[67Q2TR3
MQ5X030_A[HK*9;'P_?+')J5Q%C*F3S87578=B8\9P1WK$^$/_!0XGP+KMGX_
MTIY?B'I-PEE::5IL)675IF8HJ"/G8ZNN'QQR,#)VU]P5^<GP'T'3KK_@I)XV
M$UG%*MG<ZG=6ZLN1'+N WCW^=OIFLL/*G7<Z4H))1<E;?W;=?/S.C$QJX?DK
M0FW)R47?;WK].EK=#O?'VK_MAZ;X:NO'J7GA[2--MXC=R>$K&"*>YAA')#;X
MF+$+R0LN>#@ \5[?^R1^T8O[2'PU?5KJUBL-?TZ?[)J5M;Y\K?M#+)&"20K#
ML22"K#)QD^QZQ&LND7R.H9&@D!4]""IXKX(_X)42,MY\48 <1*U@P7L#FY'\
M@*5-QQ%&M>"7(HM6\W:WG\RJD9X:M1DIMJ;:=_31I=->Q]:?M"_'S0_V>/ ,
MWB+5T:[N9&\BPTZ-MKW4Q&0N?X5 Y9NP[$X!^== U#]L'XR:7%XJTG4_#?P^
MTJZ7S;/2;VV3S)8CRK8>"9QD?WF3/7 !%>:_M\>/].M_VK/ UEXIANKWPAX?
MM[:\N;&U17>8/,SRA59E!++&B\D<"O71_P %2/A0H 'A[QB .@^Q6G_R354:
M$U0C5A#FE)OS22T^]F>(Q,)8B5&I4Y(Q2VT;;UW[+;S.D_9U_:B\4:[\2;_X
M4?%C1;?0/'UI&9+:>UXAOE5=Q &2-VWYP5.U@&X4C!Y_]N[QA\8-+\(^*M-T
M3PII-S\,IM,1+_79IE^U1%VVNJIYZGKM&?+/4_AX'\0/VDO#'QQ_:V^#OBCP
M98ZKI5S:ZA::=>/JD$43R*UR  /+D?(VR.#G'7O7V?\ ML?\FM^/_P#KS3_T
M='4XB'L?95902<M&NET[7^:=[%8>I[?VM&%1M1M:76S5[?)W5SY'_9/\;?M(
MZ'\&["T^&OP_\.^(?"JW5PT-]J5PB3-(7.\$&\B. >!\OYU^@ND^(+O3/A_9
MZUXQ6VT6^@TY+K5U1AY-K((PTP!W-\JG=_$>!U->"?\ !.7_ )->T?\ Z_[S
M_P!&FH_^"CGBN[\-?LUWMO:2/$=7U&WT^5D.#Y9W2,/H?*P?8U>/E[3$.DHI
M-M*_76R_4670]EAE6E)M*+=M+::Z:;Z'!VO[17QO_:B\2:I;?!&PT_PKX0T^
M7R?^$DUJ)6:5_P#@:.!D8.Q8V*@C<1D"EN/VA/C=^R[XHT>V^-T.E^*O!^J3
M"#_A(M'C5&@8]?N)&#M&6*-&"PSM;@BN3_9]_;V^$_P6^$'AOPB?#WBEKRQM
MP;V6UL[8QRW+$M*X)N 2"Q."0#@#@=*R/VIOVYOAM\>/@SJWA/2]$\26^JS2
MP3VDVH6ENL4;I(I)++.S#*[QP#UKIE0E3JJG&C>%[7>[6S=_QT...)A4I>UG
M7M4:NDMD^BM^#N?HQ#=0WUBES;RK-;S1B2.2,Y5U(R"#W!%? W_!+/\ Y#WQ
M:_ZZ6/\ Z%=5]1?LFZI<:Q^S/\/KFZD,LW]D1Q;CU*IE%_\ '5%?+O\ P2S_
M .0]\6O^NEC_ .A75<M*G[+ZW3[)+[IG;4J>VAAJO\S3^^)[A^UU^U-?_ MM
M!\->$])CUOQQX@;;9P3 M'"I8(K%5(+LSG:JY X)/3!X!M"_;3TFQ77CXE\*
MZPX7SCX:$, D]?+W>0@R/:;\34W[=7P+\:Z[XK\)?%;P!;2:KK7AD1B3388_
M,EQ'*98Y$3K)AB0R#D@C&>:F^%?_  4D\':Y<)I'Q!TJ\\"ZY&?*GE>-IK02
M#@@X'F1DGLRD+W;O2H0OAU*C%2G=\U]7Y67IV#$5$L2XUYN,++E:T3=M;OO?
MOT/;O ?C?XD>*/@7-X@U/P;;:+X_:TF>UT*68B.:90?+WARIB#L/NL^0",MZ
M?G;\7/&'QGU7]K+P;?\ B/PGI&G_ !(LVLUTO1+>96M9<2NT(=A<,/F8D']X
MO3M7ZN:3J]CKVF6VHZ9>0:AI]U&)8+JUD$D4J'HRL"00?45^??[0W_*23X=?
M]==*_P#1K56!FOK?PI7O\M'L9YE!_4G[[=K=M=5O^A]'? OQE^T1KWC22V^*
M7@/P_P"&_#0M)'6\TN='E,X9=B8%W+P06_A[#D4_]H;XM?%KPMXHTKPK\,?A
MVOB&\U*V,XUR\<FTM\-AE8915(!4Y=P#N& :]^KD/B7\7/"'P?T,:MXOUVVT
M6T8E8Q*2TDS#JL<:@LY_W0<=ZX'44ZD9<B]%?7\;_P##6/35)TZ4H^T?J[77
MX6V_.Y\I>+K']LSP5H5UXID\6>&M9M[-#<S:%IUI"\OECEE -LI; SPLA8XX
MR:]G_9%_:7C_ &DO -S?7=I#IWB/2Y5M]1M+<DQDL,I*@))"MAN"205(R>M>
M97W_  4<T'7[J>P\!?#KQ7XXN5X*PVXC5QZ@()7Q]4%>4_\ !,>^ED^+GQ,C
M^RMIT<UJLK6+YS"PN&PAR!RNYAT'TKTU2E4I5/:TU&RNG:S\TUOL>3[:%*M3
M]C5<KNS3=UKM9[*S$_X*%>,?B_<:'>:/XD\*Z5I?PY_MM1IFKV\RO<W159#&
M'43L5!7<3F->0.G0]G\#_'_[5%OX#\"V>D_#7PO=>#DL+**VU"6YC$[V01 L
MI'VT'<8\'&P<_P /:MW_ (*D?\D-\/\ _8>C_P#1$U?0?[-__)OOPV_[%W3_
M /TG2HI55#!7Y$[22UOK[N[UW+JT74Q]O:25X-Z6T][9:;?U<]&HHHKQSW0H
MHHH XOP/_P A&Z_ZY_U%=I7%^!_^0C=?]<_ZBNTI( HHHI@%%%% !1110 5R
MOQ1^'.F_%KP#K'A'5Y[JVTW5(A%-+8NJ3* P;Y2RL <J.H-=510!^2O[:_[+
MOA7]FRY\(+X9U#6+X:M]H,_]K312;?+,>W;Y<28^^<YSVK]9++_CS@_ZYK_*
MOS\_X*M?\?GPU^E]_."OT#LO^/.#_KFO\J]6M4G5P5&<W=\T_P T>-1HPHXZ
MI"FK+EB0:WI,.O:-?Z9<,Z07MO);2-&0&"NI4D9!&<'TK\T?VQ_V*_!'[/7P
MLL_$OAS5/$%[?3:I%9-'JEQ!)%L:.1B0$A0YR@[XZ\5^G=?(7_!3[_DWK3/^
MQ@M__1,]<F%JSIU8J#M=Q3^__@G;C*-.M1FZBORQDUY.W_ 1[9^RW_R;G\./
M^P%:_P#HL5VGCV^_LOP+XBO,[?L^G7$N3VVQ,?Z5Q?[+?_)N?PX_[ 5K_P"B
MQ76_$KP_>^+?AWXGT/398H-0U+3+BS@EF9E1'DC9%+%02 ">PJ<>KUJR7>7Y
MLUR]\M*BWVC^2/D__@EAIGD?!_Q7?E<&XUPQ9QU"01GT_P!L_K7VI7P3\&_V
M*/C=HG@.30;GXL2?#?3_ +9)=)8>'XS-,\A 4O)-&\38(1<+O88[ Y%8?BSX
MA?'7]AWQEH[>+?$TWQ)\!:A+L$]Z[2/)C&Y0[DR12A<D LR'WP<>GB:<,7B&
MZ=17=K+7HEUV/&PE6I@\+%5*3LKW>G5OI>Y^B5%9WAW7[+Q5X?TW6M-F%QIV
MHVT=W;RC^.-U#*?R(K1KQ91<6T]T>]&2DE*.S"BBBD4%%%% !1110 5Q?@?_
M )"5U_US_P#9A7:5Q?@?_D)77_7/_P!F%(#M****8!1110 4444 %<)\:O@[
MHOQV\!W/A+7[J_M--N)HIFETV1$F#(VX %T<8SUXKNZ*:=FFN@FE).+V>GWG
MY1?M ?L[^'/V<OVA?AEH_AJ]U2^M;^XM+N5]5ECD</\ :PN%,<:#& .H-?J[
M7YY_M_?\G3?"'_=M?_2VOT,KT\14G5PE&<W=WG^:/)PU*%'&5X4U96A_Z3<^
M*_\ @IY\0+O2?AWX9\%V$K)-XBO6DN$0\R0P[<(?8R.A_P" 5]1?!_X;Z=\)
M?AKH'A738$ABT^U1)61<&68@&21O4LV3^-?&'_!1 ^?\?O@S;S_+:[URQX'S
M748;GIT K] :SE[N"IV^U*3?RT7X&D??Q]2_V(Q2_P"WES,_/KXZV\7[.?[=
MW@CQ?HZK8Z7XI,:ZC#'\J.9)/)N"1TZ&.3_>&:_06OS]_P""HG[GQ1\*9X^+
MA7NMI'7AX"./K7U[\=/C-IGP+^%VI^+-4*R20QB.SM2<&YN6'[N,?4\D]E!/
M:BI>6#H2W=Y1^YZ+\=!4FH8ZO#:-HR^]>\W]USY__;F^+VJZY?:1\#/ K-<^
M*O%#I'J!A/\ J+9CQ&Q'W=P!9CVC4YX:O%_V?_A_I_PK_P""A-KX1TUFDM]'
ML'MFF88,LG]G!I)/^!.S-[9Q7N_[#_P4U5!JGQF\=AKCQKXM+3VXG7YK6U<Y
MW '[I<8P/X4"CN17E_@__E*CKGTG_P#3<M=^'M1E/#+=0FY/^]9:>D=OO/,Q
M=Z\*>*>SJ4U'_#>]_632?I8_0:BBBO /IPHHHH **** "J>L_P#((O?^N+_^
M@FKE4]9_Y!%[_P!<7_\ 030!A^ _^/6Z_P!\?RKJ*Y?P'_QZW7^^/Y5U% !1
M110 4444 %%%% !7@G[<WC2^\#_LS^++K3I&AN[Q8M/$J'!19I CD'UV%A^-
M>]UY7^U!\*[CXS? [Q/X7L=IU.>%9[(,VT-/$PD12>VXKMS_ +5-64HN6UU?
MTOK^!,N9QDH;V=O6VGXG'_L(_#[3/ _[.'AFZLX(UO\ 7(CJ5[<A?GE9V.P$
M^BIM4#Z^IKSC_@I+\-()/A_I/Q+TM?L/B7P[?0HU] -LK0N^%RP[I)L*GMEO
M6N2_9/\ VR_#/PA\ Q_#?XIB_P#"NL>'9)+>.:XLII0T9<L(W5%9U=2Q'W<$
M!>:S?VMOVE[KX_\ PH\1Z=\.=(NI_ 6EF&;6_$U_ 88ICYJ"." ,,[B[(QSA
ML#H!R?9JTZWUWVT=N9-/I:_?;;2WR/"HU*'U'ZO+?ELX]>:W;_%K^+/M3X)^
M/O\ A:/PE\)^*FVB;5-/BFG"]!-C;*![!PP_"OD3]EA?[>_;Y^,^K8WK;)>P
MJW4?\?42#MUPA_7K7NW[">[_ (94\"[L_P"JN<9]/M4N*\(\*_L:?&G3OBQ\
M0]4T[QY9^ ]*U^\FE;5=.7[5=7$3RM*JH/D:/&[!.]3D<;AS4VA1Q=>-[*TD
MOFT5S5*^"P\[-N\).WDF?>5%?GU\5/!?[1'[)>FCQII/Q3U#XB>';9T_M"+5
MO,F,:E@ 7BEDDQ&20"T;AAGL.1]?_L^_&:Q^/7PMTGQ=9P_9)9]T-Y9[MWV>
MX0X=,]QT8'^ZRUQ3P_+3]K3DI1V?EZH[Z>*YJGL:D7&5KJ]M?1H]&HHHKD.X
M**** "BBB@ HHHH QO%W_("G_P!Y?_0A2>#_ /D!Q?[S?SI?%W_("G_WE_\
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M2/Y?.>/$D1;'7*B13ZK@=J^Y]!UB#Q%H6G:K:G=;7UM'=1'U1U#+^A%?)O\
MP5!BC;X :0[?ZQ=?@V\^L,^:]_\ V=YI)_@'\.9)23(WAZP+$^OV=*/BP2;^
MS)I?-7'\&/:7VH)OU3M^1Z%1117GGIA1110 4444 %%%% '%^.O^/ZV_ZY_U
MKM*XOQU_Q_6W_7/^M=I2 ****8!1110 4444 %%%% 'PQ_P5/N&F\+?#O2TQ
MONM3G<+ZE41?3_II7V[I=FNGZ79VJ#"00I$H]E4#^E?+W[;W[.?CGX\:EX#N
M?!TFG ://,9A?SE!&SF,K+@J0RCR^1@GD8!K \2?LF?'N\AEUFU_:)U:Y\0[
M?,&GJLUG9%P/NCRYB@&?^F6/:O1A[.6%A"4TG>3>_DEMY(\J?M88N4XP<ERQ
M2V7=O=^G]6/LJOFC_@HE?&S_ &6]?0'!N;RSA_\ (ZL?T6N._9 _:H\7^(_B
M%JGPF^*D07QA8>:+>]:-(Y)6C_UD4@3"E@OS*ZC#*#UX)]0_;2^#WB;XW_!>
M3P[X5%M)J:7T-V8+J;RA,B!LJK=-V6!^; X/-8RHO#UJ?.]+Q=^C5UJ=$:ZQ
M-"IR)II25NJ=GIZFY^R1IG]D_LT_#J +MW:1%/C&/]9F3/3_ &Z]<KXLTO\
M8Y^-]SX3TBWNOC_?^'[G3K..TMM)T.&6*TA2-0J)OBEBW8  +&,GZU@_!O\
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MKN!;>;5/+S*47(&.P)'!8 $@ $D 8@^#/_)'_ W_ & K'_TG2M+Q]>>(-/\
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MV@+&#X8_\%#/AUJOAM5M+K7);&2_AMQM#M-.]O*2!_?CY/J<GWK[B^)WPO\
M#GQ@\'W?AKQ18"_TNX(;:&*O&X^ZZ,.58>ON1T)%?#?[-6GZG^UA^UIK/Q@U
M2UDA\,:!+_H$<HX$BKMMHAZE5)E;'1L?WA7Z'UZ.)3I4J-*7Q15_2[NE\CS,
M(U5K5ZT?@D[+SLK-_,R?"GA/1_ WA^RT/0-.M]*TFS01P6MLFU%']23R2>22
M2<FOA'_@IKI%KX/\7_#?QUI!6P\3>=(IGA 5Y/(:-XG)')*DD9]"!VK] 9YX
M[6&2::18H8U+O(Y 55 R22>@ K\X]<OY?VZ?VQ--L]-5I_AYX38&2XQ^[D@1
MPTCY]9G 1?\ 9 /8TL#S2Q<:K>D;RD_*S_,>8<D,)*DE\5HQ7GI;[M_^'/T7
MT^X>[T^VGD0QO+$KLAZJ2 2*L4#C@<"BO/>KNCTHIJ*3"BBBD4%%%% !1110
M 5ROCS_4V?\ O-_(5U5<KX\_U-G_ +S?R%)@=!I?_(,M/^N*?^@BK55=+_Y!
MEI_UQ3_T$5:I@%%%% !1110 4444 %<U\2O .G_%+P+K/A/59KJWT[58/L\\
MMFRK,JY!RI96 /'<&NEHH _)S]MK]E7PG^S9;^$)?#.H:U?-J\ERL_\ :T\,
M@7RQ$5V>7$F/OG.<]J_5+P[_ ,B_I?\ UZQ?^@"OA/\ X*O?\>/PT_Z[7_\
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M?-VL=F+I2K0A&'2<9?)7N>M:K_R"[S_KB_\ Z":^!/\ @E3_ ,A3XJ?73_\
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MNDDE8C][_KDP0 !T-8W[+O[*>M^ O&6K?$SXEZK%K_Q$U7=@Q-OCLP_WSNP
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MGT6JQM:->O*I#;3\$D1E]">'PT:=3?7\6W8****X3T0HHHH **** "J&O?\
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MUKX%\;^%+B!+77M,U?S[F-E"RE'0( W<[7B<>V?>OJOX2Z;XQT?X?Z5:>/\
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M )#EI_US7_T(UVE !1110 4444 %%%% !1110 5^>'[87_)^GPC_ .NFD?\
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M_KH?Y4F!M:+_ ,@>R_ZXK_*KM4M%_P"0/9?]<5_E5VF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%^.O^/ZV_ZY_UKM*X
MOQU_Q_6W_7/^M=I2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5Q>I?\CM#_UTC_D*[2N+U+_D=H?^ND?\A2 [2BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%Z-
M_P CE=?]=)?YFNTKB]&_Y'*Z_P"NDO\ ,UVE) %%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)_JV^AKC_ ?_'S=_[B_P Z
M["3_ %;?0UQ_@/\ X^;O_<7^=(#LJ***8!1110 4444 %%%% !1110 4444
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M^\W\A28'0:7_ ,@RT_ZXI_Z"*M55TO\ Y!EI_P!<4_\ 015JF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%^,O^0Y:?\
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MF_[X%'_"K;7_ )_IO^^!0!8_MJP_Y_;?_OZO^-']M6'_ #^V_P#W]7_&J_\
MPJVU_P"?Z;_O@4?\*MM?^?Z;_O@4 6/[:L/^?VW_ ._J_P"-']M6'_/[;_\
M?U?\:K_\*MM?^?Z;_O@4?\*MM?\ G^F_[X% %C^VK#_G]M_^_J_XT?VU8?\
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MW_? H_X5;:_\_P!-_P!\"@"Q_;5A_P _MO\ ]_5_QJIJVK64FEW:)=P,[0N
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M?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\
MO@4?\*MM?^?Z;_O@4 6/[:L/^?VW_P"_J_XT?VU8?\_MO_W]7_&J_P#PJVU_
MY_IO^^!1_P *MM?^?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\
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MO_PJVU_Y_IO^^!1_PJVU_P"?Z;_O@4 6/[:L/^?VW_[^K_C1_;5A_P _MO\
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M?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\
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MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\
M3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_
M .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]
MM_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\
M:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_
M #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_W
MP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5M
MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\
M3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_
M .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&N2U"[@D\
M713K,C0AXR9 PV\ 9YKI?^%6VO\ S_3?]\"N6OO#D=IXJCTD3,T;.B^80,_,
M!_C0!V/]M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_
MX5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\
MS_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^
M-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\
MG]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W
M]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6
M'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_
M 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_
MX5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\
MS_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^
M-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\
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M_;5A_P _MO\ ]_5_QH_MJP_Y_;?_ +^K_C5?_A5MK_S_ $W_ 'P*/^%6VO\
MS_3?]\"@"Q_;5A_S^V__ ']7_&C^VK#_ )_;?_OZO^-5_P#A5MK_ ,_TW_?
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M_;5A_P _MO\ ]_5_QH_MJP_Y_;?_ +^K_C5?_A5MK_S_ $W_ 'P*/^%6VO\
MS_3?]\"@"Q_;5A_S^V__ ']7_&C^VK#_ )_;?_OZO^-5_P#A5MK_ ,_TW_?
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M_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4
M6/[:L/\ G]M_^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_
MY_IO^^!0!8_MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_
M  JVU_Y_IO\ O@4 6/[:L/\ G]M_^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7
M_G^F_P"^!1_PJVU_Y_IO^^!0!8_MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_
M /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4 6/[:L/\ G]M_^_J_XT?VU8?\_MO_
M -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_Y_IO^^!0!8_MJP_Y_;?_ +^K_C1_
M;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4 6/[:L/\ G]M_
M^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_Y_IO^^!0!8_M
MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\
MO@4 9WBS4K6ZTADAN8I7WJ=J.":E\,ZG:6^BV\<MU#&XW95G (^8U4\4>!X-
M!TLW<=S)*P=5VLH YJ7P[X"@UK1X+Q[J2)I-V5500,,1_2@#:_MJP_Y_;?\
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M 6/[:L/^?VW_ ._J_P"-']M6'_/[;_\ ?U?\:K_\*MM?^?Z;_O@4?\*MM?\
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M^F_[X% %C^VK#_G]M_\ OZO^-']M6'_/[;_]_5_QJO\ \*MM?^?Z;_O@4?\
M"K;7_G^F_P"^!0!8_MJP_P"?VW_[^K_C1_;5A_S^V_\ W]7_ !JO_P *MM?^
M?Z;_ +X%'_"K;7_G^F_[X% %C^VK#_G]M_\ OZO^-']M6'_/[;_]_5_QJO\
M\*MM?^?Z;_O@4?\ "K;7_G^F_P"^!0!S7BN[ANM8MGAF25%1061@0/F-=;_;
M5A_S^V__ ']7_&N.\3>'(]!U6WM(YFE65%8LP (RQ']*ZG_A5MK_ ,_TW_?
MH L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO
M_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-
M_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\
MX5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW
M_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH
M_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\
M/[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_?
MH L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO
M_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-
M_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\
MX5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW
M_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH
M_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\
M/[;_ /?U?\:YJUGCF\?P21R*\;2KAE.0?E ZUN_\*MM?^?Z;_O@5S]GI*:3X
M\MK)9&D2*9"&(P3\H:@#U>BBBF 4444 %%%% !1110 4444 %%%% !1110 5
MRGQ)_P"1='_7=?Y&NKKE/B3_ ,BZ/^NZ_P C28%WP/\ \BK8?1O_ $-JWJP?
M _\ R*MA]&_]#:MZF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >;_#'_D,7O_7'_P!F%>D5YO\ #'_D,7O_ %Q_]F%>D4D 4444P"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\W^&?\
MR&K[_KE_[,*](KS?X9_\AJ^_ZY?^S"D!Z11113 **** "BBB@ HHHH ****
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M<\?;5*K1=*SO=-737]?@.C75:ZM9IV:?3_@=F%%%%8'2%%%% !1110 4444
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M*** "BBB@ KA/BI_Q[Z=_OO_ "%=W7"?%3_CWT[_ 'W_ )"DP.MT/_D":?\
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MB_\ (RV'_7)/_0VKTBO-_B+_ ,C+8?\ 7)/_ $-J](H **** "BBB@ HHHH
M**** "BBB@ HJMJ6I6NCZ?=7][/':V=K$TTT\K;4C102S$]@ ":_,'Q+^W[\
M4?%_QVTMO">L-H?PZU'7(=-L;9M.MI#<Q++&LC%Y(V<,PD!(!&W> .1FNK#8
M>>*J>SI[_A_7^3.3%8JG@Z?M*GX;_P!?\ _4>BBBN4ZPHHHH **** "BBB@
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MO66']OR-TM%??1?*_P#D;8KZNYJ-5.3MI'5_.RT^;,3]B7XK>-/AI^T!XD^
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M2?\ H)K1K.\1?\B_J7_7M)_Z": .9^%O_'A??]=5_E7;UQ'PM_X\+[_KJO\
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M9-J_1JVRMZ]3.%2<\5%8B/*TG;JG?=I^B6AZK1117E'L!1110 4444 %%%%
M'-_$'_D5[G_>3_T(4GP]_P"18@_WW_\ 0J7X@_\ (KW/^\G_ *$*3X>_\BQ!
M_OO_ .A4NH'2T444P"BBB@ HHHH **** "J&M:]IGANPEOM6U&TTNRB4M)<W
MLZPQH!U)9B !5^OF#]H#]@'P7^T!XVO_ !?J/B#7M*URZACAQ:O ULOEH%4^
M6T>X\#GY_P JN"BY6F[+[S.HY1BW!7?K8^;/BQK4/[9'[<'@VT\ !M4\/^&/
MLPO=:AC/D".*<S2R!O[O1%)^\W3((-?IE7YOZ#XQ\:_\$W_B#HW@[Q*VF>)?
MA=KDADCU2STY+6Y7#!9)&*C<TB;E)61GRN K#M^CL,R7$*2Q.)(Y%#*RG(((
MR"*]#%)1HTHTM::O9]W?WK]M>AYN#DY5JLJVE1VNNR2LK=_7\!]?GY_P5CUZ
MTOM+^'?A.V7[3KUQ>S7:01C<XC*B)1CK\[M@>NP^E?;'Q0^)F@_"#P/JGBKQ
M)>+9Z98QESDC?*_\,:#^)V/ %?!W[*O@/Q!^UY^T-?\ QW\;VC0^'-+N1_9%
MF_,;S1G]S$F>J0_>+8Y<C_: SP4$ZOM9_!#5_HEYM_UJ:X^HU2]C#6<]%^K?
MDE_6C/T$\&Z;<:+X0T/3[IM]U:6,$$K'NZQJK'\P:V***XYR<Y.3ZG="*IQ4
M%T"BBBH+"BBB@ HHHH *XGXI?\@VR_ZZG_T&NVKB?BE_R#;+_KJ?_0:3 Z3P
MW_R+^F_]>Z?^@BM*LWPW_P B_IO_ %[I_P"@BM*F 4444 %%%% !1110 444
M4 %?G'X'NX_B-_P55U;5M Q+IVD_:!=S0\H?*LOLSDD>LK ?6O?_ -N+]JJW
M^ 7@-]&T6Y67QYK<;16,,; O9QG(:Y8=L=%!ZM[*:H_L!_LSW7P1^']SXB\2
MP,GC7Q,%FNDFYDM+<99(2>N\DEW]R >5KT<(O8QGB9;6<5YM[_=_P#RL8_;3
MAA(;W4I>27^?3K\F?5=9'B[Q3I_@CPKJ_B#591!INEVLEY<2>B(I8X]^*UZ^
M1/\ @IU\0I/"/[.HT:VE:.X\1ZC%9-M.#Y* RR?@2B*?9J\^,74DH1W;2^_0
M].4U3BZDMDF_N5SB_P!@_P ,W_QR^*?C7]H/Q9"9+JXNY+#1(I.5MUV@.4SV
M2,I$"/63O7W?7E?[+7@./X;?L]^ ]"2(12QZ7%<7"XY\^8>;+G_@;M^5>J5V
MXR2=9PA\,/=7HO\ /<X<#%JBJD_BG[S]7_EL%%%%<)Z 4444 %%%% !1110!
MYO\ %#_D*67_ %Q/_H1KTBO-_BA_R%++_KB?_0C7I% !1110 4444 %%%% !
M1110 5%<W,5G;RW$\BPP1(9))'.%50,DD]@!4M?$'_!0#]I2YA@B^"W@$OJ?
MC'Q"5M=06R.Z2"*0@+;C'_+27.".RGG[PJZ=.=::ITUJ_P"ON,JM6%"#JU':
M*_K[SA?^"=N[QA^U#\8_&6F1LGA^87 1E&%)GO/,B'UVQL:_1FO%OV2?V?;?
M]G/X0V.@/Y<VNW;?;=7N4Y#W#* 44]U0 */7!/\ %7M-=>,G"510IN\8I17G
M8X\#3G"FYU%:4VY-=K] K\X])O(_B-_P58>]T#]Y::-YBWMS#RI\FR,,A)'_
M $T81U]$_MM?M46G[//P_DL=*N(YO'&LQM%IUNK M;*00URX]%_A!^\WL#CG
MO^"?O[--[\'O!%YXO\4PR+XU\4 2S)<<RVML3N6-L\[W)WOGG[H/*FKPB]E&
M>*EM9Q7FW_EU_P R,9+VTX82&[:D_**U^]]/\F?6E%%%><>H%%%% !1110 4
M444 %>;ZU_R4JW_Z[0_R6O2*\WUK_DI5O_UVA_DM 'I%%%% !1110 4444 %
M%%% !1110!^;R?\ *7"/_KJ__II:OTAK\WD_Y2X1_P#75_\ TTM7Z0UZ.)_@
M8;_ OS9YF&_WG$_XC\__ /@JY=1W"_"C2))5CCN+^ZDD,C;551Y*Y). !\QY
MSQ7T)>?MT_ ?1=4&D3?$2Q>XC(C\RWM;F>#\)DC:,CWW8KJ/C=^S-X"_:$FT
M.7QGIUQ>/H\C-;FWNGAW(Q!>-MIY5MJYQAN.".:JZM^R+\&=8\/OH\OPU\.0
M6S1^7YUI81P7*C&,B= )-WONS40J4?J\*51.Z<GI;K;]$54HU_K$JM)JS45K
M?I>^WF_NL>D>%_%FB^-M%@U?P_JUGK6ES_ZN\L)UFB;'4!E)&1W'45K5^:/[
M,_\ :G[*O[<VK?"&+4+B[\*:R[11I<,,-F SV\V!QY@ \LD8SD\<#'Z75&(H
MQI\LX.\9*Z_X/F:X:O*KS0J*THNS_P UY,****Y#L"BBB@ HHHH **** /-_
M#O\ R4:]_P"NL_\ ,UZ17F_AW_DHU[_UUG_F:](I( HHHI@%%%% !1110 44
M44 %?FY^P;_R>_\ &3_=U3_TXQU^D=?FY^P;_P GO_&3_=U3_P!.,=>C@=ZO
M^"7Z'DYCM1_QQ_4_2.O'/VJ_V@K']G3X3W_B!S'-K5QFTTFS;GSKE@<$C^Z@
M^9O88ZD5Z]=745C:S7$[B*"%&DDD;HJ@9)/X5^6NH?M%_#CX^_M7#Q=\3O$2
MZ1\.O"G&@:3+8W%Q]N<-P[K%&^ S 2-NQD"-,$9QAAJ'UBIROX5J[=NR\WLO
MF^AU8O$+"T^=6YGHK[7[OR6[^[J:VK? 75/AO^P_\1OB#XO,D_C[QLUI=7<E
MR,RP6SW<4@1L]'=B'8=OE'5:^M/V /\ DTCP%_USNO\ TKFKPO\ ;+_;(^#_
M ,5OV=_$OACPKXO_ +4UR\:V,%K_ &9>0[]D\;M\TD*J,*I/)[5U'[ G[27P
MYB^$?@#X9-XBQXX(N8QI?V&Y^\9II0/-\OR_N<_>]NO%>I.-:KA:K<&GSJRM
MM%1MIY(\BG*A1Q5)1J)^[*[OO)R6_FS[1HHHKP3Z,**** "BBB@ HHHH 9-_
MJG_W37GGPM_X_;__ *YK_,UZ'-_JG_W37GGPM_X_;_\ ZYK_ #-(#T:BBBF
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MK,5W@89A@'HQ'>M^E6Q"G[+V:Y>16779MK\-PHX5Q=7VKYN??INK/_@'QO\
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MO^O:3_T$UHUG>(O^1?U+_KVD_P#030!S/PM_X\+[_KJO\J[>N(^%O_'A??\
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MX,>#=6CO[JWUKQ28V#I;ZY>HT((.1E(8XPP]FR#W%?5%G9V^GVD%K:P1VUK
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M\-Z?'"*'Q/XLTWX>?";0Y/-2+5M1@M7,><9 =P'N) ,9&5C'K_'^@GA/XS?
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MB@ HHHH \W^*'_(4LO\ KB?_ $(UZ17F_P 4/^0I9?\ 7$_^A&O2* "BBB@
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MZ**LOGW"BBBN,[PHHHH **** "BBB@ K)\5?\BWJ/_7%JUJR?%7_ "+>H_\
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MP.MT/_D":?\ ]>\?_H(J]5'0_P#D":?_ ->\?_H(J]3 **** "BBB@ HHHH
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M@%%%% !1110 4444 %%%% !1110 4444 %<I\2?^1='_ %W7^1KJZY3XD_\
M(NC_ *[K_(TF!=\#_P#(JV'T;_T-JWJP? __ "*MA]&_]#:MZF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >;_#'_D,7O\ UQ_]F%>D5YO\
M,?\ D,7O_7'_ -F%>D4D 4444P"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\W^&?_ "&K[_KE_P"S"O2*\W^&?_(:OO\
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M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ
M/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A
M:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_
MSX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BN
MH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5
MM_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W
M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ
M/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A
M:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_
MSX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BN
MH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5
MM_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W
M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
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M8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\
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M .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\
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M .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\
MH&V?_?A/\* .7_X6E;?\^$O_ 'V*JZG\2+>_TVZMELI$,T31ABXXR",UV7_"
M/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^% 'G'A'Q=%X;M[B.2W>8R.&!5@
M,8%;_P#PM*V_Y\)?^^Q74?\ "/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4
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M2MO^?"7_ +[%'_"TK;_GPE_[[%=1_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\
M[\)_A0!R_P#PM*V_Y\)?^^Q1_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4
M?\(_I?\ T#;/_OPG^% '!^)/'<.N:3+9I:21,Y4[F8$<'-)X:\=0Z%I,=H]K
M)*RLQW*P Y.:[W_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5
MM_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_
M  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\
MA']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V
M?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*
MZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_
MX6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;
M?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]
M^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?T
MO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;
M9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8
MKJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6
ME;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5
MM_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_
M  H Y?\ X6E;?\^$O_?8K!\6^+XO$EK!%';O"8W+$LP.>,5Z-_PC^E_] VS_
M ._"?X4?\(_I?_0-L_\ OPG^% '&Z7\1H-/TVUMFLI':&-8RP<<X&,U:_P"%
MI6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\
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M$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\ H&V?_?A/\*/^$?TO_H&V?_?A/\*
M.7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2
M_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\
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M\* .7_X6E;?\^$O_ 'V*Y>^\1QW?BF/5A"RHKHWEDC/R@=_PKU#_ (1_2_\
MH&V?_?A/\*/^$?TO_H&V?_?A/\* .7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?
M8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\
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M_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG^% '+_\
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M_P#PM*V_Y\)?^^Q1_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4?\(_I?\
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M]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\ /A+_ -]BNH_X1_2_^@;9_P#?A/\
M"C_A']+_ .@;9_\ ?A/\* .7_P"%I6W_ #X2_P#?8H_X6E;?\^$O_?8KJ/\
MA']+_P"@;9_]^$_PH_X1_2_^@;9_]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\
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M$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?TO\ Z!MG_P!^$_PH Y?_ (6E;?\
M/A+_ -]BC_A:5M_SX2_]]BNH_P"$?TO_ *!MG_WX3_"C_A']+_Z!MG_WX3_"
M@#E_^%I6W_/A+_WV*/\ A:5M_P ^$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?
MTO\ Z!MG_P!^$_PH Y?_ (6E;?\ /A+_ -]BC_A:5M_SX2_]]BNH_P"$?TO_
M *!MG_WX3_"C_A']+_Z!MG_WX3_"@#E_^%I6W_/A+_WV*/\ A:5M_P ^$O\
MWV*ZC_A']+_Z!MG_ -^$_P */^$?TO\ Z!MG_P!^$_PH Y?_ (6E;?\ /A+_
M -]BC_A:5M_SX2_]]BNH_P"$?TO_ *!MG_WX3_"C_A']+_Z!MG_WX3_"@#E_
M^%I6W_/A+_WV*/\ A:5M_P ^$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?TO\
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M]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\ /A+_ -]BNH_X1_2_^@;9_P#?A/\
M"C_A']+_ .@;9_\ ?A/\* .7_P"%I6W_ #X2_P#?8H_X6E;?\^$O_?8KJ/\
MA']+_P"@;9_]^$_PH_X1_2_^@;9_]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\
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MZ/\ \(_I?_0-L_\ OPG^%.BT/3H)%DCT^UCD4Y5EA4$'U!Q0!>HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%?,OQH_X*!?#SX%_$34O!FO:-XFN]4L%B:6
M;3;6W> ^9&LB[2\Z-T89RHYS5TX2JRY(*[,ZE2%*+G-V1]-45\?:#_P5*^#6
ML:A';W=KXGT.)C@W=_I\31+[D0S2-^2FOJGPEXNT7QYX=LM=\/:E;ZOI%ZGF
M07EJ^Y''0_0@Y!!Y!!! (K6IAZM)7G%I&5+$T:SM3FFS8HHHKG.D**** "BB
MB@ HKR3]JKXMZQ\#?@=K_C+0;:QN]4T]H!%#J,;O"=\R(=P1U;HQQAAS72_!
M+QM??$GX0^#_ !5J<5O!J&L:9!>SQVBLL2NZ!B$#,Q R>Y/UK14Y2INJMD[?
M.US-U(JHJ;W:O\KV.VHHHK,T"BBB@ HHHH **^<OC-^UEJ'PI_: \%?#>W\"
MWFMV_B#R=VJ1S%"/,E,9\I-A#^6!N;+#@]NM?1M:.G*,(U&M'>WRW,XU(RG*
MFGK&U_GJ@HHHK,T"BN(^-WC>^^&OPA\8>*M,BMY]0T?2Y[VWCNU9HF=$+ .%
M921D<X(/O7-_LJ_%K6/CE\"O#OC37K:QM-4U%KD2PZ=&Z0+Y=Q)$NT.[,/E0
M9RQYS]*T5.4H.HME9???_(RE4C&<:;W=_P /^'/6Z***S-0HHHH **** "BB
MB@ HHHH **^<OVWOVCO$O[-?@'0-<\,6.E7UWJ&JBQE35H99(PGE.^5$<B'=
ME!U)'7BOHFWD,UO$YX+*&./<5I[.2IJIT;:^ZS_4R]I'VGLNMK_H24445F:A
M1110 4444 %%%% !1110 4444 %%%% !117SGXU_:QU#PE^U-X?^$4?@:[O[
M35$B)UE)R"-X),BQ["&CCP=QW#HW3'.E.G*K)0AN95*D:,'.;LE_PQ]&4445
MF:A1110 4444 %%%?-W[+'[27B;XX?$;XM:!KMCI-I9^$M26SL9-.AE221#-
M<)F4O(P)Q"OW0O)/'3&D*<JBDU]E7?WI?J95*D:?*I=7;^ON/I&BBBLS4***
M* "BBB@ HHHH **** "BOG#]D']I#Q+\?]3^(]OXAL=)LT\-ZFEE:'3(98RZ
M%I03)OD?)_=KTQU/%?1]:5*;INTNR?WJZ_,RI58UH\T>[7W-I_B@HHK \?:]
M<>%? OB+6K1(Y+K3M.N+N))@2C/'&SJ& ()&0,X(K&4E%-OH;QBY-174WZ*\
M/_8Z^.&N_M"?!F+Q;XBM-.LM2>_GM3%I<<D<.U-N#AW<YYYYKW"MZM.5&;A+
M='/1K1KTU4ALPHKY5_:3_:X\5^!?BMI'PK^%OA&W\6^.KZ%;AQ?,WD0A@6"[
M0Z9.U2Q9G55&.N3CUS]G_P 2?$WQ1X-NKCXJ^&-/\*>(XKQH4M--E$D<D(1"
M),B20#)9A@.?N]JKV,O9^U>B]=7K;1>I/UB'M?8J[:WTT6E]7ML>G4445@=
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%8WC+QAI'P_\ "^I^(]?O
M/[/T;383<75R8WD\M!U.U 6/T )H V:*QO!_B_2?'WA?3/$6@W?V_1M2A6XM
M;GRWC\R,]#M<!A]" :V:J47%N,E9HF,E)*47=,****DH***^</VSOVD/$O[.
MNF>"KCPW8Z3>OK6IM97 U2&60*@4'*;)$P>>^?I6E.FZLXTX[MV^\RK58T:<
MJL]HIM_(^CZ***S-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHKYS_:4_:QU#X!_$3P1X:M/ UWXGC\1.%:ZAG,
M9!,@3RXE"-ODYW8)'&!WR-*=.56<:<-WL9U:D:-.56H[1CN?1E%4=:UJS\.Z
M+?ZMJ,WV;3[&"2ZN)BI;RXT4LS8 ). ">!FLGX=_$;P]\6/"%CXH\*ZA_:NA
M7ID%O=>1)#OV.R-\DBJPPRL.1VJ+-IM+1?K_ ,,RG))I-[_H=)17S=^U)^TC
MXF^"/Q&^%/A_0K'2;NS\5ZE]CO9-0AE>2-/.A3,1210#B5OO!N0.*^D:MTY*
MG&KTE=?=N2JD74E3ZJWX[!11169H%%%% !17@/[:GQ^\0_LX_">R\4>&K/3+
MZ_FU6*Q:/58I)(A&T<K$@1R(=V4'?')XKVWPWJ,NL>'=+OYE59KJUBG=8P0H
M9D#$#)Z9-:*FW3]ITO;YVN9NI%5/9=;7^5[?H:-%%%9F@4444 %%%% !1110
M 4444 %%%% !16=XBU9]!\/ZGJ4=I+?O9VTEPMK ,R3%$+!%]SC ^M>*_LC_
M +3E]^TUX;U_4[WPC-X6.EW@M5)G,T4^020K%%^9, ,,?Q*>^!I&G*:E*.T;
M7^;LC*=2-.4(R>LKV^2NSWNBBBLS4**** "BOD#Q3_P4^^%GA'Q-J^A7F@>,
M)+O2[R:RF>"SM3&SQN48J3<@D94XR <=JL^$?^"GGP8\3ZI'9W9U_P -+(=H
MNM7L$\D$],F&20CZD8'>NN.$KRBI1@VF<4L;AHR<)32:/K:BJVGZE:ZMI]O?
MV-S%>65Q&LT-Q;N'CE1AE65AP000017Q]J7_  51^$^EZC=64OA[QDTMO*T+
ME+*T*DJ2#C_2NG%8TZ4ZLG""NT;5*].C%3G*R9]E45\L?#__ (*3?!CQUJ\.
MG3WNK>%99F"1RZ]:)'"S$X ,D4DBH/=RH'K7U*KK(JLI#*PR&!R"/6G4HU*/
M\2-@I8BE7_AR3'45YG\:/VCOA_\  &QAF\9:]'8W-PI:WT^!#-=3@=UC7D+G
MC<V%SQFO$O"__!4#X,^(M:CL+I?$/A^*1MHO]4L(_LX.<#)BED8#W*X'?%.G
M0JUE>G%M$U<31HOEJ329]<T54TK5K+7=-M=1TV[@O["ZC6:"ZMI!)%*C#(96
M!P01W%6ZQ::=F="::N@HKC?AS\7_  C\6EUH^%-7_M8:/>-I]\1;S0^5.O5/
MWB+N^JY'O794.+CHT)24E=,****104444 %%%% !1110 445\2Z[^V9\7/B3
M\4O$WA?X%_#O2_$VG^&YF@O=0U>0@2$,4W*3-"J LK[069F"YP.0-:5.5:7+
M'U\DC&M6A1CS3[V75M^2/MJBL'P'J&MZMX+T2]\2Z?%I.OW%G%+?6$#[DMYF
M4%XP<G.TG'4].IK>J)1Y9./8TC+FBI=PHHHJ2@HHKYR^,W[66H?"G]H#P5\-
M[?P+>:W;^(/)W:I',4(\R4QGRDV$/Y8&YLL.#VZUI3IRJS5."U9G4J1HP=2;
MLE_PQ]&T445F:!1110 4444 %%%% !1110 4444 %%%<=X-^+WA'X@>*/$_A
MW0-7&H:QX9G6VU:W%O+']FD8N NYT"OS&_W">E-)RO9;?U^HG)1M=[Z?,[&B
MO)/VJOBWK'P-^!VO^,M!MK&[U33V@$4.HQN\)WS(AW!'5NC'&&'-=+\$O&U]
M\2?A#X/\5:G%;P:AK&F07L\=HK+$KN@8A S,0,GN3]:M4Y2INJMD[?.UR'4B
MJBIO=J_RO8[:BBBLS0**** "BBB@ HKQ;]KSXTZW\ ?@GJ'C#P]:Z?>:G;W5
MO D6IQN\)61PK$A'0YQT^:O0?A;XHNO&WPT\*>(;Z.&*]U;2K6^GCMU*QK))
M$KL%!)(7+'&23[FM%3DZ;J]$[?.US)U8JJJ+W:YOE>WYG44445F:A1110 44
M44 %%%% !1110 4444 %%?-WQ _:1\3>%?VQ/ WPHM+'29/#NN6/VFYNIH93
M=HVV<X1A($ _=+U0]3^'TC6DJ<HPC-[2O;Y.QG&I&4Y06\;7^:N%%%%9F@44
M44 %%%<=X3^+WA'QQXP\2^%M$U<7VN^&W6/5;46\J?9V8D ;V0*_W3]TGI32
M<KV7F)R4;7>^GS.QHHHI#"BBB@ HHHH **** "BOGO\ :V_:GOOV9K?PM)9>
M#+CQ5_;-R\+.LYA2+;MP@(1\R/N.T8_A/6O>].NVO]/M;EH)+5IHED,$PP\9
M(!VL/49P?I6GLY>S56VC=ON,_:1]HZ5]4K_)EFBBBLS0**^</C)^T?XE^'G[
M4'PQ^'&G6.E3:'XG56O+BZAE:YCS(Z_NV60*.%'56KZ/K1P:A&IT=_P=F9*I
M%U)4EO&U_FKH***^<(/VC_$LG[:T_P 'S8Z5_P (U'I?VT70AE^V;_($F-_F
M;,9/]S..]*G!U)<L=[-_=JPJ5(TH\TNZ7WNR_%GT?1114&H4444 %%%% !11
M10 4444 %%%% !1110 45\WZY^TAXFTW]M;0OA!%8Z2WAJ^TPWLMT\,IO XA
MFDPK^9LQF->J'@GFOI"M)4Y0C&3^UJOO:_0RA5C.4H+>+L_N3_4****S-0HH
MHH ***XSQC\8/"'@#Q5X9\-Z]JXL-;\2S&WTJU^SS2&YD!52-R(53EUY<@<T
MXQ<FHQ5VR924(N4G9([.BBBD4%%%% !117&_$7XO^$?A.VB#Q5J_]E'6KQ=/
ML!]GFF\Z=NB?NT;;U'+8'O3C%R:C%7;)E)13E)V2.RHHKYS^!?[66H_&+XX>
M./ %SX%O-!@\.^;C4I)R^=DHC"RH478S@EUP3P#UZU<*<JEU%;*_R1%2I&E;
MG>[LO5GT917A/[7'[3D7[,_@K3KVUTG^W?$6L7)M--L&8JA8 %G?') RHVCD
ME@,CJ.8^%/QC_: 73?%&K_%3X7Z;I6EZ=HLNJ6$>BR_Z1=S( 1;[//F(8KNZ
MA2,=#TJHTI2INKLE^-M[=R95HQJQHZN3[*]KNROV/IVBO#OV2OVCKS]ICP'J
M/B"\\+2>&&L[YK-5\\S17 "AMR,44Y&=I&.HZ\X'N-*I3G1FX35FBJ56%:"J
M4W=,****R-0HHHH **XZ#XO>$;GXH7'P[BU</XQM[,:A+IOV>7Y8#M^?S-GE
M_P 2\;L\]*M?$[QE-\/?A[XB\30:5/K<VDV,MXFGVQQ).44G:#@X^N#@=C3D
MG%7>PHM2=D=/17C/[*?[0%W^TA\,7\57GAJ3PRZ7LEFL33&6.<*JGS(V*J2N
M6*GC@J>:]FK2I3E1FX36J,Z56%:"J4W=,****R-0HHHH ***R/%_BFP\#^%=
M7\0ZK(8M-TNTEO+AU&2(XU+-@=S@4F[*[&E=V1KT5\/_  T_:T_:&^-^I0Z_
MX)^$^BO\.Y-06T-U?7!%PJ;PKL',Z;]H.24B8#!')%?<%=-6A.C;GW?2^J]3
MEHXB%>_L[V76SL_3N%%%%<YTA1110 45QLWQ@\(P?%"#X=/J^/&4UG]O33?L
MTQS!S\_F;/+'W3P6SQTKLJ;323:W)4E)M)[!1112*"BBB@ HHHH **** "BB
MB@ HHHH ***\%_:X_::O?V9?#.@ZK9^$I?%']I7IM7_T@PQP  '!8(WS-T48
M['KC!J,7.2A'=Z$SDH1<Y;+4]ZHK-\-ZL^O^'=+U26RFTZ2]M8KEK.Y&)8"Z
M!C&X_O+G!]Q6E1*+BW%] C)3BI1V84445)04444 %%<9\3OC!X0^#6EV&H^,
M=7&CV=]=K8VTGV>:;S)F!(7$2,1PIY(QQUKLZ?*[<UM">9<W+?7^O\G]P444
M4B@HHHH **** "BBB@ HHKR+]J#]H:P_9K^&$OBBYL3JE]-.MG86 D\L33,"
M?F;!PH568G';'>FDY-);L3:BG)[(]=HKYE_9S^+'[0OC_P 4V,OQ#^'.B^&_
M!=_9/=P:A:.4N%X!C5HS<2,"VX<,B=#]*^FJUJTI49<LFK^3N8T:T:\>>*=O
M-6_I!1116)N%%%9/BS7'\,^%=8UB*QFU.33[.:Z6RM_]9.40L(U_VFQ@?6DV
MHJ[&DY.R-:BO"?V1_P!I:]_::\'ZQK5YX3E\+G3[[[(O[\S17'R[OE8HOS+T
M88[CGG ]VK:I3G1DX35F8TJL*\%4INZ?_#!11161J%%%% !117!?'GQ[J'PN
M^#?B_P 6:5#;7&HZ/I\EW!%>*S0LZC@.%921]"* .]HKRS]E_P"*FK?&KX&^
M&?&>N6]G:ZIJ:3--#IZ.D"[)Y(QM#LS#A!U8\YKU.M*E.5*<J<MT[&5&K&M3
MC4ALU<****S-0HHHH **** "BN0^+_B^\^'_ ,*_%OB73HH)K_2-+N+V".Z5
MFB9XXRRA@I!(R.<$'WKC/V2_C%K7QX^!^C>,M?M;"SU2\FN(Y(=-C=(0(YF1
M<!W=NBC/S=:TC3E*$IK96_&_^1G*I&,HP>\KV^5K_F>Q4445F:!1110 4444
M %%%% !1110 4444 %%%% !17EO[3WQ2U7X*_ WQ/XST2WL[K5-+2%H8=01W
M@;?/'&=P1E8\.>C#G%:OP&\>ZA\4?@WX0\6:K#;6^HZQI\=W/%9JRPJ[=0@9
MF('U)K2--RINJMD[?.US-U(J:I]6F_NM_F=[11169H%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?!VB?\I8-;_[ X_\ 2"*OO&OS.^+&C?$/7O\ @I!XCM/A?KVG^'/%C:="
MT5_J<8>%8Q91>8I!BE&2.GR?B*[<"KUY+^Y/]#SL>[44^TH?^E(_1#QQX%\-
M_$#P_=Z5XHTBQU?2YHV62.]A5PHQ]X$CY2.H88(/(-?'7_!+6]GBT'XH:+;3
MR7/AO3];0Z=(S%E^82!L'IRL<1./7WJQJG[-/[5/Q.M)-$\=_&[1[/P]<+LN
M?[!M\2R(>JD1V]ON4C((+X/<&OI'X/?!C0/V;/A:_A_PI9W%\MNDEY,\IS<7
M]QMY9BHZG:J@ <  8/>_<PU&HG-/F2T5^CO=_=8FU3%5Z4E!Q46]7;JFK+5]
M[OT/3:\)^.7[4!^!?Q3\ >&=3\,_:M"\5SBV_M_[?Y8M)/,5&#1>4=P =&SO
M'!/ISY'_ ,-U_%S_ *-4\:?]]W?_ ,@5O?MH>"[[XY?L?P>)Y=$N-"\2Z5:V
M_B-=,GW>?9MY8-Q V55MRHSYRJG*#@=*B-!T9PG77N72>JZ^CZ;_ "+>(6(I
MSAAW[]FUH]UZJVNWS/K2O#O@M^TU_P +K^+7Q!\*:9X;\C0_",WV9O$'V[>+
MJ;>4"B'RAM'R2'.\\*..>,6P_:4A;]BE/BL\RF_30B&YQG4%_<;?QF'Y&J/_
M  3U^&<O@#]G73-3OE;^V/%,SZW=/)]\K)@0Y/?,:JWU<TU0]G[;VB^'W5_B
M;_1)_>@>(=;V/LG;G]Y_X4MOFVE\F,^+'[=&B^"_&M_X*\&>#/$/Q+\8:>Q2
M[T_1[:18X&!P59]C,2,CE49>>M4?@[^WE:>./B5:> O'/@+6/AAXFOR!8V^J
MLS),QSM1M\43(S8(7Y2">,YP#5^)7[;7AKP-\0M9\(?#+P#?_$?QNTV[4TT*
M#RXS,@",9)$1WD9 %4G:0, ;AC ^5?VK?B)\8/$WB[X8^)/B)\.[#P+#9:J'
MTB:WF#7<A$D3LDA\QB "JD91>2:ZL)AXU?9PG"REU;L[O^5=5?;?3J<6,Q4J
M'M*D*E^2[Y5&ZLNDGT=M]5KT/LW_ (*'_P#)I?C+_?L__2J*NU_9<N/LO[+_
M ,.9MN[R_#MJ^W.,XB!Q7%?\%#_^32_&7^_9_P#I5%78?LS_ /)JOP__ .Q:
MM_\ T2*X;N.7U6OY_P#VP].R>.II_P C_P#2D9G[*'[3O_#3WAO7]6_X1K_A
M&O[*OQ9>3]O^U^;E V[/E)MZXQ@_6F_M6?M0?\,QZ3X9OO\ A&?^$E_MJ]:S
M\O[?]E\G"@[L^4^[KTX^M>&_\$H?^2;^/_\ L.K_ .B5J+_@JU_R*7PT_P"P
MU+_Z+6NZIAZ<<?"BE[K<=/6U_P SACB*KP$ZU_>2GKZ-V_(^Y+K4+?3]/FOK
MR:.UM(8C---,P5(T RS,3T &>:^0=:_X*)-K6MWMK\+OA)XH^)^FV,ACN-5L
M$ECBR.ZA()3M/;?L/M6U_P %)/%E_P"&?V6;R"Q>2+^UKZUT^=X^T1W2,">P
M/EA3]<=Z\L^$O[6'Q!^&?PW\/>&_#W[*?BYM)L;.-(I[<W06X.T%IN+$Y+DE
MR<G.[K7/AJ"J0E5:O9VM>W2]V_FK(K$XITY0I<W+=<S=K];62^3O?R/IK]G;
M]J3PQ^T1;ZE;6%I>:!XFTDA=2T#5%"7$'.-P_O+N^4G (/! R,^S5^??PE\1
M?$'XD?MQ^'?'UU\&?$OPWTZ\TN?3=8EO;2X,$VV&1DDDE>WB4$LL*@'))1>>
MU?H)48JDJ3BTK75[7O;5K?Y7^9OA*SK*2;O9[VM=63V_#Y'AOQ0_::_X5O\
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M7B9HW4,I*. R\$<$"ODO2OV\)O!MQ!X<^//PTUCP%=S?Z-)J4=N;K3+CCYV
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MO[_/;H>C7K:0M/ENKVM>3^6OY;]3Z.^ ?QZ\-?M$> X_$_AIIHHUE:WNK*Z
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M7@KP)X.UGXI^*[,E;NTT0-Y4# X9-Z)(S,IZ[4(!XSG(&C\#?VUM*^*'C9?
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MZP6ZX!9D#,Q/5F)))8Y))YIT7".%DY*_O[?]NK<5:-26+BH.WN;_ /;TMO\
M@G ?LO\ [6/A[]IS2=3-CI]SH&OZ4RB^TB[<2,@;(5T< ;UR"#E5((Y'()N_
MM!?M4>$?V=_[.L]8M]2U?Q!J@)T_1M*MC)-<?,%SN.% R0.N[G@&OG;]G^TB
MT/\ X*6_&2PLE%O:2Z7)</$@ 4NSV<A./]Z1C^->Z?M(_M.> /V?=3T=]9TR
M3Q%XVFC==*TW3[=)+Q4D(5CO/^J1V4#C)8KPK8.)J4X.=*4(NTXIV6^J>B?R
M^ZXZ-:?LZT:DE>G)QYGMHUJUI^>]O0\BD_X*.:KX5U*RD^(/P.\5^!_#EU*(
MEU:Z,A//0A)+>(-QR0KDX!P#7V5I.LV6O:/9ZKIUQ'>:?>0)<V]Q$<I+&RAE
M8'T((-?GA^T=\</CK\7O@EXG34/@;%X5\#-;B6\N]<E8W5NJNK+)&LAB;<"!
MC$;=:^G_ -A?4IM4_9)\ 2S,SO'9S0 L<G:EQ*BC\%4#\*K%45#"RJJ*C*+M
MH[[I[[ZZ&.'Q$I8A4G)RBTW=QMJFMMK[GF?A?_@I9X7UWPC/<R^$M2D\9/J<
MNG6'A+1I3?W5V$1&$Q81IL0EBN-I.5. V#B?P)_P4.2]^)6E^#OB)\,M;^&-
MUJLB0V=QJ<KL"SMM0R))#$RJ6P-PW $\X&2.-_X)6^&]*;0_B'KS:?;MK2ZO
M]C6^:,&58=@8QJW4*6.2!UP,]!5O_@J_90Q?#?P%JZ(JZA:ZZ8HIP!N56A9B
M,_6-#^%=;HX>.*CA^3XN5;[72V^_J1*IB94)UXSMR\UE;>S>_P!UM/Q/M'QA
MXNTCP%X8U+Q#KU['I^D:="T]S<R9PBCV'))Z #DD@5\>W'_!1_6->6\U'P)\
M"O%?B_PQ;,RMK(>2)!MZ[A';S*O'/+Y]0*]K_:\^&>K_ !@_9L\2^']%F5=5
MD@ANXDD<(LQB=93&6) &X*1D\9QGBO#?V=_V_/@YX-^!OAO0M<O;GPYK.A:?
M'8RZ;'I\TPN)(U :2)XU9/G(+?.RG+'/J>'#TE*$Y\O-)-*VNS6^FN^AT8BO
M)2IQ4N2,DWS.V^GNZZ+36YH?!G_@H)XK^-'BC2;#2O@9K#:+=:C%87FN6=_+
M=6]AO90SR,MH%&U6W$%EX[CK7O/[07[2W@_]G#P_;7_B26>ZO[UBEAI%@H>Y
MNF&,D D *,C+$XYP,D@'P'_@G];:EXO^('Q@^*%OHTWA[P;XJU!6TNTF7;YS
M*\C,X XXW@$C(W,P!.TUY#\3OBSKFE_\%!O$VM6_PVU/XIW?ABS2TTS1;#S-
MUF!'$?M.$AE. TKX.T<R*<@@5U2P].I7C1C'EM'F:OKLM+O2]W:_WG+#$U*6
M'E6G/FO+EB[:;O6RUM97MY>9[+:?\%%=2T.ZM[SQ[\$?%W@KPK<2*B:[,DLB
M#<?E8J\$0([_ "NQ] :^P=#URP\3:-8ZMI5W%?Z;?0I<6UU VY)8V *L#Z$&
MOA_QS^UY\3?'W@W6O#>I?LG^,9;'5+22TE63[6X =2-V/L'4$@CW KV/]@/2
M_$^@?LT:%I'BS2-1T34;"ZNH8K35;9X)Q"92Z$HX# ?,0,CH*SK4$J3GR\K5
MNM[I_?JM/O\ (UP^(;JQASN:=_LM6:VZ+1Z_=YGT%J5Y_9^G75UL\SR(FEV9
MQNV@G&>W2O'?V3_VDO\ AJ#P!J7B;_A'?^$:^QZF^G?9?MWVO?MBCDW[O+3'
M^LQC';KS7K/B3_D7=4_Z]9?_ $ U\=?\$G_^2 ^)/^QEF_\ 26VKFH0C.E6E
M):Q4;?-M,[,14E"K0C%Z2<[_ "2:.]\=?MU^%?A;\:_%_@;Q;IS:5I^@Z;'?
M1:O'<F:2^E=866WCMQ&,.?-.#O(PA)P,D>>ZY_P4DU/PK<6NH:[\#/%NB^#;
MF4+#KE\SPM(AY!5'A$;,1SM$OXUB6/AO2O$O_!53Q FJZ?;ZBEGI,5Y;I<QA
MUCF2UM]D@!XW+DD'L<$<@5]*_MA:7;:M^S#\28KJ)9DCT:>X4, </&-Z,/<,
MH-:_N:-*C.4.9RBF];?T_P /(P_?UJE2,)\JB[+2[V3^[7U\STOPAXLTOQUX
M7TKQ#HMR+S2=3MTNK:=1C<C#(R.Q[$'D$$5KU\Y_\$];F6Z_9%\#-*Y<K]LC
M7/91>3 #\J^C*PQ--4:\Z:V3:.G"U77H0J2W:U]3X+_X)[_\G#_M$_\ 86/_
M *5W5?1W[6O@'PEXR^ _C6?Q/I]G)]ATFXNK:_FB4RVLR1EHW1^H.X 8!YS@
M\&O@[X!^&/C1XD^/?QM7X.^+M&\*7$.LSG4GU>)9!,INKCRPFZWFQ@A\_=ZC
MKVTVTGXG_&K]H?\ X4?\>OBA?6%O&!/%;Z3:PQ6NK$ .JHRI$.5#%6>-N4(V
MAJ]&KAW7=/EFD^2+ZW5DM5H>72Q2PZJ<U-R7.UTLVWLW<^HO^";^I:EJ/[*6
MA_V@\DD=O=W<%HTA)_<"4X /H&+@>F,=J\R_X)<_\?7QF_[#-O\ SN*^T_!O
M@S1_AYX2TWPWX?LDT[1]-@$%M;QYPJCN2>22<DD\DDD\FOR\_9%_9$\'?M.:
MO\2KKQ3J6N6$FCZJL4 TB>&,,)&F+;_,B?)^08QCO4QJ0KU,3/:+2_\ 2E^8
MI4YX>GA8;R4MO^W):7\O3H?2_P#P4MG^'8^!][%K']EMXX::'^QE4(;X-YJ^
M81CYQ'LWYS\N=O?%>S?!G5KWX;?LI^%M4\5K-%=:+X8CNKR.<XD58X-VQL]&
M"@#!YS7S9XP_X)MV/PLL9?&7PN\47LGB31(VO;>R\3V=IJ$%PR+NV@&)55N/
ME8JV#C&.H[[P]\;+W]JC]A7Q[K)L8K;Q$FDZAIU];6V?+,Z0;]R DD!D96QS
M@DCGK7/445@YPI2O9W?2VEE9=OGN=E-S>-A.O#E;32UO?5-ZZ;>GS/./V(_A
M+#^T=XD\3_';XFVD7B&_O-1>WTFQOE$MO $ )<(?E(3<J(",#8QZX(^V_&OP
MY\,_$;PU/H'B31++5](F38;:XA!"<<%#U1AV9<$=J^=O^"9NL6NI?LLZ9;0,
MIFT_4KRWN%'4.9/,&?\ @,BU]64\?[M9TEI&-DEV5OZ8LNM*@JKUE*[;[N_]
M(P_!/@O1OAWX5TSPWX>L8]-T;3H1!;V\?15'4DGDL222QY)))Y-<C\?OBIKW
MPA\$Q:WX=\":I\0[^2[2V.E:3YGFHC([&4[(I#M!4 _+_$.:]*IDO^K?Z&O-
MJ5'K4EKU?G_PYZ2BHQY(::67EV^X_*O]CS]ICQS\,=)\:_\ "._!CQ!\1(]6
MUEKZXN=*:?;:2,O^J;R[:0;N_.WZ5]S?'C]I6X^!?P-T;X@WGA*6\N[YK2.;
M0Y[PVLEJ\T9=D9S$QRA!4@H.?3I7AW_!*O\ Y$'XB_\ 8P?^TA72_P#!47_D
MV9/^PW:_^@R5[.,]G]9A3Y.L%UV?+I]VG<\C"QJPH5*CG>RJ:66Z<M?O5[;%
MWQC^WD?^$DETKX:?#'Q#\4HK)UBU+4M*$BVEK(<902)#+N*]R=HXX)'->F_'
MS]J3PE^SO9Z7'K\&H:AKVJ@_8-%TNW,LUPP(4X8X4 ,P')R<\ UTWP&\+:5X
M-^#/@S2]&LH["QCTJVD$<0QEWC5W<^K,Q))/4FN'_:2_:7^'_P"SY<Z+/X@T
M]]>\7S*_]DZ;8VZ27@5R%9@[?ZI&("Y!RV, -@XY:D:?M51A%NS:\W^B^[;[
MSHI2J^Q=>I-*Z3VT7Y7^]:].AXY<?\%'-8\*WUI/X[^!?BSP;X9N)1&-7NC)
MGGH0DEO&K'O@/G'3-?9&AZ]8>)M#L-8TJZCOM-OK=+JVN(C\LL;J&5A]017Y
M\_M"?';XZ_%_X*^*H[GX%Q^%_ [V9DO;O7I6-S!&I#"6-9#"=P(!&(V^AKZ.
M_8"U*74_V1O DDS,S1QW4 +')VI=3*H^@ %:XBC&.&E545&2:6CONGOOV.?#
MXB;Q"IN3E&2;NXVU5MM%=69P?A__ (*3>%M2\/ZFUYX6U$^+8]6ETO3O"VCR
MF_NKX*JD39\M-BDDC&"?EXW<@,\'_P#!1(-\1=*\*?$?X7:Y\,7U218K6ZU.
M5V&YFVJTB20Q,J$D#<-P&>>,FN1_X)A^&]*FU+XKZ[)I]O)K,.L?9(KYD!EC
MA.]F16_A!(!..N!GH*U?^"KVFP/\'O"&I; +VUUX1Q3 ?,JO#(6 /H2B'_@(
MK;V>'C7A1E"_-RWUVYDMOOOJ+GQ-2C4K1G;EY[*V_*WO]UM+?,^N?B7\2-!^
M$G@G5/%?B6[^QZ1I\>^5U7<[$D*J(O=F8@ >IKY,@_X*/:W>VYUVT^ WB^Y\
M" ESXBC+E?*!^9\" Q<8/'FXXZU[9^TA\%KS]HS]GF;PO:7\=CJ\\5O>VL\X
M/E-,@#!7P,A6R1D XSG!QBO$/!W[7WBS]G/0=&\)?&SX5ZMH-CIEO%I\/B30
MXUGL940!$) .P?* 3LD)]$'2N:A2@U--<TT[)7MIW7=WTM^!MB*U2\&GRP:N
MW:^O9]E;6]CW77/VD?MOP#L_B=X!\&ZUX\CO3&+?1+>WEANV!<HY*K'(<(0<
ME0RG&02.:^"OV.?VAO&GPPUKXAMH'P=U[QT=:U:.>\736G']F-NE_=R;+:3G
MYV^]M^X>/3].OA[XP\->/?!^FZWX1OK74/#]S'_HLUFNV, '!7;@%""""I (
M(P0*^/?^"9__ "'OCE_V'XO_ $.YK:A*%/VRE3V6S;VYHZ=.NM]SGQ4:E26'
M<:F[W26_)-\W7II;;YGMGQF_:D/PC^,_PZ\ GPQ_:I\7RQQ?VA]O\G[)OF$6
M?+\IM^,Y^\O3'O7N=W<?9;6:;;N\M&?;G&<#.*^%?VT/^3T_V=_^ORW_ /2U
M*^Y=6_Y!5[_UQ?\ ]!->?6BHX.%6/Q/G_!Z'I4)REC:E&3]U<EOFKO[SQ;]E
M#]IW_AI[PWK^K?\ "-?\(U_95^++R?M_VOS<H&W9\I-O7&,'ZUR'QD_;KL/
M?Q$N_ ?@GP-K7Q.\6V/_ !^V>DAE2 @ E=R1R,S+D9PF!G&<Y \Z_P""4/\
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M%'-:U:-]:T/X#^+]7\#HS%O$$9DVB-3AF(6!HP1@\>;VY(KZE^#WQ:T+XW^
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MI?A#X#^ [#2+**QM6T:UN72(8WRR1*\CL>[,S$DGUKTFHQ'LX2=.$=F]>_\
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MK6S\6?A1\3/@?^TMJWQP^'?AJW^(6G:S:"WU70]^R\A 6,,8>,G/DI@J&/+
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MM#FOS<U]%TBFON/:_P!J;]J3_AFB/PBW_",_\)'_ &_>/:?\?_V7R-NSYO\
M5/N^_P!..E>F?%+XGZ!\'/ VI^+/$UTUKI-@H+F-=TDC,0JHB]V8D #\R!DU
M\=?\%3?]1\)/^PQ-_**OHK]KGX$W?[0_P7U'PKIM[%8ZJL\=[9O<9\IY8\X1
MR,D!@Q&0#@X.#6')'ZO3F^LI)OR3C^2;-U4G]9JTUJE"+2\WS_G9(\,M_P#@
MH]K=Q;C7D^ WB]_ ?+GQ%&79/*!Y?'D>5_Y%Q[U]3>$/BMI'C[X5P>/-!2XG
MTFYL9+V".[B:WD8(&RI##CE2,C(/4$C!/RUX3_;*\3_ +2=)\+?'#X6:MX:M
M["&*PC\1:+$)["8* BG .P?* 2(W8^B#I7T]%XK\.^-O@W>:SX3O;74/#USI
M,YLYK,;8]@C8;0N!M*XP5(!4@@@$5IC81ITI2IPT6TD[I[[^?W>A& G*I5C&
MK.[>\6K-;;=;??ZG*?LJ_M%?\--?#F[\5?\ "/\ _"-_9]1DL/LGVW[5NV)&
M^_?Y:8SYF,8[=>:R_P!HK]L3PC^SW?6>B36EYXG\87RAK;0=* ,N&.%,C<[
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M<#)KUG_@F_\ \FF>&/\ KZOO_2F2O2_VI+"VU']G3XC17=O%<QKH5W*J3('
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M3A)3YDY).T?=U[/_ (+NCZ2^,G[86A? WXV>'_!'B73TM-%U+2I-3G\1279
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M &'H_P#T==TWXC_\I4OAO_V F_\ 2>^K[HHK=8FU55+;1Y?_ "7EO^OX'/\
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ME\I49X:-1J$DTM+M7\^WXVTN%>3_ +6'_)L_Q._[%^\_]%&O6**\L]D^;O\
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M?$?[37P*UA_!W@#5M)^'.G/!>:EXAU]%A>9A*JQQ0*K,K'>P)(9N.NWO]D^
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M_P#I'P/^SW:ZW^T-^V3+\;-,\&WO@OP1::>\ N+V+RGU21HVC#''#L=V25W
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MMV^WR78UIX>?M%5K3YFM%I9*^_S?<^'/^"7_ /QX?%S_ +&!?Y25=_X*M_\
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MM>9=HKS/XJ?M*?#+X*W45KXS\766CWLBAULU22XN-IZ,8HE=PI]2 *TOA?\
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MR3ZZ-/\ R/N:BLWQ%XDTGPCHUUJ^N:E:Z1I=JN^:\O9EBBC'NS$ <UY!X?\
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MNOX,L!!^H-=M\)?VH/AE\<]:O-)\$>)?[;U"SM_M4\/V"ZM]D>X+NS+$@/+
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M?_;2^*WCW6/$_P!E\*ZU81VVFW_V&ZD\XK]G&/+6(NO$;'YE'3Z5]UZ?\>/
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M)QNVXKT&E*$H.TE9E0G&HN:#NO(****@L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA;Q#I?B.VM=.NH9I]*NX[F-'-NS;2R$C."#UKP3_ ():_P#)L]S_ -A^Z_\
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M@+]BV+XAI(/[?G\.V4D,K<XNKB.-0_/7#2;L>U<[_P %+?\ DU/6O^PA9?\
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M\B>GWGUMX4^$?@7P'J3ZAX9\%^'O#M_)$87NM)TJ"UE:,D$H6C0$J2JG&<9
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MU1E]2CLY1?\ V[;F?_D\?Q.:_;N_Y.@_9I_[#:?^EEI7NW[9/@GP[XB_9_\
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MO1B>?D*@'H!7AG_!,&>ZT2/XM^#&N'GT_0M<06^XYPS&6-S^(@0U]S5\,_\
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M-&"CW)&*ZJ[7U/F::2EI=WTMJ^EMOU.##W^O\B:;<->565^;1;N^C_&QF_\
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MN+B>4CY%9$),8SC)?&/KQ45?:?5J/L;VY>G\]W?YW_X!I2]E]9K^WM?FTO\
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M_9M1D<_=F@!21F],[-_T85X5^PC8R_%CXM?%OXXWT1*ZKJ#:5I+N#\MNI5F
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M\:K70[/]E'QK'X:MK*ST ^%[N2QATV)8K<1- S*8U4!0I!SP.]<)_P $W_\
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MU&5@=+OGU#3E=OO(K"-V'^\AMV_.NM^&JGP3_P %&OB9IDYV1>*/#\&IVV>
M[1^4I ]>DO\ WR:TE&*Q4YP^&<)-?.S_ ,_N,XRD\+"G/XH5(QE\FU^;BS[
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M*W'KQ,E3A]JK_N?^WP*Q6OLDM^=?^DSN?7]?GW\9=/N/VN/VY(/A5J=Y<1>
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M_P $J_%UUK7P7\1Z'-<23VNC:P19K)UCBEC#[?0#>'; [L:\OT/X*Z'\=O\
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M)\H  F=V,Y8USW_!4;2[/1/ 'PJT_3[6&RL+756@M[:W0)'%&L2A551P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY;Z&G+'FYK:G"ZU\$/!7B#XG:1\0]0T7[1XPTF'R++4OM4Z^4F'&/+#B-O\
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M=18Y>]A:2UGD[#?)"R,_']XFMSX7_ [P'\%[*:V\%>&+'05F $TT*L\\H!R
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M7O5%*%2=/6#:]"ITX5+*<4[=RK:V%MI>G1V=E;0VEI!'Y<5O @2.-0,!54<
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MA3A37+"*2\CQ7P3^QA\%OAYKL6LZ)X"L8M2A8/%->3SW@B8'(9%GD=58'D$
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MCCZUW/7@\BEHHYFXJ+>B_7<?*N9SMJ]WZ;?<>(:A^Q/\$=4\4-XAN/A]I_\
M:;2^<WES3QP%\YSY"R"+K_LUVGQ ^!_@GXI:YX<U?Q1HO]IZCX=G^TZ9-]JG
MA^SR;D;.V-U#<QH<,"./K7=T5?M:GN^\_=VUV].Q'L:?O>ZO>WTW]>X5POPW
M^"/@KX1ZEX@O_">B_P!E7>OW NM2D^U3S>?(&=@V)'8+S(_"X'/L*[JBH4G&
MZ3W+E&,K-J]@KS'XJ_LS_#'XV7T-[XS\(VFKWT*A%O%DEMIRHZ*TD+HS*,G
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MX9'A_P 9Z.NM:2LZW*P--+"5D4$!@\;*PX8C@\YKL**B[3NC1I--/9G/> ?
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M5/G]IRKF[VU^\*^?_P!MSX5WWQ)^"5U>Z&C'Q1X7N8]>TIHQE_,AY95]RF[
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MWE)B"$9VW#:""PX (W5]PU6M]-M+.ZNKF"UA@N+IE>XFCC"O,P4*"Y RQ"@
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MIW\Y24./+9S&O,:?=4=/<UW5%'/*][ZVM\NWIY![.%N7E5KW^??UU>I@^.O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img175210594_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_5.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =X#WD# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2G*DJ=6C*+O&3BU_X$M'YHGVSJ4:\9JTHQDFO^W6TUY-'LW[*/\ R;3\,_\
ML 6G_HL5Z#XD\7:'X-T\W_B#6M/T*Q!P;K4KJ.WBSZ;G(%>??LH_\FT_#/\
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M^S^Q2IJUQ!)&$WJ^5$<*'.5'4D8SQ7OM>;4C"+M"5UZ6/4I2J25ZD>5^M_\
M(****R-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /DS_@I9_R0K0O^QD@_]);JOS4K]*_^"EG_ "0K0O\
ML9(/_26ZK\U*_<.$O^18O\3/QSBC_D8OT04445]F?)!1110 4444 %?N]7X0
MU^[U?EO&_P#S#?\ ;_\ [:?I'!W_ #$?]N_^W!1117Y<?I!^;_[>7_)[OP:_
MW-,_].,E?HKJW_(*O?\ KB__ *":_.K]O+_D]WX-?[FF?^G&2OT5U;_D%7O_
M %Q?_P!!-=F*_P"1=2_[B?F<6'_Y&-;_ +A_^DGY_P#_  25^[\5?^OBQ_\
M;BOJK]L+_DV#XE_]@6?^0KY5_P""2OW?BK_U\6/_ +<5]5?MA?\ )L'Q+_[
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M\>? ?Q!^)7C7PEXA_P"$<O('9K/?#-]G24R%%6.SC5CDMC<>_6NR_P""HO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_"ZO!G_ $&?_)6;_P"(H_UBR;_H-I?^#(?YA_9>/_Z!Y_\ @,O\CN**X?\
MX75X,_Z#/_DK-_\ $4?\+J\&?]!G_P E9O\ XBC_ %BR;_H-I?\ @R'^8?V7
MC_\ H'G_ . R_P CN**X?_A=7@S_ *#/_DK-_P#$5W%>AA,QP6/YOJE:-3EW
MY9*5K[7LW:]F<M?"XC#6]O3<;[735_O"BBBO0.4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEHG;Y[_D1SQ4_9MZVO\ *]K_ 'G0T445!84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#RS]HO_D2;+_L(I_Z*EKYTKZ+_:+_
M .1)LO\ L(I_Z*EKYTK^3?$C_D?R_P ,?R/VSA/_ )%B]6%%%%?EQ]B%%%%
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M8D:2632[I$11DLQB8 "O(Q-6=6$G-WT/8PM&G1G&--6U1\9_\$E/^25^./\
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M9;:?/8\^Y_D*_1.OS,\#ZE-_P3S_ &K-=L/$UO<)\-?%886VI0Q%T2/>6B?
M^\8BS(ZCG#;@#P#]A>.OVT_@[X(\(3ZZ/'6CZXRQ[H--T>\CN;N9L?*GEJ24
M)/=]H'<BML=>O..(IJ\9)6\K*UO6_0PR]K#PGAZLO>BW>^ETW=/TMU/D;P.Q
MT/\ X*P:Q;::-EO=75T+A8R,$/8&5\_]M.?K7Z55\ ?L _#'Q#\1/BQXL_:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=TR0[C:W\"RIN'1@".&'8CD5Y+H/[#/P*\-ZPFIV?P[L)+I&W!;VXN+N'/\
MURED:/\ \=KW:BG"I.G?DDU?L3.E3J6YXIV[H9##';PI%$BQQ(H540850.
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M/10&8\ U,I*"YF5&+D[(\Y_;B_;$TC]DOX9-=Q^3J'C?5E>#0])<YW/C!GD
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M )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\
MGT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?
M1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'
M_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]
M?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_
MPH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"
M@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\*
M+M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH N
MT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[1
M5+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4
MOMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^
MW3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=
M-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW
M_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\
M^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ
M/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_
MZ_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K
M_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^
M%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4
M?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]
MNF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ
M;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO
M^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y
M]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT
M?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_
MU_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7
M_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\
M* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH
M NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"
M[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M
M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT5
M2^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+
M[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OM
MTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3
M?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_
MSZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/
MH_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C
M_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^
MO^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_
MX4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A
M1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'
MVZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;
MIO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF
M_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_
M )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\
MGT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?
M1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'
M_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]
M?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_
MPH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"
M@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\*
M+M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH N
MT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[1
M5+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4
MOMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^
MW3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=
M-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW
M_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\
M^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ
M/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_
MZ_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K
M_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^
M%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4
M?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]
MNF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ
M;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO
M^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y
M]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT
M?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_
MU_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7
M_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\
M* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH
M NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"
M[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M
M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT5
M2^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+
M[=-_SZ/^O^%'VZ;_ )]'_7_"@!VI:38ZQ L-_9V]]"K;Q'<Q+(H;!&<$'G!/
MYUG?\(+X;_Z%[2O_  "B_P#B:O\ VZ;_ )]'_7_"C[=-_P ^C_K_ (5R5,'A
MJTN>K3C)]VDS>%>K37+";2\FRA_P@OAO_H7M*_\  *+_ .)H_P"$%\-_]"]I
M7_@%%_\ $U?^W3?\^C_K_A1]NF_Y]'_7_"LO[.P7_/F/_@*_R+^M8C_GX_O9
M0_X07PW_ -"]I7_@%%_\31_P@OAO_H7M*_\  *+_ .)J_P#;IO\ GT?]?\*/
MMTW_ #Z/^O\ A1_9V"_Y\Q_\!7^0?6L1_P _'][*'_""^&_^A>TK_P  HO\
MXFC_ (07PW_T+VE?^ 47_P 35_[=-_SZ/^O^%'VZ;_GT?]?\*/[.P7_/F/\
MX"O\@^M8C_GX_O90_P"$%\-_]"]I7_@%%_\ $UN52^W3?\^C_K_A1]NF_P"?
M1_U_PKHHX>CA[^Q@HW[)+\C*=6I4MSR;MW9=HJE]NF_Y]'_7_"C[=-_SZ/\
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M_P#+^NQ<8)4[1>M^O;^OZ9^K^H:C:Z187%]?7,-G96\;2S7%PX2.)%&69F/
M  R2:_%S3?$5M^U1_P %:-.\1>"5:\T2'7K6[%Y&I*/;6,,:O/[*YA^4GKO7
MN<4Y?V"?VT_C)LT'QYKNJP:'N5F/BSQG]OM1@\'RHIIR2.WR_B*_1;]C/]AW
MPE^R#X=NFLKAO$/C#4D5-1U^>(1DH#D0PID^7'GDC)+$ D\*%NC'DK1KR?P[
M+S_K^NT5).5*5&*^+1OR_K^K7/<_'_CS0_A?X+UCQ7XEOUTS0M)MVNKNZ=2V
MQ%]% )8DX 4#)) '6O'?V8?VXOAI^UE>ZSI_@Z74[+5M*7S9=.UJW2&:2$D+
MYT>QW5DW$ \[@2,@9&>X_:.^"]O^T+\$_%?P^N;]]+76K98X[U$W^3*DBR1L
M5R-RAT7(R,C(R*^6?^"??_!.G7/V4/'6O^,O&'B+2]7UBYLVTRQMM%,K0I"S
MH[R2-(B'>3&H"@8'/)SQG2UJ25316T]?^'LO37TNII3BX?%?7TT_X/W??\^?
M\%;/!.L?";]H_P"'?QLT:$F&86Z^=M.Q+^SE\R,,1TWIMQZ^4WI7Z;? _P"-
M'ASX_?#/1?&OA>\CN;#4(5:2%7!DM9L#S() /NNA."/H1P0:/CA\%?#'[07P
MUU;P3XMM#<Z5?I\LL9 FMI1RDT3$':ZGD'&#R"""0?R@\1?\$T_VH_@#XDOO
M^%/>)KS5=*NVP+WPUX@_L6Y>,?=%Q&\L8SR>%=Q[\XJ*4O9P=&2TNVGZ[W_K
MMYE5(\\E5B];6:]-K?UW\CZM_P""M7[2&E?#CX#W?PYLKZ.3Q;XN"1-:1N#)
M;V*N&EE<?PA]OEKGKN?'W370_P#!)[X.WGPM_94LM3U.![;4?%E[)K7ER##+
M;E5C@_!DC\P>TE?.O[-__!)OQAXF\>1>-_VAM86]7S5N9=#^WM?7E_(.UU<9
M("\#(1G+#C*]_P!5+>WBM8(X(8UAAC4(D<8 55 P  .@ K:G%48S;=Y3_!+I
M]_Z]S*<G4E%)6C'\6_\ @?IV)****@H**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRW-W'=S;>Y2.!F5C[,Z_6O6>&R^I[W/H^E_Z9X:Q69P_=^SN^]OZB0?\$T?
MM_XP_:8M_$0C9K+P_:7%Y<W&,+YDL;0HOU/F,<>B&OUZKS7X!_ 'PM^SMX(3
MP[X9A=O,;SKS4+C!GO)<8WN0.@' 4< >Y)/I5>?C\3'$U4X;)67Y_J>KEV%G
MA:3]H_>D[O\ K^M0HHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=4\'>']'\-7FF6MO;RI+J5K</,3)&&;)2=%QD\?+7C7_  ]@^+?_ $+O@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRM2UIRDK-;-I>\UWZ:]0HHHKY0^M"BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM%
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M )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\
MG[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?
MM_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W
M_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]
M?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_
MQJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&
MKM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:N
MT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[1
M0!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM%
M%+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4
MOL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^
MPS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#
M-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W
M_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\
M_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]
MO^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_
MZ_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K
M_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^
M-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT
M?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]
MAF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&
M;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O
M^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y
M^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[
M?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_
MU_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7
M_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\
M:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ
M[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM
M% %+[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4
M 4OL,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!
M2^PS?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+
M[#-_S]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL
M,W_/V_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS
M?\_;_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_
MS]O^O^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/
MV_Z_XT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;
M_K_C1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^
MO^-'V&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_
MXT?89O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C
M1]AF_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'
MV&;_ )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?8
M9O\ G[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF
M_P"?M_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_
M )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\
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M GPS_P" UU_\D5\J44?V#EG_ #X0?VWF/_/YGU7_ ,/'_B=_T"?#/_@-=?\
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MF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\
MC1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O
M^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_
M #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4O
ML,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT
M4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?
M\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M
M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89
MO^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_X
MT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_
M *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?
M\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2
M^PS?\_;_ *_XU:B4QQJI;>1_$>]/HH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KPK]N#7M3\,_LN>.-2T?4;O2M1@BMC%>6,[0S1YNH@=KJ01D$C@]":]UK.
M\0>'=*\6:1<:5K>F6>LZ7< ":QU"W2>"7!##<C@J<$ \CJ!1U3[-/[G<#\'?
M^&@/BA_T4CQ=_P"#VZ_^.4?\- ?%#_HI'B[_ ,'MU_\ '*_:W_AFWX2?]$M\
M%_\ A/6G_P ;K\J?VE[W1/B!^UL_@ZVL=+\'>$=/UN+0572[.*TCA3S5CGG<
M*H!;.X[CV51T%?68;%4L565*%/\ +^NJ/BL7@JV#HNM.KY==_P#ADSRC_AH#
MXH?]%(\7?^#VZ_\ CE'_  T!\4/^BD>+O_![=?\ QROV@T7]EGX/Z'I-GI\/
MPS\*7,5M$L2S7FC6]Q,X QN>1T+.Q[DDDUB_$K]D?X/>+O!.K:=-X%\.^'P\
M#LNIZ3IL%E/;,%)$@DC4' /)!R#CD&N6>9X>-W[/1>AUQRG%2LO:Z_,^-?\
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M04445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_  5$_P":9_\ <3_]
MM*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UPQ_R**/\ V]_Z5(_$^(O^1I5_[=_]
M)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!^E?_  33_P"2%:[_ -C)/_Z2VM?6=?)G_!-/_DA6N_\ 8R3_ /I+:U]9
MU_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/;"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "OR0_X*+?LYZS\/?BSJGCVRLI+C
MPEXBF%P]U$N5M;IAB2.3'W=S LI/!W$=17ZWU6U+3+/6M/N+'4+2"^LKA#'-
M;7,:R1R*>JLK @@^AK?#UI8>JJL?^'1S8G#QQ5)T9]?P?<_%3P#^W5\:OASH
M]KI6G>,9+W3+5=D-OJEK%=%% P%$CJ9,#C W8& .E4?B5^VC\8OBQHMUHVO>
M,)AH]T"LUCI]O%:I(IZHS1J&9<<;68@]Z_0+XE_L?_LL#6G.L7>D^#+^1B[V
M\/B%;,'Z12.54>RJ!70_#?\ 8,_9]LX[37-+T6+Q?;L?,M[N\U-[RV?!QPJ,
M(I!GC#!A7O?7,)+]Y*EKZ(^<^H8Z/[J-;3U>WH?*?_!,+X!ZOK?Q*_X6=?V<
MEKX?T>&:&PGD7 NKJ13&VS/541GR1W('KC]2ZKZ?I]KI-C!9V5M#9V=N@CAM
M[>,)'&H& JJ.  .PJQ7D8S%/%5.>UDM$>Y@<&L'2Y$[MZL****X3T HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\
M]M*^$*_>N&/^111_[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /TK_P"":?\ R0K7?^QD
MG_\ 26UKZSKY,_X)I_\ )"M=_P"QDG_]);6OK.OYZS[_ )&=?_$?NN2?\BZC
MZ!1117@GMA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJWN_JU^1UY/4E4IU+MM*3LWOLO\ A_F%%%%>*>\%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?"'_  5$_P":9_\ <3_]M*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UP
MQ_R**/\ V]_Z5(_$^(O^1I5_[=_])04445]2?-A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^E?_  33_P"2%:[_ -C)/_Z2VM?6
M=?)G_!-/_DA6N_\ 8R3_ /I+:U]9U_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/
M;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^#_B=_P5&_
MX5Q\2?$OA/\ X5G_ &C_ &-J4^G_ &S^W_*\[RW*;]GV9MN<9QDX]:^[89/.
MACDQC<H;'ID5O.A4ITXU9+W9;?U\SGAB*52I*E%^]'?\A]%>+S?MD?!^W^(9
M\#2>+]OBG^TAI'V#^S+P_P"E&3RQ'YGD[/OG&[=M[YQ7M%9N$HI2:T>WF:QJ
M0E)QB[M;^7J%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,/#?V@?^A__ /*-I_\ \CUZ,</CK*U1?C_D>?6Q67QJ24Z3;N[Z+_,^TO\
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MBBOFCZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ()I_P#)"M=_[&2?_P!);6OK.ODS_@FG_P D*UW_ +&2?_TEM:^LZ_GK/O\
MD9U_\1^ZY)_R+J/H%%%%>">V%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_(U:GA3_ (*/_LZ^-_%&D>'=%^(?VW6-6NXK&RMO[$U&/S9I7"1IN>W"KEF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<YVL!C:/UD\(_#[PM\/[>X@\+^&M(\-P7#!YH](L(K596 P"PC49('<T>-/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'_(HH
M_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Z5_\ !-/_ )(5KO\ V,D__I+:U]9U\F?\
M$T_^2%:[_P!C)/\ ^DMK7UG7\]9]_P C.O\ XC]UR3_D74?0****\$]L****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
ML^W_ .>?_CQ_QH_L^W_YY_\ CQ_QH D^TP_\]4_[Z%'VF'_GJG_?0J/^S[?_
M )Y_^/'_ !H_L^W_ .>?_CQ_QH D^TP_\]4_[Z%'VF'_ )ZI_P!]"H_[/M_^
M>?\ X\?\:/[/M_\ GG_X\?\ &@"3[3#_ ,]4_P"^A1]IA_YZI_WT*C_L^W_Y
MY_\ CQ_QH_L^W_YY_P#CQ_QH D^TP_\ /5/^^A1]IA_YZI_WT*C_ +/M_P#G
MG_X\?\:/[/M_^>?_ (\?\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ
M_P :/[/M_P#GG_X\?\: )/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'
M_&C^S[?_ )Y_^/'_ !H D^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?
M\:/[/M_^>?\ X\?\: )/M,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&
MC^S[?_GG_P"/'_&@"3[3#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S
M[?\ YY_^/'_&@"3[3#_SU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W
M_P">?_CQ_P : )/M,/\ SU3_ +Z%'VF'_GJG_?0J/^S[?_GG_P"/'_&C^S[?
M_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\ L^W_ .>?_CQ_QH_L^W_Y
MY_\ CQ_QH D^TP_\]4_[Z%'VF'_GJG_?0J/^S[?_ )Y_^/'_ !H_L^W_ .>?
M_CQ_QH D^TP_\]4_[Z%'VF'_ )ZI_P!]"H_[/M_^>?\ X\?\:/[/M_\ GG_X
M\?\ &@"3[3#_ ,]4_P"^A1]IA_YZI_WT*C_L^W_YY_\ CQ_QH_L^W_YY_P#C
MQ_QH D^TP_\ /5/^^A1]IA_YZI_WT*C_ +/M_P#GG_X\?\:/[/M_^>?_ (\?
M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M[KDG_(NH^A)]IA_YZI_WT*/M,/\ SU3_ +Z%1_V?;_\ //\ \>/^-']GV_\
MSS_\>/\ C7@GMDGVF'_GJG_?0H^TP_\ /5/^^A4?]GV__//_ ,>/^-']GV__
M #S_ /'C_C0!)]IA_P">J?\ ?0H^TP_\]4_[Z%1_V?;_ ///_P >/^-']GV_
M_//_ ,>/^- $GVF'_GJG_?0H^TP_\]4_[Z%1_P!GV_\ SS_\>/\ C1_9]O\
M\\__ !X_XT 2?:8?^>J?]]"C[3#_ ,]4_P"^A4?]GV__ #S_ /'C_C1_9]O_
M ,\__'C_ (T 2?:8?^>J?]]"C[3#_P ]4_[Z%1_V?;_\\_\ QX_XT?V?;_\
M//\ \>/^- $GVF'_ )ZI_P!]"C[3#_SU3_OH5'_9]O\ \\__ !X_XT?V?;_\
M\_\ QX_XT 2?:8?^>J?]]"C[3#_SU3_OH5'_ &?;_P#//_QX_P"-']GV_P#S
MS_\ 'C_C0!)]IA_YZI_WT*/M,/\ SU3_ +Z%1_V?;_\ //\ \>/^-']GV_\
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M_'C_ (T 2?:8?^>J?]]"C[3#_P ]4_[Z%1_V?;_\\_\ QX_XT?V?;_\ //\
M\>/^- $GVF'_ )ZI_P!]"C[3#_SU3_OH5'_9]O\ \\__ !X_XT?V?;_\\_\
MQX_XT 2?:8?^>J?]]"C[3#_SU3_OH5'_ &?;_P#//_QX_P"-']GV_P#SS_\
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MS1F1BQ1)5WA^3QN"?6OD/Q5\"_C3^SOJ#:C>^'_$7AAX!N_MC2I',*#/_/S
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M;ZVU2R@O+.XBN[2XC66&X@</'(C#*LK#@@@@@CK7A?[2_P"U58? C[)I&GV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9\3O^@%X2_\  .Z_^2:/]4LS[+[P_P!:,N[O[C]*Z*_-3_AY9\3O^@%X2_\
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M^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\ TEM:^LZ^3/\
M@FG_ ,D*UW_L9)__ $EM:^LZ_GK/O^1G7_Q'[KDG_(NH^@4445X)[84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF7,EKIXMEN]2\MBIG9R=D;'^Z -V.Y8>E?=]>7>//V8_AI\3?$DVO>)?#?\
M:6K3(D;W'V^YBRJC"C;'(J\#VKU\JQ&'PF+C7Q,7*,>UGKTW:_X<\C-L/B,7
M@YT,+)1E+2[NM.NR>^Q\3_!_]A36_BM\-+;Q8_B2VT62^5Y+&QDM&E\Q 2H:
M1PXV;B#C"MQ@]\5Y/\//&7B']G?XP1W*N]K>Z5>M9ZE:JQV3QJ^V6)O4'!P>
MQ (Y K]2O$NO>&?@#\+9+MT73] T*T6&VM0Y9FVC;'$I8DLQ.!R2><GO7Y>_
M#_P[JG[0WQYMH7C9I]:U-[Z^=>1#"7,DK9] N0,]3@=Z_0<IS*MF4L34Q/\
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MV9427-PV#+(S'[J X4,<\*H .*Y[X;?\%$/#/BSQ%!I?B/P]/X4AN'$<5_\
M;!=0JQZ>;\B%![@,!GG R:X<9A,5F+=3!TVZ--<L?1=5U=WKH=N#QF%RU*&.
MJI5ZKYI>3>R?9)62N_0^MJ*0,& (.0>AI:^4/KPHHHH **** "BBB@ HHHH
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MN60A@022 V"#UYK#'T:,,/'%4E9/IZJZ.K+<17GB9X.N[M=?1V9[+17XM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /A#_@J)_S3/_N)_P#MI7PA7W?_ ,%1
M/^:9_P#<3_\ ;2OA"OWKAC_D44?^WO\ TJ1^)\1?\C2K_P!N_P#I*"BBBOJ3
MYL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /N_\
MX)=_\U,_[AG_ +=U]WU\(?\ !+O_ )J9_P!PS_V[K[OK\%XG_P"1O6_[=_\
M28G[9P[_ ,BNE_V]_P"E,****^6/I HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X0_P""HG_-,_\
MN)_^VE?"%?=__!43_FF?_<3_ /;2OA"OWKAC_D44?^WO_2I'XGQ%_P C2K_V
M[_Z2@HHHKZD^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#]*_\ @FG_ ,D*UW_L9)__ $EM:^LZ^3/^":?_ "0K7?\ L9)__26U
MKZSK^>L^_P"1G7_Q'[KDG_(NH^@4445X)[84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '#WGP3\
M%ZC\1K?QY=:-]I\56^!#?2W4["/"E1MB+^6, G'R]3GKS7<445I.I.HDIR;M
MHK]%V1G&G"FY2A%)O5Z;ON^YA^,/!&@_$#19-(\1Z5;:QITAR8+E-P![,IZJ
MWN"#7)> ?V<?AM\,=6_M/PWX4M;'41]RZEDEN)(\\'8TK,4X)'RXX->DT5I#
M$5J<'3A-J+W2;L_5&<\/1JSC4G!.2V;2NO1] HHHKG.@**** "BBB@ HHHH
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M>:!;O?PRC^\/*!90?1U4^U?N!17=A<94PMU'5/H>=C,#2QEG/1KJC\>?@/\
M\$[_ (E_%#6K6;Q1I=SX&\,JVZXNM23R[MU!Y2* _,&/JX51UYQ@_K1X%\$:
M/\-_!^D^&- M%LM'TR!;>WA!R0HZDGNQ.23W))K>HIXG&U,4E&6B706$R^E@
M[RCK)]6?E#\5/^";_P 7-3^,>L-HD%EJWA_5-0ENDUVXOHXA"DCEOWT9;S-R
MYYV*V>HZXK]// _A%?"7P_T'PQ<3_P!IIINFP:=)-,N?/$<2QEF!S]['3WKH
MJ*SJ8FI5HQHRV7_#:FM+!TJ-:5>'Q2_X?0_+3]J/_@F]XJ\.^);[7OA=I_\
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MK''3P=.GB)XE-\TKW[:NX4445QG>%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'_(HH
M_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'W?_P2[_YJ9_W#/_;NON^OA#_@EW_S4S_N
M&?\ MW7W?7X+Q/\ \C>M_P!N_P#I,3]LX=_Y%=+_ +>_]*84445\L?2!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'PA_P5$_YIG_W$_\ VTKX0K[O_P""HG_-,_\ N)_^VE?"%?O7
M#'_(HH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!^E?_!-/_DA6N_]C)/_ .DMK7UG
M7R9_P33_ .2%:[_V,D__ *2VM?6=?SUGW_(SK_XC]UR3_D74?0****\$]L**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B
MNKJ*QM9KB>18H(4,DDCG 50,DGV KY%TW_@HQX4\/_%[Q5X#\?Z=+X=&EZM<
M6%MK=N&FMI(TD94,R8WQG 7D;@3D_**^B_%9M/BM\(]?A\,ZI:ZC;ZWI-U;6
M5_8SK)$[21,BLKJ2."?PQ5U:=2G351K1JZ^ZYG2K4JM5TE+5.S\M;/\ X<_.
MCXV?\%$/B5\3/'$_AWX/Q7&EZ2)6AM7L+$76HZ@!G+X*ML!QD*B[@.K=AY[_
M ,+6_:[\#B?6KN3XC65M#^]EGU;1YY+9 !U(FB* 8'ICK2_L7_M$:/\ LE_$
M;Q5;^-_#EX[7B+8SSVL2M=V$D3MN38Q7*L3\V#G*+P:^U-;_ ."GOP7T[2VN
M+.37-7N2F5LX-.*-G'0M(RJ/J"?QKZ.I!851A0H\ZMOO?^O^&/E:<WBG*>(K
MN#3?NWM;^OO[E3]B']N*?]H*\G\'^+[6VL_&%O ;BWNK12D-_&N _P A)VR+
MD$@'!&2 N,5]AU^3'["&FZA\5OVT+KQQIFE+I.C6<M_JMU!;_P"IM5G25(X0
M< $[I.!QD(QQQ7ZSUYN84H4YQ<5RMI-KL]3ULLK3JTYJ4N91DTGW04445Y9[
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?
M\%1/^:9_]Q/_ -M*^$*^[_\ @J)_S3/_ +B?_MI7PA7[UPQ_R**/_;W_ *5(
M_$^(O^1I5_[=_P#24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?=_\ P2[_ .:F?]PS_P!NZ^[Z^$/^"7?_ #4S_N&?
M^W=?=]?@O$__ "-ZW_;O_I,3]LX=_P"172_[>_\ 2F%%%%?+'T@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'
M_(HH_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'Z5_\ !-/_ )(5KO\ V,D__I+:U]9U
M\F?\$T_^2%:[_P!C)/\ ^DMK7UG7\]9]_P C.O\ XC]UR3_D74?0****\$]L
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\G^-W[+OPZ^/]DR^*M"C.IA-D6LV.(;V+TQ(!\P&3\KAE]J^(]>_99^/G['.
MKW'B+X1>(+KQ3X<W>;/8VL>Z1E':>S.5EXXWQY;J0$KZA_:=_;G\'?LX7W]A
M_9)O$_BTQB4Z7:RB*.W4C*F:4@["1R%"L<<D $$_*C?\%;?&7]H;QX$T,6/_
M #Q-S,9>O_/3..G^S_A7JX.&+Y;T5>+Z/9_)_H>+CIX)2M7=IKJMU\U^I7M?
MC5\ OVK=22V^-/AB3X=>.VQ!)XFT>5HH)W&%_>DAMAXQ^^5PH'WP.*]O\-_\
M$N?@S>+:ZI!XE\3:YIDH6:'R]0MC!.AY'SQP LI'=6%<;X;\9? 3_@H1?G1O
M$?AN7P%\3)49K>[M)D\VYVC)"3!0LQ &2DJ9 SM/!(XS4/@G^T9^PU?3ZM\/
M]5E\9>"5<RS6MM$TT)7C)GLR2R$XYDB)P!RPZ5V-NG^[4G2EV;O'Y/H<,4JG
M[UQ5:/=*TEZKK_D?HA\-?A5X3^#_ (;CT+P?H=MH>FJV]HX 2\K=-\CL2SMC
MC+$G  Z"NLKY3_9?_P""@'A?X_ZS8^%=4TNX\->-+E6\JU7,]K=%$9V\N0#*
M':C-M<#'0,QKZLKQ\13JTY_OMW^)[N&JT:M->PV7X?(****YCK"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_W$_P#VTKX0
MK[O_ ."HG_-,_P#N)_\ MI7PA7[UPQ_R**/_ &]_Z5(_$^(O^1I5_P"W?_24
M%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?=_P#P2[_YJ9_W#/\ V[K[OKX0_P""7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>
MM_V[_P"DQ/VSAW_D5TO^WO\ TIA1117RQ](%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_F
MF?\ W$__ &TKX0K[O_X*B?\ -,_^XG_[:5\(5^]<,?\ (HH_]O?^E2/Q/B+_
M )&E7_MW_P!)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^E?\ P33_ .2%:[_V,D__ *2VM?6=?)G_  33_P"2%:[_
M -C)/_Z2VM?6=?SUGW_(SK_XC]UR3_D74?0****\$]L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS^U;X=_:>\+W%S8P-H_B'3]HU'1Y9 [1;ONR1M@;XS@C. 01@CH3[C7XW?\
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M3?\ /H_Z_P"%'VZ;_GT?]?\ "OECZ0NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@#X=_X*B?\ -,_^XG_[:5\(5]T_\%/+AYO^%:[XFBQ_:6-W?_CT]J^%
MJ_>N&/\ D44?^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\
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M/\)[4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV<C^$8\GTO6OV_?V>-+M_!VF:;XY;3;1!';QVNAPZ_%%&.%1)Q%/M4 8"A\
M8P!76_ O_@G=\:?VG/BE;^/?VAKG4].T7>DUQ'K-P&U*_0'(MTB!_P!'CZ@Y
M";0<*O.14J?M9Q<'9)WOV_K\A1J.E%\RU:M;O_6Y^C_P-CU'XM?L@^#8/%#R
M2ZAXA\'P07TTW+R&:U",[>[!MQ^M?F]_P2E^(@^ /[3'CKX0>+W&F7VM/]@C
M\X[5_M"TDD BY_OJ\F#W*J.<BOV"L;&WTRRM[.TA2VM;>-8H88UVK&B@!5 [
M   5^?O_  4,_P""<NJ?&[Q$/B?\*S!;>.E5?[1TMYA;_P!HL@ CFBE)"I.
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MSXC$0PM*5:I\,=SW"BOS4_X>6?$[_H!>$O\ P#NO_DFC_AY9\3O^@%X2_P#
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MO^@%X2_\ [K_ .2:/]4LS[+[P_UHR[N_N/TKHK\U/^'EGQ._Z 7A+_P#NO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>N&/^111_
M[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /TK_P"":?\ R0K7?^QDG_\ 26UKZSKY,_X)
MI_\ )"M=_P"QDG_]);6OK.OYZS[_ )&=?_$?NN2?\BZCZ!1117@GMA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_TENJ^LZ^3
M/^"EG_)"M"_[&2#_ -);JO>R'_D9T/\ $>)G?_(NK>A^:E%%%?T*?A04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?6?_!-/_DNN
MN_\ 8MS_ /I5:U\F5]9_\$T_^2ZZ[_V+<_\ Z56M>!GW_(LK^A[>2?\ (QH^
MI^E=%%%?SV?NH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF?_<3
M_P#;2OA"ON__ (*B?\TS_P"XG_[:5\(5^]<,?\BBC_V]_P"E2/Q/B+_D:5?^
MW?\ TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'W?_ ,$N_P#FIG_<,_\ ;NON^OA#_@EW_P U,_[AG_MW7W?7X+Q/
M_P C>M_V[_Z3$_;.'?\ D5TO^WO_ $IA1117RQ](%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_
M  5$_P":9_\ <3_]M*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UPQ_R**/\ V]_Z
M5(_$^(O^1I5_[=_])04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!^E?_  33_P"2%:[_ -C)/_Z2VM?6=?)G_!-/_DA6
MN_\ 8R3_ /I+:U]9U_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/;"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /BS]I3_ ()U
M3_'SXM:QXX@\>QZ,VH)"OV"323,(S'"D8_>"89SLS]T8SWKQ34O^"2?C*)6_
ML_QWH=R=O N;::')]/E#\>_Z5^GU>%_MC?M"W?[-WPA;Q'I4%C=Z[<WL5E8V
MVH*[PNS99RRHRL0$5NC#G%=]'&8BFHT:<M-$E9>B/-Q&!PM1RK58ZVNW=]%Z
M]D>0?L7_ +!^N?L\_$+4O%OBO6]/U"[6T-II\.C3S%,.?WC3;T3. %"K\PY)
MZ@5[;^USX7^(/C3X&Z]HOPX>V&LWD?E7$<TACEFMB#YD<+?=$C#Y?F(&"W(.
M#7SE^R#_ ,%!?%GQR^,EIX-\8:7X?T^VU"UF-G-I,$\4AN$&\*QDF<%2BR<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^$/^"HG_
M #3/_N)_^VE?"%?=_P#P5$_YIG_W$_\ VTKX0K]ZX8_Y%%'_ +>_]*D?B?$7
M_(TJ_P#;O_I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /N_P#X)=_\U,_[AG_MW7W?7PA_P2[_ .:F?]PS_P!NZ^[Z
M_!>)_P#D;UO^W?\ TF)^V<._\BNE_P!O?^E,****^6/I HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#X0_X*B?\TS_ .XG_P"VE?"%?=__  5$_P":9_\ <3_]M*^$*_>N&/\ D44?
M^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\ TEM:^LZ^3/\
M@FG_ ,D*UW_L9)__ $EM:^LZ_GK/O^1G7_Q'[KDG_(NH^@4445X)[84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^7?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /A#_ (*B?\TS
M_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>N&/^111_[>_]*D?B?$7_ "-*
MO_;O_I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /N__@EW_P U,_[AG_MW7W?7PA_P2[_YJ9_W#/\ V[K[OK\%XG_Y
M&];_ +=_])B?MG#O_(KI?]O?^E,****^6/I HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$_
M_;2OA"ON_P#X*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?
M_24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?=__!+O_FIG_<,_]NZ^[Z^$/^"7?_-3/^X9_P"W=?=]?@O$_P#R-ZW_
M &[_ .DQ/VSAW_D5TO\ M[_TIA1117RQ](%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF
M?_<3_P#;2OA"ON__ (*B?\TS_P"XG_[:5\(5^]<,?\BBC_V]_P"E2/Q/B+_D
M:5?^W?\ TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'Z5_\$T_^2%:[_V,D_\ Z2VM?6=?)G_!-/\ Y(5KO_8R3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_ -);
MJOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ4445_0I
M^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]9_
M\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(LK^A[
M>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1
M/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5(_$^
M(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'W?_P $N_\ FIG_ '#/_;NON^OA#_@EW_S4S_N&?^W=
M?=]?@O$__(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?+'T@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\(?\%1/^:9_]Q/\ ]M*^$*^[_P#@J)_S3/\ [B?_ +:5\(5^]<,?\BBC_P!O
M?^E2/Q/B+_D:5?\ MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'Z5_\$T_^2%:[_P!C)/\ ^DMK7UG7R9_P33_Y
M(5KO_8R3_P#I+:U]9U_/6??\C.O_ (C]UR3_ )%U'T"BBBO!/;"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***;)(D*%Y&5$'5
MF.!0 ZOQV_;[_:$\2_$?XT>(_"8U.XM_"6@7;6$&F0N4BEEC.))9%'WVWAL9
MZ #&,G/[ ?VE:?\ /U#_ -_!_C7Y,?MF?#$_!#]J^Q\=W^G?VOX+UO5X=;4(
M R3%9$>YMSVW$ACSU#CWKTLM4'BXJIV=O73]+GDYM[18.3I]U?TUO^-CYFL/
MA;XSU2SBN[+PCKMY:S+NCGM]-F='7U#!<$?2I_\ A3WCW_H2/$?_ (*;C_XB
MOW9\!?$[PM\2O"MAXA\-ZS:ZCI-XFZ.6.0 J>Z,IY5AT*GD5T']I6G_/U#_W
M\'^-=\LUJ1DXN%K'FPR6E.*DJE[GYA_\$P_ 7B?PO\?]9N]9\.:MI%JWAVXC
M6>^L984+&XMR%#,H&< G'L:_46H8;R"X;;%-'(V,X1P34U>7BL2\5-3:M96_
M/_,]G!X18.#IQ=[N_P"7^04445Q'>%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$7_(TJ_]N_\ I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /N__ ()=_P#-3/\ N&?^W=?=]?"'_!+O_FIG_<,_]NZ^
M[Z_!>)_^1O6_[=_])B?MG#O_ "*Z7_;W_I3"BBBOECZ0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S]^WQ&\W[)?CY(T9
MW,5KA5&2?]+AKZ!HHZI]FG]SN!_.Q_9=[_SZ3_\ ?IO\*7^R[W_GTN/^_;?X
M5_1-7S9\8OV^/AQ\$/B'J'@WQ!8>(9]6L1$TLEA:0R0GS(UD7#-,IZ,,\=:^
MFIYI.M-4Z=.[?G_P#Y*IDT*47.=6R]/^"?C7_9=[_P ^D_\ WZ;_  H_LN]_
MY])_^_3?X5_1)%()HT=>C ,,^])<3"W@DE8,RQJ6(49)P,\#UK)YQRZN'X_\
M N.1J5K5-_+_ ()^4W_!*RSN+?\ :(UII8)(E_X1NX&YT('_ !\6U?J[7SA\
M(_V[OA_\;/BM#X%\.66LI=S0S2)>ZA!'##(8QN*J-Y?)4,>5'W:^CZX<?5J5
MIQE4ARZ?JSU,MHTZ%.4*<^;77ULM HHHKS#U@HHHH **** "OD/_ (**?MJ3
M?LG_  _T^Q\-I!<>//$7F)8?:%WQV4* ![ED_B(+*JJ>"22<A2#]>5\W?'K]
M@OX>_M'?%S0?B!XOU3Q$]]H\5O!#I5K<VZV$D<4K2[9$>!G(<N0V'&1TQUK.
M47-QC>R;U?D:1DHWE:[2T]3\T_#G[ ?[47[7NCP^/?%FOP0?;Q]ILV\;:K.)
MI8W&X-%#''+Y2'/"D)QC QBM#X6_M"?'7_@F_P#&'3_!?Q6&I:GX&N& ET^Y
MN#=PFVSM^TV$Q)QMZF,$ \AE5B"O[6*H50 , < "OSI_X+8?V#_PHOP1]J,'
M_"2?\)!_H(./-^S_ &>3S\=]N[R,]L[?:JE5]A)2IKW;I6[IZ?U^%NDPI^V3
MC4?O6;OZ*Y^A>C:Q9>(='L=4TZXCO-/OH$N;:XB.5EC=0RL#Z$$'\:\P_:T^
M)S_!W]FWXA^+8+@VE]8Z1,MG,K;2MS(/*A(/KYCITK+_ &(8;ZW_ &1?A*FH
MAQ<_\(]:D"3KY93,?_CA6OF?_@L_\2?^$;_9]\.>$(9@MQXDUA9)8\\M;VR[
MV_\ (C0_E2QT?9\]*/?E\]7;\-QX*3J<E27:_P!RN?$/P9\-_MK?M!>$Y/$W
M@'QA\0M=T..Y>S-VWCIK4>:H4LH6:[1C@.O(&.V<@U[A\%/V>_VZ]&^,7@:_
M\6ZKXXD\+6NN64^K)=^/HKB$VBSH9@\0O6,B[ V5VG(XP<XKFOV1_P#@J9X?
M_9M^$OACX=W'PQO+W3]/,KWNLVNLIYTTDDK2.ZV[0@<;L &7HHYK]3_@'^T1
MX'_:5\#Q^*/ ^J?;;,-Y5S:3KY=U92XSY<T>3M;W!*D<J2.:[%^[G[2GJHV_
MKT;.6_-'EGHW?^O6QZ71117,;GSM^W!^UOI_[(_PE;6U@BU'Q5JCM::'ITQ.
MR28+EI9 "#Y<8(+8Y)*KD;LC\O\ P?\ LJ_M/_\ !0:RD^(&N^((_P"R+IV>
MQN_%>H2P6LO.&%I;Q1OLC!&,A%4GH2<UW_\ P4@:Z^/7_!0;P+\+?.?^S[<:
M;I&R,_ZMKJ0232>Q\MT_!!7Z]Z#H=AX8T/3]'TJUCL=,T^WCM;6VA7:D42*%
M1%'8  "HHP4Z;KSUNVEY6W^_1_\ #(NK)QFJ,=+)-^=]OZ_ST_$+1/B/^T/_
M ,$POBMI6B>*I[C4?"EP1)_9$EXUUI>HVP;$C6KM_J9!GJ K [=ZE2 ?VI^'
M/Q T;XJ>!-"\7>'KG[7HNLVB7EK+C!VL,[6'9@<J1V((KYX_X*9?".Q^*G[(
M_C">:!&U/PS%_;MC<$?-&T/,H!]&B,BX]P>PKR?_ ((P^/KGQ%^SGXA\-7,O
MF#P[K;BV7/*0SHLFWZ>8)3^-;4INK&<)_%"S3[INWY_D^YC4BJ<H3AM*ZMYI
M7_+\_(_0*BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_ -);JOK.ODS_
M (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ4445_0I^%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]9_\$T_^2ZZ
M[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(LK^A[>2?\C&CZ
MGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_P#<
M3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5(_$^(O\ D:5?
M^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'W?_P $N_\ FIG_ '#/_;NON^OA#_@EW_S4S_N&?^W=?=]?@O$_
M_(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?+'T@4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^
M:9_]Q/\ ]M*^$*^[_P#@J)_S3/\ [B?_ +:5\(5^]<,?\BBC_P!O?^E2/Q/B
M+_D:5?\ MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'Z5_\$T_^2%:[_P!C)/\ ^DMK7UG7R9_P33_Y(5KO_8R3
M_P#I+:U]9U_/6??\C.O_ (C]UR3_ )%U'T"BBBO!/;"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\
M6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">
MJ?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_Y
MZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM%
M%+R[[_GJGY?_ %J^4?\ @I(MROP-T/SG5E_X2.#@>OV:Z]J^NZ^3/^"EG_)"
MM"_[&2#_ -);JO>R'_D9T/\ $>)G?_(NK>A^:E%%%?T*?A04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %?5W_!-M96^.6N>2P5O^
M$<GY/I]IM:^4:^L_^":?_)===_[%N?\ ]*K6O S[_D65_0]O)/\ D8T?4_1[
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM%?SV?NI2\N^_YZI^7_P!:CR[[_GJGY?\
MUJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+R[[_ )ZI^7_UJ/+OO^>J
M?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM% %+R[[_GJGY?_ %J/+OO^
M>J?E_P#6J[10!2\N^_YZI^7_ -:CR[[_ )ZI^7_UJNT4 4O+OO\ GJGY?_6H
M\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\
M6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">
MJ?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_Y
MZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM%
M%+R[[_GJGY?_ %J/+OO^>J?E_P#6J[10!2\N^_YZI^7_ -:CR[[_ )ZI^7_U
MJNT4 4O+OO\ GJGY?_6H\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_
M %JNT4 4O+OO^>J?E_\ 6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\
MGJGY?_6J[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO
M^>J?E_\ 6J[10!2\N^_YZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6
MH\N^_P">J?E_]:KM% %+R[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?
M_6H\N^_YZI^7_P!:KM% %+R[[_GJGY?_ %J/+OO^>J?E_P#6J[10!2\N^_YZ
MI^7_ -:CR[[_ )ZI^7_UJNT4 4O+OO\ GJGY?_6H\N^_YZI^7_UJNT4 4O+O
MO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\ 6H\N^_YZI^7_ -:KM% %
M+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[
M10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_YZI^7_P!:CR[[_GJGY?\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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MEWW_ #U3\O\ ZU'EWW_/5/R_^M5VB@"EY=]_SU3\O_K4>7??\]4_+_ZU7:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY_U2;_RY/_N2C_A[Y_U2;_RY/_N2C_AT'_U5G_RV_P#[KH_X=!_]59_\MO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_X*6?\
M)"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);JO>R'_D9T/\1XF=_\BZMZ
M'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5]9_\ !-/_ )+KKO\ V+<__I5:U\F5]9_\$T_^2ZZ[_P!BW/\ ^E5K
M7@9]_P BROZ'MY)_R,:/J?I71117\]G[J%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'PA_P5$_YIG_W$_P#VTKX0K[O_ ."HG_-,_P#N)_\ MI7PA7[UPQ_R
M**/_ &]_Z5(_$^(O^1I5_P"W?_24%%%%?4GS84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?=_P#P2[_YJ9_W#/\ V[K[OKX0_P""
M7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>M_V[_P"DQ/VSAW_D5TO^WO\ TIA1117R
MQ](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?"'_!43_FF?\ W$__ &TKX0K[O_X*B?\ -,_^XG_[
M:5\(5^]<,?\ (HH_]O?^E2/Q/B+_ )&E7_MW_P!)04445]2?-A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?\ P33_ .2%:[_V
M,D__ *2VM?6=?)G_  33_P"2%:[_ -C)/_Z2VM?6=?SUGW_(SK_XC]UR3_D7
M4?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M17]"GX4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7UG_P $T_\ DNNN_P#8MS_^E5K7R97UG_P33_Y+KKO_ &+<_P#Z56M>!GW_
M "+*_H>WDG_(QH^I^E=%%%?SV?NH4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?"'_!43_FF?_<3_ /;2OA"ON_\ X*B?\TS_ .XG_P"VE?"%?O7#'_(HH_\
M;W_I4C\3XB_Y&E7_ +=_])04445]2?-A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!]W_ /!+O_FIG_<,_P#;NON^OA#_ ()=_P#-
M3/\ N&?^W=?=]?@O$_\ R-ZW_;O_ *3$_;.'?^172_[>_P#2F%%%%?+'T@44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\(?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7
M[UPQ_P BBC_V]_Z5(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'Z5_P#!-/\ Y(5KO_8R3_\
MI+:U]9U\F?\ !-/_ )(5KO\ V,D__I+:U]9U_/6??\C.O_B/W7)/^1=1] HH
MHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_\ 2JUKP,^_Y%E?T/;R3_D8T?4_2NBBBOY[/W4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>
MN&/^111_[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /N__@EW_P U,_[AG_MW7W?7PA_P
M2[_YJ9_W#/\ V[K[OK\%XG_Y&];_ +=_])B?MG#O_(KI?]O?^E,****^6/I
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#X0_X*B?\TS_[B?\ [:5\(5]W_P#!43_FF?\ W$__ &TK
MX0K]ZX8_Y%%'_M[_ -*D?B?$7_(TJ_\ ;O\ Z2@HHHKZD^;"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]*_^":?_)"M=_[&2?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'PA_P5$_YIG_W$_P#VTKX0K[O_ ."HG_-,_P#N)_\
MMI7PA7[UPQ_R**/_ &]_Z5(_$^(O^1I5_P"W?_24%%%%?4GS84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?=_P#P2[_YJ9_W#/\
MV[K[OKX0_P""7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>M_V[_P"DQ/VSAW_D5TO^
MWO\ TIA1117RQ](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF?\ W$__ &TKX0K[O_X*
MB?\ -,_^XG_[:5\(5^]<,?\ (HH_]O?^E2/Q/B+_ )&E7_MW_P!)04445]2?
M-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?\
MP33_ .2%:[_V,D__ *2VM?6=?)G_  33_P"2%:[_ -C)/_Z2VM?6=?SUGW_(
MSK_XC]UR3_D74?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH
ME^T1?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:
M(O\ GJG_ 'T*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O^>J?]]"HO[.
MM_[GZFC^SK?^Y^IH E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\
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M4IF23X%Z$%=6/_"20=#G_EUNJ^K?[.M_[GZFOD__ (*36L4'P-T)D7!_X2.
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M?]]"C[1%_P ]4_[Z%1?V=;_W/U-']G6_]S]30!+]HB_YZI_WT*/M$7_/5/\
MOH5%_9UO_<_4T?V=;_W/U- $OVB+_GJG_?0H^T1?\]4_[Z%1?V=;_P!S]31_
M9UO_ '/U- $OVB+_ )ZI_P!]"C[1%_SU3_OH5%_9UO\ W/U-']G6_P#<_4T
M2_:(O^>J?]]"C[1%_P ]4_[Z%1?V=;_W/U-']G6_]S]30!+]HB_YZI_WT*/M
M$7_/5/\ OH5%_9UO_<_4T?V=;_W/U- $OVB+_GJG_?0H^T1?\]4_[Z%1?V=;
M_P!S]31_9UO_ '/U- $OVB+_ )ZI_P!]"C[1%_SU3_OH5%_9UO\ W/U-']G6
M_P#<_4T 2_:(O^>J?]]"C[1%_P ]4_[Z%1?V=;_W/U-']G6_]S]30!+]HB_Y
MZI_WT*/M$7_/5/\ OH5%_9UO_<_4T?V=;_W/U- $OVB+_GJG_?0H^T1?\]4_
M[Z%1?V=;_P!S]31_9UO_ '/U- $OVB+_ )ZI_P!]"C[1%_SU3_OH5%_9UO\
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M +Z%'VB+_GJG_?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_P">J?\
M?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_YZI_WT*B_LZW_N?J:/[.
MM_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH E^T1
M?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O\
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M E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\ N?J: )?M$7_/5/\
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M:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH
ME^T1?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:
M(O\ GJG_ 'T*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O^>J?]]"HO[.
MM_[GZFC^SK?^Y^IH E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\
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MYZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\
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MYZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M KY,_P""EG_)"M"_[&2#_P!);JOK.ODS_@I9_P D*T+_ +&2#_TENJ][(?\
MD9T/\1XF=_\ (NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?6?\ P33_ .2ZZ[_V+<__ *56M?)E?6?_  33
M_P"2ZZ[_ -BW/_Z56M>!GW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_
M^XG_ .VE?"%?O7#'_(HH_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W?_P2[_YJ9_W#
M/_;NON^OA#_@EW_S4S_N&?\ MW7W?7X+Q/\ \C>M_P!N_P#I,3]LX=_Y%=+_
M +>_]*84445\L?2!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_W$_\ VTKX0K[O_P""
MHG_-,_\ N)_^VE?"%?O7#'_(HH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?_!-
M/_DA6N_]C)/_ .DMK7UG7R9_P33_ .2%:[_V,D__ *2VM?6=?SUGW_(SK_XC
M]UR3_D74?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHKE=3^*7A71[YK.ZUB%;A3M98T>0*?0E00#]37'B<9AL%%3Q56,$]+
MR:7YG11P];$/EHP<GY)O\CJJ*KZ?J%MJEI'=6<\=S;R#*2Q,&4_C5BNN,E)*
M47=,PE%Q;4E9A16'H_C71O$&J76GZ?>?:KJUSYRK$X5<'!^8KM//H>:W*QH8
MBCBH*K0FI1[IIK31ZKL]#2I2J49<M6+B_-6"BBBMS(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *XWXJ?&#PA\%?#;:[XQUJ#1[#=
MLCW@O).^,[(XU!9V]@..IP*[*OQM_;.\8:]\>/VM]0\,6\WF1V>IQ^'-)M78
MB.-]ZQL?8M*22?3'H*ZL+AWBJRI)VZ_+3_,XL9B5@Z#K-7Z+U?\ PS_(^J=<
M_P""L_@2UO&CTGP9X@U&W4D>=<R0VY/N%#/Q]<?2OJ3X+?&O2OC+\(M,^(,5
MN^A:7>),[QZA*@\@12O&Y9P=N,H3GT]*_+/]L7]D/3/V6_#W@=[?7KO7=5U@
MW*WLDL:Q0*8Q$1Y2#+ 9D;[S'H.E?<7[%?A73_'/[!^B^']5B2;3M2M=3M9U
MDZ;6NK@9]L=<]L5WXJCAHX)XBAK9VO\ ??\ (\W"XC%RQD:&)LDU<]N^&/Q\
M\"?&35M?T_P=K\&N3Z(\:7;0*WE_.#M9&( =<JPW+D9'7I7H-?CW_P $W_%%
MUX3_ &K=-TB&4M;:Q:WFGSA3\KA(VF5L?[T(_,U^PE<^-PJPLXJ+NFK_ *?H
M=F!Q4L5&?.K.+:_K\OD%%%%><>F%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?)G_  4L_P"2%:%_V,D'_I+=
M5]9U\F?\%+/^2%:%_P!C)!_Z2W5>]D/_ ",Z'^(\3._^1=6]#\U****_H4_"
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^L_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X
M*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $
MT_\ DA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z
M_P#B/W7)/^1=1] HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3MY;'+@\RQ>7MO#3Y;[[/\'='E7BB'3O@S\/[BVTIF_M&_/E),Y_>.Q'+\=
MHSC'0D>M4=.AD^$GPAFOU4)K-_M.YARCO]T?\!7)^N:JK_Q=CXM9_P!9H6C=
M/[KX/_LS#_OE:Z']H*UDN/ D<B+E8;R-W]@59<_FP_.OS6M)RP6.SG!1Y:=&
M$J5"VRBM)U%ZO9[VCJ?81]VKA\#B7>=62G4O_P"2Q?RW7F<=X'^"\/C+PU_;
M.IZC=1WEX7>(H01U(W/D$MD@GJ*T?@5XFO+/5[_PK?2&00;S#N.=C(V'4>W?
M\#7=_".\ANOAWH[1N"(HC&_^RP8Y!KR[X4YUCXQ:IJ%OEK;?=3EATVNY"_\
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M$85XF-2,/=4;-66]][>FAX5+"XQ8:=.53WV]'=Z+3KN?G'_P\8^/G_0Y0?\
M@GL__C5'_#QCX^?]#E!_X)[/_P"-5^@W_#NGX!'D>#)B/^PQ>_\ QZC_ (=S
M_ +_ *$R;_P<7O\ \=KJ^N8'_GU^"_S./ZAF/_/[_P FE_D>(?L!_M9?$_XY
M_&;5- \9Z_'JFEP:)->1PI86\!$JS0*&W1HIZ.W&<<U^@E>$?!WX!_!#X*_$
M:X_X09+'3_&,UC)#)9?VW)<7)M]Z,Y\EY6( 94^;;QZ\U[O7EXRI2JSC*C'E
M5NUNK['L8&E6HTW&O+F=^[?1=PHHHKA/1"BBB@ HHHH **** "BBB@ HHHH
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M=U]WU^"\3_\ (WK?]N_^DQ/VSAW_ )%=+_M[_P!*84445\L?2!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X
M*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $
MT_\ DA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z
M_P#B/W7)/^1=1] HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7HU?F1_P2B^'%_-XZ\1>.DOM.?3+?3Y-(ELUG)O$E>2&1',>W C(C?#9Y((
MX./TWKR<;AX8:HJ<'?37^O2Q[> Q,\52]I-6UT_KUN%%%%<!Z04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
MF?\ !2S_ )(5H7_8R0?^DMU7UG7R9_P4L_Y(5H7_ &,D'_I+=5[V0_\ (SH?
MXCQ,[_Y%U;T/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KZS_P"":?\ R777?^Q;G_\ 2JUKY,KZS_X)I_\ )===
M_P"Q;G_]*K6O S[_ )%E?T/;R3_D8T?4_2NBBBOY[/W4**** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH ^$/^"HG_-,_P#N)_\ MI7PA7W?_P %1/\
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MH_M'&_\ /Z7_ ($_\P^JX?\ Y]K[D;G_  G7B3_H8-5_\#9?_BJ/^$Z\2?\
M0P:K_P"!LO\ \56'11_:.-_Y_2_\"?\ F'U7#_\ /M?<C<_X3KQ)_P!#!JO_
M (&R_P#Q5'_"=>)/^A@U7_P-E_\ BJPZ*/[1QO\ S^E_X$_\P^JX?_GVON1N
M?\)UXD_Z&#5?_ V7_P"*H_X3KQ)_T,&J_P#@;+_\56'11_:.-_Y_2_\  G_F
M'U7#_P#/M?<C<_X3KQ)_T,&J_P#@;+_\51_PG7B3_H8-5_\  V7_ .*K#HH_
MM'&_\_I?^!/_ ##ZKA_^?:^Y&Y_PG7B3_H8-5_\  V7_ .*H_P"$Z\2?]#!J
MO_@;+_\ %5AT4?VCC?\ G]+_ ,"?^8?5</\ \^U]R-S_ (3KQ)_T,&J_^!LO
M_P 51_PG7B3_ *&#5?\ P-E_^*K#HH_M'&_\_I?^!/\ S#ZKA_\ GVON1N?\
M)UXD_P"A@U7_ ,#9?_BJ/^$Z\2?]#!JO_@;+_P#%5AT4?VCC?^?TO_ G_F'U
M7#_\^U]R.T\&^,O$%UXPT.&;7-2FADOX$>.2[D964R*""">017U57Q[X%_Y'
M;P]_V$;?_P!&K7V%7]$>&%>M7P>)=:;E:2W;?3S/RSC"G"G7I*$4M'MZA111
M7[4?GP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^+?QRL[7P#^W9
MK,VOPA]+A\70ZG=)*,J]O),D[9XY!1C7[25\I?M._L(Z=^T?\6-!\52:Y_8-
MI':?9=76WAWW%R$;,7ED_*K89U+-G "\&O0R^O'#XF-2>UFOR?Z6^9YF98>6
M*PLJ<-[IK\5^M_D<U_P5,\&OXE^ >C^(K0"5=$U2.61EY'DS(8]V?3=Y?YUY
MW^RK^W#\-O#O[-Y\#_$BYDAO=(M9K.*UDLY+A-3MFW%(U**P# -Y9#[1@*<]
M<?<-W\(_#^H_"3_A7-\EQ?\ ATZ8NE'[5,9)VB5 JL7/\8P"#V(%?F'\1/\
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M/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KZS_X)I_\ )===_P"Q;G_]*K6ODROK/_@FG_R777?^Q;G_ /2JUKP,
M^_Y%E?T/;R3_ )&-'U/TKHHHK^>S]U"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS84444 %%%% !1110
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M NT52_M6'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\:
M+M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"
M[15+^U8?[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH N
MT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M
M%4O[5A_NO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[1
M5+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT5
M2_M6'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4
MO[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+
M^U8?[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_
MM6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[
M5A_NO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U
M8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6
M'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A
M_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?
M[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^
MZ_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[5A_N
MO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K
M_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6'^Z_
MY#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO^
M0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?[K_D
M/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_Y#
M_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[5A_NO^0_
MQH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_D/\
M:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6'^Z_Y#_&
MC^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO^0_QH
M_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?[K_D/\:/
M[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH ^'?\ @J)_S3/_ +B?
M_MI7PA7W3_P4\NDNO^%:[ PV_P!I9S_VZ5\+5^]<,?\ (HH_]O?^E2/Q/B+_
M )&E7_MW_P!)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^E?\ P33_ .2%:[_V,D__ *2VM?6=?(G_  3;OH[;X&ZX
MK!B3XCG/ _Z=K6OJ[^U8?[K_ )#_ !K^>L^_Y&=?_$?NN2?\BZCZ%VBJ7]JP
M_P!U_P A_C1_:L/]U_R'^->">V7:*I?VK#_=?\A_C1_:L/\ =?\ (?XT 4/'
M7_(D^(?^P=<?^BFKX]KZW\;:E%)X,U]0'RVGW ' _P">;>]?)%?S=XJ?[[A?
M\+_,_6>"_P#=ZWJOR"BBBOPT_1 HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH W/ O_([>'O\ L(V__HU:^PJ^._!+"/QGH#'HNH6Y
M/_?Q:^M_[5A_NO\ D/\ &OZ2\*_]RQ/^)?D?D_&G^\4?1_F7:*I?VK#_ '7_
M "'^-']JP_W7_(?XU^XGYT7:*I?VK#_=?\A_C1_:L/\ =?\ (?XT 7:*I?VK
M#_=?\A_C1_:L/]U_R'^- %VBJ7]JP_W7_(?XT?VK#_=?\A_C0!=HJE_:L/\
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M](K^NA]UT5';R&:WCD(P64-^8J2N#8[XR4DFNH4444B@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3
M/^"EG_)"M"_[&2#_ -);JOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'
MB9W_ ,BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5]9_\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V
M+<__ *56M>!GW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\(?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7
M[UPQ_P BBC_V]_Z5(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'W?_P $N_\ FIG_ '#/_;NO
MN^OA#_@EW_S4S_N&?^W=?=]?@O$__(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?
M+'T@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% &YX%_P"1V\/?]A&W_P#1JU]A5\>^!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O
M^QD@_P#26ZKWLA_Y&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7UG_P33_Y+KKO_ &+<_P#Z
M56M?)E?6?_!-/_DNNN_]BW/_ .E5K7@9]_R+*_H>WDG_ ",:/J?I71117\]G
M[J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_W$_\ VTKX0K[O
M_P""HG_-,_\ N)_^VE?"%?O7#'_(HH_]O?\ I4C\3XB_Y&E7_MW_ -)04445
M]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]W
M_P#!+O\ YJ9_W#/_ &[K[OKX0_X)=_\ -3/^X9_[=U]WU^"\3_\ (WK?]N_^
MDQ/VSAW_ )%=+_M[_P!*84445\L?2!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 45Q'QK\?2_"_X5^)/%%ND$MWI]J9+
M>.Y!,;RDA4# $$C<PZ$5\,_\/'OB7_T _"G_ ("7/_R17M8#*,5F4)3H)63M
MJ['B9AG&$RN48XAN\MK*Y^CM%<C\(_%UYX^^&/ACQ'J$4$-]JEA%=31VRLL:
MLRY(4,20/J3775Y56G*C4E3ENFU]QZU*I&M3C5AM))KYA17P5\4OV_\ QKX4
M^(WB/1=#TKPY<Z5IU]+:0375O<-(X1BI+%9E!Y!Z 5[1^Q_^T=XE_: 3Q2?$
M-CI5G_99MA#_ &9#+'N\SS=V[?(^?N#&,=Z]FMDN,H87ZW-+DLGOKK:VGS/#
MIY]@JV,^I0;Y[M;:75[Z_(^C:***\$^A"BBO@KXI?M_^-?"GQ&\1Z+H>E>'+
MG2M.OI;2":ZM[AI'",5)8K,H/(/0"O2P.7U\QJ.G06J5]3S,PS&AEE)5<0]&
M[::]W^A]ZT5\Y?L?_M'>)?V@$\4GQ#8Z59_V6;80_P!F0RQ[O,\W=NWR/G[@
MQC'>OHVL<7A:N"K2H5OB5OQ5S7!8REF%!8BA\+O^#L175U!8V\EQ<S1V\$:E
MGEE8*J@=22> *PO#_P 1O"?BV\DM-#\3Z-K5U&,O!I^H13NH'<JC$BOC;]K;
MQ5K7QB^/N@?!S2M0:QTD301W>S)5YI '9W (W"./!"^N?:N=_:-_9+MOV=_"
MNF^.?!7B+5OM%A=1I.UU(@EC=CA)8FC5=N&P-IS][K7N8;*:$Z=+ZQ5Y9U?A
M5K^E_7H>'BLWQ$*E986CSPH_&[VZ7:7^%;_U?]#:SM>\1:5X6TV34=:U.STC
M3XR%>ZO[A((E). "[$ 9/'6N*_9Z^)DGQ<^$/A[Q+<A5OYXFBO%08'GQL4<@
M=@Q7<!V#"OG+]K#7KWXY?&CPM\%] N&%M#.MSJTT?(1MNXD_]<XMS8/=P.M>
M=A\OG4QCPM1\O+?F?91W?^7R/2Q&94Z>!6,IJ_,ERKJW+X5_G\S[&T?6M/\
M$6FP:CI5_;:GI\X+17=G,LL4@!()5U)!Y!'![5=K/T#0[+PQH=AI&FP+;:?8
MP);P0KT5%4 #\A6A7ESY>9\FW0]6GS\BY]^MMKA1114%A1110 4444 %%%%
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M)/ !<$GIFOH^G4I5*3M4C8FE6IUE>G),****R-@HHHH **** "BBB@ HHHH
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M=0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<._\BNE_V]_Z4PHHHKY8^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ8FT:>(Z?CY^?]>9ZV"IX1.57#=?P\O+O_P+!1117GGJ!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_P#<3_\ ;2OA"ON__@J)
M_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5(_$^(O\ D:5?^W?_ $E!1117U)\V
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z5_P#!
M-/\ Y(5KO_8R3_\ I+:U]9U\F?\ !-/_ )(5KO\ V,D__I+:U]9U_/6??\C.
MO_B/W7)/^1=1] HHHKP3VPHHHH P_'7_ ")/B'_L'7'_ **:OCVOL+QU_P B
M3XA_[!UQ_P"BFKX]K^;O%3_?<+_A?YGZSP7_ +O6]5^04445^&GZ(%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &YX%_Y';P]_P!A
M&W_]&K7V%7Q[X%_Y';P]_P!A&W_]&K7V%7])>%?^Y8G_ !+\C\GXT_WBCZ/\
MPHHHK]Q/SH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-S_@I#^R
M9K-YXFG^*WA+3I-2L[F)1KEI:H6EA=%"BX"CDH5 #8^[MR>"2/TCHK6C5E0J
M*I#=?U8PKT88BDZ4]G_5S\%O!'[1WQ0^'%C#8^'/'>N:980C$5DMXSV\8]%B
M?*C\!53QQ\=/B-\4H?L?B?QEK>NVKL#]AN+MS 6SD'R@=N<].*_9GQM^R9\'
M_B)?27NN?#_1Y[R1M\EQ:QM:22,>I=H2A8^YS5WX?_LR_"SX6WD5YX8\#:1I
MU]$=T5ZT/GW$9]5ED+.OX&O>_M*@_?E3][Y?F?.?V3B5^[C5]WY_EM^)\P_\
M$W_V3]8^&L=[\1O&-A)INLZA;_9=,TZY4K-!;L0SRR*>59\* IY"@Y^]7W91
M17C8G$2Q-3GD>]A<-#"4_9P^?FPHHHKE.P**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/\ @I9_R0K0O^QD
M@_\ 26ZKZSKY,_X*6?\ )"M"_P"QD@_]);JO>R'_ )&=#_$>)G?_ "+JWH?F
MI1117]"GX4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7UG_ ,$T_P#DNNN_]BW/_P"E5K7R97UG_P $T_\ DNNN_P#8MS_^E5K7
M@9]_R+*_H>WDG_(QH^I^E=%%%?SV?NH4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:6OH3_@I1^RG_8.H2_%GPM9A=.O'"Z]:PCB&9CA;D#LKG ;_ &L'^(FOGO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X*B?\
MTS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $T_\
MDA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z_P#B
M/W7)/^1=1] HHHKP3VPHHHH P_'7_(D^(?\ L'7'_HIJ^/:^PO'7_(D^(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_MI7PA7W?\ \%1/^:9_]Q/_ -M*^$*_>N&/^111_P"WO_2I'XGQ%_R-*O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?BA\<OLFJ?MP>(8_&)\O2)/%Z0W[2$KBR$ZKDGL/) _"OVOK\\?^"B7['&M
M^*-?F^*/@?3I-4FEB5=:TNU3=,2BX6XC4<O\H 91S\H/.3CT<NK0P^*C.>UF
MOQ3_ $/+S2A/$81PIJ[33^Y-?J4O^"L&FV.C^&?A-9:9;6]EIUN;^.WM[5%2
M*- MOM"JO &/2O;/V*_%FE^!?V$="U_6IX[?2]/M]2GN'E("[1=S_+[D] .Y
M(%?E%XB^(7BGQ-H.D:!KFMW^I:9HN];"TO93(+0,%#(F[E5PBC;T&. *=)XZ
M\6Z]X7TKP8=8U*\T&TD/V+1(Y6, D=RV5B'#.6=N<$\\5[3R^4L&\+S;RO?R
M=_QU/GO[2A'%1Q/)M&UO/_(]R_X)ZBYO?VP/"LUFICB"WTLRKT6(VLHP?;)6
MOV8KXE_X)U_LEZK\(=/O?'OC&S?3_$FK6_V:RTV88DL[4D,S2#^&1RJ_+U4+
MSRQ ^VJ\S-*L*E6,8._*K?BW^I[.4TJD*4JE16<W?^OZVL%%%%>.>X%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?)G_!2S_DA6A?]C)!_P"DMU7UG7R9_P %+/\ DA6A?]C)!_Z2W5>]D/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X0_P""HG_-,_\ N)_^VE?"%?=__!43_FF?_<3_
M /;2OA"OWKAC_D44?^WO_2I'XGQ%_P C2K_V[_Z2@HHHKZD^;"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[O_X)=_\ -3/^X9_[
M=U]WU\(?\$N_^:F?]PS_ -NZ^[Z_!>)_^1O6_P"W?_28G[9P[_R*Z7_;W_I3
M"BBBOECZ0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_Y_2^Y!_K?7_P"?2^]G[1?\+\^&/_11O"7_ (/+7_XY1_POSX8_]%&\)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG@VRLC.%QN*"6S7<!N7..F1ZU^X/A6]FU+POH]W<OYEQ<6<,LCX W,R DX'
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MU.?M8SC/XH6?JGI^?Y/R,:D?9RA*/PRNO1K7\OS7F?=E%%%06%%%% !1110
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MM*^$*_>N&/\ D44?^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH ****
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M*_>C\3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@#X0_X*B?\TS_ .XG_P"VE?"%?=__  5$_P":9_\ <3_]M*^$*_>N&/\
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MB5X?_P"P?;_^BUK\M/\ @N-_R,GPA_Z]-3_]#MJ_4OP/_P B5X?_ .P?;_\
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M4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\
M^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\ KU=HH I>=>_\\4_/
M_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"E
MYU[_ ,\4_/\ ^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\ KU=H
MH I>=>_\\4_/_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4
M_/\ ^O5VB@"EYU[_ ,\4_/\ ^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O
M_/%/S_\ KU=HH I>=>_\\4_/_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_
M .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\ ^O1YU[_SQ3\__KU=HH I>=>_
M\\4_/_Z]'G7O_/%/S_\ KU=HH I>=>_\\4_/_P"O1YU[_P \4_/_ .O5VB@"
MEYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\ ^O1YU[_SQ3\_
M_KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\ KU=HH I>=>_\\4_/_P"O1YU[_P \
M4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\
M^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\ KU=HH I>=>_\\4_/
M_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@#X
M*_X*>/.W_"M?.0)_R$L8_P"W3WKX6K[O_P""HG_-,_\ N)_^VE?"%?O7#'_(
MHH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!]T_P#!,-YU_P"%E>2@?_D&YS_V]^]?
M='G7O_/%/S_^O7P[_P $N_\ FIG_ '#/_;NON^OP7B?_ )&];_MW_P!)B?MG
M#O\ R*Z7_;W_ *4REYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VBOECZ0I>=>_\
M\4_/_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5V
MB@"EYU[_ ,\4_/\ ^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\
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M?^>*?G_]>CSKW_GBGY__ %ZNT4 4O.O?^>*?G_\ 7KX7_P""GCSM_P *U\Y
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M\Z]_YXI^?_UZNT4 4O.O?^>*?G_]>CSKW_GBGY__ %ZNT4 4O.O?^>*?G_\
M7H\Z]_YXI^?_ ->KM% %+SKW_GBGY_\ UZ/.O?\ GBGY_P#UZNT4 4O.O?\
MGBGY_P#UZ/.O?^>*?G_]>KM% %+SKW_GBGY__7H\Z]_YXI^?_P!>KM% %+SK
MW_GBGY__ %Z/.O?^>*?G_P#7J[10!2\Z]_YXI^?_ ->CSKW_ )XI^?\ ]>KM
M% %+SKW_ )XI^?\ ]>CSKW_GBGY__7J[10!2\Z]_YXI^?_UZ/.O?^>*?G_\
M7J[10!2\Z]_YXI^?_P!>CSKW_GBGY_\ UZNT4 4O.O?^>*?G_P#7H\Z]_P">
M*?G_ /7J[10!2\Z]_P">*?G_ /7H\Z]_YXI^?_UZNT4 4O.O?^>*?G_]>CSK
MW_GBGY__ %ZNT4 4O.O?^>*?G_\ 7H\Z]_YXI^?_ ->KM% %+SKW_GBGY_\
MUZ/.O?\ GBGY_P#UZNT4 4O.O?\ GBGY_P#UZ/.O?^>*?G_]>KM% %+SKW_G
MBGY__7H\Z]_YXI^?_P!>KM% %+SKW_GBGY__ %Z/.O?^>*?G_P#7J[10!2\Z
M]_YXI^?_ ->CSKW_ )XI^?\ ]>KM% %+SKW_ )XI^?\ ]>CSKW_GBGY__7J[
M10!2\Z]_YXI^?_UZ/.O?^>*?G_\ 7J[10!2\Z]_YXI^?_P!>CSKW_GBGY_\
MUZNT4 4O.O?^>*?G_P#7H\Z]_P">*?G_ /7J[10!2\Z]_P">*?G_ /7H\Z]_
MYXI^?_UZNT4 4O.O?^>*?G_]>CSKW_GBGY__ %ZNT4 4O.O?^>*?G_\ 7H\Z
M]_YXI^?_ ->KM% %+SKW_GBGY_\ UZ/.O?\ GBGY_P#UZNT4 ?!7_!3QYV_X
M5KYR!/\ D)8Q_P!NGO7PM7W?_P %1/\ FF?_ '$__;2OA"OWKAC_ )%%'_M[
M_P!*D?B?$7_(TJ_]N_\ I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /TC_ .";DEPOP-UP11JZ_P#"1S\GU^S6OO7U
M=YU[_P \4_/_ .O7RS_P33_Y(5KO_8R3_P#I+:U]9U_/6??\C.O_ (C]UR3_
M )%U'T*7G7O_ #Q3\_\ Z]'G7O\ SQ3\_P#Z]7:*\$]LI>=>_P#/%/S_ /KT
M>=>_\\4_/_Z]7:* .8\;2W9\&:^&A4+_ &?<9.>WEM[U\D5]A>.O^1)\0_\
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M_/\ ^O5J(NT:EQM?N!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNI;(6D=K;%E=D"!WW.Q5<N2.%  '.?KFBIC[DG*.C:L5+WHJ$MD[_,Y[X@>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>N&/^111_[>_]
M*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /N__@EW_P U,_[AG_MW7W?7PA_P2[_YJ9_W#/\
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M *2@HHHKZD^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7R9_P4L_Y(5H7_ &,D'_I+=5]9U\F?\%+/^2%:%_V,D'_I+=5[
MV0_\C.A_B/$SO_D75O0_-2BBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "OK/_@FG_P EUUW_ +%N?_TJM:^3*^L_^":?
M_)===_[%N?\ ]*K6O S[_D65_0]O)/\ D8T?4_2NBBBOY[/W4**** "BBB@
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M44 %%%% !1110 4444 %%%% !1110 5]W_\ !+O_ )J9_P!PS_V[KX0K[O\
M^"7?_-3/^X9_[=U\MQ/_ ,BBM_V[_P"E1/I.'?\ D:4O^WO_ $EGW?1117X*
M?M@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!3T,IH5:-*4JJLY.]ODOZ^X****\@]L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_
M -);JOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ444
M5_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5]9_\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(L
MK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(
M?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5
M(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444
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M!LO_ ,56'11_:.-_Y_2_\"?^8?5</_S[7W(W/^$Z\2?]#!JO_@;+_P#%4?\
M"=>)/^A@U7_P-E_^*K#HH_M'&_\ /Z7_ ($_\P^JX?\ Y]K[D;G_  G7B3_H
M8-5_\#9?_BJ/^$Z\2?\ 0P:K_P"!LO\ \56'11_:.-_Y_2_\"?\ F'U7#_\
M/M?<C<_X3KQ)_P!#!JO_ (&R_P#Q5'_"=>)/^A@U7_P-E_\ BJPZ*/[1QO\
MS^E_X$_\P^JX?_GVON1N?\)UXD_Z&#5?_ V7_P"*H_X3KQ)_T,&J_P#@;+_\
M56'11_:.-_Y_2_\  G_F'U7#_P#/M?<C<_X3KQ)_T,&J_P#@;+_\51_PG7B3
M_H8-5_\  V7_ .*K#HH_M'&_\_I?^!/_ ##ZKA_^?:^Y&Y_PG7B3_H8-5_\
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M10 4444 %%%% !1110 4444 %?"'_!43_FF?_<3_ /;2ON^OA#_@J)_S3/\
M[B?_ +:5]3PQ_P C>C_V]_Z3(^;XB_Y%=7_MW_TI'PA1117[T?B84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?=_P#P2[_YJ9_W
M#/\ V[KX0K[O_P""7?\ S4S_ +AG_MW7RW$__(HK?]N_^E1/I.'?^1I2_P"W
MO_26?=]%%%?@I^V!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_
M]Q/_ -M*^$*^[_\ @J)_S3/_ +B?_MI7PA7[UPQ_R**/_;W_ *5(_$^(O^1I
M5_[=_P#24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X
M0_X*B?\ -,_^XG_[:5\(5]W_ /!43_FF?_<3_P#;2OA"OWKAC_D44?\ M[_T
MJ1^)\1?\C2K_ -N_^DH****^I/FPHHHH **** "BBB@ HHHH **** "BBB@
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M2\*_]RQ/^)?D?D_&G^\4?1_F%%%%?N)^=!1110 4444 %%%% !1110 4444
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M#B9XJFYU(\K3M^04445PGH!1110 4444 %%%% !1110 4444 %%%% !1110
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M?\BBC_V]_P"E2/Q/B+_D:5?^W?\ TE!1117U)\V%%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?"'_!4
M3_FF?_<3_P#;2ON^OA#_ (*B?\TS_P"XG_[:5]3PQ_R-Z/\ V]_Z3(^;XB_Y
M%=7_ +=_]*1\(4445^]'XF%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7W?_ ,$N_P#FIG_<,_\ ;NOA"ON__@EW_P U,_[AG_MW
M7RW$_P#R**W_ &[_ .E1/I.'?^1I2_[>_P#26?=]%%%?@I^V!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9J":!I%B'PGG%E1V]-S2D@GT51VKJPM!XJLJ2]?E_31QXS$K"4'6DK]%ZO\
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MWUI#K6DW%LS;K>[A:,LO=67&1^!KY8^*MU:7GQ UF6R*M 90-R="X4!R/^!
MU],>"XYH?".BI<?ZY;.(-G_<%?4\"X_$XMXW*<94]M"B[*3UNFY*U^J=KKLK
MK:QY'$F&HTZ6'Q]&')*>Z7HG]ZZGB/@OQ9-\%]:U31]<LII()&#!H ,DC(#K
MD@%6'OQCZT_2_M7QB^*,6J+;20Z59LA);^"-#E5)Z;F;)Q[GTKWG4M'L-8C5
M+^QMKY%.56YA60#Z @URWQ$\0VOP]\%SM80PVDTO[BUBA0( [#[P ]!D_@*W
MK\.U,KP\?KV+YL#AG[2,.5<SM=QBY=4F[+OM9:6RI9O'%5G*A0MB:JY>:^FN
MC:7]6.'UYC\5?BM!I49+Z+I!/G$?=8@C?^9 7Z FM_QE\<M,\*ZD^FV5DVIS
MP'9*4E$<:$?P@X.2._'%0_#_ ,/R^!/AAJ>KNNW5+BUDO"6'*@(2B_U_&LC]
MG/2K>:'5]4E02W@D6)9'&2HQDX/N2/RKFP\LTIUJ.#HS5+%8OFK5)N/-R12M
M&"3T=EIKMJ=%6&#E3J5*D>>CA[0C%.W-)OWFVO/L=MX!^*FF>/&>WCC>QU!%
MW&VE8-N7N5;OCZ UVM?/7CQ4\)?&JQN[%5@\QX)F1!A?F.U^!Z@'/U-?0M?:
M<-YIB<="OAL:TZM";@VE92MM*W2_5'SN;X*CA_95\,K0JQND];=U<****^Q/
MG@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^$/\ @J)_S3/_ +B?
M_MI7PA7W?_P5$_YIG_W$_P#VTKX0K]ZX8_Y%%'_M[_TJ1^)\1?\ (TJ_]N_^
MDH****^I/FPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ^[_^"7?_ #4S_N&?^W=?=]?"'_!+O_FIG_<,_P#;NON^OP7B?_D;UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_9?AJSE=K@CY3<3(8D3/KM:1O\ @/O7ZTUQOPE^$?ACX)^"[3POX3L!8Z;
M2[,QW2SR'&Z61_XG.!ST      '95Y&.Q*Q57FCLE9?U\SW<NPCP='EE\3=V
M%%%%><>H%%%% !1110 4444 %%%% !4<\\=K#)--(L4,:EWDD8*JJ!DDD] !
M4E>"_MV?$G_A5/[)GQ)UM)C#=R:6^G6K*<,)KDB!2/<>9N_X#656;ITW);K\
M^AK2A[2:B^ITO_#6/P0_Z+)\/_\ PJ+'_P".U9TW]I[X.:UJ-KI^G_%KP-?7
M]U*L%O:VWB2SDEFD8A51%64EF)(  Y)-?D)^QU_P3%O?VK?A(WCNY\??\(=;
M27\UG:VO]B_;3.D84-+N^T1X^<LN,'[AYKZ6^&W_  1A_P"%>_$3POXI_P"%
MP_VA_8FJ6NI?9/\ A&/+\[R95DV;_MAVYVXS@XST-=2@HS4:FBT^Y_\  .;F
MYHMPUW^]?\$_3&BBBLC02OG[X@?M^_L^_#'7I=&U_P")NF)J4+%)8=.@N-0$
M3 D%7:VCD56!!!4D$=Z^6O\ @K+^UMKO@_\ LOX*^!;JXMM:UR!9]8N+$L+@
M02,4BM8RO(,A#%L<E=HZ.:P_@C_P19\/WW@.SOOBEXLURU\3W<2S/IOAUX(H
M;'(SY3O)%)YK#N5VC.0,@;C$.:HG-?"G;U?6WI_72]SY86B_B>OHO/\ K];?
MH=\+?C3X%^-FB-JW@7Q3IOB>QC($K6,P9X21D+)&</&2.S &NUK\*OC)\'?B
M+_P2W_:"\/>*O"^M3:IX?NG9[#4=OEQWT((\ZRND!(S@CV.5=<,N%_:KX4_$
M;2OB]\-_#?C316+:9KEC'>PJWWDW+DHW^TK94^ZFMERSI^TAM>S\G_7];-XO
MFA/V<^JNO-?U_6]NKHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "ODS_@I9_R0K0O^QD@_]);J
MOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y&=#_ !'B9W_R+JWH?FI1117]"GX4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7UG_P3
M3_Y+KKO_ &+<_P#Z56M?)E?6?_!-/_DNNN_]BW/_ .E5K7@9]_R+*_H>WDG_
M ",:/J?I71117\]G[J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %<#\6;?Q1J^E#2O#VGM+%<*?M5R)XT^7IY8#,#
MSW/IQW-=]17F9E@5F>%GA)5)04]&XV3MU5VGOL]-CKPN(>$K1KJ*DX]'M^#1
M\L_\*5\9_P#0&_\ )J'_ .+H_P"%*^,_^@-_Y-0__%U]345^8_\ $+LF_P"?
MM7_P*'_R!]A_KCC_ .2'W2_^2./\;>%K_P 1_#]M)M)!#>>5%\K-A6*X)0D>
MN/ITKC?@S\-=>\*:U=:AJBBRB:$Q"W657,A)!R=I(P,?7FO8J*^\Q'#^#Q6:
MTLXJ<WM::LM=.NZWZOK;NF?/4LVQ%'"5,'&W+-W>FOR^X\V^+?PL?QLD>H:<
MR1ZK FPHYPLR=0,]B.<'WYKQJ/POXYT42V5O8:U;Q2'$D=JLGEOVY*?*:^KJ
M*^<SC@; YKBWC:=25&I+XN5Z/Y=WUUL^JN>EE_$>)P5!8>45.*VOT/G[X>?
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M445]0>(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS _]Q/\ VP_3^"?^8C_MW_VX****_GT_3@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *^WJ^(:^WJ_H+PG_YCO\ N'_[>?F/&W_,
M/_V]_P"VA1117] GY@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?"'_!43_FF?\ W$__ &TK[OKX0_X*B?\
M-,_^XG_[:5]3PQ_R-Z/_ &]_Z3(^;XB_Y%=7_MW_ -*1\(4445^]'XF%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W?_P $N_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %[75>]D/_(SH?XCQ,[_ .1=6]#\W****_H4_"@HHHH **** "BBB@ HHHH
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MN_\ I2/A:BBBOWH_$PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q_A0!=HJE_947]]_P Q_A1_947]]_S'^% %VBJ7]E1?WW_,?X4?V5%_??\
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M\*/[*B_OO^8_PH NT52_LJ+^^_YC_"C^RHO[[_F/\* +M%4O[*B_OO\ F/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZS_X)I_\
M)===_P"Q;G_]*K6ODROK/_@FG_R777?^Q;G_ /2JUKP,^_Y%E?T/;R3_ )&-
M'U/TKHHHK^>S]U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X0_X*B?\TS_[
MB?\ [:5\(5]W_P#!43_FF?\ W$__ &TKX0K]ZX8_Y%%'_M[_ -*D?B?$7_(T
MJ_\ ;O\ Z2@HHHKZD^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#[O_ ."7?_-3/^X9_P"W=?=]?"'_  2[_P":F?\ <,_]NZ^[
MZ_!>)_\ D;UO^W?_ $F)^V<._P#(KI?]O?\ I3"BBBOECZ0**** "OB&OMZO
MB&OY^\6/^8'_ +B?^V'Z?P3_ ,Q'_;O_ +<%%%%?SZ?IP4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?;U?$-?;U?T%X3_\ ,=_W
M#_\ ;S\QXV_YA_\ M[_VT****_H$_, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX0_X*B?\TS_[B?\ [:5]
MWU\(?\%1/^:9_P#<3_\ ;2OJ>&/^1O1_[>_])D?-\1?\BNK_ -N_^E(^$***
M*_>C\3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^3/^"EG_ "0K0O\ L9(/_26ZKZSKY,_X*6?\D*T+_L9(/_26
MZKWLA_Y&=#_$>)G?_(NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?6?_  33_P"2ZZ[_ -BW/_Z56M?)E?6?
M_!-/_DNNN_\ 8MS_ /I5:UX&??\ (LK^A[>2?\C&CZGZ5T445_/9^ZA1110
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M%?T"?F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\PQ=2BL/.HW!=+Z!1117L' %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/:_F[Q4_WW"_X7^9^L\%_P"[UO5?D%%%%?AI^B!1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ^LZ^3/\
M@I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\ R+JWH?FI1117]"GX4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7UG_P33_Y+KKO
M_8MS_P#I5:U\F5]9_P#!-/\ Y+KKO_8MS_\ I5:UX&??\BROZ'MY)_R,:/J?
MI71117\]G[J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_ -Q/
M_P!M*^$*^[_^"HG_ #3/_N)_^VE?"%?O7#'_ "**/_;W_I4C\3XB_P"1I5_[
M=_\ 24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?=__  2[_P":F?\ <,_]NZ^[Z^$/^"7?_-3/^X9_[=U]WU^"\3_\
MC>M_V[_Z3$_;.'?^172_[>_]*84445\L?2!1110 5\0U]O5\0U_/WBQ_S _]
MQ/\ VP_3^"?^8C_MW_VX****_GT_3@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *^WJ^(:^WJ_H+PG_YCO\ N'_[>?F/&W_,/_V]
M_P"VA1117] GY@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?"'_!43_FF?\ W$__ &TK[OKX0_X*B?\ -,_^
MXG_[:5]3PQ_R-Z/_ &]_Z3(^;XB_Y%=7_MW_ -*1\(4445^]'XF%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W?_P $N_\ FIG_
M '#/_;NOA"ON_P#X)=_\U,_[AG_MW7RW$_\ R**W_;O_ *5$^DX=_P"1I2_[
M>_\ 26?=]%%%?@I^V!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$SO_ )%U;T/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KZS_ .":?_)===_[%N?_ -*K6ODROK/_ ()I_P#)===_
M[%N?_P!*K6O S[_D65_0]O)/^1C1]3]*Z***_GL_=0HHHH **** "BOFWQ7\
M7?%NF^*-8L[;5O+M[>\FBB3[-"=JJY &2F3P.]9?_"ZO&?\ T&?_ "5A_P#B
M*_)*WB9D]"K*E*E5O%M;1Z:?SGV]/A''5(*:G"S5]W_\B?4U%?+/_"ZO&?\
MT&?_ "5A_P#B*/\ A=7C/_H,_P#DK#_\16/_ !%')O\ GU5_\!A_\F:?ZG8_
M^>'WR_\ D3ZFHKY9_P"%U>,_^@S_ .2L/_Q%'_"ZO&?_ $&?_)6'_P"(H_XB
MCDW_ #ZJ_P#@,/\ Y,/]3L?_ #P^^7_R)]345\L_\+J\9_\ 09_\E8?_ (BC
M_A=7C/\ Z#/_ )*P_P#Q%'_$4<F_Y]5?_ 8?_)A_J=C_ .>'WR_^1/J:BOEG
M_A=7C/\ Z#/_ )*P_P#Q%'_"ZO&?_09_\E8?_B*/^(HY-_SZJ_\ @,/_ ),/
M]3L?_/#[Y?\ R)]345\L_P#"ZO&?_09_\E8?_B*/^%U>,_\ H,_^2L/_ ,11
M_P 11R;_ )]5?_ 8?_)A_J=C_P">'WR_^1/J:BOEG_A=7C/_ *#/_DK#_P#$
M4?\ "ZO&?_09_P#)6'_XBC_B*.3?\^JO_@,/_DP_U.Q_\\/OE_\ (GU-17RS
M_P +J\9_]!G_ ,E8?_B*/^%U>,_^@S_Y*P__ !%'_$4<F_Y]5?\ P&'_ ,F'
M^IV/_GA]\O\ Y$^IJ*^6?^%U>,_^@S_Y*P__ !%'_"ZO&?\ T&?_ "5A_P#B
M*/\ B*.3?\^JO_@,/_DP_P!3L?\ SP^^7_R)]345\L_\+J\9_P#09_\ )6'_
M .(H_P"%U>,_^@S_ .2L/_Q%'_$4<F_Y]5?_  &'_P F'^IV/_GA]\O_ )$^
MIJ*^6?\ A=7C/_H,_P#DK#_\11_PNKQG_P!!G_R5A_\ B*/^(HY-_P ^JO\
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MG_<,_P#;NON^OP7B?_D;UO\ MW_TF)^V<._\BNE_V]_Z4PHHHKY8^D"BBB@
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M*** "BBB@ K[O_X)=_\ -3/^X9_[=U\(5]W_ /!+O_FIG_<,_P#;NOEN)_\
MD45O^W?_ $J)])P[_P C2E_V]_Z2S[OHHHK\%/VP**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3-4F,5GJ-I=R@;C'!.KL!ZX!Z<BK]>$?1A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'PA_P5$_YIG_ -Q/_P!M*^$*^[_^"HG_ #3/
M_N)_^VE?"%?O7#'_ "**/_;W_I4C\3XB_P"1I5_[=_\ 24%%%%?4GS84444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%>5?M#?M-> OV8?!X\0>.-
M5-LLQ9++3;51)>7S@9*0QY&<9&6)"KD9(R*F4E%7948N3LCU6BOR_E_X+C:(
MNO&&/X1W[Z+YF/MC:ZBW.S/WO)\@KNQ_#YF/>ON#]FW]JOX?_M4>%9=8\$ZE
M(UQ:[5O](OD$5[9,P^42("00<'#J64X(!R"!HHN2YD9N2B[,]@HHHJ2@HK#\
M;>-]!^&_A74?$GB?5;;1="TZ(S75]=OMCC7H/J22  ,DD@ $FOSO^('_  6X
M\(:+KTMKX/\ AOJ?BC3(V*_VAJ.IIIIDP2-R1B*8[3U&XJ>>0*GF7-R]2N5V
MYNA^EE%?*?[*?_!1OX:?M2:I'X=MUNO"7C)T+1Z+JK*1=8&6^SS+Q(0,G:0K
M8!(4@$CZLK247'<S4E+8****DH**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_P""EG_)"M"_[&2#
M_P!);JOK.ODS_@I9_P D*T+_ +&2#_TENJ][(?\ D9T/\1XF=_\ (NK>A^:E
M%%%?T*?A04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?6?\ P33_ .2ZZ[_V+<__ *56M?)E?6?_  33_P"2ZZ[_ -BW/_Z56M>!
MGW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 ?'OCK_D=O$/_ &$;C_T:
MU8=;GCK_ )';Q#_V$;C_ -&M6'7\&9C_ +[6_P 4OS9_2>%_W>GZ+\@HHHKS
MSJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[>HH
MHK_0,_F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /A#_@J)_P TS_[B?_MI7PA7W?\ \%1/^:9_]Q/_
M -M*^$*_>N&/^111_P"WO_2I'XGQ%_R-*O\ V[_Z2@HHHKZD^;"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[O\ ^"7?_-3/^X9_
M[=U]WU\(?\$N_P#FIG_<,_\ ;NON^OP7B?\ Y&];_MW_ -)B?MG#O_(KI?\
M;W_I3"BBBOECZ0**** "OB&OMZOB&OY^\6/^8'_N)_[8?I_!/_,1_P!N_P#M
MP4445_/I^G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5]O5\0U]O5_07A/_ ,QW_</_ -O/S'C;_F'_ .WO_;0HHHK^@3\P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OA#_@J)_P TS_[B?_MI7W?7PA_P5$_YIG_W$_\ VTKZGAC_ )&]'_M[
M_P!)D?-\1?\ (KJ_]N_^E(^$****_>C\3"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K[O\ ^"7?_-3/^X9_[=U\(5]W_P#!+O\
MYJ9_W#/_ &[KY;B?_D45O^W?_2HGTG#O_(TI?]O?^DL^[Z***_!3]L"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\6/A9YV@:#=Z@J&TMG;_ (E6H+F6-X6))"/L8A?X60@<, /U&_97^-"?M!?
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M_/E_Y%3_ .*KA_U=SG_H"J_^"Y_Y'3_:F _Z"(?^!1_S,&BM[_A!=<_Y\O\
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MO^$%US_GR_\ (J?_ !5'_""ZY_SY?^14_P#BJ/\ 5W.?^@*K_P""Y_Y!_:F
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\
MG[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\
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M (9+^*__ $*O_E1M/_CM'_#)?Q7_ .A5_P#*C:?_ !VC^U<O_P"@B'_@4?\
M,/[,QW_/B?\ X"_\CR&BO7O^&2_BO_T*O_E1M/\ X[1_PR7\5_\ H5?_ "HV
MG_QVC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\ ]"K_ .5&
MT_\ CM'_  R7\5_^A5_\J-I_\=H_M7+_ /H(A_X%'_,/[,QW_/B?_@+_ ,CR
M&BO7O^&2_BO_ -"K_P"5&T_^.T?\,E_%?_H5?_*C:?\ QVC^U<O_ .@B'_@4
M?\P_LS'?\^)_^ O_ "/(:*]>_P"&2_BO_P!"K_Y4;3_X[1_PR7\5_P#H5?\
MRHVG_P =H_M7+_\ H(A_X%'_ ##^S,=_SXG_ . O_(\AHKU[_ADOXK_]"K_Y
M4;3_ ..T?\,E_%?_ *%7_P J-I_\=H_M7+_^@B'_ (%'_,/[,QW_ #XG_P"
MO_(\AHKU[_ADOXK_ /0J_P#E1M/_ ([1_P ,E_%?_H5?_*C:?_':/[5R_P#Z
M"(?^!1_S#^S,=_SXG_X"_P#(\AHKU[_ADOXK_P#0J_\ E1M/_CM'_#)?Q7_Z
M%7_RHVG_ ,=H_M7+_P#H(A_X%'_,/[,QW_/B?_@+_P CR&BO7O\ ADOXK_\
M0J_^5&T_^.T?\,E_%?\ Z%7_ ,J-I_\ ':/[5R__ *"(?^!1_P P_LS'?\^)
M_P#@+_R/(:*]>_X9+^*__0J_^5&T_P#CM'_#)?Q7_P"A5_\ *C:?_':/[5R_
M_H(A_P"!1_S#^S,=_P ^)_\ @+_R/I'_ ()=_P#-3/\ N&?^W=?=]?&7[!?P
M]\0?!?\ X3G_ (3*P_L?^TOL/V3]]'/YGE_:-_\ JF;&/,3KC.>.AKZS_P"$
MPTC_ )^__(3_ .%?BO$56G7S2K4I24HOEU3NOA75'Z_D-*I1RZE"K%Q:OHU9
M_$S:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_ ,*^;/?-JBL7_A,-(_Y^
M_P#R$_\ A1_PF&D?\_?_ )"?_"@#:KXAK[$_X3#2/^?O_P A/_A7RS_P@NN?
M\^7_ )%3_P"*K\.\3<NQN/\ J?U2C*IR^TORQ<K7Y+7LG:]F?HO"&*P^&]O[
M>HHWY;7:5_B[F#16]_P@NN?\^7_D5/\ XJC_ (077/\ GR_\BI_\57X=_J[G
M/_0%5_\ !<_\C]%_M3 ?]!$/_ H_YF#16]_P@NN?\^7_ )%3_P"*H_X077/^
M?+_R*G_Q5'^KN<_] 57_ ,%S_P @_M3 ?]!$/_ H_P"9@T5O?\(+KG_/E_Y%
M3_XJC_A!=<_Y\O\ R*G_ ,51_J[G/_0%5_\ !<_\@_M3 ?\ 01#_ ,"C_F8-
M%;W_  @NN?\ /E_Y%3_XJC_A!=<_Y\O_ "*G_P 51_J[G/\ T!5?_!<_\@_M
M3 ?]!$/_  */^9@T5O?\(+KG_/E_Y%3_ .*H_P"$%US_ )\O_(J?_%4?ZNYS
M_P! 57_P7/\ R#^U,!_T$0_\"C_F8-%;W_""ZY_SY?\ D5/_ (JC_A!=<_Y\
MO_(J?_%4?ZNYS_T!5?\ P7/_ "#^U,!_T$0_\"C_ )F#16]_P@NN?\^7_D5/
M_BJ/^$%US_GR_P#(J?\ Q5'^KN<_] 57_P %S_R#^U,!_P!!$/\ P*/^9@T5
MO?\ ""ZY_P ^7_D5/_BJ/^$%US_GR_\ (J?_ !5'^KN<_P#0%5_\%S_R#^U,
M!_T$0_\  H_YF#16]_P@NN?\^7_D5/\ XJC_ (077/\ GR_\BI_\51_J[G/_
M $!5?_!<_P#(/[4P'_01#_P*/^9@T5O?\(+KG_/E_P"14_\ BJ/^$%US_GR_
M\BI_\51_J[G/_0%5_P#!<_\ (/[4P'_01#_P*/\ F8-%;W_""ZY_SY?^14_^
M*H_X077/^?+_ ,BI_P#%4?ZNYS_T!5?_  7/_(/[4P'_ $$0_P# H_YF#7V]
M7Q__ ,(+KG_/E_Y%3_XJOJ;_ (3#2/\ G[_\A/\ X5^X^&678W ?7/K=&5/F
M]G;FBXWMSWM=*]KH_.N+\5A\3[#V%12MS7LT[?#V-JBL7_A,-(_Y^_\ R$_^
M%'_"8:1_S]_^0G_PK]Q/SHVJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\
M* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__
M "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?^$PTC_G[_P#(3_X4?\)AI'_/W_Y"
M?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0G_PH VJ*Q?\ A,-(_P"?
MO_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G[_\ (3_X4?\ "8:1_P _
M?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?_D)_\* -JBL7_A,-(_Y^
M_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_ )^__(3_ .%'_"8:1_S]
M_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_ ,* -JBL7_A,
M-(_Y^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S
M]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A
M,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\ PH VJ*Q?^$PTC_G[_P#(3_X4?\)A
MI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0G_PH VJ*Q?\
MA,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G[_\ (3_X4?\
M"8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?_D)_\* -JBL7
M_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_ )^__(3_ .%'
M_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_ ,*
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MC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\ ]"K_ .5&T_\
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\
MG[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\
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M )4;3_X[1_PR7\5_^A5_\J-I_P#':/[5R_\ Z"(?^!1_S#^S,=_SXG_X"_\
M(\AHKU[_ (9+^*__ $*O_E1M/_CM'_#)?Q7_ .A5_P#*C:?_ !VC^U<O_P"@
MB'_@4?\ ,/[,QW_/B?\ X"_\CR&BO7O^&2_BO_T*O_E1M/\ X[1_PR7\5_\
MH5?_ "HVG_QVC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\
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MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2@$H1CEHVZ/&?=6#*?I72U^,U_:>UG[;XKN_K?7\3]QP_LO8P]A\%E;TMI^
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MY5A\/UJ-S?Y1_ X'XE?"U_B!>6EP=6^PQVL118OL_F9).2<[Q[=NU?-VB?\
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MPM;RL?*\2ND\SJ>R\K^MM?Z[A1117W1\N%%%% !1110 4444 %%%% !1110
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MTN_\?7'B[^VY]5U@A[/^SO(V&;S),[_-;.-N,8[]J_2&OEW_ (*)?\D)L?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M**^K/ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME\,?BQKG_"-^'O$BZGJ5Q#(PM6L[F N@7YL-)&HSC)P#GKZ5\W_M9_L>^"_
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MZ?+:K;'[+#!Y8<2[O]4BYSM7KGI7L\38+&5D\5*4?90M97=]6E?:U_GL?/\
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MD;]LVXE^*G[07P\^&=J[&%6C:Y"_PF=QN;_@,2;OQ-?<+,%4LQP ,DFOAO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#(/HRJ#74T454ZDZCO-W]2(4X4U:"27D%%%%0:!1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=."3>]DE<UE5J5$E.3:7F%%%%;F04444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBNH(YX)$FAD4.DD;!E92,@@CJ"*<Z<Z?QQ:]285J=3X))^C)****S-0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\#\1?MW? WPIK
MVHZ+JOCC[+J>GW$EK<P?V3?/Y<J,59=RP$'!!Y!(JX0E4=H*[\C.=2%-<TVD
MO,]\HKYWM_\ @H-\ +J9(D^("*S' ,FDWR+^+-  /Q->U>#?'WAOXB:2-3\+
MZ]I_B"PSM-QIURDRJV,[6VD[6]C@U<J-2FKSBU\B(5Z51VA-/T:-ZBBO -;_
M &\_@5X=UJ_TG4?'/V?4+&XDM;B'^R+]MDJ,5==P@(."",@D5$*<ZCM!7?D7
M.I"DN:I))>>A[_1572]4M-;TVTU&PN([RQNXEG@N(6W)+&P#*RGN""#61X_\
M?Z#\+_".H>)_$]__ &9H=@%:YNO)DEV!G5%^6-68Y9E' /6I::=GN6FI*ZV.
MAHKR;X4_M5?"WXW>(I]!\%>*/[:U6&V:\DM_[/NH,1*RJ6W2Q*O5U&,YYZ5W
M'C_X@:!\+O"5_P")_$^H#2]#L K7%T8GEV!F"+\J*S'+,!P#UJYTYTVHS33?
M<B%2%1<T))KR.AHKPCPI^W)\$/&WB33- T;QNMUJVI7"6MK VEWL0DE8X5=[
MPA1DG')%>[T3ISI_'%KU%3K4ZM_9R3MV=PHKQCXC?MC?!_X3^++OPSXJ\8+I
MFN6@1I[5=.NY]FY0RY:*)ER00<9SS7<?"_XM>%/C1X8_X2'P;JPUG1_/>V-P
M()8<2* 64K(JL,!AV[T>SGR>TY7R]^@>VI\_L^9<W:^OW'7T5XCX\_;2^#7P
MS\6ZCX9\2^,?[-US3W5+FU_LN]E\MBH<#='"RGY6!X)ZU@_\/#?V?O\ H?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !17 ?'#XV>'OV?_ -QXN\2K=S:?%-'
M;K;V"(\\LCG 5%9E4G&2<L.%-<7^SK^V)X'_ &F=3UC3O#%KK&G7VEPQW$D&
ML0PQ-+&S%=T?EROD*0 <XQO7KFM84IU(N<5=+<QG6ITYQISE9O8]SHHI"<#)
MX%9&PM%?,'Q._P""C'P=^&>N3Z3]NU+Q1>6[F.?_ (1^V2:*-AU'F22(C?\
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MU/>LS0OT5YS_ ,-)?"3_ **EX+_\*&T_^.5W]C?6^IV=O>6=Q%=VEQ&LL-Q
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MV;]%\1:?X2M]);^VVC:6ZU"W>66%HU<*8\2*O\9^\K#@5&!4Y8*HJ7Q7T_\
M)?TN5F4J<<PI2J_ EK_Y-^MCGKY-=_9I^/%S%I^H!M;\)ZNT<=W!E5F\M\<C
M^ZZ\%3V8BOWAT^Z^W6-M<A2@FC63:W49 ./UK\(_A!XB\(ZI\;-.U_XM7FI7
M>BRWQOM0EM8!,]Q*7W?O1D$1ECEMH9L9 '.1^Z?AWQ!IGBK0;#6-&O(=0TJ^
MA6>VNK=MR21L,@@TLS4E1I*IK);OI?3_ ";-,H<'6K.GI%[+K:[_ "VN?GI_
MP4,_97\=>,/%7BCXM?VEH*>%M(TV!([1[B?[9Y<8&[Y/)V9+NQ'S]*\A_P""
M7_\ R=!'_P!@6[_G'7Z'_MI?\FL?$C_L%M_Z&M?GA_P2_P#^3H(_^P+=_P X
MZ,OJREAJM-[1B[?-2%F-&,,91J+>4E?Y.)^O5%%%?.GU(4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY^UK\'=:^//P/
MUCP;X?NK"SU2\GMI(YM2D=(0(YE=LE$=LX4X^7K7L=%-/EDI+HT_N=Q22E%Q
M>S37WJQ^*OQ__8=\=_LX^"K?Q1XEU;P[?6$UZEBL>E7,\DHD9'8$B2%!MPA[
MYZ<5@?LX_LI>+?VGGU]?"VHZ+8'11 ;C^V)YH]WF^9MV>7$^<>6V<XZCK7Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]#[1_P""97[4'VB'_A47B2[_ 'L8>;P_<3-]Y>6DM<^W+K[;QV45]'?M^?\
M)I'C_P#ZY6O_ *5PU^;/[5_P'U?]E'XV17&ARW%KHMQ/_:?A_4HV.Z+:X;R]
MW]^)L#W&T]Z^O?B5^T18_M'_ /!/'QGK@,<'B"SBM+36+)#_ *JX%U#\ZC^X
MX^9?Q7)*FN3&4XUU3QE'9RC?UYE_PS\_4[LOJSP\Y8"ONMO-?UJO+T/"/^"4
MW_)Q6M_]BU<?^E-M7UK_ ,%--:_LK]EO4+;<5.HZI9VHP<9PYE(_\A5\E?\
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MCOX70:]\0M2\0^&_$%_YC0:5!"ENUFH8JOGI+&69CC=M&S (KYV^'/B?Q/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT?#O_A$/^$0L?^$$_L3_ (1;,GV3_A'?)^Q??;?Y?D_)]_=G'\6<\YK\?_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML/1CW K\5KC4/%/PHNO&'@ZY$VF27J_V7K&GS#AO*F609'JKQ@AAV)QPU?T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY%_X*8?%S_A ?@*?
M#EI-LU/Q5/\ 8]JD;A;)AYCCT/R)_P #KZZK\Y_VZOV=/CC^T!\9OMOA_P &
MO>^%=)M$L].E;5;*(2Y^>638\P9<L=O(!P@KHPT(U*T%-VCN[^7^;LO2YRXN
M<Z>'G*FFY6LK>>GX;^I\*_"_XL>*O@QXG_X2+P=J:Z1K/D/;BZ:UAN"(VQN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M32OB)X/T?Q-HEP+G2M4MDNK>3OM89P1V8'(([$$5\$_M\?\ )XOP/_ZZ6/\
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MMG "R31HA)/3!Y[5[>#D9'(KFG3G3^.+7J=4*M.I?DDG;LQ:*Q/%WC;P_P"
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M@9(&3QDBNJKG<7'1HZ8RC+6+N4-=U_3/"^DW&J:SJ-II&F6R[I[V^G6&&(9
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M,***^=/$/[=WPR\#_%K7? 'BR>^\.W^ES)#_ &C/;F6SEW1HXPT>YE/S\[E
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M+2?#EM</Y4,VK7T5JDCXSM4R, 3CG K=5@R@@Y!Y!%?G#_P5*^*'A;Q=X?\
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MJ1D$$=01WKGM9^)W@[P[XBM- U;Q9H>EZ[>%!;:7>:C##=3;VVILB9@S;F!
MP.3P*I1;?*EJ)R27,WH=+117.V?Q&\)ZAXJN/#%KXGT:Y\26X)FT>'4(GO(P
M "2T(;>, @\CN*23>PVU'<\;^,G[<?P]^"'Q0M/ VO0:Q/J,BPO<75C;(\%J
M)#\N\EPQXPQVJW![GBOH56#*".0>:\5^*?PY^!/B/XI^']1\>Q^&3X[7RAIL
M.IZDL%Q<_.1$/(,BB<;\A0RMSP*]1\4^-O#O@6QCO/$FO:7X?LY'\M+C5+R.
MVC9L$[0SL 3@$X]C6TE#V4.5/FUOV?:QSQ=3VL^9KETLNJTUO^A'HOC[PQXD
MUS4=&TGQ'I.J:QII*WNGV5]%-<6I#;2)8U8LF&X^8#GBMZOS3_8G^+'A+0_V
MHOC5KNO^*M$T73=4FN'M+S4=0BMX;@&\9E\MW8!LK@\$\<U^B/A/QQX<\>Z?
M+?\ AG7]+\16,4IADN=)O8[J))  2A:-B V&4XZX(]:NMAY4E%]TF_F9X?$Q
MK.:NM)-+S2ZGS9^SO^U=XM^+?[2WQ"^'FL:=HMMHOAX7AM9[&"9+E_*NDA7S
M&:5E.58DX4<^G2OJZOSG_8ID6']NWXV.[*B*FILS,<  7\>237U'KG[<GP,\
M.ZX^D7GQ#L&O$?8S6MO<7,(/_7:*-H__ ![BMJU&ZI*E&[<$W;\S'#U[.LZL
MK)3DE?MIH>ZT5G^'_$.E^*]'M-6T74+75=+ND\R"\LY5EBE7U5E)!YS^5:%<
M#33LSTDU)76P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6_\ ),O"/_8'L_\ T2E5&M5C@TXR:M*V_2VQFZ%*6/:E!-.-]EOS;^I\U?\
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M?-:WQ\_9Q\&?M&^&X=*\5VDHFM6+V>I6;B.YM6/78Q!!!P,JP(.!QD CXO\
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M16 D201@!P5)^]D@@&L+_@DS_P D7\7?]A\_^D\5?07[87_)L'Q+_P"P+/\
MR%=N959PQ+4':UG\[)_/_+38X\LH4YX2+FKWNM>UW]WRZZ[G'_\ !/;QM?\
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MF8-ZB.(;@IX+L,]!7TGH?[&WP7T/PFGA]/AWH=[;"+RWO+ZT6:\?(Y8W##S
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M*V=]I D9HHRTHC; )^ZK21R+Z?,HX.*]]_X*'_\ )I?C+_?L_P#TJBKR]O\
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MDLLCGDLV!G "J..BCODGO*^>/V+_ -J8_M-^ [Z;4K*+3O%&BR)!J,-L"(9
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MO0O$4:<L=2YHIWB[Z;ZFY^U]IEMHO[(OCW3[*/R;.TT46\,>XML1"BJ,DDG
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M%8Q +TXMT'%?+O\ P5;TV.X^ ?A^\8#S+;Q!$JG'.'@FS_(5])_L\:[%XE^
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MBXB4E.A4C2Y/>2OI>STM9?KL=U_P5O\ ^2>^ /\ L*7'_HH5]M^!O^1)\/\
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MKXR_W;O_ -)8Z_16EB*DHT*$8NUX1_7^D&%IQGB,3.2NU4DE^#_X?Y'YT_\
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M\95M?'7B/7;<-IVG7T2RV&G6G(15@.4+-RQR#C/][),__!47_DV9/^PW:_\
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M>+;.\U:YBM([7^S&NF2T<HQ*R,JX8G! P&"G'(-4?C%^QK\*O&WPUUG2M/\
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M^%'_ '"?_2F6OT8J:DY1PE)1=K\WYCI0C4QU=R5[<MOFO^ ?FG\ M%'[.O\
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M7[P^VZ*VEB(U(+GA>25K]--KKK^7E8QAAITYR<*EHMWMUUWL^GYKO?4^.?\
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M  #YW_;O^#&M_&[X WFE>'(C=ZSIUY%J=O9@@-<[%=6C7/\ %MD8@=R .]>
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MD1#<JR*"1D$9'H:^QJ*BG5=.%2"7QV_!W-*E%5)TYM_!?\4E^A\>?MM?LO\
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MBS1[KPS\+OA[XIN/'MTK6ZQ7]FI:S<@@NL43.\C+V!"C/)Z8/HO[!O[+.I?
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M>91T6MFEV].P2PTE4E4HSY7+5Z73??IJ^O<\F_9U^*WC'XN>&-1UCQ=X O/
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M+_Y*K!7YX_\ !73/V#X7XZ^=J&/RMZ_0ZOSR_P""N?\ QX_"[_KOJ'\K>ML
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M$K>FMSJJ4?:<EW\+OZZ&/XQ@DNO".N0PQM--)8SHD<:EF9C&P  '4DU\>_\
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MV_@31_%-Q>W&K3:9.EHT1VB0K,5V;2L4A0YY,_?(K]<HXTAC2.-0B( JJHP
M!T%/HKNQ&*EB(Q4EM^+TU_ \_#8.&&E)Q>^WDM7;\3\[/VGO#OBW]G']L*Q^
M/%AX<N?$_A2=5-U]F!Q 3;FWD1V .SY<,K$8).*]*M?V]-9^-=G_ &1\$OAE
MXAU?Q#<?NCJ6N0QPZ=IY(_UDCI(X('HQ3/N>#]DT4E7BZ<:=2%^71:VT[/\
MI \-.-652E/EYM6K)Z[77_!N?GU^PW\&?B#\,OVK/B'<>,](U%A-I]PK^(&L
M)8K&^N'N89&:&5D56W'<0!V!X&*[7_@I]X!\3^/_ (:^#[7PQX<U;Q)<P:N\
MDL.D6,MT\:>2PW,L:D@9XR:^T**)XJ4YTZC6L;?AJ*G@XTZ=2DF[3;?WJQSG
MPWM9K'X=^%[:YADM[B'2K6.6&52KHPA4%6!Y!!&"#7"?M<:'J/B3]FWQ_IFD
M:?=:KJ5UIQ2"SLH6FFE;>ORJB@EC[ 5Z]17-4E[23D^IV4X>SA&"Z*Q\V?\
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M=JA>=[>0*69%'+%613@<X)/:L/X=_P#!3"UUKPW8:$WPW\5:Y\1XX! ^FZ7
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MF^JBXV]7>X4445@=1\#_ +0'P+\>_L^?M #XZ_"71Y/$-C>.TFM:#;1EW!?
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M6R3XFG)V%U ; (/&>HK[OHHJJU9UI*36R2^X*-%44TGNV_O"BBBN<Z HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KG/#/PX\)>"[^]OO#WA?1="O;[FZN=,T^&WDN.2?WC(H+<DGG/)-='133
M:V$TGN%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<[XN^'/A/X@+:KXH\+
MZ-XD%J6-N-7T^*Z\DMC<4\Q3MSM&<=<"NBHIIM.ZW$TFK,15"J !@#@ 4M%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '-^%_AKX1\#WEY=^'/"NB:!=WG_'S/I>G0VTD_)/SLB@MR2>
M?6NDHHIMM[B22V"BBBD,**** "BBB@ HHHH **** "BBB@#D=0^#_@/5O$)U
MZ^\$^';W72XD.IW&DV\ER6'1O-*;LC YS76].!2T4^9M)/H)12;:6X4444AA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% %/6-&T_Q%I=SINJV-MJ>G72&.>SO(5EAE0]5=
M&!##V(JIX7\(Z%X)TL:9X=T73M TT.T@L]+M([:$,>K;$ &3W.*UZ*=W:PK)
MN[04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+\QS6L\+4IIMVTW5U=>J,:>,I5))1OKL[.SZZ.Q[917S!^TM^V<WPD\;:?\
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M -F\SR_-\J-GV;L';G;C.#C/0TJU*5%)RV?5:ICHUHXA\L-UHT]&ODS?HKY
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MMK--MW>6C/MSC.!G%?/7[)/[7O\ PU+=>+8?^$3_ .$8_L$V_P W]I?:_/\
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M -[2O_2V2OT6K\UOVX/$NG>#?V[OA?KVKS_9=+TV#3KNZFV%MD27<K,< $G
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MEY86DVBZ]IDBPZIHMTP:2V<YP0V!N0D, < Y4@@5\Q_\%</^17^''_7]=_\
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MG[/YGF2K']_8^,;L_=/2LZE&=&:A):NUO.^QK1KTZT'4@]%>_E;<])HKS?\
M9W^,7_"_/A#HGCG^R/["_M(SC[!]I^T>7Y<SQ?ZS8F<[,_=&,X]ZR?VHOV@/
M^&;/AFOB[^P?^$BS?16?V/[9]E^^&.[?Y;]-O3'?K4SISIU/927O7M\[V_,J
M-:$Z?MHOW;-_):GKU>!?%G]JI?A?^T%X#^%X\,G4W\4>03JGV_R1:B29HA^Z
M\IM^-A/WEKL?"OQAN_%W[/\ 9_$FQ\-7%S>W6CMJD/A^TF,TLKA"P@1Q'EF)
M& 0G?I7YG?&7X_\ BWQA^UWX'\9WWPLUK0M>T<V8M?"-T9?ME[LF=UVY@5AO
M+8&(VZ<9KLPN%<\3[.HM(MWU\G^O8X,;C%2PCJTGK)+E=O-?H^I^OM%?.OP#
M_::\>?%SQQ)H?B3X'^(OAWIZV<ER-7U5IS$SJR@1?/:Q#)#$_>_A/%3?M'?M
M83_!/Q-I?A'0? .N>-_%VK6YN+*ULHRL#J&*M\ZAV8KC)4)P",D9KFEAZD9J
MG;5[:K^NAV1Q-*5-U;^ZM]&OZW/H2BOA?Q5^TM^UGX#T>?Q1KWP8\/V_A:U'
MG7"PR&6YCA[EO+NF9<#JQBP.I%?1O[,_[1FB?M+?#X>(M*MI--O+>7[-J&F3
M2!VMIL X# #<A!R&P,\\ @BKEAIQ@YZ-+>S3MZD0Q=.<U3U3>UTU?TN2?M-?
M'=?V<_A7<>,CHG_"0&*ZAM5L?M7V;<9&QG?L?& "?N\UV7PS\9?\+%^'7ACQ
M5]C_ +/_ +:TVWU'[)YOF^3YL:OLWX7=C=C.!G'05^??_!1CX]>*?$GAW4?
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MD+$<[1T%_P (_MY>)? ?CJR\'?'[P'_P@5]>$"'6;)F:RY( )!9P4SP9$D<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_45SRJTYSH0@G[KBM>W,FON.F-&I3IXB=1J\HR>G^!K\3K/V$?\ DTOX=_\
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MVFOTST^^@U2QMKVUE6:UN(UFBD4Y#HP!4CV((KX=_:R_8/\ AAX4^ OBC7_
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MVNDN7_@'Z%S1K+#(CJ'1E(96&001R"*_./\ X)<QI#\7_BY'&JHBQQJJJ,
M7$N !7Z,7UY!I]E<75U-';6T,;22S2L%1% R68G@ #N:_.;_ ();SQW7Q<^+
M<T+K)%)%&Z.IR&4W$I!!],5RX+_E]_A_S.S&[T?\:_(_2"N.^,G_ "2+QO\
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MM-9(ED9"$8F8QG ;:<@'IQFJ_P#P2;U*>X^#7BZR=RT%MKN^-2?N[X(]V/\
MOD5[]\1_ ?P_^$'P/\;2Z3H.@^$[-=%NHC/;VL5MN8PLJ!G !9B2 ,DDDU\[
M?\$E/^25^./^PU'_ .B%KOI.D\/B%33T4=6_[WIH>=5C66*PSJM:N>B6WN][
MZG%?M]:#8^*?VU?@_HVIP?:=-U&'3K2YA+%?,BDU"177(Y&02.*_1K3M.M='
MT^VL;&VBL[*VC6&"W@0)'$BC"JJC@    "OST_;:_P"3]/@;_OZ3_P"G)Z_1
M2L*C?U*BO.?YG332^OUWY0_])/SF^(%HF@_\%6O#$UD/L[WWV>2<IQN+6;QM
MGZJHS7U'^VO\'S\9OV>_$>F6T FUC3D_M33^,MYL0)*K[LF]?^!"OF/XL?\
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M\!?]<[K_ -*YJ^A:^>/^"?LB2?LD> ]C*VU+M3M.<$7<W%?0]+'?[W5_Q/\
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MD<EZZ$@2M)<"%-^#RB<MMZ$D'L*^F_A/^R+\*O@_IEK!I'A'3[[4(0"VKZK
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M7Q#T33-4\)^+)&D@;6K2.YM@;A!LDQ("H(G4H6[ GM7WC_PS;\)/^B6^"_\
MPGK3_P"-UI4]C]7H<Z?P]+;_ &NF]]S*G[?ZSB/9M7YNJ=[?9V>UMOF?$W[/
M/Q&\,ZS_ ,%'-?OOAYJ"WWA/Q58SM(T<$MNK2"!9I#Y<B*P/FQL>G\1]:W?^
M"N'_ "*_PX_Z_KO_ - CK[/\-_!?X>^#=6BU7P_X$\,Z'JD098[W3='M[>9
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MT%JHIZ_-:_(X,'25>AB*-1W3DU=?)Z?,^=O@S^WY\)?BZMM:RZS_ ,(CKLH
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M&+]]@>BK*[?1:D_8G\'_  ?^,G[/GAR]G^'_ (.U'7M-B&FZJUQH=K)/Y\?
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MGMO_  4V^#OB?QUX/\*^+/#EE)JR>&)IWO;&&,R/Y4GEGS0@^\JF/Y@.S9Z
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M2VWIDYZ@8^I?A7^R7\*OA!IMK!HOA#3KF^A )U;4X$NKQWQ@OYC@[<^B;5]
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MR:+J!5T8$,I'V?D$$BO&_P#@E;KZ/_PMGP]I]R;GP]9:E;W=@QW#*R><F[#
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MLPN-/BCN%5LF*X10DJ'W#@]>V#WJH_[@^7^?7[M/P"5O[07-_)I_X%J>._\
M!2+X<V/C/]FO5=8DA0ZGX<FBOK6<CYE5I%CE7/H5;./55]*Z7]@OQ_>?$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3NTNC;:^ZX5S7Q*M/$VH> ]<M?!LUC;>)[BU:*PN-2D>."&1ACS&*(S?*"6
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MBM$^B22W3_-+7<B.%I1:;NVNK;;_ *UVV.*^,OPGTCXW?#?6O!NMF2.RU&,
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MDG<7\>K3)''%$%^4@-/%DECV8_=/'-/GE44:;>BV^9/)"FY5$M7OYV1\I_\
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M(TAB\SW5I2/K7U%\"?@3X9_9[\"0>&?#,+F/=YUU>W&#/=S$ &1R!Z   <
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M?UL>0?LW_LQ^%/V:/"LNFZ")+[4[PJ^H:Q=*!-=,,X&!PB#)P@Z9Y).35O\
M:6^!O_#1'PIO?!?]M_\ "/\ VFXAG^W?9/M.WRW#8V;TSGIG=Q7JE%9SJSJ5
M/:R=Y73^[8TA1ITZ?LH*T;-?)[G$?!/X:_\ "G?A7X;\&?VC_:_]CVWV?[=Y
M'D>=\Q;=LW-MZ]-QZ5Q7[5W[-O\ PT]X#T[PU_PD7_"-?8]06_\ M7V'[7OQ
M&Z;-OF)C[^<Y[=*]LHH=2<JGM6_>O?YWN.-*$:7L4O=M;Y6M^1S_ ,/O"O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6%J.LZ'VDK_+3\[_ .8GBZ2HJO\ 9;2_3\+:_A<^ZZ*^ OBSXP_;#^!F@O\
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M^%N:*?@S_P +($JC1/[&_MG=N_Y9^5YFWZ_PX]>*_,:7P[J-K8? SQIK2_\
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M[#"AF8@8 ZDUP/[?G_)I'C__ *Y6O_I7#7DG[+O[;'P7^'7P \$^&_$/C/\
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M=.QY.&E'ZK3JSYDY2@F[_$VKWW^%]=F[;'U;17@G[4W[3$_P/M=$T#PSH_\
MPD_Q$\22^1H^D8)3J%\V3!!*Y( 4$9YY !->.W=I^VUX8T^7Q;<:WX1UJ*%#
M<R>$8H(S)M R8P5A4L0.RSDGL37F4Z+G'GE)1CW?7O\ =UZ'L5,0J<_9QBY2
M[);7VOZ]%N?;M%>8?L[_ !TTWX__  IT_P 86D']G2L7M[^RD;/V6XC_ -8F
M>Z\A@?[K#.#D5\Q:E^TY\:/VFOB5K7AGX 1:;H?AK19/+N/%.IQ)(LAR0&RZ
M.H5B#M58V8@;B0,@-8>HZDJ3T<=^R^?Y=^@I8JE&E&JG=2V[M]K?GVZG>?\
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M'&"T>#U5:]%_8C_:5U;]H7P/K,7BBTAL_%WAV[%GJ @0QI*&!V2;"?E;*.K
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MU7V%*=6WPIOY]/Q/6_V2/A_JOP^^!^BIX@OKN_\ $6L%]:U.2[E9RD]P?,*
M$X7:" 0.-P8]Z]EK%\8>,-'^'OA74?$.O7:Z=HNFPF:YN3&SB-!QG:H+'J.
M#7R_>_MR:_\ $F62R^!_PIU[QPY9HEUS4XS9Z:C#ON)Y'L[QFM9*>)J2G"/^
M2[>2,HRAA:<83EK][;ZNV[/KJLOQ1XGTKP7X>U#7=;OHM-TFPA:>YNICA8T
MY)_P')/ KY-_X9U_:!^.+";XJ?%5?!^BR$,WAOP6A3*$?-&\N1_X\9A5#_@H
MAJ%WXHU#X1_"&SNI+>#Q9K48O60\F))(XUSZ@&4M]4%-8?FJ0I1FG*3MZ>=_
M2^W;<F6*Y*<ZTH-1BKZZ7[+RN]-?N'7'_!1K4O$5U=7/P^^"/BWQOX;MG*2:
MQ")(UXZG;'!* ,<_,P//(%?0?[/O[0WAO]HSP?-KGAZ*\LY+2;[-?6%_#LEM
MIL9VDC*L,<@@_4 \5R#_ +5GP ^#,EGX%B\9:7I2Z6BV<5E86\T\-OMXVM)%
M&R*P.<[FSG.>:]E\(:EX?US1(]5\,3Z?>:3J#M=+=Z6R-#<.Q^9]R<,Q(Y/7
M(YJZGL^2\:;2Z2UU]>FW8SHNHZEIU4WUBK:>G7?N;5%%?)7[/?QT\<>./VP/
MBYX)UO6_MOAC04G.G6/V2"/R-MQ&@^=$#M\K$?,QZUS4Z;JR<8]$W\E;_,ZZ
MU:-&,92ZR4?F[_Y'UK17A/[;/Q,\2?"/]GC7?$WA+4O[)URVN+5(KKR(IMJO
M.B,-LBLIRI(Y%=;\#?%VK>,/V?\ P?XDU>[^UZU?Z'#>7-UY:)YDK1!BVU0%
M'/8 #VI<C]A*OT3MY[7*]HO;QP_5J_E:]OS/2:*_.S]G_P#:L_:%^.'A:]\,
M>%--L];\4Q7TK7?C+68(K>QTZU*J(HPD2*K2;@Y^ZQQ_"PR5UKKX^?M"?LN_
M%CPGIOQGU31_%WA'Q%<+;_;].MXT6#+*K,CI#$P9-ZL5=2&7.#GD=OU&IS^R
M<ES/97W]/^#8\_\ M"ER.IROE6[MMK;7_@7/K?\ :$MOB#=_"378OA=-#!XU
M94^QM,8QD;U\P*9/D#E-P!;C/<=:3]GJW^(5K\(]"B^*,T,_C55D^V-"8R0-
M[>6',?R%PFT$KQGUZG-_:L\<ZW\-?V??&?B7PY>_V=K>GVJ26UUY22^6QE12
M=KJRG@GJ#7-_#'Q+\1_BQ^R#H6M:+KUG!\1]6TU98=7U"!$@$WFD%G1(F4#8
M",!#].]<T+^PFTE;F2\]NGEW.J3C]8@FW>S]-&M_/70U_AW^T8OQ ^/WQ ^&
M:Z!]B'A.*.3^U/MGF?:BVS(\KRQLP6_O-G%>S5^4/P3\*?M#:Q^TG\4[+PGX
M[T#3/'UJ2NOZI=P(;>[Q(%_=*;1P/F /$:<5]H_$3XQ>,OV7?V6XO$7Q N;'
MQAX_A?[(9K-?+M;BXDE<QD[8X\*L>,X1<[,=\UT5\/&G"FXR3;4=KZM]5Y-^
MGH<N&Q4JDZJG%I)RU:5DET?FEZ^I]&T5\-Z)%^VSK>AV?C2WU[PGY%U"MY%X
M1F@A21D8;EC)\G@D$<&X!&>2#7UQ\*]<\3>)?A[H>I^,-#B\-^)+FW#WFEPS
M&587R>,D<9&#MR=N<9.,UC5P[I+62;6C2>J_KR.FCB56>D6D]4VM'_7G8ZRB
MJ6LZQ9^'M(O=4U&X2TT^RA>XN)Y#A8XT4LS'V !KX=T?X]_M#_M9ZUJUU\%T
MTCP)X'T^X:WAUK6HD>2Y8<X.^.7D@@[4CPN0"Q-9TJ4JS:6RW;V1I6K1HI<V
MK>R6[]/3J?=]%?$GA+]J3XK? 7XJ:+X!_:"L].O-/UIQ'I_B[2U6.,N2%R^U
M54H&*AOD1ESN(((KV[]LOXC>(?A3^SOXE\3^%=0_LO7+-K8077D1S;-\\:-\
MLBLIRK$<CO55*$H.&J:D[)K;>WX/<FGB(U.96:<=6GOM?\>A[;17P[X7^*7[
M2W[3'@_1]4^&4VC>"]#MK.&*?Q#KT*>;J]XL:BX:*/R956,2!@,(!P<-_"OV
MCX=@U"U\/Z9#J]RMYJL=K$EW<QJ%668( [@   %LG  ZTZM"5'235[[=?Z_'
MR)HXF.(LX)V:O?IZ?UIYFC17SO\ &+]FCQAXB\>W?CSX<?%35_ _B.X2,3:?
M*HN-,N3&FQ=T73. ,EED]A7)1?M!?';X*?N?BO\ "P^+M&AX?Q-X#;SCM Y=
M[<\_4GRE'I4PI*I%.,E?L]/Q>C^_Y%3K.G*THNW=:_EJONMYGUK7@?[1'[8O
MA7X!:M9^'5TZ_P#%OC2^4-;Z!I*YD ;[AD;G;N(X #,>NW'-=A\)_P!HSP'\
M;/#>IZSX2U=KZ'2T#W]O- \,UJ2I8*ZN!V5N02.#S7R%^QEXT\':>GQ(_:%^
M)FM6.FZCK.MRV%C=Z@V9(HU19'2!0"S$K(BX4$[8L=,UK2H/GG[5-*"3:ZN[
MLE\_R1E6Q"Y(>Q:;F[)]%97D_EV[O4].\$_\% 6D\8Z5X?\ B5\*O$WPP;5Y
MEM]/N[^.6:.61B  P>")@"2!E0W49P.:^NZ\C^'?[2'P@^.VJ0:?X:\4:7KN
MIV\GVBWL[J!X+@.H/[R*.=%8E1GYE!P,UZY4U[*R]GR/Y_J5AVVF_:*:^7Z:
M!17SC^WI\6O%GP7^!B^(?!NJ_P!CZP=5M[;[3]GBG_=LKEEVRHR\[1SC/%>S
M_"[6;SQ%\,_".K:C-]HU"_TBSNKB;:J[Y'A1G;"@ 9))P !62IMTW5Z)V^=K
MFSK1C65#JX\WRO;[SIZ*^2/AS\=?'&O?M[^._AS?:WY_@S3+!I[33?LD"^6X
MCMB#Y@02'F1^K'K["D_;<_:0\6?L^^//A4^AW4S:)J%U,VKZ7;VL,LE_$CP_
MNU9U+*Q#L!M(.36L</.4J45_R\5U\TWK]WF92Q,(PJS:TIMI_)I:??Y'UQ17
MQ1KUU^V=X^T>7Q9H<OAOP!9&-I[;PI(D<U^\?55<RP2+YA&."\?/55/%>G?L
M3_M)ZE^T7\.]1F\0VD-GXJT*[^Q:@MNA1),C*2;"3M)PP(Z90D8!P'+#24)3
MNGR[J^JOIZ;]F3'%PE4C"S7-LVM'97]=NZ(_[-_:#_X:V%S]LL_^%+>7_J]U
MOC;Y'W-N/.\WS>=WW<=\<5W?[2GQP7]G?X3W_C1M&_M\VT\$"V/VK[-O,CA<
M^9L?& 2?NG.,5Y-;_&[QK)_P4"N/ALVM9\%)H_VI=,^RP<2?9U?=YNSS/O$G
M&[%>1_\ !3C2/BI#X;O-2F\1Z4WPHEN[2*'1%B'VT7.PG>S>3G;N5C_K>XX]
M*C#G=",K)-+YKFMK_>>WZF<JJA'$3A=M7^3Y4U;R5TW\S[S\+:W_ ,)+X9TC
M5_)^S?VA9PW?D[MWE^8@;;G SC.,X%:E?)?[,O@C]I/3-4\'ZCXS^(/AS5OA
MW_9ZL=)L[=%N?*:W_<+N%FARI*9_>=CR>_-^-OCY\;/C=\<_%?PX^"4FD>&K
M'PJYAU'7]6C5RTH8JP^>.0 %PRJ%C8G83D#@54PW[YTZ;75^B3MK^'<5'%_[
M.JM2+OHMMVUTMWU['VQ17S;\!]2_:0\/_$$>&/BK8:'XE\/26LEPOBW2Y%A,
M;KC$9143<22!M,:<9.X[<5])5RU*?LVE=._8[*57VJ;Y6K=PHKYQ_:T_:JNO
M@;)H?A3PCI"^)?B-XB8)IVG.&9(E+;%D=5(+%FX501G#$D <^4ZE#^VWX-T>
M3Q?<ZUX6\0PP(;F;PG#;1/,%QED^2%"Q SPDQ)QQDUI3H.</:2:C'N^MM_NZ
MO8RJ8B-.?LXQ<I=4E>U]K^O1;GW)7Q)^U9\1OB/X^_:6\)_ SP#XGF\$PWUF
M+V^U>T8I,<B1SAU(<!4B.%5EW,V"<=/<?V:/VC[']IKX8W.M:9 NC^(;,M:7
M^G2/O%M<;<JP.,F-NH)'9ASBO@C7_"'[0*_ML:'I5WXW\/M\69--+VFN1P+]
MBBM_)F.PK]EQG8)!S$>6'/<=6&P[CB7"K9.*;L^ONMKU2W?EL<>+Q2EA5.C=
MJ32NNGO)/T;U2\]S]"_V>?A+XK^$'AO4M+\5_$34OB/<377G6U_J:N)(8M@&
MSYY)&^]N/WCVZ5<_:0^)6I_!_P""7BKQCHT%I<ZGI5NLL$5\C/"Q,B+\P5E8
MC#'HPK4^#.E>.=$^'.E6?Q(UFQ\0>,8S+]MU#3D"02@RN8]H$48XC* _(.0>
MO4^??MS?\FH_$/\ Z\H__1\=<5>4I5?>:>J5UL];>1Z%",8TTHII=GO^;_,\
M%\"?M'?M@?$SPCIWB?PW\+/!>I:'J"-);77G"+S%#%2=CZ@K#YE(Y Z5T?@;
M]N;QAX3^(VD^"/CK\/1X'O=5D$5KK%FS"T+%@HR&9P4R0"ZR-M)&1CD>I_L)
M?\FE_#O_ *])O_2F6OGK_@I)XIT?XG:M\._AKX6NH=;\;-K&\PV#B5[5778%
M<J?E+$AL'D!,G Q7K6IRQCPOLUR\S6E[VO:^_3?8\2#JQP$<9[5\W*I:V:NU
M>UK7UV6MSZ=_:U^,>M? ;X'ZQXR\/VMA>:I9SVT<<.I1N\)$DRHV0CHV<,<?
M-UKYY\*_'[]LCQMX9TWQ#HOPG\%WVCZE;I=VMP)U0R1,,JVUM0##([$ ^U>D
M?\%&XS'^R+XC1CN*W%@"?7_28ZY+]G_]N7X)>!?@;X'T#6O&AM-8TS1[>VNK
M4:5>R%)4C 9=RPE3R.H./>N?#0_V><XPYI*=MF].5/IY_F=6*J?[3"$ZG)%P
MONEKS-=?+\C7^"O[;.N:M\5K7X8?%OP-)X#\87G%G-&S?9KESG:NULE0VTA6
M5W5CQQ7U7K&L67A_2KS4]2NHK'3[.)I[BYG8*D4:C+,Q/0 "O@.3Q0_[;W[7
M7@#Q%X'T:^A\$>!95FO/$-[!Y2S.D@EV*/4D(%4_-AF8@ 5W?_!4/QUJ&A_!
MS0?"NG2-%)XGU18)RI(W0Q@,4SZ%S'^ -35H\[I1C'EG/1KMK9/YK6Q5'$<B
MK2E+FIPU3[Z7:OMH]+E.Y_;B^)'QA\07^G? 'X6GQ1IUC(8WU[7"8K:0CV+Q
M*F1@@-)N(.2HK=\"_M;?%+PKX^T+PA\;/A5-X>GUZX6UT_5O#RM<6QE8\(RJ
M\H/<DK(2 ,[<<CZ+^$/PUTOX0?#?0/"6D0K#:Z;:K&S*N#++C,DC?[3,68_6
MNN>-)&0LBL4.Y2PSM.",CT."?SJ)5:$).$(7CW=[OSOT^XTA2Q%2*J3J-2?1
M)67E;=_>/HKYN_;$_:4\0_!6/PEX8\$:3#JWCGQ==&UT];H$Q189$W8R S%I
M% R0!R3P,'SR*#]M3X<R6^N7^H>%?B39%U\_P_:I%#*B$C.UE@AY XR&?'7:
MU94\/*I!3;23=E?K;<WJXF-.;IJ+DUJ[+:^U_4^U*^<?VUO&6NZ?X7\&^"?"
MFK7NB^)O&GB"VTR&^TZ=H;B" ,&FD5U(8 #8#@]&-?1%G)/)9P/<Q+!<M&IE
MBC?>J-CE0V!N .1G SZ"OEP ?%K]OS/$VD?#/0>W*KJ%WV/OY;'\8ZG#Q7MH
M\VT?>?\ V[K^+LOF/$2?L)<N\M%_V]I^";?R/8_C+\:O"O[.?P_&O^*;RX-K
M%MMK:",^;=7DNWA$W$;F(!)9B!P237S5_P /'M:T^WBUS6?@/XNTSP/(0Z^(
M=SLIB8_*X#0+&<Y''FX]ZW_^"AOP]UO7-%\ >-=.T>3Q)I7@W5OM^K:/&"S3
MVQ:-F;;W $14\<!R>@-=AJG[9WP5\6?!G7-=_P"$FT^YLS82)/H%X52^<LA7
MR/L['<Q).W*Y7ONQS6U.,?8NLX<\KNZ[;6V_F^[IN8U)2]NJ*G[.-E9V6NKO
MOIIIIOJ>T_#WX@:%\4O!NE^*/#=ZNH:-J,7FPS*,'J0RL.JLK J0>A!KHZ^:
M_P#@GO\ #W6_AW^S9I<&NP2V5SJ=Y/JD-E,"'MX)-HC4@]"0N_'^WSSFO>O&
MEOJMUX/UN'0KPZ?K;V4PL;I8TD\J?8?+;:X*G#8X((K'%PA0JSC%W2_K\#?!
MU)XBE"<U9O\ J_SW-JBOFG]@OXZ^(OCA\)]4F\8WWV_Q5H^JRV5W*8(H&*%5
M>,E(U51C++P/X*\G^+G[77CGPE^UU#I.G:CY7PMT?5M-T/6H3:P,AGN4=F8R
MLAD& &/RL!^Z]^=?JE1U_JZM?\.EOONEZLQ>-IQP_P!9:=OQZW^ZS;\DS[NH
MKR3]JWXJ7?P9^ 7BWQ3IUR+35[>W6&PF**^VXD=8T;:P*G!;=@@CBJWPE^(V
MI^&?V7]#\=?$_6C=7RZ/_;&I7S6\<3;'S(B".-57(1D0 #)(]37,H-TY5>B:
M7S:O_7JCJ=1*K&CU:;^2:7Z_@SV2BOAG0OB-^U/^T];OXH^'$F@_#+P3)(PT
MUM8C26>]C!(W$M#,3R.H1%[ MC->A?L^?M">/H?BQ=_![XS:;96GC-+3[;IF
MK:: +?4X5!W' XW8#,"H485@54KST/"S2:;7,M;7UTW^[U.58RG)II/E>G-;
M371?>^MK'U)17SW^U'^TUJ'PBO=!\&>"-%7Q3\3/$C;=-TQLF.%,D>=+@C(R
M#@94?*Q) 4Y\CU3_ (;3^'NDW'C+4-:\)^*K*UC-U<>%K>W0RK&!EE!2",L5
M&?NS,3CC=T.=.BYQYVU%=WU[_=WV-:F(5.?LXQ<I=DKVOM?UZ+<^WI.(V(]#
M7QW_ ,$UO'?B7QWX)\>3^)?$.J^(9[;7/)@DU6]ENFB3R@=JF1CM&>PXKZ#^
M!?QCTSX]?"G2/&>EQ-:QWL;+/:.VYK>="5DC)[X(X/<$' SBOES_ ()9SQVO
MP[^),TTBQ0QZ\7>1R JJ(0223T %;TJ;IQQ,:BUBH_\ I1C.HJKH3INZDW_Z
M3(^YJ*^0_!7QP^('[3G[0%S#\.-;?P[\'_#+B'4M76R@F;5Y@<^7$TL;;0W0
M%<83YCRRBNF_;"_:2\3?!^Z\(>#O .DP:IXZ\77!@L3=C,4(W*@.,@%BS@#)
MVC!)R.*Q^KSYH0^U+9=?GVTU]-S;ZS3Y:DW\,-WT^7?73UVN?2U> ?MK>%=<
MU+X/MXI\+7MU9^)/!EU'X@M%@E8),L)S(CH#AQLW'!_NX[FO+;:']M'X;W5K
MK&I7OA7XFV$DJ+<:':K'!+&C, 2'$$)!&>H+XZ[2 :^Q;BS&K:3+:WT*!;F
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M#X/\5:G%;P:AK&F07L\=HK+$KN@8A S,0,GN3]:\7_X*1?\ )I?B?_KZL?\
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M+P)HNJVUCX-\.:CXQWRA)+NXE_LZ *>,IN1W8^S(OUK[:C;?&K8QD9K\[?\
M@I9\+?!GP_\ #7P\N/"_A'0O#<]QK$B32Z1ID-JTJA%(5C&H) /8U^B$'^IC
M_P!T?RKT:T:/L(3I)K5IW\E'Y=3RJ$Z_UF=.LTU9-67=M>O0^6/$VM7WP&_;
M2T:[N+VYE\&?%"V73Y$N)F>.TU*'B+9DG:&W*H48&9&]*^JZ^4_^"DFDNW[/
M</B2URFI>&M:L]1MIE^]&V_R\_FX/X5],>%]:3Q+X9TC5XL>7J%G#=KCIB1
MP_G6+7/AXSZQ;C^37X.WHD=$7[/$RATDE+\7%_DGZMFI1117*=@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\\8VGV.2TO+K4CEIUDSO4#)*H-Q"@DD#')Q7RQH/P,_:/_9+U#4M-^#[Z/\
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MC..%4.5IJI>V^G,W]WG\STO]L15?]E_XEA@&']C3'D=Q@BN=_8!_Y-(\!?\
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MI5TWNHV^]GI8F,I5\.TM$YW\KQ5KGD_P5_Y2??%__L"-_*PKT?\ X*2?;?\
MAE'Q!]DW>7]LL_M.W/\ JO.7T[;ME<3\;OV>_B_X$_:4N/C-\%[;3M>N]4MQ
M!J&CZA,D8SL5&!WO&&0B-&X=6##TKW3P%X;\;?%SX+ZUH7QRT+2M/U'6&FMY
MM/T>7=&ELRKL.=[X<-N((9NBG-:U&I4J%2+7N**:ZWB_ZU,Z:<:N(I237M)2
M:=M+27?NNQ\Q_"/X>?M>:I\+?"5WX3^+/@RS\,S:7;-IMLUK$6AM_+78C?\
M$O;YE& ?F/(/)KJ/ _[,'[05_P#M">!_B)\3?''A;Q!'X=,D>[3PT4_DNCJ4
M54M(E;)?^(\ GZ5C^&_A)^U%^RK]H\/?#)]#^)7@@RO)86>L2)'):!CDY#RP
ME223D+(RDY. 6->V_ '3_P!H35/%USXC^+.H:#HVC26C00>%-)B$ACE+*1*9
M S8( (_UDF03PO6NVI6]Z5:FX6U:T][7IWOT."C0M&-&JIW5D]7RZ?A;J>.?
MM>?\GP?LZ_\ 7S%_Z5"ON6OD7]M+X%_$CQC\1OAM\1OAEIUGK>M^%IB6TZ\G
MCB#$2+)&W[QT#+D,& 8'D8]OJ?PS<ZG>>&]*GUJTCL-8EM(GO;6)@R0SE 9$
M4@D$!L@')Z=37G2:>$II/5.5UUU=T>E",HXVK)K22A9]-%9_B>'_ +?G_)I'
MC_\ ZY6O_I7#7.?LA_ KX:^)OV:_ &J:O\/?"NJZE<Z?OGO+[1+:::5O,<99
MV0EC@#DFO0_VO? &O?%#]G;Q?X8\,6']IZY?QP+;6OG1Q;RMQ$[?/(RJ,*K'
MDCI6C^R[X+UGX=? #P3X;\0V?]GZUIUCY-U:^:DOEOO8XW(Q4\$=":*4^7"U
M$G9N:^[E_(=2GSXJ#:NN67I>\?\ @GC'[;GP/^'/A/\ 9?\ &^JZ)X \+Z-J
MEO%;F&^T_1K:">+-S$IVNB!AD$C@]":]2_9(NHK']E7X=7,[B."'0HI)'/15
M"DD_D*D_:]\ :]\4/V=O%_ACPQ8?VGKE_' MM:^='%O*W$3M\\C*HPJL>2.E
M:/[/_@'4?"O[._A'PAXELS9:E;:.MC?6HE1S&Q4JR[T)4\'J"12]I)X.I%N\
MN=6O_A_*Y2IQCBX24;1Y7>R\XGS)I'QV^/G[7VM:R?@X^E> ? 6GW1M1KVIQ
MA[BX( ./F1_F*D-M1!MR 7YKQGX[?"?QW\(_VA/@?/XU^)5]\0=2U#6H9H6N
MD=8['9=6^5C#.PPQ8$X5?NC@]O4OA]\(?VH?V4+W6/"_PUT?P[XW\&7MXUU;
M7&I3QIY!;"[BK3PNK;57<!O7Y>.IS!\0?V2?CGXP^)'PW\?>*-8A\9:]!K<,
M^HZ?I\T5O8Z+9I+&X$(D9"YX?=M4DX'WCR?7P\J5'$4I4Y15/3?XGIUZK7T1
MXU>%:M0J0JQDZGE?E5G?3H]-.KN:G_!4C^V/MGP?%A=06-O_ &M-LNKI<P0W
M.8?+>0%6&T#<>0> W!Z5T/\ PJW]MP\CXP^"B/\ KTB_^5M?0G[17P$T7]HS
MX:W?A75Y6LI=XN+'4(T#/:W"@A7 /48)!7(R">0<$?-/A^W_ &T/@WI\/A;3
M-&\+_$;2K-1#::Q?7*>8L0X526N('.!_>5C[FN'#U$Z"I+EYDV_>ZI^;V:V]
M+=CNQ5)JO[5\W*TE[K=TU?=+=:_)W[G:?LO?LV_%CX<_&[Q9\0OB7XFT#7[O
M7M-%K.^CEU>257BV,R?9XD "1D9'//U-<3\-?^4I7Q$_[ ?_ +2M*^C/V>=#
M^+>EZ1J]Y\6]?TK5=4U"X6>UT_2H L>G)MP8MX W=N,'!!^=L\>6>!_@AXUT
M?]OCQG\1KO1?)\&:AI7V:VU+[5 WF2>7;C;Y0?S!S&_)4#CW%5"I^_ESM65.
M25M%TLE^7Y Z-J"Y%*[J1;OJ]]6_S_,]+_;$57_9?^)88!A_8TQY'<8(KE?V
M$+&WU3]CGP597<2W%K<6UY#+$XRKHUU,&4^Q!(KT3]I'PCJWC[X#^./#N@VG
MV[6-2TR6WM;;S$C\R0CA=SD*/J2!7$?L\_"'Q;X6_9%TKP#JEU/X+\6"RN[9
MKJV>*XDLGDGE9'4HQ1CM8'AN_4'IQQDOJM2+W;CI\I'7*,OKE*2V2EKVUB>7
M+^RK\8?V=+Z_N_@+XXM;SPU<3M=/X-\2H&C!_NQR$$9/ R#$2 -S-C->D_LO
M?M47GQHUKQ#X+\7^&V\(?$3PZ,ZAIRL6AE7<%+QY)*X8KE26X92&8'CRVS_X
M;3^%-N/#UAIWA?XG6,(\NWUR^G19Q&.%W[YX&9L<DLKG/\35V?[,'[./CCX<
M^)/&_P 4OB#J%GK7Q(\20%!963 0PJ,-Y9? 7)9(UP/E4(/F.>.R;BZ<I5I*
M22T:^*_3S];G%!252$:$)1;>J?PVZZ[>EOF1_MK_ !RUC2X=*^$'P]8W/Q%\
M9$6P\A\/8VK9#2$C[A8!@&_A4.W85[!^SQ\#M(_9[^%^F>$]+VSS1CSK^^V[
M6N[E@-\A]N  .RJHKX<\ _#?]K/P#\6?$GQ(7X5Z#K_BS6\A[S6M2M9?LB$\
MI $O4V#:%7G)VJ ",G/T#\-/B)^UKJGCW0[3QI\+_"FD>%)KE5U&^L[F-IH8
M>[(!?N2>G\#?2AT>6BJ<)QN]9:K?HO1?B]1+$<]=U:D)66D?=>W5^K_!61\_
M?$+2OBIKG_!13QC9_#SQ)I7A;Q4^FQ_8KS68U>)[06\!:.,-#*-QP3PO17YZ
MY]6O/A%^VO?6LUM<?%[P5)!,C1R(;2/#*1@C_D'>AKT']JC]E'4_BQXBT3X@
M> ->7PI\2]! 6UO')6*Y122J.P!((W, <,"&*L"#D<%:^)/VW=4C70I/"O@S
M2"P\H^)Y98F*]O-V+<.,]\>1_P !ITZBJ4(07+>*LU)+IU3??JNX5*3IUYSE
MSVD[IQ;[+2RVMT?:W8]7_9.^!_B+]GOX#77A+Q-J&GZA?I<W5TCZ9)(\*1NH
MPH+HASD,3Q_%7C__  2F_P"21^-?^QC?_P!$15];> M#U_2_A_I.E>+=8BU[
MQ!%:""^U.WA\E;B3&"P7UQWXR1G S@?+O[%/P9^+?[._CKQ9X2UW0]/E^'5Y
M--?6^NPW,32R7 *+'A!)O"M&#D-'PP'S8ZQ&I[1XCGDKR2L]D^5]/EMW-?9*
ME'#\D7:+>F[7,NOH]^B/LFOACXS?\I.?A+_V"?\ V2\K[GKY'_:^_9Q\?^+/
MB9X.^+'PJEM9O%_AY%A;3KN18Q.BNS*5+D(?ONK*Q7(/!KFPDXTZ\92=EJOO
M31UXR,IX><8*[TT]))_DCUW]K;[;_P ,S_$K^S]WVG^Q+C[N<[-OSXQ_L;J^
M+_V6/ _[4&O_  .\/7?PU^)OA/1/"!,ZVNGWEM&T\#"9_,$A-C(<E]S<N>&'
MTKZ_^ =]\8_&FD^(XOC;X6T#0X+A$@L[#2I!()(R'$PE FE&""F/F]>!7@-K
M^SG\>?V4_$FJR_ N]TWQ=X)U*<W \,ZY*JM Y&,_.\8X  WI(I8 ;E.T&NF@
MU1]I1DU=V:>\=+Z?COZHX<1%U_9UXJ5E=-+26MM5]VJ(-:_95_:>^(WC#P5J
M7C_XB^#];L?#>KP:E"MNAAECVR(SE/+LH]Q(7@,V,@=.M?0?[2W[+NF_M"6N
MC7\.M7GA3QAH,AFTG7K')>!LAMK*"I(W*""&!!&0>H/(_!Z']J#Q=\0-+UOX
MCR>&O!/A:Q\P7'A[3(UGDOBR$ EEDDVX)!SYO! ^0UI_M%?#KXW7?C+3/&GP
MD\:PPO8VOV:;PGJBA;2Y&[<6!(*EV^4?-M( ^5UR14U*D^>G'FC&UW>/1OO;
MO9?)ZETJ</9U)<DI7LFI;M>5WTNWTUV/*->^-_[0O[),=M=_%33=*^)/@(3K
M!+XAT?$-W"&.$W@!1G'9DPQP/,R<GV/]JWQ%8^+OV-O&FN:7-]HTW4M!2\MI
M<8WQ2%&4X[<$5X/XX^'?[5_[4>EQ>#/'FD>%_AYX3DGCEOKJRE25YU1@0-J3
MS,Q!&X+E 2!DBOJ_Q5\%=+U_X"W?PNMYY+32VT5=&M[AOF>-4C"1N?4@JI([
MXJ<3R^RO*W/?[/:W6VE[]B\*YNK:/-[.WVNCOTOK:W?J<7^PC_R:7\._^O2;
M_P!*9:]ZKX1^!/A']K+X%VND_#VS\->%]5\&6-[D:S=7:,R6[2[Y%CQ,KX.7
MQNA)&[TQC[NI8U)UI58R34FVK??KVW#+^:&'A0G%IP23NNRMIWV/G?\ :'_9
M-?XK>,-*\?\ @[Q5=>!/B-I4?E0:K;J7BG09PDJ@@_Q,N1D%6(96& /+Q^T_
M\8_V9_$VB:/\>]"TS6?#&I3BTA\9:#\N'[M(@ 4X'.W9&<!B-V,5VOQH\!_M
M%>&?B;?^-_A5XKLO$FDWD<:2>#=<VI%%L7 $62JX))8L'C;G!+#IYCKOP-_:
M)_:TU[P_:?&2ST'P+X)TF\6[GT[295DENB!@[0LLWS$97+. H8G:QXK;"\K4
M55E%PZI[KO;K]UT8XJ\92=*,E4Z-;/M?I]]G8[__ (*;,&_99NV4Y!U6S((_
MWFKW[X)_\D9\!?\ 8 L/_2>.N8_:B^![?'[X*:QX.M+N.POY/+N+&:;/EK-&
MVY0^ 3M(RI(!(SG!QBO%_P!G-/VI_!^I>$_!GBWPMX<C\"Z.%M)]::ZC>[EM
M40J@79.<D#;C,0)"\GJ:QHJ,\/.GS)/FOKIIRV_I&U;FIXJ%9Q;7)RZ:Z\U_
MN\SF_%RAO^"JWA#(!QH3$9'3_1;FON2:9+>&265@D<:EF8]  ,DU\J^(O@CX
MUOO^"@'ASXDP:+O\%6FDFUFU/[5 -DGV>=-OE%_,/S.HR%QS7U1=6R7EK-;R
MC,4J-&PSC@C!K+$2O1I*.ZB_OYI&V&BU7K.:T<E]W+'8^&;#X^?'?]KCQ)KM
MO\%6TKP1X%TNY-J?$>J('FN&'.!N23!*D,%5/E!&YQD5XI^T9\(_'WPF^,'P
M;O/&_P 3;[X@:AJ&LQO"MQ&ZQ6)2X@SY89V&&W#.%7[HZ]O5O OP9_:;_9-U
M;7?#WPNTCP_XW\%:A>-=V[ZG/&GD$@+N96GA</M500"ZG;D=:J?%']DGX[^/
MO&'@/QUXIU>W\7^(H=:ADN](TV:*WL=&LED1_P!WYK)O;(.=H).!R_6O7P\J
M5&O2E3E%0TW^)Z=>VOHK'C8B-6M1JQJ1DZFNU^5:Z6[Z>K;/HC]OS_DTCQ__
M -<K7_TKAKH?V/?^37_AI_V!8?Y&NF^.OPNB^-'PD\3>"Y+G[$=6M?+BN"NX
M12JP>-B.X#JN1Z9KY;_9^\/_ +6'PA7PW\/[GPQX9O/ ^F7B1R:W/=QO*+/S
M=TBQE9@WW2VW=#D9%>9ATIT)T>9)N2EKII:QZU=RIUX5>5M6DM-=6XM?D1_M
M0?\ *0#X!_\ 7-/_ $?+7MO[<W_)J/Q#_P"O*/\ ]'QUQ?QX^"/C7QG^V!\(
MO&^C:+]L\,:"BC4;[[5 GD8E=C\C.';AA]U3UKU+]JSP-K?Q*_9]\9^&O#EE
M_:.MZA:I';6OFI%YC"5&(W.RJ. >I%92DOJ]&/5.7_I9<(OZW6E;1J'X1,K]
MBC_DU;X<?]@W_P!J/7@_[/O_ "DD^-G_ &#7_P#0[2OI3]EWP7K/PZ^ '@GP
MWXAL_P"S]:TZQ\FZM?-27RWWL<;D8J>".A->2?!WX(^-?"O[;?Q1\?:IHOV7
MPEK5DT-AJ'VJ!_.8M;G'EJYD7B-_O*.GN*[>>/URO*^CC.WG=JWWG![.?U'#
M0Y7=2IW7:R=[^G4\/_:BL?'^J_\ !0CPQ:>"-<T_PYXFET6-=&U#5D#VZ#R[
M@R##12C<W[U1\AY(Z5Z7_P *L_;=_P"BP^"__ .+_P"5M>G_ +6/[*__  T!
M8Z/K6@:P?#/C[P\_FZ3JH+*I^8,(W*_,H# ,&7)4YX.2*\KL?$G[;UE"F@R>
M$_!UZ5'D_P#"33S0[CV\TJMPOU_U'_ :*513HQ@N7FC>_-;NVK-^NJ[CK47#
M$3G+FY96MRM]DFFEZ:/L;?P9^ ?CG]G?]FOXPV'B35M,U'6M4AU#5+9]$=V1
M9&M""?GBCPQ9>@7 P/I3/^"7$>GK^S5,]H$^V-K=U]L*CYMX6/;G_@&ROH?X
M2^&_%VC?#>QTKXB:Y:>*_$A607U]:V_E12!V8[,8 8 ';G:N0!\HKX_M_P!F
M_P"//[*7CW6[_P"!?]E^+/!VL3>:?#^JSHGDGG:&$DD?*@X#I("PQN' J8U%
M4G6ISDDY**36B]WI]VQ<J;IPH5(1;4')M/67O=?/7?KJ=?\ \%4_^3<=+_[&
M*V_]$7%?5O@;_D2?#_\ V#[?_P!%K7P=\>OV<?VD_P!HGX?R:QXQN--&KVDT
M1TSP)H,T45NI+8DFEEDEV%E7.!YC]3@CD'[X\*V4VF^%]'M+E/+N+>SABD3(
M.UE0 C(X/([5G*,:>&<.9-\U]/\ #^/Y=#:$I5<4JG*TN2VO^)OY>CUZFE+_
M *M_H:^(/^"5?_(@_$7_ +&#_P!I"ON"0%HV ZD5\K_L _!/QI\$_"/C2R\:
M:-_8USJ&L?:K6/[5!/YD7E@;LQ.P'/8X-98>2C3KIO=1MY^\;UXMU*+2VD__
M $EGFL.S_AZY-_;FW=_9/_$HW],_8AC&>^//Z=\U]YU\V?M8_LIZA\9M3T+Q
MMX(UI/#'Q(\/$&ROI"5CG16W*CL 2I5B2&P1\S @@Y'ENK?\-L?$#19?!][H
MOA?PM;7,9MKCQ1;W,2S,A&&;Y)Y"I89Y2%2,\;:TY5B*-.,9)."Y6F[=6T_G
M?7J<_,\-6J.46XS:::5^B37X:=#/_P""=^W_ (7Q^T!_96?^$=_M(>3L_P!7
MG[3<^7CM]W=CVQ5WX+*&_P""H'Q=) )716(R.G%B*^B_V8?V=-)_9J^'*>'K
M&Y.I:E<R_:M2U)DV&YF( X&3M10, 9]3U)KR_P"%_P #_&WAW]N_XC_$34-%
M^S^#M7TLVUEJ7VJ!O-DQ:?+Y:N9%_P!5)RR@?+[C/3&K3^L2L]%3<;]W:*_'
MIY'/*C4^KPO'WG54FEK9-R_+JSZNIDO^K?Z&GTR7_5O]#7A5?X<O1GN+<^(/
M^"5?_(@_$7_L8/\ VD*],_X*+7%A#^R;XK6](#R36:6P/4R_:(R,?\!#?D:^
M/_V+?#_QLM]!\9>*?A#K.EW/V75C;7WA76EQ;WOR;ED1L@*_./O)P!ECTKV*
M_P#V=_C_ /M9>+-'?XXOIG@SP3I<XG;0='F1VN&'4J$DEY897>\A*@G:O)KZ
M'%48SQ2G*:27(WWT2>W6]NAX=*O*%&<(TVVW-+L[M[]EWO8]8\ PW=O_ ,$[
MX4O01/\ \('<L <_<-K(8_\ QPK5+_@FBH7]E31R  6U&])P.O[TC^E>Z?%#
MPG-JGP9\5^&M!LE:XN-!NM.L+.-EC7<UNT<<8+$*HR0.2 *\V_8=^%_B?X/_
M +/VF>&O%VF?V1K4-Y=2O:_:(IL*\A*G=&S+R/>N7VT:GUB>W,TU][9T*C*G
M]6AORJ2;^45^-CC/^"G'_)K=Y_V%K/\ ]":MCXN?;/\ AWO=_8,^?_PA-INQ
MG/E_9XO,_P#'-U:G[=7PJ\4_&3X"7/ASP?I?]KZR^HVTZVWVB*#*(3N.Z5E7
MC/KFO5/ /A-K?X0>'/#.O6:EX]"MM.O[.1@ZY%NL<L9*D@C[PR#CT-<ZDOJD
MH]>>]O\ MU?@:RBWCX3M[OL[7\^=_C8\A_X)Y_V=_P ,E^#/[/V[MUW]JVXS
MYWVF3=N]\;>O;%>??\%5?[._X9_T;[3L_M#^WH?LG][_ %4N_'MCK^%8.F?L
M^_M ?LF^(-73X(S:5XV\$:E.;A-!UN54>V<C&3ODB&0 !N20;@!N7@5?\/\
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MX/\ VO/ OQ"\2:M)XYB-K<3Z]KQFBBCM;AX+B-8(HF<2&,;H@-J ?,>%' ]
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M6;X$_9^^,_QI^.'A?XE?' Z1H%IX7?SM-\.Z2ZN?-!#*<J[@+N"L29&)V!<
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M@EXT^-W@_P &6/@K1?[:NM/UC[5<Q_:H(/+B\LC=F5U!Y/09-?4\2E8D!X(
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M_P#T4M?%7[-3!O\ @HW\;R#D?9+CI_UWMJL_#W1_VS;'PQ8_#R2Q\,Z!I5G
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MW]MS[;_PRK\1OL&?._LX;\9_U7FIYO\ XYNK-_8%_LW_ (9.\"?V;MV^5/\
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MNCO=WZ_(]&_87^._B/XO^"?$.B^,9$N_%/A'4/[-N[^, "Z7Y@CG  W91P2
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M+(RDY. 6->V_ '3_ -H35/%USXC^+.H:#HVC26C00>%-)B$ACE+*1*9 S8(
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MCSMDD26%689 ."03R.]9?AFX_;%^(FO:9#K]IX1^&&CVMS'/=7%LJ74MU&K
MM&$6>;(.,$;H^,_-7M'[4OPIU#XU_ ?Q3X1TJ2*/5;V%'M?.;:C2QR+(JD]@
MVS&>V:PK5)1Y(MQMS)OE\FM=/+YZ>AOAZ<9.4TI7Y6O>OUOIKY_GZC?V5?\
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MJCHRFXZSJ1E;>RYXO\$KL^K****\@]T^#OV,_P#D]O\ :'_Z^KG_ -+35O\
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M9_C7ZUP3K.<.3E7R6OWGIPH*%1U.9N]]&W;7R_(^.O\ @JU_R*7PT_[#4O\
MZ+6ONF#_ %,?^Z/Y5^;'[07P]_:V_:0T[0[+Q-\+-!L8M'NFNX#I.HVL;,Y
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MW?\ 4****P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17P3\5(1\ ?^"C7@SQ8O\ H^B>.H!97;9P
MIE<"!L_1Q;N?K7WM6\Z7+3A53NI)_)IV:^7<YX5N:K4I-6<6OFFKI_\  "BO
MA3X;1?\ "^/^"C7C#Q0V+C1/ %H;"U<'<@G ,('_ 'VURP_W!7T#^V/\4/\
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M-=2Q@C(WK"CE,@@C=C(.:]$\+>*-*\;>'=/UW0[V/4=(OXA/;748(61#T(R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF,(-1C>.JCY2C:_WNVAYY_P2J_Y-TU;_ +&*X_\ 1%O6'\-?^4I7Q$_[ ?\
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M_9.D\"WP\&^/O#/A[Q9:0-/8:K!XR2:0W"#<FY'G*\L!]T*1GC%<K^T)\//
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MRG_C_P#;4>O4_P"1A#_KV_\ TMGSAX!_Y2J>-O\ L$-_Z36U;'[='Q3N-?\
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M5;NDD.GRUZE6J]8VY5Z)>]KVNY?<)\)_AY:_"?X;^'?!]G=S7UMH]HEJMS<
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M42WFO7,!PTB%6D*GGE5C3(4\,SC/04OP5_Y2??%__L"-_*PK+^.>J1_L[_\
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M***Y#N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img175210594_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img175210594_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& , # 2(  A$! Q$!_\0
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MR?*F+VQSV4C:/Z5M07O\W;4PQ4>>C*FOM)K[T,\,H+KP;J< &7CF\W_QU?\
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
